data_6e9m_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6e9m _Structure_validation_residue.Date_analyzed 2019-08-02 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.2 m95 . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.927 0.394 . . . . 0.9 111.079 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -66.55 108.95 2.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.631 -0.713 . . . . 2.73 110.463 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -108.97 25.99 11.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.676 -0.693 . . . . 2.09 110.448 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -20.08 62.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.903 -0.59 . . . . 3.61 111.414 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -69.06 -20.41 64.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.123 0.487 . . . . 2.26 110.699 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.65 7.09 87.25 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.836 -0.62 . . . . 0.95 112.637 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 m -70.96 -27.46 63.75 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.783 0.29 . . . . 2.08 111.783 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.1 t -108.53 141.64 40.14 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.93 -0.308 . . . . 1.19 110.383 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.491 ' OD1' HG21 ' A' ' 13' ' ' THR . 9.5 p30 -93.22 -19.87 21.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 1.66 112.129 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.491 HG21 ' OD1' ' A' ' 12' ' ' ASN . 19.8 p -108.86 -31.11 7.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.914 0.388 . . . . 1.12 111.957 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.13 2.09 56.96 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.749 -0.739 . . . . 0.43 111.943 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.494 ' HD3' HG23 ' A' ' 74' ' ' VAL . 78.3 mttt -94.87 89.23 5.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.127 0.489 . . . . 2.19 110.443 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 mp -93.61 128.56 39.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 1.12 109.999 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . . . -137.16 156.75 47.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.517 -0.31 . . . . 1.06 110.301 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 50' ' ' THR . 82.4 m -91.91 97.66 11.1 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.278 -0.638 . . . . 0.74 109.278 173.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 82.4 m -111.64 155.65 23.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.963 0.411 . . . . 0.5 111.066 -171.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 20.5 t0 -98.24 127.82 44.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.033 -1.099 . . . . 1.65 108.033 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.7 p -92.69 1.88 57.03 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.362 0.601 . . . . 1.12 110.501 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -105.55 -25.05 12.46 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.982 -0.748 . . . . 2.85 108.982 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 26.2 mtmm -102.32 135.9 43.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.204 -0.907 . . . . 3.03 110.092 176.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -139.96 164.45 29.97 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.561 -0.745 . . . . 2.7 111.954 -176.236 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -117.88 148.49 20.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.609 -0.723 . . . . 1.3 110.123 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -83.88 -21.43 31.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.317 -0.401 . . . . 3.31 111.191 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.9 mmpt? -94.13 136.21 34.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.349 -0.611 . . . . 4.49 109.349 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 p -156.92 96.65 1.62 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.799 0.333 . . . . 2.89 111.632 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -122.16 -69.12 0.85 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.758 -0.377 . . . . 2.23 111.475 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.37 77.87 0.49 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.974 -0.85 . . . . 1.39 110.974 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -103.43 20.55 17.62 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.449 0.537 . . . . 3.06 112.449 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . 83.8 mt-10 . . . . . 0 CA--C 1.518 -0.265 0 C-N-CA 120.102 -0.639 . . . . 2.44 109.948 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.488 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 26.1 mt-30 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.252 0.549 . . . . 1.94 111.622 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.4 t -100.14 123.08 52.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.171 -0.922 . . . . 1.98 109.713 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.04 100.48 9.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.637 -0.71 . . . . 1.06 110.658 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 12.2 pt -100.88 149.64 6.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.918 -0.583 . . . . 1.06 110.591 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.79 126.63 30.2 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.768 -0.827 . . . . 2.55 108.768 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -126.07 158.64 34.9 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.88 -0.6 . . . . 1.15 110.203 -172.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 5.2 t -160.59 127.57 4.26 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.24 -0.436 . . . . 1.16 110.116 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -116.4 107.64 15.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.496 0.665 . . . . 2.08 111.044 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mt -64.6 134.29 95.97 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 114.855 -1.066 . . . . 1.51 109.665 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -32.33 101.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.699 3.599 . . . . 1.11 114.259 -170.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 54' ' ' LEU . 3.9 pp -75.82 142.15 42.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.15 -1.387 . . . . 2.15 113.099 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.1 mp -91.68 145.26 24.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.359 -0.837 . . . . 2.07 109.288 167.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.4 136.17 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 2.56 110.778 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.12 -7.77 69.93 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.577 -0.738 . . . . 1.09 112.865 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -81.75 160.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.372 0.605 . . . . 1.29 111.762 -175.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' N ' HG23 ' A' ' 58' ' ' ILE . . . -90.07 129.95 36.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.032 -0.985 . . . . 1.34 111.202 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 61' ' ' GLU . 8.6 tp -53.92 -36.66 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 114.984 -1.007 . . . . 1.49 112.353 -177.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.461 ' N ' HG22 ' A' ' 60' ' ' ILE . 8.4 pt-20 -78.13 -21.83 49.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.744 0.307 . . . . 2.2 111.432 -174.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.91 -26.57 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.079 0.466 . . . . 1.98 110.599 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.485 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 9.7 tp10 -68.63 -35.01 76.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.802 -0.635 . . . . 2.09 111.136 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.9 p -127.39 154.44 45.0 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.872 0.368 . . . . 0.6 110.902 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -98.84 56.07 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.871 0.843 . . . . 2.81 109.726 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 52.1 m-80 -137.86 -170.38 2.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.129 -0.941 . . . . 1.39 108.727 175.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.0 m -89.35 126.09 59.63 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-O 121.114 0.483 . . . . 1.12 110.592 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.94 120.44 4.65 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.686 2.258 . . . . 0.65 111.079 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.792 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 2.8 p -120.59 157.85 28.62 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.884 -0.598 . . . . 1.1 111.567 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 34.0 t -108.97 104.51 13.76 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.206 -0.664 . . . . 1.26 109.206 170.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.476 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 92.1 m -87.38 139.59 30.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.359 -0.608 . . . . 0.29 109.359 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.1 tt0 -71.57 -31.24 66.76 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.064 -0.717 . . . . 1.69 109.064 174.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 32' ' ' GLU . 6.9 t0 -156.33 164.02 38.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.866 -1.161 . . . . 1.26 107.866 171.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.549 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.4 t -137.01 139.12 45.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.652 -0.419 . . . . 1.59 110.022 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.521 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 10.1 tt0 -100.13 159.01 15.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.156 -0.475 . . . . 1.87 109.963 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 78' ' ' GLY . 41.4 m-20 61.73 -151.22 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.066 -0.515 . . . . 1.94 110.133 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -79.65 16.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.083 0.468 . . . . 2.12 110.579 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.549 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 110.49 21.76 6.72 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.813 -0.63 . . . . 0.53 112.3 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.92 -21.87 31.72 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.758 0.281 . . . . 1.77 111.758 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 21.7 t -127.72 103.63 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.898 -0.321 . . . . 1.1 110.43 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.476 ' HA3' ' SG ' ' A' ' 71' ' ' CYS . . . -91.84 123.79 7.37 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.057 -1.068 . . . . 0.26 112.265 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.45 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -86.43 118.34 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.671 -0.492 . . . . 1.07 109.671 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 92.9 m-20 59.99 41.78 16.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.34 110.764 174.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.792 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -81.21 109.97 16.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.81 110.457 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.2 m -94.17 130.27 34.71 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.776 -0.647 . . . . 1.14 109.698 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.62 109.96 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.715 2.277 . . . . 0.59 111.442 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 5.5 pt -74.66 141.66 76.28 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 115.623 -0.717 . . . . 1.21 111.26 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.3 Cg_exo . . . . . 0 N--CA 1.46 -0.473 0 C-N-CA 123.278 2.652 . . . . 1.22 112.392 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.429 ' CH2' HD22 ' A' ' 54' ' ' LEU . 94.5 m95 . . . . . 0 N--CA 1.45 -0.454 0 CA-C-O 120.737 0.303 . . . . 0.9 110.199 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.505 ' OE1' ' HG2' ' A' ' 7' ' ' LYS . 30.9 tt0 -59.37 109.05 0.8 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.488 -0.778 . . . . 2.73 110.848 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -91.54 27.51 1.98 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.64 -0.709 . . . . 2.09 111.429 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' HG2' ' OE1' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -56.45 -25.87 52.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.066 -0.516 . . . . 3.61 112.179 -176.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p -77.15 -30.01 54.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.049 0.452 . . . . 2.26 111.537 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.55 15.04 80.65 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.95 112.087 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.409 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 10.9 p -77.47 -25.18 50.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.307 0.484 . . . . 2.08 112.307 -174.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -102.97 142.68 33.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.218 -0.446 . . . . 1.19 110.933 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.8 p30 -91.11 -29.25 17.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.789 -0.641 . . . . 1.66 111.478 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.537 HG22 ' OD1' ' A' ' 12' ' ' ASN . 13.0 p -100.91 -31.19 11.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.104 0.478 . . . . 1.12 111.627 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.86 -2.88 52.25 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.815 -0.707 . . . . 0.43 112.115 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.524 ' HD3' HG21 ' A' ' 74' ' ' VAL . 90.7 mttt -86.72 88.76 7.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.009 0.433 . . . . 2.19 110.428 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 69' ' ' THR . 9.6 mp -92.32 110.73 22.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 1.12 110.492 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.0 149.23 39.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.08 0.467 . . . . 1.06 110.482 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -87.03 106.01 17.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.64 -0.709 . . . . 0.74 109.167 172.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -122.8 154.37 38.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.084 -0.507 . . . . 0.5 111.52 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 4.1 m-20 -100.03 114.64 28.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.509 -0.769 . . . . 1.65 109.174 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.0 p -74.82 -7.02 52.17 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.134 0.492 . . . . 1.12 110.968 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -98.01 -6.51 31.8 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.018 -0.734 . . . . 2.85 109.018 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 46.1 mtpt -111.62 98.71 7.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.83 -1.077 . . . . 3.03 109.759 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.82 157.67 16.14 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.271 -0.877 . . . . 2.7 110.782 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 t -120.22 145.15 26.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.684 -0.858 . . . . 1.3 108.684 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -95.18 29.84 2.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.065 0.46 . . . . 3.31 111.442 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 7.3 mmpt? -129.17 161.16 30.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.046 -0.525 . . . . 4.49 109.831 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 p -150.12 66.2 0.97 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.129 0.49 . . . . 2.89 110.406 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 m -122.1 143.69 49.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.753 -0.658 . . . . 2.23 109.679 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.03 148.78 18.56 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.215 -0.993 . . . . 1.39 112.842 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -78.61 -38.17 40.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.915 0.388 . . . . 3.06 110.285 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 2.44 110.186 176.851 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.53 ' HB3' HG21 ' A' ' 82' ' ' ILE . 32.1 mt-30 . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.295 0.569 . . . . 1.94 111.046 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.41 105.33 15.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.258 -0.883 . . . . 1.98 110.268 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -101.33 116.0 31.8 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.67 -0.695 . . . . 1.06 110.722 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.0 pt -120.81 155.16 24.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.859 -0.61 . . . . 1.06 109.887 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.72 123.5 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.869 0.842 . . . . 2.55 109.43 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 60.2 m -122.57 157.35 32.31 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.316 -1.311 . . . . 1.15 110.598 -171.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.9 t -161.18 138.43 8.94 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.913 0.387 . . . . 1.16 110.38 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -121.58 152.09 39.64 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.548 0.69 . . . . 2.08 111.156 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.459 HG21 ' HD2' ' A' ' 53' ' ' PRO . 23.1 mt -90.6 142.13 27.72 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.779 -1.1 . . . . 1.51 108.687 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HD2' HG21 ' A' ' 52' ' ' ILE . 57.2 Cg_exo -33.59 108.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 124.216 3.277 . . . . 1.11 113.393 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.448 HD21 ' O ' ' A' ' 52' ' ' ILE . 22.5 mt -66.13 130.08 41.99 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.954 -1.021 . . . . 2.15 113.112 -166.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.617 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 86.4 mt -99.48 122.6 42.8 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.704 -0.85 . . . . 2.07 108.704 166.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.1 mt -67.81 132.3 32.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.06 0.457 . . . . 2.56 110.637 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.67 14.6 61.1 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.458 -0.792 . . . . 1.09 112.089 -176.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -105.48 155.07 6.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.773 0.797 . . . . 1.29 111.818 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.38 135.82 33.36 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.373 -1.285 . . . . 1.34 111.036 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 61' ' ' GLU . 5.7 tp -52.2 -32.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.248 -0.887 . . . . 1.49 111.106 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.529 ' N ' HG22 ' A' ' 60' ' ' ILE . 35.5 mt-10 -73.99 -27.88 61.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.998 -1.001 . . . . 2.2 111.927 -173.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -107.35 -11.73 15.48 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.881 -0.328 . . . . 1.98 111.665 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.477 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.4 tp10 -79.15 -35.21 42.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.349 0.595 . . . . 2.09 110.413 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.83 171.59 10.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.002 -0.545 . . . . 0.6 110.148 -174.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -122.01 49.41 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.364 0.602 . . . . 2.81 109.997 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -138.77 -169.05 2.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.959 -0.564 . . . . 1.39 109.922 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -83.79 125.63 72.74 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 121.399 0.618 . . . . 1.12 111.931 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -65.25 123.43 11.51 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.435 2.757 . . . . 0.65 111.226 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 77.2 p -132.21 152.85 51.11 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.779 -0.369 . . . . 1.1 111.147 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 38.3 t -103.42 108.81 20.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.019 -0.537 . . . . 1.26 109.683 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 38.6 m -96.04 135.11 38.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.0 0.428 . . . . 0.29 110.603 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.4 tt0 -71.92 -29.55 64.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.418 0.628 . . . . 1.69 109.495 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -153.33 159.37 42.47 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.214 -1.032 . . . . 1.26 108.214 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.524 HG21 ' HD3' ' A' ' 15' ' ' LYS . 1.9 t -138.71 137.51 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.225 0.466 . . . . 1.59 110.509 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -104.54 157.43 17.17 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.91 -0.586 . . . . 1.87 110.634 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 78' ' ' GLY . 2.8 t70 67.24 -149.9 0.18 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.076 0.55 . . . . 1.94 109.857 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.03 16.11 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.939 0.876 . . . . 2.12 109.727 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 49' ' ' CYS . . . 99.22 23.33 11.43 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.557 -0.747 . . . . 0.53 111.558 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 34.1 mt -81.23 -25.68 36.45 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.962 0.41 . . . . 1.77 110.954 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.13 105.36 13.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.61 -0.515 . . . . 1.1 109.61 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.617 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -95.89 143.85 16.91 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.302 -0.951 . . . . 0.26 112.052 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.53 HG21 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -101.35 117.5 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 109.824 -0.436 . . . . 1.07 109.824 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 85.5 m-20 62.39 48.61 4.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.439 -0.801 . . . . 0.34 110.527 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.617 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 61.2 m -83.7 92.4 7.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.242 -0.89 . . . . 0.81 110.703 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.3 m -79.54 128.41 75.07 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.833 -0.622 . . . . 1.14 110.369 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.76 115.85 3.32 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.557 2.172 . . . . 0.59 110.797 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.409 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 8.8 pt -91.55 151.2 42.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.114 -0.494 . . . . 1.21 111.732 -173.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.3 Cg_exo . . . . . 0 N--CA 1.459 -0.519 0 C-N-CA 123.256 2.637 . . . . 1.22 111.823 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.6 m95 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.743 0.306 . . . . 0.9 110.791 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -59.94 106.13 0.46 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.413 -0.812 . . . . 2.73 111.218 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.493 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 17.1 m -113.54 13.5 18.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.761 -0.654 . . . . 2.09 110.687 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -19.45 63.52 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.702 0.63 . . . . 3.61 112.702 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 t -81.7 -9.47 59.64 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.276 -0.57 . . . . 2.26 110.591 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.98 15.6 59.06 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.927 -0.654 . . . . 0.95 112.803 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -78.87 -29.75 44.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.854 0.359 . . . . 2.08 111.453 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 t -128.62 141.68 51.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.976 0.417 . . . . 1.19 110.647 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.471 ' OD1' HG21 ' A' ' 13' ' ' THR . 8.8 p30 -92.62 -24.43 18.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 1.66 111.846 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.471 HG21 ' OD1' ' A' ' 12' ' ' ASN . 26.1 p -97.58 -30.96 12.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.121 0.415 . . . . 1.12 112.121 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.493 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 95.34 -0.14 63.5 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.525 -0.845 . . . . 0.43 111.713 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -92.5 88.48 6.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.73 0.3 . . . . 2.19 110.352 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 69' ' ' THR . 7.8 mp -102.61 99.87 9.9 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.376 -0.375 . . . . 1.12 110.529 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.7 150.98 21.24 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.151 0.501 . . . . 1.06 110.61 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.835 ' SG ' ' HB2' ' A' ' 66' ' ' ASN . 10.4 t -84.22 100.75 11.39 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.335 -0.848 . . . . 0.74 108.72 175.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 59.3 m -125.93 150.41 48.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.177 0.513 . . . . 0.5 111.74 -169.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 9.4 t70 -92.97 130.36 38.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.231 -1.026 . . . . 1.65 108.231 172.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.6 p -85.91 -3.9 59.04 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.773 -0.371 . . . . 1.12 111.46 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -106.39 -39.19 5.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.109 0.48 . . . . 2.85 109.747 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 38.8 mtmt -74.32 132.24 41.88 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.889 0.852 . . . . 3.03 110.17 172.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.523 ' HD2' HG22 ' A' ' 47' ' ' ILE . 14.4 mmmm -124.09 156.7 36.13 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.406 -1.27 . . . . 2.7 110.821 -171.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.465 HG21 ' OE1' ' A' ' 48' ' ' GLN . 2.2 t -119.88 144.3 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.37 -0.604 . . . . 1.3 109.37 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -81.04 -19.3 44.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.255 0.55 . . . . 3.31 110.474 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 27' ' ' LYS . 2.2 mmmp? -80.14 118.98 22.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.338 -0.846 . . . . 4.49 110.33 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -144.41 113.69 6.98 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.488 -0.56 . . . . 2.89 109.488 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.7 m -152.04 -80.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.434 -0.348 . . . . 2.23 110.494 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 141.41 12.21 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.82 -0.705 . . . . 1.39 112.289 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.37 -47.19 6.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.761 0.28 . . . . 3.06 111.124 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 C--N 1.326 -0.452 0 N-CA-C 109.578 -0.527 . . . . 2.44 109.578 -179.842 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.53 ' HB3' HG21 ' A' ' 82' ' ' ILE . 30.1 mt-30 . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 121.054 0.454 . . . . 1.94 110.418 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.8 t -84.09 104.2 12.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.684 -0.689 . . . . 1.98 110.491 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -97.32 100.81 12.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.271 -0.877 . . . . 1.06 110.477 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 20' ' ' ASP . 15.2 pt -106.63 152.66 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.786 -0.643 . . . . 1.06 110.027 176.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.465 ' OE1' HG21 ' A' ' 25' ' ' VAL . 13.3 tp60 -76.73 118.74 19.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.735 0.779 . . . . 2.55 110.114 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 53.7 m -114.02 160.65 18.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.116 -1.402 . . . . 1.15 110.299 -175.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 18' ' ' CYS . 15.3 t -162.87 136.86 6.17 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.41 -0.589 . . . . 1.16 109.41 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -117.81 107.53 14.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.314 0.578 . . . . 2.08 110.856 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.2 mt -57.45 139.71 80.41 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.984 -1.007 . . . . 1.51 109.99 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -34.72 118.94 0.13 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 124.274 3.316 . . . . 1.11 113.156 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.56 136.55 53.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.435 -0.802 . . . . 2.15 113.005 -169.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.32 109.18 20.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.68 -1.229 . . . . 2.07 107.68 167.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.8 mt -55.92 126.42 13.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.244 0.545 . . . . 2.56 111.438 -170.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.64 -4.62 58.09 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.278 -0.874 . . . . 1.09 113.086 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -98.37 151.16 4.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.718 0.771 . . . . 1.29 112.012 -179.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -88.49 145.14 25.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.45 -1.25 . . . . 1.34 111.79 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 61' ' ' GLU . 6.1 tp -40.79 -46.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.621 0.768 . . . . 1.49 113.026 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -70.92 -23.14 62.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.813 0.671 . . . . 2.2 112.813 -169.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -106.67 -7.49 17.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.424 0.631 . . . . 1.98 109.877 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -74.34 -39.11 63.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.586 -0.734 . . . . 2.09 109.77 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.3 p -132.38 162.88 29.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.475 -0.784 . . . . 0.6 110.431 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -108.39 33.8 3.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.862 0.319 . . . . 2.81 111.862 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.835 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m-80 -115.21 -163.17 0.86 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.827 -0.805 . . . . 1.39 108.827 173.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 m -86.82 131.4 45.3 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 121.222 0.534 . . . . 1.12 111.068 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -79.56 126.84 6.94 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.848 2.365 . . . . 0.65 110.356 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 71.3 p -131.26 145.57 51.95 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.393 -0.523 . . . . 1.1 111.631 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.2 t -94.99 111.67 23.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.406 -0.591 . . . . 1.26 109.406 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 38.0 m -96.8 144.03 27.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.251 0.548 . . . . 0.29 110.847 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -82.14 -21.82 36.45 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.436 -0.802 . . . . 1.69 109.299 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -161.69 153.36 18.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.991 -1.114 . . . . 1.26 107.991 173.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.447 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.0 t -135.35 128.69 48.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.459 -0.497 . . . . 1.59 109.853 173.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -94.4 169.48 10.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.762 -0.654 . . . . 1.87 110.841 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 78' ' ' GLY . 9.4 m-20 56.53 -148.86 0.48 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.028 -0.987 . . . . 1.94 111.296 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -80.51 23.09 0.53 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.698 0.761 . . . . 2.12 110.127 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.447 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 92.08 23.28 27.81 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.903 -0.665 . . . . 0.53 112.235 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -91.06 -19.11 23.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.381 . . . . 1.77 111.126 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.09 101.34 7.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.294 -0.412 . . . . 1.1 109.954 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.696 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -95.25 144.68 17.35 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.485 -0.864 . . . . 0.26 112.494 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.53 HG21 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -102.64 118.78 50.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.929 -0.397 . . . . 1.07 109.929 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 62.23 35.03 15.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.59 -0.732 . . . . 0.34 110.913 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.696 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 61.1 m -74.47 95.83 2.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.614 -0.721 . . . . 0.81 110.847 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.9 m -89.74 128.38 50.65 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 121.232 0.539 . . . . 1.14 110.219 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.16 133.6 25.21 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.296 2.664 . . . . 0.59 112.645 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 pt -107.25 153.35 41.17 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.073 -0.967 . . . . 1.21 111.311 -174.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.461 -0.424 0 C-N-CA 123.202 2.601 . . . . 1.22 111.476 172.698 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.544 ' CD2' ' HB ' ' A' ' 60' ' ' ILE . 92.3 m95 . . . . . 0 C--O 1.235 0.32 0 CA-C-O 120.436 0.16 . . . . 0.9 110.795 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.478 ' OE2' ' HA ' ' A' ' 59' ' ' ALA . 2.7 mp0 -59.47 106.82 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.274 0.559 . . . . 2.73 111.173 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.482 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 42.5 m -112.61 2.46 16.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.575 -0.739 . . . . 2.09 110.741 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -16.01 62.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.979 -0.555 . . . . 3.61 111.776 -175.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.64 4.96 38.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.909 0.385 . . . . 2.26 110.894 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.05 16.16 80.99 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.224 -1.151 . . . . 0.95 110.224 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 6' ' ' SER . 2.3 p -71.71 -30.05 65.23 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.388 -0.906 . . . . 2.08 111.861 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 6' ' ' SER . 7.4 t -155.79 143.71 19.77 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.764 -0.374 . . . . 1.19 110.936 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -91.79 -30.7 16.08 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.236 0.541 . . . . 1.66 110.186 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.1 p -92.25 -15.55 27.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.554 -0.748 . . . . 1.12 111.137 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.482 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 86.51 -8.36 75.2 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.923 -0.656 . . . . 0.43 112.493 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -87.99 89.12 7.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.988 0.423 . . . . 2.19 111.015 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 69' ' ' THR . 8.9 mp -90.11 141.93 28.21 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.304 -0.628 . . . . 1.12 109.304 172.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.85 145.74 36.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.963 0.411 . . . . 1.06 110.678 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 50' ' ' THR . 32.9 m -79.9 101.79 8.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.634 -0.876 . . . . 0.74 108.634 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.8 m -124.56 146.79 48.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.942 0.401 . . . . 0.5 111.344 -170.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -94.62 117.57 30.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.989 -0.745 . . . . 1.65 108.989 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 54.0 p -79.44 -0.38 32.76 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.198 0.523 . . . . 1.12 110.714 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -104.26 -17.75 14.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.659 -0.701 . . . . 2.85 109.477 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -119.63 137.74 53.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.437 -0.801 . . . . 3.03 110.437 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -140.23 162.75 34.52 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.731 0.641 . . . . 2.7 112.731 -170.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.438 HG21 ' OE1' ' A' ' 48' ' ' GLN . 1.6 t -111.74 150.67 13.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.014 -0.994 . . . . 1.3 110.553 -173.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -76.01 -4.38 40.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.953 -0.567 . . . . 3.31 112.128 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -104.86 119.59 39.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.643 0.259 . . . . 4.49 110.842 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.4 m -102.28 8.71 40.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.016 0.436 . . . . 2.89 110.367 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.9 p -87.59 164.77 15.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.829 -0.623 . . . . 2.23 111.174 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.53 -174.62 23.24 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.156 -0.778 . . . . 1.39 111.156 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -100.64 -24.15 14.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.203 0.501 . . . . 3.06 111.62 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.028 0.442 . . . . 2.44 111.202 -177.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.502 ' HB3' HG23 ' A' ' 82' ' ' ILE . 18.7 mt-30 . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.866 0.365 . . . . 1.94 110.524 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 83' ' ' ASN . 8.2 p -103.26 118.47 50.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.205 0.526 . . . . 1.98 110.62 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.66 100.0 9.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.46 -0.791 . . . . 1.06 111.172 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 10.7 pt -106.11 155.43 7.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.064 -0.516 . . . . 1.06 110.255 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.438 ' OE1' HG21 ' A' ' 25' ' ' VAL . 10.5 tp60 -77.3 126.04 30.29 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.463 0.649 . . . . 2.55 110.087 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 45.3 m -124.29 163.02 22.53 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.763 -1.108 . . . . 1.15 110.352 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 10.0 t -160.08 142.73 13.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.831 -0.433 . . . . 1.16 109.831 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -120.54 117.96 28.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.142 0.496 . . . . 2.08 110.348 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.23 137.29 37.17 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.371 -0.831 . . . . 1.51 109.539 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -32.68 117.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 124.989 3.792 . . . . 1.11 113.807 -172.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 pp -101.88 142.63 32.89 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.897 -1.047 . . . . 2.15 112.356 -169.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.473 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 74.9 mt -92.51 132.83 36.49 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.776 -0.824 . . . . 2.07 108.776 166.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 mt -64.05 135.17 28.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.005 0.431 . . . . 2.56 110.471 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.96 12.16 60.69 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.757 -0.656 . . . . 1.09 112.245 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -109.24 147.88 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.641 0.734 . . . . 1.29 111.855 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.478 ' HA ' ' OE2' ' A' ' 5' ' ' GLU . . . -73.42 128.18 34.77 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.187 -1.37 . . . . 1.34 110.056 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.544 ' HB ' ' CD2' ' A' ' 4' ' ' TRP . 16.3 tt -57.22 -33.04 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 1.49 111.931 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -9.96 59.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.385 0.612 . . . . 2.2 110.266 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.06 -35.41 10.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.37 -0.832 . . . . 1.98 109.038 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.5 tp10 -68.6 -39.48 80.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.537 -1.211 . . . . 2.09 110.587 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.0 p -119.6 147.03 44.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.341 -0.391 . . . . 0.6 110.198 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -99.36 48.35 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.144 0.497 . . . . 2.81 110.814 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -128.12 -172.7 2.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.882 -0.599 . . . . 1.39 109.502 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.9 m -83.07 127.97 67.08 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-O 121.145 0.498 . . . . 1.12 110.831 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.01 131.7 7.04 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.925 2.417 . . . . 0.65 111.281 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 81.0 p -133.37 153.44 51.59 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.432 -0.349 . . . . 1.1 110.861 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 15.8 t -99.63 111.22 23.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.804 -0.443 . . . . 1.26 109.804 173.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.6 m -100.97 138.02 38.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.252 0.549 . . . . 0.29 110.768 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -78.05 -27.41 48.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.633 -0.712 . . . . 1.69 109.859 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -154.36 151.76 29.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.514 -0.921 . . . . 1.26 108.514 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.524 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.5 t -140.47 132.42 31.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.869 -0.419 . . . . 1.59 109.869 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.77 160.7 14.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.478 -0.328 . . . . 1.87 110.21 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 78' ' ' GLY . 9.7 m-20 59.8 -154.02 0.37 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.724 0.41 . . . . 1.94 110.238 -174.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.35 23.99 0.37 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.015 0.436 . . . . 2.12 110.721 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.524 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 102.66 22.62 9.39 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.989 -0.624 . . . . 0.53 112.637 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 2.6 mm? -78.38 -27.78 46.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 1.77 111.264 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.6 t -125.05 107.71 18.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.334 -0.394 . . . . 1.1 110.719 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -100.93 139.03 14.19 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.104 -1.045 . . . . 0.26 112.195 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.502 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -104.82 123.6 58.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 122.54 0.336 . . . . 1.07 110.143 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.578 ' HA ' HG11 ' A' ' 45' ' ' VAL . 79.6 m-20 62.63 42.69 8.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.89 -0.595 . . . . 0.34 110.714 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.534 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 59.6 m -83.12 96.64 8.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.372 -0.831 . . . . 0.81 111.054 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 26.5 m -79.12 125.01 84.36 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.236 -0.438 . . . . 1.14 110.543 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 21.9 Cg_exo -67.03 128.05 17.95 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.029 2.486 . . . . 0.59 111.962 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.1 pt -107.3 143.09 26.48 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 116.279 -0.419 . . . . 1.21 110.928 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.6 Cg_exo . . . . . 0 N--CA 1.462 -0.378 0 C-N-CA 123.336 2.69 . . . . 1.22 112.355 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 93.4 m95 . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 110.374 -0.232 . . . . 0.9 110.374 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -64.74 108.95 1.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.027 0.441 . . . . 2.73 110.399 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.7 m -96.29 27.18 3.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.465 0.65 . . . . 2.09 109.643 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -5.01 48.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.354 -0.839 . . . . 3.61 111.585 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -67.59 -30.6 70.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.085 0.469 . . . . 2.26 111.357 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.42 16.62 58.54 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.801 -0.714 . . . . 0.95 112.421 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 m -102.34 -17.02 16.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.855 0.317 . . . . 2.08 111.855 -175.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.764 ' SG ' HG23 ' A' ' 87' ' ' ILE . 3.9 m -131.1 141.55 50.16 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.851 -0.34 . . . . 1.19 111.479 -171.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.448 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.7 p30 -94.61 -28.3 15.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 1.66 112.186 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 12' ' ' ASN . 39.8 p -86.92 -31.14 20.86 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.476 0.547 . . . . 1.12 112.476 -171.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.15 5.64 82.74 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.509 -0.853 . . . . 0.43 112.679 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.456 ' HD3' HG22 ' A' ' 74' ' ' VAL . 59.4 mttp -94.38 88.27 5.47 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.065 -0.346 . . . . 2.19 110.065 176.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.684 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 7.9 mp -94.18 123.59 37.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.915 0.388 . . . . 1.12 110.299 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.18 142.62 37.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.835 -0.431 . . . . 1.06 109.835 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.1 m -80.93 118.46 22.44 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.278 -0.638 . . . . 0.74 109.278 172.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.718 ' SG ' HG13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -127.72 163.08 25.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.006 0.432 . . . . 0.5 111.152 -173.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -106.15 105.76 15.96 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.372 -0.973 . . . . 1.65 108.372 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.2 p -75.87 2.54 12.13 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.561 -0.745 . . . . 1.12 111.095 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -104.86 -3.41 23.48 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.054 -0.721 . . . . 2.85 109.054 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -113.3 102.46 10.37 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.361 -0.836 . . . . 3.03 110.562 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 3.7 mppt? -96.55 159.97 14.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.538 -0.756 . . . . 2.7 110.797 -175.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 t -119.61 149.7 22.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.946 -0.761 . . . . 1.3 108.946 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -84.45 -11.64 55.81 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.121 0.415 . . . . 3.31 112.121 -172.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -120.41 130.41 54.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.684 0.278 . . . . 4.49 110.546 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.7 m -101.45 32.68 3.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.104 -0.498 . . . . 2.89 111.207 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.9 p -86.1 150.09 24.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.263 -0.426 . . . . 2.23 110.233 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.472 ' HA3' ' OD1' ' A' ' 73' ' ' ASP . . . -150.79 -173.95 21.34 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.772 -0.728 . . . . 1.39 112.125 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -91.05 -50.65 5.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.547 0.173 . . . . 3.06 111.404 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 112.193 0.442 . . . . 2.44 112.193 -175.534 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.502 ' HB3' HG21 ' A' ' 82' ' ' ILE . 17.5 mt-30 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 121.048 0.451 . . . . 1.94 111.283 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.56 115.41 43.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.72 -0.673 . . . . 1.98 110.421 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -100.21 118.42 36.49 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.521 -0.763 . . . . 1.06 110.925 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.718 HG13 ' SG ' ' A' ' 19' ' ' CYS . 12.5 pt -116.29 153.39 17.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.049 -0.523 . . . . 1.06 110.015 173.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.54 108.47 16.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.811 0.815 . . . . 2.55 110.076 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 62.7 m -89.5 165.6 14.2 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.128 -1.396 . . . . 1.15 110.573 -175.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.0 t -159.94 117.06 2.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.953 0.883 . . . . 1.16 110.715 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -120.0 131.78 55.26 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.964 -1.016 . . . . 2.08 110.677 -174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 64' ' ' CYS . 46.1 mt -70.41 133.9 86.99 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.979 -0.749 . . . . 1.51 108.979 171.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.11 107.04 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.07 3.18 . . . . 1.11 112.68 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.9 140.51 57.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.209 -0.905 . . . . 2.15 112.865 -169.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.53 152.74 21.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.86 -1.063 . . . . 2.07 108.767 168.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.0 mt -70.66 124.34 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.115 0.483 . . . . 2.56 110.631 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.15 17.18 72.57 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.474 -0.785 . . . . 1.09 112.952 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.405 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -97.0 149.13 5.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.713 0.768 . . . . 1.29 111.563 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.15 144.67 36.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.29 -1.323 . . . . 1.34 111.358 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.543 HG21 ' N ' ' A' ' 61' ' ' GLU . 7.1 tp -53.38 -43.49 51.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.602 -0.726 . . . . 1.49 111.478 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.543 ' N ' HG21 ' A' ' 60' ' ' ILE . 45.6 mt-10 -71.34 -41.65 69.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.7 -0.682 . . . . 2.2 111.489 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -79.44 -8.37 59.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.051 -0.522 . . . . 1.98 111.036 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.7 tp10 -92.21 -41.16 10.58 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.288 -0.415 . . . . 2.09 110.793 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.468 ' HA ' HD11 ' A' ' 52' ' ' ILE . 1.7 p -113.9 173.13 6.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.6 111.185 -172.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -125.02 49.91 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.296 0.57 . . . . 2.81 109.563 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -143.24 -170.3 3.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.836 -0.62 . . . . 1.39 110.43 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.4 m -79.62 130.76 66.74 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.888 0.375 . . . . 1.12 111.142 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -79.03 120.13 4.51 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.719 2.279 . . . . 0.65 111.264 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.1 p -129.38 148.5 51.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.199 -0.455 . . . . 1.1 109.874 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.684 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 72.9 m -113.59 111.51 21.99 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.458 0.647 . . . . 1.26 110.128 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.9 m -86.56 152.59 22.49 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.962 -1.017 . . . . 0.29 111.036 -172.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 7.3 tt0 -91.53 -22.28 20.44 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.255 -0.884 . . . . 1.69 109.628 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.472 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 33.9 t0 -158.99 161.33 36.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.739 -1.208 . . . . 1.26 107.739 170.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.551 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -139.21 149.37 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 118.362 0.528 . . . . 1.59 110.793 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 8.2 tp10 -111.36 160.2 17.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.439 -0.8 . . . . 1.87 109.764 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 78' ' ' GLY . 68.9 m-20 60.49 -151.93 0.4 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.255 -0.43 . . . . 1.94 109.936 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.86 10.33 2.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.001 0.429 . . . . 2.12 110.301 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.551 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 113.27 24.03 4.94 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.895 -0.669 . . . . 0.53 112.487 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.48 -21.93 25.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 1.77 111.432 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 88.4 t -127.04 113.05 30.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.277 -0.638 . . . . 1.1 109.277 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.68 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -108.0 142.76 15.97 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.697 -1.24 . . . . 0.26 112.869 -173.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -95.75 118.17 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 109.69 -0.485 . . . . 1.07 109.69 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 93.8 m-20 60.21 42.93 14.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.279 -0.873 . . . . 0.34 110.804 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.68 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.8 m -78.0 87.71 4.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.669 -0.696 . . . . 0.81 109.919 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.2 m -83.07 134.22 46.69 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.377 -0.829 . . . . 1.14 110.256 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -70.49 118.56 5.76 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.97 2.446 . . . . 0.59 111.59 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.764 HG23 ' SG ' ' A' ' 11' ' ' CYS . 5.5 pt -88.13 140.58 30.72 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.355 -0.839 . . . . 1.21 111.671 -173.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 N--CA 1.455 -0.772 0 C-N-CA 123.374 2.716 . . . . 1.22 111.707 176.934 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 83.9 m95 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.9 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' A' ' 7' ' ' LYS . 32.8 mm-40 -85.11 109.54 18.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.732 -0.667 . . . . 2.73 110.45 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 m -80.42 27.45 0.34 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.864 -0.607 . . . . 2.09 111.021 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 8' ' ' THR . 0.2 OUTLIER -53.88 -22.68 10.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.747 -0.66 . . . . 3.61 112.12 -177.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.432 ' N ' ' HD2' ' A' ' 7' ' ' LYS . 6.9 t -73.39 -13.08 61.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.274 -0.421 . . . . 2.26 111.232 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.06 17.42 75.63 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.906 -0.664 . . . . 0.95 112.452 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -102.63 -9.86 19.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.89 0.33 . . . . 2.08 111.89 -172.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.686 ' SG ' HG22 ' A' ' 87' ' ' ILE . 2.7 m -139.65 140.32 36.89 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.267 -0.573 . . . . 1.19 111.456 -171.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -95.33 -30.6 13.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 1.66 111.867 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.7 p -80.53 -29.94 37.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.663 0.616 . . . . 1.12 112.663 -169.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.55 -4.27 85.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.503 -0.856 . . . . 0.43 112.304 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -90.69 87.86 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.425 . . . . 2.19 109.99 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.811 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 8.1 mp -96.13 139.55 32.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.698 -0.683 . . . . 1.12 109.708 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.654 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -148.39 144.71 27.67 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.894 0.378 . . . . 1.06 110.389 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 86.1 m -89.9 99.54 12.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.131 0.491 . . . . 0.74 109.698 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 83.7 m -114.41 164.69 13.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.546 . . . . 0.5 112.028 -165.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -102.15 108.34 19.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.842 -0.617 . . . . 1.65 109.516 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -77.8 0.62 23.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.298 -0.41 . . . . 1.12 111.19 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -101.13 -7.3 23.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.172 -0.677 . . . . 2.85 109.172 175.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -113.3 107.21 15.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.262 -0.881 . . . . 3.03 110.328 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -100.34 154.8 18.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.827 -0.624 . . . . 2.7 110.789 -174.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.446 HG22 ' CD ' ' A' ' 48' ' ' GLN . 11.1 t -120.78 150.3 23.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.608 -0.724 . . . . 1.3 109.782 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.08 32.89 0.27 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.974 -0.557 . . . . 3.31 111.684 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER 31.12 115.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.718 1.607 . . . . 4.49 114.752 174.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -123.92 -76.83 0.59 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.477 -0.783 . . . . 2.89 111.162 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 p -142.28 -169.71 3.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.325 -0.852 . . . . 2.23 111.211 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.1 -161.04 21.95 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.232 -1.147 . . . . 1.39 110.232 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -99.57 -46.34 5.49 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.709 0.755 . . . . 3.06 110.71 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.101 0.477 . . . . 2.44 110.844 -179.144 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.446 ' HB3' HG22 ' A' ' 82' ' ' ILE . 23.1 mt-30 . . . . . 0 C--O 1.235 0.301 0 CA-C-O 121.308 0.575 . . . . 1.94 111.406 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.85 109.19 27.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.14 -0.936 . . . . 1.98 109.745 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -102.28 122.57 44.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.675 -0.693 . . . . 1.06 110.494 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.2 pt -128.66 153.83 38.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.993 -0.549 . . . . 1.06 110.641 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.446 ' CD ' HG22 ' A' ' 25' ' ' VAL . 2.5 mp0 -70.29 141.62 52.35 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.832 -0.622 . . . . 2.55 109.503 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.654 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 2.1 t -137.78 164.53 28.67 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.073 -0.512 . . . . 1.15 110.491 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.0 t -160.81 128.03 4.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.524 0.678 . . . . 1.16 110.652 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -121.06 125.94 48.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.674 -0.694 . . . . 2.08 110.976 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 64' ' ' CYS . 16.7 mt -63.88 139.25 97.61 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.385 -0.825 . . . . 1.51 109.836 174.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD2' HG23 ' A' ' 52' ' ' ILE . 60.0 Cg_exo -34.25 121.13 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 124.788 3.659 . . . . 1.11 113.929 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.8 mt -65.48 119.71 11.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.038 -0.983 . . . . 2.15 112.261 -171.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 84.5 mt -99.73 122.89 43.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.989 -0.745 . . . . 2.07 108.989 166.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.526 HD11 ' H ' ' A' ' 56' ' ' ILE . 4.1 mp -72.87 130.18 35.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.073 0.463 . . . . 2.56 110.2 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.05 2.97 60.64 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.932 -0.651 . . . . 1.09 111.832 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -103.15 153.98 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.799 0.809 . . . . 1.29 111.732 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.18 130.52 36.31 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.306 -1.316 . . . . 1.34 109.815 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.642 HG22 ' N ' ' A' ' 61' ' ' GLU . 10.7 tt -50.77 -37.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.238 -0.892 . . . . 1.49 112.035 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.642 ' N ' HG22 ' A' ' 60' ' ' ILE . 6.6 mt-10 -62.61 -35.23 78.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.087 -0.96 . . . . 2.2 111.04 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.85 -22.21 19.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.904 -0.589 . . . . 1.98 109.999 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.82 -41.16 78.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.751 . . . . 2.09 110.954 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.501 ' HA ' HD12 ' A' ' 52' ' ' ILE . 4.7 p -114.65 167.85 10.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.997 0.427 . . . . 0.6 111.308 -173.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -121.94 41.42 3.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 2.81 110.284 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 57.1 m-80 -131.52 -169.87 2.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.481 -0.781 . . . . 1.39 109.666 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 11.2 m -83.17 127.1 70.36 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-O 120.933 0.397 . . . . 1.12 110.877 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.23 119.77 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.735 2.29 . . . . 0.65 111.294 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 84' ' ' CYS . 44.2 p -128.37 151.16 49.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.318 -0.401 . . . . 1.1 109.93 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.811 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 72.0 m -113.68 119.32 37.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.268 0.556 . . . . 1.26 110.16 175.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.2 m -97.57 149.37 22.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.064 -0.971 . . . . 0.29 111.298 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 9.3 mt-10 -85.06 -16.65 39.96 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.585 -1.188 . . . . 1.69 109.728 175.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -167.79 156.11 9.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.921 -1.036 . . . . 1.26 108.298 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.547 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -143.5 135.92 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 117.929 0.331 . . . . 1.59 110.566 178.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.412 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 10.6 tp10 -98.18 157.54 16.09 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.156 -0.475 . . . . 1.87 110.01 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 78' ' ' GLY . 56.9 m-20 61.31 -151.81 0.38 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.107 0.563 . . . . 1.94 109.93 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -82.38 21.91 0.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.112 0.482 . . . . 2.12 110.383 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 106.64 22.72 7.55 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.814 -0.708 . . . . 0.53 112.874 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.5 mm? -80.1 -26.67 39.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.784 0.292 . . . . 1.77 111.475 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 94.5 t -130.56 112.62 23.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.939 -0.393 . . . . 1.1 109.939 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.655 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -107.21 143.62 15.87 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.136 -1.03 . . . . 0.26 112.651 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.446 HG22 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -101.89 120.62 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.327 -0.619 . . . . 1.07 109.327 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 98.8 m-20 62.06 48.01 5.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.671 -0.695 . . . . 0.34 110.598 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.655 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 56.8 m -85.59 93.71 8.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.58 -0.736 . . . . 0.81 110.228 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.2 m -82.09 127.81 70.34 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.994 -0.548 . . . . 1.14 110.311 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.99 113.86 2.37 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.794 2.329 . . . . 0.59 111.579 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.686 HG22 ' SG ' ' A' ' 11' ' ' CYS . 9.1 pt -89.64 146.74 36.24 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.724 -0.671 . . . . 1.21 111.156 -175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 N--CA 1.46 -0.454 0 C-N-CA 123.225 2.617 . . . . 1.22 112.24 178.553 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 90.2 m95 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.128 0.49 . . . . 0.9 111.235 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.599 ' OE1' ' HA ' ' A' ' 59' ' ' ALA . 24.7 mp0 -70.91 107.38 4.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.384 -0.826 . . . . 2.73 111.072 -176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 t -111.72 26.14 10.93 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.016 -0.735 . . . . 2.09 109.016 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -55.04 -33.9 63.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.934 -1.03 . . . . 3.61 111.541 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.7 t -85.04 3.81 36.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.811 0.339 . . . . 2.26 111.461 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.3 18.44 69.05 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.389 -0.91 . . . . 0.95 112.558 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.0 p -70.27 -32.05 69.7 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.759 0.651 . . . . 2.08 112.759 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.2 t -129.74 144.1 51.13 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.099 0.476 . . . . 1.19 111.365 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.435 ' OD1' HG21 ' A' ' 13' ' ' THR . 8.2 p30 -91.21 -24.91 19.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.961 -0.563 . . . . 1.66 111.341 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.435 HG21 ' OD1' ' A' ' 12' ' ' ASN . 56.3 p -98.21 -30.56 12.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.076 0.465 . . . . 1.12 111.349 -177.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.21 0.06 59.97 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.832 -0.699 . . . . 0.43 111.396 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -91.61 88.46 6.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.752 0.31 . . . . 2.19 110.401 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 69' ' ' THR . 8.1 mp -96.83 151.4 19.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.694 -0.484 . . . . 1.12 109.694 175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.555 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -160.26 144.66 14.4 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.744 0.307 . . . . 1.06 110.85 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 1.2 m -80.13 97.63 6.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.854 -0.612 . . . . 0.74 109.923 173.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.13 160.59 18.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.114 -0.494 . . . . 0.5 110.82 -172.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.01 116.25 31.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.705 -0.48 . . . . 1.65 109.705 173.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.5 p -76.44 -8.66 57.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.089 0.471 . . . . 1.12 111.227 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -93.85 -15.97 24.53 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.021 0.915 . . . . 2.85 108.727 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -102.5 110.33 22.23 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.008 -1.451 . . . . 3.03 110.707 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.4 OUTLIER -103.08 163.75 12.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.281 -0.418 . . . . 2.7 110.992 -178.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.511 HG22 ' OE1' ' A' ' 48' ' ' GLN . 23.5 t -116.04 150.05 18.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.002 -0.74 . . . . 1.3 109.002 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -83.68 -17.0 42.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.39 0.515 . . . . 3.31 112.39 -171.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -114.02 156.76 23.51 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.277 -0.268 . . . . 4.49 110.277 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 p -121.42 12.68 10.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.79 0.329 . . . . 2.89 111.405 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 p -72.97 142.75 47.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.34 . . . . 2.23 110.84 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.25 165.23 25.24 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.583 -0.818 . . . . 1.39 112.803 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -81.76 -46.21 14.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.741 0.305 . . . . 3.06 111.44 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 . . . . . 0 C--N 1.324 -0.525 0 CA-C-N 116.386 -0.37 . . . . 2.44 111.307 -177.75 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.547 ' NE2' HG21 ' A' ' 82' ' ' ILE . 35.3 mt-30 . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.948 0.404 . . . . 1.94 110.839 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.27 116.54 49.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.275 -0.42 . . . . 1.98 110.112 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -105.62 117.48 34.13 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.833 -0.621 . . . . 1.06 111.138 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 13.8 pt -106.38 150.21 9.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.074 -0.512 . . . . 1.06 110.241 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.511 ' OE1' HG22 ' A' ' 25' ' ' VAL . 13.9 tp60 -76.63 116.0 16.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.599 -0.728 . . . . 2.55 109.342 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.69 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 2.2 t -110.1 169.43 8.74 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.283 -0.872 . . . . 1.15 110.235 -172.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.0 t -160.19 128.06 4.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.646 0.736 . . . . 1.16 110.808 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -120.88 114.1 21.08 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.518 -0.764 . . . . 2.08 111.059 -176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.72 133.22 72.27 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.395 -0.821 . . . . 1.51 109.46 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -38.45 102.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 124.578 3.519 . . . . 1.11 113.01 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.44 135.19 51.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.408 -0.815 . . . . 2.15 112.308 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.02 135.0 35.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.167 -0.924 . . . . 2.07 109.372 171.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.4 mt -66.6 129.63 31.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.23 0.538 . . . . 2.56 110.305 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.26 -15.66 58.8 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.224 -0.898 . . . . 1.09 111.832 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -89.7 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.586 0.708 . . . . 1.29 111.649 -177.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . . . -89.8 146.46 24.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.461 -1.245 . . . . 1.34 111.475 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.532 HG23 ' N ' ' A' ' 61' ' ' GLU . 5.0 tp -49.89 -44.05 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.621 -0.718 . . . . 1.49 110.724 173.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.532 ' N ' HG23 ' A' ' 60' ' ' ILE . 6.4 mm-40 -68.91 -16.84 63.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.431 -0.804 . . . . 2.2 111.986 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -110.46 -10.87 14.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.318 -0.401 . . . . 1.98 111.3 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.4 tp10 -93.62 -38.78 11.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.183 0.516 . . . . 2.09 110.595 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.2 p -131.38 146.92 52.49 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.913 -0.585 . . . . 0.6 110.208 -173.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -121.93 64.56 0.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.68 0.752 . . . . 2.81 111.064 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 36.5 m-80 -123.23 -155.43 0.65 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.231 -1.396 . . . . 1.39 107.231 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -86.05 121.17 72.9 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 119.418 -0.913 . . . . 1.12 110.048 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.11 130.25 9.23 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.646 2.231 . . . . 0.65 110.671 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 84' ' ' CYS . 81.1 p -131.65 155.11 48.15 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.415 -0.357 . . . . 1.1 111.374 -175.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.2 t -103.27 110.48 22.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.684 -0.858 . . . . 1.26 108.684 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.7 m -94.84 145.28 25.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.403 0.621 . . . . 0.29 110.666 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 2.6 tt0 -79.57 -18.63 51.29 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.325 -0.852 . . . . 1.69 109.235 176.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -170.13 156.3 5.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.135 -0.939 . . . . 1.26 109.178 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.502 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.4 t -143.07 134.62 23.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.331 -0.248 . . . . 1.59 110.331 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 41.4 tt0 -104.17 158.8 16.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.47 -0.332 . . . . 1.87 110.693 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.404 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 4.4 t70 66.58 -148.19 0.19 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.183 0.593 . . . . 1.94 109.672 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.85 11.83 2.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.011 0.434 . . . . 2.12 110.442 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.69 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 108.7 23.94 6.32 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.916 -0.659 . . . . 0.53 112.155 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 mt -82.93 -23.6 33.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.819 0.342 . . . . 1.77 111.197 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 60.9 t -122.79 106.37 17.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.688 -0.486 . . . . 1.1 109.688 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.61 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -106.56 133.83 11.84 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.325 -0.94 . . . . 0.26 111.954 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.547 HG21 ' NE2' ' A' ' 44' ' ' GLN . 1.8 mp -96.74 121.12 46.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 110.127 -0.323 . . . . 1.07 110.127 -177.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 82.7 m-20 60.62 35.32 19.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.553 -0.748 . . . . 0.34 111.124 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.61 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 67.3 m -69.82 95.33 0.89 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.607 -0.724 . . . . 0.81 110.702 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 30.7 m -87.56 126.89 60.47 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.951 -0.568 . . . . 1.14 110.009 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 36.2 Cg_exo -59.13 128.96 29.57 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.979 2.452 . . . . 0.59 112.321 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 pt -100.94 147.87 34.29 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.044 -0.526 . . . . 1.21 110.799 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 C--O 1.235 0.338 0 C-N-CA 123.009 2.473 . . . . 1.22 112.086 179.155 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.319 0.58 . . . . 0.9 112.023 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -65.27 113.84 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.936 -1.029 . . . . 2.73 110.911 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 m -88.5 26.82 1.38 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.9 -0.591 . . . . 2.09 110.445 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -53.74 -52.52 59.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.489 -0.778 . . . . 3.61 112.502 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -69.53 -24.46 63.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.2 -0.455 . . . . 2.26 111.846 -172.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.03 16.01 79.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.906 -0.664 . . . . 0.95 111.742 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.469 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 5.4 p -74.45 -30.51 61.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.301 0.482 . . . . 2.08 112.301 -173.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.6 t -105.2 142.29 35.24 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.004 0.431 . . . . 1.19 111.181 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.552 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.7 p30 -92.18 -27.35 17.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 1.66 111.784 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.552 HG22 ' OD1' ' A' ' 12' ' ' ASN . 11.0 p -100.34 -30.81 11.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.873 0.368 . . . . 1.12 111.973 -175.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.03 -6.36 53.93 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.528 -0.844 . . . . 0.43 112.26 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.445 ' HZ2' HG23 ' A' ' 74' ' ' VAL . 89.2 mttt -88.35 88.73 7.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 2.19 110.48 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.5 mp -92.99 127.01 38.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.454 -0.794 . . . . 1.12 110.171 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.591 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -142.53 153.09 43.28 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.786 0.327 . . . . 1.06 110.383 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 60.4 m -89.57 97.67 11.33 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.184 -0.672 . . . . 0.74 109.184 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 71.4 m -113.51 153.46 28.69 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.314 -0.403 . . . . 0.5 111.19 -169.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.613 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 8.0 t70 -92.51 119.35 31.9 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.077 -0.712 . . . . 1.65 109.077 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.8 p -80.41 -7.78 59.26 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.775 0.322 . . . . 1.12 111.706 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -104.59 -15.94 15.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 2.85 110.127 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 36.6 mtmt -103.35 129.04 50.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.709 -0.678 . . . . 3.03 110.779 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -116.55 162.35 17.74 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.912 -1.04 . . . . 2.7 111.243 -175.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 t -113.32 149.97 15.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.847 -0.615 . . . . 1.3 109.798 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -84.51 5.25 28.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.003 -0.544 . . . . 3.31 111.288 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -132.24 119.72 21.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.439 -0.346 . . . . 4.49 110.215 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -126.28 80.27 1.91 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.251 -0.431 . . . . 2.89 110.218 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.8 m -118.26 -54.91 2.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.035 0.445 . . . . 2.23 111.317 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.89 155.24 31.62 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.543 -0.753 . . . . 1.39 111.787 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -101.18 -50.37 3.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.05 0.452 . . . . 3.06 110.189 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.444 -0.727 0 CA-C-N 115.759 -0.655 . . . . 2.44 109.895 -176.253 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.495 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.7 mt-30 . . . . . 0 CA--C 1.517 -0.294 0 CA-C-O 121.028 0.442 . . . . 1.94 110.358 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.654 ' CG1' ' HA ' ' A' ' 83' ' ' ASN . 7.2 p -95.14 105.51 17.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.693 0.758 . . . . 1.98 110.825 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -96.59 101.73 13.39 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.154 -0.93 . . . . 1.06 110.25 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 20' ' ' ASP . 17.5 pt -104.13 150.0 7.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.935 -0.575 . . . . 1.06 110.311 177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -74.77 126.6 31.26 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.057 -0.72 . . . . 2.55 109.057 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.591 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 1.8 t -117.0 160.72 20.51 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.342 -0.845 . . . . 1.15 110.522 -171.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 2.5 t -150.53 121.39 7.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.335 0.588 . . . . 1.16 110.427 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -118.87 111.2 18.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.499 0.666 . . . . 2.08 110.479 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.0 mt -71.11 133.8 85.6 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 114.859 -1.064 . . . . 1.51 109.979 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -34.3 130.58 0.18 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 124.693 3.595 . . . . 1.11 114.138 -173.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.489 HD12 ' H ' ' A' ' 54' ' ' LEU . 2.4 mp -84.29 132.85 34.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.807 -1.088 . . . . 2.15 112.584 -166.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.43 133.37 40.94 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.424 -0.954 . . . . 2.07 108.424 165.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.524 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -66.09 132.35 31.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.164 0.507 . . . . 2.56 110.893 -172.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.18 4.25 84.17 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.37 -0.832 . . . . 1.09 113.101 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -96.33 152.01 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.724 0.773 . . . . 1.29 111.859 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.54 143.33 27.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.339 -1.3 . . . . 1.34 111.172 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.4 tp -55.55 -32.32 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.005 -0.998 . . . . 1.49 111.83 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.79 -8.62 55.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 2.2 111.56 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.46 -27.15 11.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.403 0.621 . . . . 1.98 109.608 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.436 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.8 tp10 -72.62 -40.49 66.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.211 -0.904 . . . . 2.09 111.234 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 8.8 p -116.56 153.49 32.12 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.69 -0.404 . . . . 0.6 110.954 -173.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -99.69 33.17 2.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.663 0.745 . . . . 2.81 109.689 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 51.9 m-80 -117.94 -165.32 1.09 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.494 -0.776 . . . . 1.39 109.512 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 14.2 m -93.77 122.23 62.75 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-O 121.335 0.588 . . . . 1.12 112.012 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.41 117.26 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.482 2.788 . . . . 0.65 111.115 172.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.9 p -129.32 146.99 51.11 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.556 -0.458 . . . . 1.1 111.405 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.1 t -98.81 111.21 23.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.852 -0.613 . . . . 1.26 109.373 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.4 m -96.94 135.15 39.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.056 0.455 . . . . 0.29 110.626 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 6.5 tt0 -72.28 -20.75 61.46 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.449 0.642 . . . . 1.69 109.487 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -163.17 166.44 23.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.451 -0.795 . . . . 1.26 109.112 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.445 HG23 ' HZ2' ' A' ' 15' ' ' LYS . 14.7 m -138.73 157.45 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 110.055 -0.35 . . . . 1.59 110.055 177.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 80' ' ' VAL . 37.1 mt-10 -126.07 164.91 19.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.408 -0.36 . . . . 1.87 110.066 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 57.68 -150.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.548 -0.751 . . . . 1.94 109.396 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.97 22.88 0.74 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.11 0.481 . . . . 2.12 110.993 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 101.41 21.81 11.15 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.902 -0.666 . . . . 0.53 112.115 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.15 -22.55 44.9 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.329 0.585 . . . . 1.77 110.252 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 75' ' ' GLU . 61.1 t -122.49 117.91 53.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.606 -0.725 . . . . 1.1 109.472 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -110.35 134.78 12.41 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.142 -1.028 . . . . 0.26 111.939 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.495 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -98.12 121.62 48.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.198 -0.297 . . . . 1.07 110.198 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.654 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 94.5 m-20 58.4 54.91 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.867 -0.606 . . . . 0.34 110.904 174.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.479 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 47.8 m -91.62 110.73 22.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.295 -0.866 . . . . 0.81 110.944 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 47.3 m -96.16 128.76 35.77 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.982 -0.554 . . . . 1.14 110.166 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 39.4 Cg_exo -62.46 119.96 7.29 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.829 2.353 . . . . 0.59 110.947 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.469 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 7.0 pt -99.8 139.77 21.06 Favored Pre-proline 0 N--CA 1.442 -0.874 0 CA-C-N 116.319 -0.4 . . . . 1.21 111.718 -173.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.6 Cg_exo . . . . . 0 N--CA 1.463 -0.299 0 C-N-CA 123.251 2.634 . . . . 1.22 112.277 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 78.4 m95 . . . . . 0 CA--C 1.516 -0.36 0 N-CA-C 110.154 -0.313 . . . . 0.9 110.154 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.35 110.11 2.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.912 -0.585 . . . . 2.73 109.983 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -102.67 26.23 8.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.889 -0.596 . . . . 2.09 110.57 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -16.24 62.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.684 -0.689 . . . . 3.61 111.066 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 t -69.47 -14.51 62.92 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.101 -0.5 . . . . 2.26 110.684 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.36 79.95 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.133 -0.556 . . . . 0.95 112.617 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.6 m -96.71 -10.32 27.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 111.896 0.332 . . . . 2.08 111.896 -173.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.8 t -139.46 141.87 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.613 -0.435 . . . . 1.19 110.83 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.474 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.4 p30 -93.41 -30.22 15.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 1.66 112.157 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.474 HG22 ' OD1' ' A' ' 12' ' ' ASN . 23.9 p -89.98 -30.67 17.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.138 0.422 . . . . 1.12 112.138 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.93 -7.39 67.43 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.527 -0.844 . . . . 0.43 112.068 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HD3' HG21 ' A' ' 74' ' ' VAL . 75.5 mttt -87.35 88.37 7.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.352 0.596 . . . . 2.19 110.043 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 mp -97.69 122.55 40.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.341 -0.845 . . . . 1.12 109.691 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.33 146.54 50.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.038 0.447 . . . . 1.06 111.189 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 50' ' ' THR . 62.9 m -81.38 109.1 15.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.719 -0.845 . . . . 0.74 108.719 172.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 72.3 m -126.53 153.38 45.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.216 0.531 . . . . 0.5 112.114 -169.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 13.0 t70 -99.6 113.22 25.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.098 -1.075 . . . . 1.65 108.098 175.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.0 p -77.06 -10.1 59.16 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.352 0.871 . . . . 1.12 113.352 -169.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -106.48 -3.83 20.47 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.884 0.85 . . . . 2.85 109.153 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -93.07 104.8 16.97 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.951 -1.477 . . . . 3.03 109.907 175.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.76 162.43 12.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.283 0.563 . . . . 2.7 111.705 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -123.61 143.22 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.225 -0.898 . . . . 1.3 108.764 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -86.68 -31.4 21.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.277 -0.419 . . . . 3.31 110.988 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -87.7 119.67 28.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.228 -0.442 . . . . 4.49 110.414 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -93.63 54.92 2.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.471 0.653 . . . . 2.89 109.584 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.1 m -92.12 132.92 36.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.378 -0.828 . . . . 2.23 110.192 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.62 164.88 16.57 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.502 -0.856 . . . . 1.39 112.515 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -100.63 -47.87 4.71 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 122.518 0.327 . . . . 3.06 110.143 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 120.658 0.266 . . . . 2.44 110.354 177.252 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HB3' HG22 ' A' ' 82' ' ' ILE . 34.2 mt-30 . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.955 0.407 . . . . 1.94 110.897 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.17 99.92 10.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.764 -0.653 . . . . 1.98 109.629 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -99.33 108.06 20.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.447 -0.797 . . . . 1.06 110.478 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 pt -118.52 159.47 18.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.836 -0.62 . . . . 1.06 110.052 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -77.56 142.04 39.23 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 122.12 0.962 . . . . 2.55 110.848 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 39.4 m -140.94 164.64 29.71 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.516 -1.675 . . . . 1.15 109.908 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 7.9 t -161.01 136.1 7.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.164 -0.471 . . . . 1.16 109.806 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -120.36 110.28 16.35 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.109 0.48 . . . . 2.08 110.447 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.9 mt -63.71 131.11 94.79 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.503 -0.771 . . . . 1.51 109.517 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -32.83 102.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.771 3.647 . . . . 1.11 113.867 -171.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 pp -70.03 135.58 49.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.101 -0.954 . . . . 2.15 112.636 -171.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.3 137.74 32.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.349 -0.842 . . . . 2.07 109.333 170.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.8 mp -71.39 131.83 34.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.405 -0.591 . . . . 2.56 109.405 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.77 -6.95 59.0 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.598 -0.728 . . . . 1.09 111.687 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -106.99 152.69 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.642 0.734 . . . . 1.29 111.803 179.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.4 152.7 20.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.458 -1.247 . . . . 1.34 111.359 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 61' ' ' GLU . 6.2 tp -56.81 -40.68 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.227 0.611 . . . . 1.49 112.1 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.433 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -84.92 -11.19 56.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.398 -0.365 . . . . 2.2 111.598 -172.149 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -95.56 -34.3 12.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.383 -0.599 . . . . 1.98 109.383 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.465 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 9.6 tp10 -67.55 -40.23 84.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.138 -0.937 . . . . 2.09 110.711 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.56 148.36 41.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.293 -0.412 . . . . 0.6 109.961 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -99.79 45.7 0.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.874 0.845 . . . . 2.81 109.667 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 46.3 m-80 -122.11 -172.36 2.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.103 -0.953 . . . . 1.39 108.982 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 m -85.93 126.12 66.59 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-O 121.167 0.508 . . . . 1.12 110.552 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -83.06 136.07 7.81 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.079 2.519 . . . . 0.65 111.105 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.8 p -133.8 150.91 51.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.794 0.33 . . . . 1.1 111.147 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 44.0 t -95.37 115.46 27.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.727 -0.842 . . . . 1.26 108.727 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.91 135.65 45.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.467 0.651 . . . . 0.29 110.829 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 9.4 mt-10 -70.14 -19.42 63.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.946 -1.025 . . . . 1.69 109.837 175.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -169.68 161.44 9.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.909 -1.041 . . . . 1.26 108.616 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.558 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -145.28 136.9 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.635 -0.505 . . . . 1.59 109.635 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.84 160.85 14.02 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.361 -0.381 . . . . 1.87 110.108 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 78' ' ' GLY . 3.1 t70 62.34 -153.34 0.35 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.348 -0.612 . . . . 1.94 109.348 -177.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.81 23.58 0.43 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.095 0.474 . . . . 2.12 110.705 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.558 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 105.38 23.58 7.54 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.889 -0.672 . . . . 0.53 112.423 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -78.66 -33.04 47.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.865 0.364 . . . . 1.77 111.243 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.69 108.29 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.319 -0.4 . . . . 1.1 110.036 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.714 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -97.16 140.04 14.83 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.064 -1.065 . . . . 0.26 112.527 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.454 HG22 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -102.97 116.8 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 109.52 -0.548 . . . . 1.07 109.52 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 96.5 m-20 62.58 41.59 9.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.428 -0.805 . . . . 0.34 110.773 175.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.714 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 60.5 m -80.42 110.9 16.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.81 111.086 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 m -103.85 132.21 21.25 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.154 -0.475 . . . . 1.14 110.13 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.41 129.13 21.82 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.041 2.494 . . . . 0.59 112.1 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 11.7 pt -105.73 146.61 33.18 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.908 -0.587 . . . . 1.21 111.776 -173.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 11.4 Cg_exo . . . . . 0 N--CA 1.461 -0.397 0 C-N-CA 123.286 2.658 . . . . 1.22 112.04 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.8 m95 . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.208 0.528 . . . . 0.9 111.773 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.89 115.77 20.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.286 -0.87 . . . . 2.73 110.202 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.2 m -88.13 23.57 2.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.236 -0.438 . . . . 2.09 110.868 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -46.98 -49.06 21.4 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.557 -0.747 . . . . 3.61 112.246 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -62.76 -21.33 65.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.676 -0.693 . . . . 2.26 111.976 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.97 16.26 76.53 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.276 -0.488 . . . . 0.95 113.336 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 m -85.35 -8.93 58.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.161 0.43 . . . . 2.08 112.161 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 87' ' ' ILE . 1.8 m -132.32 141.05 48.8 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.499 -0.481 . . . . 1.19 111.373 -170.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -92.8 -30.45 15.47 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.147 0.425 . . . . 1.66 112.147 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.4 p -92.15 -31.98 15.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.165 0.507 . . . . 1.12 111.364 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.78 4.46 67.45 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.58 -0.819 . . . . 0.43 111.99 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 63.7 mttp -87.34 87.8 7.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.069 0.462 . . . . 2.19 109.865 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.853 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 8.7 mp -94.1 134.96 35.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.872 -0.603 . . . . 1.12 109.975 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -149.01 146.57 27.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.914 0.388 . . . . 1.06 110.299 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 98.2 m -88.93 100.82 13.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.339 0.59 . . . . 0.74 110.019 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 79.9 m -111.02 158.92 18.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.723 -0.671 . . . . 0.5 111.484 -168.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -99.04 107.76 20.25 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.166 -0.679 . . . . 1.65 109.166 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.8 p -70.68 -13.18 61.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.784 -0.643 . . . . 1.12 111.162 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -95.51 -10.88 28.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.395 0.617 . . . . 2.85 109.674 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -115.04 140.37 49.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.224 -0.898 . . . . 3.03 110.113 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.541 ' HD3' HG23 ' A' ' 47' ' ' ILE . 44.5 mmtm -124.51 155.19 39.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.291 -0.868 . . . . 2.7 111.072 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.564 HG23 ' OE1' ' A' ' 48' ' ' GLN . 3.1 t -113.69 149.17 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.112 -0.699 . . . . 1.3 109.112 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -93.81 20.96 6.99 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.048 0.451 . . . . 3.31 110.704 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 30.1 mmmt -126.77 132.62 51.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.027 -0.533 . . . . 4.49 110.649 -178.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -114.48 42.82 2.03 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.709 -0.849 . . . . 2.89 108.709 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -108.36 168.12 9.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.785 -1.098 . . . . 2.23 111.601 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' OD2' ' A' ' 73' ' ' ASP . . . 170.91 -149.18 12.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.08 -0.581 . . . . 1.39 112.217 -176.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.81 -51.55 6.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.037 0.446 . . . . 3.06 110.92 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.973 -0.558 . . . . 2.44 109.738 -179.3 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.565 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 19.3 mt-30 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.078 0.466 . . . . 1.94 110.762 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 83' ' ' ASN . 13.5 p -115.35 123.8 71.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.556 -0.747 . . . . 1.98 109.965 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -105.85 100.15 9.71 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.595 -0.729 . . . . 1.06 110.38 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.541 HG23 ' HD3' ' A' ' 24' ' ' LYS . 20.1 pt -107.36 146.83 13.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.201 0.524 . . . . 1.06 110.489 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.564 ' OE1' HG23 ' A' ' 25' ' ' VAL . 17.9 tp60 -74.9 118.32 17.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.303 -0.862 . . . . 2.55 108.954 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.686 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 3.4 t -115.97 164.27 14.67 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.658 -0.701 . . . . 1.15 110.594 -171.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -162.42 131.98 4.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.174 0.511 . . . . 1.16 110.526 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -121.1 123.14 41.6 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.135 -0.484 . . . . 2.08 111.35 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 64' ' ' CYS . 45.9 mt -64.52 135.07 96.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.438 -0.801 . . . . 1.51 109.654 173.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.4 111.66 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.063 3.175 . . . . 1.11 112.593 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.68 141.91 31.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.821 -1.081 . . . . 2.15 112.769 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 mp -93.87 132.35 38.39 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.692 -0.855 . . . . 2.07 108.692 167.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.491 HD11 ' H ' ' A' ' 56' ' ' ILE . 3.9 mp -67.11 131.85 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.225 0.536 . . . . 2.56 110.072 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.69 -5.89 56.99 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.493 -0.776 . . . . 1.09 112.017 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.62 150.5 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.739 0.781 . . . . 1.29 111.471 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.47 132.17 34.97 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.91 -1.495 . . . . 1.34 110.105 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 61' ' ' GLU . 10.7 tt -53.96 -34.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.207 -0.906 . . . . 1.49 111.907 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' N ' HG23 ' A' ' 60' ' ' ILE . 2.0 pt-20 -73.75 -18.13 61.02 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.942 -1.027 . . . . 2.2 111.494 -173.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -110.99 4.8 19.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.188 0.518 . . . . 1.98 110.585 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -95.67 -40.35 9.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.436 0.636 . . . . 2.09 110.311 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.421 ' HA ' HD12 ' A' ' 52' ' ' ILE . 15.3 p -105.92 -176.4 3.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.869 -0.605 . . . . 0.6 110.667 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -127.56 35.84 4.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.372 0.606 . . . . 2.81 109.767 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 52.8 m-80 -135.01 -170.77 2.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 1.39 110.339 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 89.7 m -80.91 124.86 81.18 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 121.322 0.582 . . . . 1.12 111.996 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.76 115.52 2.97 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.393 2.728 . . . . 0.65 111.583 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -132.22 159.81 37.95 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.478 -0.564 . . . . 1.1 109.478 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.853 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 85.6 m -121.76 122.8 40.33 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.274 0.559 . . . . 1.26 109.982 174.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.443 ' HB2' HG23 ' A' ' 74' ' ' VAL . 37.8 m -100.92 143.12 31.45 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.107 -0.951 . . . . 0.29 110.627 -172.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 6.9 mm-40 -77.42 -17.35 58.2 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.673 -1.149 . . . . 1.69 109.613 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.45 ' OD2' ' HA3' ' A' ' 30' ' ' GLY . 4.3 t70 -165.04 155.61 14.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.076 -0.965 . . . . 1.26 108.889 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.496 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -149.75 130.54 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 110.207 -0.294 . . . . 1.59 110.207 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.403 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 30.5 tt0 -96.99 164.99 12.29 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.963 -0.384 . . . . 1.87 109.963 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 78' ' ' GLY . 39.5 m-20 65.26 -154.25 0.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.401 -0.592 . . . . 1.94 109.401 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -72.63 2.48 6.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.54 0.686 . . . . 2.12 109.843 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.686 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.38 24.09 2.48 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.648 -0.705 . . . . 0.53 112.271 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 2.0 mm? -79.08 -29.76 43.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.689 0.255 . . . . 1.77 111.689 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.4 t -118.38 102.97 13.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.941 -0.304 . . . . 1.1 110.192 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.592 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -104.53 136.26 12.96 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.309 -0.948 . . . . 0.26 113.009 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -99.32 122.95 51.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.12 -0.54 . . . . 1.07 109.624 177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.565 ' OD1' ' HA ' ' A' ' 44' ' ' GLN . 70.8 m-20 60.45 48.0 8.15 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.457 0.473 . . . . 0.34 110.931 175.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.592 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 58.3 m -84.54 90.76 7.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.025 -0.534 . . . . 0.81 110.422 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.7 m -79.15 127.84 77.96 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.587 -0.733 . . . . 1.14 110.227 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.03 109.53 1.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.7 2.267 . . . . 0.59 110.737 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.622 HG21 ' SG ' ' A' ' 11' ' ' CYS . 12.0 pt -82.32 146.81 55.16 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.642 -0.708 . . . . 1.21 111.87 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 N--CA 1.457 -0.653 0 C-N-CA 123.249 2.632 . . . . 1.22 111.206 175.931 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.441 ' HH2' ' OE1' ' A' ' 63' ' ' GLU . 94.1 m95 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.563 0.22 . . . . 0.9 111.423 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -59.83 111.77 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 2.73 111.551 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -99.38 -19.92 16.76 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.729 -0.669 . . . . 2.09 111.034 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -17.33 64.7 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.938 0.399 . . . . 3.61 111.141 -177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -72.97 -30.14 63.6 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.081 -0.509 . . . . 2.26 110.983 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.81 16.99 74.82 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.886 -0.597 . . . . 0.95 112.308 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.5 p -85.89 -19.26 30.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.793 0.33 . . . . 2.08 111.724 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.8 t -130.49 143.84 51.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.929 0.395 . . . . 1.19 111.033 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -91.13 -31.6 16.16 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.027 -0.533 . . . . 1.66 110.61 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.5 p -90.36 -30.57 17.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.578 -0.737 . . . . 1.12 111.002 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.58 2.22 61.71 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.632 -0.713 . . . . 0.43 111.913 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HD3' HG23 ' A' ' 74' ' ' VAL . 94.0 mttt -91.55 87.59 6.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.046 0.451 . . . . 2.19 110.267 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 mp -97.63 100.22 11.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.857 -0.61 . . . . 1.12 109.845 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.48 145.53 40.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.06 0.457 . . . . 1.06 110.437 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 66' ' ' ASN . 84.6 m -80.57 108.19 14.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.795 -0.639 . . . . 0.74 109.646 172.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 62.5 m -126.91 153.65 45.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.885 -0.598 . . . . 0.5 111.368 -172.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -95.61 111.65 23.53 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.475 -0.784 . . . . 1.65 109.854 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.4 p -75.28 -11.06 59.98 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.28 0.562 . . . . 1.12 110.709 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -93.87 -8.96 38.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.555 0.693 . . . . 2.85 109.248 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -119.74 125.4 48.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.994 -1.003 . . . . 3.03 110.692 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -113.11 154.0 27.3 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.535 -1.212 . . . . 2.7 111.066 -170.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.572 HG23 ' NE2' ' A' ' 48' ' ' GLN . 9.6 t -115.13 148.75 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.862 -0.792 . . . . 1.3 108.862 175.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -98.34 29.74 3.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.908 0.385 . . . . 3.31 111.081 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -130.38 118.74 21.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.34 -0.391 . . . . 4.49 110.791 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.5 m -111.96 53.96 0.71 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 2.89 110.089 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.42 -93.91 0.26 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.615 -0.72 . . . . 2.23 111.647 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.03 155.18 15.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 1.39 111.859 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.73 -50.22 4.54 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.598 -0.354 . . . . 3.06 110.921 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--N 1.327 -0.388 0 C-N-CA 120.887 -0.325 . . . . 2.44 110.492 -176.06 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.513 ' HB3' HG22 ' A' ' 82' ' ' ILE . 35.2 mt-30 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 121.072 0.463 . . . . 1.94 110.441 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 83' ' ' ASN . 11.9 p -101.03 120.94 51.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.41 0.624 . . . . 1.98 110.77 -174.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -103.11 117.09 33.79 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.33 -0.85 . . . . 1.06 110.707 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.416 HD13 ' HB2' ' A' ' 84' ' ' CYS . 18.3 pt -124.31 159.78 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.23 -0.441 . . . . 1.06 109.96 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.572 ' NE2' HG23 ' A' ' 25' ' ' VAL . 3.5 mp0 -72.33 131.32 42.5 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.525 0.678 . . . . 2.55 110.704 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 72.3 m -125.09 149.15 48.13 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.395 -1.275 . . . . 1.15 110.071 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.2 t -161.31 132.96 5.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.105 0.479 . . . . 1.16 110.406 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -121.61 115.93 23.67 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.833 -0.622 . . . . 2.08 110.968 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.429 ' CG2' ' HD2' ' A' ' 53' ' ' PRO . 47.1 mt -58.09 139.31 83.55 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.153 -0.93 . . . . 1.51 109.12 173.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 52' ' ' ILE . 31.4 Cg_exo -34.11 127.77 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 124.262 3.308 . . . . 1.11 114.255 -173.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.71 136.09 57.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.357 -1.292 . . . . 2.15 112.365 -170.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.1 mt -110.13 132.02 54.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.291 -0.868 . . . . 2.07 109.512 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 mt -68.57 132.62 32.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.988 0.423 . . . . 2.56 110.728 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.59 24.94 71.35 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.429 -0.805 . . . . 1.09 112.951 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.488 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -113.41 150.51 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.781 0.801 . . . . 1.29 112.264 -178.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.5 145.64 31.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.126 -1.397 . . . . 1.34 111.457 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 tp -56.9 -42.08 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.698 -0.683 . . . . 1.49 111.547 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.83 -5.23 58.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.329 -0.396 . . . . 2.2 111.675 -173.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -106.69 -28.4 10.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.147 0.498 . . . . 1.98 109.914 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.488 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 32.6 tt0 -68.51 -37.66 80.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 2.09 111.191 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.8 p -113.0 178.23 4.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.092 -0.504 . . . . 0.6 109.979 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -127.33 28.93 5.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.058 0.456 . . . . 2.81 110.763 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 8.3 t-20 -105.25 -140.57 0.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.639 -0.709 . . . . 1.39 109.356 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 27.9 m -116.43 130.23 24.65 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 120.768 0.318 . . . . 1.12 110.48 176.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -78.26 122.89 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.76 2.307 . . . . 0.65 111.404 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.2 p -130.19 147.67 51.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.959 0.409 . . . . 1.1 111.007 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.48 106.77 19.07 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.503 -0.555 . . . . 1.26 109.503 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.0 m -93.86 141.78 28.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.209 0.528 . . . . 0.29 110.72 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.9 tt0 -79.16 -25.98 42.78 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.506 -0.77 . . . . 1.69 109.745 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HA ' ' HZ1' ' A' ' 15' ' ' LYS . 45.3 t0 -160.13 160.12 32.58 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.312 -0.995 . . . . 1.26 108.312 175.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.448 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.3 t -141.69 132.86 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.76 -0.459 . . . . 1.59 109.76 175.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.48 163.73 12.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.564 -0.289 . . . . 1.87 110.444 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 66.65 -152.98 0.22 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.035 -0.53 . . . . 1.94 109.588 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.94 -7.05 19.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.444 0.64 . . . . 2.12 110.449 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.401 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 120.47 23.4 2.87 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.137 -0.785 . . . . 0.53 111.137 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 62.2 mt -91.9 -13.57 31.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.727 -0.236 . . . . 1.77 111.404 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.99 107.97 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.13 -0.322 . . . . 1.1 110.13 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -97.67 144.0 17.04 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.517 -0.849 . . . . 0.26 112.426 -178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -105.23 124.08 59.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.099 -0.334 . . . . 1.07 110.099 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.572 ' HA ' HG12 ' A' ' 45' ' ' VAL . 74.3 m-20 57.57 45.7 18.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.365 0.603 . . . . 0.34 110.796 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.576 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 81.4 m -82.25 92.33 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.248 -0.887 . . . . 0.81 110.631 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 25.1 m -84.03 123.67 75.32 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.68 -0.691 . . . . 1.14 110.385 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 25.0 Cg_exo -64.29 130.91 28.33 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.108 2.538 . . . . 0.59 111.998 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.2 pt -103.3 137.07 19.15 Favored Pre-proline 0 N--CA 1.438 -1.072 0 CA-C-N 115.857 -0.611 . . . . 1.21 110.696 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 8.2 Cg_exo . . . . . 0 N--CA 1.457 -0.625 0 C-N-CA 123.406 2.737 . . . . 1.22 112.559 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 72.3 m95 . . . . . 0 CA--C 1.515 -0.381 0 CA-C-O 121.213 0.53 . . . . 0.9 111.493 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -66.46 117.7 9.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.969 -1.014 . . . . 2.73 110.104 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.0 t -107.71 27.05 9.56 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.878 -0.786 . . . . 2.09 108.878 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -60.83 -38.22 84.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.07 -0.968 . . . . 3.61 110.902 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -65.59 -22.04 66.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.691 -0.686 . . . . 2.26 110.895 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.11 16.04 79.74 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.216 -0.516 . . . . 0.95 112.94 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.402 ' HB3' ' HB ' ' A' ' 87' ' ' ILE . 8.3 m -82.66 -18.57 40.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.998 0.37 . . . . 2.08 111.998 -175.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.3 t -116.47 141.58 47.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.884 0.373 . . . . 1.19 110.649 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.455 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.1 p30 -93.13 -26.21 17.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 1.66 111.822 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.455 HG22 ' OD1' ' A' ' 12' ' ' ASN . 32.2 p -94.98 -30.81 13.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.998 0.427 . . . . 1.12 112.034 -173.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.08 -1.64 74.22 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.591 -0.814 . . . . 0.43 111.521 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -92.47 87.93 6.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.322 -0.622 . . . . 2.19 109.322 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -96.81 139.71 32.46 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.923 -0.58 . . . . 1.12 110.619 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.6 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . . . -147.61 156.61 42.97 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.129 -1.063 . . . . 1.06 108.129 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 93.8 m -99.92 97.45 8.33 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.301 -0.56 . . . . 0.74 109.704 174.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.4 m -110.49 156.57 20.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.679 -0.691 . . . . 0.5 111.147 -168.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 33.4 m-20 -99.94 109.72 22.08 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.264 -0.643 . . . . 1.65 109.264 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.1 p -71.87 -8.03 51.96 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.808 -0.633 . . . . 1.12 111.287 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -100.85 -6.76 24.31 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.243 -0.651 . . . . 2.85 109.243 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 30.1 mtpp -116.64 117.32 29.49 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.969 -1.014 . . . . 3.03 109.812 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -128.62 152.58 48.19 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.584 0.586 . . . . 2.7 112.584 -171.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 27' ' ' LYS . 6.5 t -99.36 150.36 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.144 -0.935 . . . . 1.3 110.416 -174.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -91.29 13.21 17.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.644 -0.707 . . . . 3.31 110.088 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' H ' HG12 ' A' ' 25' ' ' VAL . 13.6 mmmm -131.62 142.3 49.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.046 -0.979 . . . . 4.49 108.767 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 t -139.18 80.39 1.78 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.7 0.762 . . . . 2.89 110.002 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.54 ' HB ' ' OE2' ' A' ' 75' ' ' GLU . 5.1 m -115.96 143.16 45.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.074 -0.966 . . . . 2.23 109.94 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -114.22 149.02 18.79 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.674 -0.774 . . . . 1.39 112.253 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.52 -51.09 4.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.399 -0.593 . . . . 3.06 109.399 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 2.44 109.928 176.778 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.539 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.5 mt-30 . . . . . 0 C--O 1.234 0.257 0 CA-C-O 121.012 0.434 . . . . 1.94 110.85 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.0 t -83.68 112.57 21.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.896 -0.593 . . . . 1.98 110.171 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.63 105.61 15.73 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.437 -0.801 . . . . 1.06 110.556 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 11.5 pt -110.21 152.76 12.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.218 -0.446 . . . . 1.06 111.014 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -72.07 142.02 49.23 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.506 -0.77 . . . . 2.55 110.287 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.639 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.4 t -144.79 165.69 27.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.56 -1.2 . . . . 1.15 109.993 -170.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.3 t -160.04 153.06 21.68 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.248 -0.279 . . . . 1.16 110.248 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -120.5 122.8 41.43 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.415 -0.587 . . . . 2.08 109.415 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 64' ' ' CYS . 46.7 mt -92.64 131.92 32.79 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.511 -0.552 . . . . 1.51 109.511 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -33.88 99.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.575 3.516 . . . . 1.11 113.504 -174.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 pp -78.31 140.61 38.8 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.987 -1.006 . . . . 2.15 111.412 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 2.6 mm? -77.74 138.86 39.26 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.199 -1.037 . . . . 2.07 108.199 171.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.7 mt -61.02 129.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.025 0.441 . . . . 2.56 110.416 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.4 2.91 88.92 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.513 -0.767 . . . . 1.09 112.763 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -95.92 152.63 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.724 0.773 . . . . 1.29 111.601 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.66 152.13 23.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.395 -1.275 . . . . 1.34 111.401 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 61' ' ' GLU . 10.5 tt -52.29 -38.77 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.943 0.878 . . . . 1.49 110.857 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.587 ' N ' HG23 ' A' ' 60' ' ' ILE . 34.9 mt-10 -64.24 -16.01 61.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.825 -1.079 . . . . 2.2 111.766 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -111.34 -8.12 14.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.036 0.384 . . . . 1.98 112.036 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 1.9 pp20? -94.53 -33.76 12.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.433 -0.507 . . . . 2.09 111.599 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.459 ' HA ' HD12 ' A' ' 52' ' ' ILE . 3.8 p -113.44 156.52 23.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.063 0.459 . . . . 0.6 111.408 -173.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 4.1 tppp? -110.89 26.41 10.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.085 0.945 . . . . 2.81 108.976 173.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 4.3 m-20 -105.07 -168.49 1.48 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.199 -0.91 . . . . 1.39 109.471 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -88.67 124.62 65.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-O 121.388 0.613 . . . . 1.12 111.408 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -60.19 113.91 1.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.21 2.607 . . . . 0.65 110.986 173.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.844 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 0.8 OUTLIER -124.99 139.54 53.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.964 0.412 . . . . 1.1 111.41 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.9 t -102.65 105.56 16.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.224 -0.658 . . . . 1.26 109.224 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 67.3 m -86.77 145.36 26.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.927 -0.397 . . . . 0.29 109.927 -174.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.4 tt0 -76.3 -24.17 54.37 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.705 -0.85 . . . . 1.69 108.705 172.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -163.25 157.98 20.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.823 -1.081 . . . . 1.26 108.481 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.519 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -138.45 138.4 42.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.804 -0.358 . . . . 1.59 110.095 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.54 ' OE2' ' HB ' ' A' ' 29' ' ' THR . 43.9 tt0 -106.42 155.33 19.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.276 -0.42 . . . . 1.87 110.311 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 78' ' ' GLY . 2.4 t70 66.78 -152.64 0.21 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.661 0.601 . . . . 1.94 109.667 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.01 0.69 5.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.111 0.482 . . . . 2.12 110.611 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 115.4 23.69 4.37 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.043 -0.599 . . . . 0.53 111.971 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.4 mt -79.35 -24.81 42.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.007 0.432 . . . . 1.77 110.892 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.97 108.67 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.721 -0.474 . . . . 1.1 109.721 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.99 133.53 11.4 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.298 -0.954 . . . . 0.26 111.81 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -95.23 118.47 41.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 110.136 -0.32 . . . . 1.07 110.136 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 89.8 m-20 57.75 42.53 23.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.382 -0.827 . . . . 0.34 110.825 174.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.844 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -78.27 105.14 9.31 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.689 -0.687 . . . . 0.81 110.351 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 20.5 m -83.45 128.22 65.1 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.422 -0.808 . . . . 1.14 109.738 177.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 33.3 Cg_exo -61.35 119.91 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.56 2.173 . . . . 0.59 110.779 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 10' ' ' SER . 8.4 pt -106.87 146.85 33.95 Favored Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-O 121.137 0.494 . . . . 1.21 111.458 -174.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 N--CA 1.444 -1.406 0 C-N-CA 123.461 2.774 . . . . 1.22 112.31 -177.593 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.509 ' CZ2' HD23 ' A' ' 54' ' ' LEU . 78.2 m95 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.678 -0.49 . . . . 0.9 109.678 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -76.81 108.28 9.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.93 0.395 . . . . 2.73 110.775 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.9 m -94.82 13.32 25.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.905 -0.589 . . . . 2.09 109.551 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -19.82 55.03 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.453 -0.794 . . . . 3.61 111.302 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -74.68 -16.47 60.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.948 -0.569 . . . . 2.26 110.898 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.22 69.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.949 -0.643 . . . . 0.95 111.607 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.6 p -87.23 -29.65 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.623 0.601 . . . . 2.08 112.623 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.4 t -129.3 141.31 51.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.604 0.716 . . . . 1.19 111.313 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.36 -30.53 15.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.509 -1.223 . . . . 1.66 111.704 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -30.55 14.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.069 0.396 . . . . 1.12 112.069 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.55 -9.51 57.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.553 -0.832 . . . . 0.43 112.626 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.514 ' HD3' HG22 ' A' ' 74' ' ' VAL . 90.9 mttt -89.48 88.11 7.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.957 0.408 . . . . 2.19 110.347 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.49 138.09 31.83 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.357 -0.609 . . . . 1.12 109.357 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.01 156.62 44.46 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.87 0.367 . . . . 1.06 110.71 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 50' ' ' THR . 51.2 m -91.34 101.93 14.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.697 -0.853 . . . . 0.74 108.697 171.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.8 m -121.32 142.51 49.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.213 0.53 . . . . 0.5 111.312 -171.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -93.72 108.26 20.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.408 -0.815 . . . . 1.65 109.235 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.7 p -74.15 -6.93 50.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.886 -0.597 . . . . 1.12 111.24 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -91.85 -20.58 21.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.843 0.83 . . . . 2.85 108.822 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -104.34 135.31 46.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.476 -1.238 . . . . 3.03 110.623 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.49 ' HD2' HG21 ' A' ' 47' ' ' ILE . 14.4 mmmm -119.91 156.56 30.52 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.831 -1.077 . . . . 2.7 110.052 -175.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.06 150.27 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.002 0.429 . . . . 1.3 110.303 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -78.1 30.25 0.17 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.44 -0.8 . . . . 3.31 111.837 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -133.49 160.06 38.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 4.49 111.26 -173.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.8 t -148.02 23.55 1.07 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.939 0.876 . . . . 2.89 108.942 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.7 p -102.56 145.09 30.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.909 -1.041 . . . . 2.23 111.652 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.66 155.77 15.94 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.966 -0.854 . . . . 1.39 110.966 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -100.88 -50.11 3.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.976 0.388 . . . . 3.06 111.158 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 120.904 0.383 . . . . 2.44 110.457 -179.793 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.496 ' HB3' HG21 ' A' ' 82' ' ' ILE . 37.0 mt-30 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 121.444 0.64 . . . . 1.94 111.105 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.606 HG11 ' HA ' ' A' ' 83' ' ' ASN . 8.3 p -99.47 136.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.356 -0.838 . . . . 1.98 109.399 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.37 110.94 17.55 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.618 -0.719 . . . . 1.06 110.576 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.49 HG21 ' HD2' ' A' ' 24' ' ' LYS . 7.9 pt -114.78 160.52 14.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.783 -0.644 . . . . 1.06 110.342 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.37 129.58 34.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.836 -0.62 . . . . 2.55 110.232 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.8 m -128.84 154.99 45.91 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.779 -1.1 . . . . 1.15 110.554 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 5.8 t -157.39 136.29 11.62 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.834 -0.621 . . . . 1.16 109.494 -177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -121.0 114.31 21.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.258 0.552 . . . . 2.08 111.262 -176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.9 mt -78.29 133.89 63.58 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.099 -0.955 . . . . 1.51 109.39 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -33.94 116.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.642 3.561 . . . . 1.11 113.564 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.509 HD23 ' CZ2' ' A' ' 4' ' ' TRP . 3.6 pp -100.12 141.72 32.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.911 -1.04 . . . . 2.15 111.989 -169.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.599 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 94.4 mt -80.72 133.74 35.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.255 -1.017 . . . . 2.07 108.255 167.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.7 mt -67.72 128.81 31.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.143 0.497 . . . . 2.56 110.199 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.53 9.18 63.29 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.554 -0.748 . . . . 1.09 111.725 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -98.76 157.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.277 0.56 . . . . 1.29 110.771 177.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' N ' HG21 ' A' ' 58' ' ' ILE . . . -88.7 137.88 31.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.969 -1.014 . . . . 1.34 110.914 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.511 HG21 ' N ' ' A' ' 61' ' ' GLU . 7.9 tp -53.1 -38.45 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.016 -0.993 . . . . 1.49 112.056 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.511 ' N ' HG21 ' A' ' 60' ' ' ILE . 3.9 pt-20 -79.49 -17.86 53.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.356 -0.384 . . . . 2.2 111.533 -174.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -102.45 -3.06 27.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.968 0.413 . . . . 1.98 110.349 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -102.38 -22.19 14.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.039 -0.528 . . . . 2.09 110.744 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.51 156.64 48.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.471 -0.331 . . . . 0.6 110.236 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -104.64 44.7 1.01 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.285 0.564 . . . . 2.81 110.889 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 3.9 m-20 -124.55 -165.68 1.41 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.492 -0.776 . . . . 1.39 109.723 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -87.76 128.35 54.68 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 120.91 0.386 . . . . 1.12 110.243 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.33 125.46 5.15 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.746 2.297 . . . . 0.65 110.915 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.82 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 2.9 p -124.64 153.42 42.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.972 0.415 . . . . 1.1 111.466 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.2 t -107.55 102.8 12.03 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.263 -0.643 . . . . 1.26 109.263 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 84' ' ' CYS . 97.6 m -84.64 142.11 30.15 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.039 -0.356 . . . . 0.29 110.039 -176.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.6 tt0 -76.1 -27.44 57.15 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.62 -0.881 . . . . 1.69 108.62 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 71' ' ' CYS . 24.6 t0 -159.57 162.8 35.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.874 -1.057 . . . . 1.26 108.66 175.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.514 HG22 ' HD3' ' A' ' 15' ' ' LYS . 2.3 t -140.16 134.72 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.841 -0.429 . . . . 1.59 109.841 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -106.15 165.91 10.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.795 -0.446 . . . . 1.87 109.795 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 78' ' ' GLY . 2.1 t70 67.4 -151.92 0.19 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.231 0.612 . . . . 1.94 109.457 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -79.17 22.86 0.39 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.969 0.414 . . . . 2.12 110.553 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 98.19 23.15 13.36 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.924 -0.655 . . . . 0.53 112.041 -177.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.73 -17.18 28.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 1.77 111.217 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.88 103.68 11.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.498 -0.319 . . . . 1.1 110.51 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA3' ' SG ' ' A' ' 71' ' ' CYS . . . -94.29 133.11 11.46 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.354 -0.926 . . . . 0.26 112.368 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.496 HG21 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -97.61 126.71 50.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 122.441 0.296 . . . . 1.07 110.255 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.606 ' HA ' HG11 ' A' ' 45' ' ' VAL . 85.3 m-20 53.52 43.56 31.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 123.84 0.712 . . . . 0.34 110.398 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.82 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -87.49 102.89 15.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.406 -0.816 . . . . 0.81 110.15 -177.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 m -83.12 130.67 56.25 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.891 -0.595 . . . . 1.14 110.111 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.33 109.84 2.98 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.974 2.449 . . . . 0.59 111.906 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.2 pt -83.69 137.44 41.33 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.576 -0.738 . . . . 1.21 111.176 -175.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.5 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 C-N-CA 123.349 2.699 . . . . 1.22 112.079 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.475 ' CE3' ' HB ' ' A' ' 60' ' ' ILE . 71.8 m95 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.053 0.454 . . . . 0.9 111.608 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -78.04 107.69 10.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 2.73 109.724 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.8 t -111.75 27.51 9.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.349 0.595 . . . . 2.09 109.744 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -24.86 61.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.514 -0.766 . . . . 3.61 112.723 -172.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 t -91.6 5.17 50.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.635 -0.426 . . . . 2.26 110.931 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.22 17.8 75.67 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.598 -0.811 . . . . 0.95 111.839 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 p -69.38 -30.81 68.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.627 0.603 . . . . 2.08 112.627 -172.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.1 t -132.35 141.3 48.87 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.263 -0.575 . . . . 1.19 111.482 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.546 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.9 p30 -93.08 -29.53 15.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.561 -0.745 . . . . 1.66 111.593 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.546 HG22 ' OD1' ' A' ' 12' ' ' ASN . 2.6 p -95.42 -31.38 13.41 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.531 0.567 . . . . 1.12 112.531 -173.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.72 -18.26 44.22 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.339 -0.934 . . . . 0.43 113.267 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HD3' HG22 ' A' ' 74' ' ' VAL . 81.9 mttt -84.83 89.4 7.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.168 0.484 . . . . 2.19 110.478 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 4' ' ' TRP . 8.8 mp -91.87 137.68 32.17 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.921 -0.4 . . . . 1.12 109.921 175.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.591 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -145.67 152.03 38.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.907 0.384 . . . . 1.06 110.383 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 36.1 m -87.5 98.65 11.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.502 -0.555 . . . . 0.74 109.502 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 86.3 m -117.3 161.97 18.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.495 . . . . 0.5 111.515 -167.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -99.46 98.71 9.59 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.65 109.939 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.8 p -70.31 -7.66 44.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.836 -0.62 . . . . 1.12 112.151 -173.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -103.14 -10.55 18.74 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.189 0.995 . . . . 2.85 108.788 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 48' ' ' GLN . 40.8 tptt -118.06 99.53 6.95 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.416 -1.72 . . . . 3.03 110.497 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.76 170.31 12.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.036 -0.984 . . . . 2.7 111.047 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.04 150.49 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.59 -0.732 . . . . 1.3 109.18 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -74.58 23.83 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.189 0.811 . . . . 3.31 113.189 -173.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -136.74 160.11 39.83 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.967 -0.458 . . . . 4.49 111.555 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 p -134.64 38.74 3.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.598 0.713 . . . . 2.89 109.605 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 p -89.39 -172.98 3.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.218 -0.901 . . . . 2.23 111.229 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.21 146.57 8.42 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.72 -0.752 . . . . 1.39 111.982 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -82.22 -50.46 8.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.943 0.402 . . . . 3.06 110.431 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.895 -0.593 . . . . 2.44 109.968 179.004 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.431 ' HB3' HG22 ' A' ' 82' ' ' ILE . 15.8 mt-30 . . . . . 0 CA--C 1.517 -0.296 0 CA-C-O 121.19 0.519 . . . . 1.94 110.687 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.68 107.53 20.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.41 -0.813 . . . . 1.98 110.067 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -95.38 122.45 38.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.488 -0.778 . . . . 1.06 110.336 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 84' ' ' CYS . 22.0 pt -122.79 157.82 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.192 -0.458 . . . . 1.06 110.472 176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.414 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -71.4 138.96 49.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.538 -0.756 . . . . 2.55 109.189 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.591 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 1.8 t -142.78 156.58 45.0 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.885 0.374 . . . . 1.15 111.172 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -162.95 122.21 2.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.552 -0.749 . . . . 1.16 109.766 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.437 ' HG2' ' SG ' ' A' ' 18' ' ' CYS . 11.5 tm0? -120.95 115.67 23.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.826 0.346 . . . . 2.08 110.539 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.3 mt -52.35 135.42 41.85 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-N 115.207 -0.906 . . . . 1.51 110.192 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -33.37 107.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 124.507 3.472 . . . . 1.11 113.88 -174.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.54 ' HA ' ' OE1' ' A' ' 63' ' ' GLU . 3.5 pp -59.3 140.76 55.72 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.755 -1.111 . . . . 2.15 113.837 -168.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -111.26 115.85 30.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.663 -1.153 . . . . 2.07 109.438 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.3 mm -63.64 139.12 21.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.416 0.627 . . . . 2.56 111.14 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.42 -23.84 33.19 Favored Glycine 0 C--N 1.315 -0.602 0 CA-C-N 115.166 -0.925 . . . . 1.09 112.961 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.66 152.04 3.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.768 0.794 . . . . 1.29 111.759 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.07 124.15 27.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.318 -1.31 . . . . 1.34 110.749 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.672 HG23 ' N ' ' A' ' 61' ' ' GLU . 13.3 tt -53.62 -33.1 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.044 -0.98 . . . . 1.49 111.017 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.672 ' N ' HG23 ' A' ' 60' ' ' ILE . 2.8 mp0 -61.34 -29.88 70.16 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.41 -1.268 . . . . 2.2 111.437 -173.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -106.64 -20.47 13.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.054 -0.521 . . . . 1.98 110.452 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 54' ' ' LEU . 29.5 tt0 -67.2 -41.14 86.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 2.09 111.129 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.6 p -105.02 -173.64 2.35 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.976 -0.556 . . . . 0.6 109.726 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -132.2 43.68 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.309 0.576 . . . . 2.81 110.817 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 49.8 m-80 -137.55 -171.16 2.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.487 -0.931 . . . . 1.39 108.487 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.8 m -81.29 122.12 80.93 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.314 0.578 . . . . 1.12 111.614 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.69 124.2 11.66 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.255 2.637 . . . . 0.65 111.036 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -132.5 149.92 52.25 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.788 -0.365 . . . . 1.1 111.237 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 11.6 t -94.74 112.11 23.86 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.477 -0.564 . . . . 1.26 109.477 172.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.4 m -99.36 139.41 35.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.253 0.549 . . . . 0.29 110.333 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.0 tt0 -77.22 -23.93 51.32 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.458 -0.792 . . . . 1.69 109.415 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -163.86 165.09 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.991 -1.004 . . . . 1.26 108.407 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.542 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.0 t -142.2 136.38 29.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 117.947 0.34 . . . . 1.59 110.339 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.81 162.6 12.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.739 -0.467 . . . . 1.87 109.739 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 62.26 -154.37 0.35 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.54 -0.541 . . . . 1.94 109.54 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.5 7.79 6.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.641 0.734 . . . . 2.12 109.848 174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.04 22.61 2.89 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.487 -0.779 . . . . 0.53 112.596 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.2 mm? -83.82 -23.62 31.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.69 0.256 . . . . 1.77 111.69 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.8 t -129.21 106.88 14.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.972 -0.381 . . . . 1.1 109.972 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -97.49 144.05 17.08 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.384 -0.912 . . . . 0.26 112.399 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.431 HG22 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -102.15 119.03 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 110.003 -0.369 . . . . 1.07 110.003 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 87.4 m-20 61.36 43.7 10.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.499 -0.773 . . . . 0.34 110.565 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.601 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 60.3 m -82.78 99.03 9.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.349 -0.841 . . . . 0.81 111.0 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.3 m -89.37 131.98 38.77 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.096 -0.502 . . . . 1.14 110.436 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.55 126.43 14.11 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.079 2.52 . . . . 0.59 112.208 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.2 pt -105.8 152.41 40.17 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.769 -0.65 . . . . 1.21 111.091 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo . . . . . 0 N--CA 1.463 -0.281 0 C-N-CA 123.246 2.63 . . . . 1.22 112.455 179.366 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.3 m95 . . . . . 0 C--O 1.236 0.36 0 N-CA-C 110.101 -0.333 . . . . 0.9 110.101 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.2 109.14 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.481 . . . . 2.73 111.174 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.478 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 11.1 m -105.44 26.45 9.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.829 -0.623 . . . . 2.09 110.491 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -59.47 -15.25 16.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.952 -0.567 . . . . 3.61 112.102 -176.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -73.02 -15.58 61.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.084 0.468 . . . . 2.26 110.958 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.4 8.26 70.42 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.822 -0.626 . . . . 0.95 111.664 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.5 t -88.07 -9.71 52.47 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.863 0.363 . . . . 2.08 110.692 -176.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.2 t -123.71 139.78 53.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.167 0.508 . . . . 1.19 110.307 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.44 -31.89 13.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.27 -0.877 . . . . 1.66 112.521 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -102.27 -20.6 14.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.263 0.468 . . . . 1.12 112.263 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.478 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 89.96 4.83 71.63 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.725 -0.75 . . . . 0.43 112.654 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HD3' HG11 ' A' ' 74' ' ' VAL . 66.7 mttm -93.8 88.9 5.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.75 0.309 . . . . 2.19 110.478 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 69' ' ' THR . 7.8 mp -93.66 109.36 21.0 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.541 -0.54 . . . . 1.12 109.541 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.563 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . . . -124.13 144.2 50.03 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.872 0.368 . . . . 1.06 110.956 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 81.5 m -79.91 98.22 7.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 0.74 109.478 175.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 73.1 m -113.42 156.99 22.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.125 0.488 . . . . 0.5 111.461 -169.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 22.7 m-20 -92.01 93.07 8.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.37 -0.832 . . . . 1.65 109.298 174.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.4 p -64.91 -15.23 61.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.693 0.627 . . . . 1.12 112.693 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -106.51 0.44 24.66 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.989 0.899 . . . . 2.85 108.67 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.457 ' HG3' HE21 ' A' ' 48' ' ' GLN . 48.2 tptt -123.98 98.9 6.0 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.08 -1.418 . . . . 3.03 109.529 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -89.16 164.76 14.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.561 -1.199 . . . . 2.7 111.022 -171.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.604 HG21 ' NE2' ' A' ' 48' ' ' GLN . 3.5 t -117.74 149.88 19.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.854 -0.612 . . . . 1.3 110.264 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -80.73 -40.14 25.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.345 -0.613 . . . . 3.31 109.345 174.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -69.4 121.24 16.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.592 -0.731 . . . . 4.49 109.11 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -149.87 79.17 1.37 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.797 -0.361 . . . . 2.89 111.584 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 m -136.54 -61.0 0.7 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.639 -0.424 . . . . 2.23 111.434 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.41 164.11 15.6 Favored Glycine 0 C--N 1.32 -0.327 0 C-N-CA 121.036 -0.602 . . . . 1.39 112.035 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -101.53 -42.26 6.31 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.235 0.457 . . . . 3.06 112.235 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--N 1.327 -0.391 0 C-N-CA 120.87 -0.332 . . . . 2.44 111.434 -175.05 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' HB3' HG23 ' A' ' 82' ' ' ILE . 12.7 mt-30 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.283 0.563 . . . . 1.94 111.407 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.17 121.52 63.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.316 -0.857 . . . . 1.98 109.334 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.99 133.2 52.64 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.638 -0.71 . . . . 1.06 111.229 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 84' ' ' CYS . 12.7 pt -125.61 153.75 33.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.529 -0.76 . . . . 1.06 109.972 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.604 ' NE2' HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -67.69 139.9 56.76 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.389 -0.597 . . . . 2.55 109.389 178.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 17' ' ' ALA . 1.8 t -138.91 156.44 47.27 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.252 -0.431 . . . . 1.15 110.757 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -161.43 140.27 9.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.981 -0.554 . . . . 1.16 109.805 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.455 HE22 HD13 ' A' ' 60' ' ' ILE . 43.9 tp60 -114.6 155.23 26.92 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.026 0.441 . . . . 2.08 110.451 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.0 mm -86.82 150.7 51.03 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.228 -0.896 . . . . 1.51 108.967 176.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -35.14 111.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.137 2.558 . . . . 1.11 111.842 171.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.66 133.17 55.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.175 -0.92 . . . . 2.15 112.926 -167.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.19 124.52 49.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.096 -0.956 . . . . 2.07 109.252 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.6 mt -64.2 130.38 29.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.24 -0.436 . . . . 2.56 110.857 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.84 15.18 71.18 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.418 -0.81 . . . . 1.09 113.217 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.443 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -100.26 152.67 4.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.693 0.759 . . . . 1.29 111.643 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.41 145.91 25.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.363 -1.29 . . . . 1.34 111.237 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.455 HD13 HE22 ' A' ' 51' ' ' GLN . 8.2 tp -53.69 -34.26 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 114.358 -1.292 . . . . 1.49 112.836 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.72 -4.81 58.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.739 0.304 . . . . 2.2 111.655 -172.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -110.09 -27.19 9.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.094 0.473 . . . . 1.98 110.133 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.443 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 32.3 tt0 -71.43 -39.49 71.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.782 -0.645 . . . . 2.09 110.933 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.7 p -121.08 169.06 10.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.214 -0.448 . . . . 0.6 110.492 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -113.98 26.83 9.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.089 0.471 . . . . 2.81 110.455 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 17.0 m-80 -107.06 -160.92 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 1.39 110.126 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 12.4 m -96.63 126.7 42.28 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 120.976 0.417 . . . . 1.12 110.501 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.96 129.21 6.1 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.979 2.453 . . . . 0.65 111.03 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 65.5 p -132.14 157.37 44.44 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.754 -0.379 . . . . 1.1 110.936 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 40.7 t -106.12 102.28 11.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.048 -0.524 . . . . 1.26 109.647 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 55.6 m -88.08 133.75 33.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.973 0.416 . . . . 0.29 110.56 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.0 tt0 -76.3 -23.58 54.34 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.875 -0.602 . . . . 1.69 110.102 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -158.77 169.26 24.78 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.65 -0.87 . . . . 1.26 108.65 170.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.518 HG11 ' HD3' ' A' ' 15' ' ' LYS . 32.8 m -135.84 146.05 30.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.77 0.319 . . . . 1.59 110.562 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -112.22 150.21 31.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.342 -0.985 . . . . 1.87 108.342 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.8 -156.32 0.33 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.754 -0.832 . . . . 1.94 108.754 -170.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -83.07 23.16 0.88 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.522 0.677 . . . . 2.12 110.762 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.552 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 104.22 21.85 9.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.588 -0.815 . . . . 0.53 112.955 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 84.0 mt -85.16 -17.13 38.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.064 0.459 . . . . 1.77 109.987 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.1 t -129.61 110.82 20.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.51 -0.768 . . . . 1.1 109.156 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -101.78 140.62 14.95 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.181 -1.009 . . . . 0.26 112.334 -176.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -97.52 119.36 45.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.058 -0.349 . . . . 1.07 110.058 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 96.0 m-20 59.81 50.54 6.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.678 -0.692 . . . . 0.34 110.832 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.561 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.5 m -85.0 91.34 8.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.379 -0.828 . . . . 0.81 110.924 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.1 m -74.94 126.09 88.64 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.675 -0.693 . . . . 1.14 110.379 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.38 121.66 9.14 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.856 2.37 . . . . 0.59 111.818 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.4 pt -101.09 154.54 37.1 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.799 -0.637 . . . . 1.21 110.847 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 C--O 1.233 0.265 0 C-N-CA 123.206 2.604 . . . . 1.22 112.794 -179.726 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 77.1 m95 . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.9 112.115 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -63.41 108.4 1.33 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.269 -0.878 . . . . 2.73 111.257 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -101.11 -17.5 16.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.162 -0.926 . . . . 2.09 109.365 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 7' ' ' LYS . 2.7 pptp? -69.54 -17.89 63.61 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.901 -0.591 . . . . 3.61 110.745 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.2 m -72.73 -26.85 61.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 2.26 111.159 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.65 16.25 75.93 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.982 -0.628 . . . . 0.95 112.654 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' ' 87' ' ' ILE . 7.8 t -87.32 -29.0 21.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.946 0.403 . . . . 2.08 110.77 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.8 t -115.39 140.94 48.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.898 0.38 . . . . 1.19 110.701 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.45 ' OD1' HG21 ' A' ' 13' ' ' THR . 8.5 p30 -93.09 -25.87 17.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.075 -0.511 . . . . 1.66 112.038 -177.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.45 HG21 ' OD1' ' A' ' 12' ' ' ASN . 43.9 p -92.97 -30.47 15.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 1.12 111.686 -174.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.97 -4.41 59.03 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.748 -0.739 . . . . 0.43 112.027 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HD3' HG22 ' A' ' 74' ' ' VAL . 53.3 mttp -94.19 89.95 6.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.862 0.363 . . . . 2.19 110.666 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 mp -96.17 113.35 24.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.256 -0.429 . . . . 1.12 110.627 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.04 151.1 49.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.877 0.37 . . . . 1.06 110.312 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 50' ' ' THR . 60.8 m -84.84 103.2 13.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.007 -0.738 . . . . 0.74 109.007 173.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 98.4 m -113.13 142.97 45.14 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.17 0.51 . . . . 0.5 110.975 -174.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -97.69 109.19 21.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.487 -0.779 . . . . 1.65 109.238 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 p -75.64 -5.88 47.66 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.411 0.624 . . . . 1.12 110.033 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -89.46 -8.63 52.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.242 -0.89 . . . . 2.85 109.053 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 26.2 mtmt -121.57 142.75 49.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.812 -1.085 . . . . 3.03 110.145 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HD3' HG22 ' A' ' 47' ' ' ILE . 33.7 mmtp -128.39 158.86 37.11 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.63 -0.714 . . . . 2.7 111.082 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 27' ' ' LYS . 10.7 t -124.15 150.03 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.085 -1.08 . . . . 1.3 108.085 173.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -76.48 31.76 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.09 0.404 . . . . 3.31 112.09 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 25' ' ' VAL . 14.6 mtmt 37.81 114.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.997 1.319 . . . . 4.49 113.451 -170.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.8 p -101.24 -81.03 0.49 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.378 -0.828 . . . . 2.89 110.008 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.74 -172.25 3.43 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.641 -1.163 . . . . 2.23 109.162 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.24 116.64 1.13 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.186 -0.766 . . . . 1.39 111.186 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.01 -31.59 72.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.89 0.345 . . . . 3.06 110.55 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 . . . . . 0 C--N 1.329 -0.315 0 N-CA-C 109.73 -0.471 . . . . 2.44 109.73 173.664 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 121.229 0.537 . . . . 1.94 111.955 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.51 126.99 75.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.338 -0.846 . . . . 1.98 109.023 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -110.88 114.33 27.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.301 -0.409 . . . . 1.06 111.805 -175.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.4 HG22 ' HD3' ' A' ' 24' ' ' LYS . 12.4 pt -111.06 163.7 7.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.78 -0.645 . . . . 1.06 109.653 172.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -88.84 127.62 35.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.47 0.652 . . . . 2.55 109.634 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 29.8 m -122.54 160.59 25.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.712 -1.131 . . . . 1.15 110.671 -172.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.597 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 11.2 t -160.89 142.49 12.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.774 -0.454 . . . . 1.16 109.774 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.403 HE21 HD11 ' A' ' 60' ' ' ILE . 8.0 tm0? -120.07 115.87 24.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.266 0.555 . . . . 2.08 110.817 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.409 HD13 ' H ' ' A' ' 65' ' ' LYS . 68.7 mt -73.83 133.14 79.54 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.225 -0.898 . . . . 1.51 109.839 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -33.57 111.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 124.817 3.678 . . . . 1.11 114.096 -172.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.425 ' HA ' ' HG2' ' A' ' 63' ' ' GLU . 4.1 pp -88.42 142.14 27.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.679 -1.146 . . . . 2.15 112.535 -170.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.7 mt -93.94 144.31 25.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.468 -0.787 . . . . 2.07 109.139 168.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 mt -68.78 130.75 33.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.932 0.396 . . . . 2.56 110.678 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.41 -0.57 80.99 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.551 -0.75 . . . . 1.09 112.51 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -93.67 154.08 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.603 0.716 . . . . 1.29 111.488 -178.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.01 132.27 34.75 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.758 -1.11 . . . . 1.34 111.377 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 61' ' ' GLU . 5.5 tp -49.84 -39.46 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 114.761 -1.109 . . . . 1.49 111.505 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 60' ' ' ILE . 8.2 pt-20 -70.9 -34.09 71.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.276 -0.874 . . . . 2.2 111.842 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -91.62 -23.17 19.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.95 0.405 . . . . 1.98 110.843 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 54' ' ' LEU . 7.7 tp10 -73.1 -40.68 64.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 2.09 111.122 -176.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 66' ' ' ASN . 19.8 p -107.15 156.6 18.63 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.915 0.388 . . . . 0.6 110.809 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.409 ' H ' HD13 ' A' ' 52' ' ' ILE . 16.1 tppt? -98.65 55.71 1.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.208 -1.034 . . . . 2.81 108.208 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.59 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 14.2 m120 -138.97 -168.68 2.47 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.13 -1.396 . . . . 1.39 109.073 -172.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -104.46 126.09 32.38 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-O 120.895 0.378 . . . . 1.12 110.119 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -77.88 129.28 9.76 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.628 2.219 . . . . 0.65 110.997 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.0 p -129.51 150.56 50.8 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.096 0.474 . . . . 1.1 111.545 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 54.0 t -98.98 99.09 10.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.686 -0.857 . . . . 1.26 108.686 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 56.6 m -86.61 141.27 29.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 0.29 110.642 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 3.0 tt0 -64.12 -45.25 89.41 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.094 -0.706 . . . . 1.69 109.094 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -151.55 167.79 26.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.66 -1.155 . . . . 1.26 108.724 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.528 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -142.97 158.55 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.472 -0.566 . . . . 1.59 109.472 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.21 156.16 33.04 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.976 -0.379 . . . . 1.87 109.976 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 67.69 -150.08 0.16 Allowed 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 123.577 0.548 . . . . 1.94 109.677 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.416 ' OD1' ' HG ' ' A' ' 79' ' ' LEU . 11.4 p-10 -76.75 0.99 18.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.281 0.563 . . . . 2.12 109.715 174.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' CYS . . . 120.94 24.21 2.56 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.5 -0.773 . . . . 0.53 112.752 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 93.7 mt -79.66 -25.55 41.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.82 0.31 . . . . 1.77 111.757 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.0 t -125.8 107.52 17.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.066 -0.346 . . . . 1.1 110.066 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.565 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -102.13 144.65 16.34 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.391 -0.909 . . . . 0.26 112.911 -174.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 mp -100.41 118.21 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.442 -0.379 . . . . 1.07 110.064 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 93.8 m-20 59.02 43.96 16.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.739 -0.664 . . . . 0.34 111.151 174.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.565 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 69.5 m -78.26 97.16 5.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.842 -0.617 . . . . 0.81 110.958 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 23.8 m -88.4 130.05 47.13 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.725 -0.67 . . . . 1.14 110.207 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.5 Cg_exo -61.07 113.82 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.994 2.463 . . . . 0.59 112.108 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.623 ' HB ' ' OG ' ' A' ' 10' ' ' SER . 7.9 pt -82.47 138.96 44.43 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.91 -0.587 . . . . 1.21 110.835 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 17.1 Cg_exo . . . . . 0 N--CA 1.454 -0.821 0 C-N-CA 123.086 2.524 . . . . 1.22 111.537 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.562 ' CD2' ' HB ' ' A' ' 60' ' ' ILE . 58.2 m95 . . . . . 0 CA--C 1.518 -0.282 0 CA-C-O 121.082 0.468 . . . . 0.9 111.59 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -66.75 109.65 2.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.361 -0.836 . . . . 2.73 110.411 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.3 m -93.95 27.98 2.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.461 -0.79 . . . . 2.09 110.441 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -45.49 -46.81 14.02 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.368 -0.833 . . . . 3.61 112.491 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 p -63.08 -23.92 67.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.202 -0.454 . . . . 2.26 112.165 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.26 5.12 89.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.097 -0.573 . . . . 0.95 111.702 -176.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.5 m -70.43 -13.89 62.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.565 -0.318 . . . . 2.08 111.635 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -131.91 141.12 49.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.015 0.436 . . . . 1.19 110.507 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -94.6 -30.29 14.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.413 -0.812 . . . . 1.66 112.479 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 p -89.52 -30.03 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.983 0.421 . . . . 1.12 111.947 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.58 3.07 71.98 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.575 -0.821 . . . . 0.43 111.556 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -95.74 87.99 4.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.347 0.594 . . . . 2.19 110.133 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 16' ' ' LEU . 8.0 mp -97.35 137.95 35.56 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.351 -0.84 . . . . 1.12 109.758 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.87 145.18 35.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.032 0.444 . . . . 1.06 110.593 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 28.1 m -82.02 102.84 11.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.387 -0.968 . . . . 0.74 108.387 173.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 59.1 m -122.45 156.6 33.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.131 0.491 . . . . 0.5 111.544 -169.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -102.85 118.01 35.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.442 -0.799 . . . . 1.65 109.312 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.9 p -80.96 -5.19 57.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.972 0.415 . . . . 1.12 111.368 -174.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -97.43 -19.85 18.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.675 0.75 . . . . 2.85 109.568 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -104.28 137.89 41.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.683 -1.144 . . . . 3.03 110.614 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.466 ' HD3' HG22 ' A' ' 47' ' ' ILE . 33.6 mmtp -127.36 155.07 44.18 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.786 -1.097 . . . . 2.7 110.393 -172.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 ' OE1' ' A' ' 48' ' ' GLN . 6.3 t -111.35 145.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.32 -0.622 . . . . 1.3 109.32 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -84.38 -40.74 17.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.274 -0.421 . . . . 3.31 111.38 -172.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -95.51 126.24 40.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.493 -0.321 . . . . 4.49 110.309 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.5 p -141.82 113.92 8.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.191 -0.459 . . . . 2.89 110.724 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.9 m -140.23 -48.52 0.45 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.197 0.522 . . . . 2.23 110.318 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.98 171.19 32.58 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.385 -0.825 . . . . 1.39 111.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -100.85 -51.13 3.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.715 -0.476 . . . . 3.06 109.715 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.778 -0.646 . . . . 2.44 109.974 -179.737 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.448 ' HB3' HG22 ' A' ' 82' ' ' ILE . 33.9 mt-30 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.918 0.389 . . . . 1.94 110.033 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.2 t -96.51 105.13 16.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 116.084 -0.507 . . . . 1.98 109.859 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -102.86 99.67 9.61 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.521 -0.763 . . . . 1.06 110.852 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.466 HG22 ' HD3' ' A' ' 24' ' ' LYS . 19.2 pt -101.89 151.51 5.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.7 -0.682 . . . . 1.06 109.822 174.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.495 ' OE1' HG23 ' A' ' 25' ' ' VAL . 14.7 tp60 -76.82 126.04 30.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.584 -0.734 . . . . 2.55 109.973 -175.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 67.2 m -115.62 156.13 26.4 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.78 -1.1 . . . . 1.15 111.289 -173.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 t -160.23 114.08 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.525 -0.762 . . . . 1.16 109.782 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -120.38 131.91 55.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.997 -0.547 . . . . 2.08 111.063 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 64' ' ' CYS . 21.7 mt -63.45 142.74 97.91 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.407 -0.815 . . . . 1.51 110.946 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -37.1 129.41 0.56 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 124.246 3.297 . . . . 1.11 113.352 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -59.55 127.09 30.32 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.054 -0.976 . . . . 2.15 112.712 -171.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.5 107.88 17.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.636 -0.876 . . . . 2.07 108.636 170.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.3 mt -65.95 134.62 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.23 0.538 . . . . 2.56 111.124 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.16 -12.77 63.65 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.297 -0.865 . . . . 1.09 112.042 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.21 152.06 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.748 0.785 . . . . 1.29 111.92 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.52 137.78 33.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.093 -1.412 . . . . 1.34 110.579 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.592 HG22 ' N ' ' A' ' 61' ' ' GLU . 11.1 tt -55.89 -39.67 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.547 -0.751 . . . . 1.49 112.244 -175.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.592 ' N ' HG22 ' A' ' 60' ' ' ILE . 2.3 pm0 -72.96 -12.68 61.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.682 -0.69 . . . . 2.2 110.903 -173.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -110.06 -17.46 13.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.433 0.635 . . . . 1.98 109.501 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -75.14 -40.95 59.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.736 -0.665 . . . . 2.09 110.09 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.453 ' HA ' HD11 ' A' ' 52' ' ' ILE . 13.9 p -108.96 175.55 5.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.012 -0.54 . . . . 0.6 110.006 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -123.82 25.72 7.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.769 0.319 . . . . 2.81 111.245 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -113.25 -169.61 1.52 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.011 -0.366 . . . . 1.39 110.011 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 m -79.56 127.05 79.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.004 0.43 . . . . 1.12 110.83 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.51 127.38 5.73 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.875 2.383 . . . . 0.65 110.806 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.3 p -129.76 148.4 51.64 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.745 -0.382 . . . . 1.1 111.113 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 39.7 t -97.29 110.7 23.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.267 -0.642 . . . . 1.26 109.267 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 50.4 m -97.94 141.16 31.26 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.966 -0.561 . . . . 0.29 110.035 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.07 -24.48 59.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.435 0.636 . . . . 1.69 109.358 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -163.31 164.38 24.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.109 -0.951 . . . . 1.26 108.688 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.518 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.4 t -138.72 138.72 41.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.566 -0.531 . . . . 1.59 109.566 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 25.3 tt0 -108.72 162.0 14.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.943 -0.571 . . . . 1.87 109.888 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 t70 65.27 -152.08 0.26 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.616 -0.512 . . . . 1.94 109.616 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.54 -5.74 31.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.609 0.719 . . . . 2.12 110.042 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 122.38 23.9 2.29 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.585 -0.734 . . . . 0.53 112.254 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.03 -19.8 28.12 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.95 0.405 . . . . 1.77 110.892 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 42.3 t -124.06 101.14 8.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.1 -0.5 . . . . 1.1 110.145 -174.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.625 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -90.77 138.55 14.44 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.073 -1.06 . . . . 0.26 111.95 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.448 HG22 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -98.72 117.31 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 109.816 -0.439 . . . . 1.07 109.816 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 62.55 52.89 2.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.348 -0.842 . . . . 0.34 110.579 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.625 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 59.7 m -89.96 105.82 18.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.457 -0.792 . . . . 0.81 111.121 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.0 m -93.74 129.36 38.41 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.879 -0.601 . . . . 1.14 110.338 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.41 119.57 6.83 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.887 2.391 . . . . 0.59 111.509 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 pt -98.19 145.45 29.83 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.893 -0.594 . . . . 1.21 111.932 -172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo . . . . . 0 N--CA 1.458 -0.577 0 C-N-CA 123.303 2.669 . . . . 1.22 111.513 175.524 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.3 m95 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.971 0.415 . . . . 0.9 110.889 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -72.69 108.03 5.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 2.73 110.751 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 m -111.52 15.16 21.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.673 -0.694 . . . . 2.09 109.597 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.81 -33.93 76.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.244 -0.889 . . . . 3.61 111.598 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.9 p -65.87 -24.38 66.85 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.929 -0.578 . . . . 2.26 111.4 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.79 16.24 31.65 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.804 -0.713 . . . . 0.95 111.974 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 p -65.88 -32.01 73.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.897 0.38 . . . . 2.08 111.96 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.5 t -126.01 141.63 51.88 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.869 -0.332 . . . . 1.19 110.91 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -93.27 -28.62 16.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.917 -0.583 . . . . 1.66 111.914 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 p -98.18 -20.4 17.31 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.495 . . . . 1.12 112.335 -174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.63 22.7 55.48 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.659 -0.782 . . . . 0.43 112.559 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.636 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 51.9 mttp -115.83 92.02 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.035 -0.357 . . . . 2.19 110.035 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.7 mp -98.36 130.5 45.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.907 0.384 . . . . 1.12 110.767 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.501 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . . . -149.9 148.89 29.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.16 -0.473 . . . . 1.06 110.412 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 67' ' ' THR . 97.0 m -86.3 100.19 12.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.289 0.566 . . . . 0.74 110.283 175.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 61.5 m -114.3 158.06 21.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.665 -0.698 . . . . 0.5 109.834 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 2.5 t70 -99.46 129.2 45.62 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.861 -0.792 . . . . 1.65 108.861 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.9 p -84.74 -1.52 56.37 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.713 -0.395 . . . . 1.12 111.116 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -106.14 -14.29 15.19 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.164 -0.68 . . . . 2.85 109.164 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 29.0 mtpp -97.52 101.92 13.56 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.181 -0.918 . . . . 3.03 109.776 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -96.21 158.63 15.35 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.362 -0.381 . . . . 2.7 110.012 176.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.544 HG22 ' OE1' ' A' ' 48' ' ' GLN . 11.1 t -114.43 147.46 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.322 -0.622 . . . . 1.3 109.322 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -76.67 -27.44 55.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.171 -0.468 . . . . 3.31 111.191 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.408 ' H ' HG11 ' A' ' 25' ' ' VAL . 31.5 mmmt -93.21 129.49 39.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.58 -0.526 . . . . 4.49 109.58 177.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.3 m -132.84 32.1 3.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.207 0.527 . . . . 2.89 110.516 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.3 m -75.23 -54.85 6.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.41 -0.814 . . . . 2.23 110.331 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.22 111.8 0.71 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.923 -0.656 . . . . 1.39 112.485 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' A' ' 75' ' ' GLU . 39.6 mt-10 -70.35 -47.69 59.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.411 0.148 . . . . 3.06 110.966 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.42 ' HB2' ' H ' ' A' ' 74' ' ' VAL . 20.4 mm-40 . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 109.715 -0.476 . . . . 2.44 109.715 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.492 ' OE1' HG21 ' A' ' 82' ' ' ILE . 32.1 mt-30 . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.883 0.373 . . . . 1.94 110.609 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.08 105.55 16.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.159 -0.473 . . . . 1.98 110.075 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -98.45 110.42 23.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.519 -0.764 . . . . 1.06 111.29 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 84' ' ' CYS . 19.8 pt -113.31 148.74 16.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.969 -0.56 . . . . 1.06 110.307 174.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.544 ' OE1' HG22 ' A' ' 25' ' ' VAL . 10.4 tp60 -75.05 132.4 41.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.33 -0.85 . . . . 2.55 109.253 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 17' ' ' ALA . 2.0 t -126.55 163.82 22.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.679 -0.691 . . . . 1.15 110.463 -171.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 t -161.2 127.96 4.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.12 0.486 . . . . 1.16 110.111 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -121.13 129.81 53.45 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.067 0.461 . . . . 2.08 111.463 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mt -71.66 137.71 83.09 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.217 -0.902 . . . . 1.51 109.717 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.3 109.29 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.037 3.158 . . . . 1.11 112.371 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.98 140.26 52.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.443 -0.798 . . . . 2.15 112.867 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.403 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 85.2 mt -93.2 147.55 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.888 -1.051 . . . . 2.07 108.544 167.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.456 HD13 ' N ' ' A' ' 56' ' ' ILE . 2.4 mp -71.73 138.19 22.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.088 0.47 . . . . 2.56 110.276 -177.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.59 5.85 83.63 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.427 -0.806 . . . . 1.09 112.715 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.456 HG21 ' N ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -93.36 154.29 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.569 0.7 . . . . 1.29 111.343 -177.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.456 ' N ' HG21 ' A' ' 58' ' ' ILE . . . -89.32 134.85 33.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.613 -1.176 . . . . 1.34 111.01 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 61' ' ' GLU . 6.6 tp -50.68 -41.45 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.36 -0.836 . . . . 1.49 111.715 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 60' ' ' ILE . 3.0 pt-20 -74.84 -27.68 60.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.752 -0.658 . . . . 2.2 111.716 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -96.39 -22.33 17.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.349 -0.387 . . . . 1.98 110.698 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.22 -36.71 79.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.576 0.703 . . . . 2.09 110.091 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.9 p -118.82 177.22 4.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.489 -0.778 . . . . 0.6 110.345 -172.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 42.3 tptt -125.53 40.92 3.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.742 0.782 . . . . 2.81 109.824 175.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 43.4 m-80 -126.65 -165.58 1.47 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.055 -0.975 . . . . 1.39 108.94 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 12.5 m -87.21 125.79 64.84 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 120.438 -0.505 . . . . 1.12 110.836 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.09 121.88 4.58 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.679 2.253 . . . . 0.65 110.472 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.5 p -129.79 151.57 50.22 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.138 -0.625 . . . . 1.1 111.809 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 12.2 t -99.35 101.58 12.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.297 -0.865 . . . . 1.26 109.105 171.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.636 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 59.8 m -84.99 133.2 34.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.627 0.727 . . . . 0.29 110.076 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 65.0 mt-10 -63.46 -40.29 96.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.779 -1.1 . . . . 1.69 109.71 175.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -153.61 166.0 34.15 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.31 -0.859 . . . . 1.26 109.002 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.49 HG11 ' HD3' ' A' ' 15' ' ' LYS . 15.8 m -133.98 160.27 41.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.159 0.504 . . . . 1.59 110.697 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 33.5 tt0 -129.55 155.03 46.44 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.8 -1.185 . . . . 1.87 107.8 173.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER 67.59 -156.01 0.21 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.565 -0.531 . . . . 1.94 109.565 -172.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.11 -3.14 24.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.55 0.69 . . . . 2.12 110.224 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.27 22.94 2.76 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.793 -0.64 . . . . 0.53 111.615 -175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.4 mt -86.05 -15.78 40.23 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.261 0.553 . . . . 1.77 109.955 175.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 73.5 t -123.32 112.86 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.37 -0.832 . . . . 1.1 108.922 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -106.82 137.06 13.72 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.011 -1.09 . . . . 0.26 112.238 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.492 HG21 ' OE1' ' A' ' 44' ' ' GLN . 1.7 mp -99.55 120.71 49.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 122.437 0.295 . . . . 1.07 110.454 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 95.6 m-20 59.16 44.07 16.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.537 -0.756 . . . . 0.34 110.997 173.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 71' ' ' CYS . 45.1 m -77.85 105.11 8.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.387 -0.824 . . . . 0.81 110.864 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.7 m -89.35 125.42 61.8 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.986 -0.552 . . . . 1.14 110.13 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.67 121.97 10.12 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.751 2.301 . . . . 0.59 111.694 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.8 pt -92.44 144.83 29.46 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 116.199 -0.455 . . . . 1.21 110.318 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--O 1.234 0.303 0 C-N-CA 123.008 2.472 . . . . 1.22 112.073 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.1 m95 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 121.3 0.571 . . . . 0.9 111.985 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -82.6 109.43 16.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.107 -0.952 . . . . 2.73 111.092 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 t -105.83 28.76 7.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.729 -0.669 . . . . 2.09 109.324 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -26.09 30.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.44 -0.8 . . . . 3.61 112.791 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.6 m -78.19 -14.06 59.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.159 0.504 . . . . 2.26 111.003 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.42 16.53 68.63 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.357 -1.497 . . . . 0.95 109.357 -168.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.456 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 2.1 p -69.81 -30.82 68.43 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.887 -1.157 . . . . 2.08 112.775 -169.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.2 t -126.02 143.31 51.15 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.541 -0.464 . . . . 1.19 111.26 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.521 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.4 p30 -92.04 -29.16 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 1.66 111.425 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.521 HG22 ' OD1' ' A' ' 12' ' ' ASN . 22.4 p -97.48 -31.02 12.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.006 0.432 . . . . 1.12 111.97 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.64 2.74 58.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.826 -0.702 . . . . 0.43 111.582 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 41.2 mttp -90.89 88.27 6.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.753 0.311 . . . . 2.19 110.376 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.95 122.04 38.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.42 -0.355 . . . . 1.12 110.091 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.568 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -131.25 146.1 52.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.73 0.3 . . . . 1.06 110.58 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 50' ' ' THR . 35.4 m -85.18 98.38 10.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 0.74 109.89 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 65.3 m -116.76 157.91 24.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.433 -0.349 . . . . 0.5 111.462 -168.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.59 ' CB ' ' HD3' ' A' ' 23' ' ' LYS . 50.3 m-20 -102.76 112.86 25.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.183 -0.673 . . . . 1.65 109.183 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.8 p -74.81 -15.88 60.72 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.388 0.514 . . . . 1.12 112.388 -172.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -98.59 -0.4 43.21 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.764 0.792 . . . . 2.85 109.422 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.59 ' HD3' ' CB ' ' A' ' 20' ' ' ASP . 35.4 mtpt -112.74 100.95 9.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.564 -1.198 . . . . 3.03 109.685 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.83 161.81 13.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.735 -0.666 . . . . 2.7 111.554 -174.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -127.79 142.31 44.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.045 -1.094 . . . . 1.3 108.045 173.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -90.94 -23.82 20.35 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.789 0.328 . . . . 3.31 111.201 -173.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 28.8 mmmt -103.48 119.78 39.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.112 0.482 . . . . 4.49 111.284 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 15.4 p -126.42 120.66 30.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.578 -0.737 . . . . 2.89 109.624 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.5 m -88.39 -54.33 4.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.548 -0.296 . . . . 2.23 110.575 -176.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.22 70.38 1.1 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.586 -0.816 . . . . 1.39 111.173 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -78.94 -27.68 43.64 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.636 0.236 . . . . 3.06 111.636 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 120.51 -0.476 . . . . 2.44 110.497 178.672 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 121.107 0.479 . . . . 1.94 111.476 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.96 119.53 62.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.643 -0.708 . . . . 1.98 110.024 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -100.45 124.99 46.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.962 -0.563 . . . . 1.06 110.899 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 84' ' ' CYS . 18.2 pt -118.93 152.11 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.127 0.489 . . . . 1.06 110.346 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.05 127.7 33.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.556 -0.905 . . . . 2.55 108.556 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.625 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 4.5 t -133.71 169.1 17.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.848 -0.614 . . . . 1.15 110.418 -170.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 11.7 t -160.02 137.04 9.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.072 0.463 . . . . 1.16 110.304 178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.27 132.82 55.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.001 0.429 . . . . 2.08 110.1 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.2 mm -80.71 144.97 57.14 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 1.51 110.468 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -37.26 126.75 0.58 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.039 3.16 . . . . 1.11 113.345 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.88 123.71 17.89 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.258 -0.883 . . . . 2.15 113.121 -171.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.72 129.41 55.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.272 -0.876 . . . . 2.07 109.289 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 56' ' ' ILE . 3.2 mp -69.55 135.73 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.169 0.509 . . . . 2.56 110.7 -176.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.1 11.02 81.71 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.308 -0.86 . . . . 1.09 113.178 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.07 154.05 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.618 0.723 . . . . 1.29 112.326 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.43 145.87 24.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.402 -1.272 . . . . 1.34 111.215 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.516 HG21 ' N ' ' A' ' 61' ' ' GLU . 7.2 tp -53.22 -43.39 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 122.866 0.466 . . . . 1.49 111.229 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.516 ' N ' HG21 ' A' ' 60' ' ' ILE . 8.5 pt-20 -74.33 -22.05 59.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.118 -0.492 . . . . 2.2 111.238 -175.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -90.48 -34.55 15.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.334 0.588 . . . . 1.98 109.753 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -67.9 -35.21 78.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.066 -0.97 . . . . 2.09 110.592 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.0 p -121.82 172.13 8.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.802 -0.635 . . . . 0.6 110.337 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -120.7 21.42 11.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 2.81 111.416 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 38.6 m-80 -104.12 -168.14 1.45 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.474 -0.565 . . . . 1.39 109.474 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -85.95 120.89 72.97 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-O 121.495 0.664 . . . . 1.12 111.465 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.83 122.52 9.9 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.353 2.702 . . . . 0.65 111.219 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.8 p -132.43 154.86 49.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.699 -0.228 . . . . 1.1 110.633 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 11.8 t -99.72 117.07 33.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.462 -0.57 . . . . 1.26 109.462 171.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 46.6 m -102.46 139.51 37.96 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.119 0.485 . . . . 0.29 109.748 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 6.6 tt0 -78.03 -20.88 51.6 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.512 0.673 . . . . 1.69 109.724 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.34 158.96 33.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.325 -0.991 . . . . 1.26 108.325 171.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.48 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.6 OUTLIER -148.65 129.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 117.852 0.297 . . . . 1.59 110.465 178.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.51 165.91 13.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.731 0.301 . . . . 1.87 110.591 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.82 -150.16 0.31 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.587 -0.733 . . . . 1.94 110.24 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.94 5.08 14.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.96 0.409 . . . . 2.12 110.141 172.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.625 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 118.57 24.04 3.25 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.665 -0.779 . . . . 0.53 112.691 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.06 -21.29 29.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.05 0.425 . . . . 1.77 111.534 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.08 102.79 8.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.891 -0.411 . . . . 1.1 109.891 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -102.34 139.76 14.56 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.455 -0.879 . . . . 0.26 112.966 -176.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.0 120.95 46.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 122.737 0.415 . . . . 1.07 109.905 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 95.5 m-20 60.76 48.62 6.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.525 -0.761 . . . . 0.34 110.975 173.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.526 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.4 m -83.1 111.42 18.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.619 -0.718 . . . . 0.81 110.564 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 24.7 m -105.29 128.11 27.27 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.704 -0.68 . . . . 1.14 109.918 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.9 Cg_exo -59.95 125.33 17.39 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.976 2.451 . . . . 0.59 112.099 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.456 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 16.2 pt -96.49 162.45 23.4 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 115.55 -0.75 . . . . 1.21 111.107 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 N--CA 1.46 -0.466 0 C-N-CA 123.237 2.624 . . . . 1.22 112.176 -178.54 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.466 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 49.1 m95 . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 120.899 0.38 . . . . 0.9 111.219 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.553 ' OE2' ' HD2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -65.77 108.25 2.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.629 -0.878 . . . . 2.73 108.629 175.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 m -106.75 28.21 8.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.968 -0.56 . . . . 2.09 112.344 -167.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -50.35 -25.24 3.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.834 0.679 . . . . 3.61 112.834 -177.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 t -71.76 -28.66 63.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 2.26 111.733 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.81 1.44 54.62 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.173 -0.537 . . . . 0.95 113.226 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -77.33 -15.89 59.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.773 0.286 . . . . 2.08 111.773 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.59 139.96 38.19 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.577 -0.449 . . . . 1.19 110.206 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.608 HD21 ' N ' ' A' ' 13' ' ' THR . 0.4 OUTLIER -94.54 -21.73 18.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.748 0.648 . . . . 1.66 112.748 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.608 ' N ' HD21 ' A' ' 12' ' ' ASN . 2.0 p -104.41 -30.89 9.79 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.229 0.455 . . . . 1.12 112.229 -174.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.47 -3.27 59.43 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.612 -0.804 . . . . 0.43 111.999 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.584 ' NZ ' ' HA ' ' A' ' 73' ' ' ASP . 90.4 mttt -87.91 88.07 7.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.095 0.474 . . . . 2.19 109.967 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -93.53 103.07 15.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.865 -0.607 . . . . 1.12 110.189 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.41 154.06 28.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.105 0.478 . . . . 1.06 110.752 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 65.6 m -88.94 103.62 16.2 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.611 -0.722 . . . . 0.74 109.179 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -125.44 150.72 47.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.057 0.456 . . . . 0.5 112.037 -170.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.87 104.24 16.32 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.619 -0.719 . . . . 1.65 110.321 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.425 HG22 ' HG3' ' A' ' 86' ' ' PRO . 74.4 p -72.48 -5.79 39.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.078 0.466 . . . . 1.12 111.327 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -96.91 -22.68 16.73 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.846 0.831 . . . . 2.85 109.013 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' CG ' ' HB2' ' A' ' 48' ' ' GLN . 27.5 tptt -106.88 110.98 23.29 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.245 -1.343 . . . . 3.03 109.895 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -100.93 161.88 13.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.428 -0.806 . . . . 2.7 111.861 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 t -126.2 148.0 30.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.236 -0.893 . . . . 1.3 108.807 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -97.93 22.14 9.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.821 0.343 . . . . 3.31 111.419 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -134.45 119.93 19.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.222 -0.444 . . . . 4.49 110.119 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 p -140.85 86.09 2.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.909 0.385 . . . . 2.89 110.528 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.1 m -108.28 -47.66 3.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.24 0.543 . . . . 2.23 110.203 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.69 164.02 34.16 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.251 -0.886 . . . . 1.39 112.739 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 21.9 mm-40 -101.78 -45.19 5.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.065 0.46 . . . . 3.06 109.915 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.445 -0.716 0 CA-C-N 115.829 -0.623 . . . . 2.44 109.78 179.582 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.5 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 27.6 mt-30 . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.236 0.541 . . . . 1.94 111.182 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.579 HG13 ' HA ' ' A' ' 83' ' ' ASN . 14.7 p -105.66 127.92 60.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.413 -0.812 . . . . 1.98 110.163 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.82 121.86 45.59 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.36 -0.836 . . . . 1.06 110.379 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 84' ' ' CYS . 19.1 pt -130.7 160.8 41.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.891 -0.595 . . . . 1.06 109.697 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.448 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 1.5 mm-40 -77.34 135.76 38.4 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.504 0.668 . . . . 2.55 110.642 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.6 m -131.11 153.57 49.21 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.453 -1.248 . . . . 1.15 110.146 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 8.4 t -156.56 128.34 7.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.083 0.468 . . . . 1.16 110.038 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 tm0? -120.87 110.62 16.53 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.989 0.424 . . . . 2.08 110.515 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mt -65.73 128.94 94.19 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.619 -0.719 . . . . 1.51 109.889 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -34.0 99.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 125.128 3.885 . . . . 1.11 113.531 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.466 HD21 ' CZ2' ' A' ' 4' ' ' TRP . 3.3 pp -70.29 136.89 50.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.851 -1.068 . . . . 2.15 112.393 -172.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.4 mt -94.95 120.6 35.43 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.494 -0.928 . . . . 2.07 108.494 168.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.06 133.09 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.361 0.601 . . . . 2.56 111.081 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.43 -24.96 22.99 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.085 -0.962 . . . . 1.09 111.478 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -87.06 155.03 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.466 0.65 . . . . 1.29 111.107 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.85 143.94 26.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.666 -1.152 . . . . 1.34 111.624 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.483 HG21 ' N ' ' A' ' 61' ' ' GLU . 6.7 tp -54.71 -35.25 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.018 -0.992 . . . . 1.49 110.974 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.483 ' N ' HG21 ' A' ' 60' ' ' ILE . 3.6 pt-20 -76.79 -16.8 59.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.069 -0.969 . . . . 2.2 111.701 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.33 -24.5 11.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.09 0.471 . . . . 1.98 110.704 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.8 tp10 -74.93 -38.04 61.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.848 -0.615 . . . . 2.09 111.1 -175.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 p -113.61 173.14 6.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.251 -0.277 . . . . 0.6 110.251 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -118.84 46.19 1.91 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.221 0.534 . . . . 2.81 110.699 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.527 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 42.4 m-80 -135.39 -174.16 3.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.822 -0.626 . . . . 1.39 109.331 175.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.6 m -80.35 125.29 81.46 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-O 121.403 0.62 . . . . 1.12 111.786 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -63.05 115.52 3.01 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.339 2.693 . . . . 0.65 110.998 171.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.3 p -127.26 143.32 51.26 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.322 -0.551 . . . . 1.1 111.265 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 36.0 t -93.27 106.19 18.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 1.26 109.68 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 57.1 m -92.73 134.0 35.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.156 -0.474 . . . . 0.29 109.959 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -64.9 -36.08 83.21 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.206 -0.665 . . . . 1.69 109.206 175.154 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.584 ' HA ' ' NZ ' ' A' ' 15' ' ' LYS . 40.3 t0 -152.25 165.55 34.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.368 -0.975 . . . . 1.26 108.368 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.49 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.2 t -136.48 133.55 49.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.633 -0.506 . . . . 1.59 109.633 175.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.479 ' HA ' ' HG2' ' A' ' 31' ' ' GLU . 16.1 tt0 -102.94 164.69 11.47 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.139 -0.482 . . . . 1.87 109.701 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 78' ' ' GLY . 1.8 m-20 63.67 -156.52 0.32 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.272 0.357 . . . . 1.94 110.156 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' A' ' 76' ' ' ASP . 2.5 m-20 -75.45 23.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.895 0.379 . . . . 2.12 110.882 173.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 76' ' ' ASP . . . 95.7 22.62 20.66 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.949 -0.643 . . . . 0.53 111.777 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.21 -18.68 25.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 1.77 111.247 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.9 t -131.69 109.98 16.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.772 -0.455 . . . . 1.1 109.772 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.592 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -97.04 144.83 17.58 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.28 -0.962 . . . . 0.26 112.382 -177.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -100.77 120.83 50.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.866 -0.42 . . . . 1.07 109.866 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.579 ' HA ' HG13 ' A' ' 45' ' ' VAL . 89.4 m-20 58.46 53.76 6.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.026 -0.534 . . . . 0.34 110.807 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.592 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 66.8 m -89.36 95.44 10.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.728 -0.669 . . . . 0.81 110.94 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 8.0 m -88.18 127.25 57.97 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.718 -0.674 . . . . 1.14 110.732 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.425 ' HG3' HG22 ' A' ' 21' ' ' THR . 39.7 Cg_exo -62.57 118.01 4.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.896 2.397 . . . . 0.59 111.63 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.6 pt -97.98 148.45 34.49 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.925 -0.579 . . . . 1.21 111.558 -174.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.4 Cg_exo . . . . . 0 C--N 1.345 0.375 0 C-N-CA 123.355 2.703 . . . . 1.22 111.872 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 N-CA-C 112.205 -0.358 . . . . 6.07 112.205 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -148.78 163.76 36.41 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.743 -0.269 . . . . 4.71 110.387 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.45 -82.32 1.35 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.817 -0.706 . . . . 2.2 112.16 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -121.5 144.33 48.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.927 0.394 . . . . 0.9 111.079 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -66.55 108.95 2.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.631 -0.713 . . . . 2.73 110.463 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -108.97 25.99 11.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.676 -0.693 . . . . 2.09 110.448 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -20.08 62.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.903 -0.59 . . . . 3.61 111.414 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -69.06 -20.41 64.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.123 0.487 . . . . 2.26 110.699 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.65 7.09 87.25 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.836 -0.62 . . . . 0.95 112.637 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 m -70.96 -27.46 63.75 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.783 0.29 . . . . 2.08 111.783 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.1 t -108.53 141.64 40.14 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.93 -0.308 . . . . 1.19 110.383 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.491 ' OD1' HG21 ' A' ' 13' ' ' THR . 9.5 p30 -93.22 -19.87 21.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 1.66 112.129 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.491 HG21 ' OD1' ' A' ' 12' ' ' ASN . 19.8 p -108.86 -31.11 7.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.914 0.388 . . . . 1.12 111.957 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.13 2.09 56.96 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.749 -0.739 . . . . 0.43 111.943 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.494 ' HD3' HG23 ' A' ' 74' ' ' VAL . 78.3 mttt -94.87 89.23 5.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.127 0.489 . . . . 2.19 110.443 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 mp -93.61 128.56 39.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 1.12 109.999 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . . . -137.16 156.75 47.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.517 -0.31 . . . . 1.06 110.301 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 50' ' ' THR . 82.4 m -91.91 97.66 11.1 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.278 -0.638 . . . . 0.74 109.278 173.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 82.4 m -111.64 155.65 23.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.963 0.411 . . . . 0.5 111.066 -171.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 20.5 t0 -98.24 127.82 44.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.033 -1.099 . . . . 1.65 108.033 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.7 p -92.69 1.88 57.03 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.362 0.601 . . . . 1.12 110.501 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -105.55 -25.05 12.46 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.982 -0.748 . . . . 2.85 108.982 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 26.2 mtmm -102.32 135.9 43.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.204 -0.907 . . . . 3.03 110.092 176.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -139.96 164.45 29.97 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.561 -0.745 . . . . 2.7 111.954 -176.236 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -117.88 148.49 20.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.609 -0.723 . . . . 1.3 110.123 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -83.88 -21.43 31.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.317 -0.401 . . . . 3.31 111.191 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.9 mmpt? -94.13 136.21 34.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.349 -0.611 . . . . 4.49 109.349 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 p -156.92 96.65 1.62 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.799 0.333 . . . . 2.89 111.632 -173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -122.16 -69.12 0.85 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.758 -0.377 . . . . 2.23 111.475 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.37 77.87 0.49 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.974 -0.85 . . . . 1.39 110.974 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -103.43 20.55 17.62 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.449 0.537 . . . . 3.06 112.449 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . 83.8 mt-10 -86.84 -60.97 1.84 Allowed 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 120.102 -0.639 . . . . 2.44 109.948 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.2 m -92.21 -31.17 15.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.59 0.71 . . . . 2.67 109.197 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.05 44.92 1.99 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.897 -1.047 . . . . 2.54 112.733 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.528 ' H ' HD11 ' A' ' 35' ' ' LEU . 5.5 mp -40.69 -53.95 2.69 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.115 0.483 . . . . 3.49 110.254 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.4 tp -108.74 97.07 6.77 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.218 -0.66 . . . . 5.24 109.218 170.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -111.87 -26.52 8.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.005 -0.543 . . . . 7.27 111.125 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.2 m -63.85 -26.44 68.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.762 -0.654 . . . . 5.82 112.372 -169.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.02 6.61 66.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.107 -1.044 . . . . 3.6 112.741 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -119.99 -51.06 2.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.077 0.465 . . . . 4.15 110.442 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.75 131.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.858 -0.61 . . . . 2.96 111.761 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.8 mt -118.56 -11.16 9.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.337 -0.847 . . . . 3.83 110.121 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -85.64 1.35 49.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.471 -0.786 . . . . 2.29 111.203 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.488 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 26.1 mt-30 -44.52 131.7 6.46 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.725 0.64 . . . . 1.94 111.622 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.4 t -100.14 123.08 52.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.171 -0.922 . . . . 1.98 109.713 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.04 100.48 9.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.637 -0.71 . . . . 1.06 110.658 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 12.2 pt -100.88 149.64 6.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.918 -0.583 . . . . 1.06 110.591 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.79 126.63 30.2 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.768 -0.827 . . . . 2.55 108.768 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -126.07 158.64 34.9 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.88 -0.6 . . . . 1.15 110.203 -172.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 5.2 t -160.59 127.57 4.26 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.24 -0.436 . . . . 1.16 110.116 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -116.4 107.64 15.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.496 0.665 . . . . 2.08 111.044 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mt -64.6 134.29 95.97 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 114.855 -1.066 . . . . 1.51 109.665 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -32.33 101.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.699 3.599 . . . . 1.11 114.259 -170.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 54' ' ' LEU . 3.9 pp -75.82 142.15 42.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.15 -1.387 . . . . 2.15 113.099 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.1 mp -91.68 145.26 24.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.359 -0.837 . . . . 2.07 109.288 167.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.4 136.17 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 2.56 110.778 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.12 -7.77 69.93 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.577 -0.738 . . . . 1.09 112.865 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -81.75 160.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.372 0.605 . . . . 1.29 111.762 -175.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' N ' HG23 ' A' ' 58' ' ' ILE . . . -90.07 129.95 36.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.032 -0.985 . . . . 1.34 111.202 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 61' ' ' GLU . 8.6 tp -53.92 -36.66 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 114.984 -1.007 . . . . 1.49 112.353 -177.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.461 ' N ' HG22 ' A' ' 60' ' ' ILE . 8.4 pt-20 -78.13 -21.83 49.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.744 0.307 . . . . 2.2 111.432 -174.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.91 -26.57 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.079 0.466 . . . . 1.98 110.599 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.485 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 9.7 tp10 -68.63 -35.01 76.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.802 -0.635 . . . . 2.09 111.136 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.9 p -127.39 154.44 45.0 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.872 0.368 . . . . 0.6 110.902 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -98.84 56.07 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.871 0.843 . . . . 2.81 109.726 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 52.1 m-80 -137.86 -170.38 2.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.129 -0.941 . . . . 1.39 108.727 175.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.0 m -89.35 126.09 59.63 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-O 121.114 0.483 . . . . 1.12 110.592 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.94 120.44 4.65 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.686 2.258 . . . . 0.65 111.079 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.792 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 2.8 p -120.59 157.85 28.62 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.884 -0.598 . . . . 1.1 111.567 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 34.0 t -108.97 104.51 13.76 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.206 -0.664 . . . . 1.26 109.206 170.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.476 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 92.1 m -87.38 139.59 30.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.359 -0.608 . . . . 0.29 109.359 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.1 tt0 -71.57 -31.24 66.76 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.064 -0.717 . . . . 1.69 109.064 174.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 32' ' ' GLU . 6.9 t0 -156.33 164.02 38.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.866 -1.161 . . . . 1.26 107.866 171.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.549 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.4 t -137.01 139.12 45.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.652 -0.419 . . . . 1.59 110.022 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.521 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 10.1 tt0 -100.13 159.01 15.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.156 -0.475 . . . . 1.87 109.963 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 78' ' ' GLY . 41.4 m-20 61.73 -151.22 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.066 -0.515 . . . . 1.94 110.133 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -79.65 16.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.083 0.468 . . . . 2.12 110.579 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.549 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 110.49 21.76 6.72 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.813 -0.63 . . . . 0.53 112.3 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.92 -21.87 31.72 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.758 0.281 . . . . 1.77 111.758 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 21.7 t -127.72 103.63 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.898 -0.321 . . . . 1.1 110.43 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.476 ' HA3' ' SG ' ' A' ' 71' ' ' CYS . . . -91.84 123.79 7.37 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.057 -1.068 . . . . 0.26 112.265 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.45 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -86.43 118.34 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.671 -0.492 . . . . 1.07 109.671 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 92.9 m-20 59.99 41.78 16.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.34 110.764 174.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.792 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -81.21 109.97 16.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.81 110.457 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.2 m -94.17 130.27 34.71 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.776 -0.647 . . . . 1.14 109.698 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.62 109.96 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.715 2.277 . . . . 0.59 111.442 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 5.5 pt -74.66 141.66 76.28 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 115.623 -0.717 . . . . 1.21 111.26 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.3 Cg_exo -68.8 154.85 70.39 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.278 2.652 . . . . 1.22 112.392 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.7 mt -91.38 24.67 2.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.635 -0.711 . . . . 1.71 110.429 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 90' ' ' ILE . 24.3 pt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 116.152 -0.477 . . . . 2.35 111.243 -173.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.882 -0.487 . . . . 6.07 111.882 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -90.78 37.73 0.93 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.883 0.373 . . . . 4.71 110.54 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.91 -62.85 3.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 2.2 111.692 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.429 ' CH2' HD22 ' A' ' 54' ' ' LEU . 94.5 m95 -92.49 139.97 30.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.737 0.303 . . . . 0.9 110.199 176.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.505 ' OE1' ' HG2' ' A' ' 7' ' ' LYS . 30.9 tt0 -59.37 109.05 0.8 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.488 -0.778 . . . . 2.73 110.848 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -91.54 27.51 1.98 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.64 -0.709 . . . . 2.09 111.429 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' HG2' ' OE1' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -56.45 -25.87 52.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.066 -0.516 . . . . 3.61 112.179 -176.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p -77.15 -30.01 54.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.049 0.452 . . . . 2.26 111.537 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.55 15.04 80.65 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.95 112.087 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.409 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 10.9 p -77.47 -25.18 50.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.307 0.484 . . . . 2.08 112.307 -174.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -102.97 142.68 33.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.218 -0.446 . . . . 1.19 110.933 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.8 p30 -91.11 -29.25 17.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.789 -0.641 . . . . 1.66 111.478 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.537 HG22 ' OD1' ' A' ' 12' ' ' ASN . 13.0 p -100.91 -31.19 11.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.104 0.478 . . . . 1.12 111.627 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.86 -2.88 52.25 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.815 -0.707 . . . . 0.43 112.115 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.524 ' HD3' HG21 ' A' ' 74' ' ' VAL . 90.7 mttt -86.72 88.76 7.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.009 0.433 . . . . 2.19 110.428 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 69' ' ' THR . 9.6 mp -92.32 110.73 22.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 1.12 110.492 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.0 149.23 39.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.08 0.467 . . . . 1.06 110.482 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -87.03 106.01 17.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.64 -0.709 . . . . 0.74 109.167 172.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -122.8 154.37 38.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.084 -0.507 . . . . 0.5 111.52 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 4.1 m-20 -100.03 114.64 28.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.509 -0.769 . . . . 1.65 109.174 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.0 p -74.82 -7.02 52.17 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.134 0.492 . . . . 1.12 110.968 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -98.01 -6.51 31.8 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.018 -0.734 . . . . 2.85 109.018 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 46.1 mtpt -111.62 98.71 7.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.83 -1.077 . . . . 3.03 109.759 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.82 157.67 16.14 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.271 -0.877 . . . . 2.7 110.782 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 t -120.22 145.15 26.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.684 -0.858 . . . . 1.3 108.684 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -95.18 29.84 2.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.065 0.46 . . . . 3.31 111.442 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 7.3 mmpt? -129.17 161.16 30.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.046 -0.525 . . . . 4.49 109.831 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 p -150.12 66.2 0.97 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.129 0.49 . . . . 2.89 110.406 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 m -122.1 143.69 49.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.753 -0.658 . . . . 2.23 109.679 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.03 148.78 18.56 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.215 -0.993 . . . . 1.39 112.842 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -78.61 -38.17 40.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.915 0.388 . . . . 3.06 110.285 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -110.96 -43.18 3.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 2.44 110.186 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.0 t -65.55 -25.34 67.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.954 -0.567 . . . . 2.67 110.034 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.3 -14.79 69.38 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.887 -0.597 . . . . 2.54 112.882 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.93 -30.14 44.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.446 0.641 . . . . 3.49 109.658 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.9 mt -91.7 173.04 8.08 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.359 -0.837 . . . . 5.24 109.724 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -78.58 -3.59 44.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.436 0.636 . . . . 7.27 109.693 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 m -72.27 -29.18 63.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.237 -0.892 . . . . 5.82 110.562 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.442 ' HA2' ' OE1' ' A' ' 44' ' ' GLN . . . -96.21 7.9 66.95 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.814 -0.63 . . . . 3.6 111.973 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.96 -47.04 15.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.529 0.68 . . . . 4.15 110.099 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 m -60.29 145.64 11.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.478 -1.237 . . . . 2.96 113.362 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.6 mt -82.32 -8.71 59.63 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.649 -1.16 . . . . 3.83 109.544 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.4 -26.55 68.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.36 -0.836 . . . . 2.29 111.341 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.53 ' HB3' HG21 ' A' ' 82' ' ' ILE . 32.1 mt-30 -51.12 131.59 27.53 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.295 0.569 . . . . 1.94 111.046 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.41 105.33 15.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.258 -0.883 . . . . 1.98 110.268 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -101.33 116.0 31.8 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.67 -0.695 . . . . 1.06 110.722 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.0 pt -120.81 155.16 24.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.859 -0.61 . . . . 1.06 109.887 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.72 123.5 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.869 0.842 . . . . 2.55 109.43 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 60.2 m -122.57 157.35 32.31 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.316 -1.311 . . . . 1.15 110.598 -171.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.9 t -161.18 138.43 8.94 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.913 0.387 . . . . 1.16 110.38 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -121.58 152.09 39.64 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.548 0.69 . . . . 2.08 111.156 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.459 HG21 ' HD2' ' A' ' 53' ' ' PRO . 23.1 mt -90.6 142.13 27.72 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.779 -1.1 . . . . 1.51 108.687 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HD2' HG21 ' A' ' 52' ' ' ILE . 57.2 Cg_exo -33.59 108.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 124.216 3.277 . . . . 1.11 113.393 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.448 HD21 ' O ' ' A' ' 52' ' ' ILE . 22.5 mt -66.13 130.08 41.99 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.954 -1.021 . . . . 2.15 113.112 -166.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.617 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 86.4 mt -99.48 122.6 42.8 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.704 -0.85 . . . . 2.07 108.704 166.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.1 mt -67.81 132.3 32.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.06 0.457 . . . . 2.56 110.637 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.67 14.6 61.1 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.458 -0.792 . . . . 1.09 112.089 -176.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -105.48 155.07 6.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.773 0.797 . . . . 1.29 111.818 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.38 135.82 33.36 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.373 -1.285 . . . . 1.34 111.036 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 61' ' ' GLU . 5.7 tp -52.2 -32.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.248 -0.887 . . . . 1.49 111.106 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.529 ' N ' HG22 ' A' ' 60' ' ' ILE . 35.5 mt-10 -73.99 -27.88 61.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.998 -1.001 . . . . 2.2 111.927 -173.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -107.35 -11.73 15.48 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.881 -0.328 . . . . 1.98 111.665 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.477 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.4 tp10 -79.15 -35.21 42.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.349 0.595 . . . . 2.09 110.413 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.83 171.59 10.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.002 -0.545 . . . . 0.6 110.148 -174.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -122.01 49.41 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.364 0.602 . . . . 2.81 109.997 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -138.77 -169.05 2.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.959 -0.564 . . . . 1.39 109.922 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -83.79 125.63 72.74 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 121.399 0.618 . . . . 1.12 111.931 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -65.25 123.43 11.51 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.435 2.757 . . . . 0.65 111.226 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 77.2 p -132.21 152.85 51.11 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.779 -0.369 . . . . 1.1 111.147 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 38.3 t -103.42 108.81 20.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.019 -0.537 . . . . 1.26 109.683 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 38.6 m -96.04 135.11 38.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.0 0.428 . . . . 0.29 110.603 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.4 tt0 -71.92 -29.55 64.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.418 0.628 . . . . 1.69 109.495 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -153.33 159.37 42.47 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.214 -1.032 . . . . 1.26 108.214 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.524 HG21 ' HD3' ' A' ' 15' ' ' LYS . 1.9 t -138.71 137.51 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.225 0.466 . . . . 1.59 110.509 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -104.54 157.43 17.17 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.91 -0.586 . . . . 1.87 110.634 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 78' ' ' GLY . 2.8 t70 67.24 -149.9 0.18 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.076 0.55 . . . . 1.94 109.857 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.03 16.11 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.939 0.876 . . . . 2.12 109.727 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 49' ' ' CYS . . . 99.22 23.33 11.43 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.557 -0.747 . . . . 0.53 111.558 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 34.1 mt -81.23 -25.68 36.45 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.962 0.41 . . . . 1.77 110.954 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.13 105.36 13.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.61 -0.515 . . . . 1.1 109.61 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.617 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -95.89 143.85 16.91 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.302 -0.951 . . . . 0.26 112.052 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.53 HG21 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -101.35 117.5 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 109.824 -0.436 . . . . 1.07 109.824 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 85.5 m-20 62.39 48.61 4.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.439 -0.801 . . . . 0.34 110.527 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.617 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 61.2 m -83.7 92.4 7.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.242 -0.89 . . . . 0.81 110.703 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.3 m -79.54 128.41 75.07 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.833 -0.622 . . . . 1.14 110.369 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.76 115.85 3.32 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.557 2.172 . . . . 0.59 110.797 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.409 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 8.8 pt -91.55 151.2 42.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.114 -0.494 . . . . 1.21 111.732 -173.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.3 Cg_exo -71.21 157.52 57.03 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.256 2.637 . . . . 1.22 111.823 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 mt -93.23 30.54 1.65 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.847 -0.615 . . . . 1.71 110.491 -177.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.7 pt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.288 -0.863 . . . . 2.35 111.232 -173.775 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.826 -0.509 . . . . 6.07 111.826 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.8 p -78.46 119.02 21.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.736 0.303 . . . . 4.71 110.694 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.55 166.55 38.01 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.926 -0.654 . . . . 2.2 111.906 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -82.2 151.74 26.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.743 0.306 . . . . 0.9 110.791 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -59.94 106.13 0.46 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.413 -0.812 . . . . 2.73 111.218 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.493 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 17.1 m -113.54 13.5 18.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.761 -0.654 . . . . 2.09 110.687 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -19.45 63.52 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.702 0.63 . . . . 3.61 112.702 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 t -81.7 -9.47 59.64 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.276 -0.57 . . . . 2.26 110.591 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.98 15.6 59.06 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.927 -0.654 . . . . 0.95 112.803 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.3 p -78.87 -29.75 44.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.854 0.359 . . . . 2.08 111.453 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 t -128.62 141.68 51.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.976 0.417 . . . . 1.19 110.647 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.471 ' OD1' HG21 ' A' ' 13' ' ' THR . 8.8 p30 -92.62 -24.43 18.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 1.66 111.846 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.471 HG21 ' OD1' ' A' ' 12' ' ' ASN . 26.1 p -97.58 -30.96 12.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.121 0.415 . . . . 1.12 112.121 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.493 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 95.34 -0.14 63.5 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.525 -0.845 . . . . 0.43 111.713 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -92.5 88.48 6.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.73 0.3 . . . . 2.19 110.352 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 69' ' ' THR . 7.8 mp -102.61 99.87 9.9 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.376 -0.375 . . . . 1.12 110.529 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.7 150.98 21.24 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.151 0.501 . . . . 1.06 110.61 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.835 ' SG ' ' HB2' ' A' ' 66' ' ' ASN . 10.4 t -84.22 100.75 11.39 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.335 -0.848 . . . . 0.74 108.72 175.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 59.3 m -125.93 150.41 48.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.177 0.513 . . . . 0.5 111.74 -169.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 9.4 t70 -92.97 130.36 38.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.231 -1.026 . . . . 1.65 108.231 172.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.6 p -85.91 -3.9 59.04 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.773 -0.371 . . . . 1.12 111.46 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -106.39 -39.19 5.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.109 0.48 . . . . 2.85 109.747 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 38.8 mtmt -74.32 132.24 41.88 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.889 0.852 . . . . 3.03 110.17 172.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.523 ' HD2' HG22 ' A' ' 47' ' ' ILE . 14.4 mmmm -124.09 156.7 36.13 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.406 -1.27 . . . . 2.7 110.821 -171.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.465 HG21 ' OE1' ' A' ' 48' ' ' GLN . 2.2 t -119.88 144.3 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.37 -0.604 . . . . 1.3 109.37 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -81.04 -19.3 44.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.255 0.55 . . . . 3.31 110.474 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 27' ' ' LYS . 2.2 mmmp? -80.14 118.98 22.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.338 -0.846 . . . . 4.49 110.33 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -144.41 113.69 6.98 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.488 -0.56 . . . . 2.89 109.488 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.7 m -152.04 -80.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.434 -0.348 . . . . 2.23 110.494 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 141.41 12.21 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.82 -0.705 . . . . 1.39 112.289 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.37 -47.19 6.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.761 0.28 . . . . 3.06 111.124 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -82.41 -39.75 22.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.578 -0.527 . . . . 2.44 109.578 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 34.2 t -70.63 -28.57 64.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.863 -0.608 . . . . 2.67 109.366 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.88 -11.08 73.59 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.79 -0.641 . . . . 2.54 112.606 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.5 tp -80.62 -21.52 41.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.421 0.629 . . . . 3.49 109.832 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' A' ' 37' ' ' HIS . 21.9 tp -110.7 177.97 4.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.559 -0.746 . . . . 5.24 109.41 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.463 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 55.2 t60 -70.34 -12.49 61.62 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.128 -0.357 . . . . 7.27 110.547 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.8 p -62.22 -32.75 73.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.744 0.306 . . . . 5.82 111.315 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.94 10.29 74.09 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.947 -0.644 . . . . 3.6 112.309 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -84.28 -37.55 21.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.668 0.747 . . . . 4.15 109.814 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 m -76.77 146.74 8.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.651 -1.159 . . . . 2.96 111.956 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 mt -89.47 0.63 56.73 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.595 -0.729 . . . . 3.83 109.205 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.53 -26.02 66.95 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.894 -1.048 . . . . 2.29 110.623 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.53 ' HB3' HG21 ' A' ' 82' ' ' ILE . 30.1 mt-30 -46.16 131.97 9.97 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 123.65 0.594 . . . . 1.94 110.418 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.8 t -84.09 104.2 12.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.684 -0.689 . . . . 1.98 110.491 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -97.32 100.81 12.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.271 -0.877 . . . . 1.06 110.477 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 20' ' ' ASP . 15.2 pt -106.63 152.66 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.786 -0.643 . . . . 1.06 110.027 176.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.465 ' OE1' HG21 ' A' ' 25' ' ' VAL . 13.3 tp60 -76.73 118.74 19.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.735 0.779 . . . . 2.55 110.114 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 53.7 m -114.02 160.65 18.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.116 -1.402 . . . . 1.15 110.299 -175.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 18' ' ' CYS . 15.3 t -162.87 136.86 6.17 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.41 -0.589 . . . . 1.16 109.41 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -117.81 107.53 14.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.314 0.578 . . . . 2.08 110.856 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.2 mt -57.45 139.71 80.41 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.984 -1.007 . . . . 1.51 109.99 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -34.72 118.94 0.13 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 124.274 3.316 . . . . 1.11 113.156 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.56 136.55 53.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.435 -0.802 . . . . 2.15 113.005 -169.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.32 109.18 20.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.68 -1.229 . . . . 2.07 107.68 167.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.8 mt -55.92 126.42 13.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.244 0.545 . . . . 2.56 111.438 -170.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.64 -4.62 58.09 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.278 -0.874 . . . . 1.09 113.086 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -98.37 151.16 4.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.718 0.771 . . . . 1.29 112.012 -179.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -88.49 145.14 25.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.45 -1.25 . . . . 1.34 111.79 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 61' ' ' GLU . 6.1 tp -40.79 -46.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.621 0.768 . . . . 1.49 113.026 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -70.92 -23.14 62.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.813 0.671 . . . . 2.2 112.813 -169.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -106.67 -7.49 17.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.424 0.631 . . . . 1.98 109.877 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -74.34 -39.11 63.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.586 -0.734 . . . . 2.09 109.77 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.3 p -132.38 162.88 29.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.475 -0.784 . . . . 0.6 110.431 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -108.39 33.8 3.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.862 0.319 . . . . 2.81 111.862 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.835 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m-80 -115.21 -163.17 0.86 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.827 -0.805 . . . . 1.39 108.827 173.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 m -86.82 131.4 45.3 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 121.222 0.534 . . . . 1.12 111.068 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -79.56 126.84 6.94 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.848 2.365 . . . . 0.65 110.356 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 71.3 p -131.26 145.57 51.95 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.393 -0.523 . . . . 1.1 111.631 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.2 t -94.99 111.67 23.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.406 -0.591 . . . . 1.26 109.406 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 38.0 m -96.8 144.03 27.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.251 0.548 . . . . 0.29 110.847 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -82.14 -21.82 36.45 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.436 -0.802 . . . . 1.69 109.299 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 14.5 t70 -161.69 153.36 18.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.991 -1.114 . . . . 1.26 107.991 173.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.447 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.0 t -135.35 128.69 48.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.459 -0.497 . . . . 1.59 109.853 173.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -94.4 169.48 10.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.762 -0.654 . . . . 1.87 110.841 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 78' ' ' GLY . 9.4 m-20 56.53 -148.86 0.48 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.028 -0.987 . . . . 1.94 111.296 177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -80.51 23.09 0.53 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.698 0.761 . . . . 2.12 110.127 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.447 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 92.08 23.28 27.81 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.903 -0.665 . . . . 0.53 112.235 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -91.06 -19.11 23.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.381 . . . . 1.77 111.126 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.09 101.34 7.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.294 -0.412 . . . . 1.1 109.954 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.696 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -95.25 144.68 17.35 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.485 -0.864 . . . . 0.26 112.494 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.53 HG21 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -102.64 118.78 50.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.929 -0.397 . . . . 1.07 109.929 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 62.23 35.03 15.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.59 -0.732 . . . . 0.34 110.913 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.696 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 61.1 m -74.47 95.83 2.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.614 -0.721 . . . . 0.81 110.847 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.9 m -89.74 128.38 50.65 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 121.232 0.539 . . . . 1.14 110.219 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.16 133.6 25.21 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.296 2.664 . . . . 0.59 112.645 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 pt -107.25 153.35 41.17 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.073 -0.967 . . . . 1.21 111.311 -174.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -71.75 162.29 42.5 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.202 2.601 . . . . 1.22 111.476 172.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.7 mt -87.32 24.78 1.53 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.014 -0.539 . . . . 1.71 110.6 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 pt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.036 -0.983 . . . . 2.35 111.068 -174.884 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 111.961 -0.455 . . . . 6.07 111.961 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -64.16 140.82 58.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.865 0.364 . . . . 4.71 110.828 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.42 -110.59 2.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.755 -0.735 . . . . 2.2 111.83 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.544 ' CD2' ' HB ' ' A' ' 60' ' ' ILE . 92.3 m95 -130.7 -175.93 3.82 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.731 -0.276 . . . . 0.9 110.795 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.478 ' OE2' ' HA ' ' A' ' 59' ' ' ALA . 2.7 mp0 -59.47 106.82 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.274 0.559 . . . . 2.73 111.173 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.482 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 42.5 m -112.61 2.46 16.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.575 -0.739 . . . . 2.09 110.741 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -16.01 62.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.979 -0.555 . . . . 3.61 111.776 -175.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.64 4.96 38.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.909 0.385 . . . . 2.26 110.894 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.05 16.16 80.99 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.224 -1.151 . . . . 0.95 110.224 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 6' ' ' SER . 2.3 p -71.71 -30.05 65.23 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.388 -0.906 . . . . 2.08 111.861 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 6' ' ' SER . 7.4 t -155.79 143.71 19.77 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.764 -0.374 . . . . 1.19 110.936 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -91.79 -30.7 16.08 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.236 0.541 . . . . 1.66 110.186 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.1 p -92.25 -15.55 27.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.554 -0.748 . . . . 1.12 111.137 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.482 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 86.51 -8.36 75.2 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.923 -0.656 . . . . 0.43 112.493 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -87.99 89.12 7.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.988 0.423 . . . . 2.19 111.015 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 69' ' ' THR . 8.9 mp -90.11 141.93 28.21 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.304 -0.628 . . . . 1.12 109.304 172.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.85 145.74 36.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.963 0.411 . . . . 1.06 110.678 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 50' ' ' THR . 32.9 m -79.9 101.79 8.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.634 -0.876 . . . . 0.74 108.634 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.8 m -124.56 146.79 48.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.942 0.401 . . . . 0.5 111.344 -170.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -94.62 117.57 30.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.989 -0.745 . . . . 1.65 108.989 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 54.0 p -79.44 -0.38 32.76 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.198 0.523 . . . . 1.12 110.714 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -104.26 -17.75 14.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.659 -0.701 . . . . 2.85 109.477 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -119.63 137.74 53.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.437 -0.801 . . . . 3.03 110.437 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -140.23 162.75 34.52 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.731 0.641 . . . . 2.7 112.731 -170.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.438 HG21 ' OE1' ' A' ' 48' ' ' GLN . 1.6 t -111.74 150.67 13.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.014 -0.994 . . . . 1.3 110.553 -173.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -76.01 -4.38 40.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.953 -0.567 . . . . 3.31 112.128 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -104.86 119.59 39.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.643 0.259 . . . . 4.49 110.842 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.4 m -102.28 8.71 40.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.016 0.436 . . . . 2.89 110.367 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.9 p -87.59 164.77 15.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.829 -0.623 . . . . 2.23 111.174 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.599 ' N ' ' HA3' ' A' ' 34' ' ' GLY . . . -152.53 -174.62 23.24 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.156 -0.778 . . . . 1.39 111.156 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -100.64 -24.15 14.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.203 0.501 . . . . 3.06 111.62 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -100.77 -68.99 0.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.028 0.442 . . . . 2.44 111.202 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 t -90.46 -27.78 19.02 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.584 -0.524 . . . . 2.67 109.584 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.599 ' HA3' ' N ' ' A' ' 30' ' ' GLY . . . -63.51 -29.33 74.29 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.486 -0.779 . . . . 2.54 113.463 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.0 mt -77.95 -22.28 49.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.014 0.435 . . . . 3.49 110.321 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt -84.25 173.21 11.18 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.64 -0.709 . . . . 5.24 110.551 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -76.61 -11.19 59.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.242 0.544 . . . . 7.27 110.124 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.1 m -72.39 -25.45 61.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.71 -0.677 . . . . 5.82 110.368 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.456 ' HA2' ' OE1' ' A' ' 44' ' ' GLN . . . -97.04 13.83 64.49 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.942 -0.572 . . . . 3.6 111.801 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.93 -35.92 67.11 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.592 0.71 . . . . 4.15 109.638 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.46 HG21 ' HG3' ' A' ' 44' ' ' GLN . 3.5 m -61.33 133.89 26.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.293 -1.321 . . . . 2.96 112.429 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 mp -87.7 2.69 50.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.306 -0.861 . . . . 3.83 109.703 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.41 -34.11 74.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.238 -0.892 . . . . 2.29 109.435 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.502 ' HB3' HG23 ' A' ' 82' ' ' ILE . 18.7 mt-30 -53.12 143.27 18.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.139 -0.937 . . . . 1.94 110.524 173.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.578 HG11 ' HA ' ' A' ' 83' ' ' ASN . 8.2 p -103.26 118.47 50.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.205 0.526 . . . . 1.98 110.62 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.66 100.0 9.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.46 -0.791 . . . . 1.06 111.172 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 10.7 pt -106.11 155.43 7.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.064 -0.516 . . . . 1.06 110.255 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.438 ' OE1' HG21 ' A' ' 25' ' ' VAL . 10.5 tp60 -77.3 126.04 30.29 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.463 0.649 . . . . 2.55 110.087 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 45.3 m -124.29 163.02 22.53 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.763 -1.108 . . . . 1.15 110.352 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 10.0 t -160.08 142.73 13.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.831 -0.433 . . . . 1.16 109.831 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -120.54 117.96 28.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.142 0.496 . . . . 2.08 110.348 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.4 mt -85.23 137.29 37.17 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.371 -0.831 . . . . 1.51 109.539 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -32.68 117.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 124.989 3.792 . . . . 1.11 113.807 -172.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 pp -101.88 142.63 32.89 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.897 -1.047 . . . . 2.15 112.356 -169.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.473 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 74.9 mt -92.51 132.83 36.49 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.776 -0.824 . . . . 2.07 108.776 166.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 mt -64.05 135.17 28.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.005 0.431 . . . . 2.56 110.471 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.96 12.16 60.69 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.757 -0.656 . . . . 1.09 112.245 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -109.24 147.88 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.641 0.734 . . . . 1.29 111.855 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.478 ' HA ' ' OE2' ' A' ' 5' ' ' GLU . . . -73.42 128.18 34.77 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.187 -1.37 . . . . 1.34 110.056 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.544 ' HB ' ' CD2' ' A' ' 4' ' ' TRP . 16.3 tt -57.22 -33.04 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 1.49 111.931 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -9.96 59.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.385 0.612 . . . . 2.2 110.266 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.06 -35.41 10.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.37 -0.832 . . . . 1.98 109.038 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.5 tp10 -68.6 -39.48 80.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.537 -1.211 . . . . 2.09 110.587 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.0 p -119.6 147.03 44.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.341 -0.391 . . . . 0.6 110.198 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -99.36 48.35 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.144 0.497 . . . . 2.81 110.814 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -128.12 -172.7 2.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.882 -0.599 . . . . 1.39 109.502 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.9 m -83.07 127.97 67.08 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-O 121.145 0.498 . . . . 1.12 110.831 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.01 131.7 7.04 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.925 2.417 . . . . 0.65 111.281 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 81.0 p -133.37 153.44 51.59 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.432 -0.349 . . . . 1.1 110.861 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 15.8 t -99.63 111.22 23.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.804 -0.443 . . . . 1.26 109.804 173.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.6 m -100.97 138.02 38.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.252 0.549 . . . . 0.29 110.768 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -78.05 -27.41 48.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.633 -0.712 . . . . 1.69 109.859 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -154.36 151.76 29.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.514 -0.921 . . . . 1.26 108.514 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.524 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.5 t -140.47 132.42 31.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.869 -0.419 . . . . 1.59 109.869 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.77 160.7 14.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.478 -0.328 . . . . 1.87 110.21 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 78' ' ' GLY . 9.7 m-20 59.8 -154.02 0.37 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.724 0.41 . . . . 1.94 110.238 -174.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.35 23.99 0.37 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.015 0.436 . . . . 2.12 110.721 176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.524 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 102.66 22.62 9.39 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.989 -0.624 . . . . 0.53 112.637 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 2.6 mm? -78.38 -27.78 46.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 1.77 111.264 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.6 t -125.05 107.71 18.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.334 -0.394 . . . . 1.1 110.719 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -100.93 139.03 14.19 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.104 -1.045 . . . . 0.26 112.195 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.502 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -104.82 123.6 58.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 122.54 0.336 . . . . 1.07 110.143 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.578 ' HA ' HG11 ' A' ' 45' ' ' VAL . 79.6 m-20 62.63 42.69 8.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.89 -0.595 . . . . 0.34 110.714 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.534 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 59.6 m -83.12 96.64 8.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.372 -0.831 . . . . 0.81 111.054 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 26.5 m -79.12 125.01 84.36 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.236 -0.438 . . . . 1.14 110.543 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 21.9 Cg_exo -67.03 128.05 17.95 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.029 2.486 . . . . 0.59 111.962 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.1 pt -107.3 143.09 26.48 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 116.279 -0.419 . . . . 1.21 110.928 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.6 Cg_exo -71.45 156.38 58.39 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.336 2.69 . . . . 1.22 112.355 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.0 mt -90.18 15.46 10.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.54 -0.754 . . . . 1.71 109.643 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.0 pt . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.212 -0.904 . . . . 2.35 110.889 -173.55 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 111.607 -0.597 . . . . 6.07 111.607 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.9 m -95.71 74.5 3.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.033 0.444 . . . . 4.71 110.528 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.02 -39.22 3.04 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.95 -0.643 . . . . 2.2 112.414 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -87.59 139.82 30.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.374 -0.232 . . . . 0.9 110.374 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -64.74 108.95 1.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.027 0.441 . . . . 2.73 110.399 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.7 m -96.29 27.18 3.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.465 0.65 . . . . 2.09 109.643 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -5.01 48.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.354 -0.839 . . . . 3.61 111.585 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -67.59 -30.6 70.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.085 0.469 . . . . 2.26 111.357 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.42 16.62 58.54 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.801 -0.714 . . . . 0.95 112.421 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 m -102.34 -17.02 16.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.855 0.317 . . . . 2.08 111.855 -175.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.764 ' SG ' HG23 ' A' ' 87' ' ' ILE . 3.9 m -131.1 141.55 50.16 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.851 -0.34 . . . . 1.19 111.479 -171.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.448 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.7 p30 -94.61 -28.3 15.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 1.66 112.186 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 12' ' ' ASN . 39.8 p -86.92 -31.14 20.86 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.476 0.547 . . . . 1.12 112.476 -171.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.15 5.64 82.74 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.509 -0.853 . . . . 0.43 112.679 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.456 ' HD3' HG22 ' A' ' 74' ' ' VAL . 59.4 mttp -94.38 88.27 5.47 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.065 -0.346 . . . . 2.19 110.065 176.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.684 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 7.9 mp -94.18 123.59 37.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.915 0.388 . . . . 1.12 110.299 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.18 142.62 37.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.835 -0.431 . . . . 1.06 109.835 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.1 m -80.93 118.46 22.44 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.278 -0.638 . . . . 0.74 109.278 172.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.718 ' SG ' HG13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -127.72 163.08 25.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.006 0.432 . . . . 0.5 111.152 -173.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -106.15 105.76 15.96 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.372 -0.973 . . . . 1.65 108.372 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.2 p -75.87 2.54 12.13 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.561 -0.745 . . . . 1.12 111.095 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -104.86 -3.41 23.48 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.054 -0.721 . . . . 2.85 109.054 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -113.3 102.46 10.37 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.361 -0.836 . . . . 3.03 110.562 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 3.7 mppt? -96.55 159.97 14.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.538 -0.756 . . . . 2.7 110.797 -175.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 t -119.61 149.7 22.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.946 -0.761 . . . . 1.3 108.946 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -84.45 -11.64 55.81 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.121 0.415 . . . . 3.31 112.121 -172.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -120.41 130.41 54.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.684 0.278 . . . . 4.49 110.546 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.7 m -101.45 32.68 3.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.104 -0.498 . . . . 2.89 111.207 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.9 p -86.1 150.09 24.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.263 -0.426 . . . . 2.23 110.233 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.472 ' HA3' ' OD1' ' A' ' 73' ' ' ASP . . . -150.79 -173.95 21.34 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.772 -0.728 . . . . 1.39 112.125 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -91.05 -50.65 5.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.547 0.173 . . . . 3.06 111.404 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -95.22 -11.87 27.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.193 0.442 . . . . 2.44 112.193 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.418 ' HA ' ' OG1' ' A' ' 38' ' ' THR . 58.0 m -50.72 -35.73 32.75 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.63 0.253 . . . . 2.67 111.411 170.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.94 -40.03 58.04 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.807 -0.711 . . . . 2.54 112.25 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.74 -51.47 55.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.147 0.498 . . . . 3.49 109.754 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.96 -179.88 5.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.374 -0.83 . . . . 5.24 110.783 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.82 1.17 57.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.469 0.652 . . . . 7.27 109.594 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.418 ' OG1' ' HA ' ' A' ' 33' ' ' SER . 53.6 p -65.71 -33.47 75.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.465 -0.788 . . . . 5.82 111.073 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.56 -2.67 56.29 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.959 -0.564 . . . . 3.6 113.217 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.37 -43.65 93.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.43 0.634 . . . . 4.15 109.968 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 m -88.26 143.53 11.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.054 -0.975 . . . . 2.96 111.737 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 tp -93.7 -3.84 51.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.376 -0.972 . . . . 3.83 108.376 172.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.48 -22.4 66.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.315 -1.311 . . . . 2.29 111.399 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.502 ' HB3' HG21 ' A' ' 82' ' ' ILE . 17.5 mt-30 -48.94 134.88 16.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.048 0.451 . . . . 1.94 111.283 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.56 115.41 43.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.72 -0.673 . . . . 1.98 110.421 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -100.21 118.42 36.49 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.521 -0.763 . . . . 1.06 110.925 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.718 HG13 ' SG ' ' A' ' 19' ' ' CYS . 12.5 pt -116.29 153.39 17.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.049 -0.523 . . . . 1.06 110.015 173.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.54 108.47 16.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.811 0.815 . . . . 2.55 110.076 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 62.7 m -89.5 165.6 14.2 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.128 -1.396 . . . . 1.15 110.573 -175.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.0 t -159.94 117.06 2.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.953 0.883 . . . . 1.16 110.715 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -120.0 131.78 55.26 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.964 -1.016 . . . . 2.08 110.677 -174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 64' ' ' CYS . 46.1 mt -70.41 133.9 86.99 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.979 -0.749 . . . . 1.51 108.979 171.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.11 107.04 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.07 3.18 . . . . 1.11 112.68 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.9 140.51 57.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.209 -0.905 . . . . 2.15 112.865 -169.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.53 152.74 21.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.86 -1.063 . . . . 2.07 108.767 168.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.0 mt -70.66 124.34 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.115 0.483 . . . . 2.56 110.631 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.15 17.18 72.57 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.474 -0.785 . . . . 1.09 112.952 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.405 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -97.0 149.13 5.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.713 0.768 . . . . 1.29 111.563 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.15 144.67 36.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.29 -1.323 . . . . 1.34 111.358 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.543 HG21 ' N ' ' A' ' 61' ' ' GLU . 7.1 tp -53.38 -43.49 51.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.602 -0.726 . . . . 1.49 111.478 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.543 ' N ' HG21 ' A' ' 60' ' ' ILE . 45.6 mt-10 -71.34 -41.65 69.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.7 -0.682 . . . . 2.2 111.489 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -79.44 -8.37 59.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.051 -0.522 . . . . 1.98 111.036 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.7 tp10 -92.21 -41.16 10.58 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.288 -0.415 . . . . 2.09 110.793 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.468 ' HA ' HD11 ' A' ' 52' ' ' ILE . 1.7 p -113.9 173.13 6.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.6 111.185 -172.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -125.02 49.91 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.296 0.57 . . . . 2.81 109.563 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -143.24 -170.3 3.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.836 -0.62 . . . . 1.39 110.43 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.4 m -79.62 130.76 66.74 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.888 0.375 . . . . 1.12 111.142 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -79.03 120.13 4.51 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.719 2.279 . . . . 0.65 111.264 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.1 p -129.38 148.5 51.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.199 -0.455 . . . . 1.1 109.874 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.684 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 72.9 m -113.59 111.51 21.99 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.458 0.647 . . . . 1.26 110.128 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.9 m -86.56 152.59 22.49 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.962 -1.017 . . . . 0.29 111.036 -172.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 7.3 tt0 -91.53 -22.28 20.44 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.255 -0.884 . . . . 1.69 109.628 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.472 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 33.9 t0 -158.99 161.33 36.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.739 -1.208 . . . . 1.26 107.739 170.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.551 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -139.21 149.37 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 118.362 0.528 . . . . 1.59 110.793 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 8.2 tp10 -111.36 160.2 17.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.439 -0.8 . . . . 1.87 109.764 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 78' ' ' GLY . 68.9 m-20 60.49 -151.93 0.4 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.255 -0.43 . . . . 1.94 109.936 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.86 10.33 2.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.001 0.429 . . . . 2.12 110.301 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.551 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 113.27 24.03 4.94 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.895 -0.669 . . . . 0.53 112.487 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.48 -21.93 25.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 1.77 111.432 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 88.4 t -127.04 113.05 30.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.277 -0.638 . . . . 1.1 109.277 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.68 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -108.0 142.76 15.97 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.697 -1.24 . . . . 0.26 112.869 -173.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -95.75 118.17 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 109.69 -0.485 . . . . 1.07 109.69 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 93.8 m-20 60.21 42.93 14.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.279 -0.873 . . . . 0.34 110.804 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.68 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.8 m -78.0 87.71 4.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.669 -0.696 . . . . 0.81 109.919 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.2 m -83.07 134.22 46.69 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.377 -0.829 . . . . 1.14 110.256 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -70.49 118.56 5.76 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.97 2.446 . . . . 0.59 111.59 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.764 HG23 ' SG ' ' A' ' 11' ' ' CYS . 5.5 pt -88.13 140.58 30.72 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.355 -0.839 . . . . 1.21 111.671 -173.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -74.91 151.76 40.39 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.374 2.716 . . . . 1.22 111.707 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.5 mt -95.35 28.16 3.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.637 -0.71 . . . . 1.71 109.625 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.6 pt . . . . . 0 C--O 1.245 0.864 0 CA-C-N 115.503 -0.771 . . . . 2.35 110.735 -173.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.637 0 N-CA-C 111.974 -0.451 . . . . 6.07 111.974 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -83.3 55.46 3.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.975 0.417 . . . . 4.71 110.598 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.43 135.0 12.77 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.773 -0.727 . . . . 2.2 111.937 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -88.25 172.82 9.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.034 0.445 . . . . 0.9 111.079 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' A' ' 7' ' ' LYS . 32.8 mm-40 -85.11 109.54 18.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.732 -0.667 . . . . 2.73 110.45 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 m -80.42 27.45 0.34 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.864 -0.607 . . . . 2.09 111.021 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 8' ' ' THR . 0.2 OUTLIER -53.88 -22.68 10.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.747 -0.66 . . . . 3.61 112.12 -177.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.432 ' N ' ' HD2' ' A' ' 7' ' ' LYS . 6.9 t -73.39 -13.08 61.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.274 -0.421 . . . . 2.26 111.232 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.06 17.42 75.63 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.906 -0.664 . . . . 0.95 112.452 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -102.63 -9.86 19.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.89 0.33 . . . . 2.08 111.89 -172.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.686 ' SG ' HG22 ' A' ' 87' ' ' ILE . 2.7 m -139.65 140.32 36.89 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.267 -0.573 . . . . 1.19 111.456 -171.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -95.33 -30.6 13.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 1.66 111.867 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.7 p -80.53 -29.94 37.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.663 0.616 . . . . 1.12 112.663 -169.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.55 -4.27 85.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.503 -0.856 . . . . 0.43 112.304 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -90.69 87.86 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.425 . . . . 2.19 109.99 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.811 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 8.1 mp -96.13 139.55 32.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.698 -0.683 . . . . 1.12 109.708 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.654 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -148.39 144.71 27.67 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.894 0.378 . . . . 1.06 110.389 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 86.1 m -89.9 99.54 12.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.131 0.491 . . . . 0.74 109.698 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 83.7 m -114.41 164.69 13.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.546 . . . . 0.5 112.028 -165.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -102.15 108.34 19.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.842 -0.617 . . . . 1.65 109.516 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -77.8 0.62 23.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.298 -0.41 . . . . 1.12 111.19 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -101.13 -7.3 23.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.172 -0.677 . . . . 2.85 109.172 175.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -113.3 107.21 15.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.262 -0.881 . . . . 3.03 110.328 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -100.34 154.8 18.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.827 -0.624 . . . . 2.7 110.789 -174.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.446 HG22 ' CD ' ' A' ' 48' ' ' GLN . 11.1 t -120.78 150.3 23.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.608 -0.724 . . . . 1.3 109.782 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.08 32.89 0.27 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.974 -0.557 . . . . 3.31 111.684 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER 31.12 115.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.718 1.607 . . . . 4.49 114.752 174.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -123.92 -76.83 0.59 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.477 -0.783 . . . . 2.89 111.162 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 p -142.28 -169.71 3.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.325 -0.852 . . . . 2.23 111.211 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.1 -161.04 21.95 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.232 -1.147 . . . . 1.39 110.232 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -99.57 -46.34 5.49 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.709 0.755 . . . . 3.06 110.71 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -86.94 -49.96 7.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.101 0.477 . . . . 2.44 110.844 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -91.18 4.35 52.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.834 -0.621 . . . . 2.67 110.237 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.91 -47.51 53.63 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.817 -0.629 . . . . 2.54 113.213 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 35' ' ' LEU . 5.4 mp -69.22 -61.95 1.58 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 3.49 110.228 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -109.03 99.77 9.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.047 -0.524 . . . . 5.24 109.816 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -109.15 -71.25 0.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 7.27 111.582 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 p -80.31 -14.18 58.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.113 0.483 . . . . 5.82 110.904 -175.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 -25.67 44.42 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.609 -0.805 . . . . 3.6 111.212 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.52 -50.67 7.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.118 0.485 . . . . 4.15 109.955 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.4 134.43 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.394 -0.821 . . . . 2.96 110.778 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.7 tp -98.21 -7.85 28.53 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.435 0.636 . . . . 3.83 110.214 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.25 0.49 57.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.788 -0.642 . . . . 2.29 111.848 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.446 ' HB3' HG22 ' A' ' 82' ' ' ILE . 23.1 mt-30 -51.76 131.36 30.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.308 0.575 . . . . 1.94 111.406 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.85 109.19 27.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.14 -0.936 . . . . 1.98 109.745 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -102.28 122.57 44.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.675 -0.693 . . . . 1.06 110.494 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.2 pt -128.66 153.83 38.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.993 -0.549 . . . . 1.06 110.641 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.446 ' CD ' HG22 ' A' ' 25' ' ' VAL . 2.5 mp0 -70.29 141.62 52.35 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.832 -0.622 . . . . 2.55 109.503 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.654 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 2.1 t -137.78 164.53 28.67 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.073 -0.512 . . . . 1.15 110.491 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.0 t -160.81 128.03 4.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.524 0.678 . . . . 1.16 110.652 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -121.06 125.94 48.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.674 -0.694 . . . . 2.08 110.976 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 64' ' ' CYS . 16.7 mt -63.88 139.25 97.61 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.385 -0.825 . . . . 1.51 109.836 174.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HD2' HG23 ' A' ' 52' ' ' ILE . 60.0 Cg_exo -34.25 121.13 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 124.788 3.659 . . . . 1.11 113.929 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.8 mt -65.48 119.71 11.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.038 -0.983 . . . . 2.15 112.261 -171.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 84.5 mt -99.73 122.89 43.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.989 -0.745 . . . . 2.07 108.989 166.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.526 HD11 ' H ' ' A' ' 56' ' ' ILE . 4.1 mp -72.87 130.18 35.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.073 0.463 . . . . 2.56 110.2 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.05 2.97 60.64 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.932 -0.651 . . . . 1.09 111.832 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -103.15 153.98 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.799 0.809 . . . . 1.29 111.732 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.18 130.52 36.31 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.306 -1.316 . . . . 1.34 109.815 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.642 HG22 ' N ' ' A' ' 61' ' ' GLU . 10.7 tt -50.77 -37.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.238 -0.892 . . . . 1.49 112.035 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.642 ' N ' HG22 ' A' ' 60' ' ' ILE . 6.6 mt-10 -62.61 -35.23 78.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.087 -0.96 . . . . 2.2 111.04 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.85 -22.21 19.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.904 -0.589 . . . . 1.98 109.999 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.82 -41.16 78.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.751 . . . . 2.09 110.954 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.501 ' HA ' HD12 ' A' ' 52' ' ' ILE . 4.7 p -114.65 167.85 10.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.997 0.427 . . . . 0.6 111.308 -173.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -121.94 41.42 3.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 2.81 110.284 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 57.1 m-80 -131.52 -169.87 2.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.481 -0.781 . . . . 1.39 109.666 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 11.2 m -83.17 127.1 70.36 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-O 120.933 0.397 . . . . 1.12 110.877 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.23 119.77 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.735 2.29 . . . . 0.65 111.294 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 84' ' ' CYS . 44.2 p -128.37 151.16 49.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.318 -0.401 . . . . 1.1 109.93 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.811 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 72.0 m -113.68 119.32 37.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.268 0.556 . . . . 1.26 110.16 175.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.2 m -97.57 149.37 22.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.064 -0.971 . . . . 0.29 111.298 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 9.3 mt-10 -85.06 -16.65 39.96 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.585 -1.188 . . . . 1.69 109.728 175.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -167.79 156.11 9.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.921 -1.036 . . . . 1.26 108.298 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.547 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -143.5 135.92 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 117.929 0.331 . . . . 1.59 110.566 178.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.412 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 10.6 tp10 -98.18 157.54 16.09 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.156 -0.475 . . . . 1.87 110.01 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 78' ' ' GLY . 56.9 m-20 61.31 -151.81 0.38 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.107 0.563 . . . . 1.94 109.93 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -82.38 21.91 0.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.112 0.482 . . . . 2.12 110.383 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 106.64 22.72 7.55 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.814 -0.708 . . . . 0.53 112.874 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.5 mm? -80.1 -26.67 39.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.784 0.292 . . . . 1.77 111.475 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 94.5 t -130.56 112.62 23.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.939 -0.393 . . . . 1.1 109.939 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.655 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -107.21 143.62 15.87 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.136 -1.03 . . . . 0.26 112.651 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.446 HG22 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -101.89 120.62 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.327 -0.619 . . . . 1.07 109.327 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 98.8 m-20 62.06 48.01 5.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.671 -0.695 . . . . 0.34 110.598 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.655 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 56.8 m -85.59 93.71 8.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.58 -0.736 . . . . 0.81 110.228 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.2 m -82.09 127.81 70.34 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.994 -0.548 . . . . 1.14 110.311 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.99 113.86 2.37 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.794 2.329 . . . . 0.59 111.579 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.686 HG22 ' SG ' ' A' ' 11' ' ' CYS . 9.1 pt -89.64 146.74 36.24 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.724 -0.671 . . . . 1.21 111.156 -175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -73.53 148.15 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.225 2.617 . . . . 1.22 112.24 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.99 21.4 1.97 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.741 -0.663 . . . . 1.71 110.617 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.417 HG13 ' OXT' ' A' ' 90' ' ' ILE . 21.4 pt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.766 -1.112 . . . . 2.35 111.119 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.634 -0.586 . . . . 6.07 111.634 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.416 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 8.0 t 67.4 -172.71 0.19 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.948 0.404 . . . . 4.71 110.9 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.29 27.0 45.78 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.076 -0.583 . . . . 2.2 112.209 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -97.39 164.13 12.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.128 0.49 . . . . 0.9 111.235 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.599 ' OE1' ' HA ' ' A' ' 59' ' ' ALA . 24.7 mp0 -70.91 107.38 4.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.384 -0.826 . . . . 2.73 111.072 -176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 t -111.72 26.14 10.93 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.016 -0.735 . . . . 2.09 109.016 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -55.04 -33.9 63.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.934 -1.03 . . . . 3.61 111.541 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.7 t -85.04 3.81 36.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.811 0.339 . . . . 2.26 111.461 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.3 18.44 69.05 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.389 -0.91 . . . . 0.95 112.558 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.0 p -70.27 -32.05 69.7 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.759 0.651 . . . . 2.08 112.759 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.2 t -129.74 144.1 51.13 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.099 0.476 . . . . 1.19 111.365 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.435 ' OD1' HG21 ' A' ' 13' ' ' THR . 8.2 p30 -91.21 -24.91 19.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.961 -0.563 . . . . 1.66 111.341 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.435 HG21 ' OD1' ' A' ' 12' ' ' ASN . 56.3 p -98.21 -30.56 12.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.076 0.465 . . . . 1.12 111.349 -177.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.21 0.06 59.97 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.832 -0.699 . . . . 0.43 111.396 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HG2' ' HB2' ' A' ' 2' ' ' SER . 61.2 mttp -91.61 88.46 6.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.752 0.31 . . . . 2.19 110.401 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 69' ' ' THR . 8.1 mp -96.83 151.4 19.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.694 -0.484 . . . . 1.12 109.694 175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.555 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -160.26 144.66 14.4 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.744 0.307 . . . . 1.06 110.85 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 1.2 m -80.13 97.63 6.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.854 -0.612 . . . . 0.74 109.923 173.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.13 160.59 18.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.114 -0.494 . . . . 0.5 110.82 -172.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.01 116.25 31.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.705 -0.48 . . . . 1.65 109.705 173.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.5 p -76.44 -8.66 57.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.089 0.471 . . . . 1.12 111.227 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -93.85 -15.97 24.53 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.021 0.915 . . . . 2.85 108.727 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -102.5 110.33 22.23 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.008 -1.451 . . . . 3.03 110.707 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.4 OUTLIER -103.08 163.75 12.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.281 -0.418 . . . . 2.7 110.992 -178.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.511 HG22 ' OE1' ' A' ' 48' ' ' GLN . 23.5 t -116.04 150.05 18.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.002 -0.74 . . . . 1.3 109.002 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -83.68 -17.0 42.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.39 0.515 . . . . 3.31 112.39 -171.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -114.02 156.76 23.51 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.277 -0.268 . . . . 4.49 110.277 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 p -121.42 12.68 10.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.79 0.329 . . . . 2.89 111.405 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 p -72.97 142.75 47.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.34 . . . . 2.23 110.84 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.25 165.23 25.24 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.583 -0.818 . . . . 1.39 112.803 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -81.76 -46.21 14.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.741 0.305 . . . . 3.06 111.44 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -95.73 -31.09 13.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.386 -0.37 . . . . 2.44 111.307 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.7 p -62.62 -23.09 66.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 2.67 111.304 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.13 97.6 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.79 -0.719 . . . . 2.54 111.891 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 35' ' ' LEU . 4.7 mp -90.35 -29.36 18.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.005 0.431 . . . . 3.49 110.49 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.3 tp -70.14 130.18 41.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.015 -0.539 . . . . 5.24 110.284 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -70.51 -24.93 62.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.372 -0.376 . . . . 7.27 111.023 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 m -80.44 -19.47 46.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.134 0.492 . . . . 5.82 110.261 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.05 13.82 66.76 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.192 -0.763 . . . . 3.6 111.192 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.12 -27.24 60.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.367 0.603 . . . . 4.15 109.996 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.429 HG22 ' CG ' ' A' ' 44' ' ' GLN . 3.7 m -61.35 149.67 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.074 -0.966 . . . . 2.96 112.085 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt -99.17 -7.44 26.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.785 -0.643 . . . . 3.83 110.602 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -86.76 0.95 53.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.94 -0.573 . . . . 2.29 111.31 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.547 ' NE2' HG21 ' A' ' 82' ' ' ILE . 35.3 mt-30 -46.0 139.81 4.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.948 0.404 . . . . 1.94 110.839 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.27 116.54 49.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.275 -0.42 . . . . 1.98 110.112 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -105.62 117.48 34.13 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.833 -0.621 . . . . 1.06 111.138 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 13.8 pt -106.38 150.21 9.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.074 -0.512 . . . . 1.06 110.241 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.511 ' OE1' HG22 ' A' ' 25' ' ' VAL . 13.9 tp60 -76.63 116.0 16.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.599 -0.728 . . . . 2.55 109.342 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.69 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 2.2 t -110.1 169.43 8.74 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.283 -0.872 . . . . 1.15 110.235 -172.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.0 t -160.19 128.06 4.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.646 0.736 . . . . 1.16 110.808 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -120.88 114.1 21.08 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.518 -0.764 . . . . 2.08 111.059 -176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.72 133.22 72.27 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.395 -0.821 . . . . 1.51 109.46 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -38.45 102.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 124.578 3.519 . . . . 1.11 113.01 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.44 135.19 51.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.408 -0.815 . . . . 2.15 112.308 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.02 135.0 35.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.167 -0.924 . . . . 2.07 109.372 171.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.4 mt -66.6 129.63 31.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.23 0.538 . . . . 2.56 110.305 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.26 -15.66 58.8 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.224 -0.898 . . . . 1.09 111.832 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -89.7 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.586 0.708 . . . . 1.29 111.649 -177.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . . . -89.8 146.46 24.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.461 -1.245 . . . . 1.34 111.475 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.532 HG23 ' N ' ' A' ' 61' ' ' GLU . 5.0 tp -49.89 -44.05 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.621 -0.718 . . . . 1.49 110.724 173.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.532 ' N ' HG23 ' A' ' 60' ' ' ILE . 6.4 mm-40 -68.91 -16.84 63.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.431 -0.804 . . . . 2.2 111.986 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -110.46 -10.87 14.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.318 -0.401 . . . . 1.98 111.3 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.4 tp10 -93.62 -38.78 11.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.183 0.516 . . . . 2.09 110.595 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.2 p -131.38 146.92 52.49 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.913 -0.585 . . . . 0.6 110.208 -173.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -121.93 64.56 0.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.68 0.752 . . . . 2.81 111.064 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 36.5 m-80 -123.23 -155.43 0.65 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.231 -1.396 . . . . 1.39 107.231 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -86.05 121.17 72.9 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 119.418 -0.913 . . . . 1.12 110.048 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.11 130.25 9.23 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.646 2.231 . . . . 0.65 110.671 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 84' ' ' CYS . 81.1 p -131.65 155.11 48.15 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.415 -0.357 . . . . 1.1 111.374 -175.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.2 t -103.27 110.48 22.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.684 -0.858 . . . . 1.26 108.684 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.7 m -94.84 145.28 25.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.403 0.621 . . . . 0.29 110.666 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 2.6 tt0 -79.57 -18.63 51.29 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.325 -0.852 . . . . 1.69 109.235 176.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -170.13 156.3 5.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.135 -0.939 . . . . 1.26 109.178 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.502 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.4 t -143.07 134.62 23.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.331 -0.248 . . . . 1.59 110.331 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 41.4 tt0 -104.17 158.8 16.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.47 -0.332 . . . . 1.87 110.693 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.404 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 4.4 t70 66.58 -148.19 0.19 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.183 0.593 . . . . 1.94 109.672 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.85 11.83 2.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.011 0.434 . . . . 2.12 110.442 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.69 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 108.7 23.94 6.32 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.916 -0.659 . . . . 0.53 112.155 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 mt -82.93 -23.6 33.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.819 0.342 . . . . 1.77 111.197 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 60.9 t -122.79 106.37 17.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.688 -0.486 . . . . 1.1 109.688 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.61 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -106.56 133.83 11.84 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.325 -0.94 . . . . 0.26 111.954 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.547 HG21 ' NE2' ' A' ' 44' ' ' GLN . 1.8 mp -96.74 121.12 46.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 110.127 -0.323 . . . . 1.07 110.127 -177.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 82.7 m-20 60.62 35.32 19.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.553 -0.748 . . . . 0.34 111.124 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.61 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 67.3 m -69.82 95.33 0.89 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.607 -0.724 . . . . 0.81 110.702 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 30.7 m -87.56 126.89 60.47 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.951 -0.568 . . . . 1.14 110.009 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 36.2 Cg_exo -59.13 128.96 29.57 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.979 2.452 . . . . 0.59 112.321 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 pt -100.94 147.87 34.29 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.044 -0.526 . . . . 1.21 110.799 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.83 156.42 66.0 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.009 2.473 . . . . 1.22 112.086 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.4 mt -79.17 11.14 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.859 -0.61 . . . . 1.71 110.901 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.4 ' OXT' HG13 ' A' ' 90' ' ' ILE . 17.6 pt . . . . . 0 C--N 1.313 -0.989 0 CA-C-N 115.252 -0.885 . . . . 2.35 110.508 -175.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 112.127 -0.389 . . . . 6.07 112.127 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -107.25 -11.79 15.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.822 0.344 . . . . 4.71 110.9 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.05 -172.37 41.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.103 -0.57 . . . . 2.2 112.085 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -129.79 155.63 45.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.319 0.58 . . . . 0.9 112.023 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -65.27 113.84 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.936 -1.029 . . . . 2.73 110.911 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 m -88.5 26.82 1.38 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.9 -0.591 . . . . 2.09 110.445 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -53.74 -52.52 59.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.489 -0.778 . . . . 3.61 112.502 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -69.53 -24.46 63.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.2 -0.455 . . . . 2.26 111.846 -172.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.03 16.01 79.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.906 -0.664 . . . . 0.95 111.742 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.469 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 5.4 p -74.45 -30.51 61.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.301 0.482 . . . . 2.08 112.301 -173.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.6 t -105.2 142.29 35.24 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.004 0.431 . . . . 1.19 111.181 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.552 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.7 p30 -92.18 -27.35 17.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 1.66 111.784 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.552 HG22 ' OD1' ' A' ' 12' ' ' ASN . 11.0 p -100.34 -30.81 11.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.873 0.368 . . . . 1.12 111.973 -175.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.03 -6.36 53.93 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.528 -0.844 . . . . 0.43 112.26 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.445 ' HZ2' HG23 ' A' ' 74' ' ' VAL . 89.2 mttt -88.35 88.73 7.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 2.19 110.48 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.5 mp -92.99 127.01 38.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.454 -0.794 . . . . 1.12 110.171 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.591 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -142.53 153.09 43.28 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.786 0.327 . . . . 1.06 110.383 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 60.4 m -89.57 97.67 11.33 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.184 -0.672 . . . . 0.74 109.184 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 71.4 m -113.51 153.46 28.69 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.314 -0.403 . . . . 0.5 111.19 -169.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.613 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 8.0 t70 -92.51 119.35 31.9 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.077 -0.712 . . . . 1.65 109.077 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.8 p -80.41 -7.78 59.26 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.775 0.322 . . . . 1.12 111.706 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -104.59 -15.94 15.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 2.85 110.127 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 36.6 mtmt -103.35 129.04 50.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.709 -0.678 . . . . 3.03 110.779 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -116.55 162.35 17.74 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.912 -1.04 . . . . 2.7 111.243 -175.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 t -113.32 149.97 15.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.847 -0.615 . . . . 1.3 109.798 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -84.51 5.25 28.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.003 -0.544 . . . . 3.31 111.288 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -132.24 119.72 21.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.439 -0.346 . . . . 4.49 110.215 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -126.28 80.27 1.91 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.251 -0.431 . . . . 2.89 110.218 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.8 m -118.26 -54.91 2.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.035 0.445 . . . . 2.23 111.317 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' HA3' ' A' ' 34' ' ' GLY . . . 91.89 155.24 31.62 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.543 -0.753 . . . . 1.39 111.787 -174.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -101.18 -50.37 3.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.05 0.452 . . . . 3.06 110.189 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -78.71 -62.65 1.62 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.759 -0.655 . . . . 2.44 109.895 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.8 m -73.17 -21.14 60.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.522 -0.763 . . . . 2.67 109.173 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 30' ' ' GLY . . . -71.86 -20.83 78.99 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.343 -0.844 . . . . 2.54 112.336 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 tt -77.69 -36.38 51.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.72 -0.844 . . . . 3.49 108.72 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 mp -78.42 -179.43 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.319 -0.855 . . . . 5.24 110.355 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -79.42 5.97 11.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.115 0.483 . . . . 7.27 110.801 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.3 m -68.09 -37.35 81.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.11 -0.495 . . . . 5.82 110.242 174.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.22 13.85 5.54 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.602 -0.726 . . . . 3.6 112.859 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.7 -50.19 32.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.419 0.628 . . . . 4.15 110.354 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.0 m -74.7 141.26 16.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.973 -1.012 . . . . 2.96 112.299 -175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.5 tp -88.32 -2.46 58.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.428 -0.953 . . . . 3.83 108.428 172.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -60.76 -30.16 69.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.389 -1.278 . . . . 2.29 110.858 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.495 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.7 mt-30 -47.74 131.33 14.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.137 -0.483 . . . . 1.94 110.358 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.654 ' CG1' ' HA ' ' A' ' 83' ' ' ASN . 7.2 p -95.14 105.51 17.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.693 0.758 . . . . 1.98 110.825 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -96.59 101.73 13.39 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.154 -0.93 . . . . 1.06 110.25 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.51 ' HB ' ' O ' ' A' ' 20' ' ' ASP . 17.5 pt -104.13 150.0 7.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.935 -0.575 . . . . 1.06 110.311 177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -74.77 126.6 31.26 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.057 -0.72 . . . . 2.55 109.057 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.591 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 1.8 t -117.0 160.72 20.51 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.342 -0.845 . . . . 1.15 110.522 -171.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 2.5 t -150.53 121.39 7.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.335 0.588 . . . . 1.16 110.427 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -118.87 111.2 18.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.499 0.666 . . . . 2.08 110.479 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.0 mt -71.11 133.8 85.6 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 114.859 -1.064 . . . . 1.51 109.979 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -34.3 130.58 0.18 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 124.693 3.595 . . . . 1.11 114.138 -173.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.489 HD12 ' H ' ' A' ' 54' ' ' LEU . 2.4 mp -84.29 132.85 34.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.807 -1.088 . . . . 2.15 112.584 -166.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.43 133.37 40.94 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.424 -0.954 . . . . 2.07 108.424 165.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.524 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -66.09 132.35 31.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.164 0.507 . . . . 2.56 110.893 -172.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.18 4.25 84.17 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.37 -0.832 . . . . 1.09 113.101 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -96.33 152.01 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.724 0.773 . . . . 1.29 111.859 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.54 143.33 27.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.339 -1.3 . . . . 1.34 111.172 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.4 tp -55.55 -32.32 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.005 -0.998 . . . . 1.49 111.83 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.79 -8.62 55.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 2.2 111.56 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.46 -27.15 11.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.403 0.621 . . . . 1.98 109.608 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.436 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.8 tp10 -72.62 -40.49 66.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.211 -0.904 . . . . 2.09 111.234 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 8.8 p -116.56 153.49 32.12 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.69 -0.404 . . . . 0.6 110.954 -173.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -99.69 33.17 2.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.663 0.745 . . . . 2.81 109.689 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 51.9 m-80 -117.94 -165.32 1.09 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.494 -0.776 . . . . 1.39 109.512 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 14.2 m -93.77 122.23 62.75 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-O 121.335 0.588 . . . . 1.12 112.012 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.41 117.26 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.482 2.788 . . . . 0.65 111.115 172.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.9 p -129.32 146.99 51.11 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.556 -0.458 . . . . 1.1 111.405 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.1 t -98.81 111.21 23.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.852 -0.613 . . . . 1.26 109.373 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.4 m -96.94 135.15 39.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.056 0.455 . . . . 0.29 110.626 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 6.5 tt0 -72.28 -20.75 61.46 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.449 0.642 . . . . 1.69 109.487 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -163.17 166.44 23.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.451 -0.795 . . . . 1.26 109.112 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.445 HG23 ' HZ2' ' A' ' 15' ' ' LYS . 14.7 m -138.73 157.45 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 110.055 -0.35 . . . . 1.59 110.055 177.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 80' ' ' VAL . 37.1 mt-10 -126.07 164.91 19.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.408 -0.36 . . . . 1.87 110.066 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 57.68 -150.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.548 -0.751 . . . . 1.94 109.396 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.97 22.88 0.74 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.11 0.481 . . . . 2.12 110.993 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 101.41 21.81 11.15 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.902 -0.666 . . . . 0.53 112.115 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.15 -22.55 44.9 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.329 0.585 . . . . 1.77 110.252 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 75' ' ' GLU . 61.1 t -122.49 117.91 53.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.606 -0.725 . . . . 1.1 109.472 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -110.35 134.78 12.41 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.142 -1.028 . . . . 0.26 111.939 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.495 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -98.12 121.62 48.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.198 -0.297 . . . . 1.07 110.198 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.654 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 94.5 m-20 58.4 54.91 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.867 -0.606 . . . . 0.34 110.904 174.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.479 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 47.8 m -91.62 110.73 22.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.295 -0.866 . . . . 0.81 110.944 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 47.3 m -96.16 128.76 35.77 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.982 -0.554 . . . . 1.14 110.166 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 39.4 Cg_exo -62.46 119.96 7.29 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.829 2.353 . . . . 0.59 110.947 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.469 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 7.0 pt -99.8 139.77 21.06 Favored Pre-proline 0 N--CA 1.442 -0.874 0 CA-C-N 116.319 -0.4 . . . . 1.21 111.718 -173.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.6 Cg_exo -71.38 159.44 51.61 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.251 2.634 . . . . 1.22 112.277 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.75 24.42 1.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.617 -0.72 . . . . 1.71 110.442 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.7 pt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 119.102 -0.475 . . . . 2.35 110.956 -173.573 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.707 -0.557 . . . . 6.07 111.707 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 m -76.24 73.56 3.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.103 0.478 . . . . 4.71 110.551 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.24 -65.26 2.86 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.289 -0.724 . . . . 2.2 111.289 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -121.8 149.62 43.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.154 -0.313 . . . . 0.9 110.154 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.35 110.11 2.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.912 -0.585 . . . . 2.73 109.983 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -102.67 26.23 8.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.889 -0.596 . . . . 2.09 110.57 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -16.24 62.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.684 -0.689 . . . . 3.61 111.066 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 t -69.47 -14.51 62.92 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.101 -0.5 . . . . 2.26 110.684 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.36 79.95 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.133 -0.556 . . . . 0.95 112.617 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.6 m -96.71 -10.32 27.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 111.896 0.332 . . . . 2.08 111.896 -173.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.8 t -139.46 141.87 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.613 -0.435 . . . . 1.19 110.83 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.474 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.4 p30 -93.41 -30.22 15.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 1.66 112.157 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.474 HG22 ' OD1' ' A' ' 12' ' ' ASN . 23.9 p -89.98 -30.67 17.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.138 0.422 . . . . 1.12 112.138 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.93 -7.39 67.43 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.527 -0.844 . . . . 0.43 112.068 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HD3' HG21 ' A' ' 74' ' ' VAL . 75.5 mttt -87.35 88.37 7.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.352 0.596 . . . . 2.19 110.043 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 mp -97.69 122.55 40.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.341 -0.845 . . . . 1.12 109.691 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.33 146.54 50.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.038 0.447 . . . . 1.06 111.189 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 50' ' ' THR . 62.9 m -81.38 109.1 15.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.719 -0.845 . . . . 0.74 108.719 172.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 72.3 m -126.53 153.38 45.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.216 0.531 . . . . 0.5 112.114 -169.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 13.0 t70 -99.6 113.22 25.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.098 -1.075 . . . . 1.65 108.098 175.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.0 p -77.06 -10.1 59.16 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.352 0.871 . . . . 1.12 113.352 -169.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -106.48 -3.83 20.47 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.884 0.85 . . . . 2.85 109.153 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -93.07 104.8 16.97 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.951 -1.477 . . . . 3.03 109.907 175.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.76 162.43 12.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.283 0.563 . . . . 2.7 111.705 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -123.61 143.22 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.225 -0.898 . . . . 1.3 108.764 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -86.68 -31.4 21.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.277 -0.419 . . . . 3.31 110.988 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -87.7 119.67 28.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.228 -0.442 . . . . 4.49 110.414 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -93.63 54.92 2.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.471 0.653 . . . . 2.89 109.584 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.1 m -92.12 132.92 36.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.378 -0.828 . . . . 2.23 110.192 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.495 ' HA3' ' OG ' ' A' ' 33' ' ' SER . . . -123.62 164.88 16.57 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.502 -0.856 . . . . 1.39 112.515 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -100.63 -47.87 4.71 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 122.518 0.327 . . . . 3.06 110.143 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 6.8 mm-40 -94.8 -34.41 12.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.658 0.266 . . . . 2.44 110.354 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.495 ' OG ' ' HA3' ' A' ' 30' ' ' GLY . 37.6 p -65.24 -6.83 10.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 2.67 111.847 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.75 -53.23 32.35 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.729 -0.748 . . . . 2.54 111.678 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.0 mt -91.48 -22.37 20.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.883 0.373 . . . . 3.49 110.898 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -83.05 148.39 27.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 5.24 109.895 -179.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.466 ' H ' HD23 ' A' ' 36' ' ' LEU . 75.0 m-70 -70.08 3.56 2.68 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.632 0.604 . . . . 7.27 112.632 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 p -78.41 -11.7 59.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.119 0.485 . . . . 5.82 110.789 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.5 -0.49 55.55 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.993 -0.622 . . . . 3.6 112.396 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.07 -30.27 70.27 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.02 0.438 . . . . 4.15 110.616 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.434 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 9.0 m -81.5 138.73 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.938 -0.574 . . . . 2.96 110.571 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.7 mt -94.24 0.79 55.9 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.585 0.707 . . . . 3.83 109.335 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.05 1.81 55.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.853 -1.067 . . . . 2.29 111.535 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HB3' HG22 ' A' ' 82' ' ' ILE . 34.2 mt-30 -42.52 134.64 3.02 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.427 0.454 . . . . 1.94 110.897 176.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.17 99.92 10.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.764 -0.653 . . . . 1.98 109.629 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -99.33 108.06 20.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.447 -0.797 . . . . 1.06 110.478 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 pt -118.52 159.47 18.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.836 -0.62 . . . . 1.06 110.052 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -77.56 142.04 39.23 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 122.12 0.962 . . . . 2.55 110.848 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 39.4 m -140.94 164.64 29.71 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.516 -1.675 . . . . 1.15 109.908 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 7.9 t -161.01 136.1 7.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.164 -0.471 . . . . 1.16 109.806 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -120.36 110.28 16.35 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.109 0.48 . . . . 2.08 110.447 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.9 mt -63.71 131.11 94.79 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.503 -0.771 . . . . 1.51 109.517 175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -32.83 102.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.771 3.647 . . . . 1.11 113.867 -171.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 pp -70.03 135.58 49.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.101 -0.954 . . . . 2.15 112.636 -171.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.3 137.74 32.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.349 -0.842 . . . . 2.07 109.333 170.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.8 mp -71.39 131.83 34.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.405 -0.591 . . . . 2.56 109.405 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.77 -6.95 59.0 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.598 -0.728 . . . . 1.09 111.687 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -106.99 152.69 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.642 0.734 . . . . 1.29 111.803 179.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.4 152.7 20.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.458 -1.247 . . . . 1.34 111.359 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 61' ' ' GLU . 6.2 tp -56.81 -40.68 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.227 0.611 . . . . 1.49 112.1 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.433 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -84.92 -11.19 56.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.398 -0.365 . . . . 2.2 111.598 -172.149 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -95.56 -34.3 12.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.383 -0.599 . . . . 1.98 109.383 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.465 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 9.6 tp10 -67.55 -40.23 84.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.138 -0.937 . . . . 2.09 110.711 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.56 148.36 41.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.293 -0.412 . . . . 0.6 109.961 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -99.79 45.7 0.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.874 0.845 . . . . 2.81 109.667 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 46.3 m-80 -122.11 -172.36 2.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.103 -0.953 . . . . 1.39 108.982 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 m -85.93 126.12 66.59 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-O 121.167 0.508 . . . . 1.12 110.552 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -83.06 136.07 7.81 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.079 2.519 . . . . 0.65 111.105 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.8 p -133.8 150.91 51.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.794 0.33 . . . . 1.1 111.147 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 44.0 t -95.37 115.46 27.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.727 -0.842 . . . . 1.26 108.727 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.91 135.65 45.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.467 0.651 . . . . 0.29 110.829 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 9.4 mt-10 -70.14 -19.42 63.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.946 -1.025 . . . . 1.69 109.837 175.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -169.68 161.44 9.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.909 -1.041 . . . . 1.26 108.616 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.558 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -145.28 136.9 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.635 -0.505 . . . . 1.59 109.635 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.84 160.85 14.02 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.361 -0.381 . . . . 1.87 110.108 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 78' ' ' GLY . 3.1 t70 62.34 -153.34 0.35 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.348 -0.612 . . . . 1.94 109.348 -177.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.81 23.58 0.43 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.095 0.474 . . . . 2.12 110.705 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.558 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 105.38 23.58 7.54 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.889 -0.672 . . . . 0.53 112.423 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -78.66 -33.04 47.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.865 0.364 . . . . 1.77 111.243 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.69 108.29 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.319 -0.4 . . . . 1.1 110.036 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.714 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -97.16 140.04 14.83 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.064 -1.065 . . . . 0.26 112.527 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.454 HG22 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -102.97 116.8 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 109.52 -0.548 . . . . 1.07 109.52 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 96.5 m-20 62.58 41.59 9.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.428 -0.805 . . . . 0.34 110.773 175.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.714 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 60.5 m -80.42 110.9 16.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.81 111.086 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 m -103.85 132.21 21.25 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.154 -0.475 . . . . 1.14 110.13 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.41 129.13 21.82 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.041 2.494 . . . . 0.59 112.1 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 11.7 pt -105.73 146.61 33.18 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.908 -0.587 . . . . 1.21 111.776 -173.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 11.4 Cg_exo -74.34 163.52 36.16 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.286 2.658 . . . . 1.22 112.04 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.3 mt -95.44 21.93 7.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.66 -0.7 . . . . 1.71 110.138 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 pt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.113 -0.946 . . . . 2.35 111.875 -171.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 111.556 -0.617 . . . . 6.07 111.556 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -85.93 -20.39 29.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.945 0.402 . . . . 4.71 110.904 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -149.19 -80.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.517 -0.849 . . . . 2.2 112.486 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -120.67 156.03 32.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.208 0.528 . . . . 0.9 111.773 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.89 115.77 20.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.286 -0.87 . . . . 2.73 110.202 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.2 m -88.13 23.57 2.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.236 -0.438 . . . . 2.09 110.868 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -46.98 -49.06 21.4 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.557 -0.747 . . . . 3.61 112.246 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -62.76 -21.33 65.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.676 -0.693 . . . . 2.26 111.976 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.97 16.26 76.53 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.276 -0.488 . . . . 0.95 113.336 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 m -85.35 -8.93 58.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.161 0.43 . . . . 2.08 112.161 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 87' ' ' ILE . 1.8 m -132.32 141.05 48.8 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.499 -0.481 . . . . 1.19 111.373 -170.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -92.8 -30.45 15.47 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.147 0.425 . . . . 1.66 112.147 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.4 p -92.15 -31.98 15.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.165 0.507 . . . . 1.12 111.364 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.78 4.46 67.45 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.58 -0.819 . . . . 0.43 111.99 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 63.7 mttp -87.34 87.8 7.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.069 0.462 . . . . 2.19 109.865 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.853 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 8.7 mp -94.1 134.96 35.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.872 -0.603 . . . . 1.12 109.975 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -149.01 146.57 27.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.914 0.388 . . . . 1.06 110.299 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 98.2 m -88.93 100.82 13.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.339 0.59 . . . . 0.74 110.019 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 79.9 m -111.02 158.92 18.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.723 -0.671 . . . . 0.5 111.484 -168.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -99.04 107.76 20.25 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.166 -0.679 . . . . 1.65 109.166 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.8 p -70.68 -13.18 61.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.784 -0.643 . . . . 1.12 111.162 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -95.51 -10.88 28.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.395 0.617 . . . . 2.85 109.674 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -115.04 140.37 49.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.224 -0.898 . . . . 3.03 110.113 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.541 ' HD3' HG23 ' A' ' 47' ' ' ILE . 44.5 mmtm -124.51 155.19 39.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.291 -0.868 . . . . 2.7 111.072 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.564 HG23 ' OE1' ' A' ' 48' ' ' GLN . 3.1 t -113.69 149.17 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.112 -0.699 . . . . 1.3 109.112 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -93.81 20.96 6.99 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.048 0.451 . . . . 3.31 110.704 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 30.1 mmmt -126.77 132.62 51.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.027 -0.533 . . . . 4.49 110.649 -178.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -114.48 42.82 2.03 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.709 -0.849 . . . . 2.89 108.709 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -108.36 168.12 9.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.785 -1.098 . . . . 2.23 111.601 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' OD2' ' A' ' 73' ' ' ASP . . . 170.91 -149.18 12.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.08 -0.581 . . . . 1.39 112.217 -176.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.81 -51.55 6.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.037 0.446 . . . . 3.06 110.92 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -104.73 -46.82 4.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.973 -0.558 . . . . 2.44 109.738 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -66.61 -20.37 65.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.634 -0.712 . . . . 2.67 109.783 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.79 -37.53 78.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.809 -0.71 . . . . 2.54 111.491 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.4 mt -81.93 -60.77 2.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.537 -0.542 . . . . 3.49 109.537 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt -110.37 97.2 6.71 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.917 -0.583 . . . . 5.24 111.195 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -112.22 -71.07 0.77 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.753 -0.379 . . . . 7.27 110.741 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 m -71.83 -24.77 61.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.179 0.514 . . . . 5.82 110.481 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.48 -3.49 82.88 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.817 -0.706 . . . . 3.6 112.693 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -118.07 -50.33 2.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.118 0.485 . . . . 4.15 109.824 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.22 129.91 3.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.369 -0.832 . . . . 2.96 111.603 -175.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mt -91.59 -9.93 42.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.896 -0.593 . . . . 3.83 111.047 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.53 0.33 54.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.178 -0.465 . . . . 2.29 111.837 -174.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.565 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 19.3 mt-30 -54.4 144.13 21.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.078 0.466 . . . . 1.94 110.762 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 83' ' ' ASN . 13.5 p -115.35 123.8 71.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.556 -0.747 . . . . 1.98 109.965 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -105.85 100.15 9.71 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.595 -0.729 . . . . 1.06 110.38 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.541 HG23 ' HD3' ' A' ' 24' ' ' LYS . 20.1 pt -107.36 146.83 13.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.201 0.524 . . . . 1.06 110.489 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.564 ' OE1' HG23 ' A' ' 25' ' ' VAL . 17.9 tp60 -74.9 118.32 17.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.303 -0.862 . . . . 2.55 108.954 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.686 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 3.4 t -115.97 164.27 14.67 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.658 -0.701 . . . . 1.15 110.594 -171.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -162.42 131.98 4.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.174 0.511 . . . . 1.16 110.526 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -121.1 123.14 41.6 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.135 -0.484 . . . . 2.08 111.35 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 64' ' ' CYS . 45.9 mt -64.52 135.07 96.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.438 -0.801 . . . . 1.51 109.654 173.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.4 111.66 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.063 3.175 . . . . 1.11 112.593 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.68 141.91 31.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.821 -1.081 . . . . 2.15 112.769 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 mp -93.87 132.35 38.39 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.692 -0.855 . . . . 2.07 108.692 167.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.491 HD11 ' H ' ' A' ' 56' ' ' ILE . 3.9 mp -67.11 131.85 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.225 0.536 . . . . 2.56 110.072 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.69 -5.89 56.99 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.493 -0.776 . . . . 1.09 112.017 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.62 150.5 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.739 0.781 . . . . 1.29 111.471 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.47 132.17 34.97 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.91 -1.495 . . . . 1.34 110.105 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 61' ' ' GLU . 10.7 tt -53.96 -34.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.207 -0.906 . . . . 1.49 111.907 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' N ' HG23 ' A' ' 60' ' ' ILE . 2.0 pt-20 -73.75 -18.13 61.02 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.942 -1.027 . . . . 2.2 111.494 -173.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -110.99 4.8 19.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.188 0.518 . . . . 1.98 110.585 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -95.67 -40.35 9.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.436 0.636 . . . . 2.09 110.311 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.421 ' HA ' HD12 ' A' ' 52' ' ' ILE . 15.3 p -105.92 -176.4 3.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.869 -0.605 . . . . 0.6 110.667 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -127.56 35.84 4.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.372 0.606 . . . . 2.81 109.767 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 52.8 m-80 -135.01 -170.77 2.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 1.39 110.339 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 89.7 m -80.91 124.86 81.18 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 121.322 0.582 . . . . 1.12 111.996 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.76 115.52 2.97 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.393 2.728 . . . . 0.65 111.583 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -132.22 159.81 37.95 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.478 -0.564 . . . . 1.1 109.478 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.853 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 85.6 m -121.76 122.8 40.33 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.274 0.559 . . . . 1.26 109.982 174.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.443 ' HB2' HG23 ' A' ' 74' ' ' VAL . 37.8 m -100.92 143.12 31.45 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.107 -0.951 . . . . 0.29 110.627 -172.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 6.9 mm-40 -77.42 -17.35 58.2 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.673 -1.149 . . . . 1.69 109.613 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.45 ' OD2' ' HA3' ' A' ' 30' ' ' GLY . 4.3 t70 -165.04 155.61 14.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.076 -0.965 . . . . 1.26 108.889 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.496 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -149.75 130.54 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 110.207 -0.294 . . . . 1.59 110.207 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.403 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 30.5 tt0 -96.99 164.99 12.29 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.963 -0.384 . . . . 1.87 109.963 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 78' ' ' GLY . 39.5 m-20 65.26 -154.25 0.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.401 -0.592 . . . . 1.94 109.401 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -72.63 2.48 6.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.54 0.686 . . . . 2.12 109.843 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.686 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.38 24.09 2.48 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.648 -0.705 . . . . 0.53 112.271 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 2.0 mm? -79.08 -29.76 43.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.689 0.255 . . . . 1.77 111.689 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.4 t -118.38 102.97 13.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.941 -0.304 . . . . 1.1 110.192 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.592 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -104.53 136.26 12.96 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.309 -0.948 . . . . 0.26 113.009 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -99.32 122.95 51.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.12 -0.54 . . . . 1.07 109.624 177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.565 ' OD1' ' HA ' ' A' ' 44' ' ' GLN . 70.8 m-20 60.45 48.0 8.15 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.457 0.473 . . . . 0.34 110.931 175.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.592 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 58.3 m -84.54 90.76 7.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.025 -0.534 . . . . 0.81 110.422 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.7 m -79.15 127.84 77.96 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.587 -0.733 . . . . 1.14 110.227 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.03 109.53 1.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.7 2.267 . . . . 0.59 110.737 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.622 HG21 ' SG ' ' A' ' 11' ' ' CYS . 12.0 pt -82.32 146.81 55.16 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.642 -0.708 . . . . 1.21 111.87 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -74.02 147.91 39.28 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.249 2.632 . . . . 1.22 111.206 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.03 36.85 0.97 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.676 -0.693 . . . . 1.71 110.147 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.9 pt . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.124 -0.941 . . . . 2.35 111.19 -173.649 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.879 0 N-CA-C 112.155 -0.378 . . . . 6.07 112.155 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -105.57 31.84 4.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.201 0.524 . . . . 4.71 110.512 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.88 81.93 1.0 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.702 -0.761 . . . . 2.2 111.659 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.441 ' HH2' ' OE1' ' A' ' 63' ' ' GLU . 94.1 m95 -103.02 -172.58 2.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.563 0.22 . . . . 0.9 111.423 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -59.83 111.77 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 2.73 111.551 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -99.38 -19.92 16.76 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.729 -0.669 . . . . 2.09 111.034 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -17.33 64.7 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.938 0.399 . . . . 3.61 111.141 -177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -72.97 -30.14 63.6 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.081 -0.509 . . . . 2.26 110.983 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.81 16.99 74.82 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.886 -0.597 . . . . 0.95 112.308 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 28.5 p -85.89 -19.26 30.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.793 0.33 . . . . 2.08 111.724 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.8 t -130.49 143.84 51.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.929 0.395 . . . . 1.19 111.033 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -91.13 -31.6 16.16 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.027 -0.533 . . . . 1.66 110.61 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.5 p -90.36 -30.57 17.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.578 -0.737 . . . . 1.12 111.002 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.58 2.22 61.71 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.632 -0.713 . . . . 0.43 111.913 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HD3' HG23 ' A' ' 74' ' ' VAL . 94.0 mttt -91.55 87.59 6.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.046 0.451 . . . . 2.19 110.267 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 mp -97.63 100.22 11.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.857 -0.61 . . . . 1.12 109.845 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.48 145.53 40.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.06 0.457 . . . . 1.06 110.437 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 66' ' ' ASN . 84.6 m -80.57 108.19 14.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.795 -0.639 . . . . 0.74 109.646 172.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 62.5 m -126.91 153.65 45.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.885 -0.598 . . . . 0.5 111.368 -172.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -95.61 111.65 23.53 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.475 -0.784 . . . . 1.65 109.854 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.4 p -75.28 -11.06 59.98 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.28 0.562 . . . . 1.12 110.709 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -93.87 -8.96 38.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.555 0.693 . . . . 2.85 109.248 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -119.74 125.4 48.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.994 -1.003 . . . . 3.03 110.692 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -113.11 154.0 27.3 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.535 -1.212 . . . . 2.7 111.066 -170.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.572 HG23 ' NE2' ' A' ' 48' ' ' GLN . 9.6 t -115.13 148.75 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.862 -0.792 . . . . 1.3 108.862 175.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -98.34 29.74 3.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.908 0.385 . . . . 3.31 111.081 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -130.38 118.74 21.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.34 -0.391 . . . . 4.49 110.791 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.5 m -111.96 53.96 0.71 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 2.89 110.089 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.42 -93.91 0.26 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.615 -0.72 . . . . 2.23 111.647 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.03 155.18 15.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 1.39 111.859 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.73 -50.22 4.54 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.598 -0.354 . . . . 3.06 110.921 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -77.44 -25.83 50.98 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.887 -0.325 . . . . 2.44 110.492 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.8 m -52.08 -34.16 42.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.351 -0.386 . . . . 2.67 111.249 167.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.34 -28.88 51.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.734 -0.746 . . . . 2.54 112.522 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -75.2 -27.48 59.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.087 0.47 . . . . 3.49 110.692 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.6 tp -110.52 168.91 9.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.785 -0.643 . . . . 5.24 109.558 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -81.15 6.88 12.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.053 0.454 . . . . 7.27 110.875 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.454 ' HB ' ' CD ' ' A' ' 72' ' ' GLU . 9.2 p -72.42 -31.46 65.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.132 -0.485 . . . . 5.82 111.198 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.03 13.06 33.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.911 -0.661 . . . . 3.6 112.34 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.25 -19.99 38.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.011 0.434 . . . . 4.15 110.964 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -89.19 142.94 12.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.857 -0.611 . . . . 2.96 111.052 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.8 mt -94.85 -6.17 43.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.165 -0.471 . . . . 3.83 110.596 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -83.03 -3.85 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 2.29 111.441 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.513 ' HB3' HG22 ' A' ' 82' ' ' ILE . 35.2 mt-30 -45.67 131.29 9.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.072 0.463 . . . . 1.94 110.441 174.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 83' ' ' ASN . 11.9 p -101.03 120.94 51.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.41 0.624 . . . . 1.98 110.77 -174.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -103.11 117.09 33.79 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.33 -0.85 . . . . 1.06 110.707 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.416 HD13 ' HB2' ' A' ' 84' ' ' CYS . 18.3 pt -124.31 159.78 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.23 -0.441 . . . . 1.06 109.96 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.572 ' NE2' HG23 ' A' ' 25' ' ' VAL . 3.5 mp0 -72.33 131.32 42.5 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.525 0.678 . . . . 2.55 110.704 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 72.3 m -125.09 149.15 48.13 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.395 -1.275 . . . . 1.15 110.071 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.2 t -161.31 132.96 5.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.105 0.479 . . . . 1.16 110.406 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -121.61 115.93 23.67 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.833 -0.622 . . . . 2.08 110.968 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.429 ' CG2' ' HD2' ' A' ' 53' ' ' PRO . 47.1 mt -58.09 139.31 83.55 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.153 -0.93 . . . . 1.51 109.12 173.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 52' ' ' ILE . 31.4 Cg_exo -34.11 127.77 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 124.262 3.308 . . . . 1.11 114.255 -173.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.71 136.09 57.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.357 -1.292 . . . . 2.15 112.365 -170.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.1 mt -110.13 132.02 54.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.291 -0.868 . . . . 2.07 109.512 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 mt -68.57 132.62 32.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.988 0.423 . . . . 2.56 110.728 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.59 24.94 71.35 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.429 -0.805 . . . . 1.09 112.951 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.488 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -113.41 150.51 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.781 0.801 . . . . 1.29 112.264 -178.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.5 145.64 31.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.126 -1.397 . . . . 1.34 111.457 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 tp -56.9 -42.08 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.698 -0.683 . . . . 1.49 111.547 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.83 -5.23 58.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.329 -0.396 . . . . 2.2 111.675 -173.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -106.69 -28.4 10.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.147 0.498 . . . . 1.98 109.914 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.488 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 32.6 tt0 -68.51 -37.66 80.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 2.09 111.191 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.8 p -113.0 178.23 4.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.092 -0.504 . . . . 0.6 109.979 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -127.33 28.93 5.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.058 0.456 . . . . 2.81 110.763 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 8.3 t-20 -105.25 -140.57 0.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.639 -0.709 . . . . 1.39 109.356 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 27.9 m -116.43 130.23 24.65 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 120.768 0.318 . . . . 1.12 110.48 176.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -78.26 122.89 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.76 2.307 . . . . 0.65 111.404 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.2 p -130.19 147.67 51.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.959 0.409 . . . . 1.1 111.007 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.48 106.77 19.07 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.503 -0.555 . . . . 1.26 109.503 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.0 m -93.86 141.78 28.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.209 0.528 . . . . 0.29 110.72 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.9 tt0 -79.16 -25.98 42.78 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.506 -0.77 . . . . 1.69 109.745 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HA ' ' HZ1' ' A' ' 15' ' ' LYS . 45.3 t0 -160.13 160.12 32.58 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.312 -0.995 . . . . 1.26 108.312 175.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.448 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.3 t -141.69 132.86 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.76 -0.459 . . . . 1.59 109.76 175.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.48 163.73 12.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.564 -0.289 . . . . 1.87 110.444 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 66.65 -152.98 0.22 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.035 -0.53 . . . . 1.94 109.588 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.94 -7.05 19.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.444 0.64 . . . . 2.12 110.449 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.401 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 120.47 23.4 2.87 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.137 -0.785 . . . . 0.53 111.137 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 62.2 mt -91.9 -13.57 31.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.727 -0.236 . . . . 1.77 111.404 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.99 107.97 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.13 -0.322 . . . . 1.1 110.13 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -97.67 144.0 17.04 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.517 -0.849 . . . . 0.26 112.426 -178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -105.23 124.08 59.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.099 -0.334 . . . . 1.07 110.099 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.572 ' HA ' HG12 ' A' ' 45' ' ' VAL . 74.3 m-20 57.57 45.7 18.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.365 0.603 . . . . 0.34 110.796 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.576 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 81.4 m -82.25 92.33 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.248 -0.887 . . . . 0.81 110.631 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 25.1 m -84.03 123.67 75.32 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.68 -0.691 . . . . 1.14 110.385 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 25.0 Cg_exo -64.29 130.91 28.33 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.108 2.538 . . . . 0.59 111.998 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.2 pt -103.3 137.07 19.15 Favored Pre-proline 0 N--CA 1.438 -1.072 0 CA-C-N 115.857 -0.611 . . . . 1.21 110.696 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 8.2 Cg_exo -76.74 156.25 35.3 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.406 2.737 . . . . 1.22 112.559 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 70.6 mt -98.44 21.7 10.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.428 -0.805 . . . . 1.71 109.953 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 pt . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.731 -0.668 . . . . 2.35 110.887 -172.418 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 111.719 -0.553 . . . . 6.07 111.719 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.5 t 60.89 84.39 0.13 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.306 0.574 . . . . 4.71 110.414 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.89 -171.39 25.99 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.138 -0.785 . . . . 2.2 111.138 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -117.89 169.1 9.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.213 0.53 . . . . 0.9 111.493 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -66.46 117.7 9.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.969 -1.014 . . . . 2.73 110.104 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.0 t -107.71 27.05 9.56 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.878 -0.786 . . . . 2.09 108.878 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -60.83 -38.22 84.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.07 -0.968 . . . . 3.61 110.902 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -65.59 -22.04 66.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.691 -0.686 . . . . 2.26 110.895 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.11 16.04 79.74 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.216 -0.516 . . . . 0.95 112.94 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.402 ' HB3' ' HB ' ' A' ' 87' ' ' ILE . 8.3 m -82.66 -18.57 40.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.998 0.37 . . . . 2.08 111.998 -175.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.3 t -116.47 141.58 47.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.884 0.373 . . . . 1.19 110.649 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.455 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.1 p30 -93.13 -26.21 17.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 1.66 111.822 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.455 HG22 ' OD1' ' A' ' 12' ' ' ASN . 32.2 p -94.98 -30.81 13.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.998 0.427 . . . . 1.12 112.034 -173.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.08 -1.64 74.22 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.591 -0.814 . . . . 0.43 111.521 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -92.47 87.93 6.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.322 -0.622 . . . . 2.19 109.322 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -96.81 139.71 32.46 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.923 -0.58 . . . . 1.12 110.619 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.6 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . . . -147.61 156.61 42.97 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.129 -1.063 . . . . 1.06 108.129 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 93.8 m -99.92 97.45 8.33 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.301 -0.56 . . . . 0.74 109.704 174.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.4 m -110.49 156.57 20.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.679 -0.691 . . . . 0.5 111.147 -168.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 33.4 m-20 -99.94 109.72 22.08 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.264 -0.643 . . . . 1.65 109.264 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.1 p -71.87 -8.03 51.96 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.808 -0.633 . . . . 1.12 111.287 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -100.85 -6.76 24.31 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.243 -0.651 . . . . 2.85 109.243 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 30.1 mtpp -116.64 117.32 29.49 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.969 -1.014 . . . . 3.03 109.812 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -128.62 152.58 48.19 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.584 0.586 . . . . 2.7 112.584 -171.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 27' ' ' LYS . 6.5 t -99.36 150.36 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.144 -0.935 . . . . 1.3 110.416 -174.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -91.29 13.21 17.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.644 -0.707 . . . . 3.31 110.088 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' H ' HG12 ' A' ' 25' ' ' VAL . 13.6 mmmm -131.62 142.3 49.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.046 -0.979 . . . . 4.49 108.767 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 t -139.18 80.39 1.78 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.7 0.762 . . . . 2.89 110.002 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.54 ' HB ' ' OE2' ' A' ' 75' ' ' GLU . 5.1 m -115.96 143.16 45.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.074 -0.966 . . . . 2.23 109.94 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -114.22 149.02 18.79 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.674 -0.774 . . . . 1.39 112.253 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.52 -51.09 4.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.399 -0.593 . . . . 3.06 109.399 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -92.25 -29.66 16.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 2.44 109.928 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 t -69.05 -19.79 64.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.812 -0.631 . . . . 2.67 109.562 174.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.59 -21.82 76.4 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.713 -0.676 . . . . 2.54 112.71 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.12 -34.66 76.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.297 0.57 . . . . 3.49 109.719 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -93.8 174.93 6.93 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.47 -0.786 . . . . 5.24 109.516 176.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -81.17 4.34 20.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.216 0.532 . . . . 7.27 110.355 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.3 p -75.66 -24.45 56.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.63 -0.714 . . . . 5.82 110.972 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.65 -13.04 82.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.629 -0.796 . . . . 3.6 112.399 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -76.77 -35.49 57.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.649 0.261 . . . . 4.15 111.219 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -76.16 135.23 27.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.426 0.631 . . . . 2.96 111.63 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -88.72 -0.26 57.13 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.191 -0.913 . . . . 3.83 109.191 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.13 -31.61 72.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.871 -1.058 . . . . 2.29 110.614 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.539 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.5 mt-30 -48.56 135.66 14.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.783 -0.644 . . . . 1.94 110.85 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.0 t -83.68 112.57 21.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.896 -0.593 . . . . 1.98 110.171 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.63 105.61 15.73 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.437 -0.801 . . . . 1.06 110.556 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 11.5 pt -110.21 152.76 12.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.218 -0.446 . . . . 1.06 111.014 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -72.07 142.02 49.23 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.506 -0.77 . . . . 2.55 110.287 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.4 t -144.79 165.69 27.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.56 -1.2 . . . . 1.15 109.993 -170.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.3 t -160.04 153.06 21.68 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.248 -0.279 . . . . 1.16 110.248 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -120.5 122.8 41.43 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.415 -0.587 . . . . 2.08 109.415 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 64' ' ' CYS . 46.7 mt -92.64 131.92 32.79 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.511 -0.552 . . . . 1.51 109.511 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -33.88 99.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.575 3.516 . . . . 1.11 113.504 -174.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 pp -78.31 140.61 38.8 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.987 -1.006 . . . . 2.15 111.412 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 2.6 mm? -77.74 138.86 39.26 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.199 -1.037 . . . . 2.07 108.199 171.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.7 mt -61.02 129.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.025 0.441 . . . . 2.56 110.416 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.4 2.91 88.92 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.513 -0.767 . . . . 1.09 112.763 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -95.92 152.63 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.724 0.773 . . . . 1.29 111.601 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.66 152.13 23.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.395 -1.275 . . . . 1.34 111.401 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 61' ' ' GLU . 10.5 tt -52.29 -38.77 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.943 0.878 . . . . 1.49 110.857 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.587 ' N ' HG23 ' A' ' 60' ' ' ILE . 34.9 mt-10 -64.24 -16.01 61.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.825 -1.079 . . . . 2.2 111.766 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -111.34 -8.12 14.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.036 0.384 . . . . 1.98 112.036 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 1.9 pp20? -94.53 -33.76 12.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.433 -0.507 . . . . 2.09 111.599 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.459 ' HA ' HD12 ' A' ' 52' ' ' ILE . 3.8 p -113.44 156.52 23.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.063 0.459 . . . . 0.6 111.408 -173.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 4.1 tppp? -110.89 26.41 10.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.085 0.945 . . . . 2.81 108.976 173.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 4.3 m-20 -105.07 -168.49 1.48 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.199 -0.91 . . . . 1.39 109.471 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -88.67 124.62 65.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-O 121.388 0.613 . . . . 1.12 111.408 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -60.19 113.91 1.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.21 2.607 . . . . 0.65 110.986 173.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.844 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 0.8 OUTLIER -124.99 139.54 53.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.964 0.412 . . . . 1.1 111.41 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.9 t -102.65 105.56 16.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.224 -0.658 . . . . 1.26 109.224 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 67.3 m -86.77 145.36 26.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.927 -0.397 . . . . 0.29 109.927 -174.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.4 tt0 -76.3 -24.17 54.37 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.705 -0.85 . . . . 1.69 108.705 172.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -163.25 157.98 20.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.823 -1.081 . . . . 1.26 108.481 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.519 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -138.45 138.4 42.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.804 -0.358 . . . . 1.59 110.095 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.54 ' OE2' ' HB ' ' A' ' 29' ' ' THR . 43.9 tt0 -106.42 155.33 19.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.276 -0.42 . . . . 1.87 110.311 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 78' ' ' GLY . 2.4 t70 66.78 -152.64 0.21 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.661 0.601 . . . . 1.94 109.667 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.01 0.69 5.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.111 0.482 . . . . 2.12 110.611 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 115.4 23.69 4.37 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.043 -0.599 . . . . 0.53 111.971 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.4 mt -79.35 -24.81 42.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.007 0.432 . . . . 1.77 110.892 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.97 108.67 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.721 -0.474 . . . . 1.1 109.721 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.99 133.53 11.4 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.298 -0.954 . . . . 0.26 111.81 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -95.23 118.47 41.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 110.136 -0.32 . . . . 1.07 110.136 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 89.8 m-20 57.75 42.53 23.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.382 -0.827 . . . . 0.34 110.825 174.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.844 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -78.27 105.14 9.31 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.689 -0.687 . . . . 0.81 110.351 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 20.5 m -83.45 128.22 65.1 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.422 -0.808 . . . . 1.14 109.738 177.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 33.3 Cg_exo -61.35 119.91 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.56 2.173 . . . . 0.59 110.779 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 10' ' ' SER . 8.4 pt -106.87 146.85 33.95 Favored Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-O 121.137 0.494 . . . . 1.21 111.458 -174.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.22 159.48 8.39 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 123.461 2.774 . . . . 1.22 112.31 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.2 mt -86.66 21.51 2.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.661 -0.7 . . . . 1.71 110.952 -173.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.5 pt . . . . . 0 C--O 1.25 1.11 0 CA-C-N 116.011 -0.54 . . . . 2.35 111.267 -173.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.855 -0.498 . . . . 6.07 111.855 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 p -91.03 -10.12 43.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.019 0.437 . . . . 4.71 110.594 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 104.08 -74.89 0.26 Allowed Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.566 -1.014 . . . . 2.2 110.566 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.509 ' CZ2' HD23 ' A' ' 54' ' ' LEU . 78.2 m95 -111.23 168.73 9.29 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.678 -0.49 . . . . 0.9 109.678 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -76.81 108.28 9.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.93 0.395 . . . . 2.73 110.775 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.9 m -94.82 13.32 25.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.905 -0.589 . . . . 2.09 109.551 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -19.82 55.03 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.453 -0.794 . . . . 3.61 111.302 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -74.68 -16.47 60.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.948 -0.569 . . . . 2.26 110.898 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.22 69.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.949 -0.643 . . . . 0.95 111.607 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.6 p -87.23 -29.65 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.623 0.601 . . . . 2.08 112.623 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.4 t -129.3 141.31 51.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.604 0.716 . . . . 1.19 111.313 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.36 -30.53 15.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.509 -1.223 . . . . 1.66 111.704 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -30.55 14.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.069 0.396 . . . . 1.12 112.069 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.55 -9.51 57.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.553 -0.832 . . . . 0.43 112.626 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.514 ' HD3' HG22 ' A' ' 74' ' ' VAL . 90.9 mttt -89.48 88.11 7.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.957 0.408 . . . . 2.19 110.347 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.49 138.09 31.83 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.357 -0.609 . . . . 1.12 109.357 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.01 156.62 44.46 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.87 0.367 . . . . 1.06 110.71 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 50' ' ' THR . 51.2 m -91.34 101.93 14.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.697 -0.853 . . . . 0.74 108.697 171.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.8 m -121.32 142.51 49.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.213 0.53 . . . . 0.5 111.312 -171.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -93.72 108.26 20.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.408 -0.815 . . . . 1.65 109.235 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.7 p -74.15 -6.93 50.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.886 -0.597 . . . . 1.12 111.24 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -91.85 -20.58 21.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.843 0.83 . . . . 2.85 108.822 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -104.34 135.31 46.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.476 -1.238 . . . . 3.03 110.623 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.49 ' HD2' HG21 ' A' ' 47' ' ' ILE . 14.4 mmmm -119.91 156.56 30.52 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.831 -1.077 . . . . 2.7 110.052 -175.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.06 150.27 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.002 0.429 . . . . 1.3 110.303 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -78.1 30.25 0.17 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.44 -0.8 . . . . 3.31 111.837 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -133.49 160.06 38.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 4.49 111.26 -173.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.8 t -148.02 23.55 1.07 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.939 0.876 . . . . 2.89 108.942 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.7 p -102.56 145.09 30.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.909 -1.041 . . . . 2.23 111.652 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.66 155.77 15.94 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.966 -0.854 . . . . 1.39 110.966 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -100.88 -50.11 3.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.976 0.388 . . . . 3.06 111.158 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -95.96 -32.83 12.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.904 0.383 . . . . 2.44 110.457 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 p -59.49 -26.37 65.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 2.67 110.97 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.62 -28.91 74.01 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.159 -0.543 . . . . 2.54 112.58 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.3 -26.37 28.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.282 0.563 . . . . 3.49 110.123 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.3 tp -86.53 168.13 13.99 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.908 -0.775 . . . . 5.24 108.908 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 46.2 m170 -87.76 5.22 41.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.007 0.432 . . . . 7.27 111.113 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.55 ' O ' HG23 ' A' ' 41' ' ' VAL . 15.8 p -82.53 -32.89 28.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.021 -0.536 . . . . 5.82 110.908 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.62 13.88 11.06 Favored Glycine 0 N--CA 1.454 -0.138 0 C-N-CA 121.198 -0.525 . . . . 3.6 112.641 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.3 -25.14 59.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.963 0.411 . . . . 4.15 110.313 176.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 38' ' ' THR . 9.2 m -72.76 140.75 17.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 2.96 111.662 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.0 mt -97.47 -5.46 35.98 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.618 -0.719 . . . . 3.83 110.177 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -91.96 1.43 57.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 2.29 111.84 -175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.496 ' HB3' HG21 ' A' ' 82' ' ' ILE . 37.0 mt-30 -41.89 134.1 2.7 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.444 0.64 . . . . 1.94 111.105 176.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.606 HG11 ' HA ' ' A' ' 83' ' ' ASN . 8.3 p -99.47 136.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.356 -0.838 . . . . 1.98 109.399 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.37 110.94 17.55 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.618 -0.719 . . . . 1.06 110.576 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.49 HG21 ' HD2' ' A' ' 24' ' ' LYS . 7.9 pt -114.78 160.52 14.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.783 -0.644 . . . . 1.06 110.342 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.37 129.58 34.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.836 -0.62 . . . . 2.55 110.232 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.8 m -128.84 154.99 45.91 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.779 -1.1 . . . . 1.15 110.554 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 5.8 t -157.39 136.29 11.62 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.834 -0.621 . . . . 1.16 109.494 -177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -121.0 114.31 21.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.258 0.552 . . . . 2.08 111.262 -176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.9 mt -78.29 133.89 63.58 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.099 -0.955 . . . . 1.51 109.39 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -33.94 116.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.642 3.561 . . . . 1.11 113.564 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.509 HD23 ' CZ2' ' A' ' 4' ' ' TRP . 3.6 pp -100.12 141.72 32.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.911 -1.04 . . . . 2.15 111.989 -169.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.599 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 94.4 mt -80.72 133.74 35.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.255 -1.017 . . . . 2.07 108.255 167.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.7 mt -67.72 128.81 31.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.143 0.497 . . . . 2.56 110.199 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.53 9.18 63.29 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.554 -0.748 . . . . 1.09 111.725 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -98.76 157.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.277 0.56 . . . . 1.29 110.771 177.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' N ' HG21 ' A' ' 58' ' ' ILE . . . -88.7 137.88 31.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.969 -1.014 . . . . 1.34 110.914 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.511 HG21 ' N ' ' A' ' 61' ' ' GLU . 7.9 tp -53.1 -38.45 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.016 -0.993 . . . . 1.49 112.056 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.511 ' N ' HG21 ' A' ' 60' ' ' ILE . 3.9 pt-20 -79.49 -17.86 53.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.356 -0.384 . . . . 2.2 111.533 -174.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -102.45 -3.06 27.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.968 0.413 . . . . 1.98 110.349 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -102.38 -22.19 14.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.039 -0.528 . . . . 2.09 110.744 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.51 156.64 48.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.471 -0.331 . . . . 0.6 110.236 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -104.64 44.7 1.01 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.285 0.564 . . . . 2.81 110.889 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 3.9 m-20 -124.55 -165.68 1.41 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.492 -0.776 . . . . 1.39 109.723 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -87.76 128.35 54.68 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 120.91 0.386 . . . . 1.12 110.243 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.33 125.46 5.15 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.746 2.297 . . . . 0.65 110.915 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.82 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 2.9 p -124.64 153.42 42.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.972 0.415 . . . . 1.1 111.466 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.2 t -107.55 102.8 12.03 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.263 -0.643 . . . . 1.26 109.263 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 84' ' ' CYS . 97.6 m -84.64 142.11 30.15 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.039 -0.356 . . . . 0.29 110.039 -176.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.6 tt0 -76.1 -27.44 57.15 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.62 -0.881 . . . . 1.69 108.62 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 71' ' ' CYS . 24.6 t0 -159.57 162.8 35.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.874 -1.057 . . . . 1.26 108.66 175.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.514 HG22 ' HD3' ' A' ' 15' ' ' LYS . 2.3 t -140.16 134.72 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.841 -0.429 . . . . 1.59 109.841 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -106.15 165.91 10.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.795 -0.446 . . . . 1.87 109.795 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 78' ' ' GLY . 2.1 t70 67.4 -151.92 0.19 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.231 0.612 . . . . 1.94 109.457 -178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -79.17 22.86 0.39 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.969 0.414 . . . . 2.12 110.553 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 98.19 23.15 13.36 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.924 -0.655 . . . . 0.53 112.041 -177.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.73 -17.18 28.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 1.77 111.217 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.88 103.68 11.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.498 -0.319 . . . . 1.1 110.51 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA3' ' SG ' ' A' ' 71' ' ' CYS . . . -94.29 133.11 11.46 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.354 -0.926 . . . . 0.26 112.368 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.496 HG21 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -97.61 126.71 50.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 122.441 0.296 . . . . 1.07 110.255 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.606 ' HA ' HG11 ' A' ' 45' ' ' VAL . 85.3 m-20 53.52 43.56 31.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 123.84 0.712 . . . . 0.34 110.398 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.82 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -87.49 102.89 15.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.406 -0.816 . . . . 0.81 110.15 -177.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 m -83.12 130.67 56.25 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.891 -0.595 . . . . 1.14 110.111 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.33 109.84 2.98 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.974 2.449 . . . . 0.59 111.906 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.2 pt -83.69 137.44 41.33 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.576 -0.738 . . . . 1.21 111.176 -175.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.5 Cg_exo -71.82 157.68 54.65 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.349 2.699 . . . . 1.22 112.079 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.7 mt -90.96 25.11 2.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.847 -0.615 . . . . 1.71 110.775 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 90' ' ' ILE . 24.1 pt . . . . . 0 C--O 1.249 1.041 0 CA-C-N 116.332 -0.395 . . . . 2.35 110.97 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.129 -0.388 . . . . 6.07 112.129 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 p -96.34 126.92 41.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.845 0.355 . . . . 4.71 110.674 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.87 173.9 27.25 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.676 -0.773 . . . . 2.2 111.906 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.475 ' CE3' ' HB ' ' A' ' 60' ' ' ILE . 71.8 m95 -83.47 -177.4 6.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.053 0.454 . . . . 0.9 111.608 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -78.04 107.69 10.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 2.73 109.724 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.8 t -111.75 27.51 9.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.349 0.595 . . . . 2.09 109.744 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -24.86 61.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.514 -0.766 . . . . 3.61 112.723 -172.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 t -91.6 5.17 50.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.635 -0.426 . . . . 2.26 110.931 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.22 17.8 75.67 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.598 -0.811 . . . . 0.95 111.839 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 p -69.38 -30.81 68.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.627 0.603 . . . . 2.08 112.627 -172.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.1 t -132.35 141.3 48.87 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.263 -0.575 . . . . 1.19 111.482 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.546 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.9 p30 -93.08 -29.53 15.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.561 -0.745 . . . . 1.66 111.593 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.546 HG22 ' OD1' ' A' ' 12' ' ' ASN . 2.6 p -95.42 -31.38 13.41 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.531 0.567 . . . . 1.12 112.531 -173.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.72 -18.26 44.22 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.339 -0.934 . . . . 0.43 113.267 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HD3' HG22 ' A' ' 74' ' ' VAL . 81.9 mttt -84.83 89.4 7.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.168 0.484 . . . . 2.19 110.478 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 4' ' ' TRP . 8.8 mp -91.87 137.68 32.17 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.921 -0.4 . . . . 1.12 109.921 175.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.591 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -145.67 152.03 38.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.907 0.384 . . . . 1.06 110.383 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 36.1 m -87.5 98.65 11.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.502 -0.555 . . . . 0.74 109.502 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 86.3 m -117.3 161.97 18.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.495 . . . . 0.5 111.515 -167.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -99.46 98.71 9.59 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.65 109.939 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.8 p -70.31 -7.66 44.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.836 -0.62 . . . . 1.12 112.151 -173.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -103.14 -10.55 18.74 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.189 0.995 . . . . 2.85 108.788 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' A' ' 48' ' ' GLN . 40.8 tptt -118.06 99.53 6.95 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.416 -1.72 . . . . 3.03 110.497 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.76 170.31 12.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.036 -0.984 . . . . 2.7 111.047 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.04 150.49 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.59 -0.732 . . . . 1.3 109.18 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -74.58 23.83 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.189 0.811 . . . . 3.31 113.189 -173.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -136.74 160.11 39.83 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.967 -0.458 . . . . 4.49 111.555 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 p -134.64 38.74 3.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.598 0.713 . . . . 2.89 109.605 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 p -89.39 -172.98 3.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.218 -0.901 . . . . 2.23 111.229 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.21 146.57 8.42 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.72 -0.752 . . . . 1.39 111.982 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -82.22 -50.46 8.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.943 0.402 . . . . 3.06 110.431 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -97.33 -38.19 9.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.895 -0.593 . . . . 2.44 109.968 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 23.1 t -66.27 -29.14 69.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 2.67 109.803 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.98 -17.43 75.5 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.957 -0.639 . . . . 2.54 112.292 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.9 mt -85.66 -30.46 23.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.294 0.569 . . . . 3.49 109.728 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.429 ' HG ' ' H ' ' A' ' 37' ' ' HIS . 18.6 tp -89.66 173.51 8.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.451 -0.795 . . . . 5.24 109.442 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.429 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 77.8 t60 -74.8 -7.47 53.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 7.27 110.788 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.2 p -68.67 -23.42 64.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 5.82 111.492 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 44' ' ' GLN . . . -83.19 -3.96 89.95 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.81 -0.709 . . . . 3.6 112.925 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.22 -29.28 68.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.396 0.617 . . . . 4.15 111.161 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.9 m -88.32 147.69 5.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.393 -0.821 . . . . 2.96 113.125 -171.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 tp -84.69 -7.85 59.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.757 -1.11 . . . . 3.83 108.612 170.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -60.63 -30.79 70.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.025 -0.989 . . . . 2.29 110.938 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.446 ' NE2' ' HA2' ' A' ' 39' ' ' GLY . 15.8 mt-30 -50.69 127.49 18.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.19 0.519 . . . . 1.94 110.687 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.68 107.53 20.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.41 -0.813 . . . . 1.98 110.067 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -95.38 122.45 38.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.488 -0.778 . . . . 1.06 110.336 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 84' ' ' CYS . 22.0 pt -122.79 157.82 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.192 -0.458 . . . . 1.06 110.472 176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.414 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -71.4 138.96 49.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.538 -0.756 . . . . 2.55 109.189 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.591 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 1.8 t -142.78 156.58 45.0 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.885 0.374 . . . . 1.15 111.172 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -162.95 122.21 2.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.552 -0.749 . . . . 1.16 109.766 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.437 ' HG2' ' SG ' ' A' ' 18' ' ' CYS . 11.5 tm0? -120.95 115.67 23.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.826 0.346 . . . . 2.08 110.539 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 63.3 mt -52.35 135.42 41.85 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-N 115.207 -0.906 . . . . 1.51 110.192 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -33.37 107.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 124.507 3.472 . . . . 1.11 113.88 -174.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.54 ' HA ' ' OE1' ' A' ' 63' ' ' GLU . 3.5 pp -59.3 140.76 55.72 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.755 -1.111 . . . . 2.15 113.837 -168.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -111.26 115.85 30.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.663 -1.153 . . . . 2.07 109.438 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.3 mm -63.64 139.12 21.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.416 0.627 . . . . 2.56 111.14 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.42 -23.84 33.19 Favored Glycine 0 C--N 1.315 -0.602 0 CA-C-N 115.166 -0.925 . . . . 1.09 112.961 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.66 152.04 3.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.768 0.794 . . . . 1.29 111.759 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.07 124.15 27.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.318 -1.31 . . . . 1.34 110.749 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.672 HG23 ' N ' ' A' ' 61' ' ' GLU . 13.3 tt -53.62 -33.1 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.044 -0.98 . . . . 1.49 111.017 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.672 ' N ' HG23 ' A' ' 60' ' ' ILE . 2.8 mp0 -61.34 -29.88 70.16 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.41 -1.268 . . . . 2.2 111.437 -173.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -106.64 -20.47 13.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.054 -0.521 . . . . 1.98 110.452 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 54' ' ' LEU . 29.5 tt0 -67.2 -41.14 86.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 2.09 111.129 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.6 p -105.02 -173.64 2.35 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.976 -0.556 . . . . 0.6 109.726 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -132.2 43.68 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.309 0.576 . . . . 2.81 110.817 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 49.8 m-80 -137.55 -171.16 2.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.487 -0.931 . . . . 1.39 108.487 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.8 m -81.29 122.12 80.93 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.314 0.578 . . . . 1.12 111.614 -177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.69 124.2 11.66 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.255 2.637 . . . . 0.65 111.036 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -132.5 149.92 52.25 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.788 -0.365 . . . . 1.1 111.237 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 11.6 t -94.74 112.11 23.86 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.477 -0.564 . . . . 1.26 109.477 172.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.4 m -99.36 139.41 35.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.253 0.549 . . . . 0.29 110.333 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.0 tt0 -77.22 -23.93 51.32 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.458 -0.792 . . . . 1.69 109.415 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 40.4 t0 -163.86 165.09 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.991 -1.004 . . . . 1.26 108.407 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.542 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.0 t -142.2 136.38 29.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 117.947 0.34 . . . . 1.59 110.339 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.81 162.6 12.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.739 -0.467 . . . . 1.87 109.739 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 62.26 -154.37 0.35 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.54 -0.541 . . . . 1.94 109.54 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.5 7.79 6.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.641 0.734 . . . . 2.12 109.848 174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.585 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.04 22.61 2.89 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.487 -0.779 . . . . 0.53 112.596 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.2 mm? -83.82 -23.62 31.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.69 0.256 . . . . 1.77 111.69 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.8 t -129.21 106.88 14.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.972 -0.381 . . . . 1.1 109.972 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -97.49 144.05 17.08 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.384 -0.912 . . . . 0.26 112.399 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.431 HG22 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -102.15 119.03 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 110.003 -0.369 . . . . 1.07 110.003 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 87.4 m-20 61.36 43.7 10.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.499 -0.773 . . . . 0.34 110.565 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.601 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 60.3 m -82.78 99.03 9.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.349 -0.841 . . . . 0.81 111.0 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.3 m -89.37 131.98 38.77 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.096 -0.502 . . . . 1.14 110.436 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -68.55 126.43 14.11 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.079 2.52 . . . . 0.59 112.208 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.2 pt -105.8 152.41 40.17 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.769 -0.65 . . . . 1.21 111.091 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -70.08 153.55 67.33 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.246 2.63 . . . . 1.22 112.455 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.8 mt -84.62 23.47 1.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.81 -0.632 . . . . 1.71 110.855 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.989 -0.529 . . . . 2.35 111.312 -173.634 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 111.705 -0.558 . . . . 6.07 111.705 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.478 ' OG ' ' HA3' ' A' ' 14' ' ' GLY . 13.4 p -66.84 -54.1 25.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 4.71 109.767 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.76 -43.42 0.68 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.823 -0.911 . . . . 2.2 110.823 172.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -136.11 161.19 36.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.491 -0.354 . . . . 0.9 110.101 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.2 109.14 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.481 . . . . 2.73 111.174 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.478 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 11.1 m -105.44 26.45 9.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.829 -0.623 . . . . 2.09 110.491 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -59.47 -15.25 16.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.952 -0.567 . . . . 3.61 112.102 -176.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -73.02 -15.58 61.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.084 0.468 . . . . 2.26 110.958 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.4 8.26 70.42 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.822 -0.626 . . . . 0.95 111.664 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.5 t -88.07 -9.71 52.47 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.863 0.363 . . . . 2.08 110.692 -176.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.2 t -123.71 139.78 53.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.167 0.508 . . . . 1.19 110.307 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.44 -31.89 13.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.27 -0.877 . . . . 1.66 112.521 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -102.27 -20.6 14.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.263 0.468 . . . . 1.12 112.263 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.478 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 89.96 4.83 71.63 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.725 -0.75 . . . . 0.43 112.654 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HD3' HG11 ' A' ' 74' ' ' VAL . 66.7 mttm -93.8 88.9 5.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.75 0.309 . . . . 2.19 110.478 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 69' ' ' THR . 7.8 mp -93.66 109.36 21.0 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.541 -0.54 . . . . 1.12 109.541 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.563 ' HB2' ' SG ' ' A' ' 49' ' ' CYS . . . -124.13 144.2 50.03 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.872 0.368 . . . . 1.06 110.956 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 81.5 m -79.91 98.22 7.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 0.74 109.478 175.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 73.1 m -113.42 156.99 22.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.125 0.488 . . . . 0.5 111.461 -169.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 22.7 m-20 -92.01 93.07 8.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.37 -0.832 . . . . 1.65 109.298 174.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.4 p -64.91 -15.23 61.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.693 0.627 . . . . 1.12 112.693 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -106.51 0.44 24.66 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.989 0.899 . . . . 2.85 108.67 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.457 ' HG3' HE21 ' A' ' 48' ' ' GLN . 48.2 tptt -123.98 98.9 6.0 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.08 -1.418 . . . . 3.03 109.529 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -89.16 164.76 14.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.561 -1.199 . . . . 2.7 111.022 -171.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.604 HG21 ' NE2' ' A' ' 48' ' ' GLN . 3.5 t -117.74 149.88 19.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.854 -0.612 . . . . 1.3 110.264 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -80.73 -40.14 25.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.345 -0.613 . . . . 3.31 109.345 174.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -69.4 121.24 16.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.592 -0.731 . . . . 4.49 109.11 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -149.87 79.17 1.37 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.797 -0.361 . . . . 2.89 111.584 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 m -136.54 -61.0 0.7 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.639 -0.424 . . . . 2.23 111.434 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.41 164.11 15.6 Favored Glycine 0 C--N 1.32 -0.327 0 C-N-CA 121.036 -0.602 . . . . 1.39 112.035 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -101.53 -42.26 6.31 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.235 0.457 . . . . 3.06 112.235 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.51 -55.32 4.55 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.87 -0.332 . . . . 2.44 111.434 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.4 m -90.24 -29.48 18.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.109 0.48 . . . . 2.67 110.12 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.33 42.54 2.17 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.653 -0.703 . . . . 2.54 113.835 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.96 -52.09 66.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.112 0.482 . . . . 3.49 109.91 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.5 mt -92.28 147.38 22.96 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.849 -0.614 . . . . 5.24 109.426 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.436 ' O ' HG22 ' A' ' 41' ' ' VAL . 18.1 m-70 -101.05 -71.81 0.7 Allowed 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 121.082 -0.247 . . . . 7.27 111.092 -176.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.1 m -74.57 -20.01 60.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.18 0.514 . . . . 5.82 110.974 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.2 0.24 58.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.318 -0.944 . . . . 3.6 112.936 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.98 -43.91 2.43 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.398 -0.521 . . . . 4.15 111.119 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.445 HG12 ' NE2' ' A' ' 44' ' ' GLN . 2.1 m -87.04 124.53 40.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.635 0.731 . . . . 2.96 110.372 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.9 mt -121.55 -35.83 3.17 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.387 -0.824 . . . . 3.83 110.582 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -142.22 1.19 1.4 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.848 -0.615 . . . . 2.29 111.918 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' NE2' HG12 ' A' ' 41' ' ' VAL . 12.7 mt-30 -54.07 133.48 43.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.283 0.563 . . . . 1.94 111.407 -175.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.17 121.52 63.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.316 -0.857 . . . . 1.98 109.334 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.99 133.2 52.64 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.638 -0.71 . . . . 1.06 111.229 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 84' ' ' CYS . 12.7 pt -125.61 153.75 33.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.529 -0.76 . . . . 1.06 109.972 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.604 ' NE2' HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -67.69 139.9 56.76 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.389 -0.597 . . . . 2.55 109.389 178.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 17' ' ' ALA . 1.8 t -138.91 156.44 47.27 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.252 -0.431 . . . . 1.15 110.757 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -161.43 140.27 9.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.981 -0.554 . . . . 1.16 109.805 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.455 HE22 HD13 ' A' ' 60' ' ' ILE . 43.9 tp60 -114.6 155.23 26.92 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.026 0.441 . . . . 2.08 110.451 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 42.0 mm -86.82 150.7 51.03 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.228 -0.896 . . . . 1.51 108.967 176.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -35.14 111.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.137 2.558 . . . . 1.11 111.842 171.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.66 133.17 55.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.175 -0.92 . . . . 2.15 112.926 -167.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.19 124.52 49.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.096 -0.956 . . . . 2.07 109.252 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.6 mt -64.2 130.38 29.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.24 -0.436 . . . . 2.56 110.857 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.84 15.18 71.18 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.418 -0.81 . . . . 1.09 113.217 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.443 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -100.26 152.67 4.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.693 0.759 . . . . 1.29 111.643 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.41 145.91 25.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.363 -1.29 . . . . 1.34 111.237 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.455 HD13 HE22 ' A' ' 51' ' ' GLN . 8.2 tp -53.69 -34.26 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 114.358 -1.292 . . . . 1.49 112.836 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.72 -4.81 58.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.739 0.304 . . . . 2.2 111.655 -172.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -110.09 -27.19 9.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.094 0.473 . . . . 1.98 110.133 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.443 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 32.3 tt0 -71.43 -39.49 71.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.782 -0.645 . . . . 2.09 110.933 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.7 p -121.08 169.06 10.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.214 -0.448 . . . . 0.6 110.492 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -113.98 26.83 9.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.089 0.471 . . . . 2.81 110.455 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 17.0 m-80 -107.06 -160.92 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 1.39 110.126 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 12.4 m -96.63 126.7 42.28 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 120.976 0.417 . . . . 1.12 110.501 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.96 129.21 6.1 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.979 2.453 . . . . 0.65 111.03 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 65.5 p -132.14 157.37 44.44 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.754 -0.379 . . . . 1.1 110.936 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 40.7 t -106.12 102.28 11.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.048 -0.524 . . . . 1.26 109.647 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 55.6 m -88.08 133.75 33.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.973 0.416 . . . . 0.29 110.56 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.0 tt0 -76.3 -23.58 54.34 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.875 -0.602 . . . . 1.69 110.102 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -158.77 169.26 24.78 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.65 -0.87 . . . . 1.26 108.65 170.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.518 HG11 ' HD3' ' A' ' 15' ' ' LYS . 32.8 m -135.84 146.05 30.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.77 0.319 . . . . 1.59 110.562 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -112.22 150.21 31.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.342 -0.985 . . . . 1.87 108.342 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.8 -156.32 0.33 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.754 -0.832 . . . . 1.94 108.754 -170.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -83.07 23.16 0.88 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.522 0.677 . . . . 2.12 110.762 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.552 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 104.22 21.85 9.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.588 -0.815 . . . . 0.53 112.955 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 84.0 mt -85.16 -17.13 38.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.064 0.459 . . . . 1.77 109.987 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.1 t -129.61 110.82 20.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.51 -0.768 . . . . 1.1 109.156 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -101.78 140.62 14.95 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.181 -1.009 . . . . 0.26 112.334 -176.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -97.52 119.36 45.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.058 -0.349 . . . . 1.07 110.058 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 96.0 m-20 59.81 50.54 6.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.678 -0.692 . . . . 0.34 110.832 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.561 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.5 m -85.0 91.34 8.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.379 -0.828 . . . . 0.81 110.924 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.1 m -74.94 126.09 88.64 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.675 -0.693 . . . . 1.14 110.379 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.38 121.66 9.14 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.856 2.37 . . . . 0.59 111.818 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.4 pt -101.09 154.54 37.1 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.799 -0.637 . . . . 1.21 110.847 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -70.39 162.57 41.92 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.206 2.604 . . . . 1.22 112.794 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.8 mt -92.74 22.74 4.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.441 -0.8 . . . . 1.71 110.54 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.404 -0.808 . . . . 2.35 111.628 -172.21 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.648 -0.581 . . . . 6.07 111.648 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t -80.2 98.75 7.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.837 0.351 . . . . 4.71 110.588 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.15 104.2 1.45 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.662 -0.78 . . . . 2.2 111.359 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -90.32 -177.23 5.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.108 0.48 . . . . 0.9 112.115 -175.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -63.41 108.4 1.33 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.269 -0.878 . . . . 2.73 111.257 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -101.11 -17.5 16.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.162 -0.926 . . . . 2.09 109.365 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 7' ' ' LYS . 2.7 pptp? -69.54 -17.89 63.61 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.901 -0.591 . . . . 3.61 110.745 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.2 m -72.73 -26.85 61.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 2.26 111.159 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.65 16.25 75.93 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.982 -0.628 . . . . 0.95 112.654 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' ' 87' ' ' ILE . 7.8 t -87.32 -29.0 21.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.946 0.403 . . . . 2.08 110.77 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.8 t -115.39 140.94 48.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.898 0.38 . . . . 1.19 110.701 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.45 ' OD1' HG21 ' A' ' 13' ' ' THR . 8.5 p30 -93.09 -25.87 17.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.075 -0.511 . . . . 1.66 112.038 -177.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.45 HG21 ' OD1' ' A' ' 12' ' ' ASN . 43.9 p -92.97 -30.47 15.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 1.12 111.686 -174.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.97 -4.41 59.03 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.748 -0.739 . . . . 0.43 112.027 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HD3' HG22 ' A' ' 74' ' ' VAL . 53.3 mttp -94.19 89.95 6.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.862 0.363 . . . . 2.19 110.666 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 mp -96.17 113.35 24.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.256 -0.429 . . . . 1.12 110.627 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.04 151.1 49.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.877 0.37 . . . . 1.06 110.312 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 50' ' ' THR . 60.8 m -84.84 103.2 13.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.007 -0.738 . . . . 0.74 109.007 173.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 98.4 m -113.13 142.97 45.14 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.17 0.51 . . . . 0.5 110.975 -174.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -97.69 109.19 21.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.487 -0.779 . . . . 1.65 109.238 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 p -75.64 -5.88 47.66 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.411 0.624 . . . . 1.12 110.033 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -89.46 -8.63 52.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.242 -0.89 . . . . 2.85 109.053 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 26.2 mtmt -121.57 142.75 49.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.812 -1.085 . . . . 3.03 110.145 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HD3' HG22 ' A' ' 47' ' ' ILE . 33.7 mmtp -128.39 158.86 37.11 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.63 -0.714 . . . . 2.7 111.082 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 27' ' ' LYS . 10.7 t -124.15 150.03 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.085 -1.08 . . . . 1.3 108.085 173.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -76.48 31.76 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.09 0.404 . . . . 3.31 112.09 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 25' ' ' VAL . 14.6 mtmt 37.81 114.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.997 1.319 . . . . 4.49 113.451 -170.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.8 p -101.24 -81.03 0.49 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.378 -0.828 . . . . 2.89 110.008 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.74 -172.25 3.43 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.641 -1.163 . . . . 2.23 109.162 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.24 116.64 1.13 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.186 -0.766 . . . . 1.39 111.186 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.01 -31.59 72.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.89 0.345 . . . . 3.06 110.55 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -75.38 -42.03 54.95 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.73 -0.471 . . . . 2.44 109.73 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.491 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 32.0 m -54.84 -27.31 41.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.757 -0.656 . . . . 2.67 111.983 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.33 64.51 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.925 -0.655 . . . . 2.54 112.668 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.5 mt -90.91 -29.44 17.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.353 0.597 . . . . 3.49 110.203 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 mp -92.71 179.82 5.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.765 . . . . 5.24 110.325 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -104.51 1.6 30.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.973 0.416 . . . . 7.27 110.681 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.91 -14.21 61.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.959 -0.564 . . . . 5.82 111.509 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 33' ' ' SER . . . -83.97 14.0 45.91 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.978 -0.555 . . . . 3.6 112.676 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -75.78 -40.84 54.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.275 0.559 . . . . 4.15 110.383 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -80.39 142.47 13.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.41 -0.813 . . . . 2.96 112.53 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.28 -8.35 56.84 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.287 -0.87 . . . . 3.83 109.145 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.95 -14.14 51.45 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.528 -1.214 . . . . 2.29 111.548 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.47 ' NE2' ' HA2' ' A' ' 39' ' ' GLY . 85.8 mt-30 -50.23 146.14 5.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.229 0.537 . . . . 1.94 111.955 177.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.51 126.99 75.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.338 -0.846 . . . . 1.98 109.023 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -110.88 114.33 27.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.301 -0.409 . . . . 1.06 111.805 -175.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.4 HG22 ' HD3' ' A' ' 24' ' ' LYS . 12.4 pt -111.06 163.7 7.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.78 -0.645 . . . . 1.06 109.653 172.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -88.84 127.62 35.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.47 0.652 . . . . 2.55 109.634 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 29.8 m -122.54 160.59 25.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.712 -1.131 . . . . 1.15 110.671 -172.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.597 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 11.2 t -160.89 142.49 12.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.774 -0.454 . . . . 1.16 109.774 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.403 HE21 HD11 ' A' ' 60' ' ' ILE . 8.0 tm0? -120.07 115.87 24.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.266 0.555 . . . . 2.08 110.817 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.409 HD13 ' H ' ' A' ' 65' ' ' LYS . 68.7 mt -73.83 133.14 79.54 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.225 -0.898 . . . . 1.51 109.839 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -33.57 111.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 124.817 3.678 . . . . 1.11 114.096 -172.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.425 ' HA ' ' HG2' ' A' ' 63' ' ' GLU . 4.1 pp -88.42 142.14 27.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.679 -1.146 . . . . 2.15 112.535 -170.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.7 mt -93.94 144.31 25.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.468 -0.787 . . . . 2.07 109.139 168.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 mt -68.78 130.75 33.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.932 0.396 . . . . 2.56 110.678 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.41 -0.57 80.99 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.551 -0.75 . . . . 1.09 112.51 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -93.67 154.08 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.603 0.716 . . . . 1.29 111.488 -178.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.01 132.27 34.75 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.758 -1.11 . . . . 1.34 111.377 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 61' ' ' GLU . 5.5 tp -49.84 -39.46 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 114.761 -1.109 . . . . 1.49 111.505 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 60' ' ' ILE . 8.2 pt-20 -70.9 -34.09 71.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.276 -0.874 . . . . 2.2 111.842 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -91.62 -23.17 19.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.95 0.405 . . . . 1.98 110.843 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 54' ' ' LEU . 7.7 tp10 -73.1 -40.68 64.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 2.09 111.122 -176.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 66' ' ' ASN . 19.8 p -107.15 156.6 18.63 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.915 0.388 . . . . 0.6 110.809 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.409 ' H ' HD13 ' A' ' 52' ' ' ILE . 16.1 tppt? -98.65 55.71 1.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.208 -1.034 . . . . 2.81 108.208 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.59 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 14.2 m120 -138.97 -168.68 2.47 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.13 -1.396 . . . . 1.39 109.073 -172.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -104.46 126.09 32.38 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-O 120.895 0.378 . . . . 1.12 110.119 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -77.88 129.28 9.76 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.628 2.219 . . . . 0.65 110.997 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.0 p -129.51 150.56 50.8 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.096 0.474 . . . . 1.1 111.545 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 54.0 t -98.98 99.09 10.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.686 -0.857 . . . . 1.26 108.686 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 56.6 m -86.61 141.27 29.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 0.29 110.642 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 3.0 tt0 -64.12 -45.25 89.41 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.094 -0.706 . . . . 1.69 109.094 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -151.55 167.79 26.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.66 -1.155 . . . . 1.26 108.724 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.528 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -142.97 158.55 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.472 -0.566 . . . . 1.59 109.472 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.21 156.16 33.04 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.976 -0.379 . . . . 1.87 109.976 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 67.69 -150.08 0.16 Allowed 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 123.577 0.548 . . . . 1.94 109.677 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.416 ' OD1' ' HG ' ' A' ' 79' ' ' LEU . 11.4 p-10 -76.75 0.99 18.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.281 0.563 . . . . 2.12 109.715 174.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 49' ' ' CYS . . . 120.94 24.21 2.56 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.5 -0.773 . . . . 0.53 112.752 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 93.7 mt -79.66 -25.55 41.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.82 0.31 . . . . 1.77 111.757 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.0 t -125.8 107.52 17.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.066 -0.346 . . . . 1.1 110.066 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.565 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -102.13 144.65 16.34 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.391 -0.909 . . . . 0.26 112.911 -174.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 mp -100.41 118.21 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.442 -0.379 . . . . 1.07 110.064 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 93.8 m-20 59.02 43.96 16.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.739 -0.664 . . . . 0.34 111.151 174.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.565 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 69.5 m -78.26 97.16 5.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.842 -0.617 . . . . 0.81 110.958 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 23.8 m -88.4 130.05 47.13 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.725 -0.67 . . . . 1.14 110.207 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.5 Cg_exo -61.07 113.82 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.994 2.463 . . . . 0.59 112.108 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.623 ' HB ' ' OG ' ' A' ' 10' ' ' SER . 7.9 pt -82.47 138.96 44.43 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.91 -0.587 . . . . 1.21 110.835 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 17.1 Cg_exo -70.68 144.08 48.16 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.086 2.524 . . . . 1.22 111.537 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 35.4 mt -92.05 32.75 1.11 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.222 -0.899 . . . . 1.71 109.486 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 C--O 1.248 1.001 0 CA-C-N 115.771 -0.65 . . . . 2.35 111.03 -173.806 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.0 -0.44 . . . . 6.07 112.0 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.0 t -153.26 128.37 9.71 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.323 -0.251 . . . . 4.71 110.323 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.72 27.18 27.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 2.2 112.374 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.562 ' CD2' ' HB ' ' A' ' 60' ' ' ILE . 58.2 m95 -77.6 161.81 27.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.082 0.468 . . . . 0.9 111.59 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -66.75 109.65 2.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.361 -0.836 . . . . 2.73 110.411 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.3 m -93.95 27.98 2.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.461 -0.79 . . . . 2.09 110.441 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -45.49 -46.81 14.02 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.368 -0.833 . . . . 3.61 112.491 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 p -63.08 -23.92 67.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.202 -0.454 . . . . 2.26 112.165 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.26 5.12 89.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.097 -0.573 . . . . 0.95 111.702 -176.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.5 m -70.43 -13.89 62.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.565 -0.318 . . . . 2.08 111.635 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -131.91 141.12 49.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.015 0.436 . . . . 1.19 110.507 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -94.6 -30.29 14.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.413 -0.812 . . . . 1.66 112.479 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 p -89.52 -30.03 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.983 0.421 . . . . 1.12 111.947 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.58 3.07 71.98 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.575 -0.821 . . . . 0.43 111.556 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -95.74 87.99 4.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.347 0.594 . . . . 2.19 110.133 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 16' ' ' LEU . 8.0 mp -97.35 137.95 35.56 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.351 -0.84 . . . . 1.12 109.758 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.87 145.18 35.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.032 0.444 . . . . 1.06 110.593 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 28.1 m -82.02 102.84 11.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.387 -0.968 . . . . 0.74 108.387 173.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 59.1 m -122.45 156.6 33.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.131 0.491 . . . . 0.5 111.544 -169.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -102.85 118.01 35.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.442 -0.799 . . . . 1.65 109.312 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.9 p -80.96 -5.19 57.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.972 0.415 . . . . 1.12 111.368 -174.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -97.43 -19.85 18.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.675 0.75 . . . . 2.85 109.568 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -104.28 137.89 41.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.683 -1.144 . . . . 3.03 110.614 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.466 ' HD3' HG22 ' A' ' 47' ' ' ILE . 33.6 mmtp -127.36 155.07 44.18 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.786 -1.097 . . . . 2.7 110.393 -172.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 ' OE1' ' A' ' 48' ' ' GLN . 6.3 t -111.35 145.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.32 -0.622 . . . . 1.3 109.32 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -84.38 -40.74 17.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.274 -0.421 . . . . 3.31 111.38 -172.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -95.51 126.24 40.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.493 -0.321 . . . . 4.49 110.309 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.5 p -141.82 113.92 8.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.191 -0.459 . . . . 2.89 110.724 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.9 m -140.23 -48.52 0.45 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.197 0.522 . . . . 2.23 110.318 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.98 171.19 32.58 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.385 -0.825 . . . . 1.39 111.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -100.85 -51.13 3.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.715 -0.476 . . . . 3.06 109.715 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -84.11 -44.69 13.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.778 -0.646 . . . . 2.44 109.974 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.5 p -75.44 -24.91 57.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.985 -0.552 . . . . 2.67 109.638 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.43 -34.05 73.53 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.52 -0.764 . . . . 2.54 112.972 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.2 tp -74.45 -24.33 59.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.49 0.662 . . . . 3.49 109.904 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 tp -91.52 168.91 11.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.474 -0.784 . . . . 5.24 109.81 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -62.12 -14.89 41.41 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.836 0.35 . . . . 7.27 111.6 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -65.5 -20.71 66.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 5.82 111.567 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.45 9.67 73.89 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.814 -0.707 . . . . 3.6 112.333 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.04 -16.95 23.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.034 0.445 . . . . 4.15 110.648 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.35 137.07 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.944 -0.571 . . . . 2.96 111.134 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.98 0.73 46.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.952 -0.758 . . . . 3.83 108.952 173.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.26 -28.7 70.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.641 -1.163 . . . . 2.29 110.32 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.448 ' HB3' HG22 ' A' ' 82' ' ' ILE . 33.9 mt-30 -48.34 135.2 14.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.013 -0.54 . . . . 1.94 110.033 175.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.2 t -96.51 105.13 16.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 116.084 -0.507 . . . . 1.98 109.859 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -102.86 99.67 9.61 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.521 -0.763 . . . . 1.06 110.852 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.466 HG22 ' HD3' ' A' ' 24' ' ' LYS . 19.2 pt -101.89 151.51 5.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.7 -0.682 . . . . 1.06 109.822 174.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.495 ' OE1' HG23 ' A' ' 25' ' ' VAL . 14.7 tp60 -76.82 126.04 30.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.584 -0.734 . . . . 2.55 109.973 -175.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 67.2 m -115.62 156.13 26.4 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.78 -1.1 . . . . 1.15 111.289 -173.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 t -160.23 114.08 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.525 -0.762 . . . . 1.16 109.782 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -120.38 131.91 55.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.997 -0.547 . . . . 2.08 111.063 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 64' ' ' CYS . 21.7 mt -63.45 142.74 97.91 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.407 -0.815 . . . . 1.51 110.946 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -37.1 129.41 0.56 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 124.246 3.297 . . . . 1.11 113.352 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -59.55 127.09 30.32 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.054 -0.976 . . . . 2.15 112.712 -171.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.5 107.88 17.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.636 -0.876 . . . . 2.07 108.636 170.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.3 mt -65.95 134.62 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.23 0.538 . . . . 2.56 111.124 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.16 -12.77 63.65 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.297 -0.865 . . . . 1.09 112.042 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.21 152.06 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.748 0.785 . . . . 1.29 111.92 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.52 137.78 33.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.093 -1.412 . . . . 1.34 110.579 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.592 HG22 ' N ' ' A' ' 61' ' ' GLU . 11.1 tt -55.89 -39.67 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.547 -0.751 . . . . 1.49 112.244 -175.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.592 ' N ' HG22 ' A' ' 60' ' ' ILE . 2.3 pm0 -72.96 -12.68 61.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.682 -0.69 . . . . 2.2 110.903 -173.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -110.06 -17.46 13.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.433 0.635 . . . . 1.98 109.501 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -75.14 -40.95 59.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.736 -0.665 . . . . 2.09 110.09 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.453 ' HA ' HD11 ' A' ' 52' ' ' ILE . 13.9 p -108.96 175.55 5.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.012 -0.54 . . . . 0.6 110.006 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -123.82 25.72 7.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.769 0.319 . . . . 2.81 111.245 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -113.25 -169.61 1.52 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.011 -0.366 . . . . 1.39 110.011 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 m -79.56 127.05 79.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.004 0.43 . . . . 1.12 110.83 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.51 127.38 5.73 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.875 2.383 . . . . 0.65 110.806 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.3 p -129.76 148.4 51.64 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.745 -0.382 . . . . 1.1 111.113 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 39.7 t -97.29 110.7 23.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.267 -0.642 . . . . 1.26 109.267 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 50.4 m -97.94 141.16 31.26 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.966 -0.561 . . . . 0.29 110.035 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -74.07 -24.48 59.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.435 0.636 . . . . 1.69 109.358 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -163.31 164.38 24.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.109 -0.951 . . . . 1.26 108.688 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.518 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.4 t -138.72 138.72 41.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.566 -0.531 . . . . 1.59 109.566 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 25.3 tt0 -108.72 162.0 14.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.943 -0.571 . . . . 1.87 109.888 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 t70 65.27 -152.08 0.26 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.616 -0.512 . . . . 1.94 109.616 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.54 -5.74 31.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.609 0.719 . . . . 2.12 110.042 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 122.38 23.9 2.29 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.585 -0.734 . . . . 0.53 112.254 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.03 -19.8 28.12 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.95 0.405 . . . . 1.77 110.892 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 42.3 t -124.06 101.14 8.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.1 -0.5 . . . . 1.1 110.145 -174.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.625 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -90.77 138.55 14.44 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.073 -1.06 . . . . 0.26 111.95 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.448 HG22 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -98.72 117.31 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 109.816 -0.439 . . . . 1.07 109.816 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 62.55 52.89 2.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.348 -0.842 . . . . 0.34 110.579 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.625 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 59.7 m -89.96 105.82 18.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.457 -0.792 . . . . 0.81 111.121 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.0 m -93.74 129.36 38.41 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.879 -0.601 . . . . 1.14 110.338 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.41 119.57 6.83 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.887 2.391 . . . . 0.59 111.509 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 pt -98.19 145.45 29.83 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.893 -0.594 . . . . 1.21 111.932 -172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -73.77 151.77 46.48 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.303 2.669 . . . . 1.22 111.513 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 70.8 mt -90.25 19.21 5.25 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.802 -0.636 . . . . 1.71 110.115 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 90' ' ' ILE . 19.2 pt . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.553 -0.749 . . . . 2.35 110.954 -173.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 111.536 -0.625 . . . . 6.07 111.536 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.4 p -157.47 150.59 23.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.976 -0.379 . . . . 4.71 109.976 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.77 65.09 3.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.074 -0.584 . . . . 2.2 112.098 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -129.13 152.12 49.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.971 0.415 . . . . 0.9 110.889 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -72.69 108.03 5.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 2.73 110.751 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 m -111.52 15.16 21.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.673 -0.694 . . . . 2.09 109.597 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.81 -33.93 76.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.244 -0.889 . . . . 3.61 111.598 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.9 p -65.87 -24.38 66.85 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.929 -0.578 . . . . 2.26 111.4 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.79 16.24 31.65 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.804 -0.713 . . . . 0.95 111.974 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 p -65.88 -32.01 73.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.897 0.38 . . . . 2.08 111.96 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.5 t -126.01 141.63 51.88 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.869 -0.332 . . . . 1.19 110.91 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -93.27 -28.62 16.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.917 -0.583 . . . . 1.66 111.914 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 p -98.18 -20.4 17.31 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.495 . . . . 1.12 112.335 -174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.63 22.7 55.48 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.659 -0.782 . . . . 0.43 112.559 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.636 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 51.9 mttp -115.83 92.02 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.035 -0.357 . . . . 2.19 110.035 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.7 mp -98.36 130.5 45.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.907 0.384 . . . . 1.12 110.767 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.501 ' HB3' ' SG ' ' A' ' 49' ' ' CYS . . . -149.9 148.89 29.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.16 -0.473 . . . . 1.06 110.412 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 67' ' ' THR . 97.0 m -86.3 100.19 12.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.289 0.566 . . . . 0.74 110.283 175.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 61.5 m -114.3 158.06 21.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.665 -0.698 . . . . 0.5 109.834 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 2.5 t70 -99.46 129.2 45.62 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.861 -0.792 . . . . 1.65 108.861 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.9 p -84.74 -1.52 56.37 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.713 -0.395 . . . . 1.12 111.116 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -106.14 -14.29 15.19 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.164 -0.68 . . . . 2.85 109.164 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 29.0 mtpp -97.52 101.92 13.56 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.181 -0.918 . . . . 3.03 109.776 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -96.21 158.63 15.35 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.362 -0.381 . . . . 2.7 110.012 176.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.544 HG22 ' OE1' ' A' ' 48' ' ' GLN . 11.1 t -114.43 147.46 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.322 -0.622 . . . . 1.3 109.322 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -76.67 -27.44 55.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.171 -0.468 . . . . 3.31 111.191 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.408 ' H ' HG11 ' A' ' 25' ' ' VAL . 31.5 mmmt -93.21 129.49 39.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.58 -0.526 . . . . 4.49 109.58 177.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.3 m -132.84 32.1 3.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.207 0.527 . . . . 2.89 110.516 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.3 m -75.23 -54.85 6.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.41 -0.814 . . . . 2.23 110.331 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.22 111.8 0.71 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.923 -0.656 . . . . 1.39 112.485 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' A' ' 75' ' ' GLU . 39.6 mt-10 -70.35 -47.69 59.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.411 0.148 . . . . 3.06 110.966 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.42 ' HB2' ' H ' ' A' ' 74' ' ' VAL . 20.4 mm-40 -70.97 -32.15 68.92 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.715 -0.476 . . . . 2.44 109.715 176.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m -52.76 -36.78 58.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.521 -0.763 . . . . 2.67 111.14 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.42 -25.38 74.81 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.88 -0.676 . . . . 2.54 112.331 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -82.42 -30.0 30.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 3.49 109.742 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.55 -176.97 4.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.361 -0.836 . . . . 5.24 110.086 175.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -82.49 -11.25 58.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.863 0.363 . . . . 7.27 110.471 176.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -26.62 68.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.398 . . . . 5.82 111.813 -176.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.39 -7.44 39.56 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 121.271 -0.49 . . . . 3.6 112.818 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.68 -31.27 71.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.12 0.486 . . . . 4.15 110.412 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.8 m -109.95 143.26 20.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.821 -0.627 . . . . 2.96 111.953 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 mt -101.27 8.29 42.54 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.651 -0.704 . . . . 3.83 109.428 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -80.97 -8.14 59.7 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.169 -0.923 . . . . 2.29 110.589 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.492 ' OE1' HG21 ' A' ' 82' ' ' ILE . 32.1 mt-30 -47.05 138.76 6.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.598 -0.728 . . . . 1.94 110.609 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.08 105.55 16.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.159 -0.473 . . . . 1.98 110.075 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -98.45 110.42 23.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.519 -0.764 . . . . 1.06 111.29 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 84' ' ' CYS . 19.8 pt -113.31 148.74 16.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.969 -0.56 . . . . 1.06 110.307 174.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.544 ' OE1' HG22 ' A' ' 25' ' ' VAL . 10.4 tp60 -75.05 132.4 41.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.33 -0.85 . . . . 2.55 109.253 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 17' ' ' ALA . 2.0 t -126.55 163.82 22.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.679 -0.691 . . . . 1.15 110.463 -171.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 t -161.2 127.96 4.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.12 0.486 . . . . 1.16 110.111 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -121.13 129.81 53.45 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.067 0.461 . . . . 2.08 111.463 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mt -71.66 137.71 83.09 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.217 -0.902 . . . . 1.51 109.717 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.3 109.29 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.037 3.158 . . . . 1.11 112.371 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.98 140.26 52.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.443 -0.798 . . . . 2.15 112.867 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.403 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 85.2 mt -93.2 147.55 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.888 -1.051 . . . . 2.07 108.544 167.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.456 HD13 ' N ' ' A' ' 56' ' ' ILE . 2.4 mp -71.73 138.19 22.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.088 0.47 . . . . 2.56 110.276 -177.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.59 5.85 83.63 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.427 -0.806 . . . . 1.09 112.715 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.456 HG21 ' N ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -93.36 154.29 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.569 0.7 . . . . 1.29 111.343 -177.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.456 ' N ' HG21 ' A' ' 58' ' ' ILE . . . -89.32 134.85 33.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.613 -1.176 . . . . 1.34 111.01 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 61' ' ' GLU . 6.6 tp -50.68 -41.45 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.36 -0.836 . . . . 1.49 111.715 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 60' ' ' ILE . 3.0 pt-20 -74.84 -27.68 60.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.752 -0.658 . . . . 2.2 111.716 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -96.39 -22.33 17.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.349 -0.387 . . . . 1.98 110.698 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.22 -36.71 79.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.576 0.703 . . . . 2.09 110.091 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.9 p -118.82 177.22 4.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.489 -0.778 . . . . 0.6 110.345 -172.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 42.3 tptt -125.53 40.92 3.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.742 0.782 . . . . 2.81 109.824 175.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 43.4 m-80 -126.65 -165.58 1.47 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.055 -0.975 . . . . 1.39 108.94 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 12.5 m -87.21 125.79 64.84 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 120.438 -0.505 . . . . 1.12 110.836 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.09 121.88 4.58 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.679 2.253 . . . . 0.65 110.472 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.5 p -129.79 151.57 50.22 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.138 -0.625 . . . . 1.1 111.809 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 12.2 t -99.35 101.58 12.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.297 -0.865 . . . . 1.26 109.105 171.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.636 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 59.8 m -84.99 133.2 34.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.627 0.727 . . . . 0.29 110.076 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 65.0 mt-10 -63.46 -40.29 96.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.779 -1.1 . . . . 1.69 109.71 175.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -153.61 166.0 34.15 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.31 -0.859 . . . . 1.26 109.002 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.49 HG11 ' HD3' ' A' ' 15' ' ' LYS . 15.8 m -133.98 160.27 41.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.159 0.504 . . . . 1.59 110.697 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 33.5 tt0 -129.55 155.03 46.44 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.8 -1.185 . . . . 1.87 107.8 173.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER 67.59 -156.01 0.21 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.565 -0.531 . . . . 1.94 109.565 -172.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.11 -3.14 24.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.55 0.69 . . . . 2.12 110.224 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 121.27 22.94 2.76 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.793 -0.64 . . . . 0.53 111.615 -175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.4 mt -86.05 -15.78 40.23 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.261 0.553 . . . . 1.77 109.955 175.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 73.5 t -123.32 112.86 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.37 -0.832 . . . . 1.1 108.922 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -106.82 137.06 13.72 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.011 -1.09 . . . . 0.26 112.238 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.492 HG21 ' OE1' ' A' ' 44' ' ' GLN . 1.7 mp -99.55 120.71 49.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 122.437 0.295 . . . . 1.07 110.454 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 95.6 m-20 59.16 44.07 16.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.537 -0.756 . . . . 0.34 110.997 173.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 71' ' ' CYS . 45.1 m -77.85 105.11 8.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.387 -0.824 . . . . 0.81 110.864 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.7 m -89.35 125.42 61.8 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.986 -0.552 . . . . 1.14 110.13 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.67 121.97 10.12 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.751 2.301 . . . . 0.59 111.694 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.8 pt -92.44 144.83 29.46 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 116.199 -0.455 . . . . 1.21 110.318 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' A' ' 90' ' ' ILE . 23.4 Cg_exo -67.3 155.0 72.38 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.008 2.472 . . . . 1.22 112.073 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.94 19.88 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.022 -0.535 . . . . 1.71 110.836 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.424 HG13 ' OXT' ' A' ' 90' ' ' ILE . 29.6 pt . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.202 -0.904 . . . . 2.35 110.604 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 111.751 -0.54 . . . . 6.07 111.751 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 p 45.85 65.46 1.15 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.474 0.71 . . . . 4.71 112.454 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.23 109.75 2.93 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.213 -0.755 . . . . 2.2 111.213 176.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -83.6 164.49 19.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.3 0.571 . . . . 0.9 111.985 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -82.6 109.43 16.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.107 -0.952 . . . . 2.73 111.092 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 t -105.83 28.76 7.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.729 -0.669 . . . . 2.09 109.324 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -26.09 30.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.44 -0.8 . . . . 3.61 112.791 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.6 m -78.19 -14.06 59.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.159 0.504 . . . . 2.26 111.003 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.42 16.53 68.63 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.357 -1.497 . . . . 0.95 109.357 -168.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.456 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 2.1 p -69.81 -30.82 68.43 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.887 -1.157 . . . . 2.08 112.775 -169.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.2 t -126.02 143.31 51.15 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.541 -0.464 . . . . 1.19 111.26 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.521 ' OD1' HG22 ' A' ' 13' ' ' THR . 8.4 p30 -92.04 -29.16 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 1.66 111.425 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.521 HG22 ' OD1' ' A' ' 12' ' ' ASN . 22.4 p -97.48 -31.02 12.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.006 0.432 . . . . 1.12 111.97 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.64 2.74 58.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.826 -0.702 . . . . 0.43 111.582 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 41.2 mttp -90.89 88.27 6.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.753 0.311 . . . . 2.19 110.376 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.95 122.04 38.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.42 -0.355 . . . . 1.12 110.091 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.568 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -131.25 146.1 52.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.73 0.3 . . . . 1.06 110.58 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 50' ' ' THR . 35.4 m -85.18 98.38 10.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 0.74 109.89 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 65.3 m -116.76 157.91 24.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.433 -0.349 . . . . 0.5 111.462 -168.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.59 ' CB ' ' HD3' ' A' ' 23' ' ' LYS . 50.3 m-20 -102.76 112.86 25.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.183 -0.673 . . . . 1.65 109.183 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.8 p -74.81 -15.88 60.72 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.388 0.514 . . . . 1.12 112.388 -172.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -98.59 -0.4 43.21 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.764 0.792 . . . . 2.85 109.422 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.59 ' HD3' ' CB ' ' A' ' 20' ' ' ASP . 35.4 mtpt -112.74 100.95 9.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.564 -1.198 . . . . 3.03 109.685 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.83 161.81 13.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.735 -0.666 . . . . 2.7 111.554 -174.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -127.79 142.31 44.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.045 -1.094 . . . . 1.3 108.045 173.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -90.94 -23.82 20.35 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.789 0.328 . . . . 3.31 111.201 -173.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 28.8 mmmt -103.48 119.78 39.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.112 0.482 . . . . 4.49 111.284 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 15.4 p -126.42 120.66 30.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.578 -0.737 . . . . 2.89 109.624 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.5 m -88.39 -54.33 4.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.548 -0.296 . . . . 2.23 110.575 -176.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.22 70.38 1.1 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.586 -0.816 . . . . 1.39 111.173 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 22.9 mt-10 -78.94 -27.68 43.64 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.636 0.236 . . . . 3.06 111.636 -174.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -99.13 -37.76 9.2 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.51 -0.476 . . . . 2.44 110.497 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.413 ' HB2' ' HB ' ' A' ' 38' ' ' THR . 26.8 p -64.9 -31.05 72.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.177 -0.465 . . . . 2.67 109.807 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.455 ' HA2' ' CA ' ' A' ' 39' ' ' GLY . . . -68.68 -31.55 73.46 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.636 -0.711 . . . . 2.54 112.27 176.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 97.3 mt -71.67 -34.3 69.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.296 0.569 . . . . 3.49 109.591 175.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.3 mt -76.57 -178.31 4.65 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.288 -0.869 . . . . 5.24 109.937 174.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -71.82 -1.98 16.09 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.954 0.407 . . . . 7.27 111.005 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 6.2 m -80.78 -2.44 47.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.104 -0.498 . . . . 5.82 111.25 -177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.455 ' CA ' ' HA2' ' A' ' 34' ' ' GLY . . . -69.15 -14.85 69.09 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.669 -0.777 . . . . 3.6 112.639 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.55 -31.61 53.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.135 0.42 . . . . 4.15 112.135 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 m -85.47 135.49 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.521 0.677 . . . . 2.96 112.012 -174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.9 tp -109.18 -2.06 18.28 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.185 -0.916 . . . . 3.83 109.005 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.54 -8.17 54.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.114 -0.948 . . . . 2.29 110.851 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -44.08 143.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.823 -0.626 . . . . 1.94 111.476 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.96 119.53 62.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.643 -0.708 . . . . 1.98 110.024 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -100.45 124.99 46.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.962 -0.563 . . . . 1.06 110.899 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 84' ' ' CYS . 18.2 pt -118.93 152.11 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.127 0.489 . . . . 1.06 110.346 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.05 127.7 33.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.556 -0.905 . . . . 2.55 108.556 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.625 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 4.5 t -133.71 169.1 17.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.848 -0.614 . . . . 1.15 110.418 -170.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 11.7 t -160.02 137.04 9.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.072 0.463 . . . . 1.16 110.304 178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.27 132.82 55.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.001 0.429 . . . . 2.08 110.1 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.2 mm -80.71 144.97 57.14 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 1.51 110.468 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -37.26 126.75 0.58 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.039 3.16 . . . . 1.11 113.345 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.88 123.71 17.89 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.258 -0.883 . . . . 2.15 113.121 -171.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.72 129.41 55.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.272 -0.876 . . . . 2.07 109.289 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 56' ' ' ILE . 3.2 mp -69.55 135.73 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.169 0.509 . . . . 2.56 110.7 -176.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.1 11.02 81.71 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.308 -0.86 . . . . 1.09 113.178 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.07 154.05 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.618 0.723 . . . . 1.29 112.326 -176.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.43 145.87 24.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.402 -1.272 . . . . 1.34 111.215 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.516 HG21 ' N ' ' A' ' 61' ' ' GLU . 7.2 tp -53.22 -43.39 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 122.866 0.466 . . . . 1.49 111.229 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.516 ' N ' HG21 ' A' ' 60' ' ' ILE . 8.5 pt-20 -74.33 -22.05 59.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.118 -0.492 . . . . 2.2 111.238 -175.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -90.48 -34.55 15.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.334 0.588 . . . . 1.98 109.753 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -67.9 -35.21 78.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.066 -0.97 . . . . 2.09 110.592 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.0 p -121.82 172.13 8.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.802 -0.635 . . . . 0.6 110.337 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -120.7 21.42 11.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 2.81 111.416 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 38.6 m-80 -104.12 -168.14 1.45 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.474 -0.565 . . . . 1.39 109.474 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -85.95 120.89 72.97 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-O 121.495 0.664 . . . . 1.12 111.465 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.83 122.52 9.9 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.353 2.702 . . . . 0.65 111.219 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.8 p -132.43 154.86 49.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.699 -0.228 . . . . 1.1 110.633 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 11.8 t -99.72 117.07 33.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.462 -0.57 . . . . 1.26 109.462 171.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 46.6 m -102.46 139.51 37.96 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.119 0.485 . . . . 0.29 109.748 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 6.6 tt0 -78.03 -20.88 51.6 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.512 0.673 . . . . 1.69 109.724 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.34 158.96 33.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.325 -0.991 . . . . 1.26 108.325 171.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.48 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.6 OUTLIER -148.65 129.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 117.852 0.297 . . . . 1.59 110.465 178.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.51 165.91 13.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.731 0.301 . . . . 1.87 110.591 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.82 -150.16 0.31 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.587 -0.733 . . . . 1.94 110.24 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.94 5.08 14.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.96 0.409 . . . . 2.12 110.141 172.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.625 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 118.57 24.04 3.25 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.665 -0.779 . . . . 0.53 112.691 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.06 -21.29 29.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.05 0.425 . . . . 1.77 111.534 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.08 102.79 8.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.891 -0.411 . . . . 1.1 109.891 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -102.34 139.76 14.56 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.455 -0.879 . . . . 0.26 112.966 -176.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.0 120.95 46.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 122.737 0.415 . . . . 1.07 109.905 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 95.5 m-20 60.76 48.62 6.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.525 -0.761 . . . . 0.34 110.975 173.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.526 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.4 m -83.1 111.42 18.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.619 -0.718 . . . . 0.81 110.564 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 24.7 m -105.29 128.11 27.27 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.704 -0.68 . . . . 1.14 109.918 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.9 Cg_exo -59.95 125.33 17.39 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.976 2.451 . . . . 0.59 112.099 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.456 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 16.2 pt -96.49 162.45 23.4 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 115.55 -0.75 . . . . 1.21 111.107 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.17 149.41 51.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.237 2.624 . . . . 1.22 112.176 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.05 33.53 1.34 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.652 -0.704 . . . . 1.71 110.137 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.266 -0.874 . . . . 2.35 111.443 -172.346 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.016 -0.434 . . . . 6.07 112.016 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 t 61.05 37.13 18.14 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.384 0.611 . . . . 4.71 110.533 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.15 -121.84 0.63 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.705 -0.679 . . . . 2.2 111.624 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.466 ' CZ2' HD21 ' A' ' 54' ' ' LEU . 49.1 m95 -141.74 166.95 23.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.899 0.38 . . . . 0.9 111.219 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.553 ' OE2' ' HD2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -65.77 108.25 2.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.629 -0.878 . . . . 2.73 108.629 175.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 m -106.75 28.21 8.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.968 -0.56 . . . . 2.09 112.344 -167.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -50.35 -25.24 3.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.834 0.679 . . . . 3.61 112.834 -177.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 t -71.76 -28.66 63.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 2.26 111.733 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.81 1.44 54.62 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.173 -0.537 . . . . 0.95 113.226 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -77.33 -15.89 59.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.773 0.286 . . . . 2.08 111.773 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.59 139.96 38.19 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.577 -0.449 . . . . 1.19 110.206 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.608 HD21 ' N ' ' A' ' 13' ' ' THR . 0.4 OUTLIER -94.54 -21.73 18.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.748 0.648 . . . . 1.66 112.748 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.608 ' N ' HD21 ' A' ' 12' ' ' ASN . 2.0 p -104.41 -30.89 9.79 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.229 0.455 . . . . 1.12 112.229 -174.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.47 -3.27 59.43 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.612 -0.804 . . . . 0.43 111.999 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.584 ' NZ ' ' HA ' ' A' ' 73' ' ' ASP . 90.4 mttt -87.91 88.07 7.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.095 0.474 . . . . 2.19 109.967 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -93.53 103.07 15.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.865 -0.607 . . . . 1.12 110.189 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.41 154.06 28.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.105 0.478 . . . . 1.06 110.752 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 65.6 m -88.94 103.62 16.2 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.611 -0.722 . . . . 0.74 109.179 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -125.44 150.72 47.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.057 0.456 . . . . 0.5 112.037 -170.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.87 104.24 16.32 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.619 -0.719 . . . . 1.65 110.321 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.425 HG22 ' HG3' ' A' ' 86' ' ' PRO . 74.4 p -72.48 -5.79 39.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.078 0.466 . . . . 1.12 111.327 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -96.91 -22.68 16.73 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.846 0.831 . . . . 2.85 109.013 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' CG ' ' HB2' ' A' ' 48' ' ' GLN . 27.5 tptt -106.88 110.98 23.29 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.245 -1.343 . . . . 3.03 109.895 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -100.93 161.88 13.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.428 -0.806 . . . . 2.7 111.861 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 t -126.2 148.0 30.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.236 -0.893 . . . . 1.3 108.807 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -97.93 22.14 9.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.821 0.343 . . . . 3.31 111.419 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -134.45 119.93 19.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.222 -0.444 . . . . 4.49 110.119 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 p -140.85 86.09 2.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.909 0.385 . . . . 2.89 110.528 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.1 m -108.28 -47.66 3.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.24 0.543 . . . . 2.23 110.203 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.69 164.02 34.16 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.251 -0.886 . . . . 1.39 112.739 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 21.9 mm-40 -101.78 -45.19 5.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.065 0.46 . . . . 3.06 109.915 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.28 -40.92 11.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.829 -0.623 . . . . 2.44 109.78 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.568 ' O ' ' HB3' ' A' ' 37' ' ' HIS . 68.8 m -83.71 3.02 34.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.036 -0.529 . . . . 2.67 109.968 172.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.5 -38.56 87.89 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.718 -0.674 . . . . 2.54 113.536 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.55 -62.95 1.26 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.891 0.377 . . . . 3.49 110.255 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.8 tp -113.59 94.63 4.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.194 -0.457 . . . . 5.24 110.316 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.568 ' HB3' ' O ' ' A' ' 33' ' ' SER . 8.2 p80 -114.76 -46.43 2.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.513 -0.312 . . . . 7.27 111.423 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.4 m -66.01 -33.25 75.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.988 0.423 . . . . 5.82 111.241 -174.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.28 -11.67 75.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 3.6 112.165 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -101.87 -51.73 3.35 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.644 -0.502 . . . . 4.15 109.644 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.22 138.6 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.495 -0.775 . . . . 2.96 111.922 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.4 tp -106.08 -7.03 18.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.01 0.91 . . . . 3.83 109.031 172.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.94 1.73 51.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.902 -1.044 . . . . 2.29 111.375 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.5 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 27.6 mt-30 -48.29 133.56 15.61 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.236 0.541 . . . . 1.94 111.182 -178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.579 HG13 ' HA ' ' A' ' 83' ' ' ASN . 14.7 p -105.66 127.92 60.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.413 -0.812 . . . . 1.98 110.163 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.82 121.86 45.59 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.36 -0.836 . . . . 1.06 110.379 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 84' ' ' CYS . 19.1 pt -130.7 160.8 41.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.891 -0.595 . . . . 1.06 109.697 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.448 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 1.5 mm-40 -77.34 135.76 38.4 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.504 0.668 . . . . 2.55 110.642 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.6 m -131.11 153.57 49.21 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.453 -1.248 . . . . 1.15 110.146 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 8.4 t -156.56 128.34 7.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.083 0.468 . . . . 1.16 110.038 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 tm0? -120.87 110.62 16.53 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.989 0.424 . . . . 2.08 110.515 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mt -65.73 128.94 94.19 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.619 -0.719 . . . . 1.51 109.889 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -34.0 99.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 125.128 3.885 . . . . 1.11 113.531 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.466 HD21 ' CZ2' ' A' ' 4' ' ' TRP . 3.3 pp -70.29 136.89 50.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.851 -1.068 . . . . 2.15 112.393 -172.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.4 mt -94.95 120.6 35.43 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.494 -0.928 . . . . 2.07 108.494 168.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.06 133.09 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.361 0.601 . . . . 2.56 111.081 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.43 -24.96 22.99 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.085 -0.962 . . . . 1.09 111.478 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -87.06 155.03 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.466 0.65 . . . . 1.29 111.107 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.85 143.94 26.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.666 -1.152 . . . . 1.34 111.624 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.483 HG21 ' N ' ' A' ' 61' ' ' GLU . 6.7 tp -54.71 -35.25 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.018 -0.992 . . . . 1.49 110.974 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.483 ' N ' HG21 ' A' ' 60' ' ' ILE . 3.6 pt-20 -76.79 -16.8 59.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.069 -0.969 . . . . 2.2 111.701 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.33 -24.5 11.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.09 0.471 . . . . 1.98 110.704 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.8 tp10 -74.93 -38.04 61.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.848 -0.615 . . . . 2.09 111.1 -175.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 p -113.61 173.14 6.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.251 -0.277 . . . . 0.6 110.251 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -118.84 46.19 1.91 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.221 0.534 . . . . 2.81 110.699 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.527 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 42.4 m-80 -135.39 -174.16 3.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.822 -0.626 . . . . 1.39 109.331 175.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.6 m -80.35 125.29 81.46 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-O 121.403 0.62 . . . . 1.12 111.786 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -63.05 115.52 3.01 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.339 2.693 . . . . 0.65 110.998 171.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.3 p -127.26 143.32 51.26 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.322 -0.551 . . . . 1.1 111.265 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 36.0 t -93.27 106.19 18.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 1.26 109.68 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 57.1 m -92.73 134.0 35.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.156 -0.474 . . . . 0.29 109.959 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -64.9 -36.08 83.21 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.206 -0.665 . . . . 1.69 109.206 175.154 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.584 ' HA ' ' NZ ' ' A' ' 15' ' ' LYS . 40.3 t0 -152.25 165.55 34.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.368 -0.975 . . . . 1.26 108.368 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.49 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.2 t -136.48 133.55 49.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.633 -0.506 . . . . 1.59 109.633 175.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.479 ' HA ' ' HG2' ' A' ' 31' ' ' GLU . 16.1 tt0 -102.94 164.69 11.47 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.139 -0.482 . . . . 1.87 109.701 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 78' ' ' GLY . 1.8 m-20 63.67 -156.52 0.32 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.272 0.357 . . . . 1.94 110.156 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' A' ' 76' ' ' ASP . 2.5 m-20 -75.45 23.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.895 0.379 . . . . 2.12 110.882 173.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 76' ' ' ASP . . . 95.7 22.62 20.66 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.949 -0.643 . . . . 0.53 111.777 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.21 -18.68 25.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 1.77 111.247 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.9 t -131.69 109.98 16.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.772 -0.455 . . . . 1.1 109.772 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.592 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -97.04 144.83 17.58 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.28 -0.962 . . . . 0.26 112.382 -177.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -100.77 120.83 50.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.866 -0.42 . . . . 1.07 109.866 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.579 ' HA ' HG13 ' A' ' 45' ' ' VAL . 89.4 m-20 58.46 53.76 6.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.026 -0.534 . . . . 0.34 110.807 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.592 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 66.8 m -89.36 95.44 10.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.728 -0.669 . . . . 0.81 110.94 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 8.0 m -88.18 127.25 57.97 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.718 -0.674 . . . . 1.14 110.732 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' HG3' HG22 ' A' ' 21' ' ' THR . 39.7 Cg_exo -62.57 118.01 4.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.896 2.397 . . . . 0.59 111.63 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.6 pt -97.98 148.45 34.49 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.925 -0.579 . . . . 1.21 111.558 -174.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.4 Cg_exo -69.86 161.12 47.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.355 2.703 . . . . 1.22 111.872 175.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.0 mt -93.55 22.61 5.24 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.744 -0.662 . . . . 1.71 110.693 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.472 -0.775 . . . . 2.35 110.973 -174.063 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.2 m95 . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.927 0.394 . . . . 0.81 111.079 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -66.55 108.95 2.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.631 -0.713 . . . . 2.73 110.463 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -108.97 25.99 11.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.676 -0.693 . . . . 1.75 110.448 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -20.08 62.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.903 -0.59 . . . . 3.24 111.414 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -69.06 -20.41 64.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.123 0.487 . . . . 2.05 110.699 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.65 7.09 87.25 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.836 -0.62 . . . . 0.88 112.637 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 m -70.96 -27.46 63.75 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.783 0.29 . . . . 1.72 111.783 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.1 t -108.53 141.64 40.14 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.93 -0.308 . . . . 1.19 110.383 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.501 ' OD1' HG23 ' A' ' 13' ' ' THR . 9.5 p30 -93.22 -19.87 21.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 1.66 112.129 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.501 HG23 ' OD1' ' A' ' 12' ' ' ASN . 19.8 p -108.86 -31.11 7.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.914 0.388 . . . . 0.52 111.957 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.13 2.09 56.96 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.749 -0.739 . . . . 0.43 111.943 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.66 ' HD3' HG23 ' A' ' 74' ' ' VAL . 78.3 mttt -94.87 89.23 5.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.127 0.489 . . . . 1.64 110.443 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.4 mp -93.61 128.56 39.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 0.55 109.999 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -137.16 156.75 47.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.517 -0.31 . . . . 0.29 110.301 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 50' ' ' THR . 82.4 m -91.91 97.66 11.1 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.278 -0.638 . . . . 0.74 109.278 173.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 82.4 m -111.64 155.65 23.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.963 0.411 . . . . 0.5 111.066 -171.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 20.5 t0 -98.24 127.82 44.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.033 -1.099 . . . . 1.65 108.033 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.7 p -92.69 1.88 57.03 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.362 0.601 . . . . 0.52 110.501 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -105.55 -25.05 12.46 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.982 -0.748 . . . . 2.2 108.982 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 26.2 mtmm -102.32 135.9 43.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.204 -0.907 . . . . 2.6 110.092 176.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -139.96 164.45 29.97 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.561 -0.745 . . . . 2.17 111.954 -176.236 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.44 HG21 HG22 ' A' ' 80' ' ' VAL . 2.5 t -117.88 148.49 20.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.609 -0.723 . . . . 0.59 110.123 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -83.88 -21.43 31.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.317 -0.401 . . . . 2.83 111.191 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.9 mmpt? -94.13 136.21 34.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.349 -0.611 . . . . 4.07 109.349 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 23.0 p -156.92 96.65 1.62 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.799 0.333 . . . . 2.46 111.632 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -122.16 -69.12 0.85 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.758 -0.377 . . . . 2.0 111.475 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.37 77.87 0.49 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.974 -0.85 . . . . 1.39 110.974 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -103.43 20.55 17.62 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.449 0.537 . . . . 3.06 112.449 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.486 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . 83.8 mt-10 . . . . . 0 CA--C 1.518 -0.265 0 C-N-CA 120.102 -0.639 . . . . 2.44 109.948 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.494 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 26.1 mt-30 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.252 0.549 . . . . 1.4 111.622 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.4 t -100.14 123.08 52.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.171 -0.922 . . . . 1.37 109.713 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . -110.04 100.48 9.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.637 -0.71 . . . . 0.3 110.658 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 12.2 pt -100.88 149.64 6.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.918 -0.583 . . . . 0.23 110.591 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.79 126.63 30.2 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.768 -0.827 . . . . 2.38 108.768 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.486 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -126.07 158.64 34.9 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.88 -0.6 . . . . 1.15 110.203 -172.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 5.2 t -160.59 127.57 4.26 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.24 -0.436 . . . . 0.6 110.116 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.434 HE21 HD12 ' A' ' 60' ' ' ILE . 5.0 tm0? -116.4 107.64 15.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.496 0.665 . . . . 2.08 111.044 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mt -64.6 134.29 95.97 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 114.855 -1.066 . . . . 0.95 109.665 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -32.33 101.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.699 3.599 . . . . 0.95 114.259 -170.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 54' ' ' LEU . 3.9 pp -75.82 142.15 42.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.15 -1.387 . . . . 1.67 113.099 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.1 mp -91.68 145.26 24.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.359 -0.837 . . . . 1.58 109.288 167.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.4 136.17 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 2.11 110.778 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.12 -7.77 69.93 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.577 -0.738 . . . . 1.03 112.865 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.491 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -81.75 160.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.372 0.605 . . . . 0.77 111.762 -175.261 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' N ' HG23 ' A' ' 58' ' ' ILE . . . -90.07 129.95 36.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.032 -0.985 . . . . 0.68 111.202 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.434 HD12 HE21 ' A' ' 51' ' ' GLN . 8.6 tp -53.92 -36.66 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 114.984 -1.007 . . . . 0.69 112.353 -177.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.13 -21.83 49.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.744 0.307 . . . . 2.2 111.432 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.91 -26.57 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.079 0.466 . . . . 1.98 110.599 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.491 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 9.7 tp10 -68.63 -35.01 76.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.802 -0.635 . . . . 2.09 111.136 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.9 p -127.39 154.44 45.0 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.872 0.368 . . . . 0.6 110.902 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -98.84 56.07 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.871 0.843 . . . . 2.32 109.726 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 52.1 m-80 -137.86 -170.38 2.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.129 -0.941 . . . . 1.06 108.727 175.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.0 m -89.35 126.09 59.63 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-O 121.114 0.483 . . . . 0.34 110.592 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.94 120.44 4.65 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.686 2.258 . . . . 0.45 111.079 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.753 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 2.8 p -120.59 157.85 28.62 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.884 -0.598 . . . . 0.31 111.567 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 34.0 t -108.97 104.51 13.76 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.206 -0.664 . . . . 1.26 109.206 170.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.489 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 92.1 m -87.38 139.59 30.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.359 -0.608 . . . . 0.29 109.359 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.1 tt0 -71.57 -31.24 66.76 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.064 -0.717 . . . . 1.53 109.064 174.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 32' ' ' GLU . 6.9 t0 -156.33 164.02 38.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.866 -1.161 . . . . 1.26 107.866 171.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.66 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.4 t -137.01 139.12 45.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.652 -0.419 . . . . 1.07 110.022 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 10.1 tt0 -100.13 159.01 15.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.156 -0.475 . . . . 1.87 109.963 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 61.73 -151.22 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.066 -0.515 . . . . 1.94 110.133 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -79.65 16.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.083 0.468 . . . . 2.12 110.579 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.562 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 110.49 21.76 6.72 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.813 -0.63 . . . . 0.51 112.3 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.92 -21.87 31.72 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.758 0.281 . . . . 1.1 111.758 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 21.7 t -127.72 103.63 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.898 -0.321 . . . . 0.33 110.43 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.489 ' HA3' ' SG ' ' A' ' 71' ' ' CYS . . . -91.84 123.79 7.37 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.057 -1.068 . . . . 0.26 112.265 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -86.43 118.34 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.671 -0.492 . . . . 0.3 109.671 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 92.9 m-20 59.99 41.78 16.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.34 110.764 174.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.753 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -81.21 109.97 16.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.81 110.457 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 17.2 m -94.17 130.27 34.71 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.776 -0.647 . . . . 0.44 109.698 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.3 Cg_exo -60.62 109.96 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.715 2.277 . . . . 0.39 111.442 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 5.5 pt -74.66 141.66 76.28 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 115.623 -0.717 . . . . 0.57 111.26 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.3 Cg_exo . . . . . 0 N--CA 1.46 -0.473 0 C-N-CA 123.278 2.652 . . . . 1.05 112.392 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.44 ' CH2' HD22 ' A' ' 54' ' ' LEU . 94.5 m95 . . . . . 0 N--CA 1.45 -0.454 0 CA-C-O 120.737 0.303 . . . . 0.81 110.199 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.521 ' OE1' ' HG2' ' A' ' 7' ' ' LYS . 30.9 tt0 -59.37 109.05 0.8 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.488 -0.778 . . . . 2.73 110.848 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -91.54 27.51 1.98 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.64 -0.709 . . . . 1.75 111.429 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HG2' ' OE1' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -56.45 -25.87 52.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.066 -0.516 . . . . 3.24 112.179 -176.031 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p -77.15 -30.01 54.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.049 0.452 . . . . 2.05 111.537 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.55 15.04 80.65 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.88 112.087 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.404 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 10.9 p -77.47 -25.18 50.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.307 0.484 . . . . 1.72 112.307 -174.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -102.97 142.68 33.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.218 -0.446 . . . . 1.19 110.933 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.539 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.8 p30 -91.11 -29.25 17.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.789 -0.641 . . . . 1.66 111.478 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.539 HG23 ' OD1' ' A' ' 12' ' ' ASN . 13.0 p -100.91 -31.19 11.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.104 0.478 . . . . 0.52 111.627 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.86 -2.88 52.25 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.815 -0.707 . . . . 0.43 112.115 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.587 ' HD3' HG23 ' A' ' 74' ' ' VAL . 90.7 mttt -86.72 88.76 7.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.009 0.433 . . . . 1.64 110.428 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 69' ' ' THR . 9.6 mp -92.32 110.73 22.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.55 110.492 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.0 149.23 39.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.08 0.467 . . . . 0.29 110.482 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -87.03 106.01 17.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.64 -0.709 . . . . 0.74 109.167 172.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -122.8 154.37 38.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.084 -0.507 . . . . 0.5 111.52 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 4.1 m-20 -100.03 114.64 28.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.509 -0.769 . . . . 1.65 109.174 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.0 p -74.82 -7.02 52.17 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.134 0.492 . . . . 0.52 110.968 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -98.01 -6.51 31.8 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.018 -0.734 . . . . 2.2 109.018 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 46.1 mtpt -111.62 98.71 7.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.83 -1.077 . . . . 2.6 109.759 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.82 157.67 16.14 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.271 -0.877 . . . . 2.17 110.782 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 t -120.22 145.15 26.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.684 -0.858 . . . . 0.59 108.684 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -95.18 29.84 2.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.065 0.46 . . . . 2.83 111.442 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 7.3 mmpt? -129.17 161.16 30.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.046 -0.525 . . . . 4.07 109.831 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 p -150.12 66.2 0.97 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.129 0.49 . . . . 2.46 110.406 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 m -122.1 143.69 49.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.753 -0.658 . . . . 2.0 109.679 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.03 148.78 18.56 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.215 -0.993 . . . . 1.39 112.842 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -78.61 -38.17 40.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.915 0.388 . . . . 3.06 110.285 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 2.44 110.186 176.851 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.587 ' HB3' HG23 ' A' ' 82' ' ' ILE . 32.1 mt-30 . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.295 0.569 . . . . 1.4 111.046 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.41 105.33 15.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.258 -0.883 . . . . 1.37 110.268 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -101.33 116.0 31.8 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.67 -0.695 . . . . 0.3 110.722 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 84' ' ' CYS . 8.0 pt -120.81 155.16 24.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.859 -0.61 . . . . 0.23 109.887 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.72 123.5 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.869 0.842 . . . . 2.38 109.43 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 60.2 m -122.57 157.35 32.31 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.316 -1.311 . . . . 1.15 110.598 -171.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.9 t -161.18 138.43 8.94 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.913 0.387 . . . . 0.6 110.38 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -121.58 152.09 39.64 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.548 0.69 . . . . 2.08 111.156 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.574 HG23 ' HD2' ' A' ' 53' ' ' PRO . 23.1 mt -90.6 142.13 27.72 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.779 -1.1 . . . . 0.95 108.687 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.574 ' HD2' HG23 ' A' ' 52' ' ' ILE . 57.2 Cg_exo -33.59 108.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 124.216 3.277 . . . . 0.95 113.393 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 52' ' ' ILE . 22.5 mt -66.13 130.08 41.99 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.954 -1.021 . . . . 1.67 113.112 -166.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.633 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 86.4 mt -99.48 122.6 42.8 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.704 -0.85 . . . . 1.58 108.704 166.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.1 mt -67.81 132.3 32.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.06 0.457 . . . . 2.11 110.637 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.67 14.6 61.1 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.458 -0.792 . . . . 1.03 112.089 -176.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -105.48 155.07 6.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.773 0.797 . . . . 0.77 111.818 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.38 135.82 33.36 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.373 -1.285 . . . . 0.68 111.036 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.403 HG21 HD23 ' A' ' 16' ' ' LEU . 5.7 tp -52.2 -32.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.248 -0.887 . . . . 0.69 111.106 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.99 -27.88 61.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.998 -1.001 . . . . 2.2 111.927 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -107.35 -11.73 15.48 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.881 -0.328 . . . . 1.98 111.665 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.4 tp10 -79.15 -35.21 42.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.349 0.595 . . . . 2.09 110.413 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.418 ' HA ' HD12 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -124.83 171.59 10.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.002 -0.545 . . . . 0.6 110.148 -174.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -122.01 49.41 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.364 0.602 . . . . 2.32 109.997 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -138.77 -169.05 2.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.959 -0.564 . . . . 1.06 109.922 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -83.79 125.63 72.74 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 121.399 0.618 . . . . 0.34 111.931 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -65.25 123.43 11.51 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.435 2.757 . . . . 0.45 111.226 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 77.2 p -132.21 152.85 51.11 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.779 -0.369 . . . . 0.31 111.147 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 38.3 t -103.42 108.81 20.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.019 -0.537 . . . . 1.26 109.683 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 38.6 m -96.04 135.11 38.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.0 0.428 . . . . 0.29 110.603 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.4 tt0 -71.92 -29.55 64.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.418 0.628 . . . . 1.53 109.495 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -153.33 159.37 42.47 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.214 -1.032 . . . . 1.26 108.214 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.587 HG23 ' HD3' ' A' ' 15' ' ' LYS . 1.9 t -138.71 137.51 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.225 0.466 . . . . 1.07 110.509 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 76' ' ' ASP . 32.7 tt0 -104.54 157.43 17.17 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.91 -0.586 . . . . 1.87 110.634 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 78' ' ' GLY . 2.8 t70 67.24 -149.9 0.18 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.076 0.55 . . . . 1.94 109.857 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.03 16.11 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.939 0.876 . . . . 2.12 109.727 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.562 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . 99.22 23.33 11.43 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.557 -0.747 . . . . 0.51 111.558 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 34.1 mt -81.23 -25.68 36.45 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.962 0.41 . . . . 1.1 110.954 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.13 105.36 13.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.61 -0.515 . . . . 0.33 109.61 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.621 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -95.89 143.85 16.91 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.302 -0.951 . . . . 0.26 112.052 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -101.35 117.5 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 109.824 -0.436 . . . . 0.3 109.824 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 85.5 m-20 62.39 48.61 4.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.439 -0.801 . . . . 0.34 110.527 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.621 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 61.2 m -83.7 92.4 7.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.242 -0.89 . . . . 0.81 110.703 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.3 m -79.54 128.41 75.07 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.833 -0.622 . . . . 0.44 110.369 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.76 115.85 3.32 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.557 2.172 . . . . 0.39 110.797 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 8.8 pt -91.55 151.2 42.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.114 -0.494 . . . . 0.57 111.732 -173.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.3 Cg_exo . . . . . 0 N--CA 1.459 -0.519 0 C-N-CA 123.256 2.637 . . . . 1.05 111.823 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.6 m95 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.743 0.306 . . . . 0.81 110.791 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -59.94 106.13 0.46 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.413 -0.812 . . . . 2.73 111.218 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.501 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 17.1 m -113.54 13.5 18.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.761 -0.654 . . . . 1.75 110.687 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -19.45 63.52 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.702 0.63 . . . . 3.24 112.702 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 t -81.7 -9.47 59.64 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.276 -0.57 . . . . 2.05 110.591 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.98 15.6 59.06 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.927 -0.654 . . . . 0.88 112.803 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.417 ' HB2' HG21 ' A' ' 87' ' ' ILE . 12.3 p -78.87 -29.75 44.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.854 0.359 . . . . 1.72 111.453 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 t -128.62 141.68 51.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.976 0.417 . . . . 1.19 110.647 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.432 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.8 p30 -92.62 -24.43 18.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 1.66 111.846 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.432 HG23 ' OD1' ' A' ' 12' ' ' ASN . 26.1 p -97.58 -30.96 12.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.121 0.415 . . . . 0.52 112.121 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.501 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 95.34 -0.14 63.5 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.525 -0.845 . . . . 0.43 111.713 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HD3' HG23 ' A' ' 74' ' ' VAL . 59.6 mttp -92.5 88.48 6.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.73 0.3 . . . . 1.64 110.352 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 69' ' ' THR . 7.8 mp -102.61 99.87 9.9 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.376 -0.375 . . . . 0.55 110.529 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.7 150.98 21.24 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.151 0.501 . . . . 0.29 110.61 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.838 ' SG ' ' HB2' ' A' ' 66' ' ' ASN . 10.4 t -84.22 100.75 11.39 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.335 -0.848 . . . . 0.74 108.72 175.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 59.3 m -125.93 150.41 48.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.177 0.513 . . . . 0.5 111.74 -169.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 9.4 t70 -92.97 130.36 38.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.231 -1.026 . . . . 1.65 108.231 172.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.41 HG21 ' HG3' ' A' ' 86' ' ' PRO . 60.6 p -85.91 -3.9 59.04 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.773 -0.371 . . . . 0.52 111.46 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -106.39 -39.19 5.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.109 0.48 . . . . 2.2 109.747 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 38.8 mtmt -74.32 132.24 41.88 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.889 0.852 . . . . 2.6 110.17 172.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.555 ' HD2' HG22 ' A' ' 47' ' ' ILE . 14.4 mmmm -124.09 156.7 36.13 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.406 -1.27 . . . . 2.17 110.821 -171.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 27' ' ' LYS . 2.2 t -119.88 144.3 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.37 -0.604 . . . . 0.59 109.37 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -81.04 -19.3 44.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.255 0.55 . . . . 2.83 110.474 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.487 ' H ' HG12 ' A' ' 25' ' ' VAL . 2.2 mmmp? -80.14 118.98 22.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.338 -0.846 . . . . 4.07 110.33 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -144.41 113.69 6.98 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.488 -0.56 . . . . 2.46 109.488 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.7 m -152.04 -80.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.434 -0.348 . . . . 2.0 110.494 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' HA2' ' OD1' ' A' ' 73' ' ' ASP . . . 98.27 141.41 12.21 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.82 -0.705 . . . . 1.39 112.289 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.37 -47.19 6.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.761 0.28 . . . . 3.06 111.124 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 C--N 1.326 -0.452 0 N-CA-C 109.578 -0.527 . . . . 2.44 109.578 -179.842 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.595 ' HB3' HG23 ' A' ' 82' ' ' ILE . 30.1 mt-30 . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 121.054 0.454 . . . . 1.4 110.418 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.8 t -84.09 104.2 12.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.684 -0.689 . . . . 1.37 110.491 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -97.32 100.81 12.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.271 -0.877 . . . . 0.3 110.477 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.555 HG22 ' HD2' ' A' ' 24' ' ' LYS . 15.2 pt -106.63 152.66 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.786 -0.643 . . . . 0.23 110.027 176.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.471 ' OE1' HG22 ' A' ' 25' ' ' VAL . 13.3 tp60 -76.73 118.74 19.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.735 0.779 . . . . 2.38 110.114 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 53.7 m -114.02 160.65 18.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.116 -1.402 . . . . 1.15 110.299 -175.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.614 ' O ' ' HB3' ' A' ' 18' ' ' CYS . 15.3 t -162.87 136.86 6.17 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.41 -0.589 . . . . 0.6 109.41 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.466 HE22 HD12 ' A' ' 60' ' ' ILE . 46.3 tp60 -117.81 107.53 14.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.314 0.578 . . . . 2.08 110.856 -175.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.485 HG23 ' HD2' ' A' ' 53' ' ' PRO . 60.2 mt -57.45 139.71 80.41 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.984 -1.007 . . . . 0.95 109.99 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 52' ' ' ILE . 50.2 Cg_exo -34.72 118.94 0.13 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 124.274 3.316 . . . . 0.95 113.156 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.56 136.55 53.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.435 -0.802 . . . . 1.67 113.005 -169.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.32 109.18 20.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.68 -1.229 . . . . 1.58 107.68 167.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 56' ' ' ILE . 15.8 mt -55.92 126.42 13.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.244 0.545 . . . . 2.11 111.438 -170.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.64 -4.62 58.09 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.278 -0.874 . . . . 1.03 113.086 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -98.37 151.16 4.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.718 0.771 . . . . 0.77 112.012 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.49 145.14 25.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.45 -1.25 . . . . 0.68 111.79 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.466 HD12 HE22 ' A' ' 51' ' ' GLN . 6.1 tp -40.79 -46.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.621 0.768 . . . . 0.69 113.026 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.433 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -70.92 -23.14 62.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.813 0.671 . . . . 2.2 112.813 -169.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -106.67 -7.49 17.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.424 0.631 . . . . 1.98 109.877 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -74.34 -39.11 63.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.586 -0.734 . . . . 2.09 109.77 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.3 p -132.38 162.88 29.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.475 -0.784 . . . . 0.6 110.431 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -108.39 33.8 3.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.862 0.319 . . . . 2.32 111.862 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.838 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m-80 -115.21 -163.17 0.86 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.827 -0.805 . . . . 1.06 108.827 173.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 m -86.82 131.4 45.3 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 121.222 0.534 . . . . 0.34 111.068 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 44.7 Cg_endo -79.56 126.84 6.94 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.848 2.365 . . . . 0.45 110.356 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 71.3 p -131.26 145.57 51.95 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.393 -0.523 . . . . 0.31 111.631 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.2 t -94.99 111.67 23.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.406 -0.591 . . . . 1.26 109.406 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 38.0 m -96.8 144.03 27.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.251 0.548 . . . . 0.29 110.847 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.8 tt0 -82.14 -21.82 36.45 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.436 -0.802 . . . . 1.53 109.299 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 14.5 t70 -161.69 153.36 18.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.991 -1.114 . . . . 1.26 107.991 173.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.48 HG12 ' HA2' ' A' ' 78' ' ' GLY . 2.0 t -135.35 128.69 48.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.459 -0.497 . . . . 1.07 109.853 173.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -94.4 169.48 10.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.762 -0.654 . . . . 1.87 110.841 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 56.53 -148.86 0.48 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.028 -0.987 . . . . 1.94 111.296 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -80.51 23.09 0.53 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.698 0.761 . . . . 2.12 110.127 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . 92.08 23.28 27.81 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.903 -0.665 . . . . 0.51 112.235 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -91.06 -19.11 23.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.381 . . . . 1.1 111.126 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 25' ' ' VAL . 60.7 t -126.09 101.34 7.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.294 -0.412 . . . . 0.33 109.954 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.702 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -95.25 144.68 17.35 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.485 -0.864 . . . . 0.26 112.494 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.595 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -102.64 118.78 50.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.929 -0.397 . . . . 0.3 109.929 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 73.6 m-20 62.23 35.03 15.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.59 -0.732 . . . . 0.34 110.913 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.702 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 61.1 m -74.47 95.83 2.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.614 -0.721 . . . . 0.81 110.847 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.9 m -89.74 128.38 50.65 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 121.232 0.539 . . . . 0.44 110.219 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 64.2 Cg_endo -70.16 133.6 25.21 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.296 2.664 . . . . 0.39 112.645 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.417 HG21 ' HB2' ' A' ' 10' ' ' SER . 4.7 pt -107.25 153.35 41.17 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.073 -0.967 . . . . 0.57 111.311 -174.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.461 -0.424 0 C-N-CA 123.202 2.601 . . . . 1.05 111.476 172.698 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.556 ' CD2' ' HB ' ' A' ' 60' ' ' ILE . 92.3 m95 . . . . . 0 C--O 1.235 0.32 0 CA-C-O 120.436 0.16 . . . . 0.81 110.795 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.464 ' OE2' ' HA ' ' A' ' 59' ' ' ALA . 2.7 mp0 -59.47 106.82 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.274 0.559 . . . . 2.73 111.173 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.492 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 42.5 m -112.61 2.46 16.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.575 -0.739 . . . . 1.75 110.741 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -16.01 62.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.979 -0.555 . . . . 3.24 111.776 -175.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.64 4.96 38.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.909 0.385 . . . . 2.05 110.894 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.05 16.16 80.99 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.224 -1.151 . . . . 0.88 110.224 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 6' ' ' SER . 2.3 p -71.71 -30.05 65.23 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.388 -0.906 . . . . 1.72 111.861 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 6' ' ' SER . 7.4 t -155.79 143.71 19.77 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.764 -0.374 . . . . 1.19 110.936 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -91.79 -30.7 16.08 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.236 0.541 . . . . 1.66 110.186 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.1 p -92.25 -15.55 27.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.554 -0.748 . . . . 0.52 111.137 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 86.51 -8.36 75.2 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.923 -0.656 . . . . 0.43 112.493 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -87.99 89.12 7.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.988 0.423 . . . . 1.64 111.015 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 4' ' ' TRP . 8.9 mp -90.11 141.93 28.21 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.304 -0.628 . . . . 0.55 109.304 172.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.85 145.74 36.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.963 0.411 . . . . 0.29 110.678 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 50' ' ' THR . 32.9 m -79.9 101.79 8.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.634 -0.876 . . . . 0.74 108.634 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.8 m -124.56 146.79 48.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.942 0.401 . . . . 0.5 111.344 -170.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -94.62 117.57 30.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.989 -0.745 . . . . 1.65 108.989 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 54.0 p -79.44 -0.38 32.76 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.198 0.523 . . . . 0.52 110.714 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -104.26 -17.75 14.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.659 -0.701 . . . . 2.2 109.477 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -119.63 137.74 53.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.437 -0.801 . . . . 2.6 110.437 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -140.23 162.75 34.52 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.731 0.641 . . . . 2.17 112.731 -170.341 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.545 HG11 HG22 ' A' ' 80' ' ' VAL . 1.6 t -111.74 150.67 13.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.014 -0.994 . . . . 0.59 110.553 -173.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -76.01 -4.38 40.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.953 -0.567 . . . . 2.83 112.128 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -104.86 119.59 39.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.643 0.259 . . . . 4.07 110.842 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.4 m -102.28 8.71 40.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.016 0.436 . . . . 2.46 110.367 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.9 p -87.59 164.77 15.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.829 -0.623 . . . . 2.0 111.174 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.53 -174.62 23.24 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.156 -0.778 . . . . 1.39 111.156 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -100.64 -24.15 14.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.203 0.501 . . . . 3.06 111.62 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.028 0.442 . . . . 2.44 111.202 -177.944 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.581 ' HB3' HG23 ' A' ' 82' ' ' ILE . 77.4 mt-30 . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.866 0.365 . . . . 1.4 110.524 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 83' ' ' ASN . 8.2 p -103.26 118.47 50.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.205 0.526 . . . . 1.37 110.62 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.66 100.0 9.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.46 -0.791 . . . . 0.3 111.172 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 10.7 pt -106.11 155.43 7.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.064 -0.516 . . . . 0.23 110.255 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.45 ' OE1' HG22 ' A' ' 25' ' ' VAL . 10.5 tp60 -77.3 126.04 30.29 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.463 0.649 . . . . 2.38 110.087 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 45.3 m -124.29 163.02 22.53 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.763 -1.108 . . . . 1.15 110.352 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 10.0 t -160.08 142.73 13.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.831 -0.433 . . . . 0.6 109.831 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -120.54 117.96 28.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.142 0.496 . . . . 2.08 110.348 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.407 HG23 ' HD2' ' A' ' 53' ' ' PRO . 56.4 mt -85.23 137.29 37.17 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.371 -0.831 . . . . 0.95 109.539 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HD2' HG23 ' A' ' 52' ' ' ILE . 10.6 Cg_exo -32.68 117.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 124.989 3.792 . . . . 0.95 113.807 -172.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 pp -101.88 142.63 32.89 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.897 -1.047 . . . . 1.67 112.356 -169.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 74.9 mt -92.51 132.83 36.49 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.776 -0.824 . . . . 1.58 108.776 166.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 mt -64.05 135.17 28.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.005 0.431 . . . . 2.11 110.471 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.96 12.16 60.69 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.757 -0.656 . . . . 1.03 112.245 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -109.24 147.88 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.641 0.734 . . . . 0.77 111.855 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HA ' ' OE2' ' A' ' 5' ' ' GLU . . . -73.42 128.18 34.77 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.187 -1.37 . . . . 0.68 110.056 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.556 ' HB ' ' CD2' ' A' ' 4' ' ' TRP . 16.3 tt -57.22 -33.04 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.69 111.931 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -9.96 59.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.385 0.612 . . . . 2.2 110.266 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.06 -35.41 10.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.37 -0.832 . . . . 1.98 109.038 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.5 tp10 -68.6 -39.48 80.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.537 -1.211 . . . . 2.09 110.587 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.0 p -119.6 147.03 44.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.341 -0.391 . . . . 0.6 110.198 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -99.36 48.35 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.144 0.497 . . . . 2.32 110.814 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 47.8 m-80 -128.12 -172.7 2.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.882 -0.599 . . . . 1.06 109.502 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.9 m -83.07 127.97 67.08 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-O 121.145 0.498 . . . . 0.34 110.831 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.01 131.7 7.04 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.925 2.417 . . . . 0.45 111.281 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 81.0 p -133.37 153.44 51.59 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.432 -0.349 . . . . 0.31 110.861 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 15.8 t -99.63 111.22 23.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.804 -0.443 . . . . 1.26 109.804 173.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.6 m -100.97 138.02 38.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.252 0.549 . . . . 0.29 110.768 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.0 tt0 -78.05 -27.41 48.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.633 -0.712 . . . . 1.53 109.859 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -154.36 151.76 29.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.514 -0.921 . . . . 1.26 108.514 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.535 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.5 t -140.47 132.42 31.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.869 -0.419 . . . . 1.07 109.869 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.77 160.7 14.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.478 -0.328 . . . . 1.87 110.21 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.446 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 9.7 m-20 59.8 -154.02 0.37 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.724 0.41 . . . . 1.94 110.238 -174.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' H ' ' HB3' ' A' ' 76' ' ' ASP . 14.8 m-20 -79.35 23.99 0.37 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.015 0.436 . . . . 2.12 110.721 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.535 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 102.66 22.62 9.39 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.989 -0.624 . . . . 0.51 112.637 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 2.6 mm? -78.38 -27.78 46.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 1.1 111.264 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.545 HG22 HG11 ' A' ' 25' ' ' VAL . 32.6 t -125.05 107.71 18.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.334 -0.394 . . . . 0.33 110.719 -174.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -100.93 139.03 14.19 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.104 -1.045 . . . . 0.26 112.195 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.581 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -104.82 123.6 58.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 122.54 0.336 . . . . 0.3 110.143 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.718 ' HA ' HG12 ' A' ' 45' ' ' VAL . 79.6 m-20 62.63 42.69 8.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.89 -0.595 . . . . 0.34 110.714 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.537 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 59.6 m -83.12 96.64 8.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.372 -0.831 . . . . 0.81 111.054 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 26.5 m -79.12 125.01 84.36 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.236 -0.438 . . . . 0.44 110.543 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 21.9 Cg_exo -67.03 128.05 17.95 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.029 2.486 . . . . 0.39 111.962 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.477 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.1 pt -107.3 143.09 26.48 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 116.279 -0.419 . . . . 0.57 110.928 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.6 Cg_exo . . . . . 0 N--CA 1.462 -0.378 0 C-N-CA 123.336 2.69 . . . . 1.05 112.355 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 93.4 m95 . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 110.374 -0.232 . . . . 0.81 110.374 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -64.74 108.95 1.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.027 0.441 . . . . 2.73 110.399 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.7 m -96.29 27.18 3.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.465 0.65 . . . . 1.75 109.643 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -5.01 48.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.354 -0.839 . . . . 3.24 111.585 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -67.59 -30.6 70.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.085 0.469 . . . . 2.05 111.357 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.42 16.62 58.54 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.801 -0.714 . . . . 0.88 112.421 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 m -102.34 -17.02 16.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.855 0.317 . . . . 1.72 111.855 -175.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.772 ' SG ' HG21 ' A' ' 87' ' ' ILE . 3.9 m -131.1 141.55 50.16 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.851 -0.34 . . . . 1.19 111.479 -171.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -94.61 -28.3 15.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 1.66 112.186 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.8 p -86.92 -31.14 20.86 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.476 0.547 . . . . 0.52 112.476 -171.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.15 5.64 82.74 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.509 -0.853 . . . . 0.43 112.679 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HD3' HG23 ' A' ' 74' ' ' VAL . 59.4 mttp -94.38 88.27 5.47 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.065 -0.346 . . . . 1.64 110.065 176.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.688 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 7.9 mp -94.18 123.59 37.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.915 0.388 . . . . 0.55 110.299 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.18 142.62 37.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.835 -0.431 . . . . 0.29 109.835 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 80.1 m -80.93 118.46 22.44 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.278 -0.638 . . . . 0.74 109.278 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.712 ' SG ' HG13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -127.72 163.08 25.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.006 0.432 . . . . 0.5 111.152 -173.459 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -106.15 105.76 15.96 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.372 -0.973 . . . . 1.65 108.372 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.2 p -75.87 2.54 12.13 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.561 -0.745 . . . . 0.52 111.095 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -104.86 -3.41 23.48 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.054 -0.721 . . . . 2.2 109.054 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -113.3 102.46 10.37 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.361 -0.836 . . . . 2.6 110.562 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.456 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 3.7 mppt? -96.55 159.97 14.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.538 -0.756 . . . . 2.17 110.797 -175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 27' ' ' LYS . 19.3 t -119.61 149.7 22.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.946 -0.761 . . . . 0.59 108.946 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -84.45 -11.64 55.81 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.121 0.415 . . . . 2.83 112.121 -172.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' H ' HG12 ' A' ' 25' ' ' VAL . 14.3 mmmm -120.41 130.41 54.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.684 0.278 . . . . 4.07 110.546 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.7 m -101.45 32.68 3.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.104 -0.498 . . . . 2.46 111.207 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.9 p -86.1 150.09 24.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.263 -0.426 . . . . 2.0 110.233 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.472 ' HA3' ' OD1' ' A' ' 73' ' ' ASP . . . -150.79 -173.95 21.34 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.772 -0.728 . . . . 1.39 112.125 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -91.05 -50.65 5.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.547 0.173 . . . . 3.06 111.404 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 112.193 0.442 . . . . 2.44 112.193 -175.534 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.602 ' HB3' HG23 ' A' ' 82' ' ' ILE . 17.5 mt-30 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 121.048 0.451 . . . . 1.4 111.283 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.56 115.41 43.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.72 -0.673 . . . . 1.37 110.421 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -100.21 118.42 36.49 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.521 -0.763 . . . . 0.3 110.925 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.712 HG13 ' SG ' ' A' ' 19' ' ' CYS . 12.5 pt -116.29 153.39 17.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.049 -0.523 . . . . 0.23 110.015 173.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.54 108.47 16.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.811 0.815 . . . . 2.38 110.076 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 62.7 m -89.5 165.6 14.2 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.128 -1.396 . . . . 1.15 110.573 -175.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.0 t -159.94 117.06 2.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.953 0.883 . . . . 0.6 110.715 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -120.0 131.78 55.26 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.964 -1.016 . . . . 2.08 110.677 -174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 64' ' ' CYS . 46.1 mt -70.41 133.9 86.99 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.979 -0.749 . . . . 0.95 108.979 171.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.11 107.04 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.07 3.18 . . . . 0.95 112.68 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.9 140.51 57.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.209 -0.905 . . . . 1.67 112.865 -169.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.53 152.74 21.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.86 -1.063 . . . . 1.58 108.767 168.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.0 mt -70.66 124.34 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.115 0.483 . . . . 2.11 110.631 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.15 17.18 72.57 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.474 -0.785 . . . . 1.03 112.952 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.412 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -97.0 149.13 5.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.713 0.768 . . . . 0.77 111.563 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.15 144.67 36.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.29 -1.323 . . . . 0.68 111.358 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.444 HG23 ' HG3' ' A' ' 61' ' ' GLU . 7.1 tp -53.38 -43.49 51.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.602 -0.726 . . . . 0.69 111.478 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.444 ' HG3' HG23 ' A' ' 60' ' ' ILE . 45.6 mt-10 -71.34 -41.65 69.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.7 -0.682 . . . . 2.2 111.489 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -79.44 -8.37 59.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.051 -0.522 . . . . 1.98 111.036 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.412 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.7 tp10 -92.21 -41.16 10.58 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.288 -0.415 . . . . 2.09 110.793 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.522 ' HA ' HD12 ' A' ' 52' ' ' ILE . 1.7 p -113.9 173.13 6.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.6 111.185 -172.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -125.02 49.91 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.296 0.57 . . . . 2.32 109.563 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 57.7 m-80 -143.24 -170.3 3.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.836 -0.62 . . . . 1.06 110.43 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 10.4 m -79.62 130.76 66.74 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.888 0.375 . . . . 0.34 111.142 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -79.03 120.13 4.51 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.719 2.279 . . . . 0.45 111.264 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 86' ' ' PRO . 68.1 p -129.38 148.5 51.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.199 -0.455 . . . . 0.31 109.874 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.688 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 72.9 m -113.59 111.51 21.99 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.458 0.647 . . . . 1.26 110.128 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.9 m -86.56 152.59 22.49 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.962 -1.017 . . . . 0.29 111.036 -172.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 7.3 tt0 -91.53 -22.28 20.44 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.255 -0.884 . . . . 1.53 109.628 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.472 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 33.9 t0 -158.99 161.33 36.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.739 -1.208 . . . . 1.26 107.739 170.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.563 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -139.21 149.37 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 118.362 0.528 . . . . 1.07 110.793 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 8.2 tp10 -111.36 160.2 17.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.439 -0.8 . . . . 1.87 109.764 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 60.49 -151.93 0.4 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.255 -0.43 . . . . 1.94 109.936 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.86 10.33 2.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.001 0.429 . . . . 2.12 110.301 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 113.27 24.03 4.94 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.895 -0.669 . . . . 0.51 112.487 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.48 -21.93 25.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 1.1 111.432 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 88.4 t -127.04 113.05 30.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.277 -0.638 . . . . 0.33 109.277 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.687 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -108.0 142.76 15.97 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.697 -1.24 . . . . 0.26 112.869 -173.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.602 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -95.75 118.17 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 109.69 -0.485 . . . . 0.3 109.69 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 93.8 m-20 60.21 42.93 14.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.279 -0.873 . . . . 0.34 110.804 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.687 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.8 m -78.0 87.71 4.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.669 -0.696 . . . . 0.81 109.919 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.2 m -83.07 134.22 46.69 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.377 -0.829 . . . . 0.44 110.256 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HA ' HG22 ' A' ' 69' ' ' THR . 13.9 Cg_endo -70.49 118.56 5.76 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.97 2.446 . . . . 0.39 111.59 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.772 HG21 ' SG ' ' A' ' 11' ' ' CYS . 5.5 pt -88.13 140.58 30.72 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.355 -0.839 . . . . 0.57 111.671 -173.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.1 Cg_exo . . . . . 0 N--CA 1.455 -0.772 0 C-N-CA 123.374 2.716 . . . . 1.05 111.707 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 83.9 m95 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.81 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -85.11 109.54 18.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.732 -0.667 . . . . 2.73 110.45 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 m -80.42 27.45 0.34 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.864 -0.607 . . . . 1.75 111.021 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -53.88 -22.68 10.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.747 -0.66 . . . . 3.24 112.12 -177.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.424 ' N ' ' HD2' ' A' ' 7' ' ' LYS . 6.9 t -73.39 -13.08 61.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.274 -0.421 . . . . 2.05 111.232 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.06 17.42 75.63 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.906 -0.664 . . . . 0.88 112.452 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -102.63 -9.86 19.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.89 0.33 . . . . 1.72 111.89 -172.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.708 ' SG ' HG21 ' A' ' 87' ' ' ILE . 2.7 m -139.65 140.32 36.89 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.267 -0.573 . . . . 1.19 111.456 -171.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -95.33 -30.6 13.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 1.66 111.867 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.7 p -80.53 -29.94 37.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.663 0.616 . . . . 0.52 112.663 -169.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.55 -4.27 85.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.503 -0.856 . . . . 0.43 112.304 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HD3' HG23 ' A' ' 74' ' ' VAL . 63.2 mttp -90.69 87.86 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.425 . . . . 1.64 109.99 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.813 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 8.1 mp -96.13 139.55 32.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.698 -0.683 . . . . 0.55 109.708 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.616 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -148.39 144.71 27.67 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.894 0.378 . . . . 0.29 110.389 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 86.1 m -89.9 99.54 12.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.131 0.491 . . . . 0.74 109.698 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 83.7 m -114.41 164.69 13.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.546 . . . . 0.5 112.028 -165.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -102.15 108.34 19.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.842 -0.617 . . . . 1.65 109.516 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -77.8 0.62 23.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.298 -0.41 . . . . 0.52 111.19 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -101.13 -7.3 23.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.172 -0.677 . . . . 2.2 109.172 175.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 35.6 mtpt -113.3 107.21 15.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.262 -0.881 . . . . 2.6 110.328 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -100.34 154.8 18.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.827 -0.624 . . . . 2.17 110.789 -174.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.449 HG22 ' CD ' ' A' ' 48' ' ' GLN . 11.1 t -120.78 150.3 23.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.608 -0.724 . . . . 0.59 109.782 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.08 32.89 0.27 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.974 -0.557 . . . . 2.83 111.684 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 31.12 115.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.718 1.607 . . . . 4.07 114.752 174.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -123.92 -76.83 0.59 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.477 -0.783 . . . . 2.46 111.162 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 p -142.28 -169.71 3.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.325 -0.852 . . . . 2.0 111.211 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.1 -161.04 21.95 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.232 -1.147 . . . . 1.39 110.232 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -99.57 -46.34 5.49 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.709 0.755 . . . . 3.06 110.71 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.101 0.477 . . . . 2.44 110.844 -179.144 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' A' ' 82' ' ' ILE . 23.7 mt-30 . . . . . 0 C--O 1.235 0.301 0 CA-C-O 121.308 0.575 . . . . 1.4 111.406 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.85 109.19 27.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.14 -0.936 . . . . 1.37 109.745 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -102.28 122.57 44.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.675 -0.693 . . . . 0.3 110.494 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' A' ' 84' ' ' CYS . 14.2 pt -128.66 153.83 38.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.993 -0.549 . . . . 0.23 110.641 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.449 ' CD ' HG22 ' A' ' 25' ' ' VAL . 2.5 mp0 -70.29 141.62 52.35 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.832 -0.622 . . . . 2.38 109.503 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.651 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 2.1 t -137.78 164.53 28.67 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.073 -0.512 . . . . 1.15 110.491 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.0 t -160.81 128.03 4.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.524 0.678 . . . . 0.6 110.652 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -121.06 125.94 48.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.674 -0.694 . . . . 2.08 110.976 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 64' ' ' CYS . 16.7 mt -63.88 139.25 97.61 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.385 -0.825 . . . . 0.95 109.836 174.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 52' ' ' ILE . 60.0 Cg_exo -34.25 121.13 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 124.788 3.659 . . . . 0.95 113.929 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.8 mt -65.48 119.71 11.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.038 -0.983 . . . . 1.67 112.261 -171.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.446 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 84.5 mt -99.73 122.89 43.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.989 -0.745 . . . . 1.58 108.989 166.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.669 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -72.87 130.18 35.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.073 0.463 . . . . 2.11 110.2 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.05 2.97 60.64 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.932 -0.651 . . . . 1.03 111.832 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -103.15 153.98 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.799 0.809 . . . . 0.77 111.732 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.18 130.52 36.31 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.306 -1.316 . . . . 0.68 109.815 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 61' ' ' GLU . 10.7 tt -50.77 -37.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.238 -0.892 . . . . 0.69 112.035 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.447 ' N ' HG23 ' A' ' 60' ' ' ILE . 6.6 mt-10 -62.61 -35.23 78.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.087 -0.96 . . . . 2.2 111.04 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.85 -22.21 19.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.904 -0.589 . . . . 1.98 109.999 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.82 -41.16 78.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.751 . . . . 2.09 110.954 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.57 ' HA ' HD12 ' A' ' 52' ' ' ILE . 4.7 p -114.65 167.85 10.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.997 0.427 . . . . 0.6 111.308 -173.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -121.94 41.42 3.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 2.32 110.284 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.553 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 57.1 m-80 -131.52 -169.87 2.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.481 -0.781 . . . . 1.06 109.666 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 11.2 m -83.17 127.1 70.36 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-O 120.933 0.397 . . . . 0.34 110.877 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.23 119.77 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.735 2.29 . . . . 0.45 111.294 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.427 ' OG1' ' HB3' ' A' ' 84' ' ' CYS . 44.2 p -128.37 151.16 49.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.318 -0.401 . . . . 0.31 109.93 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.813 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 72.0 m -113.68 119.32 37.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.268 0.556 . . . . 1.26 110.16 175.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.2 m -97.57 149.37 22.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.064 -0.971 . . . . 0.29 111.298 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 9.3 mt-10 -85.06 -16.65 39.96 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.585 -1.188 . . . . 1.53 109.728 175.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 47.3 t0 -167.79 156.11 9.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.921 -1.036 . . . . 1.26 108.298 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.566 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -143.5 135.92 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 117.929 0.331 . . . . 1.07 110.566 178.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 10.6 tp10 -98.18 157.54 16.09 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.156 -0.475 . . . . 1.87 110.01 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 61.31 -151.81 0.38 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.107 0.563 . . . . 1.94 109.93 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -82.38 21.91 0.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.112 0.482 . . . . 2.12 110.383 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.651 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 106.64 22.72 7.55 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.814 -0.708 . . . . 0.51 112.874 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.5 mm? -80.1 -26.67 39.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.784 0.292 . . . . 1.1 111.475 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 94.5 t -130.56 112.62 23.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.939 -0.393 . . . . 0.33 109.939 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.659 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -107.21 143.62 15.87 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.136 -1.03 . . . . 0.26 112.651 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -101.89 120.62 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.327 -0.619 . . . . 0.3 109.327 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 98.8 m-20 62.06 48.01 5.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.671 -0.695 . . . . 0.34 110.598 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.659 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 56.8 m -85.59 93.71 8.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.58 -0.736 . . . . 0.81 110.228 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.2 m -82.09 127.81 70.34 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.994 -0.548 . . . . 0.44 110.311 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.99 113.86 2.37 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.794 2.329 . . . . 0.39 111.579 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.708 HG21 ' SG ' ' A' ' 11' ' ' CYS . 9.1 pt -89.64 146.74 36.24 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.724 -0.671 . . . . 0.57 111.156 -175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 14.9 Cg_exo . . . . . 0 N--CA 1.46 -0.454 0 C-N-CA 123.225 2.617 . . . . 1.05 112.24 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 90.2 m95 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.128 0.49 . . . . 0.81 111.235 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.605 ' OE1' ' HA ' ' A' ' 59' ' ' ALA . 24.7 mp0 -70.91 107.38 4.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.384 -0.826 . . . . 2.73 111.072 -176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 t -111.72 26.14 10.93 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.016 -0.735 . . . . 1.75 109.016 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -55.04 -33.9 63.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.934 -1.03 . . . . 3.24 111.541 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.7 t -85.04 3.81 36.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.811 0.339 . . . . 2.05 111.461 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.3 18.44 69.05 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.389 -0.91 . . . . 0.88 112.558 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.0 p -70.27 -32.05 69.7 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.759 0.651 . . . . 1.72 112.759 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.2 t -129.74 144.1 51.13 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.099 0.476 . . . . 1.19 111.365 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.409 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.2 p30 -91.21 -24.91 19.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.961 -0.563 . . . . 1.66 111.341 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.409 HG23 ' OD1' ' A' ' 12' ' ' ASN . 56.3 p -98.21 -30.56 12.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.076 0.465 . . . . 0.52 111.349 -177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.21 0.06 59.97 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.832 -0.699 . . . . 0.43 111.396 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -91.61 88.46 6.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.752 0.31 . . . . 1.64 110.401 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 69' ' ' THR . 8.1 mp -96.83 151.4 19.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.694 -0.484 . . . . 0.55 109.694 175.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -160.26 144.66 14.4 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.744 0.307 . . . . 0.29 110.85 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 1.2 m -80.13 97.63 6.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.854 -0.612 . . . . 0.74 109.923 173.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 84.1 m -113.13 160.59 18.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.114 -0.494 . . . . 0.5 110.82 -172.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.01 116.25 31.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.705 -0.48 . . . . 1.65 109.705 173.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.5 p -76.44 -8.66 57.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.089 0.471 . . . . 0.52 111.227 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -93.85 -15.97 24.53 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.021 0.915 . . . . 2.2 108.727 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -102.5 110.33 22.23 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.008 -1.451 . . . . 2.6 110.707 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.4 OUTLIER -103.08 163.75 12.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.281 -0.418 . . . . 2.17 110.992 -178.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.515 HG22 ' OE1' ' A' ' 48' ' ' GLN . 23.5 t -116.04 150.05 18.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.002 -0.74 . . . . 0.59 109.002 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -83.68 -17.0 42.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.39 0.515 . . . . 2.83 112.39 -171.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' H ' HG12 ' A' ' 25' ' ' VAL . 32.6 mtmm -114.02 156.76 23.51 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.277 -0.268 . . . . 4.07 110.277 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 p -121.42 12.68 10.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.79 0.329 . . . . 2.46 111.405 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 p -72.97 142.75 47.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.34 . . . . 2.0 110.84 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.25 165.23 25.24 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.583 -0.818 . . . . 1.39 112.803 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -81.76 -46.21 14.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.741 0.305 . . . . 3.06 111.44 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 . . . . . 0 C--N 1.324 -0.525 0 CA-C-N 116.386 -0.37 . . . . 2.44 111.307 -177.75 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.569 ' HB3' HG23 ' A' ' 82' ' ' ILE . 35.3 mt-30 . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.948 0.404 . . . . 1.4 110.839 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.27 116.54 49.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.275 -0.42 . . . . 1.37 110.112 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -105.62 117.48 34.13 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.833 -0.621 . . . . 0.3 111.138 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 13.8 pt -106.38 150.21 9.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.074 -0.512 . . . . 0.23 110.241 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.515 ' OE1' HG22 ' A' ' 25' ' ' VAL . 13.9 tp60 -76.63 116.0 16.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.599 -0.728 . . . . 2.38 109.342 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.7 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 2.2 t -110.1 169.43 8.74 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.283 -0.872 . . . . 1.15 110.235 -172.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.0 t -160.19 128.06 4.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.646 0.736 . . . . 0.6 110.808 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -120.88 114.1 21.08 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.518 -0.764 . . . . 2.08 111.059 -176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.72 133.22 72.27 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.395 -0.821 . . . . 0.95 109.46 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -38.45 102.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 124.578 3.519 . . . . 0.95 113.01 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.44 135.19 51.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.408 -0.815 . . . . 1.67 112.308 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.02 135.0 35.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.167 -0.924 . . . . 1.58 109.372 171.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.4 mt -66.6 129.63 31.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.23 0.538 . . . . 2.11 110.305 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.26 -15.66 58.8 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.224 -0.898 . . . . 1.03 111.832 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -89.7 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.586 0.708 . . . . 0.77 111.649 -177.134 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.605 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . . . -89.8 146.46 24.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.461 -1.245 . . . . 0.68 111.475 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 61' ' ' GLU . 5.0 tp -49.89 -44.05 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.621 -0.718 . . . . 0.69 110.724 173.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 60' ' ' ILE . 6.4 mm-40 -68.91 -16.84 63.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.431 -0.804 . . . . 2.2 111.986 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -110.46 -10.87 14.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.318 -0.401 . . . . 1.98 111.3 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.4 tp10 -93.62 -38.78 11.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.183 0.516 . . . . 2.09 110.595 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.2 p -131.38 146.92 52.49 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.913 -0.585 . . . . 0.6 110.208 -173.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -121.93 64.56 0.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.68 0.752 . . . . 2.32 111.064 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 36.5 m-80 -123.23 -155.43 0.65 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.231 -1.396 . . . . 1.06 107.231 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -86.05 121.17 72.9 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 119.418 -0.913 . . . . 0.34 110.048 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.11 130.25 9.23 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.646 2.231 . . . . 0.45 110.671 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 84' ' ' CYS . 81.1 p -131.65 155.11 48.15 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.415 -0.357 . . . . 0.31 111.374 -175.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.2 t -103.27 110.48 22.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.684 -0.858 . . . . 1.26 108.684 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.7 m -94.84 145.28 25.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.403 0.621 . . . . 0.29 110.666 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 2.6 tt0 -79.57 -18.63 51.29 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.325 -0.852 . . . . 1.53 109.235 176.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -170.13 156.3 5.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.135 -0.939 . . . . 1.26 109.178 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.542 HG12 ' HA2' ' A' ' 78' ' ' GLY . 1.4 t -143.07 134.62 23.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.331 -0.248 . . . . 1.07 110.331 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 41.4 tt0 -104.17 158.8 16.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.47 -0.332 . . . . 1.87 110.693 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 4.4 t70 66.58 -148.19 0.19 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.183 0.593 . . . . 1.94 109.672 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.85 11.83 2.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.011 0.434 . . . . 2.12 110.442 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.7 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 108.7 23.94 6.32 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.916 -0.659 . . . . 0.51 112.155 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 mt -82.93 -23.6 33.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.819 0.342 . . . . 1.1 111.197 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 60.9 t -122.79 106.37 17.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.688 -0.486 . . . . 0.33 109.688 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -106.56 133.83 11.84 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.325 -0.94 . . . . 0.26 111.954 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.569 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -96.74 121.12 46.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 110.127 -0.323 . . . . 0.3 110.127 -177.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 82.7 m-20 60.62 35.32 19.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.553 -0.748 . . . . 0.34 111.124 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.615 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 67.3 m -69.82 95.33 0.89 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.607 -0.724 . . . . 0.81 110.702 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 30.7 m -87.56 126.89 60.47 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.951 -0.568 . . . . 0.44 110.009 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 36.2 Cg_exo -59.13 128.96 29.57 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.979 2.452 . . . . 0.39 112.321 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 pt -100.94 147.87 34.29 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.044 -0.526 . . . . 0.57 110.799 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 C--O 1.235 0.338 0 C-N-CA 123.009 2.473 . . . . 1.05 112.086 179.155 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.319 0.58 . . . . 0.81 112.023 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -65.27 113.84 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.936 -1.029 . . . . 2.73 110.911 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 m -88.5 26.82 1.38 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.9 -0.591 . . . . 1.75 110.445 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -53.74 -52.52 59.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.489 -0.778 . . . . 3.24 112.502 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -69.53 -24.46 63.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.2 -0.455 . . . . 2.05 111.846 -172.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.03 16.01 79.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.906 -0.664 . . . . 0.88 111.742 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.472 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 5.4 p -74.45 -30.51 61.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.301 0.482 . . . . 1.72 112.301 -173.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.6 t -105.2 142.29 35.24 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.004 0.431 . . . . 1.19 111.181 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.553 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.7 p30 -92.18 -27.35 17.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 1.66 111.784 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.553 HG23 ' OD1' ' A' ' 12' ' ' ASN . 11.0 p -100.34 -30.81 11.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.873 0.368 . . . . 0.52 111.973 -175.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.03 -6.36 53.93 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.528 -0.844 . . . . 0.43 112.26 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HD3' HG13 ' A' ' 74' ' ' VAL . 89.2 mttt -88.35 88.73 7.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 1.64 110.48 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 60' ' ' ILE . 9.5 mp -92.99 127.01 38.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.454 -0.794 . . . . 0.55 110.171 176.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.534 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -142.53 153.09 43.28 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.786 0.327 . . . . 0.29 110.383 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 60.4 m -89.57 97.67 11.33 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.184 -0.672 . . . . 0.74 109.184 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 71.4 m -113.51 153.46 28.69 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.314 -0.403 . . . . 0.5 111.19 -169.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.65 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 8.0 t70 -92.51 119.35 31.9 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.077 -0.712 . . . . 1.65 109.077 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.8 p -80.41 -7.78 59.26 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.775 0.322 . . . . 0.52 111.706 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -104.59 -15.94 15.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 2.2 110.127 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.65 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 36.6 mtmt -103.35 129.04 50.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.709 -0.678 . . . . 2.6 110.779 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -116.55 162.35 17.74 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.912 -1.04 . . . . 2.17 111.243 -175.085 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 27' ' ' LYS . 13.0 t -113.32 149.97 15.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.847 -0.615 . . . . 0.59 109.798 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -84.51 5.25 28.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.003 -0.544 . . . . 2.83 111.288 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' H ' HG12 ' A' ' 25' ' ' VAL . 29.9 mmmt -132.24 119.72 21.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.439 -0.346 . . . . 4.07 110.215 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -126.28 80.27 1.91 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.251 -0.431 . . . . 2.46 110.218 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.8 m -118.26 -54.91 2.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.035 0.445 . . . . 2.0 111.317 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.89 155.24 31.62 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.543 -0.753 . . . . 1.39 111.787 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -101.18 -50.37 3.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.05 0.452 . . . . 3.06 110.189 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.444 -0.727 0 CA-C-N 115.759 -0.655 . . . . 2.44 109.895 -176.253 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.661 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.7 mt-30 . . . . . 0 CA--C 1.517 -0.294 0 CA-C-O 121.028 0.442 . . . . 1.4 110.358 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 83' ' ' ASN . 7.2 p -95.14 105.51 17.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.693 0.758 . . . . 1.37 110.825 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -96.59 101.73 13.39 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.154 -0.93 . . . . 0.3 110.25 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 84' ' ' CYS . 17.5 pt -104.13 150.0 7.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.935 -0.575 . . . . 0.23 110.311 177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -74.77 126.6 31.26 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.057 -0.72 . . . . 2.38 109.057 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.534 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 1.8 t -117.0 160.72 20.51 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.342 -0.845 . . . . 1.15 110.522 -171.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 2.5 t -150.53 121.39 7.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.335 0.588 . . . . 0.6 110.427 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.4 HE21 HD12 ' A' ' 60' ' ' ILE . 5.0 tm0? -118.87 111.2 18.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.499 0.666 . . . . 2.08 110.479 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 64' ' ' CYS . 68.0 mt -71.11 133.8 85.6 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 114.859 -1.064 . . . . 0.95 109.979 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 52' ' ' ILE . 52.3 Cg_exo -34.3 130.58 0.18 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 124.693 3.595 . . . . 0.95 114.138 -173.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.57 HD12 ' H ' ' A' ' 54' ' ' LEU . 2.4 mp -84.29 132.85 34.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.807 -1.088 . . . . 1.67 112.584 -166.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.43 133.37 40.94 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.424 -0.954 . . . . 1.58 108.424 165.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.677 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -66.09 132.35 31.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.164 0.507 . . . . 2.11 110.893 -172.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.18 4.25 84.17 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.37 -0.832 . . . . 1.03 113.101 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -96.33 152.01 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.724 0.773 . . . . 0.77 111.859 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.54 143.33 27.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.339 -1.3 . . . . 0.68 111.172 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.42 HG21 HD23 ' A' ' 16' ' ' LEU . 8.4 tp -55.55 -32.32 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.005 -0.998 . . . . 0.69 111.83 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.79 -8.62 55.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 2.2 111.56 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.46 -27.15 11.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.403 0.621 . . . . 1.98 109.608 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.8 tp10 -72.62 -40.49 66.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.211 -0.904 . . . . 2.09 111.234 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.422 ' HA ' HD12 ' A' ' 52' ' ' ILE . 8.8 p -116.56 153.49 32.12 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.69 -0.404 . . . . 0.6 110.954 -173.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -99.69 33.17 2.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.663 0.745 . . . . 2.32 109.689 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 51.9 m-80 -117.94 -165.32 1.09 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.494 -0.776 . . . . 1.06 109.512 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 14.2 m -93.77 122.23 62.75 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-O 121.335 0.588 . . . . 0.34 112.012 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.41 117.26 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.482 2.788 . . . . 0.45 111.115 172.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.9 p -129.32 146.99 51.11 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.556 -0.458 . . . . 0.31 111.405 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 25.1 t -98.81 111.21 23.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.852 -0.613 . . . . 1.26 109.373 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.4 m -96.94 135.15 39.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.056 0.455 . . . . 0.29 110.626 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 6.5 tt0 -72.28 -20.75 61.46 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.449 0.642 . . . . 1.53 109.487 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -163.17 166.44 23.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.451 -0.795 . . . . 1.26 109.112 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.465 HG13 ' HD3' ' A' ' 15' ' ' LYS . 14.7 m -138.73 157.45 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 110.055 -0.35 . . . . 1.07 110.055 177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 80' ' ' VAL . 37.1 mt-10 -126.07 164.91 19.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.408 -0.36 . . . . 1.87 110.066 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 57.68 -150.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.548 -0.751 . . . . 1.94 109.396 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.97 22.88 0.74 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.11 0.481 . . . . 2.12 110.993 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 101.41 21.81 11.15 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.902 -0.666 . . . . 0.51 112.115 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.5 mm? -79.15 -22.55 44.9 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.329 0.585 . . . . 1.1 110.252 176.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 75' ' ' GLU . 61.1 t -122.49 117.91 53.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.606 -0.725 . . . . 0.33 109.472 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -110.35 134.78 12.41 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.142 -1.028 . . . . 0.26 111.939 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.661 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -98.12 121.62 48.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.198 -0.297 . . . . 0.3 110.198 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.705 ' HA ' HG12 ' A' ' 45' ' ' VAL . 94.5 m-20 58.4 54.91 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.867 -0.606 . . . . 0.34 110.904 174.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.536 ' HB2' HD11 ' A' ' 47' ' ' ILE . 47.8 m -91.62 110.73 22.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.295 -0.866 . . . . 0.81 110.944 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 47.3 m -96.16 128.76 35.77 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.982 -0.554 . . . . 0.44 110.166 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 39.4 Cg_exo -62.46 119.96 7.29 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.829 2.353 . . . . 0.39 110.947 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.0 pt -99.8 139.77 21.06 Favored Pre-proline 0 N--CA 1.442 -0.874 0 CA-C-N 116.319 -0.4 . . . . 0.57 111.718 -173.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.6 Cg_exo . . . . . 0 N--CA 1.463 -0.299 0 C-N-CA 123.251 2.634 . . . . 1.05 112.277 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 78.4 m95 . . . . . 0 CA--C 1.516 -0.36 0 N-CA-C 110.154 -0.313 . . . . 0.81 110.154 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.35 110.11 2.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.912 -0.585 . . . . 2.73 109.983 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -102.67 26.23 8.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.889 -0.596 . . . . 1.75 110.57 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -16.24 62.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.684 -0.689 . . . . 3.24 111.066 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 10' ' ' SER . 8.1 t -69.47 -14.51 62.92 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.101 -0.5 . . . . 2.05 110.684 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.36 79.95 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.133 -0.556 . . . . 0.88 112.617 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.4 ' H ' HG23 ' A' ' 8' ' ' THR . 5.6 m -96.71 -10.32 27.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 111.896 0.332 . . . . 1.72 111.896 -173.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.8 t -139.46 141.87 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.613 -0.435 . . . . 1.19 110.83 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.45 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.4 p30 -93.41 -30.22 15.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 1.66 112.157 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.45 HG23 ' OD1' ' A' ' 12' ' ' ASN . 23.9 p -89.98 -30.67 17.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.138 0.422 . . . . 0.52 112.138 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.93 -7.39 67.43 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.527 -0.844 . . . . 0.43 112.068 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.691 ' HD3' HG23 ' A' ' 74' ' ' VAL . 75.5 mttt -87.35 88.37 7.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.352 0.596 . . . . 1.64 110.043 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' A' ' 60' ' ' ILE . 9.0 mp -97.69 122.55 40.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.341 -0.845 . . . . 0.55 109.691 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.33 146.54 50.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.038 0.447 . . . . 0.29 111.189 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 50' ' ' THR . 62.9 m -81.38 109.1 15.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.719 -0.845 . . . . 0.74 108.719 172.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 72.3 m -126.53 153.38 45.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.216 0.531 . . . . 0.5 112.114 -169.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.62 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 13.0 t70 -99.6 113.22 25.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.098 -1.075 . . . . 1.65 108.098 175.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.0 p -77.06 -10.1 59.16 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.352 0.871 . . . . 0.52 113.352 -169.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -106.48 -3.83 20.47 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.884 0.85 . . . . 2.2 109.153 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -93.07 104.8 16.97 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.951 -1.477 . . . . 2.6 109.907 175.264 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.76 162.43 12.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.283 0.563 . . . . 2.17 111.705 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -123.61 143.22 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.225 -0.898 . . . . 0.59 108.764 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -86.68 -31.4 21.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.277 -0.419 . . . . 2.83 110.988 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -87.7 119.67 28.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.228 -0.442 . . . . 4.07 110.414 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -93.63 54.92 2.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.471 0.653 . . . . 2.46 109.584 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.1 m -92.12 132.92 36.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.378 -0.828 . . . . 2.0 110.192 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.62 164.88 16.57 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.502 -0.856 . . . . 1.39 112.515 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -100.63 -47.87 4.71 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 122.518 0.327 . . . . 3.06 110.143 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 120.658 0.266 . . . . 2.44 110.354 177.252 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' A' ' 82' ' ' ILE . 31.7 mt-30 . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.955 0.407 . . . . 1.4 110.897 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.17 99.92 10.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.764 -0.653 . . . . 1.37 109.629 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -99.33 108.06 20.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.447 -0.797 . . . . 0.3 110.478 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 pt -118.52 159.47 18.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.836 -0.62 . . . . 0.23 110.052 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -77.56 142.04 39.23 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 122.12 0.962 . . . . 2.38 110.848 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 39.4 m -140.94 164.64 29.71 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.516 -1.675 . . . . 1.15 109.908 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 7.9 t -161.01 136.1 7.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.164 -0.471 . . . . 0.6 109.806 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -120.36 110.28 16.35 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.109 0.48 . . . . 2.08 110.447 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.403 HG23 ' HD2' ' A' ' 53' ' ' PRO . 61.9 mt -63.71 131.11 94.79 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.503 -0.771 . . . . 0.95 109.517 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HD2' HG23 ' A' ' 52' ' ' ILE . 50.4 Cg_exo -32.83 102.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.771 3.647 . . . . 0.95 113.867 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 pp -70.03 135.58 49.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.101 -0.954 . . . . 1.67 112.636 -171.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.3 137.74 32.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.349 -0.842 . . . . 1.58 109.333 170.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.8 mp -71.39 131.83 34.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.405 -0.591 . . . . 2.11 109.405 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.77 -6.95 59.0 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.598 -0.728 . . . . 1.03 111.687 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.47 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -106.99 152.69 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.642 0.734 . . . . 0.77 111.803 179.535 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.4 152.7 20.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.458 -1.247 . . . . 0.68 111.359 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 16' ' ' LEU . 6.2 tp -56.81 -40.68 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.227 0.611 . . . . 0.69 112.1 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -11.19 56.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.398 -0.365 . . . . 2.2 111.598 -172.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -95.56 -34.3 12.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.383 -0.599 . . . . 1.98 109.383 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.47 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 9.6 tp10 -67.55 -40.23 84.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.138 -0.937 . . . . 2.09 110.711 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.56 148.36 41.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.293 -0.412 . . . . 0.6 109.961 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -99.79 45.7 0.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.874 0.845 . . . . 2.32 109.667 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 46.3 m-80 -122.11 -172.36 2.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.103 -0.953 . . . . 1.06 108.982 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 m -85.93 126.12 66.59 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-O 121.167 0.508 . . . . 0.34 110.552 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -83.06 136.07 7.81 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.079 2.519 . . . . 0.45 111.105 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 86' ' ' PRO . 67.8 p -133.8 150.91 51.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.794 0.33 . . . . 0.31 111.147 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 44.0 t -95.37 115.46 27.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.727 -0.842 . . . . 1.26 108.727 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.91 135.65 45.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.467 0.651 . . . . 0.29 110.829 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 9.4 mt-10 -70.14 -19.42 63.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.946 -1.025 . . . . 1.53 109.837 175.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -169.68 161.44 9.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.909 -1.041 . . . . 1.26 108.616 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.691 HG23 ' HD3' ' A' ' 15' ' ' LYS . 1.8 t -145.28 136.9 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.635 -0.505 . . . . 1.07 109.635 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.84 160.85 14.02 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.361 -0.381 . . . . 1.87 110.108 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 t70 62.34 -153.34 0.35 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.348 -0.612 . . . . 1.94 109.348 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.81 23.58 0.43 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.095 0.474 . . . . 2.12 110.705 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.571 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 105.38 23.58 7.54 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.889 -0.672 . . . . 0.51 112.423 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -78.66 -33.04 47.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.865 0.364 . . . . 1.1 111.243 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.69 108.29 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.319 -0.4 . . . . 0.33 110.036 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.721 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -97.16 140.04 14.83 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.064 -1.065 . . . . 0.26 112.527 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -102.97 116.8 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 109.52 -0.548 . . . . 0.3 109.52 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 96.5 m-20 62.58 41.59 9.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.428 -0.805 . . . . 0.34 110.773 175.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.721 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 60.5 m -80.42 110.9 16.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.81 111.086 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 m -103.85 132.21 21.25 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.154 -0.475 . . . . 0.44 110.13 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 69' ' ' THR . 9.4 Cg_endo -65.41 129.13 21.82 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.041 2.494 . . . . 0.39 112.1 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 11.7 pt -105.73 146.61 33.18 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.908 -0.587 . . . . 0.57 111.776 -173.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 11.4 Cg_exo . . . . . 0 N--CA 1.461 -0.397 0 C-N-CA 123.286 2.658 . . . . 1.05 112.04 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.8 m95 . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.208 0.528 . . . . 0.81 111.773 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.89 115.77 20.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.286 -0.87 . . . . 2.73 110.202 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.2 m -88.13 23.57 2.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.236 -0.438 . . . . 1.75 110.868 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -46.98 -49.06 21.4 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.557 -0.747 . . . . 3.24 112.246 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -62.76 -21.33 65.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.676 -0.693 . . . . 2.05 111.976 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.97 16.26 76.53 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.276 -0.488 . . . . 0.88 113.336 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 m -85.35 -8.93 58.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.161 0.43 . . . . 1.72 112.161 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.641 ' SG ' HG21 ' A' ' 87' ' ' ILE . 1.8 m -132.32 141.05 48.8 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.499 -0.481 . . . . 1.19 111.373 -170.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -92.8 -30.45 15.47 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.147 0.425 . . . . 1.66 112.147 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.4 p -92.15 -31.98 15.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.165 0.507 . . . . 0.52 111.364 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.78 4.46 67.45 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.58 -0.819 . . . . 0.43 111.99 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 63.7 mttp -87.34 87.8 7.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.069 0.462 . . . . 1.64 109.865 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.855 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 8.7 mp -94.1 134.96 35.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.872 -0.603 . . . . 0.55 109.975 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.512 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -149.01 146.57 27.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.914 0.388 . . . . 0.29 110.299 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 98.2 m -88.93 100.82 13.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.339 0.59 . . . . 0.74 110.019 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 79.9 m -111.02 158.92 18.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.723 -0.671 . . . . 0.5 111.484 -168.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -99.04 107.76 20.25 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.166 -0.679 . . . . 1.65 109.166 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.8 p -70.68 -13.18 61.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.784 -0.643 . . . . 0.52 111.162 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -95.51 -10.88 28.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.395 0.617 . . . . 2.2 109.674 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -115.04 140.37 49.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.224 -0.898 . . . . 2.6 110.113 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.626 ' HD3' HG22 ' A' ' 47' ' ' ILE . 44.5 mmtm -124.51 155.19 39.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.291 -0.868 . . . . 2.17 111.072 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.562 HG22 ' OE1' ' A' ' 48' ' ' GLN . 3.1 t -113.69 149.17 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.112 -0.699 . . . . 0.59 109.112 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -93.81 20.96 6.99 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.048 0.451 . . . . 2.83 110.704 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 30.1 mmmt -126.77 132.62 51.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.027 -0.533 . . . . 4.07 110.649 -178.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -114.48 42.82 2.03 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.709 -0.849 . . . . 2.46 108.709 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -108.36 168.12 9.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.785 -1.098 . . . . 2.0 111.601 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.457 ' HA3' ' OD2' ' A' ' 73' ' ' ASP . . . 170.91 -149.18 12.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.08 -0.581 . . . . 1.39 112.217 -176.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.81 -51.55 6.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.037 0.446 . . . . 3.06 110.92 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.973 -0.558 . . . . 2.44 109.738 -179.3 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.566 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 19.3 mt-30 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.078 0.466 . . . . 1.4 110.762 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 83' ' ' ASN . 13.5 p -115.35 123.8 71.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.556 -0.747 . . . . 1.37 109.965 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -105.85 100.15 9.71 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.595 -0.729 . . . . 0.3 110.38 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.626 HG22 ' HD3' ' A' ' 24' ' ' LYS . 20.1 pt -107.36 146.83 13.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.201 0.524 . . . . 0.23 110.489 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.562 ' OE1' HG22 ' A' ' 25' ' ' VAL . 17.9 tp60 -74.9 118.32 17.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.303 -0.862 . . . . 2.38 108.954 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.687 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 3.4 t -115.97 164.27 14.67 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.658 -0.701 . . . . 1.15 110.594 -171.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -162.42 131.98 4.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.174 0.511 . . . . 0.6 110.526 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -121.1 123.14 41.6 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.135 -0.484 . . . . 2.08 111.35 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 64' ' ' CYS . 45.9 mt -64.52 135.07 96.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.438 -0.801 . . . . 0.95 109.654 173.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.4 111.66 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.063 3.175 . . . . 0.95 112.593 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.68 141.91 31.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.821 -1.081 . . . . 1.67 112.769 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.404 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 7.8 mp -93.87 132.35 38.39 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.692 -0.855 . . . . 1.58 108.692 167.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.606 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.9 mp -67.11 131.85 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.225 0.536 . . . . 2.11 110.072 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.69 -5.89 56.99 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.493 -0.776 . . . . 1.03 112.017 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -98.62 150.5 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.739 0.781 . . . . 0.77 111.471 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.47 132.17 34.97 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.91 -1.495 . . . . 0.68 110.105 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.403 HG12 ' SG ' ' A' ' 18' ' ' CYS . 10.7 tt -53.96 -34.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.207 -0.906 . . . . 0.69 111.907 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -73.75 -18.13 61.02 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.942 -1.027 . . . . 2.2 111.494 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -110.99 4.8 19.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.188 0.518 . . . . 1.98 110.585 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -95.67 -40.35 9.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.436 0.636 . . . . 2.09 110.311 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.448 ' HA ' HD12 ' A' ' 52' ' ' ILE . 15.3 p -105.92 -176.4 3.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.869 -0.605 . . . . 0.6 110.667 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -127.56 35.84 4.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.372 0.606 . . . . 2.32 109.767 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 52.8 m-80 -135.01 -170.77 2.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 1.06 110.339 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 89.7 m -80.91 124.86 81.18 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 121.322 0.582 . . . . 0.34 111.996 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.76 115.52 2.97 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.393 2.728 . . . . 0.45 111.583 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -132.22 159.81 37.95 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.478 -0.564 . . . . 0.31 109.478 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.855 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 85.6 m -121.76 122.8 40.33 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.274 0.559 . . . . 1.26 109.982 174.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.466 ' HB2' HG22 ' A' ' 74' ' ' VAL . 37.8 m -100.92 143.12 31.45 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.107 -0.951 . . . . 0.29 110.627 -172.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 6.9 mm-40 -77.42 -17.35 58.2 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.673 -1.149 . . . . 1.53 109.613 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.457 ' OD2' ' HA3' ' A' ' 30' ' ' GLY . 4.3 t70 -165.04 155.61 14.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.076 -0.965 . . . . 1.26 108.889 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.51 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -149.75 130.54 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 110.207 -0.294 . . . . 1.07 110.207 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 30.5 tt0 -96.99 164.99 12.29 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.963 -0.384 . . . . 1.87 109.963 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 65.26 -154.25 0.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.401 -0.592 . . . . 1.94 109.401 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -72.63 2.48 6.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.54 0.686 . . . . 2.12 109.843 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.38 24.09 2.48 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.648 -0.705 . . . . 0.51 112.271 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 2.0 mm? -79.08 -29.76 43.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.689 0.255 . . . . 1.1 111.689 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG22 HG11 ' A' ' 25' ' ' VAL . 67.4 t -118.38 102.97 13.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.941 -0.304 . . . . 0.33 110.192 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.597 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -104.53 136.26 12.96 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.309 -0.948 . . . . 0.26 113.009 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -99.32 122.95 51.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.12 -0.54 . . . . 0.3 109.624 177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.716 ' HA ' HG12 ' A' ' 45' ' ' VAL . 70.8 m-20 60.45 48.0 8.15 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.457 0.473 . . . . 0.34 110.931 175.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.597 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 58.3 m -84.54 90.76 7.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.025 -0.534 . . . . 0.81 110.422 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.7 m -79.15 127.84 77.96 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.587 -0.733 . . . . 0.44 110.227 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.03 109.53 1.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.7 2.267 . . . . 0.39 110.737 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.641 HG21 ' SG ' ' A' ' 11' ' ' CYS . 12.0 pt -82.32 146.81 55.16 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.642 -0.708 . . . . 0.57 111.87 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 14.2 Cg_exo . . . . . 0 N--CA 1.457 -0.653 0 C-N-CA 123.249 2.632 . . . . 1.05 111.206 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.441 ' HH2' ' OE1' ' A' ' 63' ' ' GLU . 94.1 m95 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.563 0.22 . . . . 0.81 111.423 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -59.83 111.77 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 2.73 111.551 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -99.38 -19.92 16.76 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.729 -0.669 . . . . 1.75 111.034 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -17.33 64.7 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.938 0.399 . . . . 3.24 111.141 -177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -72.97 -30.14 63.6 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.081 -0.509 . . . . 2.05 110.983 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.81 16.99 74.82 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.886 -0.597 . . . . 0.88 112.308 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.464 ' HB2' HG21 ' A' ' 87' ' ' ILE . 28.5 p -85.89 -19.26 30.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.793 0.33 . . . . 1.72 111.724 -172.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.8 t -130.49 143.84 51.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.929 0.395 . . . . 1.19 111.033 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -91.13 -31.6 16.16 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.027 -0.533 . . . . 1.66 110.61 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.5 p -90.36 -30.57 17.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.578 -0.737 . . . . 0.52 111.002 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.58 2.22 61.71 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.632 -0.713 . . . . 0.43 111.913 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.505 ' HD3' HG23 ' A' ' 74' ' ' VAL . 94.0 mttt -91.55 87.59 6.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.046 0.451 . . . . 1.64 110.267 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 mp -97.63 100.22 11.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.857 -0.61 . . . . 0.55 109.845 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.48 145.53 40.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.06 0.457 . . . . 0.29 110.437 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 66' ' ' ASN . 84.6 m -80.57 108.19 14.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.795 -0.639 . . . . 0.74 109.646 172.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 62.5 m -126.91 153.65 45.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.885 -0.598 . . . . 0.5 111.368 -172.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -95.61 111.65 23.53 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.475 -0.784 . . . . 1.65 109.854 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.4 p -75.28 -11.06 59.98 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.28 0.562 . . . . 0.52 110.709 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -93.87 -8.96 38.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.555 0.693 . . . . 2.2 109.248 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -119.74 125.4 48.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.994 -1.003 . . . . 2.6 110.692 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -113.11 154.0 27.3 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.535 -1.212 . . . . 2.17 111.066 -170.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.577 HG22 ' NE2' ' A' ' 48' ' ' GLN . 9.6 t -115.13 148.75 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.862 -0.792 . . . . 0.59 108.862 175.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -98.34 29.74 3.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.908 0.385 . . . . 2.83 111.081 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -130.38 118.74 21.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.34 -0.391 . . . . 4.07 110.791 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.5 m -111.96 53.96 0.71 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 2.46 110.089 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.42 -93.91 0.26 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.615 -0.72 . . . . 2.0 111.647 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.03 155.18 15.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 1.39 111.859 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.73 -50.22 4.54 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.598 -0.354 . . . . 3.06 110.921 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--N 1.327 -0.388 0 C-N-CA 120.887 -0.325 . . . . 2.44 110.492 -176.06 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.605 ' HB3' HG23 ' A' ' 82' ' ' ILE . 35.2 mt-30 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 121.072 0.463 . . . . 1.4 110.441 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 83' ' ' ASN . 11.9 p -101.03 120.94 51.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.41 0.624 . . . . 1.37 110.77 -174.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -103.11 117.09 33.79 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.33 -0.85 . . . . 0.3 110.707 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.507 HD11 ' HB2' ' A' ' 84' ' ' CYS . 18.3 pt -124.31 159.78 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.23 -0.441 . . . . 0.23 109.96 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.577 ' NE2' HG22 ' A' ' 25' ' ' VAL . 3.5 mp0 -72.33 131.32 42.5 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.525 0.678 . . . . 2.38 110.704 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 72.3 m -125.09 149.15 48.13 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.395 -1.275 . . . . 1.15 110.071 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.2 t -161.31 132.96 5.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.105 0.479 . . . . 0.6 110.406 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -121.61 115.93 23.67 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.833 -0.622 . . . . 2.08 110.968 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.512 HG23 ' HD2' ' A' ' 53' ' ' PRO . 47.1 mt -58.09 139.31 83.55 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.153 -0.93 . . . . 0.95 109.12 173.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HD2' HG23 ' A' ' 52' ' ' ILE . 31.4 Cg_exo -34.11 127.77 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 124.262 3.308 . . . . 0.95 114.255 -173.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.71 136.09 57.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.357 -1.292 . . . . 1.67 112.365 -170.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.1 mt -110.13 132.02 54.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.291 -0.868 . . . . 1.58 109.512 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 mt -68.57 132.62 32.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.988 0.423 . . . . 2.11 110.728 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.59 24.94 71.35 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.429 -0.805 . . . . 1.03 112.951 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.488 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -113.41 150.51 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.781 0.801 . . . . 0.77 112.264 -178.346 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.5 145.64 31.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.126 -1.397 . . . . 0.68 111.457 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 tp -56.9 -42.08 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.698 -0.683 . . . . 0.69 111.547 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.83 -5.23 58.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.329 -0.396 . . . . 2.2 111.675 -173.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -106.69 -28.4 10.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.147 0.498 . . . . 1.98 109.914 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.488 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 32.6 tt0 -68.51 -37.66 80.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 2.09 111.191 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.415 ' HA ' HD12 ' A' ' 52' ' ' ILE . 1.8 p -113.0 178.23 4.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.092 -0.504 . . . . 0.6 109.979 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -127.33 28.93 5.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.058 0.456 . . . . 2.32 110.763 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 8.3 t-20 -105.25 -140.57 0.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.639 -0.709 . . . . 1.06 109.356 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 27.9 m -116.43 130.23 24.65 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 120.768 0.318 . . . . 0.34 110.48 176.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -78.26 122.89 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.76 2.307 . . . . 0.45 111.404 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.2 p -130.19 147.67 51.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.959 0.409 . . . . 0.31 111.007 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.48 106.77 19.07 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.503 -0.555 . . . . 1.26 109.503 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.0 m -93.86 141.78 28.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.209 0.528 . . . . 0.29 110.72 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.9 tt0 -79.16 -25.98 42.78 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.506 -0.77 . . . . 1.53 109.745 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -160.13 160.12 32.58 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.312 -0.995 . . . . 1.26 108.312 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.505 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.3 t -141.69 132.86 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.76 -0.459 . . . . 1.07 109.76 175.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.48 163.73 12.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.564 -0.289 . . . . 1.87 110.444 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 66.65 -152.98 0.22 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.035 -0.53 . . . . 1.94 109.588 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.94 -7.05 19.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.444 0.64 . . . . 2.12 110.449 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.447 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . 120.47 23.4 2.87 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.137 -0.785 . . . . 0.51 111.137 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 62.2 mt -91.9 -13.57 31.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.727 -0.236 . . . . 1.1 111.404 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.99 107.97 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.13 -0.322 . . . . 0.33 110.13 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -97.67 144.0 17.04 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.517 -0.849 . . . . 0.26 112.426 -178.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.605 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -105.23 124.08 59.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.099 -0.334 . . . . 0.3 110.099 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.778 ' HA ' HG12 ' A' ' 45' ' ' VAL . 74.3 m-20 57.57 45.7 18.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.365 0.603 . . . . 0.34 110.796 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.58 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 81.4 m -82.25 92.33 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.248 -0.887 . . . . 0.81 110.631 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 25.1 m -84.03 123.67 75.32 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.68 -0.691 . . . . 0.44 110.385 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 25.0 Cg_exo -64.29 130.91 28.33 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.108 2.538 . . . . 0.39 111.998 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.2 pt -103.3 137.07 19.15 Favored Pre-proline 0 N--CA 1.438 -1.072 0 CA-C-N 115.857 -0.611 . . . . 0.57 110.696 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 8.2 Cg_exo . . . . . 0 N--CA 1.457 -0.625 0 C-N-CA 123.406 2.737 . . . . 1.05 112.559 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 72.3 m95 . . . . . 0 CA--C 1.515 -0.381 0 CA-C-O 121.213 0.53 . . . . 0.81 111.493 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -66.46 117.7 9.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.969 -1.014 . . . . 2.73 110.104 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.0 t -107.71 27.05 9.56 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.878 -0.786 . . . . 1.75 108.878 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -60.83 -38.22 84.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.07 -0.968 . . . . 3.24 110.902 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -65.59 -22.04 66.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.691 -0.686 . . . . 2.05 110.895 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.11 16.04 79.74 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.216 -0.516 . . . . 0.88 112.94 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.439 ' HB3' ' HB ' ' A' ' 87' ' ' ILE . 8.3 m -82.66 -18.57 40.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.998 0.37 . . . . 1.72 111.998 -175.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.3 t -116.47 141.58 47.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.884 0.373 . . . . 1.19 110.649 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.439 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.1 p30 -93.13 -26.21 17.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 1.66 111.822 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.439 HG23 ' OD1' ' A' ' 12' ' ' ASN . 32.2 p -94.98 -30.81 13.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.998 0.427 . . . . 0.52 112.034 -173.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.08 -1.64 74.22 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.591 -0.814 . . . . 0.43 111.521 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -92.47 87.93 6.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.322 -0.622 . . . . 1.64 109.322 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -96.81 139.71 32.46 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.923 -0.58 . . . . 0.55 110.619 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -147.61 156.61 42.97 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.129 -1.063 . . . . 0.29 108.129 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 93.8 m -99.92 97.45 8.33 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.301 -0.56 . . . . 0.74 109.704 174.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.4 m -110.49 156.57 20.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.679 -0.691 . . . . 0.5 111.147 -168.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.48 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 33.4 m-20 -99.94 109.72 22.08 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.264 -0.643 . . . . 1.65 109.264 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.422 HG21 ' HG3' ' A' ' 86' ' ' PRO . 33.1 p -71.87 -8.03 51.96 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.808 -0.633 . . . . 0.52 111.287 -175.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -100.85 -6.76 24.31 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.243 -0.651 . . . . 2.2 109.243 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 30.1 mtpp -116.64 117.32 29.49 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.969 -1.014 . . . . 2.6 109.812 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -128.62 152.58 48.19 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.584 0.586 . . . . 2.17 112.584 -171.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 27' ' ' LYS . 6.5 t -99.36 150.36 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.144 -0.935 . . . . 0.59 110.416 -174.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -91.29 13.21 17.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.644 -0.707 . . . . 2.83 110.088 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' H ' HG12 ' A' ' 25' ' ' VAL . 13.6 mmmm -131.62 142.3 49.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.046 -0.979 . . . . 4.07 108.767 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 t -139.18 80.39 1.78 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.7 0.762 . . . . 2.46 110.002 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.549 ' HB ' ' OE2' ' A' ' 75' ' ' GLU . 5.1 m -115.96 143.16 45.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.074 -0.966 . . . . 2.0 109.94 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -114.22 149.02 18.79 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.674 -0.774 . . . . 1.39 112.253 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.52 -51.09 4.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.399 -0.593 . . . . 3.06 109.399 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 2.44 109.928 176.778 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.664 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.5 mt-30 . . . . . 0 C--O 1.234 0.257 0 CA-C-O 121.012 0.434 . . . . 1.4 110.85 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.0 t -83.68 112.57 21.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.896 -0.593 . . . . 1.37 110.171 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.63 105.61 15.73 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.437 -0.801 . . . . 0.3 110.556 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 11.5 pt -110.21 152.76 12.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.218 -0.446 . . . . 0.23 111.014 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -72.07 142.02 49.23 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.506 -0.77 . . . . 2.38 110.287 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.646 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.4 t -144.79 165.69 27.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.56 -1.2 . . . . 1.15 109.993 -170.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.3 t -160.04 153.06 21.68 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.248 -0.279 . . . . 0.6 110.248 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.5 122.8 41.43 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.415 -0.587 . . . . 2.08 109.415 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 64' ' ' CYS . 46.7 mt -92.64 131.92 32.79 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.511 -0.552 . . . . 0.95 109.511 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 52' ' ' ILE . 52.8 Cg_exo -33.88 99.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.575 3.516 . . . . 0.95 113.504 -174.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 pp -78.31 140.61 38.8 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.987 -1.006 . . . . 1.67 111.412 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.548 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 2.6 mm? -77.74 138.86 39.26 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.199 -1.037 . . . . 1.58 108.199 171.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.7 mt -61.02 129.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.025 0.441 . . . . 2.11 110.416 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.4 2.91 88.92 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.513 -0.767 . . . . 1.03 112.763 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -95.92 152.63 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.724 0.773 . . . . 0.77 111.601 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.66 152.13 23.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.395 -1.275 . . . . 0.68 111.401 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 10.5 tt -52.29 -38.77 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.943 0.878 . . . . 0.69 110.857 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.444 ' N ' HG23 ' A' ' 60' ' ' ILE . 34.9 mt-10 -64.24 -16.01 61.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.825 -1.079 . . . . 2.2 111.766 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -111.34 -8.12 14.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.036 0.384 . . . . 1.98 112.036 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 1.9 pp20? -94.53 -33.76 12.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.433 -0.507 . . . . 2.09 111.599 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.499 ' HA ' HD12 ' A' ' 52' ' ' ILE . 3.8 p -113.44 156.52 23.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.063 0.459 . . . . 0.6 111.408 -173.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 4.1 tppp? -110.89 26.41 10.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.085 0.945 . . . . 2.32 108.976 173.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.643 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 4.3 m-20 -105.07 -168.49 1.48 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.199 -0.91 . . . . 1.06 109.471 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -88.67 124.62 65.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-O 121.388 0.613 . . . . 0.34 111.408 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HB2' HG13 ' A' ' 87' ' ' ILE . 9.6 Cg_exo -60.19 113.91 1.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.21 2.607 . . . . 0.45 110.986 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.848 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 0.8 OUTLIER -124.99 139.54 53.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.964 0.412 . . . . 0.31 111.41 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.9 t -102.65 105.56 16.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.224 -0.658 . . . . 1.26 109.224 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 67.3 m -86.77 145.36 26.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.927 -0.397 . . . . 0.29 109.927 -174.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.4 tt0 -76.3 -24.17 54.37 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.705 -0.85 . . . . 1.53 108.705 172.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -163.25 157.98 20.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.823 -1.081 . . . . 1.26 108.481 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.544 HG12 ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -138.45 138.4 42.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.804 -0.358 . . . . 1.07 110.095 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.549 ' OE2' ' HB ' ' A' ' 29' ' ' THR . 43.9 tt0 -106.42 155.33 19.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.276 -0.42 . . . . 1.87 110.311 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 t70 66.78 -152.64 0.21 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.661 0.601 . . . . 1.94 109.667 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.01 0.69 5.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.111 0.482 . . . . 2.12 110.611 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 115.4 23.69 4.37 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.043 -0.599 . . . . 0.51 111.971 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.4 mt -79.35 -24.81 42.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.007 0.432 . . . . 1.1 110.892 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.97 108.67 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.721 -0.474 . . . . 0.33 109.721 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.99 133.53 11.4 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.298 -0.954 . . . . 0.26 111.81 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.664 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -95.23 118.47 41.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 110.136 -0.32 . . . . 0.3 110.136 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 89.8 m-20 57.75 42.53 23.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.382 -0.827 . . . . 0.34 110.825 174.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.848 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -78.27 105.14 9.31 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.689 -0.687 . . . . 0.81 110.351 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.5 m -83.45 128.22 65.1 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.422 -0.808 . . . . 0.44 109.738 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HG3' HG21 ' A' ' 21' ' ' THR . 33.3 Cg_exo -61.35 119.91 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.56 2.173 . . . . 0.39 110.779 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.439 ' HB ' ' HB3' ' A' ' 10' ' ' SER . 8.4 pt -106.87 146.85 33.95 Favored Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-O 121.137 0.494 . . . . 0.57 111.458 -174.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 N--CA 1.444 -1.406 0 C-N-CA 123.461 2.774 . . . . 1.05 112.31 -177.593 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.547 ' CZ2' HD22 ' A' ' 54' ' ' LEU . 78.2 m95 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.678 -0.49 . . . . 0.81 109.678 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -76.81 108.28 9.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.93 0.395 . . . . 2.73 110.775 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.9 m -94.82 13.32 25.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.905 -0.589 . . . . 1.75 109.551 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -19.82 55.03 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.453 -0.794 . . . . 3.24 111.302 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -74.68 -16.47 60.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.948 -0.569 . . . . 2.05 110.898 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.22 69.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.949 -0.643 . . . . 0.88 111.607 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.6 p -87.23 -29.65 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.623 0.601 . . . . 1.72 112.623 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.4 t -129.3 141.31 51.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.604 0.716 . . . . 1.19 111.313 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -92.36 -30.53 15.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.509 -1.223 . . . . 1.66 111.704 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -30.55 14.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.069 0.396 . . . . 0.52 112.069 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.55 -9.51 57.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.553 -0.832 . . . . 0.43 112.626 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HD3' HG23 ' A' ' 74' ' ' VAL . 90.9 mttt -89.48 88.11 7.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.957 0.408 . . . . 1.64 110.347 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' A' ' 4' ' ' TRP . 8.8 mp -90.49 138.09 31.83 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.357 -0.609 . . . . 0.55 109.357 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.01 156.62 44.46 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.87 0.367 . . . . 0.29 110.71 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 50' ' ' THR . 51.2 m -91.34 101.93 14.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.697 -0.853 . . . . 0.74 108.697 171.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.8 m -121.32 142.51 49.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.213 0.53 . . . . 0.5 111.312 -171.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -93.72 108.26 20.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.408 -0.815 . . . . 1.65 109.235 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.7 p -74.15 -6.93 50.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.886 -0.597 . . . . 0.52 111.24 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -91.85 -20.58 21.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.843 0.83 . . . . 2.2 108.822 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -104.34 135.31 46.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.476 -1.238 . . . . 2.6 110.623 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.505 ' HD2' HG22 ' A' ' 47' ' ' ILE . 14.4 mmmm -119.91 156.56 30.52 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.831 -1.077 . . . . 2.17 110.052 -175.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.06 150.27 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.002 0.429 . . . . 0.59 110.303 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -78.1 30.25 0.17 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.44 -0.8 . . . . 2.83 111.837 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 30.7 mmmt -133.49 160.06 38.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 4.07 111.26 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.8 t -148.02 23.55 1.07 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.939 0.876 . . . . 2.46 108.942 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.407 ' OG1' ' HE3' ' A' ' 27' ' ' LYS . 13.7 p -102.56 145.09 30.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.909 -1.041 . . . . 2.0 111.652 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.66 155.77 15.94 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.966 -0.854 . . . . 1.39 110.966 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -100.88 -50.11 3.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.976 0.388 . . . . 3.06 111.158 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 120.904 0.383 . . . . 2.44 110.457 -179.793 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.565 ' HB3' HG23 ' A' ' 82' ' ' ILE . 37.0 mt-30 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 121.444 0.64 . . . . 1.4 111.105 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 83' ' ' ASN . 8.3 p -99.47 136.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.356 -0.838 . . . . 1.37 109.399 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.37 110.94 17.55 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.618 -0.719 . . . . 0.3 110.576 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.505 HG22 ' HD2' ' A' ' 24' ' ' LYS . 7.9 pt -114.78 160.52 14.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.783 -0.644 . . . . 0.23 110.342 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.37 129.58 34.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.836 -0.62 . . . . 2.38 110.232 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.8 m -128.84 154.99 45.91 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.779 -1.1 . . . . 1.15 110.554 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 5.8 t -157.39 136.29 11.62 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.834 -0.621 . . . . 0.6 109.494 -177.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -121.0 114.31 21.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.258 0.552 . . . . 2.08 111.262 -176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.9 mt -78.29 133.89 63.58 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.099 -0.955 . . . . 0.95 109.39 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -33.94 116.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.642 3.561 . . . . 0.95 113.564 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.547 HD22 ' CZ2' ' A' ' 4' ' ' TRP . 3.6 pp -100.12 141.72 32.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.911 -1.04 . . . . 1.67 111.989 -169.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.617 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 94.4 mt -80.72 133.74 35.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.255 -1.017 . . . . 1.58 108.255 167.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.7 mt -67.72 128.81 31.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.143 0.497 . . . . 2.11 110.199 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.53 9.18 63.29 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.554 -0.748 . . . . 1.03 111.725 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -98.76 157.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.277 0.56 . . . . 0.77 110.771 177.113 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.7 137.88 31.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.969 -1.014 . . . . 0.68 110.914 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -53.1 -38.45 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.016 -0.993 . . . . 0.69 112.056 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -79.49 -17.86 53.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.356 -0.384 . . . . 2.2 111.533 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -102.45 -3.06 27.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.968 0.413 . . . . 1.98 110.349 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -102.38 -22.19 14.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.039 -0.528 . . . . 2.09 110.744 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.51 156.64 48.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.471 -0.331 . . . . 0.6 110.236 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -104.64 44.7 1.01 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.285 0.564 . . . . 2.32 110.889 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 3.9 m-20 -124.55 -165.68 1.41 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.492 -0.776 . . . . 1.06 109.723 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -87.76 128.35 54.68 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 120.91 0.386 . . . . 0.34 110.243 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.33 125.46 5.15 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.746 2.297 . . . . 0.45 110.915 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.786 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 2.9 p -124.64 153.42 42.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.972 0.415 . . . . 0.31 111.466 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.2 t -107.55 102.8 12.03 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.263 -0.643 . . . . 1.26 109.263 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 84' ' ' CYS . 97.6 m -84.64 142.11 30.15 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.039 -0.356 . . . . 0.29 110.039 -176.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.6 tt0 -76.1 -27.44 57.15 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.62 -0.881 . . . . 1.53 108.62 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 71' ' ' CYS . 24.6 t0 -159.57 162.8 35.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.874 -1.057 . . . . 1.26 108.66 175.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.642 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.3 t -140.16 134.72 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.841 -0.429 . . . . 1.07 109.841 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -106.15 165.91 10.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.795 -0.446 . . . . 1.87 109.795 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t70 67.4 -151.92 0.19 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.231 0.612 . . . . 1.94 109.457 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -79.17 22.86 0.39 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.969 0.414 . . . . 2.12 110.553 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.485 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 98.19 23.15 13.36 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.924 -0.655 . . . . 0.51 112.041 -177.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.73 -17.18 28.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 1.1 111.217 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.88 103.68 11.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.498 -0.319 . . . . 0.33 110.51 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.422 ' HA3' ' SG ' ' A' ' 71' ' ' CYS . . . -94.29 133.11 11.46 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.354 -0.926 . . . . 0.26 112.368 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.565 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -97.61 126.71 50.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 122.441 0.296 . . . . 0.3 110.255 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.67 ' HA ' HG12 ' A' ' 45' ' ' VAL . 85.3 m-20 53.52 43.56 31.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 123.84 0.712 . . . . 0.34 110.398 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.786 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -87.49 102.89 15.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.406 -0.816 . . . . 0.81 110.15 -177.08 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 m -83.12 130.67 56.25 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.891 -0.595 . . . . 0.44 110.111 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.33 109.84 2.98 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.974 2.449 . . . . 0.39 111.906 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.2 pt -83.69 137.44 41.33 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.576 -0.738 . . . . 0.57 111.176 -175.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.5 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 C-N-CA 123.349 2.699 . . . . 1.05 112.079 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.474 ' CE3' ' HB ' ' A' ' 60' ' ' ILE . 71.8 m95 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.053 0.454 . . . . 0.81 111.608 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -78.04 107.69 10.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 2.73 109.724 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.8 t -111.75 27.51 9.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.349 0.595 . . . . 1.75 109.744 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -24.86 61.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.514 -0.766 . . . . 3.24 112.723 -172.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 t -91.6 5.17 50.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.635 -0.426 . . . . 2.05 110.931 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.22 17.8 75.67 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.598 -0.811 . . . . 0.88 111.839 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 p -69.38 -30.81 68.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.627 0.603 . . . . 1.72 112.627 -172.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.1 t -132.35 141.3 48.87 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.263 -0.575 . . . . 1.19 111.482 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.533 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.9 p30 -93.08 -29.53 15.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.561 -0.745 . . . . 1.66 111.593 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.533 HG23 ' OD1' ' A' ' 12' ' ' ASN . 2.6 p -95.42 -31.38 13.41 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.531 0.567 . . . . 0.52 112.531 -173.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.72 -18.26 44.22 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.339 -0.934 . . . . 0.43 113.267 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.626 ' HD3' HG23 ' A' ' 74' ' ' VAL . 81.9 mttt -84.83 89.4 7.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.168 0.484 . . . . 1.64 110.478 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' A' ' 4' ' ' TRP . 8.8 mp -91.87 137.68 32.17 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.921 -0.4 . . . . 0.55 109.921 175.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.532 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -145.67 152.03 38.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.907 0.384 . . . . 0.29 110.383 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 36.1 m -87.5 98.65 11.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.502 -0.555 . . . . 0.74 109.502 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 86.3 m -117.3 161.97 18.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.495 . . . . 0.5 111.515 -167.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 11.9 m-20 -99.46 98.71 9.59 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.65 109.939 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.8 p -70.31 -7.66 44.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.836 -0.62 . . . . 0.52 112.151 -173.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -103.14 -10.55 18.74 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.189 0.995 . . . . 2.2 108.788 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.483 ' HG3' ' HB2' ' A' ' 48' ' ' GLN . 40.8 tptt -118.06 99.53 6.95 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.416 -1.72 . . . . 2.6 110.497 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 14.2 mptt -85.76 170.31 12.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.036 -0.984 . . . . 2.17 111.047 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.04 150.49 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.59 -0.732 . . . . 0.59 109.18 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -74.58 23.83 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.189 0.811 . . . . 2.83 113.189 -173.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -136.74 160.11 39.83 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.967 -0.458 . . . . 4.07 111.555 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 p -134.64 38.74 3.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.598 0.713 . . . . 2.46 109.605 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 p -89.39 -172.98 3.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.218 -0.901 . . . . 2.0 111.229 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.21 146.57 8.42 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.72 -0.752 . . . . 1.39 111.982 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -82.22 -50.46 8.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.943 0.402 . . . . 3.06 110.431 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.895 -0.593 . . . . 2.44 109.968 179.004 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.49 ' HB3' HG23 ' A' ' 82' ' ' ILE . 15.8 mt-30 . . . . . 0 CA--C 1.517 -0.296 0 CA-C-O 121.19 0.519 . . . . 1.4 110.687 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.68 107.53 20.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.41 -0.813 . . . . 1.37 110.067 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -95.38 122.45 38.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.488 -0.778 . . . . 0.3 110.336 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 84' ' ' CYS . 22.0 pt -122.79 157.82 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.192 -0.458 . . . . 0.23 110.472 176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.483 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -71.4 138.96 49.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.538 -0.756 . . . . 2.38 109.189 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.8 t -142.78 156.58 45.0 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.885 0.374 . . . . 1.15 111.172 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -162.95 122.21 2.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.552 -0.749 . . . . 0.6 109.766 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.459 ' HG2' ' SG ' ' A' ' 18' ' ' CYS . 11.5 tm0? -120.95 115.67 23.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.826 0.346 . . . . 2.08 110.539 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.447 HG23 ' HD2' ' A' ' 53' ' ' PRO . 63.3 mt -52.35 135.42 41.85 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-N 115.207 -0.906 . . . . 0.95 110.192 176.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HD2' HG23 ' A' ' 52' ' ' ILE . 89.8 Cg_exo -33.37 107.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 124.507 3.472 . . . . 0.95 113.88 -174.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.552 ' HA ' ' OE1' ' A' ' 63' ' ' GLU . 3.5 pp -59.3 140.76 55.72 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.755 -1.111 . . . . 1.67 113.837 -168.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -111.26 115.85 30.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.663 -1.153 . . . . 1.58 109.438 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.3 mm -63.64 139.12 21.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.416 0.627 . . . . 2.11 111.14 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.42 -23.84 33.19 Favored Glycine 0 C--N 1.315 -0.602 0 CA-C-N 115.166 -0.925 . . . . 1.03 112.961 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.66 152.04 3.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.768 0.794 . . . . 0.77 111.759 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.07 124.15 27.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.318 -1.31 . . . . 0.68 110.749 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.474 ' HB ' ' CE3' ' A' ' 4' ' ' TRP . 13.3 tt -53.62 -33.1 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.044 -0.98 . . . . 0.69 111.017 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 60' ' ' ILE . 2.8 mp0 -61.34 -29.88 70.16 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.41 -1.268 . . . . 2.2 111.437 -173.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -106.64 -20.47 13.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.054 -0.521 . . . . 1.98 110.452 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' A' ' 54' ' ' LEU . 29.5 tt0 -67.2 -41.14 86.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 2.09 111.129 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.6 p -105.02 -173.64 2.35 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.976 -0.556 . . . . 0.6 109.726 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -132.2 43.68 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.309 0.576 . . . . 2.32 110.817 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 49.8 m-80 -137.55 -171.16 2.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.487 -0.931 . . . . 1.06 108.487 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 22.8 m -81.29 122.12 80.93 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.314 0.578 . . . . 0.34 111.614 -177.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.69 124.2 11.66 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.255 2.637 . . . . 0.45 111.036 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 86' ' ' PRO . 72.6 p -132.5 149.92 52.25 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.788 -0.365 . . . . 0.31 111.237 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 11.6 t -94.74 112.11 23.86 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.477 -0.564 . . . . 1.26 109.477 172.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.4 m -99.36 139.41 35.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.253 0.549 . . . . 0.29 110.333 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.0 tt0 -77.22 -23.93 51.32 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.458 -0.792 . . . . 1.53 109.415 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -163.86 165.09 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.991 -1.004 . . . . 1.26 108.407 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.626 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.0 t -142.2 136.38 29.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 117.947 0.34 . . . . 1.07 110.339 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.81 162.6 12.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.739 -0.467 . . . . 1.87 109.739 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 62.26 -154.37 0.35 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.54 -0.541 . . . . 1.94 109.54 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.5 7.79 6.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.641 0.734 . . . . 2.12 109.848 174.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.04 22.61 2.89 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.487 -0.779 . . . . 0.51 112.596 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.2 mm? -83.82 -23.62 31.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.69 0.256 . . . . 1.1 111.69 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.8 t -129.21 106.88 14.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.972 -0.381 . . . . 0.33 109.972 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -97.49 144.05 17.08 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.384 -0.912 . . . . 0.26 112.399 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -102.15 119.03 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 110.003 -0.369 . . . . 0.3 110.003 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 87.4 m-20 61.36 43.7 10.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.499 -0.773 . . . . 0.34 110.565 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.632 ' HB2' HD11 ' A' ' 47' ' ' ILE . 60.3 m -82.78 99.03 9.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.349 -0.841 . . . . 0.81 111.0 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.3 m -89.37 131.98 38.77 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.436 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.438 ' HA ' HG22 ' A' ' 69' ' ' THR . 11.6 Cg_endo -68.55 126.43 14.11 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.079 2.52 . . . . 0.39 112.208 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.2 pt -105.8 152.41 40.17 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.769 -0.65 . . . . 0.57 111.091 -174.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 18.2 Cg_exo . . . . . 0 N--CA 1.463 -0.281 0 C-N-CA 123.246 2.63 . . . . 1.05 112.455 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.408 ' HB2' HD13 ' A' ' 16' ' ' LEU . 76.3 m95 . . . . . 0 C--O 1.236 0.36 0 N-CA-C 110.101 -0.333 . . . . 0.81 110.101 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.2 109.14 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.481 . . . . 2.73 111.174 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.493 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 11.1 m -105.44 26.45 9.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.829 -0.623 . . . . 1.75 110.491 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.506 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -59.47 -15.25 16.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.952 -0.567 . . . . 3.24 112.102 -176.504 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -73.02 -15.58 61.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.084 0.468 . . . . 2.05 110.958 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.4 8.26 70.42 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.822 -0.626 . . . . 0.88 111.664 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.5 t -88.07 -9.71 52.47 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.863 0.363 . . . . 1.72 110.692 -176.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.2 t -123.71 139.78 53.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.167 0.508 . . . . 1.19 110.307 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -31.89 13.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.27 -0.877 . . . . 1.66 112.521 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -102.27 -20.6 14.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.263 0.468 . . . . 0.52 112.263 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.493 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 89.96 4.83 71.63 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.725 -0.75 . . . . 0.43 112.654 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.616 ' HD3' HG13 ' A' ' 74' ' ' VAL . 66.7 mttm -93.8 88.9 5.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.75 0.309 . . . . 1.64 110.478 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 69' ' ' THR . 7.8 mp -93.66 109.36 21.0 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.541 -0.54 . . . . 0.55 109.541 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -124.13 144.2 50.03 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.872 0.368 . . . . 0.29 110.956 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 81.5 m -79.91 98.22 7.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 0.74 109.478 175.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 73.1 m -113.42 156.99 22.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.125 0.488 . . . . 0.5 111.461 -169.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 22.7 m-20 -92.01 93.07 8.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.37 -0.832 . . . . 1.65 109.298 174.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.4 p -64.91 -15.23 61.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.693 0.627 . . . . 0.52 112.693 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -106.51 0.44 24.66 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.989 0.899 . . . . 2.2 108.67 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 20' ' ' ASP . 48.2 tptt -123.98 98.9 6.0 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.08 -1.418 . . . . 2.6 109.529 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -89.16 164.76 14.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.561 -1.199 . . . . 2.17 111.022 -171.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.539 HG22 ' CD ' ' A' ' 48' ' ' GLN . 3.5 t -117.74 149.88 19.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.854 -0.612 . . . . 0.59 110.264 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -80.73 -40.14 25.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.345 -0.613 . . . . 2.83 109.345 174.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -69.4 121.24 16.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.592 -0.731 . . . . 4.07 109.11 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -149.87 79.17 1.37 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.797 -0.361 . . . . 2.46 111.584 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 m -136.54 -61.0 0.7 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.639 -0.424 . . . . 2.0 111.434 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.41 164.11 15.6 Favored Glycine 0 C--N 1.32 -0.327 0 C-N-CA 121.036 -0.602 . . . . 1.39 112.035 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -101.53 -42.26 6.31 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.235 0.457 . . . . 3.06 112.235 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--N 1.327 -0.391 0 C-N-CA 120.87 -0.332 . . . . 2.44 111.434 -175.05 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HB3' HG23 ' A' ' 82' ' ' ILE . 12.7 mt-30 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.283 0.563 . . . . 1.4 111.407 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.17 121.52 63.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.316 -0.857 . . . . 1.37 109.334 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.99 133.2 52.64 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.638 -0.71 . . . . 0.3 111.229 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.47 HD11 ' HB2' ' A' ' 84' ' ' CYS . 12.7 pt -125.61 153.75 33.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.529 -0.76 . . . . 0.23 109.972 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.539 ' CD ' HG22 ' A' ' 25' ' ' VAL . 2.9 mp0 -67.69 139.9 56.76 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.389 -0.597 . . . . 2.38 109.389 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.8 t -138.91 156.44 47.27 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.252 -0.431 . . . . 1.15 110.757 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -161.43 140.27 9.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.981 -0.554 . . . . 0.6 109.805 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.528 HE22 HD12 ' A' ' 60' ' ' ILE . 43.9 tp60 -114.6 155.23 26.92 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.026 0.441 . . . . 2.08 110.451 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.51 HG23 ' HD2' ' A' ' 53' ' ' PRO . 42.0 mm -86.82 150.7 51.03 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.228 -0.896 . . . . 0.95 108.967 176.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD2' HG23 ' A' ' 52' ' ' ILE . 51.6 Cg_exo -35.14 111.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.137 2.558 . . . . 0.95 111.842 171.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.66 133.17 55.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.175 -0.92 . . . . 1.67 112.926 -167.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.19 124.52 49.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.096 -0.956 . . . . 1.58 109.252 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 56' ' ' ILE . 15.6 mt -64.2 130.38 29.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.24 -0.436 . . . . 2.11 110.857 -174.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.84 15.18 71.18 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.418 -0.81 . . . . 1.03 113.217 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.448 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -100.26 152.67 4.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.693 0.759 . . . . 0.77 111.643 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.41 145.91 25.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.363 -1.29 . . . . 0.68 111.237 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.528 HD12 HE22 ' A' ' 51' ' ' GLN . 8.2 tp -53.69 -34.26 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 114.358 -1.292 . . . . 0.69 112.836 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.72 -4.81 58.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.739 0.304 . . . . 2.2 111.655 -172.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -110.09 -27.19 9.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.094 0.473 . . . . 1.98 110.133 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.448 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 32.3 tt0 -71.43 -39.49 71.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.782 -0.645 . . . . 2.09 110.933 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.7 p -121.08 169.06 10.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.214 -0.448 . . . . 0.6 110.492 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -113.98 26.83 9.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.089 0.471 . . . . 2.32 110.455 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 17.0 m-80 -107.06 -160.92 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 1.06 110.126 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 12.4 m -96.63 126.7 42.28 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 120.976 0.417 . . . . 0.34 110.501 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.96 129.21 6.1 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.979 2.453 . . . . 0.45 111.03 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 65.5 p -132.14 157.37 44.44 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.754 -0.379 . . . . 0.31 110.936 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 40.7 t -106.12 102.28 11.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.048 -0.524 . . . . 1.26 109.647 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 55.6 m -88.08 133.75 33.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.973 0.416 . . . . 0.29 110.56 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.0 tt0 -76.3 -23.58 54.34 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.875 -0.602 . . . . 1.53 110.102 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -158.77 169.26 24.78 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.65 -0.87 . . . . 1.26 108.65 170.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.616 HG13 ' HD3' ' A' ' 15' ' ' LYS . 32.8 m -135.84 146.05 30.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.77 0.319 . . . . 1.07 110.562 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -112.22 150.21 31.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.342 -0.985 . . . . 1.87 108.342 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.8 -156.32 0.33 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.754 -0.832 . . . . 1.94 108.754 -170.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -83.07 23.16 0.88 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.522 0.677 . . . . 2.12 110.762 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.568 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 104.22 21.85 9.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.588 -0.815 . . . . 0.51 112.955 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 84.0 mt -85.16 -17.13 38.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.064 0.459 . . . . 1.1 109.987 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.1 t -129.61 110.82 20.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.51 -0.768 . . . . 0.33 109.156 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -101.78 140.62 14.95 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.181 -1.009 . . . . 0.26 112.334 -176.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.486 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -97.52 119.36 45.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.058 -0.349 . . . . 0.3 110.058 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 96.0 m-20 59.81 50.54 6.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.678 -0.692 . . . . 0.34 110.832 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.566 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.5 m -85.0 91.34 8.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.379 -0.828 . . . . 0.81 110.924 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.1 m -74.94 126.09 88.64 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.675 -0.693 . . . . 0.44 110.379 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.38 121.66 9.14 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.856 2.37 . . . . 0.39 111.818 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.4 pt -101.09 154.54 37.1 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.799 -0.637 . . . . 0.57 110.847 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 C--O 1.233 0.265 0 C-N-CA 123.206 2.604 . . . . 1.05 112.794 -179.726 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 77.1 m95 . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.81 112.115 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -63.41 108.4 1.33 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.269 -0.878 . . . . 2.73 111.257 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -101.11 -17.5 16.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.162 -0.926 . . . . 1.75 109.365 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' C ' ' HD2' ' A' ' 7' ' ' LYS . 2.7 pptp? -69.54 -17.89 63.61 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.901 -0.591 . . . . 3.24 110.745 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.2 m -72.73 -26.85 61.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 2.05 111.159 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.65 16.25 75.93 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.982 -0.628 . . . . 0.88 112.654 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.632 ' OG ' ' HB ' ' A' ' 87' ' ' ILE . 7.8 t -87.32 -29.0 21.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.946 0.403 . . . . 1.72 110.77 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.8 t -115.39 140.94 48.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.898 0.38 . . . . 1.19 110.701 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.5 p30 -93.09 -25.87 17.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.075 -0.511 . . . . 1.66 112.038 -177.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.43 HG21 ' HA ' ' A' ' 72' ' ' GLU . 43.9 p -92.97 -30.47 15.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.52 111.686 -174.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.97 -4.41 59.03 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.748 -0.739 . . . . 0.43 112.027 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.501 ' HD3' HG23 ' A' ' 74' ' ' VAL . 53.3 mttp -94.19 89.95 6.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.862 0.363 . . . . 1.64 110.666 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.1 mp -96.17 113.35 24.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.256 -0.429 . . . . 0.55 110.627 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.04 151.1 49.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.877 0.37 . . . . 0.29 110.312 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.637 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 60.8 m -84.84 103.2 13.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.007 -0.738 . . . . 0.74 109.007 173.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 98.4 m -113.13 142.97 45.14 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.17 0.51 . . . . 0.5 110.975 -174.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 44.0 m-20 -97.69 109.19 21.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.487 -0.779 . . . . 1.65 109.238 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 p -75.64 -5.88 47.66 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.411 0.624 . . . . 0.52 110.033 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -89.46 -8.63 52.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.242 -0.89 . . . . 2.2 109.053 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.44 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 26.2 mtmt -121.57 142.75 49.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.812 -1.085 . . . . 2.6 110.145 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.472 ' HD3' HG22 ' A' ' 47' ' ' ILE . 33.7 mmtp -128.39 158.86 37.11 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.63 -0.714 . . . . 2.17 111.082 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 27' ' ' LYS . 10.7 t -124.15 150.03 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.085 -1.08 . . . . 0.59 108.085 173.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -76.48 31.76 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.09 0.404 . . . . 2.83 112.09 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 25' ' ' VAL . 14.6 mtmt 37.81 114.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.997 1.319 . . . . 4.07 113.451 -170.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.8 p -101.24 -81.03 0.49 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.378 -0.828 . . . . 2.46 110.008 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.74 -172.25 3.43 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.641 -1.163 . . . . 2.0 109.162 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.24 116.64 1.13 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.186 -0.766 . . . . 1.39 111.186 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.01 -31.59 72.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.89 0.345 . . . . 3.06 110.55 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 . . . . . 0 C--N 1.329 -0.315 0 N-CA-C 109.73 -0.471 . . . . 2.44 109.73 173.664 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 121.229 0.537 . . . . 1.4 111.955 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.51 126.99 75.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.338 -0.846 . . . . 1.37 109.023 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -110.88 114.33 27.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.301 -0.409 . . . . 0.3 111.805 -175.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.472 HG22 ' HD3' ' A' ' 24' ' ' LYS . 12.4 pt -111.06 163.7 7.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.78 -0.645 . . . . 0.23 109.653 172.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -88.84 127.62 35.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.47 0.652 . . . . 2.38 109.634 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 29.8 m -122.54 160.59 25.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.712 -1.131 . . . . 1.15 110.671 -172.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 11.2 t -160.89 142.49 12.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.774 -0.454 . . . . 0.6 109.774 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.458 HE21 HD12 ' A' ' 60' ' ' ILE . 8.0 tm0? -120.07 115.87 24.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.266 0.555 . . . . 2.08 110.817 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.418 HG23 ' HD2' ' A' ' 53' ' ' PRO . 68.7 mt -73.83 133.14 79.54 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.225 -0.898 . . . . 0.95 109.839 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD2' HG23 ' A' ' 52' ' ' ILE . 67.6 Cg_exo -33.57 111.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 124.817 3.678 . . . . 0.95 114.096 -172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 63' ' ' GLU . 4.1 pp -88.42 142.14 27.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.679 -1.146 . . . . 1.67 112.535 -170.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.418 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 67.7 mt -93.94 144.31 25.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.468 -0.787 . . . . 1.58 109.139 168.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 mt -68.78 130.75 33.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.932 0.396 . . . . 2.11 110.678 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.41 -0.57 80.99 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.551 -0.75 . . . . 1.03 112.51 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -93.67 154.08 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.603 0.716 . . . . 0.77 111.488 -178.234 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.01 132.27 34.75 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.758 -1.11 . . . . 0.68 111.377 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.458 HD12 HE21 ' A' ' 51' ' ' GLN . 5.5 tp -49.84 -39.46 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 114.761 -1.109 . . . . 0.69 111.505 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 60' ' ' ILE . 8.2 pt-20 -70.9 -34.09 71.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.276 -0.874 . . . . 2.2 111.842 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -91.62 -23.17 19.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.95 0.405 . . . . 1.98 110.843 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 54' ' ' LEU . 7.7 tp10 -73.1 -40.68 64.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 2.09 111.122 -176.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 66' ' ' ASN . 19.8 p -107.15 156.6 18.63 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.915 0.388 . . . . 0.6 110.809 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -98.65 55.71 1.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.208 -1.034 . . . . 2.32 108.208 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.637 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 14.2 m120 -138.97 -168.68 2.47 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.13 -1.396 . . . . 1.06 109.073 -172.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -104.46 126.09 32.38 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-O 120.895 0.378 . . . . 0.34 110.119 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -77.88 129.28 9.76 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.628 2.219 . . . . 0.45 110.997 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.0 p -129.51 150.56 50.8 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.096 0.474 . . . . 0.31 111.545 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 54.0 t -98.98 99.09 10.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.686 -0.857 . . . . 1.26 108.686 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 56.6 m -86.61 141.27 29.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 0.29 110.642 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 3.0 tt0 -64.12 -45.25 89.41 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.094 -0.706 . . . . 1.53 109.094 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -151.55 167.79 26.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.66 -1.155 . . . . 1.26 108.724 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.545 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -142.97 158.55 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.472 -0.566 . . . . 1.07 109.472 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.21 156.16 33.04 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.976 -0.379 . . . . 1.87 109.976 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 67.69 -150.08 0.16 Allowed 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 123.577 0.548 . . . . 1.94 109.677 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.419 ' OD1' ' HG ' ' A' ' 79' ' ' LEU . 11.4 p-10 -76.75 0.99 18.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.281 0.563 . . . . 2.12 109.715 174.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 49' ' ' CYS . . . 120.94 24.21 2.56 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.5 -0.773 . . . . 0.51 112.752 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 93.7 mt -79.66 -25.55 41.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.82 0.31 . . . . 1.1 111.757 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.0 t -125.8 107.52 17.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.066 -0.346 . . . . 0.33 110.066 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.571 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -102.13 144.65 16.34 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.391 -0.909 . . . . 0.26 112.911 -174.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 mp -100.41 118.21 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.442 -0.379 . . . . 0.3 110.064 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.607 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 93.8 m-20 59.02 43.96 16.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.739 -0.664 . . . . 0.34 111.151 174.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.571 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 69.5 m -78.26 97.16 5.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.842 -0.617 . . . . 0.81 110.958 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 23.8 m -88.4 130.05 47.13 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.725 -0.67 . . . . 0.44 110.207 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.5 Cg_exo -61.07 113.82 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.994 2.463 . . . . 0.39 112.108 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.632 ' HB ' ' OG ' ' A' ' 10' ' ' SER . 7.9 pt -82.47 138.96 44.43 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.91 -0.587 . . . . 0.57 110.835 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 17.1 Cg_exo . . . . . 0 N--CA 1.454 -0.821 0 C-N-CA 123.086 2.524 . . . . 1.05 111.537 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CD2' ' HB ' ' A' ' 60' ' ' ILE . 58.2 m95 . . . . . 0 CA--C 1.518 -0.282 0 CA-C-O 121.082 0.468 . . . . 0.81 111.59 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -66.75 109.65 2.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.361 -0.836 . . . . 2.73 110.411 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.3 m -93.95 27.98 2.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.461 -0.79 . . . . 1.75 110.441 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -45.49 -46.81 14.02 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.368 -0.833 . . . . 3.24 112.491 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 p -63.08 -23.92 67.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.202 -0.454 . . . . 2.05 112.165 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.26 5.12 89.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.097 -0.573 . . . . 0.88 111.702 -176.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.5 m -70.43 -13.89 62.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.565 -0.318 . . . . 1.72 111.635 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -131.91 141.12 49.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.015 0.436 . . . . 1.19 110.507 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -94.6 -30.29 14.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.413 -0.812 . . . . 1.66 112.479 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 p -89.52 -30.03 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.983 0.421 . . . . 0.52 111.947 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.58 3.07 71.98 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.575 -0.821 . . . . 0.43 111.556 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -95.74 87.99 4.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.347 0.594 . . . . 1.64 110.133 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.0 mp -97.35 137.95 35.56 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.351 -0.84 . . . . 0.55 109.758 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.87 145.18 35.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.032 0.444 . . . . 0.29 110.593 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 28.1 m -82.02 102.84 11.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.387 -0.968 . . . . 0.74 108.387 173.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 59.1 m -122.45 156.6 33.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.131 0.491 . . . . 0.5 111.544 -169.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -102.85 118.01 35.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.442 -0.799 . . . . 1.65 109.312 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.9 p -80.96 -5.19 57.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.972 0.415 . . . . 0.52 111.368 -174.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -97.43 -19.85 18.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.675 0.75 . . . . 2.2 109.568 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -104.28 137.89 41.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.683 -1.144 . . . . 2.6 110.614 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.501 ' HD3' HG22 ' A' ' 47' ' ' ILE . 33.6 mmtp -127.36 155.07 44.18 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.786 -1.097 . . . . 2.17 110.393 -172.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.499 HG22 ' OE1' ' A' ' 48' ' ' GLN . 6.3 t -111.35 145.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.32 -0.622 . . . . 0.59 109.32 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -84.38 -40.74 17.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.274 -0.421 . . . . 2.83 111.38 -172.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -95.51 126.24 40.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.493 -0.321 . . . . 4.07 110.309 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.5 p -141.82 113.92 8.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.191 -0.459 . . . . 2.46 110.724 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.9 m -140.23 -48.52 0.45 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.197 0.522 . . . . 2.0 110.318 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.98 171.19 32.58 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.385 -0.825 . . . . 1.39 111.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -100.85 -51.13 3.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.715 -0.476 . . . . 3.06 109.715 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.778 -0.646 . . . . 2.44 109.974 -179.737 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.461 ' HB3' HG23 ' A' ' 82' ' ' ILE . 33.9 mt-30 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.918 0.389 . . . . 1.4 110.033 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.2 t -96.51 105.13 16.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 116.084 -0.507 . . . . 1.37 109.859 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -102.86 99.67 9.61 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.521 -0.763 . . . . 0.3 110.852 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.501 HG22 ' HD3' ' A' ' 24' ' ' LYS . 19.2 pt -101.89 151.51 5.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.7 -0.682 . . . . 0.23 109.822 174.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.499 ' OE1' HG22 ' A' ' 25' ' ' VAL . 14.7 tp60 -76.82 126.04 30.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.584 -0.734 . . . . 2.38 109.973 -175.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 67.2 m -115.62 156.13 26.4 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.78 -1.1 . . . . 1.15 111.289 -173.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 t -160.23 114.08 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.525 -0.762 . . . . 0.6 109.782 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -120.38 131.91 55.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.997 -0.547 . . . . 2.08 111.063 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 64' ' ' CYS . 21.7 mt -63.45 142.74 97.91 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.407 -0.815 . . . . 0.95 110.946 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -37.1 129.41 0.56 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 124.246 3.297 . . . . 0.95 113.352 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -59.55 127.09 30.32 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.054 -0.976 . . . . 1.67 112.712 -171.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.5 107.88 17.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.636 -0.876 . . . . 1.58 108.636 170.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.3 mt -65.95 134.62 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.23 0.538 . . . . 2.11 111.124 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.16 -12.77 63.65 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.297 -0.865 . . . . 1.03 112.042 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.21 152.06 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.748 0.785 . . . . 0.77 111.92 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.52 137.78 33.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.093 -1.412 . . . . 0.68 110.579 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.569 ' HB ' ' CD2' ' A' ' 4' ' ' TRP . 11.1 tt -55.89 -39.67 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.547 -0.751 . . . . 0.69 112.244 -175.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.433 ' N ' HG23 ' A' ' 60' ' ' ILE . 2.3 pm0 -72.96 -12.68 61.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.682 -0.69 . . . . 2.2 110.903 -173.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -110.06 -17.46 13.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.433 0.635 . . . . 1.98 109.501 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -75.14 -40.95 59.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.736 -0.665 . . . . 2.09 110.09 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.543 ' HA ' HD12 ' A' ' 52' ' ' ILE . 13.9 p -108.96 175.55 5.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.012 -0.54 . . . . 0.6 110.006 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -123.82 25.72 7.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.769 0.319 . . . . 2.32 111.245 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 41.3 m-80 -113.25 -169.61 1.52 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.011 -0.366 . . . . 1.06 110.011 177.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 m -79.56 127.05 79.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.004 0.43 . . . . 0.34 110.83 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.51 127.38 5.73 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.875 2.383 . . . . 0.45 110.806 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.3 p -129.76 148.4 51.64 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.745 -0.382 . . . . 0.31 111.113 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 39.7 t -97.29 110.7 23.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.267 -0.642 . . . . 1.26 109.267 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 50.4 m -97.94 141.16 31.26 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.966 -0.561 . . . . 0.29 110.035 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 1.9 tt0 -74.07 -24.48 59.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.435 0.636 . . . . 1.53 109.358 176.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -163.31 164.38 24.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.109 -0.951 . . . . 1.26 108.688 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.533 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.4 t -138.72 138.72 41.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.566 -0.531 . . . . 1.07 109.566 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 25.3 tt0 -108.72 162.0 14.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.943 -0.571 . . . . 1.87 109.888 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 t70 65.27 -152.08 0.26 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.616 -0.512 . . . . 1.94 109.616 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.54 -5.74 31.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.609 0.719 . . . . 2.12 110.042 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.533 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 122.38 23.9 2.29 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.585 -0.734 . . . . 0.51 112.254 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.03 -19.8 28.12 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.95 0.405 . . . . 1.1 110.892 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 42.3 t -124.06 101.14 8.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.1 -0.5 . . . . 0.33 110.145 -174.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.629 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -90.77 138.55 14.44 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.073 -1.06 . . . . 0.26 111.95 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.461 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -98.72 117.31 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 109.816 -0.439 . . . . 0.3 109.816 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 92.2 m-20 62.55 52.89 2.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.348 -0.842 . . . . 0.34 110.579 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.629 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 59.7 m -89.96 105.82 18.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.457 -0.792 . . . . 0.81 111.121 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 56.0 m -93.74 129.36 38.41 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.879 -0.601 . . . . 0.44 110.338 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.3 Cg_exo -60.41 119.57 6.83 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.887 2.391 . . . . 0.39 111.509 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 pt -98.19 145.45 29.83 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.893 -0.594 . . . . 0.57 111.932 -172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo . . . . . 0 N--CA 1.458 -0.577 0 C-N-CA 123.303 2.669 . . . . 1.05 111.513 175.524 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.3 m95 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.971 0.415 . . . . 0.81 110.889 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -72.69 108.03 5.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 2.73 110.751 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 m -111.52 15.16 21.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.673 -0.694 . . . . 1.75 109.597 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.81 -33.93 76.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.244 -0.889 . . . . 3.24 111.598 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.9 p -65.87 -24.38 66.85 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.929 -0.578 . . . . 2.05 111.4 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.79 16.24 31.65 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.804 -0.713 . . . . 0.88 111.974 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 p -65.88 -32.01 73.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.897 0.38 . . . . 1.72 111.96 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.5 t -126.01 141.63 51.88 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.869 -0.332 . . . . 1.19 110.91 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.403 ' OD1' HG23 ' A' ' 13' ' ' THR . 7.2 p30 -93.27 -28.62 16.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.917 -0.583 . . . . 1.66 111.914 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 72' ' ' GLU . 1.8 p -98.18 -20.4 17.31 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.495 . . . . 0.52 112.335 -174.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.63 22.7 55.48 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.659 -0.782 . . . . 0.43 112.559 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 51.9 mttp -115.83 92.02 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.035 -0.357 . . . . 1.64 110.035 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.7 mp -98.36 130.5 45.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.907 0.384 . . . . 0.55 110.767 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -149.9 148.89 29.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.16 -0.473 . . . . 0.29 110.412 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 97.0 m -86.3 100.19 12.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.289 0.566 . . . . 0.74 110.283 175.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 61.5 m -114.3 158.06 21.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.665 -0.698 . . . . 0.5 109.834 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 2.5 t70 -99.46 129.2 45.62 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.861 -0.792 . . . . 1.65 108.861 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.9 p -84.74 -1.52 56.37 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.713 -0.395 . . . . 0.52 111.116 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -106.14 -14.29 15.19 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.164 -0.68 . . . . 2.2 109.164 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 29.0 mtpp -97.52 101.92 13.56 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.181 -0.918 . . . . 2.6 109.776 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -96.21 158.63 15.35 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.362 -0.381 . . . . 2.17 110.012 176.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.527 HG22 ' OE1' ' A' ' 48' ' ' GLN . 11.1 t -114.43 147.46 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.322 -0.622 . . . . 0.59 109.322 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -76.67 -27.44 55.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.171 -0.468 . . . . 2.83 111.191 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' H ' HG12 ' A' ' 25' ' ' VAL . 31.5 mmmt -93.21 129.49 39.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.58 -0.526 . . . . 4.07 109.58 177.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.3 m -132.84 32.1 3.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.207 0.527 . . . . 2.46 110.516 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.3 m -75.23 -54.85 6.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.41 -0.814 . . . . 2.0 110.331 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.22 111.8 0.71 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.923 -0.656 . . . . 1.39 112.485 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' A' ' 75' ' ' GLU . 39.6 mt-10 -70.35 -47.69 59.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.411 0.148 . . . . 3.06 110.966 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 74' ' ' VAL . 20.4 mm-40 . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 109.715 -0.476 . . . . 2.44 109.715 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.614 ' HB3' HG23 ' A' ' 82' ' ' ILE . 32.1 mt-30 . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.883 0.373 . . . . 1.4 110.609 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.08 105.55 16.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.159 -0.473 . . . . 1.37 110.075 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -98.45 110.42 23.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.519 -0.764 . . . . 0.3 111.29 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 84' ' ' CYS . 19.8 pt -113.31 148.74 16.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.969 -0.56 . . . . 0.23 110.307 174.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.527 ' OE1' HG22 ' A' ' 25' ' ' VAL . 10.4 tp60 -75.05 132.4 41.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.33 -0.85 . . . . 2.38 109.253 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.0 t -126.55 163.82 22.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.679 -0.691 . . . . 1.15 110.463 -171.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 t -161.2 127.96 4.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.12 0.486 . . . . 0.6 110.111 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -121.13 129.81 53.45 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.067 0.461 . . . . 2.08 111.463 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mt -71.66 137.71 83.09 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.217 -0.902 . . . . 0.95 109.717 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.3 109.29 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.037 3.158 . . . . 0.95 112.371 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.98 140.26 52.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.443 -0.798 . . . . 1.67 112.867 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 85.2 mt -93.2 147.55 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.888 -1.051 . . . . 1.58 108.544 167.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.4 mp -71.73 138.19 22.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.088 0.47 . . . . 2.11 110.276 -177.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.59 5.85 83.63 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.427 -0.806 . . . . 1.03 112.715 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.453 HG21 ' OE2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -93.36 154.29 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.569 0.7 . . . . 0.77 111.343 -177.674 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.32 134.85 33.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.613 -1.176 . . . . 0.68 111.01 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 61' ' ' GLU . 6.6 tp -50.68 -41.45 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.36 -0.836 . . . . 0.69 111.715 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.428 ' N ' HG23 ' A' ' 60' ' ' ILE . 3.0 pt-20 -74.84 -27.68 60.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.752 -0.658 . . . . 2.2 111.716 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -96.39 -22.33 17.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.349 -0.387 . . . . 1.98 110.698 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.453 ' OE2' HG21 ' A' ' 58' ' ' ILE . 9.0 tp10 -68.22 -36.71 79.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.576 0.703 . . . . 2.09 110.091 177.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.9 p -118.82 177.22 4.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.489 -0.778 . . . . 0.6 110.345 -172.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -125.53 40.92 3.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.742 0.782 . . . . 2.32 109.824 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 43.4 m-80 -126.65 -165.58 1.47 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.055 -0.975 . . . . 1.06 108.94 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 12.5 m -87.21 125.79 64.84 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 120.438 -0.505 . . . . 0.34 110.836 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.09 121.88 4.58 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.679 2.253 . . . . 0.45 110.472 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.5 p -129.79 151.57 50.22 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.138 -0.625 . . . . 0.31 111.809 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 12.2 t -99.35 101.58 12.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.297 -0.865 . . . . 1.26 109.105 171.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.642 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 59.8 m -84.99 133.2 34.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.627 0.727 . . . . 0.29 110.076 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 65.0 mt-10 -63.46 -40.29 96.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.779 -1.1 . . . . 1.53 109.71 175.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -153.61 166.0 34.15 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.31 -0.859 . . . . 1.26 109.002 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.509 HG13 ' HD3' ' A' ' 15' ' ' LYS . 15.8 m -133.98 160.27 41.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.159 0.504 . . . . 1.07 110.697 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 33.5 tt0 -129.55 155.03 46.44 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.8 -1.185 . . . . 1.87 107.8 173.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER 67.59 -156.01 0.21 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.565 -0.531 . . . . 1.94 109.565 -172.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.439 ' H ' ' HB3' ' A' ' 76' ' ' ASP . 31.2 t70 -73.11 -3.14 24.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.55 0.69 . . . . 2.12 110.224 173.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.27 22.94 2.76 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.793 -0.64 . . . . 0.51 111.615 -175.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.4 mt -86.05 -15.78 40.23 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.261 0.553 . . . . 1.1 109.955 175.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 73.5 t -123.32 112.86 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.37 -0.832 . . . . 0.33 108.922 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -106.82 137.06 13.72 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.011 -1.09 . . . . 0.26 112.238 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -99.55 120.71 49.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 122.437 0.295 . . . . 0.3 110.454 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 95.6 m-20 59.16 44.07 16.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.537 -0.756 . . . . 0.34 110.997 173.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.553 ' HB2' HD11 ' A' ' 47' ' ' ILE . 45.1 m -77.85 105.11 8.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.387 -0.824 . . . . 0.81 110.864 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 85.7 m -89.35 125.42 61.8 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.986 -0.552 . . . . 0.44 110.13 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 35.2 Cg_exo -62.67 121.97 10.12 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.751 2.301 . . . . 0.39 111.694 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.8 pt -92.44 144.83 29.46 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 116.199 -0.455 . . . . 0.57 110.318 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--O 1.234 0.303 0 C-N-CA 123.008 2.472 . . . . 1.05 112.073 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.1 m95 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 121.3 0.571 . . . . 0.81 111.985 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -82.6 109.43 16.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.107 -0.952 . . . . 2.73 111.092 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 t -105.83 28.76 7.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.729 -0.669 . . . . 1.75 109.324 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -26.09 30.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.44 -0.8 . . . . 3.24 112.791 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.6 m -78.19 -14.06 59.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.159 0.504 . . . . 2.05 111.003 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.42 16.53 68.63 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.357 -1.497 . . . . 0.88 109.357 -168.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.475 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 2.1 p -69.81 -30.82 68.43 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.887 -1.157 . . . . 1.72 112.775 -169.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.2 t -126.02 143.31 51.15 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.541 -0.464 . . . . 1.19 111.26 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.519 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.4 p30 -92.04 -29.16 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 1.66 111.425 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.519 HG23 ' OD1' ' A' ' 12' ' ' ASN . 22.4 p -97.48 -31.02 12.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.006 0.432 . . . . 0.52 111.97 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.64 2.74 58.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.826 -0.702 . . . . 0.43 111.582 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 41.2 mttp -90.89 88.27 6.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.753 0.311 . . . . 1.64 110.376 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.95 122.04 38.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.42 -0.355 . . . . 0.55 110.091 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.549 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -131.25 146.1 52.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.73 0.3 . . . . 0.29 110.58 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 50' ' ' THR . 35.4 m -85.18 98.38 10.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 0.74 109.89 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 65.3 m -116.76 157.91 24.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.433 -0.349 . . . . 0.5 111.462 -168.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.591 ' CB ' ' HD3' ' A' ' 23' ' ' LYS . 50.3 m-20 -102.76 112.86 25.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.183 -0.673 . . . . 1.65 109.183 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.8 p -74.81 -15.88 60.72 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.388 0.514 . . . . 0.52 112.388 -172.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -98.59 -0.4 43.21 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.764 0.792 . . . . 2.2 109.422 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HD3' ' CB ' ' A' ' 20' ' ' ASP . 35.4 mtpt -112.74 100.95 9.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.564 -1.198 . . . . 2.6 109.685 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.83 161.81 13.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.735 -0.666 . . . . 2.17 111.554 -174.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -127.79 142.31 44.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.045 -1.094 . . . . 0.59 108.045 173.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -90.94 -23.82 20.35 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.789 0.328 . . . . 2.83 111.201 -173.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 28.8 mmmt -103.48 119.78 39.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.112 0.482 . . . . 4.07 111.284 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.531 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 15.4 p -126.42 120.66 30.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.578 -0.737 . . . . 2.46 109.624 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.5 m -88.39 -54.33 4.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.548 -0.296 . . . . 2.0 110.575 -176.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.22 70.38 1.1 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.586 -0.816 . . . . 1.39 111.173 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -78.94 -27.68 43.64 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.636 0.236 . . . . 3.06 111.636 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 120.51 -0.476 . . . . 2.44 110.497 178.672 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HB3' HG23 ' A' ' 82' ' ' ILE . 96.2 mt-30 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 121.107 0.479 . . . . 1.4 111.476 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.96 119.53 62.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.643 -0.708 . . . . 1.37 110.024 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -100.45 124.99 46.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.962 -0.563 . . . . 0.3 110.899 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 84' ' ' CYS . 18.2 pt -118.93 152.11 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.127 0.489 . . . . 0.23 110.346 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.05 127.7 33.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.556 -0.905 . . . . 2.38 108.556 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.622 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 4.5 t -133.71 169.1 17.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.848 -0.614 . . . . 1.15 110.418 -170.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 11.7 t -160.02 137.04 9.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.072 0.463 . . . . 0.6 110.304 178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.27 132.82 55.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.001 0.429 . . . . 2.08 110.1 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.401 HG23 ' HD2' ' A' ' 53' ' ' PRO . 37.2 mm -80.71 144.97 57.14 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.95 110.468 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' HG23 ' A' ' 52' ' ' ILE . 2.7 Cg_exo -37.26 126.75 0.58 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.039 3.16 . . . . 0.95 113.345 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.88 123.71 17.89 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.258 -0.883 . . . . 1.67 113.121 -171.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.72 129.41 55.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.272 -0.876 . . . . 1.58 109.289 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 56' ' ' ILE . 3.2 mp -69.55 135.73 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.169 0.509 . . . . 2.11 110.7 -176.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.1 11.02 81.71 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.308 -0.86 . . . . 1.03 113.178 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.496 HD13 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -106.07 154.05 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.618 0.723 . . . . 0.77 112.326 -176.653 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.43 145.87 24.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.402 -1.272 . . . . 0.68 111.215 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 61' ' ' GLU . 7.2 tp -53.22 -43.39 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 122.866 0.466 . . . . 0.69 111.229 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.421 ' N ' HG23 ' A' ' 60' ' ' ILE . 8.5 pt-20 -74.33 -22.05 59.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.118 -0.492 . . . . 2.2 111.238 -175.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -90.48 -34.55 15.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.334 0.588 . . . . 1.98 109.753 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -67.9 -35.21 78.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.066 -0.97 . . . . 2.09 110.592 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.0 p -121.82 172.13 8.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.802 -0.635 . . . . 0.6 110.337 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -120.7 21.42 11.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 2.32 111.416 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.534 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 38.6 m-80 -104.12 -168.14 1.45 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.474 -0.565 . . . . 1.06 109.474 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -85.95 120.89 72.97 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-O 121.495 0.664 . . . . 0.34 111.465 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.83 122.52 9.9 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.353 2.702 . . . . 0.45 111.219 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.8 p -132.43 154.86 49.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.699 -0.228 . . . . 0.31 110.633 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 11.8 t -99.72 117.07 33.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.462 -0.57 . . . . 1.26 109.462 171.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 46.6 m -102.46 139.51 37.96 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.119 0.485 . . . . 0.29 109.748 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 6.6 tt0 -78.03 -20.88 51.6 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.512 0.673 . . . . 1.53 109.724 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.401 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 22.8 t0 -159.34 158.96 33.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.325 -0.991 . . . . 1.26 108.325 171.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.496 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.6 OUTLIER -148.65 129.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 117.852 0.297 . . . . 1.07 110.465 178.711 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.51 165.91 13.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.731 0.301 . . . . 1.87 110.591 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.82 -150.16 0.31 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.587 -0.733 . . . . 1.94 110.24 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.94 5.08 14.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.96 0.409 . . . . 2.12 110.141 172.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 118.57 24.04 3.25 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.665 -0.779 . . . . 0.51 112.691 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.06 -21.29 29.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.05 0.425 . . . . 1.1 111.534 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.08 102.79 8.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.891 -0.411 . . . . 0.33 109.891 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -102.34 139.76 14.56 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.455 -0.879 . . . . 0.26 112.966 -176.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.426 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -96.0 120.95 46.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 122.737 0.415 . . . . 0.3 109.905 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 95.5 m-20 60.76 48.62 6.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.525 -0.761 . . . . 0.34 110.975 173.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.622 ' HB2' HD11 ' A' ' 47' ' ' ILE . 57.4 m -83.1 111.42 18.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.619 -0.718 . . . . 0.81 110.564 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 24.7 m -105.29 128.11 27.27 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.704 -0.68 . . . . 0.44 109.918 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.9 Cg_exo -59.95 125.33 17.39 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.976 2.451 . . . . 0.39 112.099 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.475 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 16.2 pt -96.49 162.45 23.4 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 115.55 -0.75 . . . . 0.57 111.107 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 N--CA 1.46 -0.466 0 C-N-CA 123.237 2.624 . . . . 1.05 112.176 -178.54 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.466 ' CZ2' HD22 ' A' ' 54' ' ' LEU . 49.1 m95 . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 120.899 0.38 . . . . 0.81 111.219 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.556 ' OE2' ' HD2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -65.77 108.25 2.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.629 -0.878 . . . . 2.73 108.629 175.647 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 m -106.75 28.21 8.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.968 -0.56 . . . . 1.75 112.344 -167.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.556 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -50.35 -25.24 3.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.834 0.679 . . . . 3.24 112.834 -177.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 t -71.76 -28.66 63.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 2.05 111.733 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.81 1.44 54.62 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.173 -0.537 . . . . 0.88 113.226 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -77.33 -15.89 59.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.773 0.286 . . . . 1.72 111.773 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.59 139.96 38.19 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.577 -0.449 . . . . 1.19 110.206 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -94.54 -21.73 18.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.748 0.648 . . . . 1.66 112.748 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 p -104.41 -30.89 9.79 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.229 0.455 . . . . 0.52 112.229 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.47 -3.27 59.43 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.612 -0.804 . . . . 0.43 111.999 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.599 ' NZ ' ' HA ' ' A' ' 73' ' ' ASP . 90.4 mttt -87.91 88.07 7.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.095 0.474 . . . . 1.64 109.967 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -93.53 103.07 15.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.865 -0.607 . . . . 0.55 110.189 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.41 154.06 28.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.105 0.478 . . . . 0.29 110.752 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 65.6 m -88.94 103.62 16.2 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.611 -0.722 . . . . 0.74 109.179 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -125.44 150.72 47.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.057 0.456 . . . . 0.5 112.037 -170.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.87 104.24 16.32 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.619 -0.719 . . . . 1.65 110.321 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.473 HG21 ' HG3' ' A' ' 86' ' ' PRO . 74.4 p -72.48 -5.79 39.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.078 0.466 . . . . 0.52 111.327 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -96.91 -22.68 16.73 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.846 0.831 . . . . 2.2 109.013 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 48' ' ' GLN . 27.5 tptt -106.88 110.98 23.29 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.245 -1.343 . . . . 2.6 109.895 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -100.93 161.88 13.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.428 -0.806 . . . . 2.17 111.861 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 t -126.2 148.0 30.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.236 -0.893 . . . . 0.59 108.807 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -97.93 22.14 9.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.821 0.343 . . . . 2.83 111.419 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -134.45 119.93 19.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.222 -0.444 . . . . 4.07 110.119 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 73.5 p -140.85 86.09 2.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.909 0.385 . . . . 2.46 110.528 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.1 m -108.28 -47.66 3.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.24 0.543 . . . . 2.0 110.203 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.69 164.02 34.16 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.251 -0.886 . . . . 1.39 112.739 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 21.9 mm-40 -101.78 -45.19 5.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.065 0.46 . . . . 3.06 109.915 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.445 -0.716 0 CA-C-N 115.829 -0.623 . . . . 2.44 109.78 179.582 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.548 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.6 mt-30 . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.236 0.541 . . . . 1.4 111.182 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.776 HG12 ' HA ' ' A' ' 83' ' ' ASN . 14.7 p -105.66 127.92 60.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.413 -0.812 . . . . 1.37 110.163 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.82 121.86 45.59 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.36 -0.836 . . . . 0.3 110.379 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.569 HD11 ' HB2' ' A' ' 84' ' ' CYS . 19.1 pt -130.7 160.8 41.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.891 -0.595 . . . . 0.23 109.697 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 1.5 mm-40 -77.34 135.76 38.4 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.504 0.668 . . . . 2.38 110.642 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.6 m -131.11 153.57 49.21 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.453 -1.248 . . . . 1.15 110.146 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 8.4 t -156.56 128.34 7.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.083 0.468 . . . . 0.6 110.038 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 tm0? -120.87 110.62 16.53 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.989 0.424 . . . . 2.08 110.515 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mt -65.73 128.94 94.19 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.619 -0.719 . . . . 0.95 109.889 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -34.0 99.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 125.128 3.885 . . . . 0.95 113.531 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.466 HD22 ' CZ2' ' A' ' 4' ' ' TRP . 3.3 pp -70.29 136.89 50.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.851 -1.068 . . . . 1.67 112.393 -172.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.4 mt -94.95 120.6 35.43 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.494 -0.928 . . . . 1.58 108.494 168.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.06 133.09 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.361 0.601 . . . . 2.11 111.081 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.43 -24.96 22.99 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.085 -0.962 . . . . 1.03 111.478 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -87.06 155.03 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.466 0.65 . . . . 0.77 111.107 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.85 143.94 26.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.666 -1.152 . . . . 0.68 111.624 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 tp -54.71 -35.25 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.018 -0.992 . . . . 0.69 110.974 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -76.79 -16.8 59.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.069 -0.969 . . . . 2.2 111.701 -173.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.33 -24.5 11.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.09 0.471 . . . . 1.98 110.704 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.8 tp10 -74.93 -38.04 61.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.848 -0.615 . . . . 2.09 111.1 -175.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 p -113.61 173.14 6.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.251 -0.277 . . . . 0.6 110.251 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -118.84 46.19 1.91 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.221 0.534 . . . . 2.32 110.699 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 42.4 m-80 -135.39 -174.16 3.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.822 -0.626 . . . . 1.06 109.331 175.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.6 m -80.35 125.29 81.46 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-O 121.403 0.62 . . . . 0.34 111.786 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -63.05 115.52 3.01 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.339 2.693 . . . . 0.45 110.998 171.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.3 p -127.26 143.32 51.26 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.322 -0.551 . . . . 0.31 111.265 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 36.0 t -93.27 106.19 18.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 1.26 109.68 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 57.1 m -92.73 134.0 35.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.156 -0.474 . . . . 0.29 109.959 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -64.9 -36.08 83.21 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.206 -0.665 . . . . 1.53 109.206 175.154 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.599 ' HA ' ' NZ ' ' A' ' 15' ' ' LYS . 40.3 t0 -152.25 165.55 34.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.368 -0.975 . . . . 1.26 108.368 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.502 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.2 t -136.48 133.55 49.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.633 -0.506 . . . . 1.07 109.633 175.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 31' ' ' GLU . 16.1 tt0 -102.94 164.69 11.47 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.139 -0.482 . . . . 1.87 109.701 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 78' ' ' GLY . 1.8 m-20 63.67 -156.52 0.32 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.272 0.357 . . . . 1.94 110.156 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.45 23.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.895 0.379 . . . . 2.12 110.882 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 95.7 22.62 20.66 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.949 -0.643 . . . . 0.51 111.777 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.401 ' HB3' HE22 ' A' ' 48' ' ' GLN . 81.7 mt -90.21 -18.68 25.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 1.1 111.247 -177.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.9 t -131.69 109.98 16.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.772 -0.455 . . . . 0.33 109.772 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -97.04 144.83 17.58 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.28 -0.962 . . . . 0.26 112.382 -177.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -100.77 120.83 50.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.866 -0.42 . . . . 0.3 109.866 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.776 ' HA ' HG12 ' A' ' 45' ' ' VAL . 89.4 m-20 58.46 53.76 6.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.026 -0.534 . . . . 0.34 110.807 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.596 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 66.8 m -89.36 95.44 10.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.728 -0.669 . . . . 0.81 110.94 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 8.0 m -88.18 127.25 57.97 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.718 -0.674 . . . . 0.44 110.732 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.473 ' HG3' HG21 ' A' ' 21' ' ' THR . 39.7 Cg_exo -62.57 118.01 4.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.896 2.397 . . . . 0.39 111.63 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.6 pt -97.98 148.45 34.49 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.925 -0.579 . . . . 0.57 111.558 -174.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.4 Cg_exo . . . . . 0 C--N 1.345 0.375 0 C-N-CA 123.355 2.703 . . . . 1.05 111.872 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 N-CA-C 112.205 -0.358 . . . . 5.75 112.205 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -148.78 163.76 36.41 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.743 -0.269 . . . . 4.66 110.387 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.45 -82.32 1.35 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.817 -0.706 . . . . 1.6 112.16 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -121.5 144.33 48.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.927 0.394 . . . . 0.81 111.079 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -66.55 108.95 2.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.631 -0.713 . . . . 2.73 110.463 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -108.97 25.99 11.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.676 -0.693 . . . . 1.75 110.448 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -20.08 62.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.903 -0.59 . . . . 3.24 111.414 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -69.06 -20.41 64.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.123 0.487 . . . . 2.05 110.699 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.65 7.09 87.25 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.836 -0.62 . . . . 0.88 112.637 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 m -70.96 -27.46 63.75 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.783 0.29 . . . . 1.72 111.783 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.1 t -108.53 141.64 40.14 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.93 -0.308 . . . . 1.19 110.383 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.501 ' OD1' HG23 ' A' ' 13' ' ' THR . 9.5 p30 -93.22 -19.87 21.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 1.66 112.129 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.501 HG23 ' OD1' ' A' ' 12' ' ' ASN . 19.8 p -108.86 -31.11 7.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.914 0.388 . . . . 0.52 111.957 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.13 2.09 56.96 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.749 -0.739 . . . . 0.43 111.943 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.66 ' HD3' HG23 ' A' ' 74' ' ' VAL . 78.3 mttt -94.87 89.23 5.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.127 0.489 . . . . 1.64 110.443 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.4 mp -93.61 128.56 39.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 0.55 109.999 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -137.16 156.75 47.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.517 -0.31 . . . . 0.29 110.301 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 50' ' ' THR . 82.4 m -91.91 97.66 11.1 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.278 -0.638 . . . . 0.74 109.278 173.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 82.4 m -111.64 155.65 23.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.963 0.411 . . . . 0.5 111.066 -171.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 20.5 t0 -98.24 127.82 44.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.033 -1.099 . . . . 1.65 108.033 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.7 p -92.69 1.88 57.03 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.362 0.601 . . . . 0.52 110.501 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -105.55 -25.05 12.46 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.982 -0.748 . . . . 2.2 108.982 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 26.2 mtmm -102.32 135.9 43.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.204 -0.907 . . . . 2.6 110.092 176.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -139.96 164.45 29.97 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.561 -0.745 . . . . 2.17 111.954 -176.236 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.44 HG21 HG22 ' A' ' 80' ' ' VAL . 2.5 t -117.88 148.49 20.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.609 -0.723 . . . . 0.59 110.123 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -83.88 -21.43 31.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.317 -0.401 . . . . 2.83 111.191 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.9 mmpt? -94.13 136.21 34.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.349 -0.611 . . . . 4.07 109.349 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 23.0 p -156.92 96.65 1.62 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.799 0.333 . . . . 2.46 111.632 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -122.16 -69.12 0.85 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.758 -0.377 . . . . 2.0 111.475 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.37 77.87 0.49 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.974 -0.85 . . . . 1.39 110.974 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -103.43 20.55 17.62 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.449 0.537 . . . . 3.06 112.449 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.486 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . 83.8 mt-10 -86.84 -60.97 1.84 Allowed 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 120.102 -0.639 . . . . 2.44 109.948 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.2 m -92.21 -31.17 15.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.59 0.71 . . . . 2.36 109.197 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.05 44.92 1.99 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.897 -1.047 . . . . 2.54 112.733 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.665 HD12 ' H ' ' A' ' 35' ' ' LEU . 5.5 mp -40.69 -53.95 2.69 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.115 0.483 . . . . 3.49 110.254 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.4 tp -108.74 97.07 6.77 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.218 -0.66 . . . . 4.79 109.218 170.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -111.87 -26.52 8.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.005 -0.543 . . . . 6.59 111.125 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.2 m -63.85 -26.44 68.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.762 -0.654 . . . . 5.42 112.372 -169.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.02 6.61 66.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.107 -1.044 . . . . 3.27 112.741 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -119.99 -51.06 2.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.077 0.465 . . . . 4.15 110.442 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.75 131.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.858 -0.61 . . . . 2.58 111.761 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.8 mt -118.56 -11.16 9.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.337 -0.847 . . . . 3.5 110.121 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -85.64 1.35 49.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.471 -0.786 . . . . 2.29 111.203 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.494 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 26.1 mt-30 -44.52 131.7 6.46 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.725 0.64 . . . . 1.4 111.622 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.4 t -100.14 123.08 52.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.171 -0.922 . . . . 1.37 109.713 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . -110.04 100.48 9.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.637 -0.71 . . . . 0.3 110.658 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 12.2 pt -100.88 149.64 6.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.918 -0.583 . . . . 0.23 110.591 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.79 126.63 30.2 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.768 -0.827 . . . . 2.38 108.768 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.486 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -126.07 158.64 34.9 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.88 -0.6 . . . . 1.15 110.203 -172.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 5.2 t -160.59 127.57 4.26 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.24 -0.436 . . . . 0.6 110.116 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.434 HE21 HD12 ' A' ' 60' ' ' ILE . 5.0 tm0? -116.4 107.64 15.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.496 0.665 . . . . 2.08 111.044 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mt -64.6 134.29 95.97 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 114.855 -1.066 . . . . 0.95 109.665 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -32.33 101.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.699 3.599 . . . . 0.95 114.259 -170.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 54' ' ' LEU . 3.9 pp -75.82 142.15 42.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.15 -1.387 . . . . 1.67 113.099 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.1 mp -91.68 145.26 24.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.359 -0.837 . . . . 1.58 109.288 167.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.4 136.17 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 2.11 110.778 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.12 -7.77 69.93 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.577 -0.738 . . . . 1.03 112.865 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.491 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -81.75 160.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.372 0.605 . . . . 0.77 111.762 -175.261 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' N ' HG23 ' A' ' 58' ' ' ILE . . . -90.07 129.95 36.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.032 -0.985 . . . . 0.68 111.202 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.434 HD12 HE21 ' A' ' 51' ' ' GLN . 8.6 tp -53.92 -36.66 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 114.984 -1.007 . . . . 0.69 112.353 -177.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.13 -21.83 49.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.744 0.307 . . . . 2.2 111.432 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.91 -26.57 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.079 0.466 . . . . 1.98 110.599 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.491 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 9.7 tp10 -68.63 -35.01 76.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.802 -0.635 . . . . 2.09 111.136 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.9 p -127.39 154.44 45.0 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.872 0.368 . . . . 0.6 110.902 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -98.84 56.07 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.871 0.843 . . . . 2.32 109.726 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 52.1 m-80 -137.86 -170.38 2.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.129 -0.941 . . . . 1.06 108.727 175.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.0 m -89.35 126.09 59.63 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-O 121.114 0.483 . . . . 0.34 110.592 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.94 120.44 4.65 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.686 2.258 . . . . 0.45 111.079 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.753 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 2.8 p -120.59 157.85 28.62 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.884 -0.598 . . . . 0.31 111.567 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 34.0 t -108.97 104.51 13.76 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.206 -0.664 . . . . 1.26 109.206 170.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.489 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 92.1 m -87.38 139.59 30.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.359 -0.608 . . . . 0.29 109.359 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.1 tt0 -71.57 -31.24 66.76 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.064 -0.717 . . . . 1.53 109.064 174.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 32' ' ' GLU . 6.9 t0 -156.33 164.02 38.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.866 -1.161 . . . . 1.26 107.866 171.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.66 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.4 t -137.01 139.12 45.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.652 -0.419 . . . . 1.07 110.022 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 10.1 tt0 -100.13 159.01 15.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.156 -0.475 . . . . 1.87 109.963 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 61.73 -151.22 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.066 -0.515 . . . . 1.94 110.133 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -79.65 16.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.083 0.468 . . . . 2.12 110.579 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.562 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 110.49 21.76 6.72 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.813 -0.63 . . . . 0.51 112.3 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.92 -21.87 31.72 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.758 0.281 . . . . 1.1 111.758 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 21.7 t -127.72 103.63 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.898 -0.321 . . . . 0.33 110.43 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.489 ' HA3' ' SG ' ' A' ' 71' ' ' CYS . . . -91.84 123.79 7.37 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.057 -1.068 . . . . 0.26 112.265 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -86.43 118.34 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.671 -0.492 . . . . 0.3 109.671 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 92.9 m-20 59.99 41.78 16.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.34 110.764 174.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.753 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -81.21 109.97 16.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.81 110.457 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 17.2 m -94.17 130.27 34.71 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.776 -0.647 . . . . 0.44 109.698 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.3 Cg_exo -60.62 109.96 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.715 2.277 . . . . 0.39 111.442 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 5.5 pt -74.66 141.66 76.28 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 115.623 -0.717 . . . . 0.57 111.26 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.3 Cg_exo -68.8 154.85 70.39 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.278 2.652 . . . . 1.05 112.392 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.7 mt -91.38 24.67 2.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.635 -0.711 . . . . 1.45 110.429 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 90' ' ' ILE . 24.3 pt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 116.152 -0.477 . . . . 2.31 111.243 -173.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.882 -0.487 . . . . 5.75 111.882 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -90.78 37.73 0.93 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.883 0.373 . . . . 4.66 110.54 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.91 -62.85 3.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 1.6 111.692 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.44 ' CH2' HD22 ' A' ' 54' ' ' LEU . 94.5 m95 -92.49 139.97 30.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.737 0.303 . . . . 0.81 110.199 176.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.521 ' OE1' ' HG2' ' A' ' 7' ' ' LYS . 30.9 tt0 -59.37 109.05 0.8 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.488 -0.778 . . . . 2.73 110.848 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -91.54 27.51 1.98 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.64 -0.709 . . . . 1.75 111.429 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HG2' ' OE1' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -56.45 -25.87 52.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.066 -0.516 . . . . 3.24 112.179 -176.031 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p -77.15 -30.01 54.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.049 0.452 . . . . 2.05 111.537 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.55 15.04 80.65 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.88 112.087 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.404 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 10.9 p -77.47 -25.18 50.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.307 0.484 . . . . 1.72 112.307 -174.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -102.97 142.68 33.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.218 -0.446 . . . . 1.19 110.933 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.539 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.8 p30 -91.11 -29.25 17.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.789 -0.641 . . . . 1.66 111.478 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.539 HG23 ' OD1' ' A' ' 12' ' ' ASN . 13.0 p -100.91 -31.19 11.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.104 0.478 . . . . 0.52 111.627 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.86 -2.88 52.25 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.815 -0.707 . . . . 0.43 112.115 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.587 ' HD3' HG23 ' A' ' 74' ' ' VAL . 90.7 mttt -86.72 88.76 7.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.009 0.433 . . . . 1.64 110.428 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 69' ' ' THR . 9.6 mp -92.32 110.73 22.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.55 110.492 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.0 149.23 39.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.08 0.467 . . . . 0.29 110.482 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -87.03 106.01 17.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.64 -0.709 . . . . 0.74 109.167 172.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -122.8 154.37 38.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.084 -0.507 . . . . 0.5 111.52 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 4.1 m-20 -100.03 114.64 28.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.509 -0.769 . . . . 1.65 109.174 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.0 p -74.82 -7.02 52.17 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.134 0.492 . . . . 0.52 110.968 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -98.01 -6.51 31.8 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.018 -0.734 . . . . 2.2 109.018 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 46.1 mtpt -111.62 98.71 7.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.83 -1.077 . . . . 2.6 109.759 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.82 157.67 16.14 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.271 -0.877 . . . . 2.17 110.782 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 t -120.22 145.15 26.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.684 -0.858 . . . . 0.59 108.684 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -95.18 29.84 2.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.065 0.46 . . . . 2.83 111.442 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 7.3 mmpt? -129.17 161.16 30.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.046 -0.525 . . . . 4.07 109.831 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 p -150.12 66.2 0.97 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.129 0.49 . . . . 2.46 110.406 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 m -122.1 143.69 49.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.753 -0.658 . . . . 2.0 109.679 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.03 148.78 18.56 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.215 -0.993 . . . . 1.39 112.842 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -78.61 -38.17 40.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.915 0.388 . . . . 3.06 110.285 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -110.96 -43.18 3.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 2.44 110.186 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.0 t -65.55 -25.34 67.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.954 -0.567 . . . . 2.36 110.034 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.3 -14.79 69.38 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.887 -0.597 . . . . 2.54 112.882 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.93 -30.14 44.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.446 0.641 . . . . 3.49 109.658 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.9 mt -91.7 173.04 8.08 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.359 -0.837 . . . . 4.79 109.724 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -78.58 -3.59 44.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.436 0.636 . . . . 6.59 109.693 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 m -72.27 -29.18 63.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.237 -0.892 . . . . 5.42 110.562 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.453 ' HA2' ' OE1' ' A' ' 44' ' ' GLN . . . -96.21 7.9 66.95 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.814 -0.63 . . . . 3.27 111.973 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.96 -47.04 15.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.529 0.68 . . . . 4.15 110.099 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 41' ' ' VAL . 2.5 m -60.29 145.64 11.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.478 -1.237 . . . . 2.58 113.362 -174.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.6 mt -82.32 -8.71 59.63 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.649 -1.16 . . . . 3.5 109.544 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.4 -26.55 68.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.36 -0.836 . . . . 2.29 111.341 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.587 ' HB3' HG23 ' A' ' 82' ' ' ILE . 32.1 mt-30 -51.12 131.59 27.53 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.295 0.569 . . . . 1.4 111.046 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.41 105.33 15.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.258 -0.883 . . . . 1.37 110.268 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -101.33 116.0 31.8 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.67 -0.695 . . . . 0.3 110.722 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 84' ' ' CYS . 8.0 pt -120.81 155.16 24.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.859 -0.61 . . . . 0.23 109.887 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.72 123.5 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.869 0.842 . . . . 2.38 109.43 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 60.2 m -122.57 157.35 32.31 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.316 -1.311 . . . . 1.15 110.598 -171.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.9 t -161.18 138.43 8.94 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.913 0.387 . . . . 0.6 110.38 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -121.58 152.09 39.64 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.548 0.69 . . . . 2.08 111.156 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.574 HG23 ' HD2' ' A' ' 53' ' ' PRO . 23.1 mt -90.6 142.13 27.72 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.779 -1.1 . . . . 0.95 108.687 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.574 ' HD2' HG23 ' A' ' 52' ' ' ILE . 57.2 Cg_exo -33.59 108.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 124.216 3.277 . . . . 0.95 113.393 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 52' ' ' ILE . 22.5 mt -66.13 130.08 41.99 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.954 -1.021 . . . . 1.67 113.112 -166.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.633 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 86.4 mt -99.48 122.6 42.8 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.704 -0.85 . . . . 1.58 108.704 166.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.1 mt -67.81 132.3 32.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.06 0.457 . . . . 2.11 110.637 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.67 14.6 61.1 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.458 -0.792 . . . . 1.03 112.089 -176.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -105.48 155.07 6.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.773 0.797 . . . . 0.77 111.818 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.38 135.82 33.36 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.373 -1.285 . . . . 0.68 111.036 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.403 HG21 HD23 ' A' ' 16' ' ' LEU . 5.7 tp -52.2 -32.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.248 -0.887 . . . . 0.69 111.106 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.99 -27.88 61.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.998 -1.001 . . . . 2.2 111.927 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -107.35 -11.73 15.48 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.881 -0.328 . . . . 1.98 111.665 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.4 tp10 -79.15 -35.21 42.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.349 0.595 . . . . 2.09 110.413 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.418 ' HA ' HD12 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -124.83 171.59 10.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.002 -0.545 . . . . 0.6 110.148 -174.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -122.01 49.41 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.364 0.602 . . . . 2.32 109.997 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -138.77 -169.05 2.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.959 -0.564 . . . . 1.06 109.922 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -83.79 125.63 72.74 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 121.399 0.618 . . . . 0.34 111.931 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -65.25 123.43 11.51 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.435 2.757 . . . . 0.45 111.226 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 77.2 p -132.21 152.85 51.11 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.779 -0.369 . . . . 0.31 111.147 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 38.3 t -103.42 108.81 20.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.019 -0.537 . . . . 1.26 109.683 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 38.6 m -96.04 135.11 38.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.0 0.428 . . . . 0.29 110.603 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.4 tt0 -71.92 -29.55 64.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.418 0.628 . . . . 1.53 109.495 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -153.33 159.37 42.47 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.214 -1.032 . . . . 1.26 108.214 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.587 HG23 ' HD3' ' A' ' 15' ' ' LYS . 1.9 t -138.71 137.51 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.225 0.466 . . . . 1.07 110.509 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 76' ' ' ASP . 32.7 tt0 -104.54 157.43 17.17 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.91 -0.586 . . . . 1.87 110.634 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 78' ' ' GLY . 2.8 t70 67.24 -149.9 0.18 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.076 0.55 . . . . 1.94 109.857 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.03 16.11 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.939 0.876 . . . . 2.12 109.727 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.562 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . 99.22 23.33 11.43 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.557 -0.747 . . . . 0.51 111.558 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 34.1 mt -81.23 -25.68 36.45 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.962 0.41 . . . . 1.1 110.954 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.13 105.36 13.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.61 -0.515 . . . . 0.33 109.61 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.621 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -95.89 143.85 16.91 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.302 -0.951 . . . . 0.26 112.052 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -101.35 117.5 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 109.824 -0.436 . . . . 0.3 109.824 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 85.5 m-20 62.39 48.61 4.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.439 -0.801 . . . . 0.34 110.527 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.621 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 61.2 m -83.7 92.4 7.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.242 -0.89 . . . . 0.81 110.703 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.3 m -79.54 128.41 75.07 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.833 -0.622 . . . . 0.44 110.369 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.76 115.85 3.32 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.557 2.172 . . . . 0.39 110.797 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 8.8 pt -91.55 151.2 42.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.114 -0.494 . . . . 0.57 111.732 -173.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.3 Cg_exo -71.21 157.52 57.03 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.256 2.637 . . . . 1.05 111.823 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 mt -93.23 30.54 1.65 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.847 -0.615 . . . . 1.45 110.491 -177.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.7 pt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.288 -0.863 . . . . 2.31 111.232 -173.775 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.826 -0.509 . . . . 5.75 111.826 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.8 p -78.46 119.02 21.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.736 0.303 . . . . 4.66 110.694 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.55 166.55 38.01 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.926 -0.654 . . . . 1.6 111.906 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -82.2 151.74 26.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.743 0.306 . . . . 0.81 110.791 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -59.94 106.13 0.46 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.413 -0.812 . . . . 2.73 111.218 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.501 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 17.1 m -113.54 13.5 18.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.761 -0.654 . . . . 1.75 110.687 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -19.45 63.52 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.702 0.63 . . . . 3.24 112.702 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 t -81.7 -9.47 59.64 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.276 -0.57 . . . . 2.05 110.591 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.98 15.6 59.06 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.927 -0.654 . . . . 0.88 112.803 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.417 ' HB2' HG21 ' A' ' 87' ' ' ILE . 12.3 p -78.87 -29.75 44.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.854 0.359 . . . . 1.72 111.453 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 t -128.62 141.68 51.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.976 0.417 . . . . 1.19 110.647 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.432 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.8 p30 -92.62 -24.43 18.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 1.66 111.846 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.432 HG23 ' OD1' ' A' ' 12' ' ' ASN . 26.1 p -97.58 -30.96 12.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.121 0.415 . . . . 0.52 112.121 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.501 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 95.34 -0.14 63.5 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.525 -0.845 . . . . 0.43 111.713 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HD3' HG23 ' A' ' 74' ' ' VAL . 59.6 mttp -92.5 88.48 6.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.73 0.3 . . . . 1.64 110.352 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 69' ' ' THR . 7.8 mp -102.61 99.87 9.9 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.376 -0.375 . . . . 0.55 110.529 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.7 150.98 21.24 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.151 0.501 . . . . 0.29 110.61 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.838 ' SG ' ' HB2' ' A' ' 66' ' ' ASN . 10.4 t -84.22 100.75 11.39 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.335 -0.848 . . . . 0.74 108.72 175.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 59.3 m -125.93 150.41 48.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.177 0.513 . . . . 0.5 111.74 -169.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 9.4 t70 -92.97 130.36 38.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.231 -1.026 . . . . 1.65 108.231 172.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.41 HG21 ' HG3' ' A' ' 86' ' ' PRO . 60.6 p -85.91 -3.9 59.04 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.773 -0.371 . . . . 0.52 111.46 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -106.39 -39.19 5.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.109 0.48 . . . . 2.2 109.747 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 38.8 mtmt -74.32 132.24 41.88 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.889 0.852 . . . . 2.6 110.17 172.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.555 ' HD2' HG22 ' A' ' 47' ' ' ILE . 14.4 mmmm -124.09 156.7 36.13 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.406 -1.27 . . . . 2.17 110.821 -171.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 27' ' ' LYS . 2.2 t -119.88 144.3 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.37 -0.604 . . . . 0.59 109.37 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -81.04 -19.3 44.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.255 0.55 . . . . 2.83 110.474 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' H ' HG12 ' A' ' 25' ' ' VAL . 2.2 mmmp? -80.14 118.98 22.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.338 -0.846 . . . . 4.07 110.33 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -144.41 113.69 6.98 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.488 -0.56 . . . . 2.46 109.488 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.7 m -152.04 -80.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.434 -0.348 . . . . 2.0 110.494 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' HA2' ' OD1' ' A' ' 73' ' ' ASP . . . 98.27 141.41 12.21 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.82 -0.705 . . . . 1.39 112.289 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.37 -47.19 6.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.761 0.28 . . . . 3.06 111.124 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -82.41 -39.75 22.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.578 -0.527 . . . . 2.44 109.578 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 34.2 t -70.63 -28.57 64.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.863 -0.608 . . . . 2.36 109.366 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.88 -11.08 73.59 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.79 -0.641 . . . . 2.54 112.606 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.5 tp -80.62 -21.52 41.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.421 0.629 . . . . 3.49 109.832 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.491 ' HG ' ' H ' ' A' ' 37' ' ' HIS . 21.9 tp -110.7 177.97 4.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.559 -0.746 . . . . 4.79 109.41 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.491 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 55.2 t60 -70.34 -12.49 61.62 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.128 -0.357 . . . . 6.59 110.547 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.8 p -62.22 -32.75 73.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.744 0.306 . . . . 5.42 111.315 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.94 10.29 74.09 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.947 -0.644 . . . . 3.27 112.309 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -84.28 -37.55 21.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.668 0.747 . . . . 4.15 109.814 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 m -76.77 146.74 8.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.651 -1.159 . . . . 2.58 111.956 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 mt -89.47 0.63 56.73 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.595 -0.729 . . . . 3.5 109.205 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.53 -26.02 66.95 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.894 -1.048 . . . . 2.29 110.623 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.595 ' HB3' HG23 ' A' ' 82' ' ' ILE . 30.1 mt-30 -46.16 131.97 9.97 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 123.65 0.594 . . . . 1.4 110.418 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.8 t -84.09 104.2 12.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.684 -0.689 . . . . 1.37 110.491 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -97.32 100.81 12.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.271 -0.877 . . . . 0.3 110.477 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.555 HG22 ' HD2' ' A' ' 24' ' ' LYS . 15.2 pt -106.63 152.66 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.786 -0.643 . . . . 0.23 110.027 176.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.471 ' OE1' HG22 ' A' ' 25' ' ' VAL . 13.3 tp60 -76.73 118.74 19.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.735 0.779 . . . . 2.38 110.114 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 53.7 m -114.02 160.65 18.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.116 -1.402 . . . . 1.15 110.299 -175.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.614 ' O ' ' HB3' ' A' ' 18' ' ' CYS . 15.3 t -162.87 136.86 6.17 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.41 -0.589 . . . . 0.6 109.41 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.466 HE22 HD12 ' A' ' 60' ' ' ILE . 46.3 tp60 -117.81 107.53 14.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.314 0.578 . . . . 2.08 110.856 -175.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.485 HG23 ' HD2' ' A' ' 53' ' ' PRO . 60.2 mt -57.45 139.71 80.41 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.984 -1.007 . . . . 0.95 109.99 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 52' ' ' ILE . 50.2 Cg_exo -34.72 118.94 0.13 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 124.274 3.316 . . . . 0.95 113.156 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.56 136.55 53.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.435 -0.802 . . . . 1.67 113.005 -169.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.32 109.18 20.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.68 -1.229 . . . . 1.58 107.68 167.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 56' ' ' ILE . 15.8 mt -55.92 126.42 13.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.244 0.545 . . . . 2.11 111.438 -170.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.64 -4.62 58.09 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.278 -0.874 . . . . 1.03 113.086 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -98.37 151.16 4.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.718 0.771 . . . . 0.77 112.012 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.49 145.14 25.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.45 -1.25 . . . . 0.68 111.79 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.466 HD12 HE22 ' A' ' 51' ' ' GLN . 6.1 tp -40.79 -46.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.621 0.768 . . . . 0.69 113.026 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.433 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -70.92 -23.14 62.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.813 0.671 . . . . 2.2 112.813 -169.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -106.67 -7.49 17.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.424 0.631 . . . . 1.98 109.877 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -74.34 -39.11 63.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.586 -0.734 . . . . 2.09 109.77 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.3 p -132.38 162.88 29.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.475 -0.784 . . . . 0.6 110.431 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -108.39 33.8 3.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.862 0.319 . . . . 2.32 111.862 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.838 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m-80 -115.21 -163.17 0.86 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.827 -0.805 . . . . 1.06 108.827 173.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 m -86.82 131.4 45.3 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 121.222 0.534 . . . . 0.34 111.068 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 44.7 Cg_endo -79.56 126.84 6.94 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.848 2.365 . . . . 0.45 110.356 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 71.3 p -131.26 145.57 51.95 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.393 -0.523 . . . . 0.31 111.631 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.2 t -94.99 111.67 23.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.406 -0.591 . . . . 1.26 109.406 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 38.0 m -96.8 144.03 27.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.251 0.548 . . . . 0.29 110.847 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.8 tt0 -82.14 -21.82 36.45 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.436 -0.802 . . . . 1.53 109.299 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 14.5 t70 -161.69 153.36 18.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.991 -1.114 . . . . 1.26 107.991 173.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.48 HG12 ' HA2' ' A' ' 78' ' ' GLY . 2.0 t -135.35 128.69 48.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.459 -0.497 . . . . 1.07 109.853 173.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -94.4 169.48 10.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.762 -0.654 . . . . 1.87 110.841 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 56.53 -148.86 0.48 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.028 -0.987 . . . . 1.94 111.296 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -80.51 23.09 0.53 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.698 0.761 . . . . 2.12 110.127 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . 92.08 23.28 27.81 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.903 -0.665 . . . . 0.51 112.235 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -91.06 -19.11 23.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.381 . . . . 1.1 111.126 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 25' ' ' VAL . 60.7 t -126.09 101.34 7.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.294 -0.412 . . . . 0.33 109.954 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.702 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -95.25 144.68 17.35 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.485 -0.864 . . . . 0.26 112.494 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.595 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -102.64 118.78 50.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.929 -0.397 . . . . 0.3 109.929 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 73.6 m-20 62.23 35.03 15.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.59 -0.732 . . . . 0.34 110.913 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.702 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 61.1 m -74.47 95.83 2.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.614 -0.721 . . . . 0.81 110.847 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.9 m -89.74 128.38 50.65 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 121.232 0.539 . . . . 0.44 110.219 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 64.2 Cg_endo -70.16 133.6 25.21 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.296 2.664 . . . . 0.39 112.645 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.417 HG21 ' HB2' ' A' ' 10' ' ' SER . 4.7 pt -107.25 153.35 41.17 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.073 -0.967 . . . . 0.57 111.311 -174.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -71.75 162.29 42.5 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.202 2.601 . . . . 1.05 111.476 172.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.7 mt -87.32 24.78 1.53 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.014 -0.539 . . . . 1.45 110.6 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 pt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.036 -0.983 . . . . 2.31 111.068 -174.884 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 111.961 -0.455 . . . . 5.75 111.961 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -64.16 140.82 58.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.865 0.364 . . . . 4.66 110.828 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.42 -110.59 2.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.755 -0.735 . . . . 1.6 111.83 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.556 ' CD2' ' HB ' ' A' ' 60' ' ' ILE . 92.3 m95 -130.7 -175.93 3.82 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.731 -0.276 . . . . 0.81 110.795 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.464 ' OE2' ' HA ' ' A' ' 59' ' ' ALA . 2.7 mp0 -59.47 106.82 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.274 0.559 . . . . 2.73 111.173 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.492 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 42.5 m -112.61 2.46 16.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.575 -0.739 . . . . 1.75 110.741 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -16.01 62.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.979 -0.555 . . . . 3.24 111.776 -175.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.64 4.96 38.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.909 0.385 . . . . 2.05 110.894 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.05 16.16 80.99 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.224 -1.151 . . . . 0.88 110.224 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 6' ' ' SER . 2.3 p -71.71 -30.05 65.23 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.388 -0.906 . . . . 1.72 111.861 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 6' ' ' SER . 7.4 t -155.79 143.71 19.77 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.764 -0.374 . . . . 1.19 110.936 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -91.79 -30.7 16.08 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.236 0.541 . . . . 1.66 110.186 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.1 p -92.25 -15.55 27.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.554 -0.748 . . . . 0.52 111.137 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 86.51 -8.36 75.2 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.923 -0.656 . . . . 0.43 112.493 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -87.99 89.12 7.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.988 0.423 . . . . 1.64 111.015 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 4' ' ' TRP . 8.9 mp -90.11 141.93 28.21 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.304 -0.628 . . . . 0.55 109.304 172.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.85 145.74 36.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.963 0.411 . . . . 0.29 110.678 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 50' ' ' THR . 32.9 m -79.9 101.79 8.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.634 -0.876 . . . . 0.74 108.634 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.8 m -124.56 146.79 48.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.942 0.401 . . . . 0.5 111.344 -170.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -94.62 117.57 30.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.989 -0.745 . . . . 1.65 108.989 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 54.0 p -79.44 -0.38 32.76 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.198 0.523 . . . . 0.52 110.714 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -104.26 -17.75 14.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.659 -0.701 . . . . 2.2 109.477 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -119.63 137.74 53.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.437 -0.801 . . . . 2.6 110.437 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -140.23 162.75 34.52 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.731 0.641 . . . . 2.17 112.731 -170.341 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.545 HG11 HG22 ' A' ' 80' ' ' VAL . 1.6 t -111.74 150.67 13.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.014 -0.994 . . . . 0.59 110.553 -173.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -76.01 -4.38 40.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.953 -0.567 . . . . 2.83 112.128 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -104.86 119.59 39.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.643 0.259 . . . . 4.07 110.842 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.4 m -102.28 8.71 40.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.016 0.436 . . . . 2.46 110.367 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.9 p -87.59 164.77 15.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.829 -0.623 . . . . 2.0 111.174 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.614 ' N ' ' HA3' ' A' ' 34' ' ' GLY . . . -152.53 -174.62 23.24 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.156 -0.778 . . . . 1.39 111.156 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -100.64 -24.15 14.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.203 0.501 . . . . 3.06 111.62 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -100.77 -68.99 0.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.028 0.442 . . . . 2.44 111.202 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 t -90.46 -27.78 19.02 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.584 -0.524 . . . . 2.36 109.584 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 30' ' ' GLY . . . -63.51 -29.33 74.29 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.486 -0.779 . . . . 2.54 113.463 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.0 mt -77.95 -22.28 49.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.014 0.435 . . . . 3.49 110.321 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt -84.25 173.21 11.18 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.64 -0.709 . . . . 4.79 110.551 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -76.61 -11.19 59.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.242 0.544 . . . . 6.59 110.124 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.1 m -72.39 -25.45 61.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.71 -0.677 . . . . 5.42 110.368 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.473 ' HA2' ' OE1' ' A' ' 44' ' ' GLN . . . -97.04 13.83 64.49 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.942 -0.572 . . . . 3.27 111.801 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.93 -35.92 67.11 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.592 0.71 . . . . 4.15 109.638 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.535 HG23 ' HG3' ' A' ' 44' ' ' GLN . 3.5 m -61.33 133.89 26.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.293 -1.321 . . . . 2.58 112.429 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 mp -87.7 2.69 50.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.306 -0.861 . . . . 3.5 109.703 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.41 -34.11 74.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.238 -0.892 . . . . 2.29 109.435 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.581 ' HB3' HG23 ' A' ' 82' ' ' ILE . 18.7 mt-30 -53.12 143.27 18.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.139 -0.937 . . . . 1.4 110.524 173.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 83' ' ' ASN . 8.2 p -103.26 118.47 50.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.205 0.526 . . . . 1.37 110.62 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.66 100.0 9.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.46 -0.791 . . . . 0.3 111.172 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 10.7 pt -106.11 155.43 7.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.064 -0.516 . . . . 0.23 110.255 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.45 ' OE1' HG22 ' A' ' 25' ' ' VAL . 10.5 tp60 -77.3 126.04 30.29 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.463 0.649 . . . . 2.38 110.087 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 45.3 m -124.29 163.02 22.53 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.763 -1.108 . . . . 1.15 110.352 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 10.0 t -160.08 142.73 13.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.831 -0.433 . . . . 0.6 109.831 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -120.54 117.96 28.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.142 0.496 . . . . 2.08 110.348 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.407 HG23 ' HD2' ' A' ' 53' ' ' PRO . 56.4 mt -85.23 137.29 37.17 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.371 -0.831 . . . . 0.95 109.539 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HD2' HG23 ' A' ' 52' ' ' ILE . 10.6 Cg_exo -32.68 117.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 124.989 3.792 . . . . 0.95 113.807 -172.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 pp -101.88 142.63 32.89 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.897 -1.047 . . . . 1.67 112.356 -169.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 74.9 mt -92.51 132.83 36.49 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.776 -0.824 . . . . 1.58 108.776 166.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 mt -64.05 135.17 28.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.005 0.431 . . . . 2.11 110.471 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.96 12.16 60.69 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.757 -0.656 . . . . 1.03 112.245 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -109.24 147.88 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.641 0.734 . . . . 0.77 111.855 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HA ' ' OE2' ' A' ' 5' ' ' GLU . . . -73.42 128.18 34.77 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.187 -1.37 . . . . 0.68 110.056 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.556 ' HB ' ' CD2' ' A' ' 4' ' ' TRP . 16.3 tt -57.22 -33.04 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.69 111.931 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -9.96 59.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.385 0.612 . . . . 2.2 110.266 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.06 -35.41 10.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.37 -0.832 . . . . 1.98 109.038 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.5 tp10 -68.6 -39.48 80.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.537 -1.211 . . . . 2.09 110.587 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.0 p -119.6 147.03 44.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.341 -0.391 . . . . 0.6 110.198 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -99.36 48.35 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.144 0.497 . . . . 2.32 110.814 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 47.8 m-80 -128.12 -172.7 2.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.882 -0.599 . . . . 1.06 109.502 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.9 m -83.07 127.97 67.08 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-O 121.145 0.498 . . . . 0.34 110.831 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.01 131.7 7.04 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.925 2.417 . . . . 0.45 111.281 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 81.0 p -133.37 153.44 51.59 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.432 -0.349 . . . . 0.31 110.861 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 15.8 t -99.63 111.22 23.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.804 -0.443 . . . . 1.26 109.804 173.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.6 m -100.97 138.02 38.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.252 0.549 . . . . 0.29 110.768 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.0 tt0 -78.05 -27.41 48.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.633 -0.712 . . . . 1.53 109.859 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -154.36 151.76 29.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.514 -0.921 . . . . 1.26 108.514 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.535 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.5 t -140.47 132.42 31.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.869 -0.419 . . . . 1.07 109.869 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.77 160.7 14.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.478 -0.328 . . . . 1.87 110.21 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.446 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 9.7 m-20 59.8 -154.02 0.37 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.724 0.41 . . . . 1.94 110.238 -174.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' H ' ' HB3' ' A' ' 76' ' ' ASP . 14.8 m-20 -79.35 23.99 0.37 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.015 0.436 . . . . 2.12 110.721 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.535 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 102.66 22.62 9.39 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.989 -0.624 . . . . 0.51 112.637 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 2.6 mm? -78.38 -27.78 46.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 1.1 111.264 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.545 HG22 HG11 ' A' ' 25' ' ' VAL . 32.6 t -125.05 107.71 18.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.334 -0.394 . . . . 0.33 110.719 -174.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -100.93 139.03 14.19 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.104 -1.045 . . . . 0.26 112.195 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.581 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -104.82 123.6 58.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 122.54 0.336 . . . . 0.3 110.143 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.718 ' HA ' HG12 ' A' ' 45' ' ' VAL . 79.6 m-20 62.63 42.69 8.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.89 -0.595 . . . . 0.34 110.714 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.537 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 59.6 m -83.12 96.64 8.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.372 -0.831 . . . . 0.81 111.054 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 26.5 m -79.12 125.01 84.36 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.236 -0.438 . . . . 0.44 110.543 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 21.9 Cg_exo -67.03 128.05 17.95 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.029 2.486 . . . . 0.39 111.962 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.477 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.1 pt -107.3 143.09 26.48 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 116.279 -0.419 . . . . 0.57 110.928 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.6 Cg_exo -71.45 156.38 58.39 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.336 2.69 . . . . 1.05 112.355 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.0 mt -90.18 15.46 10.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.54 -0.754 . . . . 1.45 109.643 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.0 pt . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.212 -0.904 . . . . 2.31 110.889 -173.55 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 111.607 -0.597 . . . . 5.75 111.607 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.9 m -95.71 74.5 3.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.033 0.444 . . . . 4.66 110.528 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.02 -39.22 3.04 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.95 -0.643 . . . . 1.6 112.414 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -87.59 139.82 30.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.374 -0.232 . . . . 0.81 110.374 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -64.74 108.95 1.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.027 0.441 . . . . 2.73 110.399 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.7 m -96.29 27.18 3.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.465 0.65 . . . . 1.75 109.643 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -5.01 48.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.354 -0.839 . . . . 3.24 111.585 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -67.59 -30.6 70.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.085 0.469 . . . . 2.05 111.357 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.42 16.62 58.54 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.801 -0.714 . . . . 0.88 112.421 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 m -102.34 -17.02 16.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.855 0.317 . . . . 1.72 111.855 -175.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.772 ' SG ' HG21 ' A' ' 87' ' ' ILE . 3.9 m -131.1 141.55 50.16 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.851 -0.34 . . . . 1.19 111.479 -171.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -94.61 -28.3 15.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 1.66 112.186 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.8 p -86.92 -31.14 20.86 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.476 0.547 . . . . 0.52 112.476 -171.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.15 5.64 82.74 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.509 -0.853 . . . . 0.43 112.679 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HD3' HG23 ' A' ' 74' ' ' VAL . 59.4 mttp -94.38 88.27 5.47 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.065 -0.346 . . . . 1.64 110.065 176.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.688 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 7.9 mp -94.18 123.59 37.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.915 0.388 . . . . 0.55 110.299 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.18 142.62 37.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.835 -0.431 . . . . 0.29 109.835 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 80.1 m -80.93 118.46 22.44 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.278 -0.638 . . . . 0.74 109.278 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.712 ' SG ' HG13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -127.72 163.08 25.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.006 0.432 . . . . 0.5 111.152 -173.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -106.15 105.76 15.96 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.372 -0.973 . . . . 1.65 108.372 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.2 p -75.87 2.54 12.13 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.561 -0.745 . . . . 0.52 111.095 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -104.86 -3.41 23.48 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.054 -0.721 . . . . 2.2 109.054 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -113.3 102.46 10.37 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.361 -0.836 . . . . 2.6 110.562 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 3.7 mppt? -96.55 159.97 14.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.538 -0.756 . . . . 2.17 110.797 -175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 27' ' ' LYS . 19.3 t -119.61 149.7 22.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.946 -0.761 . . . . 0.59 108.946 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -84.45 -11.64 55.81 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.121 0.415 . . . . 2.83 112.121 -172.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' H ' HG12 ' A' ' 25' ' ' VAL . 14.3 mmmm -120.41 130.41 54.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.684 0.278 . . . . 4.07 110.546 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.7 m -101.45 32.68 3.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.104 -0.498 . . . . 2.46 111.207 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.9 p -86.1 150.09 24.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.263 -0.426 . . . . 2.0 110.233 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.472 ' HA3' ' OD1' ' A' ' 73' ' ' ASP . . . -150.79 -173.95 21.34 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.772 -0.728 . . . . 1.39 112.125 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -91.05 -50.65 5.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.547 0.173 . . . . 3.06 111.404 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -95.22 -11.87 27.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.193 0.442 . . . . 2.44 112.193 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.426 ' HA ' ' OG1' ' A' ' 38' ' ' THR . 58.0 m -50.72 -35.73 32.75 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.63 0.253 . . . . 2.36 111.411 170.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.94 -40.03 58.04 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.807 -0.711 . . . . 2.54 112.25 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.74 -51.47 55.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.147 0.498 . . . . 3.49 109.754 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.96 -179.88 5.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.374 -0.83 . . . . 4.79 110.783 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.82 1.17 57.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.469 0.652 . . . . 6.59 109.594 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.426 ' OG1' ' HA ' ' A' ' 33' ' ' SER . 53.6 p -65.71 -33.47 75.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.465 -0.788 . . . . 5.42 111.073 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.56 -2.67 56.29 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.959 -0.564 . . . . 3.27 113.217 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.37 -43.65 93.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.43 0.634 . . . . 4.15 109.968 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 m -88.26 143.53 11.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.054 -0.975 . . . . 2.58 111.737 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 tp -93.7 -3.84 51.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.376 -0.972 . . . . 3.5 108.376 172.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.48 -22.4 66.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.315 -1.311 . . . . 2.29 111.399 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.602 ' HB3' HG23 ' A' ' 82' ' ' ILE . 17.5 mt-30 -48.94 134.88 16.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.048 0.451 . . . . 1.4 111.283 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.56 115.41 43.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.72 -0.673 . . . . 1.37 110.421 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -100.21 118.42 36.49 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.521 -0.763 . . . . 0.3 110.925 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.712 HG13 ' SG ' ' A' ' 19' ' ' CYS . 12.5 pt -116.29 153.39 17.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.049 -0.523 . . . . 0.23 110.015 173.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.54 108.47 16.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.811 0.815 . . . . 2.38 110.076 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 62.7 m -89.5 165.6 14.2 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.128 -1.396 . . . . 1.15 110.573 -175.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.0 t -159.94 117.06 2.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.953 0.883 . . . . 0.6 110.715 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -120.0 131.78 55.26 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.964 -1.016 . . . . 2.08 110.677 -174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 64' ' ' CYS . 46.1 mt -70.41 133.9 86.99 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.979 -0.749 . . . . 0.95 108.979 171.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.11 107.04 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.07 3.18 . . . . 0.95 112.68 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.9 140.51 57.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.209 -0.905 . . . . 1.67 112.865 -169.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.53 152.74 21.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.86 -1.063 . . . . 1.58 108.767 168.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.0 mt -70.66 124.34 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.115 0.483 . . . . 2.11 110.631 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.15 17.18 72.57 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.474 -0.785 . . . . 1.03 112.952 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.412 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -97.0 149.13 5.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.713 0.768 . . . . 0.77 111.563 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.15 144.67 36.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.29 -1.323 . . . . 0.68 111.358 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.444 HG23 ' HG3' ' A' ' 61' ' ' GLU . 7.1 tp -53.38 -43.49 51.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.602 -0.726 . . . . 0.69 111.478 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.444 ' HG3' HG23 ' A' ' 60' ' ' ILE . 45.6 mt-10 -71.34 -41.65 69.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.7 -0.682 . . . . 2.2 111.489 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -79.44 -8.37 59.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.051 -0.522 . . . . 1.98 111.036 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.412 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.7 tp10 -92.21 -41.16 10.58 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.288 -0.415 . . . . 2.09 110.793 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.522 ' HA ' HD12 ' A' ' 52' ' ' ILE . 1.7 p -113.9 173.13 6.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.6 111.185 -172.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -125.02 49.91 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.296 0.57 . . . . 2.32 109.563 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 57.7 m-80 -143.24 -170.3 3.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.836 -0.62 . . . . 1.06 110.43 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 10.4 m -79.62 130.76 66.74 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.888 0.375 . . . . 0.34 111.142 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -79.03 120.13 4.51 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.719 2.279 . . . . 0.45 111.264 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 86' ' ' PRO . 68.1 p -129.38 148.5 51.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.199 -0.455 . . . . 0.31 109.874 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.688 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 72.9 m -113.59 111.51 21.99 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.458 0.647 . . . . 1.26 110.128 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.9 m -86.56 152.59 22.49 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.962 -1.017 . . . . 0.29 111.036 -172.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 7.3 tt0 -91.53 -22.28 20.44 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.255 -0.884 . . . . 1.53 109.628 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.472 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 33.9 t0 -158.99 161.33 36.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.739 -1.208 . . . . 1.26 107.739 170.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.563 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -139.21 149.37 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 118.362 0.528 . . . . 1.07 110.793 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 8.2 tp10 -111.36 160.2 17.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.439 -0.8 . . . . 1.87 109.764 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 60.49 -151.93 0.4 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.255 -0.43 . . . . 1.94 109.936 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.86 10.33 2.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.001 0.429 . . . . 2.12 110.301 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 113.27 24.03 4.94 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.895 -0.669 . . . . 0.51 112.487 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.48 -21.93 25.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 1.1 111.432 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 88.4 t -127.04 113.05 30.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.277 -0.638 . . . . 0.33 109.277 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.687 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -108.0 142.76 15.97 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.697 -1.24 . . . . 0.26 112.869 -173.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.602 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -95.75 118.17 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 109.69 -0.485 . . . . 0.3 109.69 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 93.8 m-20 60.21 42.93 14.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.279 -0.873 . . . . 0.34 110.804 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.687 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.8 m -78.0 87.71 4.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.669 -0.696 . . . . 0.81 109.919 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.2 m -83.07 134.22 46.69 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.377 -0.829 . . . . 0.44 110.256 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HA ' HG22 ' A' ' 69' ' ' THR . 13.9 Cg_endo -70.49 118.56 5.76 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.97 2.446 . . . . 0.39 111.59 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.772 HG21 ' SG ' ' A' ' 11' ' ' CYS . 5.5 pt -88.13 140.58 30.72 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.355 -0.839 . . . . 0.57 111.671 -173.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.1 Cg_exo -74.91 151.76 40.39 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.374 2.716 . . . . 1.05 111.707 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.5 mt -95.35 28.16 3.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.637 -0.71 . . . . 1.45 109.625 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 90' ' ' ILE . 18.6 pt . . . . . 0 C--O 1.245 0.864 0 CA-C-N 115.503 -0.771 . . . . 2.31 110.735 -173.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.637 0 N-CA-C 111.974 -0.451 . . . . 5.75 111.974 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -83.3 55.46 3.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.975 0.417 . . . . 4.66 110.598 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.43 135.0 12.77 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.773 -0.727 . . . . 1.6 111.937 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -88.25 172.82 9.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.034 0.445 . . . . 0.81 111.079 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -85.11 109.54 18.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.732 -0.667 . . . . 2.73 110.45 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 m -80.42 27.45 0.34 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.864 -0.607 . . . . 1.75 111.021 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -53.88 -22.68 10.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.747 -0.66 . . . . 3.24 112.12 -177.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.424 ' N ' ' HD2' ' A' ' 7' ' ' LYS . 6.9 t -73.39 -13.08 61.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.274 -0.421 . . . . 2.05 111.232 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.06 17.42 75.63 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.906 -0.664 . . . . 0.88 112.452 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -102.63 -9.86 19.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.89 0.33 . . . . 1.72 111.89 -172.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.708 ' SG ' HG21 ' A' ' 87' ' ' ILE . 2.7 m -139.65 140.32 36.89 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.267 -0.573 . . . . 1.19 111.456 -171.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -95.33 -30.6 13.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 1.66 111.867 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.7 p -80.53 -29.94 37.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.663 0.616 . . . . 0.52 112.663 -169.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.55 -4.27 85.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.503 -0.856 . . . . 0.43 112.304 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HD3' HG23 ' A' ' 74' ' ' VAL . 63.2 mttp -90.69 87.86 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.425 . . . . 1.64 109.99 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.813 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 8.1 mp -96.13 139.55 32.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.698 -0.683 . . . . 0.55 109.708 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.616 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -148.39 144.71 27.67 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.894 0.378 . . . . 0.29 110.389 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 86.1 m -89.9 99.54 12.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.131 0.491 . . . . 0.74 109.698 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 83.7 m -114.41 164.69 13.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.546 . . . . 0.5 112.028 -165.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -102.15 108.34 19.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.842 -0.617 . . . . 1.65 109.516 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -77.8 0.62 23.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.298 -0.41 . . . . 0.52 111.19 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -101.13 -7.3 23.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.172 -0.677 . . . . 2.2 109.172 175.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 35.6 mtpt -113.3 107.21 15.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.262 -0.881 . . . . 2.6 110.328 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -100.34 154.8 18.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.827 -0.624 . . . . 2.17 110.789 -174.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.449 HG22 ' CD ' ' A' ' 48' ' ' GLN . 11.1 t -120.78 150.3 23.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.608 -0.724 . . . . 0.59 109.782 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.08 32.89 0.27 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.974 -0.557 . . . . 2.83 111.684 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 31.12 115.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.718 1.607 . . . . 4.07 114.752 174.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -123.92 -76.83 0.59 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.477 -0.783 . . . . 2.46 111.162 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 p -142.28 -169.71 3.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.325 -0.852 . . . . 2.0 111.211 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.1 -161.04 21.95 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.232 -1.147 . . . . 1.39 110.232 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -99.57 -46.34 5.49 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.709 0.755 . . . . 3.06 110.71 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -86.94 -49.96 7.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.101 0.477 . . . . 2.44 110.844 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -91.18 4.35 52.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.834 -0.621 . . . . 2.36 110.237 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.91 -47.51 53.63 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.817 -0.629 . . . . 2.54 113.213 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.46 HD12 ' H ' ' A' ' 35' ' ' LEU . 5.4 mp -69.22 -61.95 1.58 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 3.49 110.228 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -109.03 99.77 9.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.047 -0.524 . . . . 4.79 109.816 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -109.15 -71.25 0.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 6.59 111.582 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 p -80.31 -14.18 58.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.113 0.483 . . . . 5.42 110.904 -175.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 -25.67 44.42 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.609 -0.805 . . . . 3.27 111.212 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.52 -50.67 7.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.118 0.485 . . . . 4.15 109.955 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.403 HG23 ' CG ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -146.4 134.43 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.394 -0.821 . . . . 2.58 110.778 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.7 tp -98.21 -7.85 28.53 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.435 0.636 . . . . 3.5 110.214 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.25 0.49 57.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.788 -0.642 . . . . 2.29 111.848 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' A' ' 82' ' ' ILE . 23.1 mt-30 -51.76 131.36 30.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.308 0.575 . . . . 1.4 111.406 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.85 109.19 27.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.14 -0.936 . . . . 1.37 109.745 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -102.28 122.57 44.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.675 -0.693 . . . . 0.3 110.494 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' A' ' 84' ' ' CYS . 14.2 pt -128.66 153.83 38.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.993 -0.549 . . . . 0.23 110.641 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.449 ' CD ' HG22 ' A' ' 25' ' ' VAL . 2.5 mp0 -70.29 141.62 52.35 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.832 -0.622 . . . . 2.38 109.503 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.651 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 2.1 t -137.78 164.53 28.67 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.073 -0.512 . . . . 1.15 110.491 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.0 t -160.81 128.03 4.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.524 0.678 . . . . 0.6 110.652 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -121.06 125.94 48.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.674 -0.694 . . . . 2.08 110.976 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 64' ' ' CYS . 16.7 mt -63.88 139.25 97.61 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.385 -0.825 . . . . 0.95 109.836 174.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 52' ' ' ILE . 60.0 Cg_exo -34.25 121.13 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 124.788 3.659 . . . . 0.95 113.929 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.8 mt -65.48 119.71 11.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.038 -0.983 . . . . 1.67 112.261 -171.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.446 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 84.5 mt -99.73 122.89 43.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.989 -0.745 . . . . 1.58 108.989 166.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.669 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -72.87 130.18 35.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.073 0.463 . . . . 2.11 110.2 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.05 2.97 60.64 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.932 -0.651 . . . . 1.03 111.832 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -103.15 153.98 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.799 0.809 . . . . 0.77 111.732 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.18 130.52 36.31 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.306 -1.316 . . . . 0.68 109.815 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 61' ' ' GLU . 10.7 tt -50.77 -37.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.238 -0.892 . . . . 0.69 112.035 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.447 ' N ' HG23 ' A' ' 60' ' ' ILE . 6.6 mt-10 -62.61 -35.23 78.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.087 -0.96 . . . . 2.2 111.04 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.85 -22.21 19.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.904 -0.589 . . . . 1.98 109.999 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.82 -41.16 78.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.751 . . . . 2.09 110.954 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.57 ' HA ' HD12 ' A' ' 52' ' ' ILE . 4.7 p -114.65 167.85 10.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.997 0.427 . . . . 0.6 111.308 -173.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -121.94 41.42 3.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 2.32 110.284 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.553 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 57.1 m-80 -131.52 -169.87 2.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.481 -0.781 . . . . 1.06 109.666 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 11.2 m -83.17 127.1 70.36 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-O 120.933 0.397 . . . . 0.34 110.877 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HG3' HD21 ' A' ' 89' ' ' LEU . 55.8 Cg_endo -79.23 119.77 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.735 2.29 . . . . 0.45 111.294 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.427 ' OG1' ' HB3' ' A' ' 84' ' ' CYS . 44.2 p -128.37 151.16 49.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.318 -0.401 . . . . 0.31 109.93 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.813 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 72.0 m -113.68 119.32 37.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.268 0.556 . . . . 1.26 110.16 175.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.2 m -97.57 149.37 22.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.064 -0.971 . . . . 0.29 111.298 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 9.3 mt-10 -85.06 -16.65 39.96 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.585 -1.188 . . . . 1.53 109.728 175.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 47.3 t0 -167.79 156.11 9.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.921 -1.036 . . . . 1.26 108.298 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.566 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -143.5 135.92 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 117.929 0.331 . . . . 1.07 110.566 178.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 10.6 tp10 -98.18 157.54 16.09 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.156 -0.475 . . . . 1.87 110.01 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 61.31 -151.81 0.38 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.107 0.563 . . . . 1.94 109.93 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -82.38 21.91 0.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.112 0.482 . . . . 2.12 110.383 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.651 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 106.64 22.72 7.55 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.814 -0.708 . . . . 0.51 112.874 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.5 mm? -80.1 -26.67 39.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.784 0.292 . . . . 1.1 111.475 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 94.5 t -130.56 112.62 23.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.939 -0.393 . . . . 0.33 109.939 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.659 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -107.21 143.62 15.87 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.136 -1.03 . . . . 0.26 112.651 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -101.89 120.62 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.327 -0.619 . . . . 0.3 109.327 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 98.8 m-20 62.06 48.01 5.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.671 -0.695 . . . . 0.34 110.598 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.659 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 56.8 m -85.59 93.71 8.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.58 -0.736 . . . . 0.81 110.228 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.2 m -82.09 127.81 70.34 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.994 -0.548 . . . . 0.44 110.311 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.99 113.86 2.37 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.794 2.329 . . . . 0.39 111.579 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.708 HG21 ' SG ' ' A' ' 11' ' ' CYS . 9.1 pt -89.64 146.74 36.24 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.724 -0.671 . . . . 0.57 111.156 -175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 14.9 Cg_exo -73.53 148.15 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.225 2.617 . . . . 1.05 112.24 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.414 HD21 ' HG3' ' A' ' 68' ' ' PRO . 93.7 mt -85.99 21.4 1.97 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.741 -0.663 . . . . 1.45 110.617 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.426 HG13 ' OXT' ' A' ' 90' ' ' ILE . 21.4 pt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.766 -1.112 . . . . 2.31 111.119 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.634 -0.586 . . . . 5.75 111.634 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.433 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 8.0 t 67.4 -172.71 0.19 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.948 0.404 . . . . 4.66 110.9 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.29 27.0 45.78 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.076 -0.583 . . . . 1.6 112.209 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -97.39 164.13 12.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.128 0.49 . . . . 0.81 111.235 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.605 ' OE1' ' HA ' ' A' ' 59' ' ' ALA . 24.7 mp0 -70.91 107.38 4.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.384 -0.826 . . . . 2.73 111.072 -176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 t -111.72 26.14 10.93 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.016 -0.735 . . . . 1.75 109.016 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -55.04 -33.9 63.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.934 -1.03 . . . . 3.24 111.541 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.7 t -85.04 3.81 36.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.811 0.339 . . . . 2.05 111.461 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.3 18.44 69.05 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.389 -0.91 . . . . 0.88 112.558 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.0 p -70.27 -32.05 69.7 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.759 0.651 . . . . 1.72 112.759 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.2 t -129.74 144.1 51.13 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.099 0.476 . . . . 1.19 111.365 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.409 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.2 p30 -91.21 -24.91 19.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.961 -0.563 . . . . 1.66 111.341 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.409 HG23 ' OD1' ' A' ' 12' ' ' ASN . 56.3 p -98.21 -30.56 12.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.076 0.465 . . . . 0.52 111.349 -177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.21 0.06 59.97 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.832 -0.699 . . . . 0.43 111.396 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HG2' ' HB2' ' A' ' 2' ' ' SER . 61.2 mttp -91.61 88.46 6.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.752 0.31 . . . . 1.64 110.401 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 69' ' ' THR . 8.1 mp -96.83 151.4 19.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.694 -0.484 . . . . 0.55 109.694 175.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -160.26 144.66 14.4 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.744 0.307 . . . . 0.29 110.85 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 1.2 m -80.13 97.63 6.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.854 -0.612 . . . . 0.74 109.923 173.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 84.1 m -113.13 160.59 18.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.114 -0.494 . . . . 0.5 110.82 -172.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.01 116.25 31.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.705 -0.48 . . . . 1.65 109.705 173.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.5 p -76.44 -8.66 57.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.089 0.471 . . . . 0.52 111.227 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -93.85 -15.97 24.53 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.021 0.915 . . . . 2.2 108.727 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -102.5 110.33 22.23 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.008 -1.451 . . . . 2.6 110.707 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.4 OUTLIER -103.08 163.75 12.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.281 -0.418 . . . . 2.17 110.992 -178.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.515 HG22 ' OE1' ' A' ' 48' ' ' GLN . 23.5 t -116.04 150.05 18.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.002 -0.74 . . . . 0.59 109.002 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -83.68 -17.0 42.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.39 0.515 . . . . 2.83 112.39 -171.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' H ' HG12 ' A' ' 25' ' ' VAL . 32.6 mtmm -114.02 156.76 23.51 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.277 -0.268 . . . . 4.07 110.277 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 p -121.42 12.68 10.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.79 0.329 . . . . 2.46 111.405 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 p -72.97 142.75 47.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.34 . . . . 2.0 110.84 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.25 165.23 25.24 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.583 -0.818 . . . . 1.39 112.803 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -81.76 -46.21 14.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.741 0.305 . . . . 3.06 111.44 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -95.73 -31.09 13.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.386 -0.37 . . . . 2.44 111.307 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.7 p -62.62 -23.09 66.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 2.36 111.304 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.13 97.6 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.79 -0.719 . . . . 2.54 111.891 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 35' ' ' LEU . 4.7 mp -90.35 -29.36 18.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.005 0.431 . . . . 3.49 110.49 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.3 tp -70.14 130.18 41.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.015 -0.539 . . . . 4.79 110.284 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -70.51 -24.93 62.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.372 -0.376 . . . . 6.59 111.023 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 m -80.44 -19.47 46.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.134 0.492 . . . . 5.42 110.261 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.05 13.82 66.76 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.192 -0.763 . . . . 3.27 111.192 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.12 -27.24 60.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.367 0.603 . . . . 4.15 109.996 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' CG ' ' A' ' 44' ' ' GLN . 3.7 m -61.35 149.67 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.074 -0.966 . . . . 2.58 112.085 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt -99.17 -7.44 26.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.785 -0.643 . . . . 3.5 110.602 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -86.76 0.95 53.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.94 -0.573 . . . . 2.29 111.31 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.569 ' HB3' HG23 ' A' ' 82' ' ' ILE . 33.0 mt-30 -46.0 139.81 4.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.948 0.404 . . . . 1.4 110.839 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.27 116.54 49.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.275 -0.42 . . . . 1.37 110.112 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -105.62 117.48 34.13 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.833 -0.621 . . . . 0.3 111.138 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 13.8 pt -106.38 150.21 9.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.074 -0.512 . . . . 0.23 110.241 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.515 ' OE1' HG22 ' A' ' 25' ' ' VAL . 13.9 tp60 -76.63 116.0 16.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.599 -0.728 . . . . 2.38 109.342 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.7 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 2.2 t -110.1 169.43 8.74 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.283 -0.872 . . . . 1.15 110.235 -172.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.0 t -160.19 128.06 4.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.646 0.736 . . . . 0.6 110.808 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -120.88 114.1 21.08 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.518 -0.764 . . . . 2.08 111.059 -176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.72 133.22 72.27 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.395 -0.821 . . . . 0.95 109.46 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -38.45 102.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 124.578 3.519 . . . . 0.95 113.01 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.44 135.19 51.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.408 -0.815 . . . . 1.67 112.308 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.02 135.0 35.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.167 -0.924 . . . . 1.58 109.372 171.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.4 mt -66.6 129.63 31.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.23 0.538 . . . . 2.11 110.305 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.26 -15.66 58.8 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.224 -0.898 . . . . 1.03 111.832 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -89.7 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.586 0.708 . . . . 0.77 111.649 -177.134 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.605 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . . . -89.8 146.46 24.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.461 -1.245 . . . . 0.68 111.475 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 61' ' ' GLU . 5.0 tp -49.89 -44.05 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.621 -0.718 . . . . 0.69 110.724 173.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 60' ' ' ILE . 6.4 mm-40 -68.91 -16.84 63.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.431 -0.804 . . . . 2.2 111.986 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -110.46 -10.87 14.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.318 -0.401 . . . . 1.98 111.3 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.4 tp10 -93.62 -38.78 11.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.183 0.516 . . . . 2.09 110.595 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.2 p -131.38 146.92 52.49 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.913 -0.585 . . . . 0.6 110.208 -173.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -121.93 64.56 0.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.68 0.752 . . . . 2.32 111.064 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 36.5 m-80 -123.23 -155.43 0.65 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.231 -1.396 . . . . 1.06 107.231 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -86.05 121.17 72.9 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 119.418 -0.913 . . . . 0.34 110.048 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.11 130.25 9.23 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.646 2.231 . . . . 0.45 110.671 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 84' ' ' CYS . 81.1 p -131.65 155.11 48.15 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.415 -0.357 . . . . 0.31 111.374 -175.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.2 t -103.27 110.48 22.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.684 -0.858 . . . . 1.26 108.684 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.7 m -94.84 145.28 25.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.403 0.621 . . . . 0.29 110.666 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 2.6 tt0 -79.57 -18.63 51.29 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.325 -0.852 . . . . 1.53 109.235 176.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -170.13 156.3 5.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.135 -0.939 . . . . 1.26 109.178 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.542 HG12 ' HA2' ' A' ' 78' ' ' GLY . 1.4 t -143.07 134.62 23.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.331 -0.248 . . . . 1.07 110.331 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 41.4 tt0 -104.17 158.8 16.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.47 -0.332 . . . . 1.87 110.693 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 4.4 t70 66.58 -148.19 0.19 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.183 0.593 . . . . 1.94 109.672 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.85 11.83 2.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.011 0.434 . . . . 2.12 110.442 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.7 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 108.7 23.94 6.32 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.916 -0.659 . . . . 0.51 112.155 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 mt -82.93 -23.6 33.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.819 0.342 . . . . 1.1 111.197 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 60.9 t -122.79 106.37 17.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.688 -0.486 . . . . 0.33 109.688 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -106.56 133.83 11.84 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.325 -0.94 . . . . 0.26 111.954 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.569 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -96.74 121.12 46.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 110.127 -0.323 . . . . 0.3 110.127 -177.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 82.7 m-20 60.62 35.32 19.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.553 -0.748 . . . . 0.34 111.124 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.615 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 67.3 m -69.82 95.33 0.89 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.607 -0.724 . . . . 0.81 110.702 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 30.7 m -87.56 126.89 60.47 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.951 -0.568 . . . . 0.44 110.009 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 36.2 Cg_exo -59.13 128.96 29.57 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.979 2.452 . . . . 0.39 112.321 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 pt -100.94 147.87 34.29 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.044 -0.526 . . . . 0.57 110.799 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.83 156.42 66.0 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.009 2.473 . . . . 1.05 112.086 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.4 mt -79.17 11.14 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.859 -0.61 . . . . 1.45 110.901 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.412 HG13 ' OXT' ' A' ' 90' ' ' ILE . 17.6 pt . . . . . 0 C--N 1.313 -0.989 0 CA-C-N 115.252 -0.885 . . . . 2.31 110.508 -175.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 112.127 -0.389 . . . . 5.75 112.127 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -107.25 -11.79 15.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.822 0.344 . . . . 4.66 110.9 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.05 -172.37 41.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.103 -0.57 . . . . 1.6 112.085 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -129.79 155.63 45.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.319 0.58 . . . . 0.81 112.023 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -65.27 113.84 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.936 -1.029 . . . . 2.73 110.911 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 m -88.5 26.82 1.38 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.9 -0.591 . . . . 1.75 110.445 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -53.74 -52.52 59.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.489 -0.778 . . . . 3.24 112.502 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -69.53 -24.46 63.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.2 -0.455 . . . . 2.05 111.846 -172.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.03 16.01 79.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.906 -0.664 . . . . 0.88 111.742 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.472 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 5.4 p -74.45 -30.51 61.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.301 0.482 . . . . 1.72 112.301 -173.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.6 t -105.2 142.29 35.24 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.004 0.431 . . . . 1.19 111.181 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.553 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.7 p30 -92.18 -27.35 17.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 1.66 111.784 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.553 HG23 ' OD1' ' A' ' 12' ' ' ASN . 11.0 p -100.34 -30.81 11.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.873 0.368 . . . . 0.52 111.973 -175.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.03 -6.36 53.93 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.528 -0.844 . . . . 0.43 112.26 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HD3' HG13 ' A' ' 74' ' ' VAL . 89.2 mttt -88.35 88.73 7.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 1.64 110.48 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 60' ' ' ILE . 9.5 mp -92.99 127.01 38.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.454 -0.794 . . . . 0.55 110.171 176.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.534 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -142.53 153.09 43.28 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.786 0.327 . . . . 0.29 110.383 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 60.4 m -89.57 97.67 11.33 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.184 -0.672 . . . . 0.74 109.184 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 71.4 m -113.51 153.46 28.69 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.314 -0.403 . . . . 0.5 111.19 -169.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.65 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 8.0 t70 -92.51 119.35 31.9 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.077 -0.712 . . . . 1.65 109.077 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.8 p -80.41 -7.78 59.26 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.775 0.322 . . . . 0.52 111.706 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -104.59 -15.94 15.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 2.2 110.127 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.65 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 36.6 mtmt -103.35 129.04 50.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.709 -0.678 . . . . 2.6 110.779 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -116.55 162.35 17.74 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.912 -1.04 . . . . 2.17 111.243 -175.085 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 27' ' ' LYS . 13.0 t -113.32 149.97 15.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.847 -0.615 . . . . 0.59 109.798 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -84.51 5.25 28.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.003 -0.544 . . . . 2.83 111.288 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' H ' HG12 ' A' ' 25' ' ' VAL . 29.9 mmmt -132.24 119.72 21.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.439 -0.346 . . . . 4.07 110.215 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -126.28 80.27 1.91 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.251 -0.431 . . . . 2.46 110.218 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.8 m -118.26 -54.91 2.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.035 0.445 . . . . 2.0 111.317 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' O ' ' HA3' ' A' ' 34' ' ' GLY . . . 91.89 155.24 31.62 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.543 -0.753 . . . . 1.39 111.787 -174.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -101.18 -50.37 3.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.05 0.452 . . . . 3.06 110.189 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -78.71 -62.65 1.62 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.759 -0.655 . . . . 2.44 109.895 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.8 m -73.17 -21.14 60.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.522 -0.763 . . . . 2.36 109.173 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 30' ' ' GLY . . . -71.86 -20.83 78.99 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.343 -0.844 . . . . 2.54 112.336 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 tt -77.69 -36.38 51.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.72 -0.844 . . . . 3.49 108.72 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 mp -78.42 -179.43 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.319 -0.855 . . . . 4.79 110.355 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -79.42 5.97 11.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.115 0.483 . . . . 6.59 110.801 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.3 m -68.09 -37.35 81.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.11 -0.495 . . . . 5.42 110.242 174.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' HA2' ' NE2' ' A' ' 44' ' ' GLN . . . -75.22 13.85 5.54 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.602 -0.726 . . . . 3.27 112.859 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.7 -50.19 32.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.419 0.628 . . . . 4.15 110.354 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.0 m -74.7 141.26 16.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.973 -1.012 . . . . 2.58 112.299 -175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.5 tp -88.32 -2.46 58.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.428 -0.953 . . . . 3.5 108.428 172.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -60.76 -30.16 69.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.389 -1.278 . . . . 2.29 110.858 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.661 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.7 mt-30 -47.74 131.33 14.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.137 -0.483 . . . . 1.4 110.358 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 83' ' ' ASN . 7.2 p -95.14 105.51 17.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.693 0.758 . . . . 1.37 110.825 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -96.59 101.73 13.39 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.154 -0.93 . . . . 0.3 110.25 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 84' ' ' CYS . 17.5 pt -104.13 150.0 7.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.935 -0.575 . . . . 0.23 110.311 177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -74.77 126.6 31.26 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.057 -0.72 . . . . 2.38 109.057 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.534 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 1.8 t -117.0 160.72 20.51 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.342 -0.845 . . . . 1.15 110.522 -171.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 2.5 t -150.53 121.39 7.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.335 0.588 . . . . 0.6 110.427 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.4 HE21 HD12 ' A' ' 60' ' ' ILE . 5.0 tm0? -118.87 111.2 18.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.499 0.666 . . . . 2.08 110.479 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 64' ' ' CYS . 68.0 mt -71.11 133.8 85.6 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 114.859 -1.064 . . . . 0.95 109.979 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 52' ' ' ILE . 52.3 Cg_exo -34.3 130.58 0.18 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 124.693 3.595 . . . . 0.95 114.138 -173.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.57 HD12 ' H ' ' A' ' 54' ' ' LEU . 2.4 mp -84.29 132.85 34.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.807 -1.088 . . . . 1.67 112.584 -166.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.43 133.37 40.94 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.424 -0.954 . . . . 1.58 108.424 165.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.677 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -66.09 132.35 31.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.164 0.507 . . . . 2.11 110.893 -172.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.18 4.25 84.17 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.37 -0.832 . . . . 1.03 113.101 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -96.33 152.01 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.724 0.773 . . . . 0.77 111.859 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.54 143.33 27.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.339 -1.3 . . . . 0.68 111.172 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.42 HG21 HD23 ' A' ' 16' ' ' LEU . 8.4 tp -55.55 -32.32 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.005 -0.998 . . . . 0.69 111.83 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.79 -8.62 55.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 2.2 111.56 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.46 -27.15 11.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.403 0.621 . . . . 1.98 109.608 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.8 tp10 -72.62 -40.49 66.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.211 -0.904 . . . . 2.09 111.234 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.422 ' HA ' HD12 ' A' ' 52' ' ' ILE . 8.8 p -116.56 153.49 32.12 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.69 -0.404 . . . . 0.6 110.954 -173.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -99.69 33.17 2.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.663 0.745 . . . . 2.32 109.689 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 51.9 m-80 -117.94 -165.32 1.09 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.494 -0.776 . . . . 1.06 109.512 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 14.2 m -93.77 122.23 62.75 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-O 121.335 0.588 . . . . 0.34 112.012 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.41 117.26 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.482 2.788 . . . . 0.45 111.115 172.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.9 p -129.32 146.99 51.11 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.556 -0.458 . . . . 0.31 111.405 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 25.1 t -98.81 111.21 23.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.852 -0.613 . . . . 1.26 109.373 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.4 m -96.94 135.15 39.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.056 0.455 . . . . 0.29 110.626 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 6.5 tt0 -72.28 -20.75 61.46 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.449 0.642 . . . . 1.53 109.487 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -163.17 166.44 23.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.451 -0.795 . . . . 1.26 109.112 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.465 HG13 ' HD3' ' A' ' 15' ' ' LYS . 14.7 m -138.73 157.45 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 110.055 -0.35 . . . . 1.07 110.055 177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 80' ' ' VAL . 37.1 mt-10 -126.07 164.91 19.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.408 -0.36 . . . . 1.87 110.066 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 57.68 -150.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.548 -0.751 . . . . 1.94 109.396 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.97 22.88 0.74 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.11 0.481 . . . . 2.12 110.993 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 101.41 21.81 11.15 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.902 -0.666 . . . . 0.51 112.115 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.5 mm? -79.15 -22.55 44.9 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.329 0.585 . . . . 1.1 110.252 176.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 75' ' ' GLU . 61.1 t -122.49 117.91 53.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.606 -0.725 . . . . 0.33 109.472 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -110.35 134.78 12.41 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.142 -1.028 . . . . 0.26 111.939 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.661 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -98.12 121.62 48.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.198 -0.297 . . . . 0.3 110.198 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.705 ' HA ' HG12 ' A' ' 45' ' ' VAL . 94.5 m-20 58.4 54.91 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.867 -0.606 . . . . 0.34 110.904 174.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.536 ' HB2' HD11 ' A' ' 47' ' ' ILE . 47.8 m -91.62 110.73 22.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.295 -0.866 . . . . 0.81 110.944 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 47.3 m -96.16 128.76 35.77 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.982 -0.554 . . . . 0.44 110.166 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 39.4 Cg_exo -62.46 119.96 7.29 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.829 2.353 . . . . 0.39 110.947 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.0 pt -99.8 139.77 21.06 Favored Pre-proline 0 N--CA 1.442 -0.874 0 CA-C-N 116.319 -0.4 . . . . 0.57 111.718 -173.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.6 Cg_exo -71.38 159.44 51.61 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.251 2.634 . . . . 1.05 112.277 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.75 24.42 1.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.617 -0.72 . . . . 1.45 110.442 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.7 pt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 119.102 -0.475 . . . . 2.31 110.956 -173.573 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.707 -0.557 . . . . 5.75 111.707 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 m -76.24 73.56 3.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.103 0.478 . . . . 4.66 110.551 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.24 -65.26 2.86 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.289 -0.724 . . . . 1.6 111.289 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -121.8 149.62 43.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.154 -0.313 . . . . 0.81 110.154 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.35 110.11 2.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.912 -0.585 . . . . 2.73 109.983 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -102.67 26.23 8.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.889 -0.596 . . . . 1.75 110.57 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -16.24 62.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.684 -0.689 . . . . 3.24 111.066 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 10' ' ' SER . 8.1 t -69.47 -14.51 62.92 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.101 -0.5 . . . . 2.05 110.684 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.36 79.95 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.133 -0.556 . . . . 0.88 112.617 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.4 ' H ' HG23 ' A' ' 8' ' ' THR . 5.6 m -96.71 -10.32 27.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 111.896 0.332 . . . . 1.72 111.896 -173.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.8 t -139.46 141.87 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.613 -0.435 . . . . 1.19 110.83 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.45 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.4 p30 -93.41 -30.22 15.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 1.66 112.157 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.45 HG23 ' OD1' ' A' ' 12' ' ' ASN . 23.9 p -89.98 -30.67 17.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.138 0.422 . . . . 0.52 112.138 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.93 -7.39 67.43 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.527 -0.844 . . . . 0.43 112.068 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.691 ' HD3' HG23 ' A' ' 74' ' ' VAL . 75.5 mttt -87.35 88.37 7.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.352 0.596 . . . . 1.64 110.043 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' A' ' 60' ' ' ILE . 9.0 mp -97.69 122.55 40.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.341 -0.845 . . . . 0.55 109.691 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.33 146.54 50.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.038 0.447 . . . . 0.29 111.189 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 50' ' ' THR . 62.9 m -81.38 109.1 15.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.719 -0.845 . . . . 0.74 108.719 172.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 72.3 m -126.53 153.38 45.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.216 0.531 . . . . 0.5 112.114 -169.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.62 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 13.0 t70 -99.6 113.22 25.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.098 -1.075 . . . . 1.65 108.098 175.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.0 p -77.06 -10.1 59.16 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.352 0.871 . . . . 0.52 113.352 -169.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -106.48 -3.83 20.47 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.884 0.85 . . . . 2.2 109.153 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -93.07 104.8 16.97 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.951 -1.477 . . . . 2.6 109.907 175.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.76 162.43 12.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.283 0.563 . . . . 2.17 111.705 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -123.61 143.22 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.225 -0.898 . . . . 0.59 108.764 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -86.68 -31.4 21.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.277 -0.419 . . . . 2.83 110.988 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -87.7 119.67 28.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.228 -0.442 . . . . 4.07 110.414 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -93.63 54.92 2.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.471 0.653 . . . . 2.46 109.584 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.1 m -92.12 132.92 36.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.378 -0.828 . . . . 2.0 110.192 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.503 ' HA3' ' OG ' ' A' ' 33' ' ' SER . . . -123.62 164.88 16.57 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.502 -0.856 . . . . 1.39 112.515 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -100.63 -47.87 4.71 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 122.518 0.327 . . . . 3.06 110.143 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 6.8 mm-40 -94.8 -34.41 12.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.658 0.266 . . . . 2.44 110.354 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.503 ' OG ' ' HA3' ' A' ' 30' ' ' GLY . 37.6 p -65.24 -6.83 10.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 2.36 111.847 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.75 -53.23 32.35 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.729 -0.748 . . . . 2.54 111.678 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.0 mt -91.48 -22.37 20.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.883 0.373 . . . . 3.49 110.898 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -83.05 148.39 27.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 4.79 109.895 -179.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.501 ' H ' HD23 ' A' ' 36' ' ' LEU . 75.0 m-70 -70.08 3.56 2.68 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.632 0.604 . . . . 6.59 112.632 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 p -78.41 -11.7 59.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.119 0.485 . . . . 5.42 110.789 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.5 -0.49 55.55 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.993 -0.622 . . . . 3.27 112.396 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.07 -30.27 70.27 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.02 0.438 . . . . 4.15 110.616 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 9.0 m -81.5 138.73 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.938 -0.574 . . . . 2.58 110.571 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.7 mt -94.24 0.79 55.9 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.585 0.707 . . . . 3.5 109.335 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.05 1.81 55.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.853 -1.067 . . . . 2.29 111.535 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' A' ' 82' ' ' ILE . 31.7 mt-30 -42.52 134.64 3.02 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.427 0.454 . . . . 1.4 110.897 176.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.17 99.92 10.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.764 -0.653 . . . . 1.37 109.629 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -99.33 108.06 20.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.447 -0.797 . . . . 0.3 110.478 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 pt -118.52 159.47 18.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.836 -0.62 . . . . 0.23 110.052 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -77.56 142.04 39.23 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 122.12 0.962 . . . . 2.38 110.848 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 39.4 m -140.94 164.64 29.71 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.516 -1.675 . . . . 1.15 109.908 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 7.9 t -161.01 136.1 7.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.164 -0.471 . . . . 0.6 109.806 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -120.36 110.28 16.35 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.109 0.48 . . . . 2.08 110.447 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.403 HG23 ' HD2' ' A' ' 53' ' ' PRO . 61.9 mt -63.71 131.11 94.79 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.503 -0.771 . . . . 0.95 109.517 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HD2' HG23 ' A' ' 52' ' ' ILE . 50.4 Cg_exo -32.83 102.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.771 3.647 . . . . 0.95 113.867 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 pp -70.03 135.58 49.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.101 -0.954 . . . . 1.67 112.636 -171.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.3 137.74 32.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.349 -0.842 . . . . 1.58 109.333 170.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.8 mp -71.39 131.83 34.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.405 -0.591 . . . . 2.11 109.405 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.77 -6.95 59.0 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.598 -0.728 . . . . 1.03 111.687 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.47 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -106.99 152.69 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.642 0.734 . . . . 0.77 111.803 179.535 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.4 152.7 20.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.458 -1.247 . . . . 0.68 111.359 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 16' ' ' LEU . 6.2 tp -56.81 -40.68 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.227 0.611 . . . . 0.69 112.1 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -11.19 56.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.398 -0.365 . . . . 2.2 111.598 -172.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -95.56 -34.3 12.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.383 -0.599 . . . . 1.98 109.383 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.47 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 9.6 tp10 -67.55 -40.23 84.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.138 -0.937 . . . . 2.09 110.711 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.56 148.36 41.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.293 -0.412 . . . . 0.6 109.961 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -99.79 45.7 0.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.874 0.845 . . . . 2.32 109.667 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 46.3 m-80 -122.11 -172.36 2.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.103 -0.953 . . . . 1.06 108.982 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 m -85.93 126.12 66.59 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-O 121.167 0.508 . . . . 0.34 110.552 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -83.06 136.07 7.81 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.079 2.519 . . . . 0.45 111.105 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 86' ' ' PRO . 67.8 p -133.8 150.91 51.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.794 0.33 . . . . 0.31 111.147 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 44.0 t -95.37 115.46 27.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.727 -0.842 . . . . 1.26 108.727 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.91 135.65 45.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.467 0.651 . . . . 0.29 110.829 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 9.4 mt-10 -70.14 -19.42 63.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.946 -1.025 . . . . 1.53 109.837 175.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -169.68 161.44 9.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.909 -1.041 . . . . 1.26 108.616 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.691 HG23 ' HD3' ' A' ' 15' ' ' LYS . 1.8 t -145.28 136.9 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.635 -0.505 . . . . 1.07 109.635 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.84 160.85 14.02 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.361 -0.381 . . . . 1.87 110.108 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 t70 62.34 -153.34 0.35 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.348 -0.612 . . . . 1.94 109.348 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.81 23.58 0.43 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.095 0.474 . . . . 2.12 110.705 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.571 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 105.38 23.58 7.54 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.889 -0.672 . . . . 0.51 112.423 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -78.66 -33.04 47.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.865 0.364 . . . . 1.1 111.243 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.69 108.29 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.319 -0.4 . . . . 0.33 110.036 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.721 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -97.16 140.04 14.83 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.064 -1.065 . . . . 0.26 112.527 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -102.97 116.8 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 109.52 -0.548 . . . . 0.3 109.52 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 96.5 m-20 62.58 41.59 9.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.428 -0.805 . . . . 0.34 110.773 175.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.721 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 60.5 m -80.42 110.9 16.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.81 111.086 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 m -103.85 132.21 21.25 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.154 -0.475 . . . . 0.44 110.13 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 69' ' ' THR . 9.4 Cg_endo -65.41 129.13 21.82 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.041 2.494 . . . . 0.39 112.1 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 11.7 pt -105.73 146.61 33.18 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.908 -0.587 . . . . 0.57 111.776 -173.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 11.4 Cg_exo -74.34 163.52 36.16 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.286 2.658 . . . . 1.05 112.04 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.3 mt -95.44 21.93 7.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.66 -0.7 . . . . 1.45 110.138 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 pt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.113 -0.946 . . . . 2.31 111.875 -171.911 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 111.556 -0.617 . . . . 5.75 111.556 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -85.93 -20.39 29.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.945 0.402 . . . . 4.66 110.904 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -149.19 -80.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.517 -0.849 . . . . 1.6 112.486 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -120.67 156.03 32.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.208 0.528 . . . . 0.81 111.773 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.89 115.77 20.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.286 -0.87 . . . . 2.73 110.202 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.2 m -88.13 23.57 2.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.236 -0.438 . . . . 1.75 110.868 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -46.98 -49.06 21.4 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.557 -0.747 . . . . 3.24 112.246 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -62.76 -21.33 65.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.676 -0.693 . . . . 2.05 111.976 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.97 16.26 76.53 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.276 -0.488 . . . . 0.88 113.336 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 m -85.35 -8.93 58.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.161 0.43 . . . . 1.72 112.161 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.641 ' SG ' HG21 ' A' ' 87' ' ' ILE . 1.8 m -132.32 141.05 48.8 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.499 -0.481 . . . . 1.19 111.373 -170.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -92.8 -30.45 15.47 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.147 0.425 . . . . 1.66 112.147 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.4 p -92.15 -31.98 15.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.165 0.507 . . . . 0.52 111.364 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.78 4.46 67.45 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.58 -0.819 . . . . 0.43 111.99 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 63.7 mttp -87.34 87.8 7.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.069 0.462 . . . . 1.64 109.865 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.855 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 8.7 mp -94.1 134.96 35.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.872 -0.603 . . . . 0.55 109.975 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.512 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -149.01 146.57 27.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.914 0.388 . . . . 0.29 110.299 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 98.2 m -88.93 100.82 13.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.339 0.59 . . . . 0.74 110.019 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 79.9 m -111.02 158.92 18.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.723 -0.671 . . . . 0.5 111.484 -168.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -99.04 107.76 20.25 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.166 -0.679 . . . . 1.65 109.166 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.8 p -70.68 -13.18 61.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.784 -0.643 . . . . 0.52 111.162 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -95.51 -10.88 28.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.395 0.617 . . . . 2.2 109.674 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -115.04 140.37 49.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.224 -0.898 . . . . 2.6 110.113 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.626 ' HD3' HG22 ' A' ' 47' ' ' ILE . 44.5 mmtm -124.51 155.19 39.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.291 -0.868 . . . . 2.17 111.072 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.562 HG22 ' OE1' ' A' ' 48' ' ' GLN . 3.1 t -113.69 149.17 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.112 -0.699 . . . . 0.59 109.112 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -93.81 20.96 6.99 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.048 0.451 . . . . 2.83 110.704 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 30.1 mmmt -126.77 132.62 51.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.027 -0.533 . . . . 4.07 110.649 -178.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -114.48 42.82 2.03 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.709 -0.849 . . . . 2.46 108.709 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -108.36 168.12 9.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.785 -1.098 . . . . 2.0 111.601 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.457 ' HA3' ' OD2' ' A' ' 73' ' ' ASP . . . 170.91 -149.18 12.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.08 -0.581 . . . . 1.39 112.217 -176.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.81 -51.55 6.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.037 0.446 . . . . 3.06 110.92 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -104.73 -46.82 4.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.973 -0.558 . . . . 2.44 109.738 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -66.61 -20.37 65.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.634 -0.712 . . . . 2.36 109.783 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.79 -37.53 78.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.809 -0.71 . . . . 2.54 111.491 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.4 mt -81.93 -60.77 2.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.537 -0.542 . . . . 3.49 109.537 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt -110.37 97.2 6.71 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.917 -0.583 . . . . 4.79 111.195 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -112.22 -71.07 0.77 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.753 -0.379 . . . . 6.59 110.741 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 m -71.83 -24.77 61.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.179 0.514 . . . . 5.42 110.481 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.48 -3.49 82.88 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.817 -0.706 . . . . 3.27 112.693 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -118.07 -50.33 2.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.118 0.485 . . . . 4.15 109.824 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.22 129.91 3.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.369 -0.832 . . . . 2.58 111.603 -175.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mt -91.59 -9.93 42.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.896 -0.593 . . . . 3.5 111.047 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.53 0.33 54.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.178 -0.465 . . . . 2.29 111.837 -174.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.566 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 19.3 mt-30 -54.4 144.13 21.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.078 0.466 . . . . 1.4 110.762 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 83' ' ' ASN . 13.5 p -115.35 123.8 71.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.556 -0.747 . . . . 1.37 109.965 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -105.85 100.15 9.71 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.595 -0.729 . . . . 0.3 110.38 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.626 HG22 ' HD3' ' A' ' 24' ' ' LYS . 20.1 pt -107.36 146.83 13.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.201 0.524 . . . . 0.23 110.489 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.562 ' OE1' HG22 ' A' ' 25' ' ' VAL . 17.9 tp60 -74.9 118.32 17.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.303 -0.862 . . . . 2.38 108.954 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.687 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 3.4 t -115.97 164.27 14.67 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.658 -0.701 . . . . 1.15 110.594 -171.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -162.42 131.98 4.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.174 0.511 . . . . 0.6 110.526 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -121.1 123.14 41.6 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.135 -0.484 . . . . 2.08 111.35 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 64' ' ' CYS . 45.9 mt -64.52 135.07 96.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.438 -0.801 . . . . 0.95 109.654 173.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.4 111.66 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.063 3.175 . . . . 0.95 112.593 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.68 141.91 31.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.821 -1.081 . . . . 1.67 112.769 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.404 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 7.8 mp -93.87 132.35 38.39 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.692 -0.855 . . . . 1.58 108.692 167.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.606 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.9 mp -67.11 131.85 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.225 0.536 . . . . 2.11 110.072 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.69 -5.89 56.99 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.493 -0.776 . . . . 1.03 112.017 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -98.62 150.5 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.739 0.781 . . . . 0.77 111.471 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.47 132.17 34.97 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.91 -1.495 . . . . 0.68 110.105 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.403 HG12 ' SG ' ' A' ' 18' ' ' CYS . 10.7 tt -53.96 -34.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.207 -0.906 . . . . 0.69 111.907 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -73.75 -18.13 61.02 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.942 -1.027 . . . . 2.2 111.494 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -110.99 4.8 19.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.188 0.518 . . . . 1.98 110.585 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -95.67 -40.35 9.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.436 0.636 . . . . 2.09 110.311 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.448 ' HA ' HD12 ' A' ' 52' ' ' ILE . 15.3 p -105.92 -176.4 3.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.869 -0.605 . . . . 0.6 110.667 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -127.56 35.84 4.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.372 0.606 . . . . 2.32 109.767 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 52.8 m-80 -135.01 -170.77 2.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 1.06 110.339 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 89.7 m -80.91 124.86 81.18 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 121.322 0.582 . . . . 0.34 111.996 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.76 115.52 2.97 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.393 2.728 . . . . 0.45 111.583 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -132.22 159.81 37.95 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.478 -0.564 . . . . 0.31 109.478 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.855 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 85.6 m -121.76 122.8 40.33 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.274 0.559 . . . . 1.26 109.982 174.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.466 ' HB2' HG22 ' A' ' 74' ' ' VAL . 37.8 m -100.92 143.12 31.45 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.107 -0.951 . . . . 0.29 110.627 -172.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 6.9 mm-40 -77.42 -17.35 58.2 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.673 -1.149 . . . . 1.53 109.613 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.457 ' OD2' ' HA3' ' A' ' 30' ' ' GLY . 4.3 t70 -165.04 155.61 14.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.076 -0.965 . . . . 1.26 108.889 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.51 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -149.75 130.54 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 110.207 -0.294 . . . . 1.07 110.207 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 30.5 tt0 -96.99 164.99 12.29 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.963 -0.384 . . . . 1.87 109.963 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 65.26 -154.25 0.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.401 -0.592 . . . . 1.94 109.401 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -72.63 2.48 6.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.54 0.686 . . . . 2.12 109.843 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.38 24.09 2.48 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.648 -0.705 . . . . 0.51 112.271 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 2.0 mm? -79.08 -29.76 43.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.689 0.255 . . . . 1.1 111.689 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG22 HG11 ' A' ' 25' ' ' VAL . 67.4 t -118.38 102.97 13.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.941 -0.304 . . . . 0.33 110.192 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -104.53 136.26 12.96 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.309 -0.948 . . . . 0.26 113.009 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -99.32 122.95 51.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.12 -0.54 . . . . 0.3 109.624 177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.716 ' HA ' HG12 ' A' ' 45' ' ' VAL . 70.8 m-20 60.45 48.0 8.15 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.457 0.473 . . . . 0.34 110.931 175.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.597 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 58.3 m -84.54 90.76 7.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.025 -0.534 . . . . 0.81 110.422 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.7 m -79.15 127.84 77.96 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.587 -0.733 . . . . 0.44 110.227 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.03 109.53 1.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.7 2.267 . . . . 0.39 110.737 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.641 HG21 ' SG ' ' A' ' 11' ' ' CYS . 12.0 pt -82.32 146.81 55.16 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.642 -0.708 . . . . 0.57 111.87 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 14.2 Cg_exo -74.02 147.91 39.28 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.249 2.632 . . . . 1.05 111.206 175.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.03 36.85 0.97 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.676 -0.693 . . . . 1.45 110.147 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.9 pt . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.124 -0.941 . . . . 2.31 111.19 -173.649 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.879 0 N-CA-C 112.155 -0.378 . . . . 5.75 112.155 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -105.57 31.84 4.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.201 0.524 . . . . 4.66 110.512 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.88 81.93 1.0 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.702 -0.761 . . . . 1.6 111.659 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.441 ' HH2' ' OE1' ' A' ' 63' ' ' GLU . 94.1 m95 -103.02 -172.58 2.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.563 0.22 . . . . 0.81 111.423 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -59.83 111.77 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 2.73 111.551 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -99.38 -19.92 16.76 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.729 -0.669 . . . . 1.75 111.034 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -17.33 64.7 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.938 0.399 . . . . 3.24 111.141 -177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -72.97 -30.14 63.6 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.081 -0.509 . . . . 2.05 110.983 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.81 16.99 74.82 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.886 -0.597 . . . . 0.88 112.308 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.464 ' HB2' HG21 ' A' ' 87' ' ' ILE . 28.5 p -85.89 -19.26 30.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.793 0.33 . . . . 1.72 111.724 -172.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.8 t -130.49 143.84 51.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.929 0.395 . . . . 1.19 111.033 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -91.13 -31.6 16.16 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.027 -0.533 . . . . 1.66 110.61 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.5 p -90.36 -30.57 17.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.578 -0.737 . . . . 0.52 111.002 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.58 2.22 61.71 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.632 -0.713 . . . . 0.43 111.913 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.505 ' HD3' HG23 ' A' ' 74' ' ' VAL . 94.0 mttt -91.55 87.59 6.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.046 0.451 . . . . 1.64 110.267 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 mp -97.63 100.22 11.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.857 -0.61 . . . . 0.55 109.845 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.48 145.53 40.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.06 0.457 . . . . 0.29 110.437 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 66' ' ' ASN . 84.6 m -80.57 108.19 14.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.795 -0.639 . . . . 0.74 109.646 172.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 62.5 m -126.91 153.65 45.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.885 -0.598 . . . . 0.5 111.368 -172.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -95.61 111.65 23.53 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.475 -0.784 . . . . 1.65 109.854 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.4 p -75.28 -11.06 59.98 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.28 0.562 . . . . 0.52 110.709 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -93.87 -8.96 38.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.555 0.693 . . . . 2.2 109.248 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -119.74 125.4 48.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.994 -1.003 . . . . 2.6 110.692 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -113.11 154.0 27.3 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.535 -1.212 . . . . 2.17 111.066 -170.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.577 HG22 ' NE2' ' A' ' 48' ' ' GLN . 9.6 t -115.13 148.75 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.862 -0.792 . . . . 0.59 108.862 175.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -98.34 29.74 3.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.908 0.385 . . . . 2.83 111.081 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -130.38 118.74 21.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.34 -0.391 . . . . 4.07 110.791 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.5 m -111.96 53.96 0.71 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 2.46 110.089 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.42 -93.91 0.26 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.615 -0.72 . . . . 2.0 111.647 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.03 155.18 15.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 1.39 111.859 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.73 -50.22 4.54 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.598 -0.354 . . . . 3.06 110.921 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -77.44 -25.83 50.98 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.887 -0.325 . . . . 2.44 110.492 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.8 m -52.08 -34.16 42.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.351 -0.386 . . . . 2.36 111.249 167.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.34 -28.88 51.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.734 -0.746 . . . . 2.54 112.522 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -75.2 -27.48 59.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.087 0.47 . . . . 3.49 110.692 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.6 tp -110.52 168.91 9.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.785 -0.643 . . . . 4.79 109.558 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -81.15 6.88 12.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.053 0.454 . . . . 6.59 110.875 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.465 ' HB ' ' CD ' ' A' ' 72' ' ' GLU . 9.2 p -72.42 -31.46 65.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.132 -0.485 . . . . 5.42 111.198 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.03 13.06 33.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.911 -0.661 . . . . 3.27 112.34 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.25 -19.99 38.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.011 0.434 . . . . 4.15 110.964 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.402 HG23 ' CG ' ' A' ' 44' ' ' GLN . 3.6 m -89.19 142.94 12.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.857 -0.611 . . . . 2.58 111.052 176.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.8 mt -94.85 -6.17 43.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.165 -0.471 . . . . 3.5 110.596 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -83.03 -3.85 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 2.29 111.441 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.605 ' HB3' HG23 ' A' ' 82' ' ' ILE . 35.2 mt-30 -45.67 131.29 9.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.072 0.463 . . . . 1.4 110.441 174.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 83' ' ' ASN . 11.9 p -101.03 120.94 51.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.41 0.624 . . . . 1.37 110.77 -174.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -103.11 117.09 33.79 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.33 -0.85 . . . . 0.3 110.707 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.507 HD11 ' HB2' ' A' ' 84' ' ' CYS . 18.3 pt -124.31 159.78 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.23 -0.441 . . . . 0.23 109.96 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.577 ' NE2' HG22 ' A' ' 25' ' ' VAL . 3.5 mp0 -72.33 131.32 42.5 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.525 0.678 . . . . 2.38 110.704 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 72.3 m -125.09 149.15 48.13 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.395 -1.275 . . . . 1.15 110.071 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.2 t -161.31 132.96 5.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.105 0.479 . . . . 0.6 110.406 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -121.61 115.93 23.67 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.833 -0.622 . . . . 2.08 110.968 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.512 HG23 ' HD2' ' A' ' 53' ' ' PRO . 47.1 mt -58.09 139.31 83.55 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.153 -0.93 . . . . 0.95 109.12 173.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HD2' HG23 ' A' ' 52' ' ' ILE . 31.4 Cg_exo -34.11 127.77 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 124.262 3.308 . . . . 0.95 114.255 -173.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.71 136.09 57.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.357 -1.292 . . . . 1.67 112.365 -170.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.1 mt -110.13 132.02 54.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.291 -0.868 . . . . 1.58 109.512 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 mt -68.57 132.62 32.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.988 0.423 . . . . 2.11 110.728 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.59 24.94 71.35 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.429 -0.805 . . . . 1.03 112.951 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.488 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -113.41 150.51 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.781 0.801 . . . . 0.77 112.264 -178.346 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.5 145.64 31.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.126 -1.397 . . . . 0.68 111.457 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 tp -56.9 -42.08 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.698 -0.683 . . . . 0.69 111.547 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.83 -5.23 58.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.329 -0.396 . . . . 2.2 111.675 -173.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -106.69 -28.4 10.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.147 0.498 . . . . 1.98 109.914 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.488 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 32.6 tt0 -68.51 -37.66 80.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 2.09 111.191 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.415 ' HA ' HD12 ' A' ' 52' ' ' ILE . 1.8 p -113.0 178.23 4.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.092 -0.504 . . . . 0.6 109.979 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -127.33 28.93 5.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.058 0.456 . . . . 2.32 110.763 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 8.3 t-20 -105.25 -140.57 0.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.639 -0.709 . . . . 1.06 109.356 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 27.9 m -116.43 130.23 24.65 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 120.768 0.318 . . . . 0.34 110.48 176.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -78.26 122.89 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.76 2.307 . . . . 0.45 111.404 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.2 p -130.19 147.67 51.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.959 0.409 . . . . 0.31 111.007 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.48 106.77 19.07 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.503 -0.555 . . . . 1.26 109.503 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.0 m -93.86 141.78 28.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.209 0.528 . . . . 0.29 110.72 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.9 tt0 -79.16 -25.98 42.78 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.506 -0.77 . . . . 1.53 109.745 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -160.13 160.12 32.58 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.312 -0.995 . . . . 1.26 108.312 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.505 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.3 t -141.69 132.86 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.76 -0.459 . . . . 1.07 109.76 175.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.48 163.73 12.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.564 -0.289 . . . . 1.87 110.444 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 66.65 -152.98 0.22 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.035 -0.53 . . . . 1.94 109.588 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.94 -7.05 19.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.444 0.64 . . . . 2.12 110.449 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.447 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . 120.47 23.4 2.87 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.137 -0.785 . . . . 0.51 111.137 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 62.2 mt -91.9 -13.57 31.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.727 -0.236 . . . . 1.1 111.404 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.99 107.97 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.13 -0.322 . . . . 0.33 110.13 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -97.67 144.0 17.04 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.517 -0.849 . . . . 0.26 112.426 -178.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.605 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -105.23 124.08 59.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.099 -0.334 . . . . 0.3 110.099 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.778 ' HA ' HG12 ' A' ' 45' ' ' VAL . 74.3 m-20 57.57 45.7 18.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.365 0.603 . . . . 0.34 110.796 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.58 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 81.4 m -82.25 92.33 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.248 -0.887 . . . . 0.81 110.631 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 25.1 m -84.03 123.67 75.32 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.68 -0.691 . . . . 0.44 110.385 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 25.0 Cg_exo -64.29 130.91 28.33 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.108 2.538 . . . . 0.39 111.998 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.2 pt -103.3 137.07 19.15 Favored Pre-proline 0 N--CA 1.438 -1.072 0 CA-C-N 115.857 -0.611 . . . . 0.57 110.696 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 8.2 Cg_exo -76.74 156.25 35.3 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.406 2.737 . . . . 1.05 112.559 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 70.6 mt -98.44 21.7 10.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.428 -0.805 . . . . 1.45 109.953 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 pt . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.731 -0.668 . . . . 2.31 110.887 -172.418 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 111.719 -0.553 . . . . 5.75 111.719 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.5 t 60.89 84.39 0.13 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.306 0.574 . . . . 4.66 110.414 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.89 -171.39 25.99 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.138 -0.785 . . . . 1.6 111.138 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -117.89 169.1 9.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.213 0.53 . . . . 0.81 111.493 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -66.46 117.7 9.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.969 -1.014 . . . . 2.73 110.104 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.0 t -107.71 27.05 9.56 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.878 -0.786 . . . . 1.75 108.878 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -60.83 -38.22 84.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.07 -0.968 . . . . 3.24 110.902 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -65.59 -22.04 66.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.691 -0.686 . . . . 2.05 110.895 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.11 16.04 79.74 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.216 -0.516 . . . . 0.88 112.94 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.439 ' HB3' ' HB ' ' A' ' 87' ' ' ILE . 8.3 m -82.66 -18.57 40.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.998 0.37 . . . . 1.72 111.998 -175.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.3 t -116.47 141.58 47.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.884 0.373 . . . . 1.19 110.649 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.439 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.1 p30 -93.13 -26.21 17.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 1.66 111.822 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.439 HG23 ' OD1' ' A' ' 12' ' ' ASN . 32.2 p -94.98 -30.81 13.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.998 0.427 . . . . 0.52 112.034 -173.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.08 -1.64 74.22 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.591 -0.814 . . . . 0.43 111.521 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -92.47 87.93 6.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.322 -0.622 . . . . 1.64 109.322 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -96.81 139.71 32.46 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.923 -0.58 . . . . 0.55 110.619 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -147.61 156.61 42.97 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.129 -1.063 . . . . 0.29 108.129 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 93.8 m -99.92 97.45 8.33 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.301 -0.56 . . . . 0.74 109.704 174.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.4 m -110.49 156.57 20.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.679 -0.691 . . . . 0.5 111.147 -168.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.48 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 33.4 m-20 -99.94 109.72 22.08 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.264 -0.643 . . . . 1.65 109.264 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.422 HG21 ' HG3' ' A' ' 86' ' ' PRO . 33.1 p -71.87 -8.03 51.96 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.808 -0.633 . . . . 0.52 111.287 -175.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -100.85 -6.76 24.31 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.243 -0.651 . . . . 2.2 109.243 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 30.1 mtpp -116.64 117.32 29.49 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.969 -1.014 . . . . 2.6 109.812 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -128.62 152.58 48.19 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.584 0.586 . . . . 2.17 112.584 -171.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 27' ' ' LYS . 6.5 t -99.36 150.36 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.144 -0.935 . . . . 0.59 110.416 -174.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -91.29 13.21 17.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.644 -0.707 . . . . 2.83 110.088 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' H ' HG12 ' A' ' 25' ' ' VAL . 13.6 mmmm -131.62 142.3 49.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.046 -0.979 . . . . 4.07 108.767 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 t -139.18 80.39 1.78 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.7 0.762 . . . . 2.46 110.002 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.549 ' HB ' ' OE2' ' A' ' 75' ' ' GLU . 5.1 m -115.96 143.16 45.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.074 -0.966 . . . . 2.0 109.94 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -114.22 149.02 18.79 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.674 -0.774 . . . . 1.39 112.253 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.52 -51.09 4.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.399 -0.593 . . . . 3.06 109.399 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -92.25 -29.66 16.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 2.44 109.928 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 t -69.05 -19.79 64.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.812 -0.631 . . . . 2.36 109.562 174.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.59 -21.82 76.4 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.713 -0.676 . . . . 2.54 112.71 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.12 -34.66 76.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.297 0.57 . . . . 3.49 109.719 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -93.8 174.93 6.93 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.47 -0.786 . . . . 4.79 109.516 176.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -81.17 4.34 20.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.216 0.532 . . . . 6.59 110.355 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.3 p -75.66 -24.45 56.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.63 -0.714 . . . . 5.42 110.972 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.65 -13.04 82.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.629 -0.796 . . . . 3.27 112.399 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -76.77 -35.49 57.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.649 0.261 . . . . 4.15 111.219 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -76.16 135.23 27.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.426 0.631 . . . . 2.58 111.63 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -88.72 -0.26 57.13 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.191 -0.913 . . . . 3.5 109.191 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.13 -31.61 72.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.871 -1.058 . . . . 2.29 110.614 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.664 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.5 mt-30 -48.56 135.66 14.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.783 -0.644 . . . . 1.4 110.85 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.0 t -83.68 112.57 21.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.896 -0.593 . . . . 1.37 110.171 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.63 105.61 15.73 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.437 -0.801 . . . . 0.3 110.556 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 11.5 pt -110.21 152.76 12.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.218 -0.446 . . . . 0.23 111.014 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -72.07 142.02 49.23 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.506 -0.77 . . . . 2.38 110.287 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.646 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.4 t -144.79 165.69 27.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.56 -1.2 . . . . 1.15 109.993 -170.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.3 t -160.04 153.06 21.68 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.248 -0.279 . . . . 0.6 110.248 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.5 122.8 41.43 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.415 -0.587 . . . . 2.08 109.415 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 64' ' ' CYS . 46.7 mt -92.64 131.92 32.79 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.511 -0.552 . . . . 0.95 109.511 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 52' ' ' ILE . 52.8 Cg_exo -33.88 99.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.575 3.516 . . . . 0.95 113.504 -174.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 pp -78.31 140.61 38.8 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.987 -1.006 . . . . 1.67 111.412 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.548 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 2.6 mm? -77.74 138.86 39.26 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.199 -1.037 . . . . 1.58 108.199 171.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.7 mt -61.02 129.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.025 0.441 . . . . 2.11 110.416 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.4 2.91 88.92 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.513 -0.767 . . . . 1.03 112.763 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -95.92 152.63 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.724 0.773 . . . . 0.77 111.601 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.66 152.13 23.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.395 -1.275 . . . . 0.68 111.401 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 10.5 tt -52.29 -38.77 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.943 0.878 . . . . 0.69 110.857 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.444 ' N ' HG23 ' A' ' 60' ' ' ILE . 34.9 mt-10 -64.24 -16.01 61.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.825 -1.079 . . . . 2.2 111.766 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -111.34 -8.12 14.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.036 0.384 . . . . 1.98 112.036 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 1.9 pp20? -94.53 -33.76 12.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.433 -0.507 . . . . 2.09 111.599 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.499 ' HA ' HD12 ' A' ' 52' ' ' ILE . 3.8 p -113.44 156.52 23.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.063 0.459 . . . . 0.6 111.408 -173.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 4.1 tppp? -110.89 26.41 10.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.085 0.945 . . . . 2.32 108.976 173.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.643 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 4.3 m-20 -105.07 -168.49 1.48 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.199 -0.91 . . . . 1.06 109.471 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -88.67 124.62 65.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-O 121.388 0.613 . . . . 0.34 111.408 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HB2' HG13 ' A' ' 87' ' ' ILE . 9.6 Cg_exo -60.19 113.91 1.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.21 2.607 . . . . 0.45 110.986 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.848 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 0.8 OUTLIER -124.99 139.54 53.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.964 0.412 . . . . 0.31 111.41 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.9 t -102.65 105.56 16.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.224 -0.658 . . . . 1.26 109.224 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 67.3 m -86.77 145.36 26.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.927 -0.397 . . . . 0.29 109.927 -174.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.4 tt0 -76.3 -24.17 54.37 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.705 -0.85 . . . . 1.53 108.705 172.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -163.25 157.98 20.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.823 -1.081 . . . . 1.26 108.481 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.544 HG12 ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -138.45 138.4 42.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.804 -0.358 . . . . 1.07 110.095 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.549 ' OE2' ' HB ' ' A' ' 29' ' ' THR . 43.9 tt0 -106.42 155.33 19.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.276 -0.42 . . . . 1.87 110.311 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 t70 66.78 -152.64 0.21 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.661 0.601 . . . . 1.94 109.667 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.01 0.69 5.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.111 0.482 . . . . 2.12 110.611 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 115.4 23.69 4.37 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.043 -0.599 . . . . 0.51 111.971 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.4 mt -79.35 -24.81 42.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.007 0.432 . . . . 1.1 110.892 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.97 108.67 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.721 -0.474 . . . . 0.33 109.721 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.99 133.53 11.4 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.298 -0.954 . . . . 0.26 111.81 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.664 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -95.23 118.47 41.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 110.136 -0.32 . . . . 0.3 110.136 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 89.8 m-20 57.75 42.53 23.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.382 -0.827 . . . . 0.34 110.825 174.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.848 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -78.27 105.14 9.31 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.689 -0.687 . . . . 0.81 110.351 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.5 m -83.45 128.22 65.1 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.422 -0.808 . . . . 0.44 109.738 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HG3' HG21 ' A' ' 21' ' ' THR . 33.3 Cg_exo -61.35 119.91 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.56 2.173 . . . . 0.39 110.779 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.439 ' HB ' ' HB3' ' A' ' 10' ' ' SER . 8.4 pt -106.87 146.85 33.95 Favored Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-O 121.137 0.494 . . . . 0.57 111.458 -174.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.22 159.48 8.39 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 123.461 2.774 . . . . 1.05 112.31 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.2 mt -86.66 21.51 2.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.661 -0.7 . . . . 1.45 110.952 -173.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.5 pt . . . . . 0 C--O 1.25 1.11 0 CA-C-N 116.011 -0.54 . . . . 2.31 111.267 -173.972 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.855 -0.498 . . . . 5.75 111.855 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 p -91.03 -10.12 43.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.019 0.437 . . . . 4.66 110.594 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 104.08 -74.89 0.26 Allowed Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.566 -1.014 . . . . 1.6 110.566 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.547 ' CZ2' HD22 ' A' ' 54' ' ' LEU . 78.2 m95 -111.23 168.73 9.29 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.678 -0.49 . . . . 0.81 109.678 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -76.81 108.28 9.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.93 0.395 . . . . 2.73 110.775 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.9 m -94.82 13.32 25.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.905 -0.589 . . . . 1.75 109.551 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -19.82 55.03 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.453 -0.794 . . . . 3.24 111.302 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -74.68 -16.47 60.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.948 -0.569 . . . . 2.05 110.898 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.22 69.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.949 -0.643 . . . . 0.88 111.607 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.6 p -87.23 -29.65 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.623 0.601 . . . . 1.72 112.623 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.4 t -129.3 141.31 51.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.604 0.716 . . . . 1.19 111.313 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -92.36 -30.53 15.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.509 -1.223 . . . . 1.66 111.704 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -30.55 14.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.069 0.396 . . . . 0.52 112.069 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.55 -9.51 57.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.553 -0.832 . . . . 0.43 112.626 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HD3' HG23 ' A' ' 74' ' ' VAL . 90.9 mttt -89.48 88.11 7.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.957 0.408 . . . . 1.64 110.347 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' A' ' 4' ' ' TRP . 8.8 mp -90.49 138.09 31.83 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.357 -0.609 . . . . 0.55 109.357 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.01 156.62 44.46 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.87 0.367 . . . . 0.29 110.71 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 50' ' ' THR . 51.2 m -91.34 101.93 14.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.697 -0.853 . . . . 0.74 108.697 171.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.8 m -121.32 142.51 49.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.213 0.53 . . . . 0.5 111.312 -171.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -93.72 108.26 20.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.408 -0.815 . . . . 1.65 109.235 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.7 p -74.15 -6.93 50.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.886 -0.597 . . . . 0.52 111.24 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -91.85 -20.58 21.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.843 0.83 . . . . 2.2 108.822 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -104.34 135.31 46.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.476 -1.238 . . . . 2.6 110.623 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.505 ' HD2' HG22 ' A' ' 47' ' ' ILE . 14.4 mmmm -119.91 156.56 30.52 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.831 -1.077 . . . . 2.17 110.052 -175.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.06 150.27 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.002 0.429 . . . . 0.59 110.303 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -78.1 30.25 0.17 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.44 -0.8 . . . . 2.83 111.837 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 30.7 mmmt -133.49 160.06 38.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 4.07 111.26 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.8 t -148.02 23.55 1.07 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.939 0.876 . . . . 2.46 108.942 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.407 ' OG1' ' HE3' ' A' ' 27' ' ' LYS . 13.7 p -102.56 145.09 30.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.909 -1.041 . . . . 2.0 111.652 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.66 155.77 15.94 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.966 -0.854 . . . . 1.39 110.966 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -100.88 -50.11 3.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.976 0.388 . . . . 3.06 111.158 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -95.96 -32.83 12.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.904 0.383 . . . . 2.44 110.457 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 p -59.49 -26.37 65.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 2.36 110.97 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.62 -28.91 74.01 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.159 -0.543 . . . . 2.54 112.58 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.3 -26.37 28.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.282 0.563 . . . . 3.49 110.123 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.3 tp -86.53 168.13 13.99 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.908 -0.775 . . . . 4.79 108.908 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 46.2 m170 -87.76 5.22 41.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.007 0.432 . . . . 6.59 111.113 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.568 ' O ' HG22 ' A' ' 41' ' ' VAL . 15.8 p -82.53 -32.89 28.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.021 -0.536 . . . . 5.42 110.908 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.62 13.88 11.06 Favored Glycine 0 N--CA 1.454 -0.138 0 C-N-CA 121.198 -0.525 . . . . 3.27 112.641 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.3 -25.14 59.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.963 0.411 . . . . 4.15 110.313 176.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 38' ' ' THR . 9.2 m -72.76 140.75 17.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 2.58 111.662 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.0 mt -97.47 -5.46 35.98 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.618 -0.719 . . . . 3.5 110.177 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -91.96 1.43 57.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 2.29 111.84 -175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.565 ' HB3' HG23 ' A' ' 82' ' ' ILE . 37.0 mt-30 -41.89 134.1 2.7 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.444 0.64 . . . . 1.4 111.105 176.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 83' ' ' ASN . 8.3 p -99.47 136.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.356 -0.838 . . . . 1.37 109.399 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.37 110.94 17.55 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.618 -0.719 . . . . 0.3 110.576 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.505 HG22 ' HD2' ' A' ' 24' ' ' LYS . 7.9 pt -114.78 160.52 14.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.783 -0.644 . . . . 0.23 110.342 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.37 129.58 34.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.836 -0.62 . . . . 2.38 110.232 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.8 m -128.84 154.99 45.91 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.779 -1.1 . . . . 1.15 110.554 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 5.8 t -157.39 136.29 11.62 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.834 -0.621 . . . . 0.6 109.494 -177.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -121.0 114.31 21.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.258 0.552 . . . . 2.08 111.262 -176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.9 mt -78.29 133.89 63.58 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.099 -0.955 . . . . 0.95 109.39 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -33.94 116.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.642 3.561 . . . . 0.95 113.564 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.547 HD22 ' CZ2' ' A' ' 4' ' ' TRP . 3.6 pp -100.12 141.72 32.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.911 -1.04 . . . . 1.67 111.989 -169.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.617 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 94.4 mt -80.72 133.74 35.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.255 -1.017 . . . . 1.58 108.255 167.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.7 mt -67.72 128.81 31.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.143 0.497 . . . . 2.11 110.199 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.53 9.18 63.29 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.554 -0.748 . . . . 1.03 111.725 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -98.76 157.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.277 0.56 . . . . 0.77 110.771 177.113 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.7 137.88 31.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.969 -1.014 . . . . 0.68 110.914 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -53.1 -38.45 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.016 -0.993 . . . . 0.69 112.056 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -79.49 -17.86 53.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.356 -0.384 . . . . 2.2 111.533 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -102.45 -3.06 27.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.968 0.413 . . . . 1.98 110.349 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -102.38 -22.19 14.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.039 -0.528 . . . . 2.09 110.744 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.51 156.64 48.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.471 -0.331 . . . . 0.6 110.236 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -104.64 44.7 1.01 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.285 0.564 . . . . 2.32 110.889 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 3.9 m-20 -124.55 -165.68 1.41 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.492 -0.776 . . . . 1.06 109.723 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -87.76 128.35 54.68 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 120.91 0.386 . . . . 0.34 110.243 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.33 125.46 5.15 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.746 2.297 . . . . 0.45 110.915 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.786 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 2.9 p -124.64 153.42 42.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.972 0.415 . . . . 0.31 111.466 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.2 t -107.55 102.8 12.03 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.263 -0.643 . . . . 1.26 109.263 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 84' ' ' CYS . 97.6 m -84.64 142.11 30.15 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.039 -0.356 . . . . 0.29 110.039 -176.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.6 tt0 -76.1 -27.44 57.15 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.62 -0.881 . . . . 1.53 108.62 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 71' ' ' CYS . 24.6 t0 -159.57 162.8 35.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.874 -1.057 . . . . 1.26 108.66 175.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.642 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.3 t -140.16 134.72 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.841 -0.429 . . . . 1.07 109.841 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -106.15 165.91 10.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.795 -0.446 . . . . 1.87 109.795 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t70 67.4 -151.92 0.19 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.231 0.612 . . . . 1.94 109.457 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -79.17 22.86 0.39 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.969 0.414 . . . . 2.12 110.553 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.485 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 98.19 23.15 13.36 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.924 -0.655 . . . . 0.51 112.041 -177.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.73 -17.18 28.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 1.1 111.217 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.88 103.68 11.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.498 -0.319 . . . . 0.33 110.51 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.422 ' HA3' ' SG ' ' A' ' 71' ' ' CYS . . . -94.29 133.11 11.46 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.354 -0.926 . . . . 0.26 112.368 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.565 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -97.61 126.71 50.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 122.441 0.296 . . . . 0.3 110.255 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.67 ' HA ' HG12 ' A' ' 45' ' ' VAL . 85.3 m-20 53.52 43.56 31.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 123.84 0.712 . . . . 0.34 110.398 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.786 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -87.49 102.89 15.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.406 -0.816 . . . . 0.81 110.15 -177.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 m -83.12 130.67 56.25 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.891 -0.595 . . . . 0.44 110.111 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.33 109.84 2.98 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.974 2.449 . . . . 0.39 111.906 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.2 pt -83.69 137.44 41.33 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.576 -0.738 . . . . 0.57 111.176 -175.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.5 Cg_exo -71.82 157.68 54.65 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.349 2.699 . . . . 1.05 112.079 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.7 mt -90.96 25.11 2.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.847 -0.615 . . . . 1.45 110.775 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 90' ' ' ILE . 24.1 pt . . . . . 0 C--O 1.249 1.041 0 CA-C-N 116.332 -0.395 . . . . 2.31 110.97 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.129 -0.388 . . . . 5.75 112.129 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 p -96.34 126.92 41.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.845 0.355 . . . . 4.66 110.674 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.87 173.9 27.25 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.676 -0.773 . . . . 1.6 111.906 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.474 ' CE3' ' HB ' ' A' ' 60' ' ' ILE . 71.8 m95 -83.47 -177.4 6.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.053 0.454 . . . . 0.81 111.608 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -78.04 107.69 10.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 2.73 109.724 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.8 t -111.75 27.51 9.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.349 0.595 . . . . 1.75 109.744 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -24.86 61.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.514 -0.766 . . . . 3.24 112.723 -172.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 t -91.6 5.17 50.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.635 -0.426 . . . . 2.05 110.931 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.22 17.8 75.67 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.598 -0.811 . . . . 0.88 111.839 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 p -69.38 -30.81 68.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.627 0.603 . . . . 1.72 112.627 -172.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.1 t -132.35 141.3 48.87 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.263 -0.575 . . . . 1.19 111.482 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.533 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.9 p30 -93.08 -29.53 15.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.561 -0.745 . . . . 1.66 111.593 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.533 HG23 ' OD1' ' A' ' 12' ' ' ASN . 2.6 p -95.42 -31.38 13.41 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.531 0.567 . . . . 0.52 112.531 -173.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.72 -18.26 44.22 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.339 -0.934 . . . . 0.43 113.267 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.626 ' HD3' HG23 ' A' ' 74' ' ' VAL . 81.9 mttt -84.83 89.4 7.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.168 0.484 . . . . 1.64 110.478 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' A' ' 4' ' ' TRP . 8.8 mp -91.87 137.68 32.17 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.921 -0.4 . . . . 0.55 109.921 175.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.532 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -145.67 152.03 38.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.907 0.384 . . . . 0.29 110.383 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 36.1 m -87.5 98.65 11.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.502 -0.555 . . . . 0.74 109.502 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 86.3 m -117.3 161.97 18.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.495 . . . . 0.5 111.515 -167.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 11.9 m-20 -99.46 98.71 9.59 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.65 109.939 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.8 p -70.31 -7.66 44.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.836 -0.62 . . . . 0.52 112.151 -173.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -103.14 -10.55 18.74 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.189 0.995 . . . . 2.2 108.788 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.483 ' HG3' ' HB2' ' A' ' 48' ' ' GLN . 40.8 tptt -118.06 99.53 6.95 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.416 -1.72 . . . . 2.6 110.497 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 14.2 mptt -85.76 170.31 12.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.036 -0.984 . . . . 2.17 111.047 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.04 150.49 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.59 -0.732 . . . . 0.59 109.18 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -74.58 23.83 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.189 0.811 . . . . 2.83 113.189 -173.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -136.74 160.11 39.83 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.967 -0.458 . . . . 4.07 111.555 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 p -134.64 38.74 3.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.598 0.713 . . . . 2.46 109.605 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 p -89.39 -172.98 3.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.218 -0.901 . . . . 2.0 111.229 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.21 146.57 8.42 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.72 -0.752 . . . . 1.39 111.982 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -82.22 -50.46 8.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.943 0.402 . . . . 3.06 110.431 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -97.33 -38.19 9.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.895 -0.593 . . . . 2.44 109.968 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 23.1 t -66.27 -29.14 69.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 2.36 109.803 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.98 -17.43 75.5 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.957 -0.639 . . . . 2.54 112.292 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.9 mt -85.66 -30.46 23.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.294 0.569 . . . . 3.49 109.728 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.434 ' HG ' ' H ' ' A' ' 37' ' ' HIS . 18.6 tp -89.66 173.51 8.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.451 -0.795 . . . . 4.79 109.442 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.434 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 77.8 t60 -74.8 -7.47 53.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 6.59 110.788 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.2 p -68.67 -23.42 64.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 5.42 111.492 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.456 ' HA2' ' NE2' ' A' ' 44' ' ' GLN . . . -83.19 -3.96 89.95 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.81 -0.709 . . . . 3.27 112.925 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.22 -29.28 68.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.396 0.617 . . . . 4.15 111.161 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.9 m -88.32 147.69 5.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.393 -0.821 . . . . 2.58 113.125 -171.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 tp -84.69 -7.85 59.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.757 -1.11 . . . . 3.5 108.612 170.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -60.63 -30.79 70.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.025 -0.989 . . . . 2.29 110.938 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.49 ' HB3' HG23 ' A' ' 82' ' ' ILE . 15.8 mt-30 -50.69 127.49 18.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.19 0.519 . . . . 1.4 110.687 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.68 107.53 20.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.41 -0.813 . . . . 1.37 110.067 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -95.38 122.45 38.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.488 -0.778 . . . . 0.3 110.336 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 84' ' ' CYS . 22.0 pt -122.79 157.82 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.192 -0.458 . . . . 0.23 110.472 176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.483 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -71.4 138.96 49.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.538 -0.756 . . . . 2.38 109.189 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.8 t -142.78 156.58 45.0 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.885 0.374 . . . . 1.15 111.172 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -162.95 122.21 2.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.552 -0.749 . . . . 0.6 109.766 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.459 ' HG2' ' SG ' ' A' ' 18' ' ' CYS . 11.5 tm0? -120.95 115.67 23.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.826 0.346 . . . . 2.08 110.539 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.447 HG23 ' HD2' ' A' ' 53' ' ' PRO . 63.3 mt -52.35 135.42 41.85 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-N 115.207 -0.906 . . . . 0.95 110.192 176.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HD2' HG23 ' A' ' 52' ' ' ILE . 89.8 Cg_exo -33.37 107.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 124.507 3.472 . . . . 0.95 113.88 -174.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.552 ' HA ' ' OE1' ' A' ' 63' ' ' GLU . 3.5 pp -59.3 140.76 55.72 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.755 -1.111 . . . . 1.67 113.837 -168.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -111.26 115.85 30.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.663 -1.153 . . . . 1.58 109.438 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.3 mm -63.64 139.12 21.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.416 0.627 . . . . 2.11 111.14 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.42 -23.84 33.19 Favored Glycine 0 C--N 1.315 -0.602 0 CA-C-N 115.166 -0.925 . . . . 1.03 112.961 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.66 152.04 3.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.768 0.794 . . . . 0.77 111.759 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.07 124.15 27.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.318 -1.31 . . . . 0.68 110.749 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.474 ' HB ' ' CE3' ' A' ' 4' ' ' TRP . 13.3 tt -53.62 -33.1 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.044 -0.98 . . . . 0.69 111.017 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 60' ' ' ILE . 2.8 mp0 -61.34 -29.88 70.16 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.41 -1.268 . . . . 2.2 111.437 -173.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -106.64 -20.47 13.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.054 -0.521 . . . . 1.98 110.452 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' A' ' 54' ' ' LEU . 29.5 tt0 -67.2 -41.14 86.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 2.09 111.129 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.6 p -105.02 -173.64 2.35 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.976 -0.556 . . . . 0.6 109.726 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -132.2 43.68 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.309 0.576 . . . . 2.32 110.817 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 49.8 m-80 -137.55 -171.16 2.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.487 -0.931 . . . . 1.06 108.487 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 22.8 m -81.29 122.12 80.93 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.314 0.578 . . . . 0.34 111.614 -177.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.69 124.2 11.66 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.255 2.637 . . . . 0.45 111.036 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 86' ' ' PRO . 72.6 p -132.5 149.92 52.25 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.788 -0.365 . . . . 0.31 111.237 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 11.6 t -94.74 112.11 23.86 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.477 -0.564 . . . . 1.26 109.477 172.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.4 m -99.36 139.41 35.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.253 0.549 . . . . 0.29 110.333 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.0 tt0 -77.22 -23.93 51.32 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.458 -0.792 . . . . 1.53 109.415 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 40.4 t0 -163.86 165.09 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.991 -1.004 . . . . 1.26 108.407 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.626 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.0 t -142.2 136.38 29.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 117.947 0.34 . . . . 1.07 110.339 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.81 162.6 12.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.739 -0.467 . . . . 1.87 109.739 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 62.26 -154.37 0.35 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.54 -0.541 . . . . 1.94 109.54 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.5 7.79 6.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.641 0.734 . . . . 2.12 109.848 174.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.04 22.61 2.89 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.487 -0.779 . . . . 0.51 112.596 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.2 mm? -83.82 -23.62 31.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.69 0.256 . . . . 1.1 111.69 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.8 t -129.21 106.88 14.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.972 -0.381 . . . . 0.33 109.972 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -97.49 144.05 17.08 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.384 -0.912 . . . . 0.26 112.399 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -102.15 119.03 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 110.003 -0.369 . . . . 0.3 110.003 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 87.4 m-20 61.36 43.7 10.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.499 -0.773 . . . . 0.34 110.565 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.632 ' HB2' HD11 ' A' ' 47' ' ' ILE . 60.3 m -82.78 99.03 9.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.349 -0.841 . . . . 0.81 111.0 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.3 m -89.37 131.98 38.77 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.436 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.438 ' HA ' HG22 ' A' ' 69' ' ' THR . 11.6 Cg_endo -68.55 126.43 14.11 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.079 2.52 . . . . 0.39 112.208 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.2 pt -105.8 152.41 40.17 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.769 -0.65 . . . . 0.57 111.091 -174.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 18.2 Cg_exo -70.08 153.55 67.33 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.246 2.63 . . . . 1.05 112.455 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.8 mt -84.62 23.47 1.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.81 -0.632 . . . . 1.45 110.855 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.989 -0.529 . . . . 2.31 111.312 -173.634 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 111.705 -0.558 . . . . 5.75 111.705 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.482 ' OG ' ' HA3' ' A' ' 14' ' ' GLY . 13.4 p -66.84 -54.1 25.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 4.66 109.767 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.76 -43.42 0.68 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.823 -0.911 . . . . 1.6 110.823 172.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.408 ' HB2' HD13 ' A' ' 16' ' ' LEU . 76.3 m95 -136.11 161.19 36.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.491 -0.354 . . . . 0.81 110.101 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.2 109.14 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.481 . . . . 2.73 111.174 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.493 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 11.1 m -105.44 26.45 9.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.829 -0.623 . . . . 1.75 110.491 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -59.47 -15.25 16.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.952 -0.567 . . . . 3.24 112.102 -176.504 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -73.02 -15.58 61.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.084 0.468 . . . . 2.05 110.958 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.4 8.26 70.42 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.822 -0.626 . . . . 0.88 111.664 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.5 t -88.07 -9.71 52.47 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.863 0.363 . . . . 1.72 110.692 -176.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.2 t -123.71 139.78 53.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.167 0.508 . . . . 1.19 110.307 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -31.89 13.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.27 -0.877 . . . . 1.66 112.521 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -102.27 -20.6 14.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.263 0.468 . . . . 0.52 112.263 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.493 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 89.96 4.83 71.63 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.725 -0.75 . . . . 0.43 112.654 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.616 ' HD3' HG13 ' A' ' 74' ' ' VAL . 66.7 mttm -93.8 88.9 5.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.75 0.309 . . . . 1.64 110.478 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 69' ' ' THR . 7.8 mp -93.66 109.36 21.0 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.541 -0.54 . . . . 0.55 109.541 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -124.13 144.2 50.03 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.872 0.368 . . . . 0.29 110.956 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 81.5 m -79.91 98.22 7.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 0.74 109.478 175.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 73.1 m -113.42 156.99 22.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.125 0.488 . . . . 0.5 111.461 -169.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 22.7 m-20 -92.01 93.07 8.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.37 -0.832 . . . . 1.65 109.298 174.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.4 p -64.91 -15.23 61.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.693 0.627 . . . . 0.52 112.693 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -106.51 0.44 24.66 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.989 0.899 . . . . 2.2 108.67 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 20' ' ' ASP . 48.2 tptt -123.98 98.9 6.0 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.08 -1.418 . . . . 2.6 109.529 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -89.16 164.76 14.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.561 -1.199 . . . . 2.17 111.022 -171.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.539 HG22 ' CD ' ' A' ' 48' ' ' GLN . 3.5 t -117.74 149.88 19.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.854 -0.612 . . . . 0.59 110.264 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -80.73 -40.14 25.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.345 -0.613 . . . . 2.83 109.345 174.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -69.4 121.24 16.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.592 -0.731 . . . . 4.07 109.11 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -149.87 79.17 1.37 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.797 -0.361 . . . . 2.46 111.584 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.416 ' HA ' HG11 ' A' ' 41' ' ' VAL . 22.1 m -136.54 -61.0 0.7 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.639 -0.424 . . . . 2.0 111.434 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.41 164.11 15.6 Favored Glycine 0 C--N 1.32 -0.327 0 C-N-CA 121.036 -0.602 . . . . 1.39 112.035 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -101.53 -42.26 6.31 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.235 0.457 . . . . 3.06 112.235 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.51 -55.32 4.55 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.87 -0.332 . . . . 2.44 111.434 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.4 m -90.24 -29.48 18.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.109 0.48 . . . . 2.36 110.12 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.33 42.54 2.17 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.653 -0.703 . . . . 2.54 113.835 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.96 -52.09 66.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.112 0.482 . . . . 3.49 109.91 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.5 mt -92.28 147.38 22.96 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.849 -0.614 . . . . 4.79 109.426 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.441 ' O ' HG22 ' A' ' 41' ' ' VAL . 18.1 m-70 -101.05 -71.81 0.7 Allowed 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 121.082 -0.247 . . . . 6.59 111.092 -176.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.1 m -74.57 -20.01 60.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.18 0.514 . . . . 5.42 110.974 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.2 0.24 58.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.318 -0.944 . . . . 3.27 112.936 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.98 -43.91 2.43 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.398 -0.521 . . . . 4.15 111.119 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 37' ' ' HIS . 2.1 m -87.04 124.53 40.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.635 0.731 . . . . 2.58 110.372 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.9 mt -121.55 -35.83 3.17 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.387 -0.824 . . . . 3.5 110.582 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -142.22 1.19 1.4 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.848 -0.615 . . . . 2.29 111.918 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HB3' HG23 ' A' ' 82' ' ' ILE . 50.6 mt-30 -54.07 133.48 43.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.283 0.563 . . . . 1.4 111.407 -175.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.17 121.52 63.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.316 -0.857 . . . . 1.37 109.334 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.99 133.2 52.64 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.638 -0.71 . . . . 0.3 111.229 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.47 HD11 ' HB2' ' A' ' 84' ' ' CYS . 12.7 pt -125.61 153.75 33.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.529 -0.76 . . . . 0.23 109.972 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.539 ' CD ' HG22 ' A' ' 25' ' ' VAL . 2.9 mp0 -67.69 139.9 56.76 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.389 -0.597 . . . . 2.38 109.389 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.8 t -138.91 156.44 47.27 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.252 -0.431 . . . . 1.15 110.757 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -161.43 140.27 9.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.981 -0.554 . . . . 0.6 109.805 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.528 HE22 HD12 ' A' ' 60' ' ' ILE . 43.9 tp60 -114.6 155.23 26.92 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.026 0.441 . . . . 2.08 110.451 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.51 HG23 ' HD2' ' A' ' 53' ' ' PRO . 42.0 mm -86.82 150.7 51.03 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.228 -0.896 . . . . 0.95 108.967 176.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD2' HG23 ' A' ' 52' ' ' ILE . 51.6 Cg_exo -35.14 111.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.137 2.558 . . . . 0.95 111.842 171.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.66 133.17 55.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.175 -0.92 . . . . 1.67 112.926 -167.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.19 124.52 49.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.096 -0.956 . . . . 1.58 109.252 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 56' ' ' ILE . 15.6 mt -64.2 130.38 29.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.24 -0.436 . . . . 2.11 110.857 -174.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.84 15.18 71.18 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.418 -0.81 . . . . 1.03 113.217 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.448 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -100.26 152.67 4.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.693 0.759 . . . . 0.77 111.643 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.41 145.91 25.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.363 -1.29 . . . . 0.68 111.237 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.528 HD12 HE22 ' A' ' 51' ' ' GLN . 8.2 tp -53.69 -34.26 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 114.358 -1.292 . . . . 0.69 112.836 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.72 -4.81 58.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.739 0.304 . . . . 2.2 111.655 -172.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -110.09 -27.19 9.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.094 0.473 . . . . 1.98 110.133 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.448 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 32.3 tt0 -71.43 -39.49 71.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.782 -0.645 . . . . 2.09 110.933 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.7 p -121.08 169.06 10.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.214 -0.448 . . . . 0.6 110.492 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -113.98 26.83 9.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.089 0.471 . . . . 2.32 110.455 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 17.0 m-80 -107.06 -160.92 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 1.06 110.126 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 12.4 m -96.63 126.7 42.28 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 120.976 0.417 . . . . 0.34 110.501 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.96 129.21 6.1 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.979 2.453 . . . . 0.45 111.03 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 65.5 p -132.14 157.37 44.44 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.754 -0.379 . . . . 0.31 110.936 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 40.7 t -106.12 102.28 11.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.048 -0.524 . . . . 1.26 109.647 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 55.6 m -88.08 133.75 33.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.973 0.416 . . . . 0.29 110.56 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.0 tt0 -76.3 -23.58 54.34 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.875 -0.602 . . . . 1.53 110.102 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -158.77 169.26 24.78 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.65 -0.87 . . . . 1.26 108.65 170.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.616 HG13 ' HD3' ' A' ' 15' ' ' LYS . 32.8 m -135.84 146.05 30.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.77 0.319 . . . . 1.07 110.562 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -112.22 150.21 31.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.342 -0.985 . . . . 1.87 108.342 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.8 -156.32 0.33 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.754 -0.832 . . . . 1.94 108.754 -170.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -83.07 23.16 0.88 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.522 0.677 . . . . 2.12 110.762 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.568 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 104.22 21.85 9.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.588 -0.815 . . . . 0.51 112.955 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 84.0 mt -85.16 -17.13 38.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.064 0.459 . . . . 1.1 109.987 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.1 t -129.61 110.82 20.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.51 -0.768 . . . . 0.33 109.156 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -101.78 140.62 14.95 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.181 -1.009 . . . . 0.26 112.334 -176.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.486 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -97.52 119.36 45.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.058 -0.349 . . . . 0.3 110.058 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 96.0 m-20 59.81 50.54 6.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.678 -0.692 . . . . 0.34 110.832 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.566 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.5 m -85.0 91.34 8.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.379 -0.828 . . . . 0.81 110.924 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.1 m -74.94 126.09 88.64 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.675 -0.693 . . . . 0.44 110.379 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.38 121.66 9.14 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.856 2.37 . . . . 0.39 111.818 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.4 pt -101.09 154.54 37.1 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.799 -0.637 . . . . 0.57 110.847 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -70.39 162.57 41.92 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.206 2.604 . . . . 1.05 112.794 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.8 mt -92.74 22.74 4.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.441 -0.8 . . . . 1.45 110.54 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.404 -0.808 . . . . 2.31 111.628 -172.21 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.648 -0.581 . . . . 5.75 111.648 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t -80.2 98.75 7.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.837 0.351 . . . . 4.66 110.588 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.15 104.2 1.45 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.662 -0.78 . . . . 1.6 111.359 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -90.32 -177.23 5.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.108 0.48 . . . . 0.81 112.115 -175.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -63.41 108.4 1.33 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.269 -0.878 . . . . 2.73 111.257 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -101.11 -17.5 16.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.162 -0.926 . . . . 1.75 109.365 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' C ' ' HD2' ' A' ' 7' ' ' LYS . 2.7 pptp? -69.54 -17.89 63.61 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.901 -0.591 . . . . 3.24 110.745 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.2 m -72.73 -26.85 61.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 2.05 111.159 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.65 16.25 75.93 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.982 -0.628 . . . . 0.88 112.654 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.632 ' OG ' ' HB ' ' A' ' 87' ' ' ILE . 7.8 t -87.32 -29.0 21.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.946 0.403 . . . . 1.72 110.77 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.8 t -115.39 140.94 48.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.898 0.38 . . . . 1.19 110.701 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.5 p30 -93.09 -25.87 17.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.075 -0.511 . . . . 1.66 112.038 -177.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.43 HG21 ' HA ' ' A' ' 72' ' ' GLU . 43.9 p -92.97 -30.47 15.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.52 111.686 -174.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.97 -4.41 59.03 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.748 -0.739 . . . . 0.43 112.027 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.501 ' HD3' HG23 ' A' ' 74' ' ' VAL . 53.3 mttp -94.19 89.95 6.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.862 0.363 . . . . 1.64 110.666 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.1 mp -96.17 113.35 24.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.256 -0.429 . . . . 0.55 110.627 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.04 151.1 49.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.877 0.37 . . . . 0.29 110.312 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.637 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 60.8 m -84.84 103.2 13.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.007 -0.738 . . . . 0.74 109.007 173.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 98.4 m -113.13 142.97 45.14 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.17 0.51 . . . . 0.5 110.975 -174.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 44.0 m-20 -97.69 109.19 21.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.487 -0.779 . . . . 1.65 109.238 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 p -75.64 -5.88 47.66 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.411 0.624 . . . . 0.52 110.033 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -89.46 -8.63 52.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.242 -0.89 . . . . 2.2 109.053 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.44 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 26.2 mtmt -121.57 142.75 49.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.812 -1.085 . . . . 2.6 110.145 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.472 ' HD3' HG22 ' A' ' 47' ' ' ILE . 33.7 mmtp -128.39 158.86 37.11 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.63 -0.714 . . . . 2.17 111.082 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 27' ' ' LYS . 10.7 t -124.15 150.03 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.085 -1.08 . . . . 0.59 108.085 173.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -76.48 31.76 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.09 0.404 . . . . 2.83 112.09 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 25' ' ' VAL . 14.6 mtmt 37.81 114.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.997 1.319 . . . . 4.07 113.451 -170.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.8 p -101.24 -81.03 0.49 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.378 -0.828 . . . . 2.46 110.008 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.74 -172.25 3.43 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.641 -1.163 . . . . 2.0 109.162 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.24 116.64 1.13 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.186 -0.766 . . . . 1.39 111.186 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.01 -31.59 72.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.89 0.345 . . . . 3.06 110.55 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -75.38 -42.03 54.95 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.73 -0.471 . . . . 2.44 109.73 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.528 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 32.0 m -54.84 -27.31 41.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.757 -0.656 . . . . 2.36 111.983 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.33 64.51 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.925 -0.655 . . . . 2.54 112.668 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.5 mt -90.91 -29.44 17.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.353 0.597 . . . . 3.49 110.203 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 mp -92.71 179.82 5.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.765 . . . . 4.79 110.325 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -104.51 1.6 30.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.973 0.416 . . . . 6.59 110.681 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.91 -14.21 61.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.959 -0.564 . . . . 5.42 111.509 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 33' ' ' SER . . . -83.97 14.0 45.91 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.978 -0.555 . . . . 3.27 112.676 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -75.78 -40.84 54.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.275 0.559 . . . . 4.15 110.383 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -80.39 142.47 13.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.41 -0.813 . . . . 2.58 112.53 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.28 -8.35 56.84 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.287 -0.87 . . . . 3.5 109.145 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.95 -14.14 51.45 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.528 -1.214 . . . . 2.29 111.548 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -50.23 146.14 5.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.229 0.537 . . . . 1.4 111.955 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.51 126.99 75.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.338 -0.846 . . . . 1.37 109.023 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -110.88 114.33 27.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.301 -0.409 . . . . 0.3 111.805 -175.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.472 HG22 ' HD3' ' A' ' 24' ' ' LYS . 12.4 pt -111.06 163.7 7.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.78 -0.645 . . . . 0.23 109.653 172.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -88.84 127.62 35.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.47 0.652 . . . . 2.38 109.634 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 29.8 m -122.54 160.59 25.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.712 -1.131 . . . . 1.15 110.671 -172.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 11.2 t -160.89 142.49 12.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.774 -0.454 . . . . 0.6 109.774 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.458 HE21 HD12 ' A' ' 60' ' ' ILE . 8.0 tm0? -120.07 115.87 24.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.266 0.555 . . . . 2.08 110.817 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.418 HG23 ' HD2' ' A' ' 53' ' ' PRO . 68.7 mt -73.83 133.14 79.54 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.225 -0.898 . . . . 0.95 109.839 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD2' HG23 ' A' ' 52' ' ' ILE . 67.6 Cg_exo -33.57 111.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 124.817 3.678 . . . . 0.95 114.096 -172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 63' ' ' GLU . 4.1 pp -88.42 142.14 27.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.679 -1.146 . . . . 1.67 112.535 -170.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.418 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 67.7 mt -93.94 144.31 25.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.468 -0.787 . . . . 1.58 109.139 168.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 mt -68.78 130.75 33.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.932 0.396 . . . . 2.11 110.678 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.41 -0.57 80.99 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.551 -0.75 . . . . 1.03 112.51 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -93.67 154.08 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.603 0.716 . . . . 0.77 111.488 -178.234 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.01 132.27 34.75 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.758 -1.11 . . . . 0.68 111.377 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.458 HD12 HE21 ' A' ' 51' ' ' GLN . 5.5 tp -49.84 -39.46 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 114.761 -1.109 . . . . 0.69 111.505 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 60' ' ' ILE . 8.2 pt-20 -70.9 -34.09 71.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.276 -0.874 . . . . 2.2 111.842 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -91.62 -23.17 19.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.95 0.405 . . . . 1.98 110.843 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 54' ' ' LEU . 7.7 tp10 -73.1 -40.68 64.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 2.09 111.122 -176.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 66' ' ' ASN . 19.8 p -107.15 156.6 18.63 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.915 0.388 . . . . 0.6 110.809 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -98.65 55.71 1.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.208 -1.034 . . . . 2.32 108.208 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.637 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 14.2 m120 -138.97 -168.68 2.47 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.13 -1.396 . . . . 1.06 109.073 -172.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -104.46 126.09 32.38 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-O 120.895 0.378 . . . . 0.34 110.119 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -77.88 129.28 9.76 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.628 2.219 . . . . 0.45 110.997 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.0 p -129.51 150.56 50.8 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.096 0.474 . . . . 0.31 111.545 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 54.0 t -98.98 99.09 10.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.686 -0.857 . . . . 1.26 108.686 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 56.6 m -86.61 141.27 29.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 0.29 110.642 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 3.0 tt0 -64.12 -45.25 89.41 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.094 -0.706 . . . . 1.53 109.094 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -151.55 167.79 26.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.66 -1.155 . . . . 1.26 108.724 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.545 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -142.97 158.55 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.472 -0.566 . . . . 1.07 109.472 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.21 156.16 33.04 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.976 -0.379 . . . . 1.87 109.976 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 67.69 -150.08 0.16 Allowed 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 123.577 0.548 . . . . 1.94 109.677 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.419 ' OD1' ' HG ' ' A' ' 79' ' ' LEU . 11.4 p-10 -76.75 0.99 18.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.281 0.563 . . . . 2.12 109.715 174.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 49' ' ' CYS . . . 120.94 24.21 2.56 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.5 -0.773 . . . . 0.51 112.752 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 93.7 mt -79.66 -25.55 41.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.82 0.31 . . . . 1.1 111.757 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.0 t -125.8 107.52 17.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.066 -0.346 . . . . 0.33 110.066 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.571 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -102.13 144.65 16.34 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.391 -0.909 . . . . 0.26 112.911 -174.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 mp -100.41 118.21 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.442 -0.379 . . . . 0.3 110.064 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.607 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 93.8 m-20 59.02 43.96 16.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.739 -0.664 . . . . 0.34 111.151 174.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.571 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 69.5 m -78.26 97.16 5.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.842 -0.617 . . . . 0.81 110.958 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 23.8 m -88.4 130.05 47.13 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.725 -0.67 . . . . 0.44 110.207 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.5 Cg_exo -61.07 113.82 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.994 2.463 . . . . 0.39 112.108 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.632 ' HB ' ' OG ' ' A' ' 10' ' ' SER . 7.9 pt -82.47 138.96 44.43 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.91 -0.587 . . . . 0.57 110.835 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 17.1 Cg_exo -70.68 144.08 48.16 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.086 2.524 . . . . 1.05 111.537 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 35.4 mt -92.05 32.75 1.11 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.222 -0.899 . . . . 1.45 109.486 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 C--O 1.248 1.001 0 CA-C-N 115.771 -0.65 . . . . 2.31 111.03 -173.806 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.0 -0.44 . . . . 5.75 112.0 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.0 t -153.26 128.37 9.71 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.323 -0.251 . . . . 4.66 110.323 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.72 27.18 27.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 1.6 112.374 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CD2' ' HB ' ' A' ' 60' ' ' ILE . 58.2 m95 -77.6 161.81 27.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.082 0.468 . . . . 0.81 111.59 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -66.75 109.65 2.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.361 -0.836 . . . . 2.73 110.411 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.3 m -93.95 27.98 2.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.461 -0.79 . . . . 1.75 110.441 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -45.49 -46.81 14.02 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.368 -0.833 . . . . 3.24 112.491 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 p -63.08 -23.92 67.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.202 -0.454 . . . . 2.05 112.165 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.26 5.12 89.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.097 -0.573 . . . . 0.88 111.702 -176.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.5 m -70.43 -13.89 62.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.565 -0.318 . . . . 1.72 111.635 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -131.91 141.12 49.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.015 0.436 . . . . 1.19 110.507 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -94.6 -30.29 14.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.413 -0.812 . . . . 1.66 112.479 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 p -89.52 -30.03 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.983 0.421 . . . . 0.52 111.947 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.58 3.07 71.98 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.575 -0.821 . . . . 0.43 111.556 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -95.74 87.99 4.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.347 0.594 . . . . 1.64 110.133 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.0 mp -97.35 137.95 35.56 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.351 -0.84 . . . . 0.55 109.758 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.87 145.18 35.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.032 0.444 . . . . 0.29 110.593 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 28.1 m -82.02 102.84 11.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.387 -0.968 . . . . 0.74 108.387 173.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 59.1 m -122.45 156.6 33.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.131 0.491 . . . . 0.5 111.544 -169.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -102.85 118.01 35.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.442 -0.799 . . . . 1.65 109.312 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.9 p -80.96 -5.19 57.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.972 0.415 . . . . 0.52 111.368 -174.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -97.43 -19.85 18.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.675 0.75 . . . . 2.2 109.568 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -104.28 137.89 41.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.683 -1.144 . . . . 2.6 110.614 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.501 ' HD3' HG22 ' A' ' 47' ' ' ILE . 33.6 mmtp -127.36 155.07 44.18 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.786 -1.097 . . . . 2.17 110.393 -172.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.499 HG22 ' OE1' ' A' ' 48' ' ' GLN . 6.3 t -111.35 145.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.32 -0.622 . . . . 0.59 109.32 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -84.38 -40.74 17.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.274 -0.421 . . . . 2.83 111.38 -172.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -95.51 126.24 40.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.493 -0.321 . . . . 4.07 110.309 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.5 p -141.82 113.92 8.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.191 -0.459 . . . . 2.46 110.724 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.9 m -140.23 -48.52 0.45 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.197 0.522 . . . . 2.0 110.318 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.98 171.19 32.58 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.385 -0.825 . . . . 1.39 111.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -100.85 -51.13 3.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.715 -0.476 . . . . 3.06 109.715 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -84.11 -44.69 13.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.778 -0.646 . . . . 2.44 109.974 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.5 p -75.44 -24.91 57.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.985 -0.552 . . . . 2.36 109.638 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.43 -34.05 73.53 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.52 -0.764 . . . . 2.54 112.972 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.2 tp -74.45 -24.33 59.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.49 0.662 . . . . 3.49 109.904 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 tp -91.52 168.91 11.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.474 -0.784 . . . . 4.79 109.81 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -62.12 -14.89 41.41 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.836 0.35 . . . . 6.59 111.6 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -65.5 -20.71 66.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 5.42 111.567 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.45 9.67 73.89 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.814 -0.707 . . . . 3.27 112.333 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.04 -16.95 23.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.034 0.445 . . . . 4.15 110.648 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.35 137.07 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.944 -0.571 . . . . 2.58 111.134 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 42' ' ' LEU . 4.1 mm? -83.98 0.73 46.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.952 -0.758 . . . . 3.5 108.952 173.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.26 -28.7 70.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.641 -1.163 . . . . 2.29 110.32 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.461 ' HB3' HG23 ' A' ' 82' ' ' ILE . 33.9 mt-30 -48.34 135.2 14.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.013 -0.54 . . . . 1.4 110.033 175.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.2 t -96.51 105.13 16.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 116.084 -0.507 . . . . 1.37 109.859 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -102.86 99.67 9.61 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.521 -0.763 . . . . 0.3 110.852 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.501 HG22 ' HD3' ' A' ' 24' ' ' LYS . 19.2 pt -101.89 151.51 5.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.7 -0.682 . . . . 0.23 109.822 174.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.499 ' OE1' HG22 ' A' ' 25' ' ' VAL . 14.7 tp60 -76.82 126.04 30.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.584 -0.734 . . . . 2.38 109.973 -175.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 67.2 m -115.62 156.13 26.4 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.78 -1.1 . . . . 1.15 111.289 -173.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 t -160.23 114.08 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.525 -0.762 . . . . 0.6 109.782 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -120.38 131.91 55.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.997 -0.547 . . . . 2.08 111.063 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 64' ' ' CYS . 21.7 mt -63.45 142.74 97.91 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.407 -0.815 . . . . 0.95 110.946 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -37.1 129.41 0.56 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 124.246 3.297 . . . . 0.95 113.352 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -59.55 127.09 30.32 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.054 -0.976 . . . . 1.67 112.712 -171.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.5 107.88 17.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.636 -0.876 . . . . 1.58 108.636 170.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.3 mt -65.95 134.62 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.23 0.538 . . . . 2.11 111.124 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.16 -12.77 63.65 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.297 -0.865 . . . . 1.03 112.042 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.21 152.06 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.748 0.785 . . . . 0.77 111.92 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.52 137.78 33.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.093 -1.412 . . . . 0.68 110.579 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.569 ' HB ' ' CD2' ' A' ' 4' ' ' TRP . 11.1 tt -55.89 -39.67 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.547 -0.751 . . . . 0.69 112.244 -175.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.433 ' N ' HG23 ' A' ' 60' ' ' ILE . 2.3 pm0 -72.96 -12.68 61.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.682 -0.69 . . . . 2.2 110.903 -173.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -110.06 -17.46 13.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.433 0.635 . . . . 1.98 109.501 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -75.14 -40.95 59.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.736 -0.665 . . . . 2.09 110.09 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.543 ' HA ' HD12 ' A' ' 52' ' ' ILE . 13.9 p -108.96 175.55 5.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.012 -0.54 . . . . 0.6 110.006 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -123.82 25.72 7.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.769 0.319 . . . . 2.32 111.245 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 41.3 m-80 -113.25 -169.61 1.52 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.011 -0.366 . . . . 1.06 110.011 177.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 m -79.56 127.05 79.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.004 0.43 . . . . 0.34 110.83 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.51 127.38 5.73 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.875 2.383 . . . . 0.45 110.806 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.3 p -129.76 148.4 51.64 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.745 -0.382 . . . . 0.31 111.113 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 39.7 t -97.29 110.7 23.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.267 -0.642 . . . . 1.26 109.267 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 50.4 m -97.94 141.16 31.26 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.966 -0.561 . . . . 0.29 110.035 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 1.9 tt0 -74.07 -24.48 59.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.435 0.636 . . . . 1.53 109.358 176.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -163.31 164.38 24.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.109 -0.951 . . . . 1.26 108.688 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.533 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.4 t -138.72 138.72 41.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.566 -0.531 . . . . 1.07 109.566 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 25.3 tt0 -108.72 162.0 14.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.943 -0.571 . . . . 1.87 109.888 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 t70 65.27 -152.08 0.26 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.616 -0.512 . . . . 1.94 109.616 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.54 -5.74 31.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.609 0.719 . . . . 2.12 110.042 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.533 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 122.38 23.9 2.29 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.585 -0.734 . . . . 0.51 112.254 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.03 -19.8 28.12 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.95 0.405 . . . . 1.1 110.892 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 42.3 t -124.06 101.14 8.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.1 -0.5 . . . . 0.33 110.145 -174.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.629 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -90.77 138.55 14.44 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.073 -1.06 . . . . 0.26 111.95 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.461 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -98.72 117.31 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 109.816 -0.439 . . . . 0.3 109.816 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 92.2 m-20 62.55 52.89 2.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.348 -0.842 . . . . 0.34 110.579 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.629 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 59.7 m -89.96 105.82 18.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.457 -0.792 . . . . 0.81 111.121 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 56.0 m -93.74 129.36 38.41 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.879 -0.601 . . . . 0.44 110.338 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.3 Cg_exo -60.41 119.57 6.83 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.887 2.391 . . . . 0.39 111.509 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 pt -98.19 145.45 29.83 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.893 -0.594 . . . . 0.57 111.932 -172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -73.77 151.77 46.48 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.303 2.669 . . . . 1.05 111.513 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 70.8 mt -90.25 19.21 5.25 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.802 -0.636 . . . . 1.45 110.115 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 90' ' ' ILE . 19.2 pt . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.553 -0.749 . . . . 2.31 110.954 -173.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 111.536 -0.625 . . . . 5.75 111.536 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.4 p -157.47 150.59 23.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.976 -0.379 . . . . 4.66 109.976 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.77 65.09 3.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.074 -0.584 . . . . 1.6 112.098 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -129.13 152.12 49.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.971 0.415 . . . . 0.81 110.889 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -72.69 108.03 5.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 2.73 110.751 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 m -111.52 15.16 21.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.673 -0.694 . . . . 1.75 109.597 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.81 -33.93 76.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.244 -0.889 . . . . 3.24 111.598 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.9 p -65.87 -24.38 66.85 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.929 -0.578 . . . . 2.05 111.4 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.79 16.24 31.65 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.804 -0.713 . . . . 0.88 111.974 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 p -65.88 -32.01 73.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.897 0.38 . . . . 1.72 111.96 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.5 t -126.01 141.63 51.88 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.869 -0.332 . . . . 1.19 110.91 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.403 ' OD1' HG23 ' A' ' 13' ' ' THR . 7.2 p30 -93.27 -28.62 16.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.917 -0.583 . . . . 1.66 111.914 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 72' ' ' GLU . 1.8 p -98.18 -20.4 17.31 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.495 . . . . 0.52 112.335 -174.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.63 22.7 55.48 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.659 -0.782 . . . . 0.43 112.559 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 51.9 mttp -115.83 92.02 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.035 -0.357 . . . . 1.64 110.035 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.7 mp -98.36 130.5 45.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.907 0.384 . . . . 0.55 110.767 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -149.9 148.89 29.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.16 -0.473 . . . . 0.29 110.412 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 97.0 m -86.3 100.19 12.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.289 0.566 . . . . 0.74 110.283 175.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 61.5 m -114.3 158.06 21.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.665 -0.698 . . . . 0.5 109.834 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 2.5 t70 -99.46 129.2 45.62 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.861 -0.792 . . . . 1.65 108.861 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.9 p -84.74 -1.52 56.37 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.713 -0.395 . . . . 0.52 111.116 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -106.14 -14.29 15.19 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.164 -0.68 . . . . 2.2 109.164 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 29.0 mtpp -97.52 101.92 13.56 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.181 -0.918 . . . . 2.6 109.776 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -96.21 158.63 15.35 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.362 -0.381 . . . . 2.17 110.012 176.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.527 HG22 ' OE1' ' A' ' 48' ' ' GLN . 11.1 t -114.43 147.46 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.322 -0.622 . . . . 0.59 109.322 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -76.67 -27.44 55.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.171 -0.468 . . . . 2.83 111.191 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' H ' HG12 ' A' ' 25' ' ' VAL . 31.5 mmmt -93.21 129.49 39.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.58 -0.526 . . . . 4.07 109.58 177.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.3 m -132.84 32.1 3.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.207 0.527 . . . . 2.46 110.516 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.3 m -75.23 -54.85 6.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.41 -0.814 . . . . 2.0 110.331 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.22 111.8 0.71 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.923 -0.656 . . . . 1.39 112.485 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' A' ' 75' ' ' GLU . 39.6 mt-10 -70.35 -47.69 59.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.411 0.148 . . . . 3.06 110.966 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 74' ' ' VAL . 20.4 mm-40 -70.97 -32.15 68.92 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.715 -0.476 . . . . 2.44 109.715 176.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m -52.76 -36.78 58.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.521 -0.763 . . . . 2.36 111.14 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.42 -25.38 74.81 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.88 -0.676 . . . . 2.54 112.331 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -82.42 -30.0 30.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 3.49 109.742 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 36' ' ' LEU . 4.3 mm? -92.55 -176.97 4.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.361 -0.836 . . . . 4.79 110.086 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -82.49 -11.25 58.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.863 0.363 . . . . 6.59 110.471 176.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -26.62 68.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.398 . . . . 5.42 111.813 -176.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.39 -7.44 39.56 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 121.271 -0.49 . . . . 3.27 112.818 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.68 -31.27 71.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.12 0.486 . . . . 4.15 110.412 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.8 m -109.95 143.26 20.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.821 -0.627 . . . . 2.58 111.953 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 mt -101.27 8.29 42.54 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.651 -0.704 . . . . 3.5 109.428 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -80.97 -8.14 59.7 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.169 -0.923 . . . . 2.29 110.589 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.614 ' HB3' HG23 ' A' ' 82' ' ' ILE . 32.1 mt-30 -47.05 138.76 6.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.598 -0.728 . . . . 1.4 110.609 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.08 105.55 16.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.159 -0.473 . . . . 1.37 110.075 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -98.45 110.42 23.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.519 -0.764 . . . . 0.3 111.29 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 84' ' ' CYS . 19.8 pt -113.31 148.74 16.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.969 -0.56 . . . . 0.23 110.307 174.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.527 ' OE1' HG22 ' A' ' 25' ' ' VAL . 10.4 tp60 -75.05 132.4 41.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.33 -0.85 . . . . 2.38 109.253 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.0 t -126.55 163.82 22.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.679 -0.691 . . . . 1.15 110.463 -171.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 t -161.2 127.96 4.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.12 0.486 . . . . 0.6 110.111 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -121.13 129.81 53.45 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.067 0.461 . . . . 2.08 111.463 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mt -71.66 137.71 83.09 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.217 -0.902 . . . . 0.95 109.717 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.3 109.29 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.037 3.158 . . . . 0.95 112.371 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.98 140.26 52.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.443 -0.798 . . . . 1.67 112.867 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 85.2 mt -93.2 147.55 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.888 -1.051 . . . . 1.58 108.544 167.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.4 mp -71.73 138.19 22.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.088 0.47 . . . . 2.11 110.276 -177.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.59 5.85 83.63 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.427 -0.806 . . . . 1.03 112.715 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.453 HG21 ' OE2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -93.36 154.29 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.569 0.7 . . . . 0.77 111.343 -177.674 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.32 134.85 33.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.613 -1.176 . . . . 0.68 111.01 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 61' ' ' GLU . 6.6 tp -50.68 -41.45 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.36 -0.836 . . . . 0.69 111.715 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.428 ' N ' HG23 ' A' ' 60' ' ' ILE . 3.0 pt-20 -74.84 -27.68 60.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.752 -0.658 . . . . 2.2 111.716 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -96.39 -22.33 17.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.349 -0.387 . . . . 1.98 110.698 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.453 ' OE2' HG21 ' A' ' 58' ' ' ILE . 9.0 tp10 -68.22 -36.71 79.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.576 0.703 . . . . 2.09 110.091 177.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.9 p -118.82 177.22 4.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.489 -0.778 . . . . 0.6 110.345 -172.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -125.53 40.92 3.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.742 0.782 . . . . 2.32 109.824 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 43.4 m-80 -126.65 -165.58 1.47 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.055 -0.975 . . . . 1.06 108.94 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 12.5 m -87.21 125.79 64.84 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 120.438 -0.505 . . . . 0.34 110.836 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.09 121.88 4.58 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.679 2.253 . . . . 0.45 110.472 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.5 p -129.79 151.57 50.22 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.138 -0.625 . . . . 0.31 111.809 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 12.2 t -99.35 101.58 12.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.297 -0.865 . . . . 1.26 109.105 171.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.642 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 59.8 m -84.99 133.2 34.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.627 0.727 . . . . 0.29 110.076 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 65.0 mt-10 -63.46 -40.29 96.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.779 -1.1 . . . . 1.53 109.71 175.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -153.61 166.0 34.15 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.31 -0.859 . . . . 1.26 109.002 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.509 HG13 ' HD3' ' A' ' 15' ' ' LYS . 15.8 m -133.98 160.27 41.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.159 0.504 . . . . 1.07 110.697 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 33.5 tt0 -129.55 155.03 46.44 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.8 -1.185 . . . . 1.87 107.8 173.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER 67.59 -156.01 0.21 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.565 -0.531 . . . . 1.94 109.565 -172.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.439 ' H ' ' HB3' ' A' ' 76' ' ' ASP . 31.2 t70 -73.11 -3.14 24.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.55 0.69 . . . . 2.12 110.224 173.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.27 22.94 2.76 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.793 -0.64 . . . . 0.51 111.615 -175.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.4 mt -86.05 -15.78 40.23 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.261 0.553 . . . . 1.1 109.955 175.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 73.5 t -123.32 112.86 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.37 -0.832 . . . . 0.33 108.922 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -106.82 137.06 13.72 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.011 -1.09 . . . . 0.26 112.238 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -99.55 120.71 49.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 122.437 0.295 . . . . 0.3 110.454 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 95.6 m-20 59.16 44.07 16.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.537 -0.756 . . . . 0.34 110.997 173.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.553 ' HB2' HD11 ' A' ' 47' ' ' ILE . 45.1 m -77.85 105.11 8.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.387 -0.824 . . . . 0.81 110.864 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 85.7 m -89.35 125.42 61.8 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.986 -0.552 . . . . 0.44 110.13 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 35.2 Cg_exo -62.67 121.97 10.12 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.751 2.301 . . . . 0.39 111.694 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.8 pt -92.44 144.83 29.46 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 116.199 -0.455 . . . . 0.57 110.318 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.3 155.0 72.38 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.008 2.472 . . . . 1.05 112.073 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.94 19.88 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.022 -0.535 . . . . 1.45 110.836 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.44 HG13 ' OXT' ' A' ' 90' ' ' ILE . 29.6 pt . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.202 -0.904 . . . . 2.31 110.604 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 111.751 -0.54 . . . . 5.75 111.751 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 p 45.85 65.46 1.15 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.474 0.71 . . . . 4.66 112.454 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.23 109.75 2.93 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.213 -0.755 . . . . 1.6 111.213 176.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -83.6 164.49 19.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.3 0.571 . . . . 0.81 111.985 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -82.6 109.43 16.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.107 -0.952 . . . . 2.73 111.092 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 t -105.83 28.76 7.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.729 -0.669 . . . . 1.75 109.324 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -26.09 30.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.44 -0.8 . . . . 3.24 112.791 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.6 m -78.19 -14.06 59.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.159 0.504 . . . . 2.05 111.003 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.42 16.53 68.63 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.357 -1.497 . . . . 0.88 109.357 -168.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.475 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 2.1 p -69.81 -30.82 68.43 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.887 -1.157 . . . . 1.72 112.775 -169.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.2 t -126.02 143.31 51.15 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.541 -0.464 . . . . 1.19 111.26 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.519 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.4 p30 -92.04 -29.16 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 1.66 111.425 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.519 HG23 ' OD1' ' A' ' 12' ' ' ASN . 22.4 p -97.48 -31.02 12.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.006 0.432 . . . . 0.52 111.97 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.64 2.74 58.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.826 -0.702 . . . . 0.43 111.582 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 41.2 mttp -90.89 88.27 6.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.753 0.311 . . . . 1.64 110.376 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.95 122.04 38.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.42 -0.355 . . . . 0.55 110.091 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.549 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -131.25 146.1 52.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.73 0.3 . . . . 0.29 110.58 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 50' ' ' THR . 35.4 m -85.18 98.38 10.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 0.74 109.89 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 65.3 m -116.76 157.91 24.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.433 -0.349 . . . . 0.5 111.462 -168.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.591 ' CB ' ' HD3' ' A' ' 23' ' ' LYS . 50.3 m-20 -102.76 112.86 25.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.183 -0.673 . . . . 1.65 109.183 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.8 p -74.81 -15.88 60.72 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.388 0.514 . . . . 0.52 112.388 -172.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -98.59 -0.4 43.21 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.764 0.792 . . . . 2.2 109.422 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HD3' ' CB ' ' A' ' 20' ' ' ASP . 35.4 mtpt -112.74 100.95 9.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.564 -1.198 . . . . 2.6 109.685 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.83 161.81 13.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.735 -0.666 . . . . 2.17 111.554 -174.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -127.79 142.31 44.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.045 -1.094 . . . . 0.59 108.045 173.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -90.94 -23.82 20.35 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.789 0.328 . . . . 2.83 111.201 -173.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 28.8 mmmt -103.48 119.78 39.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.112 0.482 . . . . 4.07 111.284 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.531 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 15.4 p -126.42 120.66 30.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.578 -0.737 . . . . 2.46 109.624 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.5 m -88.39 -54.33 4.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.548 -0.296 . . . . 2.0 110.575 -176.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.22 70.38 1.1 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.586 -0.816 . . . . 1.39 111.173 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 22.9 mt-10 -78.94 -27.68 43.64 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.636 0.236 . . . . 3.06 111.636 -174.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -99.13 -37.76 9.2 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.51 -0.476 . . . . 2.44 110.497 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.428 ' HB2' ' HB ' ' A' ' 38' ' ' THR . 26.8 p -64.9 -31.05 72.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.177 -0.465 . . . . 2.36 109.807 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' HA2' ' CA ' ' A' ' 39' ' ' GLY . . . -68.68 -31.55 73.46 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.636 -0.711 . . . . 2.54 112.27 176.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 97.3 mt -71.67 -34.3 69.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.296 0.569 . . . . 3.49 109.591 175.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.3 mt -76.57 -178.31 4.65 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.288 -0.869 . . . . 4.79 109.937 174.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -71.82 -1.98 16.09 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.954 0.407 . . . . 6.59 111.005 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 6.2 m -80.78 -2.44 47.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.104 -0.498 . . . . 5.42 111.25 -177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' CA ' ' HA2' ' A' ' 34' ' ' GLY . . . -69.15 -14.85 69.09 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.669 -0.777 . . . . 3.27 112.639 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.55 -31.61 53.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.135 0.42 . . . . 4.15 112.135 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 m -85.47 135.49 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.521 0.677 . . . . 2.58 112.012 -174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 59.9 tp -109.18 -2.06 18.28 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.185 -0.916 . . . . 3.5 109.005 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.54 -8.17 54.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.114 -0.948 . . . . 2.29 110.851 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HB3' HG23 ' A' ' 82' ' ' ILE . 96.2 mt-30 -44.08 143.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.823 -0.626 . . . . 1.4 111.476 173.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.96 119.53 62.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.643 -0.708 . . . . 1.37 110.024 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -100.45 124.99 46.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.962 -0.563 . . . . 0.3 110.899 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 84' ' ' CYS . 18.2 pt -118.93 152.11 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.127 0.489 . . . . 0.23 110.346 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.05 127.7 33.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.556 -0.905 . . . . 2.38 108.556 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.622 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 4.5 t -133.71 169.1 17.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.848 -0.614 . . . . 1.15 110.418 -170.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 11.7 t -160.02 137.04 9.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.072 0.463 . . . . 0.6 110.304 178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.27 132.82 55.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.001 0.429 . . . . 2.08 110.1 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.401 HG23 ' HD2' ' A' ' 53' ' ' PRO . 37.2 mm -80.71 144.97 57.14 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.95 110.468 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' HG23 ' A' ' 52' ' ' ILE . 2.7 Cg_exo -37.26 126.75 0.58 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.039 3.16 . . . . 0.95 113.345 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.88 123.71 17.89 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.258 -0.883 . . . . 1.67 113.121 -171.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.72 129.41 55.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.272 -0.876 . . . . 1.58 109.289 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 56' ' ' ILE . 3.2 mp -69.55 135.73 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.169 0.509 . . . . 2.11 110.7 -176.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.1 11.02 81.71 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.308 -0.86 . . . . 1.03 113.178 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.496 HD13 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -106.07 154.05 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.618 0.723 . . . . 0.77 112.326 -176.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.43 145.87 24.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.402 -1.272 . . . . 0.68 111.215 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 61' ' ' GLU . 7.2 tp -53.22 -43.39 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 122.866 0.466 . . . . 0.69 111.229 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' N ' HG23 ' A' ' 60' ' ' ILE . 8.5 pt-20 -74.33 -22.05 59.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.118 -0.492 . . . . 2.2 111.238 -175.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -90.48 -34.55 15.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.334 0.588 . . . . 1.98 109.753 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -67.9 -35.21 78.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.066 -0.97 . . . . 2.09 110.592 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.0 p -121.82 172.13 8.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.802 -0.635 . . . . 0.6 110.337 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -120.7 21.42 11.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 2.32 111.416 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.534 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 38.6 m-80 -104.12 -168.14 1.45 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.474 -0.565 . . . . 1.06 109.474 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -85.95 120.89 72.97 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-O 121.495 0.664 . . . . 0.34 111.465 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.83 122.52 9.9 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.353 2.702 . . . . 0.45 111.219 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.8 p -132.43 154.86 49.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.699 -0.228 . . . . 0.31 110.633 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 11.8 t -99.72 117.07 33.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.462 -0.57 . . . . 1.26 109.462 171.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 46.6 m -102.46 139.51 37.96 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.119 0.485 . . . . 0.29 109.748 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 6.6 tt0 -78.03 -20.88 51.6 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.512 0.673 . . . . 1.53 109.724 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.401 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 22.8 t0 -159.34 158.96 33.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.325 -0.991 . . . . 1.26 108.325 171.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.496 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.6 OUTLIER -148.65 129.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 117.852 0.297 . . . . 1.07 110.465 178.711 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.51 165.91 13.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.731 0.301 . . . . 1.87 110.591 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.82 -150.16 0.31 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.587 -0.733 . . . . 1.94 110.24 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.94 5.08 14.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.96 0.409 . . . . 2.12 110.141 172.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 118.57 24.04 3.25 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.665 -0.779 . . . . 0.51 112.691 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.06 -21.29 29.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.05 0.425 . . . . 1.1 111.534 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.08 102.79 8.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.891 -0.411 . . . . 0.33 109.891 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -102.34 139.76 14.56 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.455 -0.879 . . . . 0.26 112.966 -176.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.426 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -96.0 120.95 46.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 122.737 0.415 . . . . 0.3 109.905 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 95.5 m-20 60.76 48.62 6.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.525 -0.761 . . . . 0.34 110.975 173.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.622 ' HB2' HD11 ' A' ' 47' ' ' ILE . 57.4 m -83.1 111.42 18.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.619 -0.718 . . . . 0.81 110.564 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 24.7 m -105.29 128.11 27.27 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.704 -0.68 . . . . 0.44 109.918 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.9 Cg_exo -59.95 125.33 17.39 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.976 2.451 . . . . 0.39 112.099 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.475 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 16.2 pt -96.49 162.45 23.4 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 115.55 -0.75 . . . . 0.57 111.107 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.17 149.41 51.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.237 2.624 . . . . 1.05 112.176 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.05 33.53 1.34 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.652 -0.704 . . . . 1.45 110.137 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.266 -0.874 . . . . 2.31 111.443 -172.346 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.016 -0.434 . . . . 5.75 112.016 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 t 61.05 37.13 18.14 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.384 0.611 . . . . 4.66 110.533 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.15 -121.84 0.63 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.705 -0.679 . . . . 1.6 111.624 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.466 ' CZ2' HD22 ' A' ' 54' ' ' LEU . 49.1 m95 -141.74 166.95 23.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.899 0.38 . . . . 0.81 111.219 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.556 ' OE2' ' HD2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -65.77 108.25 2.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.629 -0.878 . . . . 2.73 108.629 175.647 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 m -106.75 28.21 8.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.968 -0.56 . . . . 1.75 112.344 -167.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.556 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -50.35 -25.24 3.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.834 0.679 . . . . 3.24 112.834 -177.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 t -71.76 -28.66 63.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 2.05 111.733 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.81 1.44 54.62 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.173 -0.537 . . . . 0.88 113.226 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -77.33 -15.89 59.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.773 0.286 . . . . 1.72 111.773 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.59 139.96 38.19 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.577 -0.449 . . . . 1.19 110.206 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -94.54 -21.73 18.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.748 0.648 . . . . 1.66 112.748 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.0 p -104.41 -30.89 9.79 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.229 0.455 . . . . 0.52 112.229 -174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.47 -3.27 59.43 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.612 -0.804 . . . . 0.43 111.999 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.599 ' NZ ' ' HA ' ' A' ' 73' ' ' ASP . 90.4 mttt -87.91 88.07 7.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.095 0.474 . . . . 1.64 109.967 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -93.53 103.07 15.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.865 -0.607 . . . . 0.55 110.189 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.41 154.06 28.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.105 0.478 . . . . 0.29 110.752 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 65.6 m -88.94 103.62 16.2 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.611 -0.722 . . . . 0.74 109.179 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -125.44 150.72 47.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.057 0.456 . . . . 0.5 112.037 -170.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.87 104.24 16.32 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.619 -0.719 . . . . 1.65 110.321 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.473 HG21 ' HG3' ' A' ' 86' ' ' PRO . 74.4 p -72.48 -5.79 39.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.078 0.466 . . . . 0.52 111.327 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -96.91 -22.68 16.73 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.846 0.831 . . . . 2.2 109.013 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 48' ' ' GLN . 27.5 tptt -106.88 110.98 23.29 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.245 -1.343 . . . . 2.6 109.895 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -100.93 161.88 13.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.428 -0.806 . . . . 2.17 111.861 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 t -126.2 148.0 30.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.236 -0.893 . . . . 0.59 108.807 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -97.93 22.14 9.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.821 0.343 . . . . 2.83 111.419 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -134.45 119.93 19.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.222 -0.444 . . . . 4.07 110.119 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 73.5 p -140.85 86.09 2.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.909 0.385 . . . . 2.46 110.528 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.1 m -108.28 -47.66 3.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.24 0.543 . . . . 2.0 110.203 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.69 164.02 34.16 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.251 -0.886 . . . . 1.39 112.739 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 21.9 mm-40 -101.78 -45.19 5.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.065 0.46 . . . . 3.06 109.915 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.28 -40.92 11.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.829 -0.623 . . . . 2.44 109.78 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 37' ' ' HIS . 68.8 m -83.71 3.02 34.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.036 -0.529 . . . . 2.36 109.968 172.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.5 -38.56 87.89 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.718 -0.674 . . . . 2.54 113.536 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.55 -62.95 1.26 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.891 0.377 . . . . 3.49 110.255 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.8 tp -113.59 94.63 4.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.194 -0.457 . . . . 4.79 110.316 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.571 ' HB3' ' O ' ' A' ' 33' ' ' SER . 8.2 p80 -114.76 -46.43 2.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.513 -0.312 . . . . 6.59 111.423 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.4 m -66.01 -33.25 75.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.988 0.423 . . . . 5.42 111.241 -174.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.28 -11.67 75.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 3.27 112.165 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -101.87 -51.73 3.35 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.644 -0.502 . . . . 4.15 109.644 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.22 138.6 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.495 -0.775 . . . . 2.58 111.922 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.4 tp -106.08 -7.03 18.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.01 0.91 . . . . 3.5 109.031 172.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.94 1.73 51.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.902 -1.044 . . . . 2.29 111.375 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.548 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.6 mt-30 -48.29 133.56 15.61 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.236 0.541 . . . . 1.4 111.182 -178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.776 HG12 ' HA ' ' A' ' 83' ' ' ASN . 14.7 p -105.66 127.92 60.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.413 -0.812 . . . . 1.37 110.163 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.82 121.86 45.59 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.36 -0.836 . . . . 0.3 110.379 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.569 HD11 ' HB2' ' A' ' 84' ' ' CYS . 19.1 pt -130.7 160.8 41.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.891 -0.595 . . . . 0.23 109.697 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 1.5 mm-40 -77.34 135.76 38.4 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.504 0.668 . . . . 2.38 110.642 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.6 m -131.11 153.57 49.21 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.453 -1.248 . . . . 1.15 110.146 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 8.4 t -156.56 128.34 7.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.083 0.468 . . . . 0.6 110.038 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 tm0? -120.87 110.62 16.53 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.989 0.424 . . . . 2.08 110.515 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mt -65.73 128.94 94.19 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.619 -0.719 . . . . 0.95 109.889 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -34.0 99.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 125.128 3.885 . . . . 0.95 113.531 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.466 HD22 ' CZ2' ' A' ' 4' ' ' TRP . 3.3 pp -70.29 136.89 50.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.851 -1.068 . . . . 1.67 112.393 -172.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.4 mt -94.95 120.6 35.43 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.494 -0.928 . . . . 1.58 108.494 168.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.06 133.09 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.361 0.601 . . . . 2.11 111.081 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.43 -24.96 22.99 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.085 -0.962 . . . . 1.03 111.478 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -87.06 155.03 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.466 0.65 . . . . 0.77 111.107 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.85 143.94 26.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.666 -1.152 . . . . 0.68 111.624 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 tp -54.71 -35.25 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.018 -0.992 . . . . 0.69 110.974 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -76.79 -16.8 59.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.069 -0.969 . . . . 2.2 111.701 -173.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.33 -24.5 11.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.09 0.471 . . . . 1.98 110.704 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.8 tp10 -74.93 -38.04 61.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.848 -0.615 . . . . 2.09 111.1 -175.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 p -113.61 173.14 6.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.251 -0.277 . . . . 0.6 110.251 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -118.84 46.19 1.91 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.221 0.534 . . . . 2.32 110.699 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 42.4 m-80 -135.39 -174.16 3.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.822 -0.626 . . . . 1.06 109.331 175.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.6 m -80.35 125.29 81.46 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-O 121.403 0.62 . . . . 0.34 111.786 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -63.05 115.52 3.01 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.339 2.693 . . . . 0.45 110.998 171.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.3 p -127.26 143.32 51.26 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.322 -0.551 . . . . 0.31 111.265 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 36.0 t -93.27 106.19 18.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 1.26 109.68 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 57.1 m -92.73 134.0 35.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.156 -0.474 . . . . 0.29 109.959 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -64.9 -36.08 83.21 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.206 -0.665 . . . . 1.53 109.206 175.154 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.599 ' HA ' ' NZ ' ' A' ' 15' ' ' LYS . 40.3 t0 -152.25 165.55 34.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.368 -0.975 . . . . 1.26 108.368 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.502 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.2 t -136.48 133.55 49.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.633 -0.506 . . . . 1.07 109.633 175.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 31' ' ' GLU . 16.1 tt0 -102.94 164.69 11.47 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.139 -0.482 . . . . 1.87 109.701 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 78' ' ' GLY . 1.8 m-20 63.67 -156.52 0.32 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.272 0.357 . . . . 1.94 110.156 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.45 23.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.895 0.379 . . . . 2.12 110.882 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 95.7 22.62 20.66 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.949 -0.643 . . . . 0.51 111.777 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.401 ' HB3' HE22 ' A' ' 48' ' ' GLN . 81.7 mt -90.21 -18.68 25.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 1.1 111.247 -177.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.9 t -131.69 109.98 16.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.772 -0.455 . . . . 0.33 109.772 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -97.04 144.83 17.58 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.28 -0.962 . . . . 0.26 112.382 -177.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -100.77 120.83 50.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.866 -0.42 . . . . 0.3 109.866 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.776 ' HA ' HG12 ' A' ' 45' ' ' VAL . 89.4 m-20 58.46 53.76 6.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.026 -0.534 . . . . 0.34 110.807 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.596 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 66.8 m -89.36 95.44 10.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.728 -0.669 . . . . 0.81 110.94 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 8.0 m -88.18 127.25 57.97 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.718 -0.674 . . . . 0.44 110.732 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.473 ' HG3' HG21 ' A' ' 21' ' ' THR . 39.7 Cg_exo -62.57 118.01 4.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.896 2.397 . . . . 0.39 111.63 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.6 pt -97.98 148.45 34.49 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.925 -0.579 . . . . 0.57 111.558 -174.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.4 Cg_exo -69.86 161.12 47.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.355 2.703 . . . . 1.05 111.872 175.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.0 mt -93.55 22.61 5.24 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.744 -0.662 . . . . 1.45 110.693 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.472 -0.775 . . . . 2.31 110.973 -174.063 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.2 m95 . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.927 0.394 . . . . 0.81 111.079 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -66.55 108.95 2.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.631 -0.713 . . . . 2.73 110.463 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -108.97 25.99 11.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.676 -0.693 . . . . 1.75 110.448 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -20.08 62.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.903 -0.59 . . . . 3.24 111.414 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -69.06 -20.41 64.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.123 0.487 . . . . 2.05 110.699 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.65 7.09 87.25 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.836 -0.62 . . . . 0.88 112.637 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 m -70.96 -27.46 63.75 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.783 0.29 . . . . 1.72 111.783 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.1 t -108.53 141.64 40.14 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.93 -0.308 . . . . 1.19 110.383 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.501 ' OD1' HG23 ' A' ' 13' ' ' THR . 9.5 p30 -93.22 -19.87 21.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 1.66 112.129 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.501 HG23 ' OD1' ' A' ' 12' ' ' ASN . 19.8 p -108.86 -31.11 7.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.914 0.388 . . . . 0.52 111.957 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.13 2.09 56.96 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.749 -0.739 . . . . 0.43 111.943 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.66 ' HD3' HG23 ' A' ' 74' ' ' VAL . 78.3 mttt -94.87 89.23 5.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.127 0.489 . . . . 1.64 110.443 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.4 mp -93.61 128.56 39.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 0.55 109.999 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -137.16 156.75 47.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.517 -0.31 . . . . 0.29 110.301 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 50' ' ' THR . 82.4 m -91.91 97.66 11.1 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.278 -0.638 . . . . 0.74 109.278 173.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 82.4 m -111.64 155.65 23.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.963 0.411 . . . . 0.5 111.066 -171.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 20.5 t0 -98.24 127.82 44.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.033 -1.099 . . . . 1.65 108.033 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.7 p -92.69 1.88 57.03 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.362 0.601 . . . . 0.52 110.501 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -105.55 -25.05 12.46 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.982 -0.748 . . . . 2.2 108.982 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 26.2 mtmm -102.32 135.9 43.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.204 -0.907 . . . . 2.6 110.092 176.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -139.96 164.45 29.97 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.561 -0.745 . . . . 2.17 111.954 -176.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.44 HG21 HG22 ' A' ' 80' ' ' VAL . 2.5 t -117.88 148.49 20.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.609 -0.723 . . . . 0.59 110.123 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -83.88 -21.43 31.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.317 -0.401 . . . . 2.83 111.191 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.9 mmpt? -94.13 136.21 34.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.349 -0.611 . . . . 4.07 109.349 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 23.0 p -156.92 96.65 1.62 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.799 0.333 . . . . 2.46 111.632 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -122.16 -69.12 0.85 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.758 -0.377 . . . . 2.0 111.475 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.37 77.87 0.49 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.974 -0.85 . . . . 1.39 110.974 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -103.43 20.55 17.62 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.449 0.537 . . . . 3.06 112.449 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.486 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . 83.8 mt-10 . . . . . 0 CA--C 1.518 -0.265 0 C-N-CA 120.102 -0.639 . . . . 2.44 109.948 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.494 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 26.1 mt-30 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.252 0.549 . . . . 1.4 111.622 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.4 t -100.14 123.08 52.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.171 -0.922 . . . . 1.37 109.713 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . -110.04 100.48 9.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.637 -0.71 . . . . 0.3 110.658 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 12.2 pt -100.88 149.64 6.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.918 -0.583 . . . . 0.23 110.591 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.79 126.63 30.2 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.768 -0.827 . . . . 2.38 108.768 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.486 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -126.07 158.64 34.9 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.88 -0.6 . . . . 1.15 110.203 -172.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 5.2 t -160.59 127.57 4.26 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.24 -0.436 . . . . 0.6 110.116 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.434 HE21 HD12 ' A' ' 60' ' ' ILE . 5.0 tm0? -116.4 107.64 15.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.496 0.665 . . . . 2.08 111.044 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mt -64.6 134.29 95.97 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 114.855 -1.066 . . . . 0.95 109.665 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -32.33 101.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.699 3.599 . . . . 0.95 114.259 -170.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 54' ' ' LEU . 3.9 pp -75.82 142.15 42.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.15 -1.387 . . . . 1.67 113.099 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.1 mp -91.68 145.26 24.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.359 -0.837 . . . . 1.58 109.288 167.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.4 136.17 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 2.11 110.778 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.12 -7.77 69.93 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.577 -0.738 . . . . 1.03 112.865 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.491 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -81.75 160.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.372 0.605 . . . . 0.77 111.762 -175.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' N ' HG23 ' A' ' 58' ' ' ILE . . . -90.07 129.95 36.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.032 -0.985 . . . . 0.68 111.202 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.434 HD12 HE21 ' A' ' 51' ' ' GLN . 8.6 tp -53.92 -36.66 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 114.984 -1.007 . . . . 0.69 112.353 -177.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.13 -21.83 49.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.744 0.307 . . . . 2.2 111.432 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.91 -26.57 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.079 0.466 . . . . 1.98 110.599 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.491 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 9.7 tp10 -68.63 -35.01 76.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.802 -0.635 . . . . 2.09 111.136 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.9 p -127.39 154.44 45.0 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.872 0.368 . . . . 0.6 110.902 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -98.84 56.07 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.871 0.843 . . . . 2.32 109.726 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 52.1 m-80 -137.86 -170.38 2.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.129 -0.941 . . . . 1.06 108.727 175.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.0 m -89.35 126.09 59.63 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-O 121.114 0.483 . . . . 0.34 110.592 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.94 120.44 4.65 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.686 2.258 . . . . 0.45 111.079 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.753 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 2.8 p -120.59 157.85 28.62 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.884 -0.598 . . . . 0.31 111.567 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 34.0 t -108.97 104.51 13.76 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.206 -0.664 . . . . 1.26 109.206 170.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.489 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 92.1 m -87.38 139.59 30.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.359 -0.608 . . . . 0.29 109.359 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.1 tt0 -71.57 -31.24 66.76 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.064 -0.717 . . . . 1.53 109.064 174.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 32' ' ' GLU . 6.9 t0 -156.33 164.02 38.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.866 -1.161 . . . . 1.26 107.866 171.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.66 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.4 t -137.01 139.12 45.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.652 -0.419 . . . . 1.07 110.022 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 10.1 tt0 -100.13 159.01 15.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.156 -0.475 . . . . 1.87 109.963 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 61.73 -151.22 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.066 -0.515 . . . . 1.94 110.133 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -79.65 16.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.083 0.468 . . . . 2.12 110.579 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.562 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 110.49 21.76 6.72 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.813 -0.63 . . . . 0.51 112.3 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.92 -21.87 31.72 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.758 0.281 . . . . 1.1 111.758 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 21.7 t -127.72 103.63 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.898 -0.321 . . . . 0.33 110.43 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.489 ' HA3' ' SG ' ' A' ' 71' ' ' CYS . . . -91.84 123.79 7.37 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.057 -1.068 . . . . 0.26 112.265 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -86.43 118.34 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.671 -0.492 . . . . 0.3 109.671 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 92.9 m-20 59.99 41.78 16.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.34 110.764 174.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.753 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -81.21 109.97 16.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.81 110.457 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 17.2 m -94.17 130.27 34.71 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.776 -0.647 . . . . 0.44 109.698 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.3 Cg_exo -60.62 109.96 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.715 2.277 . . . . 0.39 111.442 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 5.5 pt -74.66 141.66 76.28 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 115.623 -0.717 . . . . 0.57 111.26 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.3 Cg_exo . . . . . 0 N--CA 1.46 -0.473 0 C-N-CA 123.278 2.652 . . . . 1.05 112.392 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.44 ' CH2' HD22 ' A' ' 54' ' ' LEU . 94.5 m95 . . . . . 0 N--CA 1.45 -0.454 0 CA-C-O 120.737 0.303 . . . . 0.81 110.199 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.521 ' OE1' ' HG2' ' A' ' 7' ' ' LYS . 30.9 tt0 -59.37 109.05 0.8 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.488 -0.778 . . . . 2.73 110.848 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -91.54 27.51 1.98 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.64 -0.709 . . . . 1.75 111.429 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HG2' ' OE1' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -56.45 -25.87 52.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.066 -0.516 . . . . 3.24 112.179 -176.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p -77.15 -30.01 54.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.049 0.452 . . . . 2.05 111.537 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.55 15.04 80.65 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.88 112.087 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.404 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 10.9 p -77.47 -25.18 50.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.307 0.484 . . . . 1.72 112.307 -174.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -102.97 142.68 33.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.218 -0.446 . . . . 1.19 110.933 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.539 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.8 p30 -91.11 -29.25 17.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.789 -0.641 . . . . 1.66 111.478 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.539 HG23 ' OD1' ' A' ' 12' ' ' ASN . 13.0 p -100.91 -31.19 11.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.104 0.478 . . . . 0.52 111.627 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.86 -2.88 52.25 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.815 -0.707 . . . . 0.43 112.115 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.587 ' HD3' HG23 ' A' ' 74' ' ' VAL . 90.7 mttt -86.72 88.76 7.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.009 0.433 . . . . 1.64 110.428 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 69' ' ' THR . 9.6 mp -92.32 110.73 22.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.55 110.492 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.0 149.23 39.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.08 0.467 . . . . 0.29 110.482 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -87.03 106.01 17.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.64 -0.709 . . . . 0.74 109.167 172.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -122.8 154.37 38.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.084 -0.507 . . . . 0.5 111.52 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 4.1 m-20 -100.03 114.64 28.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.509 -0.769 . . . . 1.65 109.174 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.0 p -74.82 -7.02 52.17 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.134 0.492 . . . . 0.52 110.968 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -98.01 -6.51 31.8 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.018 -0.734 . . . . 2.2 109.018 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 46.1 mtpt -111.62 98.71 7.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.83 -1.077 . . . . 2.6 109.759 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.82 157.67 16.14 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.271 -0.877 . . . . 2.17 110.782 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 t -120.22 145.15 26.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.684 -0.858 . . . . 0.59 108.684 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -95.18 29.84 2.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.065 0.46 . . . . 2.83 111.442 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 7.3 mmpt? -129.17 161.16 30.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.046 -0.525 . . . . 4.07 109.831 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 p -150.12 66.2 0.97 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.129 0.49 . . . . 2.46 110.406 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 m -122.1 143.69 49.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.753 -0.658 . . . . 2.0 109.679 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.03 148.78 18.56 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.215 -0.993 . . . . 1.39 112.842 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -78.61 -38.17 40.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.915 0.388 . . . . 3.06 110.285 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 2.44 110.186 176.851 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.587 ' HB3' HG23 ' A' ' 82' ' ' ILE . 32.1 mt-30 . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.295 0.569 . . . . 1.4 111.046 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.41 105.33 15.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.258 -0.883 . . . . 1.37 110.268 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -101.33 116.0 31.8 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.67 -0.695 . . . . 0.3 110.722 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 84' ' ' CYS . 8.0 pt -120.81 155.16 24.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.859 -0.61 . . . . 0.23 109.887 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.72 123.5 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.869 0.842 . . . . 2.38 109.43 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 60.2 m -122.57 157.35 32.31 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.316 -1.311 . . . . 1.15 110.598 -171.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.9 t -161.18 138.43 8.94 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.913 0.387 . . . . 0.6 110.38 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -121.58 152.09 39.64 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.548 0.69 . . . . 2.08 111.156 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.574 HG23 ' HD2' ' A' ' 53' ' ' PRO . 23.1 mt -90.6 142.13 27.72 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.779 -1.1 . . . . 0.95 108.687 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.574 ' HD2' HG23 ' A' ' 52' ' ' ILE . 57.2 Cg_exo -33.59 108.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 124.216 3.277 . . . . 0.95 113.393 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 52' ' ' ILE . 22.5 mt -66.13 130.08 41.99 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.954 -1.021 . . . . 1.67 113.112 -166.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.633 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 86.4 mt -99.48 122.6 42.8 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.704 -0.85 . . . . 1.58 108.704 166.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.1 mt -67.81 132.3 32.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.06 0.457 . . . . 2.11 110.637 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.67 14.6 61.1 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.458 -0.792 . . . . 1.03 112.089 -176.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -105.48 155.07 6.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.773 0.797 . . . . 0.77 111.818 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.38 135.82 33.36 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.373 -1.285 . . . . 0.68 111.036 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.403 HG21 HD23 ' A' ' 16' ' ' LEU . 5.7 tp -52.2 -32.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.248 -0.887 . . . . 0.69 111.106 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.99 -27.88 61.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.998 -1.001 . . . . 2.2 111.927 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -107.35 -11.73 15.48 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.881 -0.328 . . . . 1.98 111.665 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.4 tp10 -79.15 -35.21 42.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.349 0.595 . . . . 2.09 110.413 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.418 ' HA ' HD12 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -124.83 171.59 10.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.002 -0.545 . . . . 0.6 110.148 -174.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -122.01 49.41 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.364 0.602 . . . . 2.32 109.997 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -138.77 -169.05 2.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.959 -0.564 . . . . 1.06 109.922 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -83.79 125.63 72.74 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 121.399 0.618 . . . . 0.34 111.931 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -65.25 123.43 11.51 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.435 2.757 . . . . 0.45 111.226 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 77.2 p -132.21 152.85 51.11 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.779 -0.369 . . . . 0.31 111.147 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 38.3 t -103.42 108.81 20.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.019 -0.537 . . . . 1.26 109.683 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 38.6 m -96.04 135.11 38.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.0 0.428 . . . . 0.29 110.603 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.4 tt0 -71.92 -29.55 64.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.418 0.628 . . . . 1.53 109.495 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -153.33 159.37 42.47 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.214 -1.032 . . . . 1.26 108.214 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.587 HG23 ' HD3' ' A' ' 15' ' ' LYS . 1.9 t -138.71 137.51 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.225 0.466 . . . . 1.07 110.509 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 76' ' ' ASP . 32.7 tt0 -104.54 157.43 17.17 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.91 -0.586 . . . . 1.87 110.634 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 78' ' ' GLY . 2.8 t70 67.24 -149.9 0.18 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.076 0.55 . . . . 1.94 109.857 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.03 16.11 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.939 0.876 . . . . 2.12 109.727 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.562 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . 99.22 23.33 11.43 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.557 -0.747 . . . . 0.51 111.558 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 34.1 mt -81.23 -25.68 36.45 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.962 0.41 . . . . 1.1 110.954 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.13 105.36 13.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.61 -0.515 . . . . 0.33 109.61 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.621 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -95.89 143.85 16.91 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.302 -0.951 . . . . 0.26 112.052 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -101.35 117.5 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 109.824 -0.436 . . . . 0.3 109.824 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 85.5 m-20 62.39 48.61 4.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.439 -0.801 . . . . 0.34 110.527 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.621 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 61.2 m -83.7 92.4 7.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.242 -0.89 . . . . 0.81 110.703 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.3 m -79.54 128.41 75.07 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.833 -0.622 . . . . 0.44 110.369 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.76 115.85 3.32 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.557 2.172 . . . . 0.39 110.797 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 8.8 pt -91.55 151.2 42.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.114 -0.494 . . . . 0.57 111.732 -173.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.3 Cg_exo . . . . . 0 N--CA 1.459 -0.519 0 C-N-CA 123.256 2.637 . . . . 1.05 111.823 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.6 m95 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.743 0.306 . . . . 0.81 110.791 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -59.94 106.13 0.46 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.413 -0.812 . . . . 2.73 111.218 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.501 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 17.1 m -113.54 13.5 18.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.761 -0.654 . . . . 1.75 110.687 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -19.45 63.52 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.702 0.63 . . . . 3.24 112.702 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 t -81.7 -9.47 59.64 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.276 -0.57 . . . . 2.05 110.591 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.98 15.6 59.06 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.927 -0.654 . . . . 0.88 112.803 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.417 ' HB2' HG21 ' A' ' 87' ' ' ILE . 12.3 p -78.87 -29.75 44.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.854 0.359 . . . . 1.72 111.453 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 t -128.62 141.68 51.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.976 0.417 . . . . 1.19 110.647 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.432 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.8 p30 -92.62 -24.43 18.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 1.66 111.846 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.432 HG23 ' OD1' ' A' ' 12' ' ' ASN . 26.1 p -97.58 -30.96 12.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.121 0.415 . . . . 0.52 112.121 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.501 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 95.34 -0.14 63.5 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.525 -0.845 . . . . 0.43 111.713 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HD3' HG23 ' A' ' 74' ' ' VAL . 59.6 mttp -92.5 88.48 6.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.73 0.3 . . . . 1.64 110.352 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 69' ' ' THR . 7.8 mp -102.61 99.87 9.9 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.376 -0.375 . . . . 0.55 110.529 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.7 150.98 21.24 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.151 0.501 . . . . 0.29 110.61 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.838 ' SG ' ' HB2' ' A' ' 66' ' ' ASN . 10.4 t -84.22 100.75 11.39 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.335 -0.848 . . . . 0.74 108.72 175.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 59.3 m -125.93 150.41 48.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.177 0.513 . . . . 0.5 111.74 -169.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 9.4 t70 -92.97 130.36 38.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.231 -1.026 . . . . 1.65 108.231 172.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.41 HG21 ' HG3' ' A' ' 86' ' ' PRO . 60.6 p -85.91 -3.9 59.04 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.773 -0.371 . . . . 0.52 111.46 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -106.39 -39.19 5.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.109 0.48 . . . . 2.2 109.747 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 38.8 mtmt -74.32 132.24 41.88 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.889 0.852 . . . . 2.6 110.17 172.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.555 ' HD2' HG22 ' A' ' 47' ' ' ILE . 14.4 mmmm -124.09 156.7 36.13 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.406 -1.27 . . . . 2.17 110.821 -171.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 27' ' ' LYS . 2.2 t -119.88 144.3 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.37 -0.604 . . . . 0.59 109.37 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -81.04 -19.3 44.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.255 0.55 . . . . 2.83 110.474 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.487 ' H ' HG12 ' A' ' 25' ' ' VAL . 2.2 mmmp? -80.14 118.98 22.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.338 -0.846 . . . . 4.07 110.33 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -144.41 113.69 6.98 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.488 -0.56 . . . . 2.46 109.488 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.7 m -152.04 -80.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.434 -0.348 . . . . 2.0 110.494 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' HA2' ' OD1' ' A' ' 73' ' ' ASP . . . 98.27 141.41 12.21 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.82 -0.705 . . . . 1.39 112.289 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.37 -47.19 6.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.761 0.28 . . . . 3.06 111.124 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 C--N 1.326 -0.452 0 N-CA-C 109.578 -0.527 . . . . 2.44 109.578 -179.842 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.595 ' HB3' HG23 ' A' ' 82' ' ' ILE . 30.1 mt-30 . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 121.054 0.454 . . . . 1.4 110.418 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.8 t -84.09 104.2 12.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.684 -0.689 . . . . 1.37 110.491 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -97.32 100.81 12.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.271 -0.877 . . . . 0.3 110.477 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.555 HG22 ' HD2' ' A' ' 24' ' ' LYS . 15.2 pt -106.63 152.66 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.786 -0.643 . . . . 0.23 110.027 176.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.471 ' OE1' HG22 ' A' ' 25' ' ' VAL . 13.3 tp60 -76.73 118.74 19.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.735 0.779 . . . . 2.38 110.114 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 53.7 m -114.02 160.65 18.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.116 -1.402 . . . . 1.15 110.299 -175.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.614 ' O ' ' HB3' ' A' ' 18' ' ' CYS . 15.3 t -162.87 136.86 6.17 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.41 -0.589 . . . . 0.6 109.41 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.466 HE22 HD12 ' A' ' 60' ' ' ILE . 46.3 tp60 -117.81 107.53 14.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.314 0.578 . . . . 2.08 110.856 -175.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.485 HG23 ' HD2' ' A' ' 53' ' ' PRO . 60.2 mt -57.45 139.71 80.41 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.984 -1.007 . . . . 0.95 109.99 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 52' ' ' ILE . 50.2 Cg_exo -34.72 118.94 0.13 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 124.274 3.316 . . . . 0.95 113.156 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.56 136.55 53.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.435 -0.802 . . . . 1.67 113.005 -169.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.32 109.18 20.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.68 -1.229 . . . . 1.58 107.68 167.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 56' ' ' ILE . 15.8 mt -55.92 126.42 13.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.244 0.545 . . . . 2.11 111.438 -170.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.64 -4.62 58.09 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.278 -0.874 . . . . 1.03 113.086 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -98.37 151.16 4.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.718 0.771 . . . . 0.77 112.012 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.49 145.14 25.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.45 -1.25 . . . . 0.68 111.79 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.466 HD12 HE22 ' A' ' 51' ' ' GLN . 6.1 tp -40.79 -46.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.621 0.768 . . . . 0.69 113.026 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.433 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -70.92 -23.14 62.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.813 0.671 . . . . 2.2 112.813 -169.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -106.67 -7.49 17.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.424 0.631 . . . . 1.98 109.877 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -74.34 -39.11 63.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.586 -0.734 . . . . 2.09 109.77 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.3 p -132.38 162.88 29.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.475 -0.784 . . . . 0.6 110.431 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -108.39 33.8 3.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.862 0.319 . . . . 2.32 111.862 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.838 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m-80 -115.21 -163.17 0.86 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.827 -0.805 . . . . 1.06 108.827 173.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 m -86.82 131.4 45.3 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 121.222 0.534 . . . . 0.34 111.068 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 44.7 Cg_endo -79.56 126.84 6.94 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.848 2.365 . . . . 0.45 110.356 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 71.3 p -131.26 145.57 51.95 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.393 -0.523 . . . . 0.31 111.631 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.2 t -94.99 111.67 23.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.406 -0.591 . . . . 1.26 109.406 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 38.0 m -96.8 144.03 27.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.251 0.548 . . . . 0.29 110.847 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.8 tt0 -82.14 -21.82 36.45 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.436 -0.802 . . . . 1.53 109.299 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 14.5 t70 -161.69 153.36 18.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.991 -1.114 . . . . 1.26 107.991 173.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.48 HG12 ' HA2' ' A' ' 78' ' ' GLY . 2.0 t -135.35 128.69 48.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.459 -0.497 . . . . 1.07 109.853 173.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -94.4 169.48 10.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.762 -0.654 . . . . 1.87 110.841 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 56.53 -148.86 0.48 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.028 -0.987 . . . . 1.94 111.296 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -80.51 23.09 0.53 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.698 0.761 . . . . 2.12 110.127 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . 92.08 23.28 27.81 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.903 -0.665 . . . . 0.51 112.235 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -91.06 -19.11 23.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.381 . . . . 1.1 111.126 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 25' ' ' VAL . 60.7 t -126.09 101.34 7.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.294 -0.412 . . . . 0.33 109.954 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.702 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -95.25 144.68 17.35 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.485 -0.864 . . . . 0.26 112.494 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.595 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -102.64 118.78 50.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.929 -0.397 . . . . 0.3 109.929 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 73.6 m-20 62.23 35.03 15.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.59 -0.732 . . . . 0.34 110.913 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.702 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 61.1 m -74.47 95.83 2.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.614 -0.721 . . . . 0.81 110.847 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.9 m -89.74 128.38 50.65 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 121.232 0.539 . . . . 0.44 110.219 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 64.2 Cg_endo -70.16 133.6 25.21 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.296 2.664 . . . . 0.39 112.645 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.417 HG21 ' HB2' ' A' ' 10' ' ' SER . 4.7 pt -107.25 153.35 41.17 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.073 -0.967 . . . . 0.57 111.311 -174.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.461 -0.424 0 C-N-CA 123.202 2.601 . . . . 1.05 111.476 172.698 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.556 ' CD2' ' HB ' ' A' ' 60' ' ' ILE . 92.3 m95 . . . . . 0 C--O 1.235 0.32 0 CA-C-O 120.436 0.16 . . . . 0.81 110.795 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.464 ' OE2' ' HA ' ' A' ' 59' ' ' ALA . 2.7 mp0 -59.47 106.82 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.274 0.559 . . . . 2.73 111.173 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.492 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 42.5 m -112.61 2.46 16.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.575 -0.739 . . . . 1.75 110.741 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -16.01 62.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.979 -0.555 . . . . 3.24 111.776 -175.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.64 4.96 38.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.909 0.385 . . . . 2.05 110.894 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.05 16.16 80.99 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.224 -1.151 . . . . 0.88 110.224 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 6' ' ' SER . 2.3 p -71.71 -30.05 65.23 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.388 -0.906 . . . . 1.72 111.861 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 6' ' ' SER . 7.4 t -155.79 143.71 19.77 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.764 -0.374 . . . . 1.19 110.936 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -91.79 -30.7 16.08 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.236 0.541 . . . . 1.66 110.186 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.1 p -92.25 -15.55 27.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.554 -0.748 . . . . 0.52 111.137 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 86.51 -8.36 75.2 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.923 -0.656 . . . . 0.43 112.493 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -87.99 89.12 7.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.988 0.423 . . . . 1.64 111.015 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 4' ' ' TRP . 8.9 mp -90.11 141.93 28.21 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.304 -0.628 . . . . 0.55 109.304 172.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.85 145.74 36.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.963 0.411 . . . . 0.29 110.678 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 50' ' ' THR . 32.9 m -79.9 101.79 8.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.634 -0.876 . . . . 0.74 108.634 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.8 m -124.56 146.79 48.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.942 0.401 . . . . 0.5 111.344 -170.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -94.62 117.57 30.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.989 -0.745 . . . . 1.65 108.989 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 54.0 p -79.44 -0.38 32.76 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.198 0.523 . . . . 0.52 110.714 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -104.26 -17.75 14.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.659 -0.701 . . . . 2.2 109.477 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -119.63 137.74 53.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.437 -0.801 . . . . 2.6 110.437 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -140.23 162.75 34.52 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.731 0.641 . . . . 2.17 112.731 -170.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.545 HG11 HG22 ' A' ' 80' ' ' VAL . 1.6 t -111.74 150.67 13.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.014 -0.994 . . . . 0.59 110.553 -173.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -76.01 -4.38 40.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.953 -0.567 . . . . 2.83 112.128 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -104.86 119.59 39.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.643 0.259 . . . . 4.07 110.842 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.4 m -102.28 8.71 40.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.016 0.436 . . . . 2.46 110.367 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.9 p -87.59 164.77 15.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.829 -0.623 . . . . 2.0 111.174 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.53 -174.62 23.24 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.156 -0.778 . . . . 1.39 111.156 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -100.64 -24.15 14.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.203 0.501 . . . . 3.06 111.62 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 121.028 0.442 . . . . 2.44 111.202 -177.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.581 ' HB3' HG23 ' A' ' 82' ' ' ILE . 18.7 mt-30 . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.866 0.365 . . . . 1.4 110.524 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 83' ' ' ASN . 8.2 p -103.26 118.47 50.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.205 0.526 . . . . 1.37 110.62 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.66 100.0 9.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.46 -0.791 . . . . 0.3 111.172 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 10.7 pt -106.11 155.43 7.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.064 -0.516 . . . . 0.23 110.255 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.45 ' OE1' HG22 ' A' ' 25' ' ' VAL . 10.5 tp60 -77.3 126.04 30.29 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.463 0.649 . . . . 2.38 110.087 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 45.3 m -124.29 163.02 22.53 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.763 -1.108 . . . . 1.15 110.352 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 10.0 t -160.08 142.73 13.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.831 -0.433 . . . . 0.6 109.831 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -120.54 117.96 28.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.142 0.496 . . . . 2.08 110.348 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.407 HG23 ' HD2' ' A' ' 53' ' ' PRO . 56.4 mt -85.23 137.29 37.17 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.371 -0.831 . . . . 0.95 109.539 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HD2' HG23 ' A' ' 52' ' ' ILE . 10.6 Cg_exo -32.68 117.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 124.989 3.792 . . . . 0.95 113.807 -172.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 pp -101.88 142.63 32.89 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.897 -1.047 . . . . 1.67 112.356 -169.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 74.9 mt -92.51 132.83 36.49 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.776 -0.824 . . . . 1.58 108.776 166.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 mt -64.05 135.17 28.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.005 0.431 . . . . 2.11 110.471 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.96 12.16 60.69 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.757 -0.656 . . . . 1.03 112.245 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -109.24 147.88 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.641 0.734 . . . . 0.77 111.855 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HA ' ' OE2' ' A' ' 5' ' ' GLU . . . -73.42 128.18 34.77 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.187 -1.37 . . . . 0.68 110.056 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.556 ' HB ' ' CD2' ' A' ' 4' ' ' TRP . 16.3 tt -57.22 -33.04 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.69 111.931 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -9.96 59.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.385 0.612 . . . . 2.2 110.266 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.06 -35.41 10.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.37 -0.832 . . . . 1.98 109.038 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.5 tp10 -68.6 -39.48 80.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.537 -1.211 . . . . 2.09 110.587 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.0 p -119.6 147.03 44.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.341 -0.391 . . . . 0.6 110.198 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -99.36 48.35 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.144 0.497 . . . . 2.32 110.814 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 47.8 m-80 -128.12 -172.7 2.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.882 -0.599 . . . . 1.06 109.502 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.9 m -83.07 127.97 67.08 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-O 121.145 0.498 . . . . 0.34 110.831 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.01 131.7 7.04 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.925 2.417 . . . . 0.45 111.281 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 81.0 p -133.37 153.44 51.59 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.432 -0.349 . . . . 0.31 110.861 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 15.8 t -99.63 111.22 23.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.804 -0.443 . . . . 1.26 109.804 173.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.6 m -100.97 138.02 38.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.252 0.549 . . . . 0.29 110.768 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.0 tt0 -78.05 -27.41 48.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.633 -0.712 . . . . 1.53 109.859 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -154.36 151.76 29.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.514 -0.921 . . . . 1.26 108.514 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.535 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.5 t -140.47 132.42 31.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.869 -0.419 . . . . 1.07 109.869 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.77 160.7 14.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.478 -0.328 . . . . 1.87 110.21 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.446 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 9.7 m-20 59.8 -154.02 0.37 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.724 0.41 . . . . 1.94 110.238 -174.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' H ' ' HB3' ' A' ' 76' ' ' ASP . 14.8 m-20 -79.35 23.99 0.37 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.015 0.436 . . . . 2.12 110.721 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.535 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 102.66 22.62 9.39 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.989 -0.624 . . . . 0.51 112.637 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 2.6 mm? -78.38 -27.78 46.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 1.1 111.264 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.545 HG22 HG11 ' A' ' 25' ' ' VAL . 32.6 t -125.05 107.71 18.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.334 -0.394 . . . . 0.33 110.719 -174.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -100.93 139.03 14.19 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.104 -1.045 . . . . 0.26 112.195 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.581 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -104.82 123.6 58.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 122.54 0.336 . . . . 0.3 110.143 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.718 ' HA ' HG12 ' A' ' 45' ' ' VAL . 79.6 m-20 62.63 42.69 8.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.89 -0.595 . . . . 0.34 110.714 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.537 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 59.6 m -83.12 96.64 8.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.372 -0.831 . . . . 0.81 111.054 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 26.5 m -79.12 125.01 84.36 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.236 -0.438 . . . . 0.44 110.543 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 21.9 Cg_exo -67.03 128.05 17.95 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.029 2.486 . . . . 0.39 111.962 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.477 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.1 pt -107.3 143.09 26.48 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 116.279 -0.419 . . . . 0.57 110.928 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.6 Cg_exo . . . . . 0 N--CA 1.462 -0.378 0 C-N-CA 123.336 2.69 . . . . 1.05 112.355 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 93.4 m95 . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 110.374 -0.232 . . . . 0.81 110.374 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -64.74 108.95 1.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.027 0.441 . . . . 2.73 110.399 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.7 m -96.29 27.18 3.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.465 0.65 . . . . 1.75 109.643 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -5.01 48.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.354 -0.839 . . . . 3.24 111.585 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -67.59 -30.6 70.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.085 0.469 . . . . 2.05 111.357 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.42 16.62 58.54 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.801 -0.714 . . . . 0.88 112.421 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 m -102.34 -17.02 16.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.855 0.317 . . . . 1.72 111.855 -175.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.772 ' SG ' HG21 ' A' ' 87' ' ' ILE . 3.9 m -131.1 141.55 50.16 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.851 -0.34 . . . . 1.19 111.479 -171.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -94.61 -28.3 15.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 1.66 112.186 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.8 p -86.92 -31.14 20.86 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.476 0.547 . . . . 0.52 112.476 -171.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.15 5.64 82.74 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.509 -0.853 . . . . 0.43 112.679 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HD3' HG23 ' A' ' 74' ' ' VAL . 59.4 mttp -94.38 88.27 5.47 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.065 -0.346 . . . . 1.64 110.065 176.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.688 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 7.9 mp -94.18 123.59 37.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.915 0.388 . . . . 0.55 110.299 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.18 142.62 37.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.835 -0.431 . . . . 0.29 109.835 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 80.1 m -80.93 118.46 22.44 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.278 -0.638 . . . . 0.74 109.278 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.712 ' SG ' HG13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -127.72 163.08 25.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.006 0.432 . . . . 0.5 111.152 -173.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -106.15 105.76 15.96 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.372 -0.973 . . . . 1.65 108.372 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.2 p -75.87 2.54 12.13 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.561 -0.745 . . . . 0.52 111.095 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -104.86 -3.41 23.48 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.054 -0.721 . . . . 2.2 109.054 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -113.3 102.46 10.37 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.361 -0.836 . . . . 2.6 110.562 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.456 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 3.7 mppt? -96.55 159.97 14.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.538 -0.756 . . . . 2.17 110.797 -175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 27' ' ' LYS . 19.3 t -119.61 149.7 22.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.946 -0.761 . . . . 0.59 108.946 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -84.45 -11.64 55.81 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.121 0.415 . . . . 2.83 112.121 -172.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' H ' HG12 ' A' ' 25' ' ' VAL . 14.3 mmmm -120.41 130.41 54.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.684 0.278 . . . . 4.07 110.546 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.7 m -101.45 32.68 3.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.104 -0.498 . . . . 2.46 111.207 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.9 p -86.1 150.09 24.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.263 -0.426 . . . . 2.0 110.233 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.472 ' HA3' ' OD1' ' A' ' 73' ' ' ASP . . . -150.79 -173.95 21.34 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.772 -0.728 . . . . 1.39 112.125 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -91.05 -50.65 5.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.547 0.173 . . . . 3.06 111.404 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 112.193 0.442 . . . . 2.44 112.193 -175.534 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.602 ' HB3' HG23 ' A' ' 82' ' ' ILE . 17.5 mt-30 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 121.048 0.451 . . . . 1.4 111.283 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.56 115.41 43.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.72 -0.673 . . . . 1.37 110.421 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -100.21 118.42 36.49 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.521 -0.763 . . . . 0.3 110.925 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.712 HG13 ' SG ' ' A' ' 19' ' ' CYS . 12.5 pt -116.29 153.39 17.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.049 -0.523 . . . . 0.23 110.015 173.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.54 108.47 16.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.811 0.815 . . . . 2.38 110.076 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 62.7 m -89.5 165.6 14.2 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.128 -1.396 . . . . 1.15 110.573 -175.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.0 t -159.94 117.06 2.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.953 0.883 . . . . 0.6 110.715 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -120.0 131.78 55.26 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.964 -1.016 . . . . 2.08 110.677 -174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 64' ' ' CYS . 46.1 mt -70.41 133.9 86.99 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.979 -0.749 . . . . 0.95 108.979 171.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.11 107.04 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.07 3.18 . . . . 0.95 112.68 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.9 140.51 57.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.209 -0.905 . . . . 1.67 112.865 -169.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.53 152.74 21.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.86 -1.063 . . . . 1.58 108.767 168.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.0 mt -70.66 124.34 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.115 0.483 . . . . 2.11 110.631 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.15 17.18 72.57 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.474 -0.785 . . . . 1.03 112.952 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.412 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -97.0 149.13 5.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.713 0.768 . . . . 0.77 111.563 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.15 144.67 36.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.29 -1.323 . . . . 0.68 111.358 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.444 HG23 ' HG3' ' A' ' 61' ' ' GLU . 7.1 tp -53.38 -43.49 51.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.602 -0.726 . . . . 0.69 111.478 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.444 ' HG3' HG23 ' A' ' 60' ' ' ILE . 45.6 mt-10 -71.34 -41.65 69.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.7 -0.682 . . . . 2.2 111.489 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -79.44 -8.37 59.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.051 -0.522 . . . . 1.98 111.036 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.412 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.7 tp10 -92.21 -41.16 10.58 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.288 -0.415 . . . . 2.09 110.793 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.522 ' HA ' HD12 ' A' ' 52' ' ' ILE . 1.7 p -113.9 173.13 6.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.6 111.185 -172.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -125.02 49.91 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.296 0.57 . . . . 2.32 109.563 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 57.7 m-80 -143.24 -170.3 3.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.836 -0.62 . . . . 1.06 110.43 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 10.4 m -79.62 130.76 66.74 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.888 0.375 . . . . 0.34 111.142 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -79.03 120.13 4.51 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.719 2.279 . . . . 0.45 111.264 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 86' ' ' PRO . 68.1 p -129.38 148.5 51.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.199 -0.455 . . . . 0.31 109.874 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.688 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 72.9 m -113.59 111.51 21.99 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.458 0.647 . . . . 1.26 110.128 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.9 m -86.56 152.59 22.49 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.962 -1.017 . . . . 0.29 111.036 -172.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 7.3 tt0 -91.53 -22.28 20.44 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.255 -0.884 . . . . 1.53 109.628 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.472 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 33.9 t0 -158.99 161.33 36.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.739 -1.208 . . . . 1.26 107.739 170.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.563 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -139.21 149.37 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 118.362 0.528 . . . . 1.07 110.793 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 8.2 tp10 -111.36 160.2 17.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.439 -0.8 . . . . 1.87 109.764 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 60.49 -151.93 0.4 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.255 -0.43 . . . . 1.94 109.936 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.86 10.33 2.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.001 0.429 . . . . 2.12 110.301 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 113.27 24.03 4.94 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.895 -0.669 . . . . 0.51 112.487 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.48 -21.93 25.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 1.1 111.432 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 88.4 t -127.04 113.05 30.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.277 -0.638 . . . . 0.33 109.277 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.687 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -108.0 142.76 15.97 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.697 -1.24 . . . . 0.26 112.869 -173.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.602 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -95.75 118.17 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 109.69 -0.485 . . . . 0.3 109.69 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 93.8 m-20 60.21 42.93 14.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.279 -0.873 . . . . 0.34 110.804 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.687 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.8 m -78.0 87.71 4.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.669 -0.696 . . . . 0.81 109.919 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.2 m -83.07 134.22 46.69 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.377 -0.829 . . . . 0.44 110.256 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HA ' HG22 ' A' ' 69' ' ' THR . 13.9 Cg_endo -70.49 118.56 5.76 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.97 2.446 . . . . 0.39 111.59 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.772 HG21 ' SG ' ' A' ' 11' ' ' CYS . 5.5 pt -88.13 140.58 30.72 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.355 -0.839 . . . . 0.57 111.671 -173.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.1 Cg_exo . . . . . 0 N--CA 1.455 -0.772 0 C-N-CA 123.374 2.716 . . . . 1.05 111.707 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 83.9 m95 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.034 0.445 . . . . 0.81 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -85.11 109.54 18.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.732 -0.667 . . . . 2.73 110.45 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 m -80.42 27.45 0.34 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.864 -0.607 . . . . 1.75 111.021 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -53.88 -22.68 10.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.747 -0.66 . . . . 3.24 112.12 -177.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.424 ' N ' ' HD2' ' A' ' 7' ' ' LYS . 6.9 t -73.39 -13.08 61.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.274 -0.421 . . . . 2.05 111.232 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.06 17.42 75.63 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.906 -0.664 . . . . 0.88 112.452 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -102.63 -9.86 19.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.89 0.33 . . . . 1.72 111.89 -172.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.708 ' SG ' HG21 ' A' ' 87' ' ' ILE . 2.7 m -139.65 140.32 36.89 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.267 -0.573 . . . . 1.19 111.456 -171.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -95.33 -30.6 13.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 1.66 111.867 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.7 p -80.53 -29.94 37.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.663 0.616 . . . . 0.52 112.663 -169.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.55 -4.27 85.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.503 -0.856 . . . . 0.43 112.304 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HD3' HG23 ' A' ' 74' ' ' VAL . 63.2 mttp -90.69 87.86 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.425 . . . . 1.64 109.99 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.813 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 8.1 mp -96.13 139.55 32.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.698 -0.683 . . . . 0.55 109.708 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.616 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -148.39 144.71 27.67 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.894 0.378 . . . . 0.29 110.389 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 86.1 m -89.9 99.54 12.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.131 0.491 . . . . 0.74 109.698 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 83.7 m -114.41 164.69 13.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.546 . . . . 0.5 112.028 -165.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -102.15 108.34 19.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.842 -0.617 . . . . 1.65 109.516 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -77.8 0.62 23.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.298 -0.41 . . . . 0.52 111.19 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -101.13 -7.3 23.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.172 -0.677 . . . . 2.2 109.172 175.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 35.6 mtpt -113.3 107.21 15.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.262 -0.881 . . . . 2.6 110.328 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -100.34 154.8 18.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.827 -0.624 . . . . 2.17 110.789 -174.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.449 HG22 ' CD ' ' A' ' 48' ' ' GLN . 11.1 t -120.78 150.3 23.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.608 -0.724 . . . . 0.59 109.782 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.08 32.89 0.27 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.974 -0.557 . . . . 2.83 111.684 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 31.12 115.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.718 1.607 . . . . 4.07 114.752 174.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -123.92 -76.83 0.59 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.477 -0.783 . . . . 2.46 111.162 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 p -142.28 -169.71 3.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.325 -0.852 . . . . 2.0 111.211 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.1 -161.04 21.95 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.232 -1.147 . . . . 1.39 110.232 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -99.57 -46.34 5.49 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.709 0.755 . . . . 3.06 110.71 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.101 0.477 . . . . 2.44 110.844 -179.144 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' A' ' 82' ' ' ILE . 23.1 mt-30 . . . . . 0 C--O 1.235 0.301 0 CA-C-O 121.308 0.575 . . . . 1.4 111.406 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.85 109.19 27.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.14 -0.936 . . . . 1.37 109.745 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -102.28 122.57 44.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.675 -0.693 . . . . 0.3 110.494 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' A' ' 84' ' ' CYS . 14.2 pt -128.66 153.83 38.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.993 -0.549 . . . . 0.23 110.641 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.449 ' CD ' HG22 ' A' ' 25' ' ' VAL . 2.5 mp0 -70.29 141.62 52.35 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.832 -0.622 . . . . 2.38 109.503 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.651 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 2.1 t -137.78 164.53 28.67 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.073 -0.512 . . . . 1.15 110.491 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.0 t -160.81 128.03 4.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.524 0.678 . . . . 0.6 110.652 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -121.06 125.94 48.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.674 -0.694 . . . . 2.08 110.976 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 64' ' ' CYS . 16.7 mt -63.88 139.25 97.61 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.385 -0.825 . . . . 0.95 109.836 174.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 52' ' ' ILE . 60.0 Cg_exo -34.25 121.13 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 124.788 3.659 . . . . 0.95 113.929 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.8 mt -65.48 119.71 11.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.038 -0.983 . . . . 1.67 112.261 -171.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.446 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 84.5 mt -99.73 122.89 43.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.989 -0.745 . . . . 1.58 108.989 166.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.669 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -72.87 130.18 35.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.073 0.463 . . . . 2.11 110.2 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.05 2.97 60.64 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.932 -0.651 . . . . 1.03 111.832 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -103.15 153.98 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.799 0.809 . . . . 0.77 111.732 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.18 130.52 36.31 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.306 -1.316 . . . . 0.68 109.815 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 61' ' ' GLU . 10.7 tt -50.77 -37.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.238 -0.892 . . . . 0.69 112.035 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.447 ' N ' HG23 ' A' ' 60' ' ' ILE . 6.6 mt-10 -62.61 -35.23 78.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.087 -0.96 . . . . 2.2 111.04 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.85 -22.21 19.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.904 -0.589 . . . . 1.98 109.999 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.82 -41.16 78.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.751 . . . . 2.09 110.954 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.57 ' HA ' HD12 ' A' ' 52' ' ' ILE . 4.7 p -114.65 167.85 10.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.997 0.427 . . . . 0.6 111.308 -173.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -121.94 41.42 3.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 2.32 110.284 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.553 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 57.1 m-80 -131.52 -169.87 2.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.481 -0.781 . . . . 1.06 109.666 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 11.2 m -83.17 127.1 70.36 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-O 120.933 0.397 . . . . 0.34 110.877 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.23 119.77 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.735 2.29 . . . . 0.45 111.294 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.427 ' OG1' ' HB3' ' A' ' 84' ' ' CYS . 44.2 p -128.37 151.16 49.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.318 -0.401 . . . . 0.31 109.93 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.813 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 72.0 m -113.68 119.32 37.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.268 0.556 . . . . 1.26 110.16 175.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.2 m -97.57 149.37 22.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.064 -0.971 . . . . 0.29 111.298 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 9.3 mt-10 -85.06 -16.65 39.96 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.585 -1.188 . . . . 1.53 109.728 175.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 47.3 t0 -167.79 156.11 9.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.921 -1.036 . . . . 1.26 108.298 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.566 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -143.5 135.92 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 117.929 0.331 . . . . 1.07 110.566 178.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 10.6 tp10 -98.18 157.54 16.09 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.156 -0.475 . . . . 1.87 110.01 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 61.31 -151.81 0.38 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.107 0.563 . . . . 1.94 109.93 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -82.38 21.91 0.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.112 0.482 . . . . 2.12 110.383 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.651 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 106.64 22.72 7.55 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.814 -0.708 . . . . 0.51 112.874 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.5 mm? -80.1 -26.67 39.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.784 0.292 . . . . 1.1 111.475 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 94.5 t -130.56 112.62 23.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.939 -0.393 . . . . 0.33 109.939 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.659 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -107.21 143.62 15.87 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.136 -1.03 . . . . 0.26 112.651 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -101.89 120.62 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.327 -0.619 . . . . 0.3 109.327 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 98.8 m-20 62.06 48.01 5.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.671 -0.695 . . . . 0.34 110.598 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.659 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 56.8 m -85.59 93.71 8.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.58 -0.736 . . . . 0.81 110.228 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.2 m -82.09 127.81 70.34 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.994 -0.548 . . . . 0.44 110.311 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.99 113.86 2.37 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.794 2.329 . . . . 0.39 111.579 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.708 HG21 ' SG ' ' A' ' 11' ' ' CYS . 9.1 pt -89.64 146.74 36.24 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.724 -0.671 . . . . 0.57 111.156 -175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 14.9 Cg_exo . . . . . 0 N--CA 1.46 -0.454 0 C-N-CA 123.225 2.617 . . . . 1.05 112.24 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 90.2 m95 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.128 0.49 . . . . 0.81 111.235 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.605 ' OE1' ' HA ' ' A' ' 59' ' ' ALA . 24.7 mp0 -70.91 107.38 4.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.384 -0.826 . . . . 2.73 111.072 -176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 t -111.72 26.14 10.93 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.016 -0.735 . . . . 1.75 109.016 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -55.04 -33.9 63.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.934 -1.03 . . . . 3.24 111.541 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.7 t -85.04 3.81 36.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.811 0.339 . . . . 2.05 111.461 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.3 18.44 69.05 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.389 -0.91 . . . . 0.88 112.558 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.0 p -70.27 -32.05 69.7 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.759 0.651 . . . . 1.72 112.759 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.2 t -129.74 144.1 51.13 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.099 0.476 . . . . 1.19 111.365 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.409 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.2 p30 -91.21 -24.91 19.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.961 -0.563 . . . . 1.66 111.341 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.409 HG23 ' OD1' ' A' ' 12' ' ' ASN . 56.3 p -98.21 -30.56 12.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.076 0.465 . . . . 0.52 111.349 -177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.21 0.06 59.97 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.832 -0.699 . . . . 0.43 111.396 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -91.61 88.46 6.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.752 0.31 . . . . 1.64 110.401 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 69' ' ' THR . 8.1 mp -96.83 151.4 19.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.694 -0.484 . . . . 0.55 109.694 175.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -160.26 144.66 14.4 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.744 0.307 . . . . 0.29 110.85 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 1.2 m -80.13 97.63 6.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.854 -0.612 . . . . 0.74 109.923 173.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 84.1 m -113.13 160.59 18.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.114 -0.494 . . . . 0.5 110.82 -172.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.01 116.25 31.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.705 -0.48 . . . . 1.65 109.705 173.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.5 p -76.44 -8.66 57.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.089 0.471 . . . . 0.52 111.227 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -93.85 -15.97 24.53 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.021 0.915 . . . . 2.2 108.727 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -102.5 110.33 22.23 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.008 -1.451 . . . . 2.6 110.707 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.4 OUTLIER -103.08 163.75 12.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.281 -0.418 . . . . 2.17 110.992 -178.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.515 HG22 ' OE1' ' A' ' 48' ' ' GLN . 23.5 t -116.04 150.05 18.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.002 -0.74 . . . . 0.59 109.002 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -83.68 -17.0 42.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.39 0.515 . . . . 2.83 112.39 -171.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' H ' HG12 ' A' ' 25' ' ' VAL . 32.6 mtmm -114.02 156.76 23.51 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.277 -0.268 . . . . 4.07 110.277 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 p -121.42 12.68 10.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.79 0.329 . . . . 2.46 111.405 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 p -72.97 142.75 47.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.34 . . . . 2.0 110.84 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.25 165.23 25.24 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.583 -0.818 . . . . 1.39 112.803 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -81.76 -46.21 14.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.741 0.305 . . . . 3.06 111.44 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 . . . . . 0 C--N 1.324 -0.525 0 CA-C-N 116.386 -0.37 . . . . 2.44 111.307 -177.75 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.569 ' HB3' HG23 ' A' ' 82' ' ' ILE . 35.3 mt-30 . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.948 0.404 . . . . 1.4 110.839 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.27 116.54 49.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.275 -0.42 . . . . 1.37 110.112 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -105.62 117.48 34.13 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.833 -0.621 . . . . 0.3 111.138 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 13.8 pt -106.38 150.21 9.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.074 -0.512 . . . . 0.23 110.241 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.515 ' OE1' HG22 ' A' ' 25' ' ' VAL . 13.9 tp60 -76.63 116.0 16.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.599 -0.728 . . . . 2.38 109.342 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.7 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 2.2 t -110.1 169.43 8.74 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.283 -0.872 . . . . 1.15 110.235 -172.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.0 t -160.19 128.06 4.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.646 0.736 . . . . 0.6 110.808 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -120.88 114.1 21.08 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.518 -0.764 . . . . 2.08 111.059 -176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.72 133.22 72.27 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.395 -0.821 . . . . 0.95 109.46 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -38.45 102.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 124.578 3.519 . . . . 0.95 113.01 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.44 135.19 51.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.408 -0.815 . . . . 1.67 112.308 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.02 135.0 35.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.167 -0.924 . . . . 1.58 109.372 171.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.4 mt -66.6 129.63 31.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.23 0.538 . . . . 2.11 110.305 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.26 -15.66 58.8 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.224 -0.898 . . . . 1.03 111.832 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -89.7 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.586 0.708 . . . . 0.77 111.649 -177.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.605 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . . . -89.8 146.46 24.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.461 -1.245 . . . . 0.68 111.475 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 61' ' ' GLU . 5.0 tp -49.89 -44.05 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.621 -0.718 . . . . 0.69 110.724 173.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 60' ' ' ILE . 6.4 mm-40 -68.91 -16.84 63.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.431 -0.804 . . . . 2.2 111.986 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -110.46 -10.87 14.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.318 -0.401 . . . . 1.98 111.3 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.4 tp10 -93.62 -38.78 11.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.183 0.516 . . . . 2.09 110.595 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.2 p -131.38 146.92 52.49 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.913 -0.585 . . . . 0.6 110.208 -173.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -121.93 64.56 0.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.68 0.752 . . . . 2.32 111.064 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 36.5 m-80 -123.23 -155.43 0.65 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.231 -1.396 . . . . 1.06 107.231 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -86.05 121.17 72.9 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 119.418 -0.913 . . . . 0.34 110.048 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.11 130.25 9.23 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.646 2.231 . . . . 0.45 110.671 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 84' ' ' CYS . 81.1 p -131.65 155.11 48.15 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.415 -0.357 . . . . 0.31 111.374 -175.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.2 t -103.27 110.48 22.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.684 -0.858 . . . . 1.26 108.684 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.7 m -94.84 145.28 25.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.403 0.621 . . . . 0.29 110.666 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 2.6 tt0 -79.57 -18.63 51.29 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.325 -0.852 . . . . 1.53 109.235 176.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -170.13 156.3 5.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.135 -0.939 . . . . 1.26 109.178 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.542 HG12 ' HA2' ' A' ' 78' ' ' GLY . 1.4 t -143.07 134.62 23.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.331 -0.248 . . . . 1.07 110.331 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 41.4 tt0 -104.17 158.8 16.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.47 -0.332 . . . . 1.87 110.693 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 4.4 t70 66.58 -148.19 0.19 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.183 0.593 . . . . 1.94 109.672 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.85 11.83 2.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.011 0.434 . . . . 2.12 110.442 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.7 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 108.7 23.94 6.32 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.916 -0.659 . . . . 0.51 112.155 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 mt -82.93 -23.6 33.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.819 0.342 . . . . 1.1 111.197 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 60.9 t -122.79 106.37 17.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.688 -0.486 . . . . 0.33 109.688 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -106.56 133.83 11.84 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.325 -0.94 . . . . 0.26 111.954 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.569 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -96.74 121.12 46.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 110.127 -0.323 . . . . 0.3 110.127 -177.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 82.7 m-20 60.62 35.32 19.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.553 -0.748 . . . . 0.34 111.124 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.615 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 67.3 m -69.82 95.33 0.89 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.607 -0.724 . . . . 0.81 110.702 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 30.7 m -87.56 126.89 60.47 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.951 -0.568 . . . . 0.44 110.009 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 36.2 Cg_exo -59.13 128.96 29.57 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.979 2.452 . . . . 0.39 112.321 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 pt -100.94 147.87 34.29 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.044 -0.526 . . . . 0.57 110.799 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 C--O 1.235 0.338 0 C-N-CA 123.009 2.473 . . . . 1.05 112.086 179.155 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.319 0.58 . . . . 0.81 112.023 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -65.27 113.84 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.936 -1.029 . . . . 2.73 110.911 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 m -88.5 26.82 1.38 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.9 -0.591 . . . . 1.75 110.445 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -53.74 -52.52 59.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.489 -0.778 . . . . 3.24 112.502 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -69.53 -24.46 63.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.2 -0.455 . . . . 2.05 111.846 -172.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.03 16.01 79.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.906 -0.664 . . . . 0.88 111.742 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.472 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 5.4 p -74.45 -30.51 61.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.301 0.482 . . . . 1.72 112.301 -173.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.6 t -105.2 142.29 35.24 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.004 0.431 . . . . 1.19 111.181 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.553 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.7 p30 -92.18 -27.35 17.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 1.66 111.784 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.553 HG23 ' OD1' ' A' ' 12' ' ' ASN . 11.0 p -100.34 -30.81 11.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.873 0.368 . . . . 0.52 111.973 -175.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.03 -6.36 53.93 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.528 -0.844 . . . . 0.43 112.26 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HD3' HG13 ' A' ' 74' ' ' VAL . 89.2 mttt -88.35 88.73 7.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 1.64 110.48 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 60' ' ' ILE . 9.5 mp -92.99 127.01 38.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.454 -0.794 . . . . 0.55 110.171 176.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.534 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -142.53 153.09 43.28 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.786 0.327 . . . . 0.29 110.383 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 60.4 m -89.57 97.67 11.33 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.184 -0.672 . . . . 0.74 109.184 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 71.4 m -113.51 153.46 28.69 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.314 -0.403 . . . . 0.5 111.19 -169.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.65 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 8.0 t70 -92.51 119.35 31.9 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.077 -0.712 . . . . 1.65 109.077 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.8 p -80.41 -7.78 59.26 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.775 0.322 . . . . 0.52 111.706 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -104.59 -15.94 15.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 2.2 110.127 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.65 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 36.6 mtmt -103.35 129.04 50.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.709 -0.678 . . . . 2.6 110.779 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -116.55 162.35 17.74 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.912 -1.04 . . . . 2.17 111.243 -175.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 27' ' ' LYS . 13.0 t -113.32 149.97 15.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.847 -0.615 . . . . 0.59 109.798 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -84.51 5.25 28.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.003 -0.544 . . . . 2.83 111.288 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' H ' HG12 ' A' ' 25' ' ' VAL . 29.9 mmmt -132.24 119.72 21.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.439 -0.346 . . . . 4.07 110.215 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -126.28 80.27 1.91 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.251 -0.431 . . . . 2.46 110.218 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.8 m -118.26 -54.91 2.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.035 0.445 . . . . 2.0 111.317 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.89 155.24 31.62 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.543 -0.753 . . . . 1.39 111.787 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -101.18 -50.37 3.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.05 0.452 . . . . 3.06 110.189 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.444 -0.727 0 CA-C-N 115.759 -0.655 . . . . 2.44 109.895 -176.253 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.661 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.7 mt-30 . . . . . 0 CA--C 1.517 -0.294 0 CA-C-O 121.028 0.442 . . . . 1.4 110.358 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 83' ' ' ASN . 7.2 p -95.14 105.51 17.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.693 0.758 . . . . 1.37 110.825 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -96.59 101.73 13.39 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.154 -0.93 . . . . 0.3 110.25 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 84' ' ' CYS . 17.5 pt -104.13 150.0 7.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.935 -0.575 . . . . 0.23 110.311 177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -74.77 126.6 31.26 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.057 -0.72 . . . . 2.38 109.057 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.534 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 1.8 t -117.0 160.72 20.51 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.342 -0.845 . . . . 1.15 110.522 -171.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 2.5 t -150.53 121.39 7.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.335 0.588 . . . . 0.6 110.427 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.4 HE21 HD12 ' A' ' 60' ' ' ILE . 5.0 tm0? -118.87 111.2 18.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.499 0.666 . . . . 2.08 110.479 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 64' ' ' CYS . 68.0 mt -71.11 133.8 85.6 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 114.859 -1.064 . . . . 0.95 109.979 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 52' ' ' ILE . 52.3 Cg_exo -34.3 130.58 0.18 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 124.693 3.595 . . . . 0.95 114.138 -173.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.57 HD12 ' H ' ' A' ' 54' ' ' LEU . 2.4 mp -84.29 132.85 34.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.807 -1.088 . . . . 1.67 112.584 -166.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.43 133.37 40.94 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.424 -0.954 . . . . 1.58 108.424 165.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.677 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -66.09 132.35 31.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.164 0.507 . . . . 2.11 110.893 -172.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.18 4.25 84.17 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.37 -0.832 . . . . 1.03 113.101 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -96.33 152.01 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.724 0.773 . . . . 0.77 111.859 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.54 143.33 27.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.339 -1.3 . . . . 0.68 111.172 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.42 HG21 HD23 ' A' ' 16' ' ' LEU . 8.4 tp -55.55 -32.32 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.005 -0.998 . . . . 0.69 111.83 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.79 -8.62 55.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 2.2 111.56 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.46 -27.15 11.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.403 0.621 . . . . 1.98 109.608 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.8 tp10 -72.62 -40.49 66.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.211 -0.904 . . . . 2.09 111.234 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.422 ' HA ' HD12 ' A' ' 52' ' ' ILE . 8.8 p -116.56 153.49 32.12 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.69 -0.404 . . . . 0.6 110.954 -173.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -99.69 33.17 2.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.663 0.745 . . . . 2.32 109.689 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 51.9 m-80 -117.94 -165.32 1.09 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.494 -0.776 . . . . 1.06 109.512 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 14.2 m -93.77 122.23 62.75 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-O 121.335 0.588 . . . . 0.34 112.012 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.41 117.26 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.482 2.788 . . . . 0.45 111.115 172.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.9 p -129.32 146.99 51.11 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.556 -0.458 . . . . 0.31 111.405 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 25.1 t -98.81 111.21 23.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.852 -0.613 . . . . 1.26 109.373 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.4 m -96.94 135.15 39.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.056 0.455 . . . . 0.29 110.626 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 6.5 tt0 -72.28 -20.75 61.46 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.449 0.642 . . . . 1.53 109.487 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -163.17 166.44 23.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.451 -0.795 . . . . 1.26 109.112 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.465 HG13 ' HD3' ' A' ' 15' ' ' LYS . 14.7 m -138.73 157.45 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 110.055 -0.35 . . . . 1.07 110.055 177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 80' ' ' VAL . 37.1 mt-10 -126.07 164.91 19.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.408 -0.36 . . . . 1.87 110.066 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 57.68 -150.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.548 -0.751 . . . . 1.94 109.396 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.97 22.88 0.74 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.11 0.481 . . . . 2.12 110.993 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 101.41 21.81 11.15 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.902 -0.666 . . . . 0.51 112.115 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.5 mm? -79.15 -22.55 44.9 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.329 0.585 . . . . 1.1 110.252 176.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 75' ' ' GLU . 61.1 t -122.49 117.91 53.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.606 -0.725 . . . . 0.33 109.472 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -110.35 134.78 12.41 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.142 -1.028 . . . . 0.26 111.939 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.661 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -98.12 121.62 48.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.198 -0.297 . . . . 0.3 110.198 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.705 ' HA ' HG12 ' A' ' 45' ' ' VAL . 94.5 m-20 58.4 54.91 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.867 -0.606 . . . . 0.34 110.904 174.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.536 ' HB2' HD11 ' A' ' 47' ' ' ILE . 47.8 m -91.62 110.73 22.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.295 -0.866 . . . . 0.81 110.944 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 47.3 m -96.16 128.76 35.77 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.982 -0.554 . . . . 0.44 110.166 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 39.4 Cg_exo -62.46 119.96 7.29 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.829 2.353 . . . . 0.39 110.947 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.0 pt -99.8 139.77 21.06 Favored Pre-proline 0 N--CA 1.442 -0.874 0 CA-C-N 116.319 -0.4 . . . . 0.57 111.718 -173.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.6 Cg_exo . . . . . 0 N--CA 1.463 -0.299 0 C-N-CA 123.251 2.634 . . . . 1.05 112.277 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 78.4 m95 . . . . . 0 CA--C 1.516 -0.36 0 N-CA-C 110.154 -0.313 . . . . 0.81 110.154 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.35 110.11 2.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.912 -0.585 . . . . 2.73 109.983 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -102.67 26.23 8.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.889 -0.596 . . . . 1.75 110.57 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -16.24 62.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.684 -0.689 . . . . 3.24 111.066 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 10' ' ' SER . 8.1 t -69.47 -14.51 62.92 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.101 -0.5 . . . . 2.05 110.684 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.36 79.95 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.133 -0.556 . . . . 0.88 112.617 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.4 ' H ' HG23 ' A' ' 8' ' ' THR . 5.6 m -96.71 -10.32 27.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 111.896 0.332 . . . . 1.72 111.896 -173.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.8 t -139.46 141.87 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.613 -0.435 . . . . 1.19 110.83 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.45 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.4 p30 -93.41 -30.22 15.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 1.66 112.157 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.45 HG23 ' OD1' ' A' ' 12' ' ' ASN . 23.9 p -89.98 -30.67 17.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.138 0.422 . . . . 0.52 112.138 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.93 -7.39 67.43 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.527 -0.844 . . . . 0.43 112.068 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.691 ' HD3' HG23 ' A' ' 74' ' ' VAL . 75.5 mttt -87.35 88.37 7.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.352 0.596 . . . . 1.64 110.043 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' A' ' 60' ' ' ILE . 9.0 mp -97.69 122.55 40.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.341 -0.845 . . . . 0.55 109.691 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.33 146.54 50.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.038 0.447 . . . . 0.29 111.189 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 50' ' ' THR . 62.9 m -81.38 109.1 15.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.719 -0.845 . . . . 0.74 108.719 172.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 72.3 m -126.53 153.38 45.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.216 0.531 . . . . 0.5 112.114 -169.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.62 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 13.0 t70 -99.6 113.22 25.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.098 -1.075 . . . . 1.65 108.098 175.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.0 p -77.06 -10.1 59.16 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.352 0.871 . . . . 0.52 113.352 -169.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -106.48 -3.83 20.47 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.884 0.85 . . . . 2.2 109.153 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -93.07 104.8 16.97 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.951 -1.477 . . . . 2.6 109.907 175.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.76 162.43 12.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.283 0.563 . . . . 2.17 111.705 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -123.61 143.22 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.225 -0.898 . . . . 0.59 108.764 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -86.68 -31.4 21.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.277 -0.419 . . . . 2.83 110.988 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -87.7 119.67 28.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.228 -0.442 . . . . 4.07 110.414 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -93.63 54.92 2.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.471 0.653 . . . . 2.46 109.584 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.1 m -92.12 132.92 36.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.378 -0.828 . . . . 2.0 110.192 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.62 164.88 16.57 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.502 -0.856 . . . . 1.39 112.515 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -100.63 -47.87 4.71 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 122.518 0.327 . . . . 3.06 110.143 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 120.658 0.266 . . . . 2.44 110.354 177.252 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' A' ' 82' ' ' ILE . 34.2 mt-30 . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.955 0.407 . . . . 1.4 110.897 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.17 99.92 10.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.764 -0.653 . . . . 1.37 109.629 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -99.33 108.06 20.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.447 -0.797 . . . . 0.3 110.478 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 pt -118.52 159.47 18.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.836 -0.62 . . . . 0.23 110.052 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -77.56 142.04 39.23 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 122.12 0.962 . . . . 2.38 110.848 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 39.4 m -140.94 164.64 29.71 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.516 -1.675 . . . . 1.15 109.908 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 7.9 t -161.01 136.1 7.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.164 -0.471 . . . . 0.6 109.806 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -120.36 110.28 16.35 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.109 0.48 . . . . 2.08 110.447 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.403 HG23 ' HD2' ' A' ' 53' ' ' PRO . 61.9 mt -63.71 131.11 94.79 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.503 -0.771 . . . . 0.95 109.517 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HD2' HG23 ' A' ' 52' ' ' ILE . 50.4 Cg_exo -32.83 102.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.771 3.647 . . . . 0.95 113.867 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 pp -70.03 135.58 49.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.101 -0.954 . . . . 1.67 112.636 -171.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.3 137.74 32.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.349 -0.842 . . . . 1.58 109.333 170.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.8 mp -71.39 131.83 34.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.405 -0.591 . . . . 2.11 109.405 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.77 -6.95 59.0 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.598 -0.728 . . . . 1.03 111.687 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.47 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -106.99 152.69 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.642 0.734 . . . . 0.77 111.803 179.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.4 152.7 20.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.458 -1.247 . . . . 0.68 111.359 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 16' ' ' LEU . 6.2 tp -56.81 -40.68 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.227 0.611 . . . . 0.69 112.1 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -11.19 56.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.398 -0.365 . . . . 2.2 111.598 -172.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -95.56 -34.3 12.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.383 -0.599 . . . . 1.98 109.383 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.47 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 9.6 tp10 -67.55 -40.23 84.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.138 -0.937 . . . . 2.09 110.711 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.56 148.36 41.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.293 -0.412 . . . . 0.6 109.961 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -99.79 45.7 0.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.874 0.845 . . . . 2.32 109.667 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 46.3 m-80 -122.11 -172.36 2.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.103 -0.953 . . . . 1.06 108.982 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 m -85.93 126.12 66.59 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-O 121.167 0.508 . . . . 0.34 110.552 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -83.06 136.07 7.81 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.079 2.519 . . . . 0.45 111.105 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 86' ' ' PRO . 67.8 p -133.8 150.91 51.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.794 0.33 . . . . 0.31 111.147 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 44.0 t -95.37 115.46 27.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.727 -0.842 . . . . 1.26 108.727 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.91 135.65 45.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.467 0.651 . . . . 0.29 110.829 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 9.4 mt-10 -70.14 -19.42 63.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.946 -1.025 . . . . 1.53 109.837 175.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -169.68 161.44 9.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.909 -1.041 . . . . 1.26 108.616 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.691 HG23 ' HD3' ' A' ' 15' ' ' LYS . 1.8 t -145.28 136.9 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.635 -0.505 . . . . 1.07 109.635 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.84 160.85 14.02 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.361 -0.381 . . . . 1.87 110.108 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 t70 62.34 -153.34 0.35 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.348 -0.612 . . . . 1.94 109.348 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.81 23.58 0.43 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.095 0.474 . . . . 2.12 110.705 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.571 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 105.38 23.58 7.54 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.889 -0.672 . . . . 0.51 112.423 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -78.66 -33.04 47.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.865 0.364 . . . . 1.1 111.243 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.69 108.29 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.319 -0.4 . . . . 0.33 110.036 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.721 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -97.16 140.04 14.83 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.064 -1.065 . . . . 0.26 112.527 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -102.97 116.8 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 109.52 -0.548 . . . . 0.3 109.52 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 96.5 m-20 62.58 41.59 9.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.428 -0.805 . . . . 0.34 110.773 175.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.721 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 60.5 m -80.42 110.9 16.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.81 111.086 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 m -103.85 132.21 21.25 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.154 -0.475 . . . . 0.44 110.13 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 69' ' ' THR . 9.4 Cg_endo -65.41 129.13 21.82 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.041 2.494 . . . . 0.39 112.1 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 11.7 pt -105.73 146.61 33.18 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.908 -0.587 . . . . 0.57 111.776 -173.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 11.4 Cg_exo . . . . . 0 N--CA 1.461 -0.397 0 C-N-CA 123.286 2.658 . . . . 1.05 112.04 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.8 m95 . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.208 0.528 . . . . 0.81 111.773 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.89 115.77 20.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.286 -0.87 . . . . 2.73 110.202 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.2 m -88.13 23.57 2.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.236 -0.438 . . . . 1.75 110.868 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -46.98 -49.06 21.4 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.557 -0.747 . . . . 3.24 112.246 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -62.76 -21.33 65.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.676 -0.693 . . . . 2.05 111.976 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.97 16.26 76.53 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.276 -0.488 . . . . 0.88 113.336 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 m -85.35 -8.93 58.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.161 0.43 . . . . 1.72 112.161 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.641 ' SG ' HG21 ' A' ' 87' ' ' ILE . 1.8 m -132.32 141.05 48.8 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.499 -0.481 . . . . 1.19 111.373 -170.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -92.8 -30.45 15.47 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.147 0.425 . . . . 1.66 112.147 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.4 p -92.15 -31.98 15.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.165 0.507 . . . . 0.52 111.364 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.78 4.46 67.45 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.58 -0.819 . . . . 0.43 111.99 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 63.7 mttp -87.34 87.8 7.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.069 0.462 . . . . 1.64 109.865 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.855 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 8.7 mp -94.1 134.96 35.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.872 -0.603 . . . . 0.55 109.975 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.512 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -149.01 146.57 27.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.914 0.388 . . . . 0.29 110.299 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 98.2 m -88.93 100.82 13.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.339 0.59 . . . . 0.74 110.019 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 79.9 m -111.02 158.92 18.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.723 -0.671 . . . . 0.5 111.484 -168.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -99.04 107.76 20.25 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.166 -0.679 . . . . 1.65 109.166 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.8 p -70.68 -13.18 61.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.784 -0.643 . . . . 0.52 111.162 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -95.51 -10.88 28.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.395 0.617 . . . . 2.2 109.674 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -115.04 140.37 49.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.224 -0.898 . . . . 2.6 110.113 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.626 ' HD3' HG22 ' A' ' 47' ' ' ILE . 44.5 mmtm -124.51 155.19 39.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.291 -0.868 . . . . 2.17 111.072 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.562 HG22 ' OE1' ' A' ' 48' ' ' GLN . 3.1 t -113.69 149.17 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.112 -0.699 . . . . 0.59 109.112 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -93.81 20.96 6.99 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.048 0.451 . . . . 2.83 110.704 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 30.1 mmmt -126.77 132.62 51.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.027 -0.533 . . . . 4.07 110.649 -178.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -114.48 42.82 2.03 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.709 -0.849 . . . . 2.46 108.709 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -108.36 168.12 9.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.785 -1.098 . . . . 2.0 111.601 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.457 ' HA3' ' OD2' ' A' ' 73' ' ' ASP . . . 170.91 -149.18 12.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.08 -0.581 . . . . 1.39 112.217 -176.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.81 -51.55 6.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.037 0.446 . . . . 3.06 110.92 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.973 -0.558 . . . . 2.44 109.738 -179.3 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.566 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 19.3 mt-30 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.078 0.466 . . . . 1.4 110.762 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 83' ' ' ASN . 13.5 p -115.35 123.8 71.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.556 -0.747 . . . . 1.37 109.965 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -105.85 100.15 9.71 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.595 -0.729 . . . . 0.3 110.38 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.626 HG22 ' HD3' ' A' ' 24' ' ' LYS . 20.1 pt -107.36 146.83 13.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.201 0.524 . . . . 0.23 110.489 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.562 ' OE1' HG22 ' A' ' 25' ' ' VAL . 17.9 tp60 -74.9 118.32 17.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.303 -0.862 . . . . 2.38 108.954 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.687 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 3.4 t -115.97 164.27 14.67 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.658 -0.701 . . . . 1.15 110.594 -171.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -162.42 131.98 4.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.174 0.511 . . . . 0.6 110.526 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -121.1 123.14 41.6 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.135 -0.484 . . . . 2.08 111.35 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 64' ' ' CYS . 45.9 mt -64.52 135.07 96.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.438 -0.801 . . . . 0.95 109.654 173.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.4 111.66 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.063 3.175 . . . . 0.95 112.593 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.68 141.91 31.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.821 -1.081 . . . . 1.67 112.769 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.404 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 7.8 mp -93.87 132.35 38.39 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.692 -0.855 . . . . 1.58 108.692 167.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.606 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.9 mp -67.11 131.85 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.225 0.536 . . . . 2.11 110.072 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.69 -5.89 56.99 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.493 -0.776 . . . . 1.03 112.017 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -98.62 150.5 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.739 0.781 . . . . 0.77 111.471 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.47 132.17 34.97 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.91 -1.495 . . . . 0.68 110.105 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.403 HG12 ' SG ' ' A' ' 18' ' ' CYS . 10.7 tt -53.96 -34.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.207 -0.906 . . . . 0.69 111.907 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -73.75 -18.13 61.02 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.942 -1.027 . . . . 2.2 111.494 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -110.99 4.8 19.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.188 0.518 . . . . 1.98 110.585 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -95.67 -40.35 9.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.436 0.636 . . . . 2.09 110.311 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.448 ' HA ' HD12 ' A' ' 52' ' ' ILE . 15.3 p -105.92 -176.4 3.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.869 -0.605 . . . . 0.6 110.667 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -127.56 35.84 4.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.372 0.606 . . . . 2.32 109.767 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 52.8 m-80 -135.01 -170.77 2.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 1.06 110.339 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 89.7 m -80.91 124.86 81.18 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 121.322 0.582 . . . . 0.34 111.996 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.76 115.52 2.97 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.393 2.728 . . . . 0.45 111.583 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -132.22 159.81 37.95 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.478 -0.564 . . . . 0.31 109.478 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.855 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 85.6 m -121.76 122.8 40.33 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.274 0.559 . . . . 1.26 109.982 174.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.466 ' HB2' HG22 ' A' ' 74' ' ' VAL . 37.8 m -100.92 143.12 31.45 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.107 -0.951 . . . . 0.29 110.627 -172.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 6.9 mm-40 -77.42 -17.35 58.2 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.673 -1.149 . . . . 1.53 109.613 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.457 ' OD2' ' HA3' ' A' ' 30' ' ' GLY . 4.3 t70 -165.04 155.61 14.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.076 -0.965 . . . . 1.26 108.889 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.51 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -149.75 130.54 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 110.207 -0.294 . . . . 1.07 110.207 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 30.5 tt0 -96.99 164.99 12.29 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.963 -0.384 . . . . 1.87 109.963 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 65.26 -154.25 0.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.401 -0.592 . . . . 1.94 109.401 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -72.63 2.48 6.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.54 0.686 . . . . 2.12 109.843 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.38 24.09 2.48 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.648 -0.705 . . . . 0.51 112.271 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 2.0 mm? -79.08 -29.76 43.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.689 0.255 . . . . 1.1 111.689 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG22 HG11 ' A' ' 25' ' ' VAL . 67.4 t -118.38 102.97 13.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.941 -0.304 . . . . 0.33 110.192 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.597 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -104.53 136.26 12.96 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.309 -0.948 . . . . 0.26 113.009 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -99.32 122.95 51.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.12 -0.54 . . . . 0.3 109.624 177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.716 ' HA ' HG12 ' A' ' 45' ' ' VAL . 70.8 m-20 60.45 48.0 8.15 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.457 0.473 . . . . 0.34 110.931 175.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.597 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 58.3 m -84.54 90.76 7.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.025 -0.534 . . . . 0.81 110.422 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.7 m -79.15 127.84 77.96 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.587 -0.733 . . . . 0.44 110.227 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.03 109.53 1.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.7 2.267 . . . . 0.39 110.737 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.641 HG21 ' SG ' ' A' ' 11' ' ' CYS . 12.0 pt -82.32 146.81 55.16 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.642 -0.708 . . . . 0.57 111.87 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 14.2 Cg_exo . . . . . 0 N--CA 1.457 -0.653 0 C-N-CA 123.249 2.632 . . . . 1.05 111.206 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.441 ' HH2' ' OE1' ' A' ' 63' ' ' GLU . 94.1 m95 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.563 0.22 . . . . 0.81 111.423 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -59.83 111.77 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 2.73 111.551 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -99.38 -19.92 16.76 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.729 -0.669 . . . . 1.75 111.034 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -17.33 64.7 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.938 0.399 . . . . 3.24 111.141 -177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -72.97 -30.14 63.6 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.081 -0.509 . . . . 2.05 110.983 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.81 16.99 74.82 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.886 -0.597 . . . . 0.88 112.308 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.464 ' HB2' HG21 ' A' ' 87' ' ' ILE . 28.5 p -85.89 -19.26 30.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.793 0.33 . . . . 1.72 111.724 -172.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.8 t -130.49 143.84 51.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.929 0.395 . . . . 1.19 111.033 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -91.13 -31.6 16.16 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.027 -0.533 . . . . 1.66 110.61 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.5 p -90.36 -30.57 17.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.578 -0.737 . . . . 0.52 111.002 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.58 2.22 61.71 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.632 -0.713 . . . . 0.43 111.913 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.505 ' HD3' HG23 ' A' ' 74' ' ' VAL . 94.0 mttt -91.55 87.59 6.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.046 0.451 . . . . 1.64 110.267 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 mp -97.63 100.22 11.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.857 -0.61 . . . . 0.55 109.845 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.48 145.53 40.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.06 0.457 . . . . 0.29 110.437 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 66' ' ' ASN . 84.6 m -80.57 108.19 14.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.795 -0.639 . . . . 0.74 109.646 172.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 62.5 m -126.91 153.65 45.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.885 -0.598 . . . . 0.5 111.368 -172.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -95.61 111.65 23.53 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.475 -0.784 . . . . 1.65 109.854 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.4 p -75.28 -11.06 59.98 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.28 0.562 . . . . 0.52 110.709 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -93.87 -8.96 38.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.555 0.693 . . . . 2.2 109.248 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -119.74 125.4 48.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.994 -1.003 . . . . 2.6 110.692 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -113.11 154.0 27.3 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.535 -1.212 . . . . 2.17 111.066 -170.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.577 HG22 ' NE2' ' A' ' 48' ' ' GLN . 9.6 t -115.13 148.75 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.862 -0.792 . . . . 0.59 108.862 175.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -98.34 29.74 3.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.908 0.385 . . . . 2.83 111.081 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -130.38 118.74 21.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.34 -0.391 . . . . 4.07 110.791 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.5 m -111.96 53.96 0.71 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 2.46 110.089 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.42 -93.91 0.26 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.615 -0.72 . . . . 2.0 111.647 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.03 155.18 15.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 1.39 111.859 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.73 -50.22 4.54 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.598 -0.354 . . . . 3.06 110.921 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--N 1.327 -0.388 0 C-N-CA 120.887 -0.325 . . . . 2.44 110.492 -176.06 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.605 ' HB3' HG23 ' A' ' 82' ' ' ILE . 35.2 mt-30 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 121.072 0.463 . . . . 1.4 110.441 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 83' ' ' ASN . 11.9 p -101.03 120.94 51.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.41 0.624 . . . . 1.37 110.77 -174.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -103.11 117.09 33.79 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.33 -0.85 . . . . 0.3 110.707 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.507 HD11 ' HB2' ' A' ' 84' ' ' CYS . 18.3 pt -124.31 159.78 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.23 -0.441 . . . . 0.23 109.96 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.577 ' NE2' HG22 ' A' ' 25' ' ' VAL . 3.5 mp0 -72.33 131.32 42.5 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.525 0.678 . . . . 2.38 110.704 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 72.3 m -125.09 149.15 48.13 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.395 -1.275 . . . . 1.15 110.071 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.2 t -161.31 132.96 5.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.105 0.479 . . . . 0.6 110.406 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -121.61 115.93 23.67 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.833 -0.622 . . . . 2.08 110.968 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.512 HG23 ' HD2' ' A' ' 53' ' ' PRO . 47.1 mt -58.09 139.31 83.55 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.153 -0.93 . . . . 0.95 109.12 173.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HD2' HG23 ' A' ' 52' ' ' ILE . 31.4 Cg_exo -34.11 127.77 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 124.262 3.308 . . . . 0.95 114.255 -173.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.71 136.09 57.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.357 -1.292 . . . . 1.67 112.365 -170.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.1 mt -110.13 132.02 54.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.291 -0.868 . . . . 1.58 109.512 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 mt -68.57 132.62 32.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.988 0.423 . . . . 2.11 110.728 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.59 24.94 71.35 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.429 -0.805 . . . . 1.03 112.951 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.488 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -113.41 150.51 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.781 0.801 . . . . 0.77 112.264 -178.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.5 145.64 31.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.126 -1.397 . . . . 0.68 111.457 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 tp -56.9 -42.08 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.698 -0.683 . . . . 0.69 111.547 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.83 -5.23 58.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.329 -0.396 . . . . 2.2 111.675 -173.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -106.69 -28.4 10.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.147 0.498 . . . . 1.98 109.914 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.488 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 32.6 tt0 -68.51 -37.66 80.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 2.09 111.191 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.415 ' HA ' HD12 ' A' ' 52' ' ' ILE . 1.8 p -113.0 178.23 4.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.092 -0.504 . . . . 0.6 109.979 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -127.33 28.93 5.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.058 0.456 . . . . 2.32 110.763 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 8.3 t-20 -105.25 -140.57 0.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.639 -0.709 . . . . 1.06 109.356 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 27.9 m -116.43 130.23 24.65 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 120.768 0.318 . . . . 0.34 110.48 176.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -78.26 122.89 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.76 2.307 . . . . 0.45 111.404 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.2 p -130.19 147.67 51.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.959 0.409 . . . . 0.31 111.007 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.48 106.77 19.07 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.503 -0.555 . . . . 1.26 109.503 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.0 m -93.86 141.78 28.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.209 0.528 . . . . 0.29 110.72 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.9 tt0 -79.16 -25.98 42.78 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.506 -0.77 . . . . 1.53 109.745 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -160.13 160.12 32.58 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.312 -0.995 . . . . 1.26 108.312 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.505 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.3 t -141.69 132.86 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.76 -0.459 . . . . 1.07 109.76 175.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.48 163.73 12.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.564 -0.289 . . . . 1.87 110.444 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 66.65 -152.98 0.22 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.035 -0.53 . . . . 1.94 109.588 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.94 -7.05 19.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.444 0.64 . . . . 2.12 110.449 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.447 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . 120.47 23.4 2.87 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.137 -0.785 . . . . 0.51 111.137 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 62.2 mt -91.9 -13.57 31.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.727 -0.236 . . . . 1.1 111.404 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.99 107.97 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.13 -0.322 . . . . 0.33 110.13 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -97.67 144.0 17.04 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.517 -0.849 . . . . 0.26 112.426 -178.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.605 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -105.23 124.08 59.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.099 -0.334 . . . . 0.3 110.099 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.778 ' HA ' HG12 ' A' ' 45' ' ' VAL . 74.3 m-20 57.57 45.7 18.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.365 0.603 . . . . 0.34 110.796 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.58 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 81.4 m -82.25 92.33 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.248 -0.887 . . . . 0.81 110.631 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 25.1 m -84.03 123.67 75.32 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.68 -0.691 . . . . 0.44 110.385 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 25.0 Cg_exo -64.29 130.91 28.33 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.108 2.538 . . . . 0.39 111.998 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.2 pt -103.3 137.07 19.15 Favored Pre-proline 0 N--CA 1.438 -1.072 0 CA-C-N 115.857 -0.611 . . . . 0.57 110.696 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 8.2 Cg_exo . . . . . 0 N--CA 1.457 -0.625 0 C-N-CA 123.406 2.737 . . . . 1.05 112.559 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 72.3 m95 . . . . . 0 CA--C 1.515 -0.381 0 CA-C-O 121.213 0.53 . . . . 0.81 111.493 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -66.46 117.7 9.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.969 -1.014 . . . . 2.73 110.104 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.0 t -107.71 27.05 9.56 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.878 -0.786 . . . . 1.75 108.878 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -60.83 -38.22 84.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.07 -0.968 . . . . 3.24 110.902 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -65.59 -22.04 66.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.691 -0.686 . . . . 2.05 110.895 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.11 16.04 79.74 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.216 -0.516 . . . . 0.88 112.94 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.439 ' HB3' ' HB ' ' A' ' 87' ' ' ILE . 8.3 m -82.66 -18.57 40.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.998 0.37 . . . . 1.72 111.998 -175.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.3 t -116.47 141.58 47.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.884 0.373 . . . . 1.19 110.649 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.439 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.1 p30 -93.13 -26.21 17.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 1.66 111.822 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.439 HG23 ' OD1' ' A' ' 12' ' ' ASN . 32.2 p -94.98 -30.81 13.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.998 0.427 . . . . 0.52 112.034 -173.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.08 -1.64 74.22 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.591 -0.814 . . . . 0.43 111.521 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -92.47 87.93 6.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.322 -0.622 . . . . 1.64 109.322 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -96.81 139.71 32.46 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.923 -0.58 . . . . 0.55 110.619 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -147.61 156.61 42.97 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.129 -1.063 . . . . 0.29 108.129 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 93.8 m -99.92 97.45 8.33 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.301 -0.56 . . . . 0.74 109.704 174.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.4 m -110.49 156.57 20.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.679 -0.691 . . . . 0.5 111.147 -168.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.48 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 33.4 m-20 -99.94 109.72 22.08 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.264 -0.643 . . . . 1.65 109.264 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.422 HG21 ' HG3' ' A' ' 86' ' ' PRO . 33.1 p -71.87 -8.03 51.96 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.808 -0.633 . . . . 0.52 111.287 -175.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -100.85 -6.76 24.31 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.243 -0.651 . . . . 2.2 109.243 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 30.1 mtpp -116.64 117.32 29.49 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.969 -1.014 . . . . 2.6 109.812 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -128.62 152.58 48.19 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.584 0.586 . . . . 2.17 112.584 -171.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 27' ' ' LYS . 6.5 t -99.36 150.36 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.144 -0.935 . . . . 0.59 110.416 -174.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -91.29 13.21 17.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.644 -0.707 . . . . 2.83 110.088 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' H ' HG12 ' A' ' 25' ' ' VAL . 13.6 mmmm -131.62 142.3 49.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.046 -0.979 . . . . 4.07 108.767 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 t -139.18 80.39 1.78 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.7 0.762 . . . . 2.46 110.002 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.549 ' HB ' ' OE2' ' A' ' 75' ' ' GLU . 5.1 m -115.96 143.16 45.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.074 -0.966 . . . . 2.0 109.94 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -114.22 149.02 18.79 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.674 -0.774 . . . . 1.39 112.253 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.52 -51.09 4.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.399 -0.593 . . . . 3.06 109.399 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 2.44 109.928 176.778 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.664 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.5 mt-30 . . . . . 0 C--O 1.234 0.257 0 CA-C-O 121.012 0.434 . . . . 1.4 110.85 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.0 t -83.68 112.57 21.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.896 -0.593 . . . . 1.37 110.171 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.63 105.61 15.73 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.437 -0.801 . . . . 0.3 110.556 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 11.5 pt -110.21 152.76 12.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.218 -0.446 . . . . 0.23 111.014 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -72.07 142.02 49.23 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.506 -0.77 . . . . 2.38 110.287 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.646 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.4 t -144.79 165.69 27.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.56 -1.2 . . . . 1.15 109.993 -170.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.3 t -160.04 153.06 21.68 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.248 -0.279 . . . . 0.6 110.248 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -120.5 122.8 41.43 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.415 -0.587 . . . . 2.08 109.415 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 64' ' ' CYS . 46.7 mt -92.64 131.92 32.79 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.511 -0.552 . . . . 0.95 109.511 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 52' ' ' ILE . 52.8 Cg_exo -33.88 99.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.575 3.516 . . . . 0.95 113.504 -174.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 pp -78.31 140.61 38.8 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.987 -1.006 . . . . 1.67 111.412 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.548 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 2.6 mm? -77.74 138.86 39.26 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.199 -1.037 . . . . 1.58 108.199 171.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.7 mt -61.02 129.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.025 0.441 . . . . 2.11 110.416 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.4 2.91 88.92 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.513 -0.767 . . . . 1.03 112.763 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -95.92 152.63 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.724 0.773 . . . . 0.77 111.601 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.66 152.13 23.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.395 -1.275 . . . . 0.68 111.401 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 10.5 tt -52.29 -38.77 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.943 0.878 . . . . 0.69 110.857 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.444 ' N ' HG23 ' A' ' 60' ' ' ILE . 34.9 mt-10 -64.24 -16.01 61.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.825 -1.079 . . . . 2.2 111.766 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -111.34 -8.12 14.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.036 0.384 . . . . 1.98 112.036 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 1.9 pp20? -94.53 -33.76 12.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.433 -0.507 . . . . 2.09 111.599 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.499 ' HA ' HD12 ' A' ' 52' ' ' ILE . 3.8 p -113.44 156.52 23.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.063 0.459 . . . . 0.6 111.408 -173.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 4.1 tppp? -110.89 26.41 10.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.085 0.945 . . . . 2.32 108.976 173.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.643 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 4.3 m-20 -105.07 -168.49 1.48 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.199 -0.91 . . . . 1.06 109.471 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -88.67 124.62 65.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-O 121.388 0.613 . . . . 0.34 111.408 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HB2' HG13 ' A' ' 87' ' ' ILE . 9.6 Cg_exo -60.19 113.91 1.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.21 2.607 . . . . 0.45 110.986 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.848 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 0.8 OUTLIER -124.99 139.54 53.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.964 0.412 . . . . 0.31 111.41 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.9 t -102.65 105.56 16.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.224 -0.658 . . . . 1.26 109.224 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 67.3 m -86.77 145.36 26.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.927 -0.397 . . . . 0.29 109.927 -174.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.4 tt0 -76.3 -24.17 54.37 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.705 -0.85 . . . . 1.53 108.705 172.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -163.25 157.98 20.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.823 -1.081 . . . . 1.26 108.481 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.544 HG12 ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -138.45 138.4 42.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.804 -0.358 . . . . 1.07 110.095 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.549 ' OE2' ' HB ' ' A' ' 29' ' ' THR . 43.9 tt0 -106.42 155.33 19.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.276 -0.42 . . . . 1.87 110.311 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 t70 66.78 -152.64 0.21 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.661 0.601 . . . . 1.94 109.667 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.01 0.69 5.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.111 0.482 . . . . 2.12 110.611 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 115.4 23.69 4.37 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.043 -0.599 . . . . 0.51 111.971 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.4 mt -79.35 -24.81 42.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.007 0.432 . . . . 1.1 110.892 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.97 108.67 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.721 -0.474 . . . . 0.33 109.721 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.99 133.53 11.4 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.298 -0.954 . . . . 0.26 111.81 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.664 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -95.23 118.47 41.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 110.136 -0.32 . . . . 0.3 110.136 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 89.8 m-20 57.75 42.53 23.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.382 -0.827 . . . . 0.34 110.825 174.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.848 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -78.27 105.14 9.31 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.689 -0.687 . . . . 0.81 110.351 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.5 m -83.45 128.22 65.1 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.422 -0.808 . . . . 0.44 109.738 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HG3' HG21 ' A' ' 21' ' ' THR . 33.3 Cg_exo -61.35 119.91 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.56 2.173 . . . . 0.39 110.779 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.439 ' HB ' ' HB3' ' A' ' 10' ' ' SER . 8.4 pt -106.87 146.85 33.95 Favored Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-O 121.137 0.494 . . . . 0.57 111.458 -174.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 N--CA 1.444 -1.406 0 C-N-CA 123.461 2.774 . . . . 1.05 112.31 -177.593 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.547 ' CZ2' HD22 ' A' ' 54' ' ' LEU . 78.2 m95 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.678 -0.49 . . . . 0.81 109.678 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -76.81 108.28 9.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.93 0.395 . . . . 2.73 110.775 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.9 m -94.82 13.32 25.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.905 -0.589 . . . . 1.75 109.551 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -19.82 55.03 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.453 -0.794 . . . . 3.24 111.302 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -74.68 -16.47 60.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.948 -0.569 . . . . 2.05 110.898 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.22 69.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.949 -0.643 . . . . 0.88 111.607 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.6 p -87.23 -29.65 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.623 0.601 . . . . 1.72 112.623 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.4 t -129.3 141.31 51.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.604 0.716 . . . . 1.19 111.313 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.36 -30.53 15.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.509 -1.223 . . . . 1.66 111.704 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -30.55 14.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.069 0.396 . . . . 0.52 112.069 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.55 -9.51 57.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.553 -0.832 . . . . 0.43 112.626 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HD3' HG23 ' A' ' 74' ' ' VAL . 90.9 mttt -89.48 88.11 7.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.957 0.408 . . . . 1.64 110.347 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' A' ' 4' ' ' TRP . 8.8 mp -90.49 138.09 31.83 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.357 -0.609 . . . . 0.55 109.357 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.01 156.62 44.46 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.87 0.367 . . . . 0.29 110.71 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 50' ' ' THR . 51.2 m -91.34 101.93 14.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.697 -0.853 . . . . 0.74 108.697 171.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.8 m -121.32 142.51 49.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.213 0.53 . . . . 0.5 111.312 -171.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -93.72 108.26 20.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.408 -0.815 . . . . 1.65 109.235 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.7 p -74.15 -6.93 50.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.886 -0.597 . . . . 0.52 111.24 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -91.85 -20.58 21.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.843 0.83 . . . . 2.2 108.822 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -104.34 135.31 46.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.476 -1.238 . . . . 2.6 110.623 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.505 ' HD2' HG22 ' A' ' 47' ' ' ILE . 14.4 mmmm -119.91 156.56 30.52 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.831 -1.077 . . . . 2.17 110.052 -175.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.06 150.27 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.002 0.429 . . . . 0.59 110.303 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -78.1 30.25 0.17 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.44 -0.8 . . . . 2.83 111.837 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 30.7 mmmt -133.49 160.06 38.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 4.07 111.26 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.8 t -148.02 23.55 1.07 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.939 0.876 . . . . 2.46 108.942 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.407 ' OG1' ' HE3' ' A' ' 27' ' ' LYS . 13.7 p -102.56 145.09 30.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.909 -1.041 . . . . 2.0 111.652 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.66 155.77 15.94 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.966 -0.854 . . . . 1.39 110.966 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -100.88 -50.11 3.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.976 0.388 . . . . 3.06 111.158 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 120.904 0.383 . . . . 2.44 110.457 -179.793 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.565 ' HB3' HG23 ' A' ' 82' ' ' ILE . 37.0 mt-30 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 121.444 0.64 . . . . 1.4 111.105 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 83' ' ' ASN . 8.3 p -99.47 136.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.356 -0.838 . . . . 1.37 109.399 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.37 110.94 17.55 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.618 -0.719 . . . . 0.3 110.576 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.505 HG22 ' HD2' ' A' ' 24' ' ' LYS . 7.9 pt -114.78 160.52 14.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.783 -0.644 . . . . 0.23 110.342 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.37 129.58 34.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.836 -0.62 . . . . 2.38 110.232 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.8 m -128.84 154.99 45.91 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.779 -1.1 . . . . 1.15 110.554 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 5.8 t -157.39 136.29 11.62 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.834 -0.621 . . . . 0.6 109.494 -177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -121.0 114.31 21.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.258 0.552 . . . . 2.08 111.262 -176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.9 mt -78.29 133.89 63.58 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.099 -0.955 . . . . 0.95 109.39 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -33.94 116.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.642 3.561 . . . . 0.95 113.564 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.547 HD22 ' CZ2' ' A' ' 4' ' ' TRP . 3.6 pp -100.12 141.72 32.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.911 -1.04 . . . . 1.67 111.989 -169.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.617 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 94.4 mt -80.72 133.74 35.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.255 -1.017 . . . . 1.58 108.255 167.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.7 mt -67.72 128.81 31.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.143 0.497 . . . . 2.11 110.199 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.53 9.18 63.29 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.554 -0.748 . . . . 1.03 111.725 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -98.76 157.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.277 0.56 . . . . 0.77 110.771 177.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.7 137.88 31.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.969 -1.014 . . . . 0.68 110.914 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -53.1 -38.45 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.016 -0.993 . . . . 0.69 112.056 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -79.49 -17.86 53.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.356 -0.384 . . . . 2.2 111.533 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -102.45 -3.06 27.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.968 0.413 . . . . 1.98 110.349 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -102.38 -22.19 14.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.039 -0.528 . . . . 2.09 110.744 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.51 156.64 48.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.471 -0.331 . . . . 0.6 110.236 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -104.64 44.7 1.01 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.285 0.564 . . . . 2.32 110.889 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 3.9 m-20 -124.55 -165.68 1.41 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.492 -0.776 . . . . 1.06 109.723 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -87.76 128.35 54.68 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 120.91 0.386 . . . . 0.34 110.243 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.33 125.46 5.15 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.746 2.297 . . . . 0.45 110.915 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.786 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 2.9 p -124.64 153.42 42.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.972 0.415 . . . . 0.31 111.466 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.2 t -107.55 102.8 12.03 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.263 -0.643 . . . . 1.26 109.263 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 84' ' ' CYS . 97.6 m -84.64 142.11 30.15 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.039 -0.356 . . . . 0.29 110.039 -176.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.6 tt0 -76.1 -27.44 57.15 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.62 -0.881 . . . . 1.53 108.62 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 71' ' ' CYS . 24.6 t0 -159.57 162.8 35.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.874 -1.057 . . . . 1.26 108.66 175.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.642 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.3 t -140.16 134.72 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.841 -0.429 . . . . 1.07 109.841 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -106.15 165.91 10.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.795 -0.446 . . . . 1.87 109.795 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t70 67.4 -151.92 0.19 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.231 0.612 . . . . 1.94 109.457 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -79.17 22.86 0.39 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.969 0.414 . . . . 2.12 110.553 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.485 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 98.19 23.15 13.36 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.924 -0.655 . . . . 0.51 112.041 -177.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.73 -17.18 28.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 1.1 111.217 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.88 103.68 11.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.498 -0.319 . . . . 0.33 110.51 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.422 ' HA3' ' SG ' ' A' ' 71' ' ' CYS . . . -94.29 133.11 11.46 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.354 -0.926 . . . . 0.26 112.368 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.565 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -97.61 126.71 50.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 122.441 0.296 . . . . 0.3 110.255 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.67 ' HA ' HG12 ' A' ' 45' ' ' VAL . 85.3 m-20 53.52 43.56 31.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 123.84 0.712 . . . . 0.34 110.398 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.786 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -87.49 102.89 15.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.406 -0.816 . . . . 0.81 110.15 -177.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 m -83.12 130.67 56.25 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.891 -0.595 . . . . 0.44 110.111 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.33 109.84 2.98 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.974 2.449 . . . . 0.39 111.906 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.2 pt -83.69 137.44 41.33 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.576 -0.738 . . . . 0.57 111.176 -175.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.5 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 C-N-CA 123.349 2.699 . . . . 1.05 112.079 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.474 ' CE3' ' HB ' ' A' ' 60' ' ' ILE . 71.8 m95 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.053 0.454 . . . . 0.81 111.608 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -78.04 107.69 10.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 2.73 109.724 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.8 t -111.75 27.51 9.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.349 0.595 . . . . 1.75 109.744 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -24.86 61.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.514 -0.766 . . . . 3.24 112.723 -172.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 t -91.6 5.17 50.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.635 -0.426 . . . . 2.05 110.931 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.22 17.8 75.67 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.598 -0.811 . . . . 0.88 111.839 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 p -69.38 -30.81 68.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.627 0.603 . . . . 1.72 112.627 -172.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.1 t -132.35 141.3 48.87 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.263 -0.575 . . . . 1.19 111.482 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.533 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.9 p30 -93.08 -29.53 15.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.561 -0.745 . . . . 1.66 111.593 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.533 HG23 ' OD1' ' A' ' 12' ' ' ASN . 2.6 p -95.42 -31.38 13.41 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.531 0.567 . . . . 0.52 112.531 -173.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.72 -18.26 44.22 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.339 -0.934 . . . . 0.43 113.267 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.626 ' HD3' HG23 ' A' ' 74' ' ' VAL . 81.9 mttt -84.83 89.4 7.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.168 0.484 . . . . 1.64 110.478 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' A' ' 4' ' ' TRP . 8.8 mp -91.87 137.68 32.17 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.921 -0.4 . . . . 0.55 109.921 175.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.532 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -145.67 152.03 38.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.907 0.384 . . . . 0.29 110.383 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 36.1 m -87.5 98.65 11.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.502 -0.555 . . . . 0.74 109.502 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 86.3 m -117.3 161.97 18.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.495 . . . . 0.5 111.515 -167.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 11.9 m-20 -99.46 98.71 9.59 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.65 109.939 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.8 p -70.31 -7.66 44.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.836 -0.62 . . . . 0.52 112.151 -173.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -103.14 -10.55 18.74 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.189 0.995 . . . . 2.2 108.788 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.483 ' HG3' ' HB2' ' A' ' 48' ' ' GLN . 40.8 tptt -118.06 99.53 6.95 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.416 -1.72 . . . . 2.6 110.497 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 14.2 mptt -85.76 170.31 12.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.036 -0.984 . . . . 2.17 111.047 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.04 150.49 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.59 -0.732 . . . . 0.59 109.18 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -74.58 23.83 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.189 0.811 . . . . 2.83 113.189 -173.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -136.74 160.11 39.83 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.967 -0.458 . . . . 4.07 111.555 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 p -134.64 38.74 3.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.598 0.713 . . . . 2.46 109.605 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 p -89.39 -172.98 3.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.218 -0.901 . . . . 2.0 111.229 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.21 146.57 8.42 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.72 -0.752 . . . . 1.39 111.982 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -82.22 -50.46 8.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.943 0.402 . . . . 3.06 110.431 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.895 -0.593 . . . . 2.44 109.968 179.004 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.49 ' HB3' HG23 ' A' ' 82' ' ' ILE . 15.8 mt-30 . . . . . 0 CA--C 1.517 -0.296 0 CA-C-O 121.19 0.519 . . . . 1.4 110.687 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.68 107.53 20.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.41 -0.813 . . . . 1.37 110.067 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -95.38 122.45 38.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.488 -0.778 . . . . 0.3 110.336 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 84' ' ' CYS . 22.0 pt -122.79 157.82 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.192 -0.458 . . . . 0.23 110.472 176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.483 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -71.4 138.96 49.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.538 -0.756 . . . . 2.38 109.189 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.8 t -142.78 156.58 45.0 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.885 0.374 . . . . 1.15 111.172 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -162.95 122.21 2.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.552 -0.749 . . . . 0.6 109.766 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.459 ' HG2' ' SG ' ' A' ' 18' ' ' CYS . 11.5 tm0? -120.95 115.67 23.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.826 0.346 . . . . 2.08 110.539 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.447 HG23 ' HD2' ' A' ' 53' ' ' PRO . 63.3 mt -52.35 135.42 41.85 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-N 115.207 -0.906 . . . . 0.95 110.192 176.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HD2' HG23 ' A' ' 52' ' ' ILE . 89.8 Cg_exo -33.37 107.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 124.507 3.472 . . . . 0.95 113.88 -174.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.552 ' HA ' ' OE1' ' A' ' 63' ' ' GLU . 3.5 pp -59.3 140.76 55.72 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.755 -1.111 . . . . 1.67 113.837 -168.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -111.26 115.85 30.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.663 -1.153 . . . . 1.58 109.438 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.3 mm -63.64 139.12 21.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.416 0.627 . . . . 2.11 111.14 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.42 -23.84 33.19 Favored Glycine 0 C--N 1.315 -0.602 0 CA-C-N 115.166 -0.925 . . . . 1.03 112.961 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.66 152.04 3.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.768 0.794 . . . . 0.77 111.759 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.07 124.15 27.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.318 -1.31 . . . . 0.68 110.749 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.474 ' HB ' ' CE3' ' A' ' 4' ' ' TRP . 13.3 tt -53.62 -33.1 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.044 -0.98 . . . . 0.69 111.017 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 60' ' ' ILE . 2.8 mp0 -61.34 -29.88 70.16 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.41 -1.268 . . . . 2.2 111.437 -173.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -106.64 -20.47 13.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.054 -0.521 . . . . 1.98 110.452 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' A' ' 54' ' ' LEU . 29.5 tt0 -67.2 -41.14 86.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 2.09 111.129 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.6 p -105.02 -173.64 2.35 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.976 -0.556 . . . . 0.6 109.726 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -132.2 43.68 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.309 0.576 . . . . 2.32 110.817 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 49.8 m-80 -137.55 -171.16 2.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.487 -0.931 . . . . 1.06 108.487 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 22.8 m -81.29 122.12 80.93 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.314 0.578 . . . . 0.34 111.614 -177.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.69 124.2 11.66 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.255 2.637 . . . . 0.45 111.036 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 86' ' ' PRO . 72.6 p -132.5 149.92 52.25 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.788 -0.365 . . . . 0.31 111.237 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 11.6 t -94.74 112.11 23.86 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.477 -0.564 . . . . 1.26 109.477 172.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.4 m -99.36 139.41 35.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.253 0.549 . . . . 0.29 110.333 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.0 tt0 -77.22 -23.93 51.32 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.458 -0.792 . . . . 1.53 109.415 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -163.86 165.09 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.991 -1.004 . . . . 1.26 108.407 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.626 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.0 t -142.2 136.38 29.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 117.947 0.34 . . . . 1.07 110.339 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.81 162.6 12.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.739 -0.467 . . . . 1.87 109.739 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 62.26 -154.37 0.35 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.54 -0.541 . . . . 1.94 109.54 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.5 7.79 6.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.641 0.734 . . . . 2.12 109.848 174.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.04 22.61 2.89 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.487 -0.779 . . . . 0.51 112.596 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.2 mm? -83.82 -23.62 31.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.69 0.256 . . . . 1.1 111.69 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.8 t -129.21 106.88 14.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.972 -0.381 . . . . 0.33 109.972 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -97.49 144.05 17.08 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.384 -0.912 . . . . 0.26 112.399 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -102.15 119.03 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 110.003 -0.369 . . . . 0.3 110.003 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 87.4 m-20 61.36 43.7 10.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.499 -0.773 . . . . 0.34 110.565 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.632 ' HB2' HD11 ' A' ' 47' ' ' ILE . 60.3 m -82.78 99.03 9.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.349 -0.841 . . . . 0.81 111.0 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.3 m -89.37 131.98 38.77 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.436 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.438 ' HA ' HG22 ' A' ' 69' ' ' THR . 11.6 Cg_endo -68.55 126.43 14.11 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.079 2.52 . . . . 0.39 112.208 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.2 pt -105.8 152.41 40.17 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.769 -0.65 . . . . 0.57 111.091 -174.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 18.2 Cg_exo . . . . . 0 N--CA 1.463 -0.281 0 C-N-CA 123.246 2.63 . . . . 1.05 112.455 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.408 ' HB2' HD13 ' A' ' 16' ' ' LEU . 76.3 m95 . . . . . 0 C--O 1.236 0.36 0 N-CA-C 110.101 -0.333 . . . . 0.81 110.101 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.2 109.14 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.481 . . . . 2.73 111.174 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.493 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 11.1 m -105.44 26.45 9.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.829 -0.623 . . . . 1.75 110.491 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.506 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -59.47 -15.25 16.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.952 -0.567 . . . . 3.24 112.102 -176.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -73.02 -15.58 61.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.084 0.468 . . . . 2.05 110.958 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.4 8.26 70.42 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.822 -0.626 . . . . 0.88 111.664 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.5 t -88.07 -9.71 52.47 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.863 0.363 . . . . 1.72 110.692 -176.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.2 t -123.71 139.78 53.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.167 0.508 . . . . 1.19 110.307 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.44 -31.89 13.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.27 -0.877 . . . . 1.66 112.521 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -102.27 -20.6 14.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.263 0.468 . . . . 0.52 112.263 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.493 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 89.96 4.83 71.63 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.725 -0.75 . . . . 0.43 112.654 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.616 ' HD3' HG13 ' A' ' 74' ' ' VAL . 66.7 mttm -93.8 88.9 5.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.75 0.309 . . . . 1.64 110.478 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 69' ' ' THR . 7.8 mp -93.66 109.36 21.0 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.541 -0.54 . . . . 0.55 109.541 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -124.13 144.2 50.03 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.872 0.368 . . . . 0.29 110.956 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 81.5 m -79.91 98.22 7.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 0.74 109.478 175.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 73.1 m -113.42 156.99 22.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.125 0.488 . . . . 0.5 111.461 -169.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 22.7 m-20 -92.01 93.07 8.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.37 -0.832 . . . . 1.65 109.298 174.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.4 p -64.91 -15.23 61.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.693 0.627 . . . . 0.52 112.693 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -106.51 0.44 24.66 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.989 0.899 . . . . 2.2 108.67 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HG3' HE21 ' A' ' 48' ' ' GLN . 48.2 tptt -123.98 98.9 6.0 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.08 -1.418 . . . . 2.6 109.529 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -89.16 164.76 14.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.561 -1.199 . . . . 2.17 111.022 -171.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.628 HG22 ' NE2' ' A' ' 48' ' ' GLN . 3.5 t -117.74 149.88 19.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.854 -0.612 . . . . 0.59 110.264 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -80.73 -40.14 25.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.345 -0.613 . . . . 2.83 109.345 174.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -69.4 121.24 16.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.592 -0.731 . . . . 4.07 109.11 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -149.87 79.17 1.37 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.797 -0.361 . . . . 2.46 111.584 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 m -136.54 -61.0 0.7 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.639 -0.424 . . . . 2.0 111.434 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.41 164.11 15.6 Favored Glycine 0 C--N 1.32 -0.327 0 C-N-CA 121.036 -0.602 . . . . 1.39 112.035 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -101.53 -42.26 6.31 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.235 0.457 . . . . 3.06 112.235 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--N 1.327 -0.391 0 C-N-CA 120.87 -0.332 . . . . 2.44 111.434 -175.05 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HB3' HG23 ' A' ' 82' ' ' ILE . 12.7 mt-30 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.283 0.563 . . . . 1.4 111.407 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.17 121.52 63.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.316 -0.857 . . . . 1.37 109.334 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.99 133.2 52.64 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.638 -0.71 . . . . 0.3 111.229 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.47 HD11 ' HB2' ' A' ' 84' ' ' CYS . 12.7 pt -125.61 153.75 33.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.529 -0.76 . . . . 0.23 109.972 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.628 ' NE2' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -67.69 139.9 56.76 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.389 -0.597 . . . . 2.38 109.389 178.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.8 t -138.91 156.44 47.27 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.252 -0.431 . . . . 1.15 110.757 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -161.43 140.27 9.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.981 -0.554 . . . . 0.6 109.805 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.528 HE22 HD12 ' A' ' 60' ' ' ILE . 43.9 tp60 -114.6 155.23 26.92 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.026 0.441 . . . . 2.08 110.451 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.51 HG23 ' HD2' ' A' ' 53' ' ' PRO . 42.0 mm -86.82 150.7 51.03 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.228 -0.896 . . . . 0.95 108.967 176.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD2' HG23 ' A' ' 52' ' ' ILE . 51.6 Cg_exo -35.14 111.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.137 2.558 . . . . 0.95 111.842 171.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.66 133.17 55.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.175 -0.92 . . . . 1.67 112.926 -167.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.19 124.52 49.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.096 -0.956 . . . . 1.58 109.252 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 56' ' ' ILE . 15.6 mt -64.2 130.38 29.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.24 -0.436 . . . . 2.11 110.857 -174.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.84 15.18 71.18 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.418 -0.81 . . . . 1.03 113.217 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.448 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -100.26 152.67 4.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.693 0.759 . . . . 0.77 111.643 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.41 145.91 25.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.363 -1.29 . . . . 0.68 111.237 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.528 HD12 HE22 ' A' ' 51' ' ' GLN . 8.2 tp -53.69 -34.26 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 114.358 -1.292 . . . . 0.69 112.836 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.72 -4.81 58.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.739 0.304 . . . . 2.2 111.655 -172.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -110.09 -27.19 9.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.094 0.473 . . . . 1.98 110.133 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.448 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 32.3 tt0 -71.43 -39.49 71.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.782 -0.645 . . . . 2.09 110.933 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.7 p -121.08 169.06 10.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.214 -0.448 . . . . 0.6 110.492 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -113.98 26.83 9.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.089 0.471 . . . . 2.32 110.455 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 17.0 m-80 -107.06 -160.92 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 1.06 110.126 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 12.4 m -96.63 126.7 42.28 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 120.976 0.417 . . . . 0.34 110.501 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.96 129.21 6.1 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.979 2.453 . . . . 0.45 111.03 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 65.5 p -132.14 157.37 44.44 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.754 -0.379 . . . . 0.31 110.936 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 40.7 t -106.12 102.28 11.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.048 -0.524 . . . . 1.26 109.647 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 55.6 m -88.08 133.75 33.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.973 0.416 . . . . 0.29 110.56 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.0 tt0 -76.3 -23.58 54.34 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.875 -0.602 . . . . 1.53 110.102 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -158.77 169.26 24.78 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.65 -0.87 . . . . 1.26 108.65 170.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.616 HG13 ' HD3' ' A' ' 15' ' ' LYS . 32.8 m -135.84 146.05 30.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.77 0.319 . . . . 1.07 110.562 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -112.22 150.21 31.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.342 -0.985 . . . . 1.87 108.342 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.8 -156.32 0.33 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.754 -0.832 . . . . 1.94 108.754 -170.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -83.07 23.16 0.88 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.522 0.677 . . . . 2.12 110.762 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.568 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 104.22 21.85 9.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.588 -0.815 . . . . 0.51 112.955 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 84.0 mt -85.16 -17.13 38.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.064 0.459 . . . . 1.1 109.987 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.1 t -129.61 110.82 20.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.51 -0.768 . . . . 0.33 109.156 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -101.78 140.62 14.95 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.181 -1.009 . . . . 0.26 112.334 -176.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.486 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -97.52 119.36 45.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.058 -0.349 . . . . 0.3 110.058 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 96.0 m-20 59.81 50.54 6.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.678 -0.692 . . . . 0.34 110.832 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.566 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.5 m -85.0 91.34 8.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.379 -0.828 . . . . 0.81 110.924 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.1 m -74.94 126.09 88.64 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.675 -0.693 . . . . 0.44 110.379 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.38 121.66 9.14 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.856 2.37 . . . . 0.39 111.818 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.4 pt -101.09 154.54 37.1 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.799 -0.637 . . . . 0.57 110.847 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 C--O 1.233 0.265 0 C-N-CA 123.206 2.604 . . . . 1.05 112.794 -179.726 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 77.1 m95 . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.81 112.115 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -63.41 108.4 1.33 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.269 -0.878 . . . . 2.73 111.257 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -101.11 -17.5 16.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.162 -0.926 . . . . 1.75 109.365 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' C ' ' HD2' ' A' ' 7' ' ' LYS . 2.7 pptp? -69.54 -17.89 63.61 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.901 -0.591 . . . . 3.24 110.745 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.2 m -72.73 -26.85 61.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 2.05 111.159 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.65 16.25 75.93 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.982 -0.628 . . . . 0.88 112.654 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.632 ' OG ' ' HB ' ' A' ' 87' ' ' ILE . 7.8 t -87.32 -29.0 21.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.946 0.403 . . . . 1.72 110.77 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.8 t -115.39 140.94 48.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.898 0.38 . . . . 1.19 110.701 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.5 p30 -93.09 -25.87 17.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.075 -0.511 . . . . 1.66 112.038 -177.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.43 HG21 ' HA ' ' A' ' 72' ' ' GLU . 43.9 p -92.97 -30.47 15.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.52 111.686 -174.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.97 -4.41 59.03 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.748 -0.739 . . . . 0.43 112.027 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.501 ' HD3' HG23 ' A' ' 74' ' ' VAL . 53.3 mttp -94.19 89.95 6.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.862 0.363 . . . . 1.64 110.666 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.1 mp -96.17 113.35 24.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.256 -0.429 . . . . 0.55 110.627 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.04 151.1 49.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.877 0.37 . . . . 0.29 110.312 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.637 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 60.8 m -84.84 103.2 13.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.007 -0.738 . . . . 0.74 109.007 173.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 98.4 m -113.13 142.97 45.14 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.17 0.51 . . . . 0.5 110.975 -174.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 44.0 m-20 -97.69 109.19 21.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.487 -0.779 . . . . 1.65 109.238 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 p -75.64 -5.88 47.66 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.411 0.624 . . . . 0.52 110.033 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -89.46 -8.63 52.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.242 -0.89 . . . . 2.2 109.053 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.44 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 26.2 mtmt -121.57 142.75 49.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.812 -1.085 . . . . 2.6 110.145 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.472 ' HD3' HG22 ' A' ' 47' ' ' ILE . 33.7 mmtp -128.39 158.86 37.11 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.63 -0.714 . . . . 2.17 111.082 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 27' ' ' LYS . 10.7 t -124.15 150.03 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.085 -1.08 . . . . 0.59 108.085 173.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -76.48 31.76 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.09 0.404 . . . . 2.83 112.09 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 25' ' ' VAL . 14.6 mtmt 37.81 114.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.997 1.319 . . . . 4.07 113.451 -170.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.8 p -101.24 -81.03 0.49 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.378 -0.828 . . . . 2.46 110.008 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.74 -172.25 3.43 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.641 -1.163 . . . . 2.0 109.162 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.24 116.64 1.13 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.186 -0.766 . . . . 1.39 111.186 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.01 -31.59 72.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.89 0.345 . . . . 3.06 110.55 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 . . . . . 0 C--N 1.329 -0.315 0 N-CA-C 109.73 -0.471 . . . . 2.44 109.73 173.664 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 121.229 0.537 . . . . 1.4 111.955 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.51 126.99 75.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.338 -0.846 . . . . 1.37 109.023 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -110.88 114.33 27.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.301 -0.409 . . . . 0.3 111.805 -175.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.472 HG22 ' HD3' ' A' ' 24' ' ' LYS . 12.4 pt -111.06 163.7 7.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.78 -0.645 . . . . 0.23 109.653 172.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -88.84 127.62 35.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.47 0.652 . . . . 2.38 109.634 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 29.8 m -122.54 160.59 25.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.712 -1.131 . . . . 1.15 110.671 -172.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 11.2 t -160.89 142.49 12.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.774 -0.454 . . . . 0.6 109.774 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.458 HE21 HD12 ' A' ' 60' ' ' ILE . 8.0 tm0? -120.07 115.87 24.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.266 0.555 . . . . 2.08 110.817 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.418 HG23 ' HD2' ' A' ' 53' ' ' PRO . 68.7 mt -73.83 133.14 79.54 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.225 -0.898 . . . . 0.95 109.839 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD2' HG23 ' A' ' 52' ' ' ILE . 67.6 Cg_exo -33.57 111.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 124.817 3.678 . . . . 0.95 114.096 -172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 63' ' ' GLU . 4.1 pp -88.42 142.14 27.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.679 -1.146 . . . . 1.67 112.535 -170.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.418 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 67.7 mt -93.94 144.31 25.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.468 -0.787 . . . . 1.58 109.139 168.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 mt -68.78 130.75 33.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.932 0.396 . . . . 2.11 110.678 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.41 -0.57 80.99 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.551 -0.75 . . . . 1.03 112.51 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -93.67 154.08 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.603 0.716 . . . . 0.77 111.488 -178.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.01 132.27 34.75 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.758 -1.11 . . . . 0.68 111.377 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.458 HD12 HE21 ' A' ' 51' ' ' GLN . 5.5 tp -49.84 -39.46 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 114.761 -1.109 . . . . 0.69 111.505 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 60' ' ' ILE . 8.2 pt-20 -70.9 -34.09 71.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.276 -0.874 . . . . 2.2 111.842 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -91.62 -23.17 19.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.95 0.405 . . . . 1.98 110.843 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 54' ' ' LEU . 7.7 tp10 -73.1 -40.68 64.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 2.09 111.122 -176.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 66' ' ' ASN . 19.8 p -107.15 156.6 18.63 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.915 0.388 . . . . 0.6 110.809 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -98.65 55.71 1.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.208 -1.034 . . . . 2.32 108.208 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.637 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 14.2 m120 -138.97 -168.68 2.47 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.13 -1.396 . . . . 1.06 109.073 -172.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -104.46 126.09 32.38 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-O 120.895 0.378 . . . . 0.34 110.119 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -77.88 129.28 9.76 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.628 2.219 . . . . 0.45 110.997 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.0 p -129.51 150.56 50.8 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.096 0.474 . . . . 0.31 111.545 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 54.0 t -98.98 99.09 10.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.686 -0.857 . . . . 1.26 108.686 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 56.6 m -86.61 141.27 29.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 0.29 110.642 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 3.0 tt0 -64.12 -45.25 89.41 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.094 -0.706 . . . . 1.53 109.094 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -151.55 167.79 26.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.66 -1.155 . . . . 1.26 108.724 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.545 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -142.97 158.55 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.472 -0.566 . . . . 1.07 109.472 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.21 156.16 33.04 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.976 -0.379 . . . . 1.87 109.976 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 67.69 -150.08 0.16 Allowed 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 123.577 0.548 . . . . 1.94 109.677 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.419 ' OD1' ' HG ' ' A' ' 79' ' ' LEU . 11.4 p-10 -76.75 0.99 18.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.281 0.563 . . . . 2.12 109.715 174.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 49' ' ' CYS . . . 120.94 24.21 2.56 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.5 -0.773 . . . . 0.51 112.752 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 93.7 mt -79.66 -25.55 41.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.82 0.31 . . . . 1.1 111.757 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.0 t -125.8 107.52 17.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.066 -0.346 . . . . 0.33 110.066 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.571 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -102.13 144.65 16.34 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.391 -0.909 . . . . 0.26 112.911 -174.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 mp -100.41 118.21 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.442 -0.379 . . . . 0.3 110.064 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.607 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 93.8 m-20 59.02 43.96 16.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.739 -0.664 . . . . 0.34 111.151 174.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.571 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 69.5 m -78.26 97.16 5.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.842 -0.617 . . . . 0.81 110.958 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 23.8 m -88.4 130.05 47.13 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.725 -0.67 . . . . 0.44 110.207 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.5 Cg_exo -61.07 113.82 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.994 2.463 . . . . 0.39 112.108 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.632 ' HB ' ' OG ' ' A' ' 10' ' ' SER . 7.9 pt -82.47 138.96 44.43 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.91 -0.587 . . . . 0.57 110.835 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 17.1 Cg_exo . . . . . 0 N--CA 1.454 -0.821 0 C-N-CA 123.086 2.524 . . . . 1.05 111.537 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CD2' ' HB ' ' A' ' 60' ' ' ILE . 58.2 m95 . . . . . 0 CA--C 1.518 -0.282 0 CA-C-O 121.082 0.468 . . . . 0.81 111.59 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -66.75 109.65 2.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.361 -0.836 . . . . 2.73 110.411 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.3 m -93.95 27.98 2.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.461 -0.79 . . . . 1.75 110.441 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -45.49 -46.81 14.02 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.368 -0.833 . . . . 3.24 112.491 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 p -63.08 -23.92 67.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.202 -0.454 . . . . 2.05 112.165 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.26 5.12 89.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.097 -0.573 . . . . 0.88 111.702 -176.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.5 m -70.43 -13.89 62.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.565 -0.318 . . . . 1.72 111.635 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -131.91 141.12 49.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.015 0.436 . . . . 1.19 110.507 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -94.6 -30.29 14.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.413 -0.812 . . . . 1.66 112.479 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 p -89.52 -30.03 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.983 0.421 . . . . 0.52 111.947 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.58 3.07 71.98 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.575 -0.821 . . . . 0.43 111.556 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -95.74 87.99 4.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.347 0.594 . . . . 1.64 110.133 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.0 mp -97.35 137.95 35.56 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.351 -0.84 . . . . 0.55 109.758 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.87 145.18 35.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.032 0.444 . . . . 0.29 110.593 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 28.1 m -82.02 102.84 11.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.387 -0.968 . . . . 0.74 108.387 173.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 59.1 m -122.45 156.6 33.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.131 0.491 . . . . 0.5 111.544 -169.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -102.85 118.01 35.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.442 -0.799 . . . . 1.65 109.312 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.9 p -80.96 -5.19 57.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.972 0.415 . . . . 0.52 111.368 -174.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -97.43 -19.85 18.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.675 0.75 . . . . 2.2 109.568 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -104.28 137.89 41.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.683 -1.144 . . . . 2.6 110.614 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.501 ' HD3' HG22 ' A' ' 47' ' ' ILE . 33.6 mmtp -127.36 155.07 44.18 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.786 -1.097 . . . . 2.17 110.393 -172.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.499 HG22 ' OE1' ' A' ' 48' ' ' GLN . 6.3 t -111.35 145.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.32 -0.622 . . . . 0.59 109.32 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -84.38 -40.74 17.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.274 -0.421 . . . . 2.83 111.38 -172.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -95.51 126.24 40.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.493 -0.321 . . . . 4.07 110.309 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.5 p -141.82 113.92 8.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.191 -0.459 . . . . 2.46 110.724 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.9 m -140.23 -48.52 0.45 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.197 0.522 . . . . 2.0 110.318 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.98 171.19 32.58 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.385 -0.825 . . . . 1.39 111.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -100.85 -51.13 3.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.715 -0.476 . . . . 3.06 109.715 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.778 -0.646 . . . . 2.44 109.974 -179.737 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.461 ' HB3' HG23 ' A' ' 82' ' ' ILE . 33.9 mt-30 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.918 0.389 . . . . 1.4 110.033 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.2 t -96.51 105.13 16.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 116.084 -0.507 . . . . 1.37 109.859 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -102.86 99.67 9.61 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.521 -0.763 . . . . 0.3 110.852 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.501 HG22 ' HD3' ' A' ' 24' ' ' LYS . 19.2 pt -101.89 151.51 5.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.7 -0.682 . . . . 0.23 109.822 174.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.499 ' OE1' HG22 ' A' ' 25' ' ' VAL . 14.7 tp60 -76.82 126.04 30.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.584 -0.734 . . . . 2.38 109.973 -175.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 67.2 m -115.62 156.13 26.4 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.78 -1.1 . . . . 1.15 111.289 -173.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 t -160.23 114.08 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.525 -0.762 . . . . 0.6 109.782 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -120.38 131.91 55.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.997 -0.547 . . . . 2.08 111.063 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 64' ' ' CYS . 21.7 mt -63.45 142.74 97.91 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.407 -0.815 . . . . 0.95 110.946 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -37.1 129.41 0.56 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 124.246 3.297 . . . . 0.95 113.352 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -59.55 127.09 30.32 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.054 -0.976 . . . . 1.67 112.712 -171.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.5 107.88 17.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.636 -0.876 . . . . 1.58 108.636 170.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.3 mt -65.95 134.62 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.23 0.538 . . . . 2.11 111.124 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.16 -12.77 63.65 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.297 -0.865 . . . . 1.03 112.042 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.21 152.06 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.748 0.785 . . . . 0.77 111.92 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.52 137.78 33.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.093 -1.412 . . . . 0.68 110.579 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.569 ' HB ' ' CD2' ' A' ' 4' ' ' TRP . 11.1 tt -55.89 -39.67 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.547 -0.751 . . . . 0.69 112.244 -175.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.433 ' N ' HG23 ' A' ' 60' ' ' ILE . 2.3 pm0 -72.96 -12.68 61.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.682 -0.69 . . . . 2.2 110.903 -173.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -110.06 -17.46 13.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.433 0.635 . . . . 1.98 109.501 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -75.14 -40.95 59.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.736 -0.665 . . . . 2.09 110.09 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.543 ' HA ' HD12 ' A' ' 52' ' ' ILE . 13.9 p -108.96 175.55 5.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.012 -0.54 . . . . 0.6 110.006 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -123.82 25.72 7.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.769 0.319 . . . . 2.32 111.245 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 41.3 m-80 -113.25 -169.61 1.52 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.011 -0.366 . . . . 1.06 110.011 177.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 m -79.56 127.05 79.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.004 0.43 . . . . 0.34 110.83 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.51 127.38 5.73 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.875 2.383 . . . . 0.45 110.806 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.3 p -129.76 148.4 51.64 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.745 -0.382 . . . . 0.31 111.113 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 39.7 t -97.29 110.7 23.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.267 -0.642 . . . . 1.26 109.267 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 50.4 m -97.94 141.16 31.26 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.966 -0.561 . . . . 0.29 110.035 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 1.9 tt0 -74.07 -24.48 59.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.435 0.636 . . . . 1.53 109.358 176.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -163.31 164.38 24.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.109 -0.951 . . . . 1.26 108.688 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.533 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.4 t -138.72 138.72 41.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.566 -0.531 . . . . 1.07 109.566 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 25.3 tt0 -108.72 162.0 14.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.943 -0.571 . . . . 1.87 109.888 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 t70 65.27 -152.08 0.26 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.616 -0.512 . . . . 1.94 109.616 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.54 -5.74 31.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.609 0.719 . . . . 2.12 110.042 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.533 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 122.38 23.9 2.29 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.585 -0.734 . . . . 0.51 112.254 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.03 -19.8 28.12 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.95 0.405 . . . . 1.1 110.892 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 42.3 t -124.06 101.14 8.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.1 -0.5 . . . . 0.33 110.145 -174.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.629 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -90.77 138.55 14.44 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.073 -1.06 . . . . 0.26 111.95 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.461 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -98.72 117.31 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 109.816 -0.439 . . . . 0.3 109.816 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 92.2 m-20 62.55 52.89 2.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.348 -0.842 . . . . 0.34 110.579 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.629 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 59.7 m -89.96 105.82 18.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.457 -0.792 . . . . 0.81 111.121 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 56.0 m -93.74 129.36 38.41 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.879 -0.601 . . . . 0.44 110.338 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.3 Cg_exo -60.41 119.57 6.83 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.887 2.391 . . . . 0.39 111.509 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 pt -98.19 145.45 29.83 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.893 -0.594 . . . . 0.57 111.932 -172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo . . . . . 0 N--CA 1.458 -0.577 0 C-N-CA 123.303 2.669 . . . . 1.05 111.513 175.524 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.3 m95 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.971 0.415 . . . . 0.81 110.889 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -72.69 108.03 5.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 2.73 110.751 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 m -111.52 15.16 21.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.673 -0.694 . . . . 1.75 109.597 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.81 -33.93 76.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.244 -0.889 . . . . 3.24 111.598 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.9 p -65.87 -24.38 66.85 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.929 -0.578 . . . . 2.05 111.4 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.79 16.24 31.65 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.804 -0.713 . . . . 0.88 111.974 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 p -65.88 -32.01 73.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.897 0.38 . . . . 1.72 111.96 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.5 t -126.01 141.63 51.88 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.869 -0.332 . . . . 1.19 110.91 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.403 ' OD1' HG23 ' A' ' 13' ' ' THR . 7.2 p30 -93.27 -28.62 16.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.917 -0.583 . . . . 1.66 111.914 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 72' ' ' GLU . 1.8 p -98.18 -20.4 17.31 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.495 . . . . 0.52 112.335 -174.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.63 22.7 55.48 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.659 -0.782 . . . . 0.43 112.559 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 51.9 mttp -115.83 92.02 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.035 -0.357 . . . . 1.64 110.035 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.7 mp -98.36 130.5 45.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.907 0.384 . . . . 0.55 110.767 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -149.9 148.89 29.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.16 -0.473 . . . . 0.29 110.412 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 97.0 m -86.3 100.19 12.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.289 0.566 . . . . 0.74 110.283 175.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 61.5 m -114.3 158.06 21.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.665 -0.698 . . . . 0.5 109.834 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 2.5 t70 -99.46 129.2 45.62 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.861 -0.792 . . . . 1.65 108.861 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.9 p -84.74 -1.52 56.37 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.713 -0.395 . . . . 0.52 111.116 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -106.14 -14.29 15.19 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.164 -0.68 . . . . 2.2 109.164 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 29.0 mtpp -97.52 101.92 13.56 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.181 -0.918 . . . . 2.6 109.776 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -96.21 158.63 15.35 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.362 -0.381 . . . . 2.17 110.012 176.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.527 HG22 ' OE1' ' A' ' 48' ' ' GLN . 11.1 t -114.43 147.46 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.322 -0.622 . . . . 0.59 109.322 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -76.67 -27.44 55.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.171 -0.468 . . . . 2.83 111.191 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' H ' HG12 ' A' ' 25' ' ' VAL . 31.5 mmmt -93.21 129.49 39.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.58 -0.526 . . . . 4.07 109.58 177.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.3 m -132.84 32.1 3.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.207 0.527 . . . . 2.46 110.516 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.3 m -75.23 -54.85 6.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.41 -0.814 . . . . 2.0 110.331 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.22 111.8 0.71 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.923 -0.656 . . . . 1.39 112.485 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' A' ' 75' ' ' GLU . 39.6 mt-10 -70.35 -47.69 59.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.411 0.148 . . . . 3.06 110.966 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 74' ' ' VAL . 20.4 mm-40 . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 109.715 -0.476 . . . . 2.44 109.715 176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.614 ' HB3' HG23 ' A' ' 82' ' ' ILE . 32.1 mt-30 . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.883 0.373 . . . . 1.4 110.609 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.08 105.55 16.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.159 -0.473 . . . . 1.37 110.075 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -98.45 110.42 23.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.519 -0.764 . . . . 0.3 111.29 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 84' ' ' CYS . 19.8 pt -113.31 148.74 16.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.969 -0.56 . . . . 0.23 110.307 174.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.527 ' OE1' HG22 ' A' ' 25' ' ' VAL . 10.4 tp60 -75.05 132.4 41.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.33 -0.85 . . . . 2.38 109.253 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.0 t -126.55 163.82 22.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.679 -0.691 . . . . 1.15 110.463 -171.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 t -161.2 127.96 4.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.12 0.486 . . . . 0.6 110.111 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -121.13 129.81 53.45 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.067 0.461 . . . . 2.08 111.463 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mt -71.66 137.71 83.09 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.217 -0.902 . . . . 0.95 109.717 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.3 109.29 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.037 3.158 . . . . 0.95 112.371 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.98 140.26 52.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.443 -0.798 . . . . 1.67 112.867 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 85.2 mt -93.2 147.55 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.888 -1.051 . . . . 1.58 108.544 167.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.4 mp -71.73 138.19 22.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.088 0.47 . . . . 2.11 110.276 -177.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.59 5.85 83.63 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.427 -0.806 . . . . 1.03 112.715 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.453 HG21 ' OE2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -93.36 154.29 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.569 0.7 . . . . 0.77 111.343 -177.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.32 134.85 33.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.613 -1.176 . . . . 0.68 111.01 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 61' ' ' GLU . 6.6 tp -50.68 -41.45 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.36 -0.836 . . . . 0.69 111.715 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.428 ' N ' HG23 ' A' ' 60' ' ' ILE . 3.0 pt-20 -74.84 -27.68 60.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.752 -0.658 . . . . 2.2 111.716 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -96.39 -22.33 17.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.349 -0.387 . . . . 1.98 110.698 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.453 ' OE2' HG21 ' A' ' 58' ' ' ILE . 9.0 tp10 -68.22 -36.71 79.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.576 0.703 . . . . 2.09 110.091 177.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.9 p -118.82 177.22 4.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.489 -0.778 . . . . 0.6 110.345 -172.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -125.53 40.92 3.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.742 0.782 . . . . 2.32 109.824 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 43.4 m-80 -126.65 -165.58 1.47 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.055 -0.975 . . . . 1.06 108.94 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 12.5 m -87.21 125.79 64.84 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 120.438 -0.505 . . . . 0.34 110.836 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.09 121.88 4.58 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.679 2.253 . . . . 0.45 110.472 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.5 p -129.79 151.57 50.22 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.138 -0.625 . . . . 0.31 111.809 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 12.2 t -99.35 101.58 12.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.297 -0.865 . . . . 1.26 109.105 171.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.642 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 59.8 m -84.99 133.2 34.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.627 0.727 . . . . 0.29 110.076 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 65.0 mt-10 -63.46 -40.29 96.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.779 -1.1 . . . . 1.53 109.71 175.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -153.61 166.0 34.15 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.31 -0.859 . . . . 1.26 109.002 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.509 HG13 ' HD3' ' A' ' 15' ' ' LYS . 15.8 m -133.98 160.27 41.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.159 0.504 . . . . 1.07 110.697 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 33.5 tt0 -129.55 155.03 46.44 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.8 -1.185 . . . . 1.87 107.8 173.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER 67.59 -156.01 0.21 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.565 -0.531 . . . . 1.94 109.565 -172.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.439 ' H ' ' HB3' ' A' ' 76' ' ' ASP . 31.2 t70 -73.11 -3.14 24.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.55 0.69 . . . . 2.12 110.224 173.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.27 22.94 2.76 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.793 -0.64 . . . . 0.51 111.615 -175.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.4 mt -86.05 -15.78 40.23 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.261 0.553 . . . . 1.1 109.955 175.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 73.5 t -123.32 112.86 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.37 -0.832 . . . . 0.33 108.922 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -106.82 137.06 13.72 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.011 -1.09 . . . . 0.26 112.238 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -99.55 120.71 49.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 122.437 0.295 . . . . 0.3 110.454 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 95.6 m-20 59.16 44.07 16.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.537 -0.756 . . . . 0.34 110.997 173.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.553 ' HB2' HD11 ' A' ' 47' ' ' ILE . 45.1 m -77.85 105.11 8.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.387 -0.824 . . . . 0.81 110.864 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 85.7 m -89.35 125.42 61.8 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.986 -0.552 . . . . 0.44 110.13 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 35.2 Cg_exo -62.67 121.97 10.12 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.751 2.301 . . . . 0.39 111.694 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.8 pt -92.44 144.83 29.46 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 116.199 -0.455 . . . . 0.57 110.318 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--O 1.234 0.303 0 C-N-CA 123.008 2.472 . . . . 1.05 112.073 -179.762 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.1 m95 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 121.3 0.571 . . . . 0.81 111.985 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -82.6 109.43 16.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.107 -0.952 . . . . 2.73 111.092 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 t -105.83 28.76 7.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.729 -0.669 . . . . 1.75 109.324 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -26.09 30.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.44 -0.8 . . . . 3.24 112.791 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.6 m -78.19 -14.06 59.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.159 0.504 . . . . 2.05 111.003 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.42 16.53 68.63 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.357 -1.497 . . . . 0.88 109.357 -168.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.475 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 2.1 p -69.81 -30.82 68.43 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.887 -1.157 . . . . 1.72 112.775 -169.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.2 t -126.02 143.31 51.15 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.541 -0.464 . . . . 1.19 111.26 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.519 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.4 p30 -92.04 -29.16 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 1.66 111.425 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.519 HG23 ' OD1' ' A' ' 12' ' ' ASN . 22.4 p -97.48 -31.02 12.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.006 0.432 . . . . 0.52 111.97 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.64 2.74 58.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.826 -0.702 . . . . 0.43 111.582 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 41.2 mttp -90.89 88.27 6.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.753 0.311 . . . . 1.64 110.376 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.95 122.04 38.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.42 -0.355 . . . . 0.55 110.091 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.549 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -131.25 146.1 52.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.73 0.3 . . . . 0.29 110.58 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 50' ' ' THR . 35.4 m -85.18 98.38 10.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 0.74 109.89 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 65.3 m -116.76 157.91 24.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.433 -0.349 . . . . 0.5 111.462 -168.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.591 ' CB ' ' HD3' ' A' ' 23' ' ' LYS . 50.3 m-20 -102.76 112.86 25.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.183 -0.673 . . . . 1.65 109.183 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.8 p -74.81 -15.88 60.72 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.388 0.514 . . . . 0.52 112.388 -172.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -98.59 -0.4 43.21 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.764 0.792 . . . . 2.2 109.422 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HD3' ' CB ' ' A' ' 20' ' ' ASP . 35.4 mtpt -112.74 100.95 9.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.564 -1.198 . . . . 2.6 109.685 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.83 161.81 13.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.735 -0.666 . . . . 2.17 111.554 -174.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -127.79 142.31 44.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.045 -1.094 . . . . 0.59 108.045 173.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -90.94 -23.82 20.35 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.789 0.328 . . . . 2.83 111.201 -173.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 28.8 mmmt -103.48 119.78 39.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.112 0.482 . . . . 4.07 111.284 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.531 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 15.4 p -126.42 120.66 30.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.578 -0.737 . . . . 2.46 109.624 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.5 m -88.39 -54.33 4.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.548 -0.296 . . . . 2.0 110.575 -176.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.22 70.38 1.1 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.586 -0.816 . . . . 1.39 111.173 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -78.94 -27.68 43.64 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.636 0.236 . . . . 3.06 111.636 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 120.51 -0.476 . . . . 2.44 110.497 178.672 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HB3' HG23 ' A' ' 82' ' ' ILE . 96.2 mt-30 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 121.107 0.479 . . . . 1.4 111.476 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.96 119.53 62.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.643 -0.708 . . . . 1.37 110.024 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -100.45 124.99 46.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.962 -0.563 . . . . 0.3 110.899 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 84' ' ' CYS . 18.2 pt -118.93 152.11 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.127 0.489 . . . . 0.23 110.346 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.05 127.7 33.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.556 -0.905 . . . . 2.38 108.556 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.622 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 4.5 t -133.71 169.1 17.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.848 -0.614 . . . . 1.15 110.418 -170.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 11.7 t -160.02 137.04 9.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.072 0.463 . . . . 0.6 110.304 178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.27 132.82 55.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.001 0.429 . . . . 2.08 110.1 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.401 HG23 ' HD2' ' A' ' 53' ' ' PRO . 37.2 mm -80.71 144.97 57.14 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.95 110.468 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' HG23 ' A' ' 52' ' ' ILE . 2.7 Cg_exo -37.26 126.75 0.58 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.039 3.16 . . . . 0.95 113.345 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.88 123.71 17.89 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.258 -0.883 . . . . 1.67 113.121 -171.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.72 129.41 55.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.272 -0.876 . . . . 1.58 109.289 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 56' ' ' ILE . 3.2 mp -69.55 135.73 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.169 0.509 . . . . 2.11 110.7 -176.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.1 11.02 81.71 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.308 -0.86 . . . . 1.03 113.178 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.496 HD13 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -106.07 154.05 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.618 0.723 . . . . 0.77 112.326 -176.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.43 145.87 24.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.402 -1.272 . . . . 0.68 111.215 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 61' ' ' GLU . 7.2 tp -53.22 -43.39 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 122.866 0.466 . . . . 0.69 111.229 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.421 ' N ' HG23 ' A' ' 60' ' ' ILE . 8.5 pt-20 -74.33 -22.05 59.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.118 -0.492 . . . . 2.2 111.238 -175.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -90.48 -34.55 15.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.334 0.588 . . . . 1.98 109.753 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -67.9 -35.21 78.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.066 -0.97 . . . . 2.09 110.592 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.0 p -121.82 172.13 8.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.802 -0.635 . . . . 0.6 110.337 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -120.7 21.42 11.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 2.32 111.416 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.534 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 38.6 m-80 -104.12 -168.14 1.45 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.474 -0.565 . . . . 1.06 109.474 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -85.95 120.89 72.97 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-O 121.495 0.664 . . . . 0.34 111.465 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.83 122.52 9.9 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.353 2.702 . . . . 0.45 111.219 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.8 p -132.43 154.86 49.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.699 -0.228 . . . . 0.31 110.633 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 11.8 t -99.72 117.07 33.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.462 -0.57 . . . . 1.26 109.462 171.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 46.6 m -102.46 139.51 37.96 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.119 0.485 . . . . 0.29 109.748 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 6.6 tt0 -78.03 -20.88 51.6 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.512 0.673 . . . . 1.53 109.724 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.401 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 22.8 t0 -159.34 158.96 33.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.325 -0.991 . . . . 1.26 108.325 171.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.496 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.6 OUTLIER -148.65 129.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 117.852 0.297 . . . . 1.07 110.465 178.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.51 165.91 13.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.731 0.301 . . . . 1.87 110.591 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.82 -150.16 0.31 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.587 -0.733 . . . . 1.94 110.24 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.94 5.08 14.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.96 0.409 . . . . 2.12 110.141 172.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 118.57 24.04 3.25 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.665 -0.779 . . . . 0.51 112.691 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.06 -21.29 29.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.05 0.425 . . . . 1.1 111.534 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.08 102.79 8.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.891 -0.411 . . . . 0.33 109.891 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -102.34 139.76 14.56 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.455 -0.879 . . . . 0.26 112.966 -176.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.426 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -96.0 120.95 46.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 122.737 0.415 . . . . 0.3 109.905 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 95.5 m-20 60.76 48.62 6.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.525 -0.761 . . . . 0.34 110.975 173.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.622 ' HB2' HD11 ' A' ' 47' ' ' ILE . 57.4 m -83.1 111.42 18.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.619 -0.718 . . . . 0.81 110.564 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 24.7 m -105.29 128.11 27.27 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.704 -0.68 . . . . 0.44 109.918 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.9 Cg_exo -59.95 125.33 17.39 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.976 2.451 . . . . 0.39 112.099 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.475 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 16.2 pt -96.49 162.45 23.4 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 115.55 -0.75 . . . . 0.57 111.107 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 N--CA 1.46 -0.466 0 C-N-CA 123.237 2.624 . . . . 1.05 112.176 -178.54 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.466 ' CZ2' HD22 ' A' ' 54' ' ' LEU . 49.1 m95 . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 120.899 0.38 . . . . 0.81 111.219 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.556 ' OE2' ' HD2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -65.77 108.25 2.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.629 -0.878 . . . . 2.73 108.629 175.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 m -106.75 28.21 8.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.968 -0.56 . . . . 1.75 112.344 -167.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.556 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -50.35 -25.24 3.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.834 0.679 . . . . 3.24 112.834 -177.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 t -71.76 -28.66 63.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 2.05 111.733 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.81 1.44 54.62 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.173 -0.537 . . . . 0.88 113.226 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -77.33 -15.89 59.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.773 0.286 . . . . 1.72 111.773 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.59 139.96 38.19 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.577 -0.449 . . . . 1.19 110.206 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.65 HD22 ' N ' ' A' ' 13' ' ' THR . 0.4 OUTLIER -94.54 -21.73 18.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.748 0.648 . . . . 1.66 112.748 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.65 ' N ' HD22 ' A' ' 12' ' ' ASN . 2.0 p -104.41 -30.89 9.79 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.229 0.455 . . . . 0.52 112.229 -174.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.47 -3.27 59.43 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.612 -0.804 . . . . 0.43 111.999 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.599 ' NZ ' ' HA ' ' A' ' 73' ' ' ASP . 90.4 mttt -87.91 88.07 7.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.095 0.474 . . . . 1.64 109.967 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -93.53 103.07 15.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.865 -0.607 . . . . 0.55 110.189 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.41 154.06 28.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.105 0.478 . . . . 0.29 110.752 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 65.6 m -88.94 103.62 16.2 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.611 -0.722 . . . . 0.74 109.179 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -125.44 150.72 47.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.057 0.456 . . . . 0.5 112.037 -170.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.87 104.24 16.32 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.619 -0.719 . . . . 1.65 110.321 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.473 HG21 ' HG3' ' A' ' 86' ' ' PRO . 74.4 p -72.48 -5.79 39.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.078 0.466 . . . . 0.52 111.327 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -96.91 -22.68 16.73 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.846 0.831 . . . . 2.2 109.013 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 48' ' ' GLN . 27.5 tptt -106.88 110.98 23.29 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.245 -1.343 . . . . 2.6 109.895 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -100.93 161.88 13.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.428 -0.806 . . . . 2.17 111.861 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 t -126.2 148.0 30.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.236 -0.893 . . . . 0.59 108.807 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -97.93 22.14 9.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.821 0.343 . . . . 2.83 111.419 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -134.45 119.93 19.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.222 -0.444 . . . . 4.07 110.119 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 73.5 p -140.85 86.09 2.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.909 0.385 . . . . 2.46 110.528 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.1 m -108.28 -47.66 3.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.24 0.543 . . . . 2.0 110.203 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.69 164.02 34.16 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.251 -0.886 . . . . 1.39 112.739 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 21.9 mm-40 -101.78 -45.19 5.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.065 0.46 . . . . 3.06 109.915 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.445 -0.716 0 CA-C-N 115.829 -0.623 . . . . 2.44 109.78 179.582 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.548 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.6 mt-30 . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.236 0.541 . . . . 1.4 111.182 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.776 HG12 ' HA ' ' A' ' 83' ' ' ASN . 14.7 p -105.66 127.92 60.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.413 -0.812 . . . . 1.37 110.163 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.82 121.86 45.59 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.36 -0.836 . . . . 0.3 110.379 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.569 HD11 ' HB2' ' A' ' 84' ' ' CYS . 19.1 pt -130.7 160.8 41.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.891 -0.595 . . . . 0.23 109.697 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 1.5 mm-40 -77.34 135.76 38.4 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.504 0.668 . . . . 2.38 110.642 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.6 m -131.11 153.57 49.21 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.453 -1.248 . . . . 1.15 110.146 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 8.4 t -156.56 128.34 7.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.083 0.468 . . . . 0.6 110.038 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 tm0? -120.87 110.62 16.53 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.989 0.424 . . . . 2.08 110.515 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mt -65.73 128.94 94.19 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.619 -0.719 . . . . 0.95 109.889 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -34.0 99.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 125.128 3.885 . . . . 0.95 113.531 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.466 HD22 ' CZ2' ' A' ' 4' ' ' TRP . 3.3 pp -70.29 136.89 50.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.851 -1.068 . . . . 1.67 112.393 -172.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.4 mt -94.95 120.6 35.43 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.494 -0.928 . . . . 1.58 108.494 168.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.06 133.09 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.361 0.601 . . . . 2.11 111.081 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.43 -24.96 22.99 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.085 -0.962 . . . . 1.03 111.478 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -87.06 155.03 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.466 0.65 . . . . 0.77 111.107 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.85 143.94 26.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.666 -1.152 . . . . 0.68 111.624 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 tp -54.71 -35.25 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.018 -0.992 . . . . 0.69 110.974 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -76.79 -16.8 59.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.069 -0.969 . . . . 2.2 111.701 -173.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.33 -24.5 11.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.09 0.471 . . . . 1.98 110.704 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.8 tp10 -74.93 -38.04 61.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.848 -0.615 . . . . 2.09 111.1 -175.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 p -113.61 173.14 6.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.251 -0.277 . . . . 0.6 110.251 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -118.84 46.19 1.91 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.221 0.534 . . . . 2.32 110.699 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 42.4 m-80 -135.39 -174.16 3.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.822 -0.626 . . . . 1.06 109.331 175.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.6 m -80.35 125.29 81.46 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-O 121.403 0.62 . . . . 0.34 111.786 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -63.05 115.52 3.01 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.339 2.693 . . . . 0.45 110.998 171.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.3 p -127.26 143.32 51.26 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.322 -0.551 . . . . 0.31 111.265 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 36.0 t -93.27 106.19 18.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 1.26 109.68 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 57.1 m -92.73 134.0 35.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.156 -0.474 . . . . 0.29 109.959 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -64.9 -36.08 83.21 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.206 -0.665 . . . . 1.53 109.206 175.154 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.599 ' HA ' ' NZ ' ' A' ' 15' ' ' LYS . 40.3 t0 -152.25 165.55 34.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.368 -0.975 . . . . 1.26 108.368 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.502 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.2 t -136.48 133.55 49.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.633 -0.506 . . . . 1.07 109.633 175.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 31' ' ' GLU . 16.1 tt0 -102.94 164.69 11.47 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.139 -0.482 . . . . 1.87 109.701 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 78' ' ' GLY . 1.8 m-20 63.67 -156.52 0.32 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.272 0.357 . . . . 1.94 110.156 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.45 23.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.895 0.379 . . . . 2.12 110.882 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 95.7 22.62 20.66 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.949 -0.643 . . . . 0.51 111.777 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.401 ' HB3' HE22 ' A' ' 48' ' ' GLN . 81.7 mt -90.21 -18.68 25.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 1.1 111.247 -177.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.9 t -131.69 109.98 16.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.772 -0.455 . . . . 0.33 109.772 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -97.04 144.83 17.58 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.28 -0.962 . . . . 0.26 112.382 -177.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -100.77 120.83 50.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.866 -0.42 . . . . 0.3 109.866 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.776 ' HA ' HG12 ' A' ' 45' ' ' VAL . 89.4 m-20 58.46 53.76 6.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.026 -0.534 . . . . 0.34 110.807 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.596 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 66.8 m -89.36 95.44 10.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.728 -0.669 . . . . 0.81 110.94 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 8.0 m -88.18 127.25 57.97 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.718 -0.674 . . . . 0.44 110.732 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.473 ' HG3' HG21 ' A' ' 21' ' ' THR . 39.7 Cg_exo -62.57 118.01 4.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.896 2.397 . . . . 0.39 111.63 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.6 pt -97.98 148.45 34.49 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.925 -0.579 . . . . 0.57 111.558 -174.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.4 Cg_exo . . . . . 0 C--N 1.345 0.375 0 C-N-CA 123.355 2.703 . . . . 1.05 111.872 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 N-CA-C 112.205 -0.358 . . . . 5.75 112.205 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -148.78 163.76 36.41 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.743 -0.269 . . . . 4.66 110.387 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.45 -82.32 1.35 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.817 -0.706 . . . . 1.6 112.16 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -121.5 144.33 48.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.927 0.394 . . . . 0.81 111.079 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -66.55 108.95 2.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.631 -0.713 . . . . 2.73 110.463 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -108.97 25.99 11.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.676 -0.693 . . . . 1.75 110.448 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -20.08 62.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.903 -0.59 . . . . 3.24 111.414 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -69.06 -20.41 64.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.123 0.487 . . . . 2.05 110.699 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.65 7.09 87.25 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.836 -0.62 . . . . 0.88 112.637 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 m -70.96 -27.46 63.75 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.783 0.29 . . . . 1.72 111.783 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.1 t -108.53 141.64 40.14 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.93 -0.308 . . . . 1.19 110.383 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.501 ' OD1' HG23 ' A' ' 13' ' ' THR . 9.5 p30 -93.22 -19.87 21.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 1.66 112.129 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.501 HG23 ' OD1' ' A' ' 12' ' ' ASN . 19.8 p -108.86 -31.11 7.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.914 0.388 . . . . 0.52 111.957 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.13 2.09 56.96 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.749 -0.739 . . . . 0.43 111.943 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.66 ' HD3' HG23 ' A' ' 74' ' ' VAL . 78.3 mttt -94.87 89.23 5.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.127 0.489 . . . . 1.64 110.443 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.4 mp -93.61 128.56 39.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 0.55 109.999 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -137.16 156.75 47.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.517 -0.31 . . . . 0.29 110.301 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 50' ' ' THR . 82.4 m -91.91 97.66 11.1 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.278 -0.638 . . . . 0.74 109.278 173.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 82.4 m -111.64 155.65 23.06 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.963 0.411 . . . . 0.5 111.066 -171.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 20.5 t0 -98.24 127.82 44.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.033 -1.099 . . . . 1.65 108.033 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.7 p -92.69 1.88 57.03 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.362 0.601 . . . . 0.52 110.501 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -105.55 -25.05 12.46 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.982 -0.748 . . . . 2.2 108.982 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 26.2 mtmm -102.32 135.9 43.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.204 -0.907 . . . . 2.6 110.092 176.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -139.96 164.45 29.97 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.561 -0.745 . . . . 2.17 111.954 -176.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.44 HG21 HG22 ' A' ' 80' ' ' VAL . 2.5 t -117.88 148.49 20.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.609 -0.723 . . . . 0.59 110.123 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -83.88 -21.43 31.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.317 -0.401 . . . . 2.83 111.191 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 8.9 mmpt? -94.13 136.21 34.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.349 -0.611 . . . . 4.07 109.349 176.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 23.0 p -156.92 96.65 1.62 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.799 0.333 . . . . 2.46 111.632 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -122.16 -69.12 0.85 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.758 -0.377 . . . . 2.0 111.475 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.37 77.87 0.49 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.974 -0.85 . . . . 1.39 110.974 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -103.43 20.55 17.62 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.449 0.537 . . . . 3.06 112.449 -174.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.486 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . 83.8 mt-10 -86.84 -60.97 1.84 Allowed 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 120.102 -0.639 . . . . 2.44 109.948 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.2 m -92.21 -31.17 15.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.59 0.71 . . . . 2.36 109.197 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.05 44.92 1.99 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.897 -1.047 . . . . 2.54 112.733 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.665 HD12 ' H ' ' A' ' 35' ' ' LEU . 5.5 mp -40.69 -53.95 2.69 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.115 0.483 . . . . 3.49 110.254 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.4 tp -108.74 97.07 6.77 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.218 -0.66 . . . . 4.79 109.218 170.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -111.87 -26.52 8.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.005 -0.543 . . . . 6.59 111.125 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.2 m -63.85 -26.44 68.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.762 -0.654 . . . . 5.42 112.372 -169.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.02 6.61 66.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.107 -1.044 . . . . 3.27 112.741 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -119.99 -51.06 2.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.077 0.465 . . . . 4.15 110.442 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.75 131.1 50.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.858 -0.61 . . . . 2.58 111.761 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.8 mt -118.56 -11.16 9.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.337 -0.847 . . . . 3.5 110.121 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -85.64 1.35 49.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.471 -0.786 . . . . 2.29 111.203 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.494 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 26.1 mt-30 -44.52 131.7 6.46 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.725 0.64 . . . . 1.4 111.622 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.4 t -100.14 123.08 52.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.171 -0.922 . . . . 1.37 109.713 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . -110.04 100.48 9.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.637 -0.71 . . . . 0.3 110.658 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 12.2 pt -100.88 149.64 6.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.918 -0.583 . . . . 0.23 110.591 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.79 126.63 30.2 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.768 -0.827 . . . . 2.38 108.768 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.486 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -126.07 158.64 34.9 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.88 -0.6 . . . . 1.15 110.203 -172.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 5.2 t -160.59 127.57 4.26 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.24 -0.436 . . . . 0.6 110.116 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.434 HE21 HD12 ' A' ' 60' ' ' ILE . 5.0 tm0? -116.4 107.64 15.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.496 0.665 . . . . 2.08 111.044 -176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.8 mt -64.6 134.29 95.97 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 114.855 -1.066 . . . . 0.95 109.665 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -32.33 101.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.699 3.599 . . . . 0.95 114.259 -170.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 54' ' ' LEU . 3.9 pp -75.82 142.15 42.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.15 -1.387 . . . . 1.67 113.099 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.1 mp -91.68 145.26 24.73 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.359 -0.837 . . . . 1.58 109.288 167.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.4 136.17 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.85 0.357 . . . . 2.11 110.778 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.12 -7.77 69.93 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.577 -0.738 . . . . 1.03 112.865 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.491 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -81.75 160.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.372 0.605 . . . . 0.77 111.762 -175.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' N ' HG23 ' A' ' 58' ' ' ILE . . . -90.07 129.95 36.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.032 -0.985 . . . . 0.68 111.202 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.434 HD12 HE21 ' A' ' 51' ' ' GLN . 8.6 tp -53.92 -36.66 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 114.984 -1.007 . . . . 0.69 112.353 -177.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.13 -21.83 49.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.744 0.307 . . . . 2.2 111.432 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.91 -26.57 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.079 0.466 . . . . 1.98 110.599 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.491 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 9.7 tp10 -68.63 -35.01 76.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.802 -0.635 . . . . 2.09 111.136 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.9 p -127.39 154.44 45.0 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 120.872 0.368 . . . . 0.6 110.902 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -98.84 56.07 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.871 0.843 . . . . 2.32 109.726 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 52.1 m-80 -137.86 -170.38 2.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.129 -0.941 . . . . 1.06 108.727 175.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.0 m -89.35 126.09 59.63 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-O 121.114 0.483 . . . . 0.34 110.592 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.94 120.44 4.65 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.686 2.258 . . . . 0.45 111.079 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.753 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 2.8 p -120.59 157.85 28.62 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.884 -0.598 . . . . 0.31 111.567 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 34.0 t -108.97 104.51 13.76 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.206 -0.664 . . . . 1.26 109.206 170.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.489 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 92.1 m -87.38 139.59 30.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.359 -0.608 . . . . 0.29 109.359 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.1 tt0 -71.57 -31.24 66.76 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.064 -0.717 . . . . 1.53 109.064 174.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 32' ' ' GLU . 6.9 t0 -156.33 164.02 38.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.866 -1.161 . . . . 1.26 107.866 171.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.66 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.4 t -137.01 139.12 45.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.652 -0.419 . . . . 1.07 110.022 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 10.1 tt0 -100.13 159.01 15.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.156 -0.475 . . . . 1.87 109.963 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 61.73 -151.22 0.38 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.066 -0.515 . . . . 1.94 110.133 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -79.65 16.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.083 0.468 . . . . 2.12 110.579 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.562 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 110.49 21.76 6.72 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.813 -0.63 . . . . 0.51 112.3 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.92 -21.87 31.72 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.758 0.281 . . . . 1.1 111.758 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 21.7 t -127.72 103.63 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 C-N-CA 120.898 -0.321 . . . . 0.33 110.43 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.489 ' HA3' ' SG ' ' A' ' 71' ' ' CYS . . . -91.84 123.79 7.37 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.057 -1.068 . . . . 0.26 112.265 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -86.43 118.34 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.671 -0.492 . . . . 0.3 109.671 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 92.9 m-20 59.99 41.78 16.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.665 -0.698 . . . . 0.34 110.764 174.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.753 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -81.21 109.97 16.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.81 110.457 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 17.2 m -94.17 130.27 34.71 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 115.776 -0.647 . . . . 0.44 109.698 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.3 Cg_exo -60.62 109.96 0.74 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.715 2.277 . . . . 0.39 111.442 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 5.5 pt -74.66 141.66 76.28 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-N 115.623 -0.717 . . . . 0.57 111.26 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.3 Cg_exo -68.8 154.85 70.39 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.278 2.652 . . . . 1.05 112.392 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.7 mt -91.38 24.67 2.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.635 -0.711 . . . . 1.45 110.429 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 90' ' ' ILE . 24.3 pt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 116.152 -0.477 . . . . 2.31 111.243 -173.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.882 -0.487 . . . . 5.75 111.882 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.8 m -90.78 37.73 0.93 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.883 0.373 . . . . 4.66 110.54 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.91 -62.85 3.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 1.6 111.692 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.44 ' CH2' HD22 ' A' ' 54' ' ' LEU . 94.5 m95 -92.49 139.97 30.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.737 0.303 . . . . 0.81 110.199 176.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.521 ' OE1' ' HG2' ' A' ' 7' ' ' LYS . 30.9 tt0 -59.37 109.05 0.8 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.488 -0.778 . . . . 2.73 110.848 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -91.54 27.51 1.98 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.64 -0.709 . . . . 1.75 111.429 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HG2' ' OE1' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -56.45 -25.87 52.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.066 -0.516 . . . . 3.24 112.179 -176.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 p -77.15 -30.01 54.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.049 0.452 . . . . 2.05 111.537 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.55 15.04 80.65 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.88 112.087 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.404 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 10.9 p -77.47 -25.18 50.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.307 0.484 . . . . 1.72 112.307 -174.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -102.97 142.68 33.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.218 -0.446 . . . . 1.19 110.933 -173.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.539 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.8 p30 -91.11 -29.25 17.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.789 -0.641 . . . . 1.66 111.478 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.539 HG23 ' OD1' ' A' ' 12' ' ' ASN . 13.0 p -100.91 -31.19 11.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.104 0.478 . . . . 0.52 111.627 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.86 -2.88 52.25 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.815 -0.707 . . . . 0.43 112.115 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.587 ' HD3' HG23 ' A' ' 74' ' ' VAL . 90.7 mttt -86.72 88.76 7.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.009 0.433 . . . . 1.64 110.428 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 69' ' ' THR . 9.6 mp -92.32 110.73 22.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.55 110.492 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.0 149.23 39.16 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.08 0.467 . . . . 0.29 110.482 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -87.03 106.01 17.55 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.64 -0.709 . . . . 0.74 109.167 172.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.2 m -122.8 154.37 38.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.084 -0.507 . . . . 0.5 111.52 -172.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 4.1 m-20 -100.03 114.64 28.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.509 -0.769 . . . . 1.65 109.174 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.0 p -74.82 -7.02 52.17 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.134 0.492 . . . . 0.52 110.968 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -98.01 -6.51 31.8 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.018 -0.734 . . . . 2.2 109.018 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 46.1 mtpt -111.62 98.71 7.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.83 -1.077 . . . . 2.6 109.759 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.82 157.67 16.14 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.271 -0.877 . . . . 2.17 110.782 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.4 t -120.22 145.15 26.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.684 -0.858 . . . . 0.59 108.684 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -95.18 29.84 2.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.065 0.46 . . . . 2.83 111.442 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 7.3 mmpt? -129.17 161.16 30.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.046 -0.525 . . . . 4.07 109.831 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 p -150.12 66.2 0.97 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.129 0.49 . . . . 2.46 110.406 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 m -122.1 143.69 49.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.753 -0.658 . . . . 2.0 109.679 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.03 148.78 18.56 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.215 -0.993 . . . . 1.39 112.842 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -78.61 -38.17 40.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.915 0.388 . . . . 3.06 110.285 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -110.96 -43.18 3.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 2.44 110.186 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.0 t -65.55 -25.34 67.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.954 -0.567 . . . . 2.36 110.034 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.3 -14.79 69.38 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.887 -0.597 . . . . 2.54 112.882 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.7 mp -78.93 -30.14 44.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.446 0.641 . . . . 3.49 109.658 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.9 mt -91.7 173.04 8.08 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.359 -0.837 . . . . 4.79 109.724 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -78.58 -3.59 44.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.436 0.636 . . . . 6.59 109.693 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 m -72.27 -29.18 63.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.237 -0.892 . . . . 5.42 110.562 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.453 ' HA2' ' OE1' ' A' ' 44' ' ' GLN . . . -96.21 7.9 66.95 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.814 -0.63 . . . . 3.27 111.973 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.96 -47.04 15.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.529 0.68 . . . . 4.15 110.099 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 41' ' ' VAL . 2.5 m -60.29 145.64 11.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.478 -1.237 . . . . 2.58 113.362 -174.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.6 mt -82.32 -8.71 59.63 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.649 -1.16 . . . . 3.5 109.544 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -64.4 -26.55 68.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.36 -0.836 . . . . 2.29 111.341 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.587 ' HB3' HG23 ' A' ' 82' ' ' ILE . 32.1 mt-30 -51.12 131.59 27.53 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.295 0.569 . . . . 1.4 111.046 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.8 t -89.41 105.33 15.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.258 -0.883 . . . . 1.37 110.268 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -101.33 116.0 31.8 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.67 -0.695 . . . . 0.3 110.722 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 84' ' ' CYS . 8.0 pt -120.81 155.16 24.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.859 -0.61 . . . . 0.23 109.887 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.72 123.5 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.869 0.842 . . . . 2.38 109.43 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 60.2 m -122.57 157.35 32.31 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.316 -1.311 . . . . 1.15 110.598 -171.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.9 t -161.18 138.43 8.94 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.913 0.387 . . . . 0.6 110.38 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -121.58 152.09 39.64 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.548 0.69 . . . . 2.08 111.156 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.574 HG23 ' HD2' ' A' ' 53' ' ' PRO . 23.1 mt -90.6 142.13 27.72 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.779 -1.1 . . . . 0.95 108.687 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.574 ' HD2' HG23 ' A' ' 52' ' ' ILE . 57.2 Cg_exo -33.59 108.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 124.216 3.277 . . . . 0.95 113.393 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 52' ' ' ILE . 22.5 mt -66.13 130.08 41.99 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 114.954 -1.021 . . . . 1.67 113.112 -166.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.633 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 86.4 mt -99.48 122.6 42.8 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.704 -0.85 . . . . 1.58 108.704 166.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.1 mt -67.81 132.3 32.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.06 0.457 . . . . 2.11 110.637 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.67 14.6 61.1 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.458 -0.792 . . . . 1.03 112.089 -176.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -105.48 155.07 6.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.773 0.797 . . . . 0.77 111.818 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.38 135.82 33.36 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.373 -1.285 . . . . 0.68 111.036 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.403 HG21 HD23 ' A' ' 16' ' ' LEU . 5.7 tp -52.2 -32.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.248 -0.887 . . . . 0.69 111.106 177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.99 -27.88 61.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.998 -1.001 . . . . 2.2 111.927 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -107.35 -11.73 15.48 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.881 -0.328 . . . . 1.98 111.665 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.4 tp10 -79.15 -35.21 42.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.349 0.595 . . . . 2.09 110.413 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.418 ' HA ' HD12 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -124.83 171.59 10.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.002 -0.545 . . . . 0.6 110.148 -174.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -122.01 49.41 1.57 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.364 0.602 . . . . 2.32 109.997 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -138.77 -169.05 2.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.959 -0.564 . . . . 1.06 109.922 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -83.79 125.63 72.74 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 121.399 0.618 . . . . 0.34 111.931 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -65.25 123.43 11.51 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.435 2.757 . . . . 0.45 111.226 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 77.2 p -132.21 152.85 51.11 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.779 -0.369 . . . . 0.31 111.147 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 38.3 t -103.42 108.81 20.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.019 -0.537 . . . . 1.26 109.683 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 38.6 m -96.04 135.11 38.25 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.0 0.428 . . . . 0.29 110.603 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.4 tt0 -71.92 -29.55 64.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.418 0.628 . . . . 1.53 109.495 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -153.33 159.37 42.47 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.214 -1.032 . . . . 1.26 108.214 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.587 HG23 ' HD3' ' A' ' 15' ' ' LYS . 1.9 t -138.71 137.51 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.225 0.466 . . . . 1.07 110.509 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 76' ' ' ASP . 32.7 tt0 -104.54 157.43 17.17 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.91 -0.586 . . . . 1.87 110.634 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 78' ' ' GLY . 2.8 t70 67.24 -149.9 0.18 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.076 0.55 . . . . 1.94 109.857 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.03 16.11 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.939 0.876 . . . . 2.12 109.727 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.562 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . 99.22 23.33 11.43 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.557 -0.747 . . . . 0.51 111.558 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 34.1 mt -81.23 -25.68 36.45 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.962 0.41 . . . . 1.1 110.954 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.13 105.36 13.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.61 -0.515 . . . . 0.33 109.61 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.621 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -95.89 143.85 16.91 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.302 -0.951 . . . . 0.26 112.052 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -101.35 117.5 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 109.824 -0.436 . . . . 0.3 109.824 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 85.5 m-20 62.39 48.61 4.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.439 -0.801 . . . . 0.34 110.527 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.621 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 61.2 m -83.7 92.4 7.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.242 -0.89 . . . . 0.81 110.703 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.3 m -79.54 128.41 75.07 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.833 -0.622 . . . . 0.44 110.369 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -63.76 115.85 3.32 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.557 2.172 . . . . 0.39 110.797 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 8.8 pt -91.55 151.2 42.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.114 -0.494 . . . . 0.57 111.732 -173.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.3 Cg_exo -71.21 157.52 57.03 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.256 2.637 . . . . 1.05 111.823 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 mt -93.23 30.54 1.65 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.847 -0.615 . . . . 1.45 110.491 -177.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.7 pt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.288 -0.863 . . . . 2.31 111.232 -173.775 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.826 -0.509 . . . . 5.75 111.826 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.8 p -78.46 119.02 21.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.736 0.303 . . . . 4.66 110.694 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.55 166.55 38.01 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.926 -0.654 . . . . 1.6 111.906 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -82.2 151.74 26.74 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.743 0.306 . . . . 0.81 110.791 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -59.94 106.13 0.46 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.413 -0.812 . . . . 2.73 111.218 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.501 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 17.1 m -113.54 13.5 18.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.761 -0.654 . . . . 1.75 110.687 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -19.45 63.52 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.702 0.63 . . . . 3.24 112.702 -173.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 t -81.7 -9.47 59.64 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.276 -0.57 . . . . 2.05 110.591 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.98 15.6 59.06 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.927 -0.654 . . . . 0.88 112.803 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.417 ' HB2' HG21 ' A' ' 87' ' ' ILE . 12.3 p -78.87 -29.75 44.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.854 0.359 . . . . 1.72 111.453 -177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.4 t -128.62 141.68 51.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.976 0.417 . . . . 1.19 110.647 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.432 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.8 p30 -92.62 -24.43 18.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 1.66 111.846 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.432 HG23 ' OD1' ' A' ' 12' ' ' ASN . 26.1 p -97.58 -30.96 12.56 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.121 0.415 . . . . 0.52 112.121 -174.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.501 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 95.34 -0.14 63.5 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.525 -0.845 . . . . 0.43 111.713 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HD3' HG23 ' A' ' 74' ' ' VAL . 59.6 mttp -92.5 88.48 6.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.73 0.3 . . . . 1.64 110.352 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 69' ' ' THR . 7.8 mp -102.61 99.87 9.9 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.376 -0.375 . . . . 0.55 110.529 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.7 150.98 21.24 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.151 0.501 . . . . 0.29 110.61 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.838 ' SG ' ' HB2' ' A' ' 66' ' ' ASN . 10.4 t -84.22 100.75 11.39 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.335 -0.848 . . . . 0.74 108.72 175.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 59.3 m -125.93 150.41 48.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.177 0.513 . . . . 0.5 111.74 -169.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 9.4 t70 -92.97 130.36 38.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.231 -1.026 . . . . 1.65 108.231 172.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.41 HG21 ' HG3' ' A' ' 86' ' ' PRO . 60.6 p -85.91 -3.9 59.04 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.773 -0.371 . . . . 0.52 111.46 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -106.39 -39.19 5.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.109 0.48 . . . . 2.2 109.747 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 38.8 mtmt -74.32 132.24 41.88 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.889 0.852 . . . . 2.6 110.17 172.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.555 ' HD2' HG22 ' A' ' 47' ' ' ILE . 14.4 mmmm -124.09 156.7 36.13 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.406 -1.27 . . . . 2.17 110.821 -171.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 27' ' ' LYS . 2.2 t -119.88 144.3 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.37 -0.604 . . . . 0.59 109.37 175.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -81.04 -19.3 44.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.255 0.55 . . . . 2.83 110.474 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' H ' HG12 ' A' ' 25' ' ' VAL . 2.2 mmmp? -80.14 118.98 22.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.338 -0.846 . . . . 4.07 110.33 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -144.41 113.69 6.98 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.488 -0.56 . . . . 2.46 109.488 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.7 m -152.04 -80.17 0.11 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.434 -0.348 . . . . 2.0 110.494 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' HA2' ' OD1' ' A' ' 73' ' ' ASP . . . 98.27 141.41 12.21 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.82 -0.705 . . . . 1.39 112.289 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.37 -47.19 6.09 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.761 0.28 . . . . 3.06 111.124 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -82.41 -39.75 22.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.578 -0.527 . . . . 2.44 109.578 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 34.2 t -70.63 -28.57 64.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.863 -0.608 . . . . 2.36 109.366 173.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.88 -11.08 73.59 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.79 -0.641 . . . . 2.54 112.606 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.5 tp -80.62 -21.52 41.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.421 0.629 . . . . 3.49 109.832 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.491 ' HG ' ' H ' ' A' ' 37' ' ' HIS . 21.9 tp -110.7 177.97 4.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.559 -0.746 . . . . 4.79 109.41 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.491 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 55.2 t60 -70.34 -12.49 61.62 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.128 -0.357 . . . . 6.59 110.547 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.8 p -62.22 -32.75 73.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.744 0.306 . . . . 5.42 111.315 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.94 10.29 74.09 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.947 -0.644 . . . . 3.27 112.309 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -84.28 -37.55 21.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.668 0.747 . . . . 4.15 109.814 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 m -76.77 146.74 8.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.651 -1.159 . . . . 2.58 111.956 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.6 mt -89.47 0.63 56.73 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.595 -0.729 . . . . 3.5 109.205 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.53 -26.02 66.95 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.894 -1.048 . . . . 2.29 110.623 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.595 ' HB3' HG23 ' A' ' 82' ' ' ILE . 30.1 mt-30 -46.16 131.97 9.97 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 123.65 0.594 . . . . 1.4 110.418 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.8 t -84.09 104.2 12.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.684 -0.689 . . . . 1.37 110.491 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -97.32 100.81 12.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.271 -0.877 . . . . 0.3 110.477 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.555 HG22 ' HD2' ' A' ' 24' ' ' LYS . 15.2 pt -106.63 152.66 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.786 -0.643 . . . . 0.23 110.027 176.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.471 ' OE1' HG22 ' A' ' 25' ' ' VAL . 13.3 tp60 -76.73 118.74 19.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.735 0.779 . . . . 2.38 110.114 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 53.7 m -114.02 160.65 18.63 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 114.116 -1.402 . . . . 1.15 110.299 -175.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.614 ' O ' ' HB3' ' A' ' 18' ' ' CYS . 15.3 t -162.87 136.86 6.17 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.41 -0.589 . . . . 0.6 109.41 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.466 HE22 HD12 ' A' ' 60' ' ' ILE . 46.3 tp60 -117.81 107.53 14.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.314 0.578 . . . . 2.08 110.856 -175.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.485 HG23 ' HD2' ' A' ' 53' ' ' PRO . 60.2 mt -57.45 139.71 80.41 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.984 -1.007 . . . . 0.95 109.99 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 52' ' ' ILE . 50.2 Cg_exo -34.72 118.94 0.13 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 124.274 3.316 . . . . 0.95 113.156 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.56 136.55 53.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.435 -0.802 . . . . 1.67 113.005 -169.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.32 109.18 20.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.68 -1.229 . . . . 1.58 107.68 167.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 56' ' ' ILE . 15.8 mt -55.92 126.42 13.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.244 0.545 . . . . 2.11 111.438 -170.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.64 -4.62 58.09 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.278 -0.874 . . . . 1.03 113.086 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -98.37 151.16 4.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.718 0.771 . . . . 0.77 112.012 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.49 145.14 25.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.45 -1.25 . . . . 0.68 111.79 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.466 HD12 HE22 ' A' ' 51' ' ' GLN . 6.1 tp -40.79 -46.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.621 0.768 . . . . 0.69 113.026 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.433 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -70.92 -23.14 62.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.813 0.671 . . . . 2.2 112.813 -169.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -106.67 -7.49 17.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.424 0.631 . . . . 1.98 109.877 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -74.34 -39.11 63.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.586 -0.734 . . . . 2.09 109.77 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.3 p -132.38 162.88 29.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.475 -0.784 . . . . 0.6 110.431 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -108.39 33.8 3.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.862 0.319 . . . . 2.32 111.862 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.838 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 33.1 m-80 -115.21 -163.17 0.86 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.827 -0.805 . . . . 1.06 108.827 173.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.8 m -86.82 131.4 45.3 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 121.222 0.534 . . . . 0.34 111.068 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 44.7 Cg_endo -79.56 126.84 6.94 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.848 2.365 . . . . 0.45 110.356 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 71.3 p -131.26 145.57 51.95 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.393 -0.523 . . . . 0.31 111.631 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 42.2 t -94.99 111.67 23.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.406 -0.591 . . . . 1.26 109.406 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 38.0 m -96.8 144.03 27.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.251 0.548 . . . . 0.29 110.847 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.8 tt0 -82.14 -21.82 36.45 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.436 -0.802 . . . . 1.53 109.299 175.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 14.5 t70 -161.69 153.36 18.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.991 -1.114 . . . . 1.26 107.991 173.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.48 HG12 ' HA2' ' A' ' 78' ' ' GLY . 2.0 t -135.35 128.69 48.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.459 -0.497 . . . . 1.07 109.853 173.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -94.4 169.48 10.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.762 -0.654 . . . . 1.87 110.841 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 56.53 -148.86 0.48 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.028 -0.987 . . . . 1.94 111.296 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -80.51 23.09 0.53 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.698 0.761 . . . . 2.12 110.127 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.48 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . 92.08 23.28 27.81 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.903 -0.665 . . . . 0.51 112.235 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -91.06 -19.11 23.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.381 . . . . 1.1 111.126 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 25' ' ' VAL . 60.7 t -126.09 101.34 7.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.294 -0.412 . . . . 0.33 109.954 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.702 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -95.25 144.68 17.35 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.485 -0.864 . . . . 0.26 112.494 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.595 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -102.64 118.78 50.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.929 -0.397 . . . . 0.3 109.929 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 73.6 m-20 62.23 35.03 15.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.59 -0.732 . . . . 0.34 110.913 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.702 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 61.1 m -74.47 95.83 2.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.614 -0.721 . . . . 0.81 110.847 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.9 m -89.74 128.38 50.65 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 121.232 0.539 . . . . 0.44 110.219 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 68' ' ' PRO . 64.2 Cg_endo -70.16 133.6 25.21 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.296 2.664 . . . . 0.39 112.645 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.417 HG21 ' HB2' ' A' ' 10' ' ' SER . 4.7 pt -107.25 153.35 41.17 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.073 -0.967 . . . . 0.57 111.311 -174.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -71.75 162.29 42.5 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.202 2.601 . . . . 1.05 111.476 172.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.7 mt -87.32 24.78 1.53 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.014 -0.539 . . . . 1.45 110.6 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 pt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.036 -0.983 . . . . 2.31 111.068 -174.884 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 111.961 -0.455 . . . . 5.75 111.961 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -64.16 140.82 58.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.865 0.364 . . . . 4.66 110.828 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.42 -110.59 2.82 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.755 -0.735 . . . . 1.6 111.83 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.556 ' CD2' ' HB ' ' A' ' 60' ' ' ILE . 92.3 m95 -130.7 -175.93 3.82 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.731 -0.276 . . . . 0.81 110.795 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.464 ' OE2' ' HA ' ' A' ' 59' ' ' ALA . 2.7 mp0 -59.47 106.82 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.274 0.559 . . . . 2.73 111.173 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.492 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 42.5 m -112.61 2.46 16.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.575 -0.739 . . . . 1.75 110.741 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -16.01 62.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.979 -0.555 . . . . 3.24 111.776 -175.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.64 4.96 38.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.909 0.385 . . . . 2.05 110.894 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.05 16.16 80.99 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.224 -1.151 . . . . 0.88 110.224 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 6' ' ' SER . 2.3 p -71.71 -30.05 65.23 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.388 -0.906 . . . . 1.72 111.861 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 6' ' ' SER . 7.4 t -155.79 143.71 19.77 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.764 -0.374 . . . . 1.19 110.936 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -91.79 -30.7 16.08 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.236 0.541 . . . . 1.66 110.186 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.1 p -92.25 -15.55 27.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.554 -0.748 . . . . 0.52 111.137 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 86.51 -8.36 75.2 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.923 -0.656 . . . . 0.43 112.493 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -87.99 89.12 7.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.988 0.423 . . . . 1.64 111.015 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 4' ' ' TRP . 8.9 mp -90.11 141.93 28.21 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.304 -0.628 . . . . 0.55 109.304 172.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.85 145.74 36.61 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.963 0.411 . . . . 0.29 110.678 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 50' ' ' THR . 32.9 m -79.9 101.79 8.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.634 -0.876 . . . . 0.74 108.634 174.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.8 m -124.56 146.79 48.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.942 0.401 . . . . 0.5 111.344 -170.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -94.62 117.57 30.34 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.989 -0.745 . . . . 1.65 108.989 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 54.0 p -79.44 -0.38 32.76 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.198 0.523 . . . . 0.52 110.714 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -104.26 -17.75 14.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.659 -0.701 . . . . 2.2 109.477 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -119.63 137.74 53.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.437 -0.801 . . . . 2.6 110.437 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -140.23 162.75 34.52 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 112.731 0.641 . . . . 2.17 112.731 -170.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.545 HG11 HG22 ' A' ' 80' ' ' VAL . 1.6 t -111.74 150.67 13.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.014 -0.994 . . . . 0.59 110.553 -173.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -76.01 -4.38 40.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.953 -0.567 . . . . 2.83 112.128 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -104.86 119.59 39.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.643 0.259 . . . . 4.07 110.842 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.4 m -102.28 8.71 40.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.016 0.436 . . . . 2.46 110.367 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.9 p -87.59 164.77 15.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.829 -0.623 . . . . 2.0 111.174 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.614 ' N ' ' HA3' ' A' ' 34' ' ' GLY . . . -152.53 -174.62 23.24 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.156 -0.778 . . . . 1.39 111.156 -177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -100.64 -24.15 14.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.203 0.501 . . . . 3.06 111.62 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -100.77 -68.99 0.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.028 0.442 . . . . 2.44 111.202 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 t -90.46 -27.78 19.02 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.584 -0.524 . . . . 2.36 109.584 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 30' ' ' GLY . . . -63.51 -29.33 74.29 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.486 -0.779 . . . . 2.54 113.463 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.0 mt -77.95 -22.28 49.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.014 0.435 . . . . 3.49 110.321 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt -84.25 173.21 11.18 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.64 -0.709 . . . . 4.79 110.551 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -76.61 -11.19 59.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.242 0.544 . . . . 6.59 110.124 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.1 m -72.39 -25.45 61.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.71 -0.677 . . . . 5.42 110.368 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.473 ' HA2' ' OE1' ' A' ' 44' ' ' GLN . . . -97.04 13.83 64.49 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.942 -0.572 . . . . 3.27 111.801 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.93 -35.92 67.11 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.592 0.71 . . . . 4.15 109.638 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.535 HG23 ' HG3' ' A' ' 44' ' ' GLN . 3.5 m -61.33 133.89 26.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.293 -1.321 . . . . 2.58 112.429 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 mp -87.7 2.69 50.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.306 -0.861 . . . . 3.5 109.703 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.41 -34.11 74.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.238 -0.892 . . . . 2.29 109.435 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.581 ' HB3' HG23 ' A' ' 82' ' ' ILE . 18.7 mt-30 -53.12 143.27 18.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.139 -0.937 . . . . 1.4 110.524 173.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 83' ' ' ASN . 8.2 p -103.26 118.47 50.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.205 0.526 . . . . 1.37 110.62 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.66 100.0 9.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.46 -0.791 . . . . 0.3 111.172 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 10.7 pt -106.11 155.43 7.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.064 -0.516 . . . . 0.23 110.255 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.45 ' OE1' HG22 ' A' ' 25' ' ' VAL . 10.5 tp60 -77.3 126.04 30.29 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.463 0.649 . . . . 2.38 110.087 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 45.3 m -124.29 163.02 22.53 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.763 -1.108 . . . . 1.15 110.352 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 10.0 t -160.08 142.73 13.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.831 -0.433 . . . . 0.6 109.831 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -120.54 117.96 28.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.142 0.496 . . . . 2.08 110.348 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.407 HG23 ' HD2' ' A' ' 53' ' ' PRO . 56.4 mt -85.23 137.29 37.17 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.371 -0.831 . . . . 0.95 109.539 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HD2' HG23 ' A' ' 52' ' ' ILE . 10.6 Cg_exo -32.68 117.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 124.989 3.792 . . . . 0.95 113.807 -172.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 pp -101.88 142.63 32.89 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.897 -1.047 . . . . 1.67 112.356 -169.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 74.9 mt -92.51 132.83 36.49 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.776 -0.824 . . . . 1.58 108.776 166.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 mt -64.05 135.17 28.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.005 0.431 . . . . 2.11 110.471 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.96 12.16 60.69 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.757 -0.656 . . . . 1.03 112.245 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -109.24 147.88 13.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.641 0.734 . . . . 0.77 111.855 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HA ' ' OE2' ' A' ' 5' ' ' GLU . . . -73.42 128.18 34.77 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.187 -1.37 . . . . 0.68 110.056 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.556 ' HB ' ' CD2' ' A' ' 4' ' ' TRP . 16.3 tt -57.22 -33.04 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.69 111.931 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -9.96 59.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.385 0.612 . . . . 2.2 110.266 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.06 -35.41 10.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.37 -0.832 . . . . 1.98 109.038 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.5 tp10 -68.6 -39.48 80.88 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.537 -1.211 . . . . 2.09 110.587 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.0 p -119.6 147.03 44.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.341 -0.391 . . . . 0.6 110.198 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -99.36 48.35 0.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.144 0.497 . . . . 2.32 110.814 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 47.8 m-80 -128.12 -172.7 2.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.882 -0.599 . . . . 1.06 109.502 176.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.9 m -83.07 127.97 67.08 Favored Pre-proline 0 N--CA 1.446 -0.637 0 CA-C-O 121.145 0.498 . . . . 0.34 110.831 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.01 131.7 7.04 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.925 2.417 . . . . 0.45 111.281 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 81.0 p -133.37 153.44 51.59 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.432 -0.349 . . . . 0.31 110.861 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 15.8 t -99.63 111.22 23.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.804 -0.443 . . . . 1.26 109.804 173.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 57.6 m -100.97 138.02 38.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.252 0.549 . . . . 0.29 110.768 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.0 tt0 -78.05 -27.41 48.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.633 -0.712 . . . . 1.53 109.859 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -154.36 151.76 29.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.514 -0.921 . . . . 1.26 108.514 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.535 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.5 t -140.47 132.42 31.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.869 -0.419 . . . . 1.07 109.869 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -101.77 160.7 14.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.478 -0.328 . . . . 1.87 110.21 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.446 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 9.7 m-20 59.8 -154.02 0.37 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.724 0.41 . . . . 1.94 110.238 -174.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' H ' ' HB3' ' A' ' 76' ' ' ASP . 14.8 m-20 -79.35 23.99 0.37 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.015 0.436 . . . . 2.12 110.721 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.535 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 102.66 22.62 9.39 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.989 -0.624 . . . . 0.51 112.637 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 2.6 mm? -78.38 -27.78 46.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 1.1 111.264 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.545 HG22 HG11 ' A' ' 25' ' ' VAL . 32.6 t -125.05 107.71 18.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.334 -0.394 . . . . 0.33 110.719 -174.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -100.93 139.03 14.19 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.104 -1.045 . . . . 0.26 112.195 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.581 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -104.82 123.6 58.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 122.54 0.336 . . . . 0.3 110.143 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.718 ' HA ' HG12 ' A' ' 45' ' ' VAL . 79.6 m-20 62.63 42.69 8.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.89 -0.595 . . . . 0.34 110.714 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.537 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 59.6 m -83.12 96.64 8.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.372 -0.831 . . . . 0.81 111.054 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 26.5 m -79.12 125.01 84.36 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.236 -0.438 . . . . 0.44 110.543 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 21.9 Cg_exo -67.03 128.05 17.95 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.029 2.486 . . . . 0.39 111.962 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.477 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.1 pt -107.3 143.09 26.48 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 116.279 -0.419 . . . . 0.57 110.928 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 16.6 Cg_exo -71.45 156.38 58.39 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.336 2.69 . . . . 1.05 112.355 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.0 mt -90.18 15.46 10.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.54 -0.754 . . . . 1.45 109.643 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.0 pt . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.212 -0.904 . . . . 2.31 110.889 -173.55 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 111.607 -0.597 . . . . 5.75 111.607 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.9 m -95.71 74.5 3.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.033 0.444 . . . . 4.66 110.528 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.02 -39.22 3.04 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.95 -0.643 . . . . 1.6 112.414 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -87.59 139.82 30.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.374 -0.232 . . . . 0.81 110.374 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -64.74 108.95 1.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.027 0.441 . . . . 2.73 110.399 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.7 m -96.29 27.18 3.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.465 0.65 . . . . 1.75 109.643 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -5.01 48.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.354 -0.839 . . . . 3.24 111.585 -176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 m -67.59 -30.6 70.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.085 0.469 . . . . 2.05 111.357 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.42 16.62 58.54 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.801 -0.714 . . . . 0.88 112.421 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 m -102.34 -17.02 16.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.855 0.317 . . . . 1.72 111.855 -175.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.772 ' SG ' HG21 ' A' ' 87' ' ' ILE . 3.9 m -131.1 141.55 50.16 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.851 -0.34 . . . . 1.19 111.479 -171.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -94.61 -28.3 15.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 1.66 112.186 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.8 p -86.92 -31.14 20.86 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.476 0.547 . . . . 0.52 112.476 -171.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.15 5.64 82.74 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.509 -0.853 . . . . 0.43 112.679 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HD3' HG23 ' A' ' 74' ' ' VAL . 59.4 mttp -94.38 88.27 5.47 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.065 -0.346 . . . . 1.64 110.065 176.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.688 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 7.9 mp -94.18 123.59 37.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.915 0.388 . . . . 0.55 110.299 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.18 142.62 37.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.835 -0.431 . . . . 0.29 109.835 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 80.1 m -80.93 118.46 22.44 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.278 -0.638 . . . . 0.74 109.278 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.712 ' SG ' HG13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -127.72 163.08 25.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.006 0.432 . . . . 0.5 111.152 -173.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -106.15 105.76 15.96 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.372 -0.973 . . . . 1.65 108.372 171.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.2 p -75.87 2.54 12.13 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.561 -0.745 . . . . 0.52 111.095 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -104.86 -3.41 23.48 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.054 -0.721 . . . . 2.2 109.054 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -113.3 102.46 10.37 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.361 -0.836 . . . . 2.6 110.562 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 3.7 mppt? -96.55 159.97 14.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.538 -0.756 . . . . 2.17 110.797 -175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 27' ' ' LYS . 19.3 t -119.61 149.7 22.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 108.946 -0.761 . . . . 0.59 108.946 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -84.45 -11.64 55.81 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.121 0.415 . . . . 2.83 112.121 -172.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' H ' HG12 ' A' ' 25' ' ' VAL . 14.3 mmmm -120.41 130.41 54.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.684 0.278 . . . . 4.07 110.546 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.7 m -101.45 32.68 3.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.104 -0.498 . . . . 2.46 111.207 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.9 p -86.1 150.09 24.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.263 -0.426 . . . . 2.0 110.233 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.472 ' HA3' ' OD1' ' A' ' 73' ' ' ASP . . . -150.79 -173.95 21.34 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.772 -0.728 . . . . 1.39 112.125 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -91.05 -50.65 5.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.547 0.173 . . . . 3.06 111.404 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -95.22 -11.87 27.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.193 0.442 . . . . 2.44 112.193 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.426 ' HA ' ' OG1' ' A' ' 38' ' ' THR . 58.0 m -50.72 -35.73 32.75 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.63 0.253 . . . . 2.36 111.411 170.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.94 -40.03 58.04 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.807 -0.711 . . . . 2.54 112.25 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.74 -51.47 55.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.147 0.498 . . . . 3.49 109.754 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.96 -179.88 5.78 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.374 -0.83 . . . . 4.79 110.783 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.82 1.17 57.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.469 0.652 . . . . 6.59 109.594 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.426 ' OG1' ' HA ' ' A' ' 33' ' ' SER . 53.6 p -65.71 -33.47 75.95 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.465 -0.788 . . . . 5.42 111.073 -177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.56 -2.67 56.29 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.959 -0.564 . . . . 3.27 113.217 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.37 -43.65 93.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.43 0.634 . . . . 4.15 109.968 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 m -88.26 143.53 11.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.054 -0.975 . . . . 2.58 111.737 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 tp -93.7 -3.84 51.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.376 -0.972 . . . . 3.5 108.376 172.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.48 -22.4 66.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.315 -1.311 . . . . 2.29 111.399 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.602 ' HB3' HG23 ' A' ' 82' ' ' ILE . 17.5 mt-30 -48.94 134.88 16.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.048 0.451 . . . . 1.4 111.283 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.56 115.41 43.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.72 -0.673 . . . . 1.37 110.421 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -100.21 118.42 36.49 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.521 -0.763 . . . . 0.3 110.925 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.712 HG13 ' SG ' ' A' ' 19' ' ' CYS . 12.5 pt -116.29 153.39 17.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.049 -0.523 . . . . 0.23 110.015 173.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.54 108.47 16.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.811 0.815 . . . . 2.38 110.076 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 62.7 m -89.5 165.6 14.2 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.128 -1.396 . . . . 1.15 110.573 -175.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.0 t -159.94 117.06 2.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.953 0.883 . . . . 0.6 110.715 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -120.0 131.78 55.26 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.964 -1.016 . . . . 2.08 110.677 -174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 64' ' ' CYS . 46.1 mt -70.41 133.9 86.99 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.979 -0.749 . . . . 0.95 108.979 171.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.11 107.04 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.07 3.18 . . . . 0.95 112.68 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.9 140.51 57.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.209 -0.905 . . . . 1.67 112.865 -169.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.53 152.74 21.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.86 -1.063 . . . . 1.58 108.767 168.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.0 mt -70.66 124.34 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.115 0.483 . . . . 2.11 110.631 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.15 17.18 72.57 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.474 -0.785 . . . . 1.03 112.952 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.412 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -97.0 149.13 5.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.713 0.768 . . . . 0.77 111.563 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.15 144.67 36.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.29 -1.323 . . . . 0.68 111.358 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.444 HG23 ' HG3' ' A' ' 61' ' ' GLU . 7.1 tp -53.38 -43.49 51.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.602 -0.726 . . . . 0.69 111.478 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.444 ' HG3' HG23 ' A' ' 60' ' ' ILE . 45.6 mt-10 -71.34 -41.65 69.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.7 -0.682 . . . . 2.2 111.489 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -79.44 -8.37 59.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.051 -0.522 . . . . 1.98 111.036 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.412 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 7.7 tp10 -92.21 -41.16 10.58 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.288 -0.415 . . . . 2.09 110.793 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.522 ' HA ' HD12 ' A' ' 52' ' ' ILE . 1.7 p -113.9 173.13 6.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.6 111.185 -172.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -125.02 49.91 1.82 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.296 0.57 . . . . 2.32 109.563 177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 57.7 m-80 -143.24 -170.3 3.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.836 -0.62 . . . . 1.06 110.43 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 10.4 m -79.62 130.76 66.74 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.888 0.375 . . . . 0.34 111.142 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -79.03 120.13 4.51 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.719 2.279 . . . . 0.45 111.264 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 86' ' ' PRO . 68.1 p -129.38 148.5 51.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.199 -0.455 . . . . 0.31 109.874 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.688 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 72.9 m -113.59 111.51 21.99 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.458 0.647 . . . . 1.26 110.128 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.9 m -86.56 152.59 22.49 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.962 -1.017 . . . . 0.29 111.036 -172.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 7.3 tt0 -91.53 -22.28 20.44 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.255 -0.884 . . . . 1.53 109.628 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.472 ' OD1' ' HA3' ' A' ' 30' ' ' GLY . 33.9 t0 -158.99 161.33 36.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.739 -1.208 . . . . 1.26 107.739 170.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.563 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -139.21 149.37 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 118.362 0.528 . . . . 1.07 110.793 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 8.2 tp10 -111.36 160.2 17.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.439 -0.8 . . . . 1.87 109.764 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 60.49 -151.93 0.4 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.255 -0.43 . . . . 1.94 109.936 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.86 10.33 2.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.001 0.429 . . . . 2.12 110.301 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 113.27 24.03 4.94 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.895 -0.669 . . . . 0.51 112.487 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -87.48 -21.93 25.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.907 0.384 . . . . 1.1 111.432 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 88.4 t -127.04 113.05 30.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.277 -0.638 . . . . 0.33 109.277 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.687 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -108.0 142.76 15.97 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.697 -1.24 . . . . 0.26 112.869 -173.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.602 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -95.75 118.17 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 109.69 -0.485 . . . . 0.3 109.69 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 93.8 m-20 60.21 42.93 14.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.279 -0.873 . . . . 0.34 110.804 174.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.687 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.8 m -78.0 87.71 4.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.669 -0.696 . . . . 0.81 109.919 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.2 m -83.07 134.22 46.69 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.377 -0.829 . . . . 0.44 110.256 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HA ' HG22 ' A' ' 69' ' ' THR . 13.9 Cg_endo -70.49 118.56 5.76 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.97 2.446 . . . . 0.39 111.59 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.772 HG21 ' SG ' ' A' ' 11' ' ' CYS . 5.5 pt -88.13 140.58 30.72 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.355 -0.839 . . . . 0.57 111.671 -173.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 12.1 Cg_exo -74.91 151.76 40.39 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.374 2.716 . . . . 1.05 111.707 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.5 mt -95.35 28.16 3.02 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.637 -0.71 . . . . 1.45 109.625 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 90' ' ' ILE . 18.6 pt . . . . . 0 C--O 1.245 0.864 0 CA-C-N 115.503 -0.771 . . . . 2.31 110.735 -173.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.637 0 N-CA-C 111.974 -0.451 . . . . 5.75 111.974 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -83.3 55.46 3.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.975 0.417 . . . . 4.66 110.598 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.43 135.0 12.77 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.773 -0.727 . . . . 1.6 111.937 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -88.25 172.82 9.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.034 0.445 . . . . 0.81 111.079 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -85.11 109.54 18.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.732 -0.667 . . . . 2.73 110.45 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 m -80.42 27.45 0.34 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.864 -0.607 . . . . 1.75 111.021 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -53.88 -22.68 10.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.747 -0.66 . . . . 3.24 112.12 -177.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.424 ' N ' ' HD2' ' A' ' 7' ' ' LYS . 6.9 t -73.39 -13.08 61.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.274 -0.421 . . . . 2.05 111.232 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.06 17.42 75.63 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.906 -0.664 . . . . 0.88 112.452 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 m -102.63 -9.86 19.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.89 0.33 . . . . 1.72 111.89 -172.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.708 ' SG ' HG21 ' A' ' 87' ' ' ILE . 2.7 m -139.65 140.32 36.89 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.267 -0.573 . . . . 1.19 111.456 -171.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -95.33 -30.6 13.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 1.66 111.867 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.7 p -80.53 -29.94 37.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.663 0.616 . . . . 0.52 112.663 -169.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.55 -4.27 85.97 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.503 -0.856 . . . . 0.43 112.304 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HD3' HG23 ' A' ' 74' ' ' VAL . 63.2 mttp -90.69 87.86 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.425 . . . . 1.64 109.99 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.813 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 8.1 mp -96.13 139.55 32.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.698 -0.683 . . . . 0.55 109.708 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.616 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -148.39 144.71 27.67 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.894 0.378 . . . . 0.29 110.389 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 86.1 m -89.9 99.54 12.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.131 0.491 . . . . 0.74 109.698 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 83.7 m -114.41 164.69 13.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.546 . . . . 0.5 112.028 -165.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -102.15 108.34 19.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.842 -0.617 . . . . 1.65 109.516 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.4 p -77.8 0.62 23.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.298 -0.41 . . . . 0.52 111.19 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -101.13 -7.3 23.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.172 -0.677 . . . . 2.2 109.172 175.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 35.6 mtpt -113.3 107.21 15.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.262 -0.881 . . . . 2.6 110.328 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -100.34 154.8 18.2 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.827 -0.624 . . . . 2.17 110.789 -174.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.449 HG22 ' CD ' ' A' ' 48' ' ' GLN . 11.1 t -120.78 150.3 23.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.608 -0.724 . . . . 0.59 109.782 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.08 32.89 0.27 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.974 -0.557 . . . . 2.83 111.684 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 31.12 115.21 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.718 1.607 . . . . 4.07 114.752 174.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -123.92 -76.83 0.59 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.477 -0.783 . . . . 2.46 111.162 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 p -142.28 -169.71 3.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.325 -0.852 . . . . 2.0 111.211 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.1 -161.04 21.95 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.232 -1.147 . . . . 1.39 110.232 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -99.57 -46.34 5.49 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.709 0.755 . . . . 3.06 110.71 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -86.94 -49.96 7.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.101 0.477 . . . . 2.44 110.844 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -91.18 4.35 52.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.834 -0.621 . . . . 2.36 110.237 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.91 -47.51 53.63 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.817 -0.629 . . . . 2.54 113.213 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.46 HD12 ' H ' ' A' ' 35' ' ' LEU . 5.4 mp -69.22 -61.95 1.58 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.123 0.487 . . . . 3.49 110.228 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -109.03 99.77 9.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.047 -0.524 . . . . 4.79 109.816 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -109.15 -71.25 0.77 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.117 -0.492 . . . . 6.59 111.582 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 p -80.31 -14.18 58.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.113 0.483 . . . . 5.42 110.904 -175.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 -25.67 44.42 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.609 -0.805 . . . . 3.27 111.212 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.52 -50.67 7.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.118 0.485 . . . . 4.15 109.955 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.403 HG23 ' CG ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -146.4 134.43 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.394 -0.821 . . . . 2.58 110.778 178.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.7 tp -98.21 -7.85 28.53 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.435 0.636 . . . . 3.5 110.214 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.25 0.49 57.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.788 -0.642 . . . . 2.29 111.848 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' A' ' 82' ' ' ILE . 23.1 mt-30 -51.76 131.36 30.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.308 0.575 . . . . 1.4 111.406 -178.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.85 109.19 27.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.14 -0.936 . . . . 1.37 109.745 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -102.28 122.57 44.48 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.675 -0.693 . . . . 0.3 110.494 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' A' ' 84' ' ' CYS . 14.2 pt -128.66 153.83 38.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.993 -0.549 . . . . 0.23 110.641 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.449 ' CD ' HG22 ' A' ' 25' ' ' VAL . 2.5 mp0 -70.29 141.62 52.35 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.832 -0.622 . . . . 2.38 109.503 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.651 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 2.1 t -137.78 164.53 28.67 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.073 -0.512 . . . . 1.15 110.491 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.0 t -160.81 128.03 4.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.524 0.678 . . . . 0.6 110.652 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -121.06 125.94 48.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.674 -0.694 . . . . 2.08 110.976 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 64' ' ' CYS . 16.7 mt -63.88 139.25 97.61 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.385 -0.825 . . . . 0.95 109.836 174.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 52' ' ' ILE . 60.0 Cg_exo -34.25 121.13 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 124.788 3.659 . . . . 0.95 113.929 -177.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 33.8 mt -65.48 119.71 11.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.038 -0.983 . . . . 1.67 112.261 -171.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.446 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 84.5 mt -99.73 122.89 43.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.989 -0.745 . . . . 1.58 108.989 166.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.669 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -72.87 130.18 35.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.073 0.463 . . . . 2.11 110.2 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.05 2.97 60.64 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.932 -0.651 . . . . 1.03 111.832 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -103.15 153.98 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.799 0.809 . . . . 0.77 111.732 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.18 130.52 36.31 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.306 -1.316 . . . . 0.68 109.815 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 61' ' ' GLU . 10.7 tt -50.77 -37.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.238 -0.892 . . . . 0.69 112.035 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.447 ' N ' HG23 ' A' ' 60' ' ' ILE . 6.6 mt-10 -62.61 -35.23 78.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.087 -0.96 . . . . 2.2 111.04 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.85 -22.21 19.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.904 -0.589 . . . . 1.98 109.999 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.82 -41.16 78.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.751 . . . . 2.09 110.954 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.57 ' HA ' HD12 ' A' ' 52' ' ' ILE . 4.7 p -114.65 167.85 10.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.997 0.427 . . . . 0.6 111.308 -173.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -121.94 41.42 3.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 2.32 110.284 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.553 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 57.1 m-80 -131.52 -169.87 2.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.481 -0.781 . . . . 1.06 109.666 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 11.2 m -83.17 127.1 70.36 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-O 120.933 0.397 . . . . 0.34 110.877 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HG3' HD21 ' A' ' 89' ' ' LEU . 55.8 Cg_endo -79.23 119.77 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.735 2.29 . . . . 0.45 111.294 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.427 ' OG1' ' HB3' ' A' ' 84' ' ' CYS . 44.2 p -128.37 151.16 49.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.318 -0.401 . . . . 0.31 109.93 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.813 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 72.0 m -113.68 119.32 37.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.268 0.556 . . . . 1.26 110.16 175.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.2 m -97.57 149.37 22.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.064 -0.971 . . . . 0.29 111.298 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 9.3 mt-10 -85.06 -16.65 39.96 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.585 -1.188 . . . . 1.53 109.728 175.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 47.3 t0 -167.79 156.11 9.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.921 -1.036 . . . . 1.26 108.298 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.566 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -143.5 135.92 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 117.929 0.331 . . . . 1.07 110.566 178.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 10.6 tp10 -98.18 157.54 16.09 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.156 -0.475 . . . . 1.87 110.01 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 61.31 -151.81 0.38 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.107 0.563 . . . . 1.94 109.93 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -82.38 21.91 0.9 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.112 0.482 . . . . 2.12 110.383 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.651 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 106.64 22.72 7.55 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.814 -0.708 . . . . 0.51 112.874 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.5 mm? -80.1 -26.67 39.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.784 0.292 . . . . 1.1 111.475 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 94.5 t -130.56 112.62 23.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.939 -0.393 . . . . 0.33 109.939 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.659 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -107.21 143.62 15.87 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.136 -1.03 . . . . 0.26 112.651 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -101.89 120.62 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.327 -0.619 . . . . 0.3 109.327 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 98.8 m-20 62.06 48.01 5.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.671 -0.695 . . . . 0.34 110.598 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.659 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 56.8 m -85.59 93.71 8.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.58 -0.736 . . . . 0.81 110.228 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.2 m -82.09 127.81 70.34 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.994 -0.548 . . . . 0.44 110.311 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.99 113.86 2.37 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.794 2.329 . . . . 0.39 111.579 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.708 HG21 ' SG ' ' A' ' 11' ' ' CYS . 9.1 pt -89.64 146.74 36.24 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.724 -0.671 . . . . 0.57 111.156 -175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 14.9 Cg_exo -73.53 148.15 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.225 2.617 . . . . 1.05 112.24 178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.414 HD21 ' HG3' ' A' ' 68' ' ' PRO . 93.7 mt -85.99 21.4 1.97 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.741 -0.663 . . . . 1.45 110.617 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.426 HG13 ' OXT' ' A' ' 90' ' ' ILE . 21.4 pt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.766 -1.112 . . . . 2.31 111.119 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.634 -0.586 . . . . 5.75 111.634 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.433 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 8.0 t 67.4 -172.71 0.19 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.948 0.404 . . . . 4.66 110.9 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.29 27.0 45.78 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.076 -0.583 . . . . 1.6 112.209 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -97.39 164.13 12.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.128 0.49 . . . . 0.81 111.235 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.605 ' OE1' ' HA ' ' A' ' 59' ' ' ALA . 24.7 mp0 -70.91 107.38 4.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.384 -0.826 . . . . 2.73 111.072 -176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 t -111.72 26.14 10.93 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.016 -0.735 . . . . 1.75 109.016 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -55.04 -33.9 63.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.934 -1.03 . . . . 3.24 111.541 -176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.7 t -85.04 3.81 36.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.811 0.339 . . . . 2.05 111.461 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.3 18.44 69.05 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.389 -0.91 . . . . 0.88 112.558 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.0 p -70.27 -32.05 69.7 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.759 0.651 . . . . 1.72 112.759 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.2 t -129.74 144.1 51.13 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.099 0.476 . . . . 1.19 111.365 -173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.409 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.2 p30 -91.21 -24.91 19.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.961 -0.563 . . . . 1.66 111.341 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.409 HG23 ' OD1' ' A' ' 12' ' ' ASN . 56.3 p -98.21 -30.56 12.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.076 0.465 . . . . 0.52 111.349 -177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.21 0.06 59.97 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.832 -0.699 . . . . 0.43 111.396 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HG2' ' HB2' ' A' ' 2' ' ' SER . 61.2 mttp -91.61 88.46 6.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.752 0.31 . . . . 1.64 110.401 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 69' ' ' THR . 8.1 mp -96.83 151.4 19.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.694 -0.484 . . . . 0.55 109.694 175.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -160.26 144.66 14.4 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.744 0.307 . . . . 0.29 110.85 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 1.2 m -80.13 97.63 6.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.854 -0.612 . . . . 0.74 109.923 173.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 84.1 m -113.13 160.59 18.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.114 -0.494 . . . . 0.5 110.82 -172.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.01 116.25 31.62 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.705 -0.48 . . . . 1.65 109.705 173.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.5 p -76.44 -8.66 57.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.089 0.471 . . . . 0.52 111.227 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -93.85 -15.97 24.53 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.021 0.915 . . . . 2.2 108.727 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -102.5 110.33 22.23 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.008 -1.451 . . . . 2.6 110.707 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.4 OUTLIER -103.08 163.75 12.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.281 -0.418 . . . . 2.17 110.992 -178.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.515 HG22 ' OE1' ' A' ' 48' ' ' GLN . 23.5 t -116.04 150.05 18.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.002 -0.74 . . . . 0.59 109.002 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -83.68 -17.0 42.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.39 0.515 . . . . 2.83 112.39 -171.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' H ' HG12 ' A' ' 25' ' ' VAL . 32.6 mtmm -114.02 156.76 23.51 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.277 -0.268 . . . . 4.07 110.277 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 p -121.42 12.68 10.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.79 0.329 . . . . 2.46 111.405 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 p -72.97 142.75 47.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.453 -0.34 . . . . 2.0 110.84 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.25 165.23 25.24 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.583 -0.818 . . . . 1.39 112.803 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -81.76 -46.21 14.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.741 0.305 . . . . 3.06 111.44 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -95.73 -31.09 13.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.386 -0.37 . . . . 2.44 111.307 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.429 ' HB2' HE22 ' A' ' 44' ' ' GLN . 20.7 p -62.62 -23.09 66.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 2.36 111.304 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.13 97.6 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.79 -0.719 . . . . 2.54 111.891 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 35' ' ' LEU . 4.7 mp -90.35 -29.36 18.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.005 0.431 . . . . 3.49 110.49 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.3 tp -70.14 130.18 41.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.015 -0.539 . . . . 4.79 110.284 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -70.51 -24.93 62.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.372 -0.376 . . . . 6.59 111.023 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 m -80.44 -19.47 46.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.134 0.492 . . . . 5.42 110.261 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.05 13.82 66.76 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.192 -0.763 . . . . 3.27 111.192 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.12 -27.24 60.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.367 0.603 . . . . 4.15 109.996 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.46 HG23 ' CG ' ' A' ' 44' ' ' GLN . 3.7 m -61.35 149.67 8.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.074 -0.966 . . . . 2.58 112.085 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt -99.17 -7.44 26.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.785 -0.643 . . . . 3.5 110.602 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -86.76 0.95 53.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.94 -0.573 . . . . 2.29 111.31 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.569 ' HB3' HG23 ' A' ' 82' ' ' ILE . 35.3 mt-30 -46.0 139.81 4.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.948 0.404 . . . . 1.4 110.839 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.1 t -105.27 116.54 49.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.275 -0.42 . . . . 1.37 110.112 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -105.62 117.48 34.13 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.833 -0.621 . . . . 0.3 111.138 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 13.8 pt -106.38 150.21 9.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.074 -0.512 . . . . 0.23 110.241 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.515 ' OE1' HG22 ' A' ' 25' ' ' VAL . 13.9 tp60 -76.63 116.0 16.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.599 -0.728 . . . . 2.38 109.342 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.7 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 2.2 t -110.1 169.43 8.74 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.283 -0.872 . . . . 1.15 110.235 -172.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.0 t -160.19 128.06 4.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.646 0.736 . . . . 0.6 110.808 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -120.88 114.1 21.08 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.518 -0.764 . . . . 2.08 111.059 -176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.72 133.22 72.27 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.395 -0.821 . . . . 0.95 109.46 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -38.45 102.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 124.578 3.519 . . . . 0.95 113.01 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.44 135.19 51.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.408 -0.815 . . . . 1.67 112.308 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.02 135.0 35.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.167 -0.924 . . . . 1.58 109.372 171.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.4 mt -66.6 129.63 31.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.23 0.538 . . . . 2.11 110.305 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.26 -15.66 58.8 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.224 -0.898 . . . . 1.03 111.832 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -89.7 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.586 0.708 . . . . 0.77 111.649 -177.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.605 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . . . -89.8 146.46 24.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.461 -1.245 . . . . 0.68 111.475 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 61' ' ' GLU . 5.0 tp -49.89 -44.05 20.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.621 -0.718 . . . . 0.69 110.724 173.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 60' ' ' ILE . 6.4 mm-40 -68.91 -16.84 63.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.431 -0.804 . . . . 2.2 111.986 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -110.46 -10.87 14.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.318 -0.401 . . . . 1.98 111.3 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.431 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.4 tp10 -93.62 -38.78 11.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.183 0.516 . . . . 2.09 110.595 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.2 p -131.38 146.92 52.49 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.913 -0.585 . . . . 0.6 110.208 -173.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -121.93 64.56 0.92 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.68 0.752 . . . . 2.32 111.064 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 36.5 m-80 -123.23 -155.43 0.65 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.231 -1.396 . . . . 1.06 107.231 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -86.05 121.17 72.9 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 119.418 -0.913 . . . . 0.34 110.048 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.11 130.25 9.23 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.646 2.231 . . . . 0.45 110.671 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' A' ' 84' ' ' CYS . 81.1 p -131.65 155.11 48.15 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.415 -0.357 . . . . 0.31 111.374 -175.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 20.2 t -103.27 110.48 22.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.684 -0.858 . . . . 1.26 108.684 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 39.7 m -94.84 145.28 25.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.403 0.621 . . . . 0.29 110.666 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 2.6 tt0 -79.57 -18.63 51.29 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.325 -0.852 . . . . 1.53 109.235 176.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -170.13 156.3 5.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.135 -0.939 . . . . 1.26 109.178 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.542 HG12 ' HA2' ' A' ' 78' ' ' GLY . 1.4 t -143.07 134.62 23.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.331 -0.248 . . . . 1.07 110.331 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 41.4 tt0 -104.17 158.8 16.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.47 -0.332 . . . . 1.87 110.693 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 4.4 t70 66.58 -148.19 0.19 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.183 0.593 . . . . 1.94 109.672 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.85 11.83 2.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.011 0.434 . . . . 2.12 110.442 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.7 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 108.7 23.94 6.32 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.916 -0.659 . . . . 0.51 112.155 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.9 mt -82.93 -23.6 33.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.819 0.342 . . . . 1.1 111.197 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 60.9 t -122.79 106.37 17.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.688 -0.486 . . . . 0.33 109.688 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -106.56 133.83 11.84 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.325 -0.94 . . . . 0.26 111.954 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.569 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -96.74 121.12 46.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 110.127 -0.323 . . . . 0.3 110.127 -177.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 82.7 m-20 60.62 35.32 19.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.553 -0.748 . . . . 0.34 111.124 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.615 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 67.3 m -69.82 95.33 0.89 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.607 -0.724 . . . . 0.81 110.702 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 30.7 m -87.56 126.89 60.47 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.951 -0.568 . . . . 0.44 110.009 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 36.2 Cg_exo -59.13 128.96 29.57 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.979 2.452 . . . . 0.39 112.321 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 pt -100.94 147.87 34.29 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.044 -0.526 . . . . 0.57 110.799 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -67.83 156.42 66.0 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.009 2.473 . . . . 1.05 112.086 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.4 mt -79.17 11.14 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.859 -0.61 . . . . 1.45 110.901 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.412 HG13 ' OXT' ' A' ' 90' ' ' ILE . 17.6 pt . . . . . 0 C--N 1.313 -0.989 0 CA-C-N 115.252 -0.885 . . . . 2.31 110.508 -175.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 112.127 -0.389 . . . . 5.75 112.127 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -107.25 -11.79 15.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.822 0.344 . . . . 4.66 110.9 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.05 -172.37 41.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.103 -0.57 . . . . 1.6 112.085 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -129.79 155.63 45.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.319 0.58 . . . . 0.81 112.023 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -65.27 113.84 4.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.936 -1.029 . . . . 2.73 110.911 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 m -88.5 26.82 1.38 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.9 -0.591 . . . . 1.75 110.445 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -53.74 -52.52 59.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.489 -0.778 . . . . 3.24 112.502 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -69.53 -24.46 63.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.2 -0.455 . . . . 2.05 111.846 -172.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.03 16.01 79.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.906 -0.664 . . . . 0.88 111.742 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.472 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 5.4 p -74.45 -30.51 61.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.301 0.482 . . . . 1.72 112.301 -173.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.6 t -105.2 142.29 35.24 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.004 0.431 . . . . 1.19 111.181 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.553 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.7 p30 -92.18 -27.35 17.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 1.66 111.784 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.553 HG23 ' OD1' ' A' ' 12' ' ' ASN . 11.0 p -100.34 -30.81 11.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.873 0.368 . . . . 0.52 111.973 -175.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.03 -6.36 53.93 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.528 -0.844 . . . . 0.43 112.26 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HD3' HG13 ' A' ' 74' ' ' VAL . 89.2 mttt -88.35 88.73 7.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.161 0.505 . . . . 1.64 110.48 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 60' ' ' ILE . 9.5 mp -92.99 127.01 38.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.454 -0.794 . . . . 0.55 110.171 176.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.534 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -142.53 153.09 43.28 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.786 0.327 . . . . 0.29 110.383 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 60.4 m -89.57 97.67 11.33 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.184 -0.672 . . . . 0.74 109.184 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 71.4 m -113.51 153.46 28.69 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.314 -0.403 . . . . 0.5 111.19 -169.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.65 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 8.0 t70 -92.51 119.35 31.9 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.077 -0.712 . . . . 1.65 109.077 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.8 p -80.41 -7.78 59.26 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.775 0.322 . . . . 0.52 111.706 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -104.59 -15.94 15.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 2.2 110.127 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.65 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 36.6 mtmt -103.35 129.04 50.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.709 -0.678 . . . . 2.6 110.779 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -116.55 162.35 17.74 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.912 -1.04 . . . . 2.17 111.243 -175.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 27' ' ' LYS . 13.0 t -113.32 149.97 15.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.847 -0.615 . . . . 0.59 109.798 178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -84.51 5.25 28.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.003 -0.544 . . . . 2.83 111.288 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' H ' HG12 ' A' ' 25' ' ' VAL . 29.9 mmmt -132.24 119.72 21.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.439 -0.346 . . . . 4.07 110.215 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -126.28 80.27 1.91 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.251 -0.431 . . . . 2.46 110.218 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.8 m -118.26 -54.91 2.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.035 0.445 . . . . 2.0 111.317 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' O ' ' HA3' ' A' ' 34' ' ' GLY . . . 91.89 155.24 31.62 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.543 -0.753 . . . . 1.39 111.787 -174.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -101.18 -50.37 3.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.05 0.452 . . . . 3.06 110.189 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -78.71 -62.65 1.62 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.759 -0.655 . . . . 2.44 109.895 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.8 m -73.17 -21.14 60.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.522 -0.763 . . . . 2.36 109.173 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 30' ' ' GLY . . . -71.86 -20.83 78.99 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.343 -0.844 . . . . 2.54 112.336 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 tt -77.69 -36.38 51.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.72 -0.844 . . . . 3.49 108.72 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 mp -78.42 -179.43 6.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.319 -0.855 . . . . 4.79 110.355 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -79.42 5.97 11.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.115 0.483 . . . . 6.59 110.801 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.3 m -68.09 -37.35 81.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.11 -0.495 . . . . 5.42 110.242 174.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' HA2' ' NE2' ' A' ' 44' ' ' GLN . . . -75.22 13.85 5.54 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.602 -0.726 . . . . 3.27 112.859 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.7 -50.19 32.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.419 0.628 . . . . 4.15 110.354 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.0 m -74.7 141.26 16.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.973 -1.012 . . . . 2.58 112.299 -175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.5 tp -88.32 -2.46 58.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.428 -0.953 . . . . 3.5 108.428 172.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -60.76 -30.16 69.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.389 -1.278 . . . . 2.29 110.858 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.661 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.7 mt-30 -47.74 131.33 14.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.137 -0.483 . . . . 1.4 110.358 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 83' ' ' ASN . 7.2 p -95.14 105.51 17.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.693 0.758 . . . . 1.37 110.825 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -96.59 101.73 13.39 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.154 -0.93 . . . . 0.3 110.25 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 84' ' ' CYS . 17.5 pt -104.13 150.0 7.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.935 -0.575 . . . . 0.23 110.311 177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -74.77 126.6 31.26 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.057 -0.72 . . . . 2.38 109.057 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.534 ' SG ' ' HB1' ' A' ' 17' ' ' ALA . 1.8 t -117.0 160.72 20.51 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.342 -0.845 . . . . 1.15 110.522 -171.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 2.5 t -150.53 121.39 7.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.335 0.588 . . . . 0.6 110.427 -174.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.4 HE21 HD12 ' A' ' 60' ' ' ILE . 5.0 tm0? -118.87 111.2 18.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.499 0.666 . . . . 2.08 110.479 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 64' ' ' CYS . 68.0 mt -71.11 133.8 85.6 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 114.859 -1.064 . . . . 0.95 109.979 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 52' ' ' ILE . 52.3 Cg_exo -34.3 130.58 0.18 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 124.693 3.595 . . . . 0.95 114.138 -173.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.57 HD12 ' H ' ' A' ' 54' ' ' LEU . 2.4 mp -84.29 132.85 34.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.807 -1.088 . . . . 1.67 112.584 -166.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.43 133.37 40.94 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.424 -0.954 . . . . 1.58 108.424 165.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.677 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -66.09 132.35 31.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.164 0.507 . . . . 2.11 110.893 -172.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.18 4.25 84.17 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.37 -0.832 . . . . 1.03 113.101 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -96.33 152.01 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.724 0.773 . . . . 0.77 111.859 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.54 143.33 27.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.339 -1.3 . . . . 0.68 111.172 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.42 HG21 HD23 ' A' ' 16' ' ' LEU . 8.4 tp -55.55 -32.32 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.005 -0.998 . . . . 0.69 111.83 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.79 -8.62 55.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 2.2 111.56 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.46 -27.15 11.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.403 0.621 . . . . 1.98 109.608 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.8 tp10 -72.62 -40.49 66.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.211 -0.904 . . . . 2.09 111.234 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.422 ' HA ' HD12 ' A' ' 52' ' ' ILE . 8.8 p -116.56 153.49 32.12 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.69 -0.404 . . . . 0.6 110.954 -173.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -99.69 33.17 2.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.663 0.745 . . . . 2.32 109.689 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 51.9 m-80 -117.94 -165.32 1.09 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.494 -0.776 . . . . 1.06 109.512 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 14.2 m -93.77 122.23 62.75 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-O 121.335 0.588 . . . . 0.34 112.012 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.41 117.26 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.482 2.788 . . . . 0.45 111.115 172.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.9 p -129.32 146.99 51.11 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.556 -0.458 . . . . 0.31 111.405 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 25.1 t -98.81 111.21 23.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.852 -0.613 . . . . 1.26 109.373 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.4 m -96.94 135.15 39.34 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.056 0.455 . . . . 0.29 110.626 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 6.5 tt0 -72.28 -20.75 61.46 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.449 0.642 . . . . 1.53 109.487 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -163.17 166.44 23.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.451 -0.795 . . . . 1.26 109.112 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.465 HG13 ' HD3' ' A' ' 15' ' ' LYS . 14.7 m -138.73 157.45 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 110.055 -0.35 . . . . 1.07 110.055 177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 80' ' ' VAL . 37.1 mt-10 -126.07 164.91 19.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.408 -0.36 . . . . 1.87 110.066 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 57.68 -150.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.548 -0.751 . . . . 1.94 109.396 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.97 22.88 0.74 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.11 0.481 . . . . 2.12 110.993 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 101.41 21.81 11.15 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.902 -0.666 . . . . 0.51 112.115 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.5 mm? -79.15 -22.55 44.9 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.329 0.585 . . . . 1.1 110.252 176.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 75' ' ' GLU . 61.1 t -122.49 117.91 53.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.606 -0.725 . . . . 0.33 109.472 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -110.35 134.78 12.41 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.142 -1.028 . . . . 0.26 111.939 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.661 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -98.12 121.62 48.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 110.198 -0.297 . . . . 0.3 110.198 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.705 ' HA ' HG12 ' A' ' 45' ' ' VAL . 94.5 m-20 58.4 54.91 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.867 -0.606 . . . . 0.34 110.904 174.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.536 ' HB2' HD11 ' A' ' 47' ' ' ILE . 47.8 m -91.62 110.73 22.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.295 -0.866 . . . . 0.81 110.944 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 47.3 m -96.16 128.76 35.77 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.982 -0.554 . . . . 0.44 110.166 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 39.4 Cg_exo -62.46 119.96 7.29 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.829 2.353 . . . . 0.39 110.947 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 7.0 pt -99.8 139.77 21.06 Favored Pre-proline 0 N--CA 1.442 -0.874 0 CA-C-N 116.319 -0.4 . . . . 0.57 111.718 -173.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.6 Cg_exo -71.38 159.44 51.61 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.251 2.634 . . . . 1.05 112.277 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.6 mt -87.75 24.42 1.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.617 -0.72 . . . . 1.45 110.442 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.7 pt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 119.102 -0.475 . . . . 2.31 110.956 -173.573 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.707 -0.557 . . . . 5.75 111.707 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 m -76.24 73.56 3.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.103 0.478 . . . . 4.66 110.551 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.24 -65.26 2.86 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.289 -0.724 . . . . 1.6 111.289 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -121.8 149.62 43.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.154 -0.313 . . . . 0.81 110.154 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.35 110.11 2.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.912 -0.585 . . . . 2.73 109.983 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -102.67 26.23 8.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.889 -0.596 . . . . 1.75 110.57 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -16.24 62.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.684 -0.689 . . . . 3.24 111.066 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 10' ' ' SER . 8.1 t -69.47 -14.51 62.92 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.101 -0.5 . . . . 2.05 110.684 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.4 16.36 79.95 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.133 -0.556 . . . . 0.88 112.617 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.4 ' H ' HG23 ' A' ' 8' ' ' THR . 5.6 m -96.71 -10.32 27.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 111.896 0.332 . . . . 1.72 111.896 -173.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.8 t -139.46 141.87 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.613 -0.435 . . . . 1.19 110.83 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.45 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.4 p30 -93.41 -30.22 15.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 1.66 112.157 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.45 HG23 ' OD1' ' A' ' 12' ' ' ASN . 23.9 p -89.98 -30.67 17.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.138 0.422 . . . . 0.52 112.138 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.93 -7.39 67.43 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.527 -0.844 . . . . 0.43 112.068 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.691 ' HD3' HG23 ' A' ' 74' ' ' VAL . 75.5 mttt -87.35 88.37 7.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.352 0.596 . . . . 1.64 110.043 177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' A' ' 60' ' ' ILE . 9.0 mp -97.69 122.55 40.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.341 -0.845 . . . . 0.55 109.691 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.33 146.54 50.74 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.038 0.447 . . . . 0.29 111.189 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 50' ' ' THR . 62.9 m -81.38 109.1 15.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.719 -0.845 . . . . 0.74 108.719 172.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 72.3 m -126.53 153.38 45.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.216 0.531 . . . . 0.5 112.114 -169.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.62 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 13.0 t70 -99.6 113.22 25.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.098 -1.075 . . . . 1.65 108.098 175.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.0 p -77.06 -10.1 59.16 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.352 0.871 . . . . 0.52 113.352 -169.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -106.48 -3.83 20.47 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.884 0.85 . . . . 2.2 109.153 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -93.07 104.8 16.97 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.951 -1.477 . . . . 2.6 109.907 175.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.76 162.43 12.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.283 0.563 . . . . 2.17 111.705 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -123.61 143.22 37.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.225 -0.898 . . . . 0.59 108.764 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -86.68 -31.4 21.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.277 -0.419 . . . . 2.83 110.988 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -87.7 119.67 28.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.228 -0.442 . . . . 4.07 110.414 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -93.63 54.92 2.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.471 0.653 . . . . 2.46 109.584 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.1 m -92.12 132.92 36.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.378 -0.828 . . . . 2.0 110.192 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.503 ' HA3' ' OG ' ' A' ' 33' ' ' SER . . . -123.62 164.88 16.57 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.502 -0.856 . . . . 1.39 112.515 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -100.63 -47.87 4.71 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 122.518 0.327 . . . . 3.06 110.143 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 36' ' ' LEU . 6.8 mm-40 -94.8 -34.41 12.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.658 0.266 . . . . 2.44 110.354 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.503 ' OG ' ' HA3' ' A' ' 30' ' ' GLY . 37.6 p -65.24 -6.83 10.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 2.36 111.847 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.75 -53.23 32.35 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.729 -0.748 . . . . 2.54 111.678 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.0 mt -91.48 -22.37 20.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.883 0.373 . . . . 3.49 110.898 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -83.05 148.39 27.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 4.79 109.895 -179.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.501 ' H ' HD23 ' A' ' 36' ' ' LEU . 75.0 m-70 -70.08 3.56 2.68 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.632 0.604 . . . . 6.59 112.632 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 p -78.41 -11.7 59.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.119 0.485 . . . . 5.42 110.789 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.5 -0.49 55.55 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.993 -0.622 . . . . 3.27 112.396 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.07 -30.27 70.27 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.02 0.438 . . . . 4.15 110.616 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 9.0 m -81.5 138.73 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.938 -0.574 . . . . 2.58 110.571 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.7 mt -94.24 0.79 55.9 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.585 0.707 . . . . 3.5 109.335 173.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.05 1.81 55.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.853 -1.067 . . . . 2.29 111.535 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HB3' HG23 ' A' ' 82' ' ' ILE . 34.2 mt-30 -42.52 134.64 3.02 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.427 0.454 . . . . 1.4 110.897 176.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.17 99.92 10.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.764 -0.653 . . . . 1.37 109.629 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -99.33 108.06 20.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.447 -0.797 . . . . 0.3 110.478 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.6 pt -118.52 159.47 18.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.836 -0.62 . . . . 0.23 110.052 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -77.56 142.04 39.23 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 122.12 0.962 . . . . 2.38 110.848 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 39.4 m -140.94 164.64 29.71 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.516 -1.675 . . . . 1.15 109.908 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 7.9 t -161.01 136.1 7.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.164 -0.471 . . . . 0.6 109.806 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -120.36 110.28 16.35 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.109 0.48 . . . . 2.08 110.447 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.403 HG23 ' HD2' ' A' ' 53' ' ' PRO . 61.9 mt -63.71 131.11 94.79 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.503 -0.771 . . . . 0.95 109.517 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HD2' HG23 ' A' ' 52' ' ' ILE . 50.4 Cg_exo -32.83 102.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.771 3.647 . . . . 0.95 113.867 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 pp -70.03 135.58 49.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.101 -0.954 . . . . 1.67 112.636 -171.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.3 137.74 32.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.349 -0.842 . . . . 1.58 109.333 170.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.8 mp -71.39 131.83 34.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.405 -0.591 . . . . 2.11 109.405 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.77 -6.95 59.0 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.598 -0.728 . . . . 1.03 111.687 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.47 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -106.99 152.69 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 121.642 0.734 . . . . 0.77 111.803 179.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.4 152.7 20.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.458 -1.247 . . . . 0.68 111.359 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 16' ' ' LEU . 6.2 tp -56.81 -40.68 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.227 0.611 . . . . 0.69 112.1 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.92 -11.19 56.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.398 -0.365 . . . . 2.2 111.598 -172.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -95.56 -34.3 12.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.383 -0.599 . . . . 1.98 109.383 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.47 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 9.6 tp10 -67.55 -40.23 84.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.138 -0.937 . . . . 2.09 110.711 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.56 148.36 41.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.293 -0.412 . . . . 0.6 109.961 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -99.79 45.7 0.98 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.874 0.845 . . . . 2.32 109.667 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 46.3 m-80 -122.11 -172.36 2.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.103 -0.953 . . . . 1.06 108.982 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 m -85.93 126.12 66.59 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-O 121.167 0.508 . . . . 0.34 110.552 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -83.06 136.07 7.81 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.079 2.519 . . . . 0.45 111.105 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 86' ' ' PRO . 67.8 p -133.8 150.91 51.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.794 0.33 . . . . 0.31 111.147 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 44.0 t -95.37 115.46 27.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.727 -0.842 . . . . 1.26 108.727 171.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.8 m -103.91 135.65 45.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.467 0.651 . . . . 0.29 110.829 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 9.4 mt-10 -70.14 -19.42 63.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.946 -1.025 . . . . 1.53 109.837 175.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -169.68 161.44 9.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.909 -1.041 . . . . 1.26 108.616 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.691 HG23 ' HD3' ' A' ' 15' ' ' LYS . 1.8 t -145.28 136.9 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.635 -0.505 . . . . 1.07 109.635 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.84 160.85 14.02 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.361 -0.381 . . . . 1.87 110.108 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 t70 62.34 -153.34 0.35 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.348 -0.612 . . . . 1.94 109.348 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -79.81 23.58 0.43 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.095 0.474 . . . . 2.12 110.705 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.571 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 105.38 23.58 7.54 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.889 -0.672 . . . . 0.51 112.423 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -78.66 -33.04 47.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.865 0.364 . . . . 1.1 111.243 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.69 108.29 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.319 -0.4 . . . . 0.33 110.036 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.721 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -97.16 140.04 14.83 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.064 -1.065 . . . . 0.26 112.527 -176.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.464 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -102.97 116.8 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 109.52 -0.548 . . . . 0.3 109.52 178.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 96.5 m-20 62.58 41.59 9.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.428 -0.805 . . . . 0.34 110.773 175.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.721 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 60.5 m -80.42 110.9 16.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.81 111.086 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 m -103.85 132.21 21.25 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 116.154 -0.475 . . . . 0.44 110.13 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 69' ' ' THR . 9.4 Cg_endo -65.41 129.13 21.82 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.041 2.494 . . . . 0.39 112.1 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 11.7 pt -105.73 146.61 33.18 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.908 -0.587 . . . . 0.57 111.776 -173.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 11.4 Cg_exo -74.34 163.52 36.16 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.286 2.658 . . . . 1.05 112.04 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.3 mt -95.44 21.93 7.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.66 -0.7 . . . . 1.45 110.138 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 pt . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.113 -0.946 . . . . 2.31 111.875 -171.911 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 111.556 -0.617 . . . . 5.75 111.556 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -85.93 -20.39 29.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.945 0.402 . . . . 4.66 110.904 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -149.19 -80.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.517 -0.849 . . . . 1.6 112.486 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -120.67 156.03 32.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.208 0.528 . . . . 0.81 111.773 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.89 115.77 20.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.286 -0.87 . . . . 2.73 110.202 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.2 m -88.13 23.57 2.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.236 -0.438 . . . . 1.75 110.868 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -46.98 -49.06 21.4 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.557 -0.747 . . . . 3.24 112.246 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 m -62.76 -21.33 65.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.676 -0.693 . . . . 2.05 111.976 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.97 16.26 76.53 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.276 -0.488 . . . . 0.88 113.336 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 m -85.35 -8.93 58.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.161 0.43 . . . . 1.72 112.161 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.641 ' SG ' HG21 ' A' ' 87' ' ' ILE . 1.8 m -132.32 141.05 48.8 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.499 -0.481 . . . . 1.19 111.373 -170.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -92.8 -30.45 15.47 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.147 0.425 . . . . 1.66 112.147 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.4 p -92.15 -31.98 15.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.165 0.507 . . . . 0.52 111.364 -174.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.78 4.46 67.45 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.58 -0.819 . . . . 0.43 111.99 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 63.7 mttp -87.34 87.8 7.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.069 0.462 . . . . 1.64 109.865 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.855 ' HG ' ' SG ' ' A' ' 70' ' ' CYS . 8.7 mp -94.1 134.96 35.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.872 -0.603 . . . . 0.55 109.975 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.512 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -149.01 146.57 27.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.914 0.388 . . . . 0.29 110.299 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 98.2 m -88.93 100.82 13.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.339 0.59 . . . . 0.74 110.019 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 79.9 m -111.02 158.92 18.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.723 -0.671 . . . . 0.5 111.484 -168.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -99.04 107.76 20.25 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.166 -0.679 . . . . 1.65 109.166 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.8 p -70.68 -13.18 61.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.784 -0.643 . . . . 0.52 111.162 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -95.51 -10.88 28.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.395 0.617 . . . . 2.2 109.674 -176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -115.04 140.37 49.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.224 -0.898 . . . . 2.6 110.113 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.626 ' HD3' HG22 ' A' ' 47' ' ' ILE . 44.5 mmtm -124.51 155.19 39.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.291 -0.868 . . . . 2.17 111.072 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.562 HG22 ' OE1' ' A' ' 48' ' ' GLN . 3.1 t -113.69 149.17 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.112 -0.699 . . . . 0.59 109.112 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -93.81 20.96 6.99 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.048 0.451 . . . . 2.83 110.704 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 30.1 mmmt -126.77 132.62 51.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.027 -0.533 . . . . 4.07 110.649 -178.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -114.48 42.82 2.03 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.709 -0.849 . . . . 2.46 108.709 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -108.36 168.12 9.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.785 -1.098 . . . . 2.0 111.601 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.457 ' HA3' ' OD2' ' A' ' 73' ' ' ASP . . . 170.91 -149.18 12.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.08 -0.581 . . . . 1.39 112.217 -176.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.81 -51.55 6.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.037 0.446 . . . . 3.06 110.92 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -104.73 -46.82 4.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.973 -0.558 . . . . 2.44 109.738 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -66.61 -20.37 65.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.634 -0.712 . . . . 2.36 109.783 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.79 -37.53 78.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.809 -0.71 . . . . 2.54 111.491 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.4 mt -81.93 -60.77 2.12 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.537 -0.542 . . . . 3.49 109.537 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt -110.37 97.2 6.71 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.917 -0.583 . . . . 4.79 111.195 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -112.22 -71.07 0.77 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.753 -0.379 . . . . 6.59 110.741 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 m -71.83 -24.77 61.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.179 0.514 . . . . 5.42 110.481 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.48 -3.49 82.88 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.817 -0.706 . . . . 3.27 112.693 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -118.07 -50.33 2.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.118 0.485 . . . . 4.15 109.824 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.22 129.91 3.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.369 -0.832 . . . . 2.58 111.603 -175.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mt -91.59 -9.93 42.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.896 -0.593 . . . . 3.5 111.047 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -86.53 0.33 54.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.178 -0.465 . . . . 2.29 111.837 -174.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.566 ' HA ' ' OD1' ' A' ' 83' ' ' ASN . 19.3 mt-30 -54.4 144.13 21.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.078 0.466 . . . . 1.4 110.762 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 83' ' ' ASN . 13.5 p -115.35 123.8 71.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.556 -0.747 . . . . 1.37 109.965 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -105.85 100.15 9.71 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.595 -0.729 . . . . 0.3 110.38 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.626 HG22 ' HD3' ' A' ' 24' ' ' LYS . 20.1 pt -107.36 146.83 13.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.201 0.524 . . . . 0.23 110.489 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.562 ' OE1' HG22 ' A' ' 25' ' ' VAL . 17.9 tp60 -74.9 118.32 17.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.303 -0.862 . . . . 2.38 108.954 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.687 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 3.4 t -115.97 164.27 14.67 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.658 -0.701 . . . . 1.15 110.594 -171.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -162.42 131.98 4.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.174 0.511 . . . . 0.6 110.526 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -121.1 123.14 41.6 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.135 -0.484 . . . . 2.08 111.35 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 64' ' ' CYS . 45.9 mt -64.52 135.07 96.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.438 -0.801 . . . . 0.95 109.654 173.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.4 111.66 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 124.063 3.175 . . . . 0.95 112.593 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.68 141.91 31.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.821 -1.081 . . . . 1.67 112.769 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.404 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 7.8 mp -93.87 132.35 38.39 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.692 -0.855 . . . . 1.58 108.692 167.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.606 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.9 mp -67.11 131.85 32.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.225 0.536 . . . . 2.11 110.072 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.69 -5.89 56.99 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.493 -0.776 . . . . 1.03 112.017 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -98.62 150.5 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.739 0.781 . . . . 0.77 111.471 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.47 132.17 34.97 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.91 -1.495 . . . . 0.68 110.105 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.403 HG12 ' SG ' ' A' ' 18' ' ' CYS . 10.7 tt -53.96 -34.97 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.207 -0.906 . . . . 0.69 111.907 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -73.75 -18.13 61.02 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.942 -1.027 . . . . 2.2 111.494 -173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -110.99 4.8 19.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.188 0.518 . . . . 1.98 110.585 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -95.67 -40.35 9.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.436 0.636 . . . . 2.09 110.311 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.448 ' HA ' HD12 ' A' ' 52' ' ' ILE . 15.3 p -105.92 -176.4 3.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.869 -0.605 . . . . 0.6 110.667 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -127.56 35.84 4.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.372 0.606 . . . . 2.32 109.767 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 52.8 m-80 -135.01 -170.77 2.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 1.06 110.339 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 89.7 m -80.91 124.86 81.18 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 121.322 0.582 . . . . 0.34 111.996 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.76 115.52 2.97 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.393 2.728 . . . . 0.45 111.583 173.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -132.22 159.81 37.95 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.478 -0.564 . . . . 0.31 109.478 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.855 ' SG ' ' HG ' ' A' ' 16' ' ' LEU . 85.6 m -121.76 122.8 40.33 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.274 0.559 . . . . 1.26 109.982 174.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.466 ' HB2' HG22 ' A' ' 74' ' ' VAL . 37.8 m -100.92 143.12 31.45 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.107 -0.951 . . . . 0.29 110.627 -172.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 6.9 mm-40 -77.42 -17.35 58.2 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.673 -1.149 . . . . 1.53 109.613 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.457 ' OD2' ' HA3' ' A' ' 30' ' ' GLY . 4.3 t70 -165.04 155.61 14.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.076 -0.965 . . . . 1.26 108.889 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.51 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -149.75 130.54 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 110.207 -0.294 . . . . 1.07 110.207 178.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 30.5 tt0 -96.99 164.99 12.29 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.963 -0.384 . . . . 1.87 109.963 176.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 65.26 -154.25 0.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.401 -0.592 . . . . 1.94 109.401 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -72.63 2.48 6.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.54 0.686 . . . . 2.12 109.843 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.687 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.38 24.09 2.48 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.648 -0.705 . . . . 0.51 112.271 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 2.0 mm? -79.08 -29.76 43.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.689 0.255 . . . . 1.1 111.689 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG22 HG11 ' A' ' 25' ' ' VAL . 67.4 t -118.38 102.97 13.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.941 -0.304 . . . . 0.33 110.192 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -104.53 136.26 12.96 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.309 -0.948 . . . . 0.26 113.009 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -99.32 122.95 51.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.12 -0.54 . . . . 0.3 109.624 177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.716 ' HA ' HG12 ' A' ' 45' ' ' VAL . 70.8 m-20 60.45 48.0 8.15 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.457 0.473 . . . . 0.34 110.931 175.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.597 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 58.3 m -84.54 90.76 7.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.025 -0.534 . . . . 0.81 110.422 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.7 m -79.15 127.84 77.96 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.587 -0.733 . . . . 0.44 110.227 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.03 109.53 1.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.7 2.267 . . . . 0.39 110.737 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.641 HG21 ' SG ' ' A' ' 11' ' ' CYS . 12.0 pt -82.32 146.81 55.16 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.642 -0.708 . . . . 0.57 111.87 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 14.2 Cg_exo -74.02 147.91 39.28 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.249 2.632 . . . . 1.05 111.206 175.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.03 36.85 0.97 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.676 -0.693 . . . . 1.45 110.147 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.9 pt . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.124 -0.941 . . . . 2.31 111.19 -173.649 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.879 0 N-CA-C 112.155 -0.378 . . . . 5.75 112.155 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -105.57 31.84 4.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.201 0.524 . . . . 4.66 110.512 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.88 81.93 1.0 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.702 -0.761 . . . . 1.6 111.659 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.441 ' HH2' ' OE1' ' A' ' 63' ' ' GLU . 94.1 m95 -103.02 -172.58 2.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.563 0.22 . . . . 0.81 111.423 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -59.83 111.77 1.59 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 2.73 111.551 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -99.38 -19.92 16.76 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.729 -0.669 . . . . 1.75 111.034 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -17.33 64.7 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.938 0.399 . . . . 3.24 111.141 -177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -72.97 -30.14 63.6 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.081 -0.509 . . . . 2.05 110.983 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.81 16.99 74.82 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.886 -0.597 . . . . 0.88 112.308 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.464 ' HB2' HG21 ' A' ' 87' ' ' ILE . 28.5 p -85.89 -19.26 30.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.793 0.33 . . . . 1.72 111.724 -172.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.8 t -130.49 143.84 51.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.929 0.395 . . . . 1.19 111.033 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -91.13 -31.6 16.16 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.027 -0.533 . . . . 1.66 110.61 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.5 p -90.36 -30.57 17.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.578 -0.737 . . . . 0.52 111.002 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.58 2.22 61.71 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.632 -0.713 . . . . 0.43 111.913 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.505 ' HD3' HG23 ' A' ' 74' ' ' VAL . 94.0 mttt -91.55 87.59 6.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.046 0.451 . . . . 1.64 110.267 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.0 mp -97.63 100.22 11.61 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.857 -0.61 . . . . 0.55 109.845 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.48 145.53 40.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.06 0.457 . . . . 0.29 110.437 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 66' ' ' ASN . 84.6 m -80.57 108.19 14.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.795 -0.639 . . . . 0.74 109.646 172.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 62.5 m -126.91 153.65 45.5 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.885 -0.598 . . . . 0.5 111.368 -172.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -95.61 111.65 23.53 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.475 -0.784 . . . . 1.65 109.854 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.4 p -75.28 -11.06 59.98 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.28 0.562 . . . . 0.52 110.709 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -93.87 -8.96 38.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.555 0.693 . . . . 2.2 109.248 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -119.74 125.4 48.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.994 -1.003 . . . . 2.6 110.692 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -113.11 154.0 27.3 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.535 -1.212 . . . . 2.17 111.066 -170.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.577 HG22 ' NE2' ' A' ' 48' ' ' GLN . 9.6 t -115.13 148.75 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.862 -0.792 . . . . 0.59 108.862 175.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -98.34 29.74 3.46 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.908 0.385 . . . . 2.83 111.081 -175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -130.38 118.74 21.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.34 -0.391 . . . . 4.07 110.791 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.5 m -111.96 53.96 0.71 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 2.46 110.089 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.42 -93.91 0.26 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.615 -0.72 . . . . 2.0 111.647 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.03 155.18 15.05 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 1.39 111.859 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.73 -50.22 4.54 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.598 -0.354 . . . . 3.06 110.921 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -77.44 -25.83 50.98 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.887 -0.325 . . . . 2.44 110.492 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.8 m -52.08 -34.16 42.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.351 -0.386 . . . . 2.36 111.249 167.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.34 -28.88 51.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.734 -0.746 . . . . 2.54 112.522 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.4 mt -75.2 -27.48 59.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.087 0.47 . . . . 3.49 110.692 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.6 tp -110.52 168.91 9.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.785 -0.643 . . . . 4.79 109.558 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -81.15 6.88 12.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.053 0.454 . . . . 6.59 110.875 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.465 ' HB ' ' CD ' ' A' ' 72' ' ' GLU . 9.2 p -72.42 -31.46 65.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.132 -0.485 . . . . 5.42 111.198 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.03 13.06 33.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.911 -0.661 . . . . 3.27 112.34 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.25 -19.99 38.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.011 0.434 . . . . 4.15 110.964 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.402 HG23 ' CG ' ' A' ' 44' ' ' GLN . 3.6 m -89.19 142.94 12.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.857 -0.611 . . . . 2.58 111.052 176.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.8 mt -94.85 -6.17 43.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.165 -0.471 . . . . 3.5 110.596 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -83.03 -3.85 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 2.29 111.441 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.605 ' HB3' HG23 ' A' ' 82' ' ' ILE . 35.2 mt-30 -45.67 131.29 9.01 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.072 0.463 . . . . 1.4 110.441 174.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 83' ' ' ASN . 11.9 p -101.03 120.94 51.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.41 0.624 . . . . 1.37 110.77 -174.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -103.11 117.09 33.79 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.33 -0.85 . . . . 0.3 110.707 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.507 HD11 ' HB2' ' A' ' 84' ' ' CYS . 18.3 pt -124.31 159.78 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.23 -0.441 . . . . 0.23 109.96 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.577 ' NE2' HG22 ' A' ' 25' ' ' VAL . 3.5 mp0 -72.33 131.32 42.5 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.525 0.678 . . . . 2.38 110.704 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 72.3 m -125.09 149.15 48.13 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.395 -1.275 . . . . 1.15 110.071 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.2 t -161.31 132.96 5.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.105 0.479 . . . . 0.6 110.406 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -121.61 115.93 23.67 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.833 -0.622 . . . . 2.08 110.968 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.512 HG23 ' HD2' ' A' ' 53' ' ' PRO . 47.1 mt -58.09 139.31 83.55 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.153 -0.93 . . . . 0.95 109.12 173.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HD2' HG23 ' A' ' 52' ' ' ILE . 31.4 Cg_exo -34.11 127.77 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 124.262 3.308 . . . . 0.95 114.255 -173.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.71 136.09 57.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.357 -1.292 . . . . 1.67 112.365 -170.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.1 mt -110.13 132.02 54.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.291 -0.868 . . . . 1.58 109.512 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 mt -68.57 132.62 32.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.988 0.423 . . . . 2.11 110.728 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.59 24.94 71.35 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.429 -0.805 . . . . 1.03 112.951 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.488 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -113.41 150.51 15.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.781 0.801 . . . . 0.77 112.264 -178.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.5 145.64 31.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.126 -1.397 . . . . 0.68 111.457 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 tp -56.9 -42.08 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.698 -0.683 . . . . 0.69 111.547 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.83 -5.23 58.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.329 -0.396 . . . . 2.2 111.675 -173.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -106.69 -28.4 10.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.147 0.498 . . . . 1.98 109.914 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.488 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 32.6 tt0 -68.51 -37.66 80.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 2.09 111.191 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.415 ' HA ' HD12 ' A' ' 52' ' ' ILE . 1.8 p -113.0 178.23 4.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.092 -0.504 . . . . 0.6 109.979 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -127.33 28.93 5.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.058 0.456 . . . . 2.32 110.763 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 8.3 t-20 -105.25 -140.57 0.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.639 -0.709 . . . . 1.06 109.356 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 27.9 m -116.43 130.23 24.65 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 120.768 0.318 . . . . 0.34 110.48 176.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -78.26 122.89 5.84 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.76 2.307 . . . . 0.45 111.404 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.2 p -130.19 147.67 51.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.959 0.409 . . . . 0.31 111.007 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.48 106.77 19.07 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.503 -0.555 . . . . 1.26 109.503 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 58.0 m -93.86 141.78 28.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.209 0.528 . . . . 0.29 110.72 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.9 tt0 -79.16 -25.98 42.78 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.506 -0.77 . . . . 1.53 109.745 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -160.13 160.12 32.58 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.312 -0.995 . . . . 1.26 108.312 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.505 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.3 t -141.69 132.86 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.76 -0.459 . . . . 1.07 109.76 175.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -105.48 163.73 12.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.564 -0.289 . . . . 1.87 110.444 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 66.65 -152.98 0.22 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.035 -0.53 . . . . 1.94 109.588 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.94 -7.05 19.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.444 0.64 . . . . 2.12 110.449 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.447 ' HA2' HG12 ' A' ' 74' ' ' VAL . . . 120.47 23.4 2.87 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.137 -0.785 . . . . 0.51 111.137 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 62.2 mt -91.9 -13.57 31.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.727 -0.236 . . . . 1.1 111.404 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.99 107.97 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.13 -0.322 . . . . 0.33 110.13 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -97.67 144.0 17.04 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.517 -0.849 . . . . 0.26 112.426 -178.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.605 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -105.23 124.08 59.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.099 -0.334 . . . . 0.3 110.099 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.778 ' HA ' HG12 ' A' ' 45' ' ' VAL . 74.3 m-20 57.57 45.7 18.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.365 0.603 . . . . 0.34 110.796 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.58 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 81.4 m -82.25 92.33 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.248 -0.887 . . . . 0.81 110.631 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 25.1 m -84.03 123.67 75.32 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.68 -0.691 . . . . 0.44 110.385 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 25.0 Cg_exo -64.29 130.91 28.33 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.108 2.538 . . . . 0.39 111.998 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.485 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.2 pt -103.3 137.07 19.15 Favored Pre-proline 0 N--CA 1.438 -1.072 0 CA-C-N 115.857 -0.611 . . . . 0.57 110.696 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 8.2 Cg_exo -76.74 156.25 35.3 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.406 2.737 . . . . 1.05 112.559 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 70.6 mt -98.44 21.7 10.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.428 -0.805 . . . . 1.45 109.953 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 pt . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.731 -0.668 . . . . 2.31 110.887 -172.418 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 111.719 -0.553 . . . . 5.75 111.719 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.5 t 60.89 84.39 0.13 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.306 0.574 . . . . 4.66 110.414 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.89 -171.39 25.99 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.138 -0.785 . . . . 1.6 111.138 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -117.89 169.1 9.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.213 0.53 . . . . 0.81 111.493 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -66.46 117.7 9.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.969 -1.014 . . . . 2.73 110.104 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.0 t -107.71 27.05 9.56 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.878 -0.786 . . . . 1.75 108.878 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -60.83 -38.22 84.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.07 -0.968 . . . . 3.24 110.902 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.7 m -65.59 -22.04 66.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.691 -0.686 . . . . 2.05 110.895 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.11 16.04 79.74 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.216 -0.516 . . . . 0.88 112.94 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.439 ' HB3' ' HB ' ' A' ' 87' ' ' ILE . 8.3 m -82.66 -18.57 40.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.998 0.37 . . . . 1.72 111.998 -175.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.3 t -116.47 141.58 47.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.884 0.373 . . . . 1.19 110.649 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.439 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.1 p30 -93.13 -26.21 17.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 1.66 111.822 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.439 HG23 ' OD1' ' A' ' 12' ' ' ASN . 32.2 p -94.98 -30.81 13.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.998 0.427 . . . . 0.52 112.034 -173.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.08 -1.64 74.22 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.591 -0.814 . . . . 0.43 111.521 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -92.47 87.93 6.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.322 -0.622 . . . . 1.64 109.322 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -96.81 139.71 32.46 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.923 -0.58 . . . . 0.55 110.619 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -147.61 156.61 42.97 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.129 -1.063 . . . . 0.29 108.129 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 93.8 m -99.92 97.45 8.33 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.301 -0.56 . . . . 0.74 109.704 174.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.4 m -110.49 156.57 20.68 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.679 -0.691 . . . . 0.5 111.147 -168.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.48 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 33.4 m-20 -99.94 109.72 22.08 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.264 -0.643 . . . . 1.65 109.264 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.422 HG21 ' HG3' ' A' ' 86' ' ' PRO . 33.1 p -71.87 -8.03 51.96 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.808 -0.633 . . . . 0.52 111.287 -175.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -100.85 -6.76 24.31 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.243 -0.651 . . . . 2.2 109.243 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 30.1 mtpp -116.64 117.32 29.49 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.969 -1.014 . . . . 2.6 109.812 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -128.62 152.58 48.19 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 112.584 0.586 . . . . 2.17 112.584 -171.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 27' ' ' LYS . 6.5 t -99.36 150.36 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.144 -0.935 . . . . 0.59 110.416 -174.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -91.29 13.21 17.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.644 -0.707 . . . . 2.83 110.088 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' H ' HG12 ' A' ' 25' ' ' VAL . 13.6 mmmm -131.62 142.3 49.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.046 -0.979 . . . . 4.07 108.767 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.1 t -139.18 80.39 1.78 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.7 0.762 . . . . 2.46 110.002 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.549 ' HB ' ' OE2' ' A' ' 75' ' ' GLU . 5.1 m -115.96 143.16 45.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.074 -0.966 . . . . 2.0 109.94 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -114.22 149.02 18.79 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.674 -0.774 . . . . 1.39 112.253 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.52 -51.09 4.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.399 -0.593 . . . . 3.06 109.399 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -92.25 -29.66 16.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 2.44 109.928 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 t -69.05 -19.79 64.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.812 -0.631 . . . . 2.36 109.562 174.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.59 -21.82 76.4 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.713 -0.676 . . . . 2.54 112.71 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.12 -34.66 76.78 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.297 0.57 . . . . 3.49 109.719 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -93.8 174.93 6.93 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.47 -0.786 . . . . 4.79 109.516 176.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -81.17 4.34 20.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.216 0.532 . . . . 6.59 110.355 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.3 p -75.66 -24.45 56.37 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.63 -0.714 . . . . 5.42 110.972 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.65 -13.04 82.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.629 -0.796 . . . . 3.27 112.399 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -76.77 -35.49 57.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.649 0.261 . . . . 4.15 111.219 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -76.16 135.23 27.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.426 0.631 . . . . 2.58 111.63 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.0 mt -88.72 -0.26 57.13 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.191 -0.913 . . . . 3.5 109.191 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.13 -31.61 72.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.871 -1.058 . . . . 2.29 110.614 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.664 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.5 mt-30 -48.56 135.66 14.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.783 -0.644 . . . . 1.4 110.85 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.0 t -83.68 112.57 21.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.896 -0.593 . . . . 1.37 110.171 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.63 105.61 15.73 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.437 -0.801 . . . . 0.3 110.556 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 11.5 pt -110.21 152.76 12.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.218 -0.446 . . . . 0.23 111.014 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -72.07 142.02 49.23 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.506 -0.77 . . . . 2.38 110.287 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.646 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.4 t -144.79 165.69 27.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.56 -1.2 . . . . 1.15 109.993 -170.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.3 t -160.04 153.06 21.68 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.248 -0.279 . . . . 0.6 110.248 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -120.5 122.8 41.43 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.415 -0.587 . . . . 2.08 109.415 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 64' ' ' CYS . 46.7 mt -92.64 131.92 32.79 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.511 -0.552 . . . . 0.95 109.511 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 52' ' ' ILE . 52.8 Cg_exo -33.88 99.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.575 3.516 . . . . 0.95 113.504 -174.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.1 pp -78.31 140.61 38.8 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.987 -1.006 . . . . 1.67 111.412 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.548 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 2.6 mm? -77.74 138.86 39.26 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.199 -1.037 . . . . 1.58 108.199 171.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.7 mt -61.02 129.21 23.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.025 0.441 . . . . 2.11 110.416 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.4 2.91 88.92 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.513 -0.767 . . . . 1.03 112.763 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -95.92 152.63 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.724 0.773 . . . . 0.77 111.601 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.66 152.13 23.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.395 -1.275 . . . . 0.68 111.401 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 10.5 tt -52.29 -38.77 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.943 0.878 . . . . 0.69 110.857 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.444 ' N ' HG23 ' A' ' 60' ' ' ILE . 34.9 mt-10 -64.24 -16.01 61.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.825 -1.079 . . . . 2.2 111.766 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -111.34 -8.12 14.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.036 0.384 . . . . 1.98 112.036 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 1.9 pp20? -94.53 -33.76 12.94 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.433 -0.507 . . . . 2.09 111.599 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.499 ' HA ' HD12 ' A' ' 52' ' ' ILE . 3.8 p -113.44 156.52 23.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.063 0.459 . . . . 0.6 111.408 -173.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 4.1 tppp? -110.89 26.41 10.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.085 0.945 . . . . 2.32 108.976 173.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.643 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 4.3 m-20 -105.07 -168.49 1.48 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.199 -0.91 . . . . 1.06 109.471 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.5 m -88.67 124.62 65.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-O 121.388 0.613 . . . . 0.34 111.408 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HB2' HG13 ' A' ' 87' ' ' ILE . 9.6 Cg_exo -60.19 113.91 1.87 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.21 2.607 . . . . 0.45 110.986 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.848 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 0.8 OUTLIER -124.99 139.54 53.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.964 0.412 . . . . 0.31 111.41 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.9 t -102.65 105.56 16.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.224 -0.658 . . . . 1.26 109.224 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 67.3 m -86.77 145.36 26.67 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.927 -0.397 . . . . 0.29 109.927 -174.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 3.4 tt0 -76.3 -24.17 54.37 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.705 -0.85 . . . . 1.53 108.705 172.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -163.25 157.98 20.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.823 -1.081 . . . . 1.26 108.481 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.544 HG12 ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -138.45 138.4 42.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.804 -0.358 . . . . 1.07 110.095 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.549 ' OE2' ' HB ' ' A' ' 29' ' ' THR . 43.9 tt0 -106.42 155.33 19.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.276 -0.42 . . . . 1.87 110.311 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 t70 66.78 -152.64 0.21 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.661 0.601 . . . . 1.94 109.667 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -70.01 0.69 5.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.111 0.482 . . . . 2.12 110.611 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 115.4 23.69 4.37 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.043 -0.599 . . . . 0.51 111.971 -177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.4 mt -79.35 -24.81 42.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.007 0.432 . . . . 1.1 110.892 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.97 108.67 21.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.721 -0.474 . . . . 0.33 109.721 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.99 133.53 11.4 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.298 -0.954 . . . . 0.26 111.81 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.664 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -95.23 118.47 41.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 110.136 -0.32 . . . . 0.3 110.136 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 89.8 m-20 57.75 42.53 23.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.382 -0.827 . . . . 0.34 110.825 174.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.848 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -78.27 105.14 9.31 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.689 -0.687 . . . . 0.81 110.351 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.5 m -83.45 128.22 65.1 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.422 -0.808 . . . . 0.44 109.738 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HG3' HG21 ' A' ' 21' ' ' THR . 33.3 Cg_exo -61.35 119.91 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.56 2.173 . . . . 0.39 110.779 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.439 ' HB ' ' HB3' ' A' ' 10' ' ' SER . 8.4 pt -106.87 146.85 33.95 Favored Pre-proline 0 N--CA 1.439 -1.0 0 CA-C-O 121.137 0.494 . . . . 0.57 111.458 -174.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.22 159.48 8.39 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 123.461 2.774 . . . . 1.05 112.31 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.2 mt -86.66 21.51 2.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.661 -0.7 . . . . 1.45 110.952 -173.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.5 pt . . . . . 0 C--O 1.25 1.11 0 CA-C-N 116.011 -0.54 . . . . 2.31 111.267 -173.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.855 -0.498 . . . . 5.75 111.855 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 p -91.03 -10.12 43.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.019 0.437 . . . . 4.66 110.594 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 104.08 -74.89 0.26 Allowed Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.566 -1.014 . . . . 1.6 110.566 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.547 ' CZ2' HD22 ' A' ' 54' ' ' LEU . 78.2 m95 -111.23 168.73 9.29 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.678 -0.49 . . . . 0.81 109.678 172.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -76.81 108.28 9.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.93 0.395 . . . . 2.73 110.775 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.9 m -94.82 13.32 25.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.905 -0.589 . . . . 1.75 109.551 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -19.82 55.03 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.453 -0.794 . . . . 3.24 111.302 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -74.68 -16.47 60.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.948 -0.569 . . . . 2.05 110.898 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.22 69.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.949 -0.643 . . . . 0.88 111.607 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.6 p -87.23 -29.65 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.623 0.601 . . . . 1.72 112.623 -173.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.4 t -129.3 141.31 51.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.604 0.716 . . . . 1.19 111.313 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.36 -30.53 15.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.509 -1.223 . . . . 1.66 111.704 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -30.55 14.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.069 0.396 . . . . 0.52 112.069 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.55 -9.51 57.27 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.553 -0.832 . . . . 0.43 112.626 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HD3' HG23 ' A' ' 74' ' ' VAL . 90.9 mttt -89.48 88.11 7.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.957 0.408 . . . . 1.64 110.347 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' A' ' 4' ' ' TRP . 8.8 mp -90.49 138.09 31.83 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.357 -0.609 . . . . 0.55 109.357 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.01 156.62 44.46 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.87 0.367 . . . . 0.29 110.71 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 50' ' ' THR . 51.2 m -91.34 101.93 14.62 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.697 -0.853 . . . . 0.74 108.697 171.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.8 m -121.32 142.51 49.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.213 0.53 . . . . 0.5 111.312 -171.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -93.72 108.26 20.03 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.408 -0.815 . . . . 1.65 109.235 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.7 p -74.15 -6.93 50.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.886 -0.597 . . . . 0.52 111.24 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -91.85 -20.58 21.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.843 0.83 . . . . 2.2 108.822 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -104.34 135.31 46.03 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.476 -1.238 . . . . 2.6 110.623 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.505 ' HD2' HG22 ' A' ' 47' ' ' ILE . 14.4 mmmm -119.91 156.56 30.52 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.831 -1.077 . . . . 2.17 110.052 -175.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.06 150.27 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.002 0.429 . . . . 0.59 110.303 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -78.1 30.25 0.17 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.44 -0.8 . . . . 2.83 111.837 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 30.7 mmmt -133.49 160.06 38.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.822 0.344 . . . . 4.07 111.26 -173.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.8 t -148.02 23.55 1.07 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.939 0.876 . . . . 2.46 108.942 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.407 ' OG1' ' HE3' ' A' ' 27' ' ' LYS . 13.7 p -102.56 145.09 30.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.909 -1.041 . . . . 2.0 111.652 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.66 155.77 15.94 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.966 -0.854 . . . . 1.39 110.966 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -100.88 -50.11 3.93 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.976 0.388 . . . . 3.06 111.158 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -95.96 -32.83 12.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.904 0.383 . . . . 2.44 110.457 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 p -59.49 -26.37 65.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 2.36 110.97 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.62 -28.91 74.01 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.159 -0.543 . . . . 2.54 112.58 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.3 -26.37 28.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.282 0.563 . . . . 3.49 110.123 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.3 tp -86.53 168.13 13.99 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.908 -0.775 . . . . 4.79 108.908 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 46.2 m170 -87.76 5.22 41.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.007 0.432 . . . . 6.59 111.113 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.568 ' O ' HG22 ' A' ' 41' ' ' VAL . 15.8 p -82.53 -32.89 28.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.021 -0.536 . . . . 5.42 110.908 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.62 13.88 11.06 Favored Glycine 0 N--CA 1.454 -0.138 0 C-N-CA 121.198 -0.525 . . . . 3.27 112.641 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.3 -25.14 59.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.963 0.411 . . . . 4.15 110.313 176.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 38' ' ' THR . 9.2 m -72.76 140.75 17.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 2.58 111.662 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.0 mt -97.47 -5.46 35.98 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.618 -0.719 . . . . 3.5 110.177 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -91.96 1.43 57.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 2.29 111.84 -175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.565 ' HB3' HG23 ' A' ' 82' ' ' ILE . 37.0 mt-30 -41.89 134.1 2.7 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.444 0.64 . . . . 1.4 111.105 176.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 83' ' ' ASN . 8.3 p -99.47 136.81 29.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.356 -0.838 . . . . 1.37 109.399 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.37 110.94 17.55 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.618 -0.719 . . . . 0.3 110.576 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.505 HG22 ' HD2' ' A' ' 24' ' ' LYS . 7.9 pt -114.78 160.52 14.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.783 -0.644 . . . . 0.23 110.342 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.37 129.58 34.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.836 -0.62 . . . . 2.38 110.232 -174.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 51.8 m -128.84 154.99 45.91 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.779 -1.1 . . . . 1.15 110.554 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 5.8 t -157.39 136.29 11.62 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.834 -0.621 . . . . 0.6 109.494 -177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -121.0 114.31 21.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.258 0.552 . . . . 2.08 111.262 -176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.9 mt -78.29 133.89 63.58 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.099 -0.955 . . . . 0.95 109.39 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -33.94 116.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.642 3.561 . . . . 0.95 113.564 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.547 HD22 ' CZ2' ' A' ' 4' ' ' TRP . 3.6 pp -100.12 141.72 32.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.911 -1.04 . . . . 1.67 111.989 -169.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.617 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 94.4 mt -80.72 133.74 35.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.255 -1.017 . . . . 1.58 108.255 167.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.7 mt -67.72 128.81 31.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.143 0.497 . . . . 2.11 110.199 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.53 9.18 63.29 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.554 -0.748 . . . . 1.03 111.725 -176.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -98.76 157.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.277 0.56 . . . . 0.77 110.771 177.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.7 137.88 31.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.969 -1.014 . . . . 0.68 110.914 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -53.1 -38.45 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.016 -0.993 . . . . 0.69 112.056 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -79.49 -17.86 53.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.356 -0.384 . . . . 2.2 111.533 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -102.45 -3.06 27.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.968 0.413 . . . . 1.98 110.349 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -102.38 -22.19 14.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.039 -0.528 . . . . 2.09 110.744 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.51 156.64 48.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.471 -0.331 . . . . 0.6 110.236 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -104.64 44.7 1.01 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.285 0.564 . . . . 2.32 110.889 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 3.9 m-20 -124.55 -165.68 1.41 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.492 -0.776 . . . . 1.06 109.723 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -87.76 128.35 54.68 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 120.91 0.386 . . . . 0.34 110.243 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -81.33 125.46 5.15 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.746 2.297 . . . . 0.45 110.915 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.786 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 2.9 p -124.64 153.42 42.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.972 0.415 . . . . 0.31 111.466 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 8.2 t -107.55 102.8 12.03 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.263 -0.643 . . . . 1.26 109.263 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 84' ' ' CYS . 97.6 m -84.64 142.11 30.15 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.039 -0.356 . . . . 0.29 110.039 -176.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.6 tt0 -76.1 -27.44 57.15 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.62 -0.881 . . . . 1.53 108.62 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 71' ' ' CYS . 24.6 t0 -159.57 162.8 35.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.874 -1.057 . . . . 1.26 108.66 175.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.642 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.3 t -140.16 134.72 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.841 -0.429 . . . . 1.07 109.841 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -106.15 165.91 10.89 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.795 -0.446 . . . . 1.87 109.795 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t70 67.4 -151.92 0.19 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.231 0.612 . . . . 1.94 109.457 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -79.17 22.86 0.39 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.969 0.414 . . . . 2.12 110.553 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.485 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 98.19 23.15 13.36 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.924 -0.655 . . . . 0.51 112.041 -177.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.73 -17.18 28.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 1.1 111.217 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.88 103.68 11.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.498 -0.319 . . . . 0.33 110.51 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.422 ' HA3' ' SG ' ' A' ' 71' ' ' CYS . . . -94.29 133.11 11.46 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.354 -0.926 . . . . 0.26 112.368 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.565 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -97.61 126.71 50.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 122.441 0.296 . . . . 0.3 110.255 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.67 ' HA ' HG12 ' A' ' 45' ' ' VAL . 85.3 m-20 53.52 43.56 31.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 123.84 0.712 . . . . 0.34 110.398 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.786 ' SG ' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -87.49 102.89 15.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.406 -0.816 . . . . 0.81 110.15 -177.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.4 m -83.12 130.67 56.25 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.891 -0.595 . . . . 0.44 110.111 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.33 109.84 2.98 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.974 2.449 . . . . 0.39 111.906 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.2 pt -83.69 137.44 41.33 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.576 -0.738 . . . . 0.57 111.176 -175.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 15.5 Cg_exo -71.82 157.68 54.65 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.349 2.699 . . . . 1.05 112.079 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.7 mt -90.96 25.11 2.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.847 -0.615 . . . . 1.45 110.775 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 90' ' ' ILE . 24.1 pt . . . . . 0 C--O 1.249 1.041 0 CA-C-N 116.332 -0.395 . . . . 2.31 110.97 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.129 -0.388 . . . . 5.75 112.129 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 p -96.34 126.92 41.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.845 0.355 . . . . 4.66 110.674 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.87 173.9 27.25 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.676 -0.773 . . . . 1.6 111.906 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.474 ' CE3' ' HB ' ' A' ' 60' ' ' ILE . 71.8 m95 -83.47 -177.4 6.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.053 0.454 . . . . 0.81 111.608 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -78.04 107.69 10.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 2.73 109.724 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.8 t -111.75 27.51 9.59 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.349 0.595 . . . . 1.75 109.744 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -24.86 61.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.514 -0.766 . . . . 3.24 112.723 -172.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 t -91.6 5.17 50.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.635 -0.426 . . . . 2.05 110.931 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.22 17.8 75.67 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.598 -0.811 . . . . 0.88 111.839 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 p -69.38 -30.81 68.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.627 0.603 . . . . 1.72 112.627 -172.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.1 t -132.35 141.3 48.87 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.263 -0.575 . . . . 1.19 111.482 -176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.533 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.9 p30 -93.08 -29.53 15.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.561 -0.745 . . . . 1.66 111.593 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.533 HG23 ' OD1' ' A' ' 12' ' ' ASN . 2.6 p -95.42 -31.38 13.41 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.531 0.567 . . . . 0.52 112.531 -173.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.72 -18.26 44.22 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.339 -0.934 . . . . 0.43 113.267 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.626 ' HD3' HG23 ' A' ' 74' ' ' VAL . 81.9 mttt -84.83 89.4 7.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.168 0.484 . . . . 1.64 110.478 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' A' ' 4' ' ' TRP . 8.8 mp -91.87 137.68 32.17 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.921 -0.4 . . . . 0.55 109.921 175.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.532 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -145.67 152.03 38.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.907 0.384 . . . . 0.29 110.383 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 36.1 m -87.5 98.65 11.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.502 -0.555 . . . . 0.74 109.502 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 86.3 m -117.3 161.97 18.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.11 -0.495 . . . . 0.5 111.515 -167.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 11.9 m-20 -99.46 98.71 9.59 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.65 109.939 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.8 p -70.31 -7.66 44.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.836 -0.62 . . . . 0.52 112.151 -173.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -103.14 -10.55 18.74 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 122.189 0.995 . . . . 2.2 108.788 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.483 ' HG3' ' HB2' ' A' ' 48' ' ' GLN . 40.8 tptt -118.06 99.53 6.95 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.416 -1.72 . . . . 2.6 110.497 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 14.2 mptt -85.76 170.31 12.58 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.036 -0.984 . . . . 2.17 111.047 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.04 150.49 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.59 -0.732 . . . . 0.59 109.18 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -74.58 23.83 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.189 0.811 . . . . 2.83 113.189 -173.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -136.74 160.11 39.83 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.967 -0.458 . . . . 4.07 111.555 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 p -134.64 38.74 3.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.598 0.713 . . . . 2.46 109.605 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.8 p -89.39 -172.98 3.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.218 -0.901 . . . . 2.0 111.229 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.21 146.57 8.42 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.72 -0.752 . . . . 1.39 111.982 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -82.22 -50.46 8.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.943 0.402 . . . . 3.06 110.431 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -97.33 -38.19 9.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.895 -0.593 . . . . 2.44 109.968 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 73' ' ' ASP . 23.1 t -66.27 -29.14 69.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.97 -0.559 . . . . 2.36 109.803 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.98 -17.43 75.5 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.957 -0.639 . . . . 2.54 112.292 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.9 mt -85.66 -30.46 23.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.294 0.569 . . . . 3.49 109.728 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.434 ' HG ' ' H ' ' A' ' 37' ' ' HIS . 18.6 tp -89.66 173.51 8.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.451 -0.795 . . . . 4.79 109.442 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.434 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 77.8 t60 -74.8 -7.47 53.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.959 0.409 . . . . 6.59 110.788 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.2 p -68.67 -23.42 64.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 5.42 111.492 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.456 ' HA2' ' NE2' ' A' ' 44' ' ' GLN . . . -83.19 -3.96 89.95 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.81 -0.709 . . . . 3.27 112.925 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.22 -29.28 68.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.396 0.617 . . . . 4.15 111.161 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.9 m -88.32 147.69 5.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.393 -0.821 . . . . 2.58 113.125 -171.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.1 tp -84.69 -7.85 59.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.757 -1.11 . . . . 3.5 108.612 170.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -60.63 -30.79 70.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.025 -0.989 . . . . 2.29 110.938 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.49 ' HB3' HG23 ' A' ' 82' ' ' ILE . 15.8 mt-30 -50.69 127.49 18.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.19 0.519 . . . . 1.4 110.687 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.68 107.53 20.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.41 -0.813 . . . . 1.37 110.067 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -95.38 122.45 38.11 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.488 -0.778 . . . . 0.3 110.336 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 84' ' ' CYS . 22.0 pt -122.79 157.82 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.192 -0.458 . . . . 0.23 110.472 176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.483 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -71.4 138.96 49.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.538 -0.756 . . . . 2.38 109.189 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.8 t -142.78 156.58 45.0 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.885 0.374 . . . . 1.15 111.172 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -162.95 122.21 2.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.552 -0.749 . . . . 0.6 109.766 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.459 ' HG2' ' SG ' ' A' ' 18' ' ' CYS . 11.5 tm0? -120.95 115.67 23.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.826 0.346 . . . . 2.08 110.539 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.447 HG23 ' HD2' ' A' ' 53' ' ' PRO . 63.3 mt -52.35 135.42 41.85 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-N 115.207 -0.906 . . . . 0.95 110.192 176.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HD2' HG23 ' A' ' 52' ' ' ILE . 89.8 Cg_exo -33.37 107.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 124.507 3.472 . . . . 0.95 113.88 -174.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.552 ' HA ' ' OE1' ' A' ' 63' ' ' GLU . 3.5 pp -59.3 140.76 55.72 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.755 -1.111 . . . . 1.67 113.837 -168.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -111.26 115.85 30.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.663 -1.153 . . . . 1.58 109.438 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.3 mm -63.64 139.12 21.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.416 0.627 . . . . 2.11 111.14 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.42 -23.84 33.19 Favored Glycine 0 C--N 1.315 -0.602 0 CA-C-N 115.166 -0.925 . . . . 1.03 112.961 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.66 152.04 3.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.768 0.794 . . . . 0.77 111.759 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.07 124.15 27.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.318 -1.31 . . . . 0.68 110.749 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.474 ' HB ' ' CE3' ' A' ' 4' ' ' TRP . 13.3 tt -53.62 -33.1 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.044 -0.98 . . . . 0.69 111.017 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 60' ' ' ILE . 2.8 mp0 -61.34 -29.88 70.16 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.41 -1.268 . . . . 2.2 111.437 -173.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -106.64 -20.47 13.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.054 -0.521 . . . . 1.98 110.452 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' A' ' 54' ' ' LEU . 29.5 tt0 -67.2 -41.14 86.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.766 -0.652 . . . . 2.09 111.129 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.6 p -105.02 -173.64 2.35 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.976 -0.556 . . . . 0.6 109.726 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -132.2 43.68 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.309 0.576 . . . . 2.32 110.817 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 49.8 m-80 -137.55 -171.16 2.91 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.487 -0.931 . . . . 1.06 108.487 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 22.8 m -81.29 122.12 80.93 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.314 0.578 . . . . 0.34 111.614 -177.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.69 124.2 11.66 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.255 2.637 . . . . 0.45 111.036 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 86' ' ' PRO . 72.6 p -132.5 149.92 52.25 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.788 -0.365 . . . . 0.31 111.237 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 11.6 t -94.74 112.11 23.86 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.477 -0.564 . . . . 1.26 109.477 172.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.4 m -99.36 139.41 35.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.253 0.549 . . . . 0.29 110.333 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.0 tt0 -77.22 -23.93 51.32 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.458 -0.792 . . . . 1.53 109.415 177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 40.4 t0 -163.86 165.09 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.991 -1.004 . . . . 1.26 108.407 171.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.626 HG23 ' HD3' ' A' ' 15' ' ' LYS . 2.0 t -142.2 136.38 29.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 117.947 0.34 . . . . 1.07 110.339 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.81 162.6 12.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.739 -0.467 . . . . 1.87 109.739 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 62.26 -154.37 0.35 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.54 -0.541 . . . . 1.94 109.54 -173.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.5 7.79 6.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.641 0.734 . . . . 2.12 109.848 174.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.594 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.04 22.61 2.89 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.487 -0.779 . . . . 0.51 112.596 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 79' ' ' LEU . 2.2 mm? -83.82 -23.62 31.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.69 0.256 . . . . 1.1 111.69 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.8 t -129.21 106.88 14.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.972 -0.381 . . . . 0.33 109.972 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -97.49 144.05 17.08 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.384 -0.912 . . . . 0.26 112.399 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -102.15 119.03 49.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 110.003 -0.369 . . . . 0.3 110.003 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 87.4 m-20 61.36 43.7 10.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.499 -0.773 . . . . 0.34 110.565 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.632 ' HB2' HD11 ' A' ' 47' ' ' ILE . 60.3 m -82.78 99.03 9.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.349 -0.841 . . . . 0.81 111.0 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.3 m -89.37 131.98 38.77 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.436 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.438 ' HA ' HG22 ' A' ' 69' ' ' THR . 11.6 Cg_endo -68.55 126.43 14.11 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.079 2.52 . . . . 0.39 112.208 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 14.2 pt -105.8 152.41 40.17 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.769 -0.65 . . . . 0.57 111.091 -174.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 18.2 Cg_exo -70.08 153.55 67.33 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.246 2.63 . . . . 1.05 112.455 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.8 mt -84.62 23.47 1.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.81 -0.632 . . . . 1.45 110.855 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.989 -0.529 . . . . 2.31 111.312 -173.634 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 111.705 -0.558 . . . . 5.75 111.705 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.482 ' OG ' ' HA3' ' A' ' 14' ' ' GLY . 13.4 p -66.84 -54.1 25.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.263 0.554 . . . . 4.66 109.767 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.76 -43.42 0.68 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.823 -0.911 . . . . 1.6 110.823 172.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.408 ' HB2' HD13 ' A' ' 16' ' ' LEU . 76.3 m95 -136.11 161.19 36.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.491 -0.354 . . . . 0.81 110.101 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.2 109.14 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.481 . . . . 2.73 111.174 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.493 ' OG ' ' HA2' ' A' ' 14' ' ' GLY . 11.1 m -105.44 26.45 9.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.829 -0.623 . . . . 1.75 110.491 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -59.47 -15.25 16.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.952 -0.567 . . . . 3.24 112.102 -176.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -73.02 -15.58 61.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.084 0.468 . . . . 2.05 110.958 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.4 8.26 70.42 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.822 -0.626 . . . . 0.88 111.664 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.5 t -88.07 -9.71 52.47 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.863 0.363 . . . . 1.72 110.692 -176.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.2 t -123.71 139.78 53.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.167 0.508 . . . . 1.19 110.307 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.44 -31.89 13.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.27 -0.877 . . . . 1.66 112.521 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -102.27 -20.6 14.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.263 0.468 . . . . 0.52 112.263 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.493 ' HA2' ' OG ' ' A' ' 6' ' ' SER . . . 89.96 4.83 71.63 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.725 -0.75 . . . . 0.43 112.654 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.616 ' HD3' HG13 ' A' ' 74' ' ' VAL . 66.7 mttm -93.8 88.9 5.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.75 0.309 . . . . 1.64 110.478 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 69' ' ' THR . 7.8 mp -93.66 109.36 21.0 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.541 -0.54 . . . . 0.55 109.541 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -124.13 144.2 50.03 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.872 0.368 . . . . 0.29 110.956 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 81.5 m -79.91 98.22 7.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.908 -0.587 . . . . 0.74 109.478 175.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 73.1 m -113.42 156.99 22.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.125 0.488 . . . . 0.5 111.461 -169.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 22.7 m-20 -92.01 93.07 8.58 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.37 -0.832 . . . . 1.65 109.298 174.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.4 p -64.91 -15.23 61.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.693 0.627 . . . . 0.52 112.693 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -106.51 0.44 24.66 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.989 0.899 . . . . 2.2 108.67 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HG3' HE21 ' A' ' 48' ' ' GLN . 48.2 tptt -123.98 98.9 6.0 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.08 -1.418 . . . . 2.6 109.529 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -89.16 164.76 14.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.561 -1.199 . . . . 2.17 111.022 -171.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.628 HG22 ' NE2' ' A' ' 48' ' ' GLN . 3.5 t -117.74 149.88 19.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.854 -0.612 . . . . 0.59 110.264 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -80.73 -40.14 25.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.345 -0.613 . . . . 2.83 109.345 174.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -69.4 121.24 16.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.592 -0.731 . . . . 4.07 109.11 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -149.87 79.17 1.37 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.797 -0.361 . . . . 2.46 111.584 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.416 ' HA ' HG11 ' A' ' 41' ' ' VAL . 22.1 m -136.54 -61.0 0.7 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.639 -0.424 . . . . 2.0 111.434 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.41 164.11 15.6 Favored Glycine 0 C--N 1.32 -0.327 0 C-N-CA 121.036 -0.602 . . . . 1.39 112.035 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -101.53 -42.26 6.31 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.235 0.457 . . . . 3.06 112.235 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.51 -55.32 4.55 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.87 -0.332 . . . . 2.44 111.434 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.4 m -90.24 -29.48 18.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.109 0.48 . . . . 2.36 110.12 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.33 42.54 2.17 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.653 -0.703 . . . . 2.54 113.835 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.96 -52.09 66.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.112 0.482 . . . . 3.49 109.91 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.5 mt -92.28 147.38 22.96 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.849 -0.614 . . . . 4.79 109.426 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.441 ' O ' HG22 ' A' ' 41' ' ' VAL . 18.1 m-70 -101.05 -71.81 0.7 Allowed 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 121.082 -0.247 . . . . 6.59 111.092 -176.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.1 m -74.57 -20.01 60.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.18 0.514 . . . . 5.42 110.974 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.2 0.24 58.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.318 -0.944 . . . . 3.27 112.936 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.98 -43.91 2.43 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.398 -0.521 . . . . 4.15 111.119 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 37' ' ' HIS . 2.1 m -87.04 124.53 40.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.635 0.731 . . . . 2.58 110.372 -177.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.9 mt -121.55 -35.83 3.17 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.387 -0.824 . . . . 3.5 110.582 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -142.22 1.19 1.4 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.848 -0.615 . . . . 2.29 111.918 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HB3' HG23 ' A' ' 82' ' ' ILE . 12.7 mt-30 -54.07 133.48 43.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.283 0.563 . . . . 1.4 111.407 -175.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.17 121.52 63.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.316 -0.857 . . . . 1.37 109.334 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.99 133.2 52.64 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.638 -0.71 . . . . 0.3 111.229 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.47 HD11 ' HB2' ' A' ' 84' ' ' CYS . 12.7 pt -125.61 153.75 33.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.529 -0.76 . . . . 0.23 109.972 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.628 ' NE2' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -67.69 139.9 56.76 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.389 -0.597 . . . . 2.38 109.389 178.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.8 t -138.91 156.44 47.27 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.252 -0.431 . . . . 1.15 110.757 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -161.43 140.27 9.85 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.981 -0.554 . . . . 0.6 109.805 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.528 HE22 HD12 ' A' ' 60' ' ' ILE . 43.9 tp60 -114.6 155.23 26.92 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.026 0.441 . . . . 2.08 110.451 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.51 HG23 ' HD2' ' A' ' 53' ' ' PRO . 42.0 mm -86.82 150.7 51.03 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.228 -0.896 . . . . 0.95 108.967 176.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD2' HG23 ' A' ' 52' ' ' ILE . 51.6 Cg_exo -35.14 111.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.137 2.558 . . . . 0.95 111.842 171.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.66 133.17 55.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.175 -0.92 . . . . 1.67 112.926 -167.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -107.19 124.52 49.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.096 -0.956 . . . . 1.58 109.252 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 56' ' ' ILE . 15.6 mt -64.2 130.38 29.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.24 -0.436 . . . . 2.11 110.857 -174.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.84 15.18 71.18 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.418 -0.81 . . . . 1.03 113.217 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.448 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -100.26 152.67 4.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.693 0.759 . . . . 0.77 111.643 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.41 145.91 25.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.363 -1.29 . . . . 0.68 111.237 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.528 HD12 HE22 ' A' ' 51' ' ' GLN . 8.2 tp -53.69 -34.26 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 114.358 -1.292 . . . . 0.69 112.836 -176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.72 -4.81 58.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.739 0.304 . . . . 2.2 111.655 -172.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -110.09 -27.19 9.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.094 0.473 . . . . 1.98 110.133 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.448 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 32.3 tt0 -71.43 -39.49 71.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.782 -0.645 . . . . 2.09 110.933 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.7 p -121.08 169.06 10.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.214 -0.448 . . . . 0.6 110.492 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -113.98 26.83 9.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.089 0.471 . . . . 2.32 110.455 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 17.0 m-80 -107.06 -160.92 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 1.06 110.126 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 12.4 m -96.63 126.7 42.28 Favored Pre-proline 0 N--CA 1.448 -0.563 0 CA-C-O 120.976 0.417 . . . . 0.34 110.501 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -81.96 129.21 6.1 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.979 2.453 . . . . 0.45 111.03 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 16' ' ' LEU . 65.5 p -132.14 157.37 44.44 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.754 -0.379 . . . . 0.31 110.936 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 40.7 t -106.12 102.28 11.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.048 -0.524 . . . . 1.26 109.647 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 55.6 m -88.08 133.75 33.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.973 0.416 . . . . 0.29 110.56 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 4.0 tt0 -76.3 -23.58 54.34 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.875 -0.602 . . . . 1.53 110.102 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -158.77 169.26 24.78 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.65 -0.87 . . . . 1.26 108.65 170.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.616 HG13 ' HD3' ' A' ' 15' ' ' LYS . 32.8 m -135.84 146.05 30.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.77 0.319 . . . . 1.07 110.562 177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -112.22 150.21 31.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.342 -0.985 . . . . 1.87 108.342 173.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.8 -156.32 0.33 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.754 -0.832 . . . . 1.94 108.754 -170.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -83.07 23.16 0.88 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.522 0.677 . . . . 2.12 110.762 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.568 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 104.22 21.85 9.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.588 -0.815 . . . . 0.51 112.955 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 84.0 mt -85.16 -17.13 38.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.064 0.459 . . . . 1.1 109.987 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 78.1 t -129.61 110.82 20.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.51 -0.768 . . . . 0.33 109.156 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -101.78 140.62 14.95 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.181 -1.009 . . . . 0.26 112.334 -176.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.486 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -97.52 119.36 45.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 110.058 -0.349 . . . . 0.3 110.058 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 96.0 m-20 59.81 50.54 6.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.678 -0.692 . . . . 0.34 110.832 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.566 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 57.5 m -85.0 91.34 8.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.379 -0.828 . . . . 0.81 110.924 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.1 m -74.94 126.09 88.64 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.675 -0.693 . . . . 0.44 110.379 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.38 121.66 9.14 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.856 2.37 . . . . 0.39 111.818 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.4 pt -101.09 154.54 37.1 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.799 -0.637 . . . . 0.57 110.847 -176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -70.39 162.57 41.92 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.206 2.604 . . . . 1.05 112.794 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.8 mt -92.74 22.74 4.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.441 -0.8 . . . . 1.45 110.54 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.8 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.404 -0.808 . . . . 2.31 111.628 -172.21 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.648 -0.581 . . . . 5.75 111.648 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t -80.2 98.75 7.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.837 0.351 . . . . 4.66 110.588 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.15 104.2 1.45 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.662 -0.78 . . . . 1.6 111.359 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -90.32 -177.23 5.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.108 0.48 . . . . 0.81 112.115 -175.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -63.41 108.4 1.33 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.269 -0.878 . . . . 2.73 111.257 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -101.11 -17.5 16.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.162 -0.926 . . . . 1.75 109.365 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' C ' ' HD2' ' A' ' 7' ' ' LYS . 2.7 pptp? -69.54 -17.89 63.61 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.901 -0.591 . . . . 3.24 110.745 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.2 m -72.73 -26.85 61.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.063 -0.517 . . . . 2.05 111.159 -177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.65 16.25 75.93 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.982 -0.628 . . . . 0.88 112.654 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.632 ' OG ' ' HB ' ' A' ' 87' ' ' ILE . 7.8 t -87.32 -29.0 21.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.946 0.403 . . . . 1.72 110.77 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.8 t -115.39 140.94 48.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.898 0.38 . . . . 1.19 110.701 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.5 p30 -93.09 -25.87 17.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.075 -0.511 . . . . 1.66 112.038 -177.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.43 HG21 ' HA ' ' A' ' 72' ' ' GLU . 43.9 p -92.97 -30.47 15.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.879 0.371 . . . . 0.52 111.686 -174.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.97 -4.41 59.03 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.748 -0.739 . . . . 0.43 112.027 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.501 ' HD3' HG23 ' A' ' 74' ' ' VAL . 53.3 mttp -94.19 89.95 6.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.862 0.363 . . . . 1.64 110.666 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.1 mp -96.17 113.35 24.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.256 -0.429 . . . . 0.55 110.627 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.04 151.1 49.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.877 0.37 . . . . 0.29 110.312 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.637 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 60.8 m -84.84 103.2 13.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.007 -0.738 . . . . 0.74 109.007 173.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 98.4 m -113.13 142.97 45.14 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.17 0.51 . . . . 0.5 110.975 -174.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 44.0 m-20 -97.69 109.19 21.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.487 -0.779 . . . . 1.65 109.238 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.4 p -75.64 -5.88 47.66 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.411 0.624 . . . . 0.52 110.033 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -89.46 -8.63 52.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.242 -0.89 . . . . 2.2 109.053 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.44 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 26.2 mtmt -121.57 142.75 49.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.812 -1.085 . . . . 2.6 110.145 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.472 ' HD3' HG22 ' A' ' 47' ' ' ILE . 33.7 mmtp -128.39 158.86 37.11 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.63 -0.714 . . . . 2.17 111.082 -175.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 27' ' ' LYS . 10.7 t -124.15 150.03 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.085 -1.08 . . . . 0.59 108.085 173.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -76.48 31.76 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.09 0.404 . . . . 2.83 112.09 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 25' ' ' VAL . 14.6 mtmt 37.81 114.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.997 1.319 . . . . 4.07 113.451 -170.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.8 p -101.24 -81.03 0.49 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.378 -0.828 . . . . 2.46 110.008 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.74 -172.25 3.43 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.641 -1.163 . . . . 2.0 109.162 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.24 116.64 1.13 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.186 -0.766 . . . . 1.39 111.186 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.01 -31.59 72.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.89 0.345 . . . . 3.06 110.55 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -75.38 -42.03 54.95 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.73 -0.471 . . . . 2.44 109.73 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.528 ' HB3' ' HA3' ' A' ' 39' ' ' GLY . 32.0 m -54.84 -27.31 41.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.757 -0.656 . . . . 2.36 111.983 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.33 64.51 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.925 -0.655 . . . . 2.54 112.668 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.5 mt -90.91 -29.44 17.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.353 0.597 . . . . 3.49 110.203 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 mp -92.71 179.82 5.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.765 . . . . 4.79 110.325 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -104.51 1.6 30.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.973 0.416 . . . . 6.59 110.681 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.91 -14.21 61.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.959 -0.564 . . . . 5.42 111.509 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 33' ' ' SER . . . -83.97 14.0 45.91 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.978 -0.555 . . . . 3.27 112.676 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -75.78 -40.84 54.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.275 0.559 . . . . 4.15 110.383 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -80.39 142.47 13.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.41 -0.813 . . . . 2.58 112.53 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.6 mt -87.28 -8.35 56.84 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.287 -0.87 . . . . 3.5 109.145 169.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.95 -14.14 51.45 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.528 -1.214 . . . . 2.29 111.548 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.477 ' NE2' ' HA2' ' A' ' 39' ' ' GLY . 85.8 mt-30 -50.23 146.14 5.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.229 0.537 . . . . 1.4 111.955 177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.7 t -118.51 126.99 75.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.338 -0.846 . . . . 1.37 109.023 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -110.88 114.33 27.59 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.301 -0.409 . . . . 0.3 111.805 -175.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.472 HG22 ' HD3' ' A' ' 24' ' ' LYS . 12.4 pt -111.06 163.7 7.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.78 -0.645 . . . . 0.23 109.653 172.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -88.84 127.62 35.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.47 0.652 . . . . 2.38 109.634 -176.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 78' ' ' GLY . 29.8 m -122.54 160.59 25.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.712 -1.131 . . . . 1.15 110.671 -172.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 11.2 t -160.89 142.49 12.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.774 -0.454 . . . . 0.6 109.774 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.458 HE21 HD12 ' A' ' 60' ' ' ILE . 8.0 tm0? -120.07 115.87 24.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.266 0.555 . . . . 2.08 110.817 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.418 HG23 ' HD2' ' A' ' 53' ' ' PRO . 68.7 mt -73.83 133.14 79.54 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.225 -0.898 . . . . 0.95 109.839 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD2' HG23 ' A' ' 52' ' ' ILE . 67.6 Cg_exo -33.57 111.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 124.817 3.678 . . . . 0.95 114.096 -172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 63' ' ' GLU . 4.1 pp -88.42 142.14 27.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.679 -1.146 . . . . 1.67 112.535 -170.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.418 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 67.7 mt -93.94 144.31 25.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.468 -0.787 . . . . 1.58 109.139 168.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 mt -68.78 130.75 33.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.932 0.396 . . . . 2.11 110.678 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.41 -0.57 80.99 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.551 -0.75 . . . . 1.03 112.51 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -93.67 154.08 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.603 0.716 . . . . 0.77 111.488 -178.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.01 132.27 34.75 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.758 -1.11 . . . . 0.68 111.377 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.458 HD12 HE21 ' A' ' 51' ' ' GLN . 5.5 tp -49.84 -39.46 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 114.761 -1.109 . . . . 0.69 111.505 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 60' ' ' ILE . 8.2 pt-20 -70.9 -34.09 71.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.276 -0.874 . . . . 2.2 111.842 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -91.62 -23.17 19.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.95 0.405 . . . . 1.98 110.843 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 54' ' ' LEU . 7.7 tp10 -73.1 -40.68 64.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 2.09 111.122 -176.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 66' ' ' ASN . 19.8 p -107.15 156.6 18.63 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.915 0.388 . . . . 0.6 110.809 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -98.65 55.71 1.08 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.208 -1.034 . . . . 2.32 108.208 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.637 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 14.2 m120 -138.97 -168.68 2.47 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.13 -1.396 . . . . 1.06 109.073 -172.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.9 m -104.46 126.09 32.38 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-O 120.895 0.378 . . . . 0.34 110.119 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -77.88 129.28 9.76 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.628 2.219 . . . . 0.45 110.997 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.0 p -129.51 150.56 50.8 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.096 0.474 . . . . 0.31 111.545 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 54.0 t -98.98 99.09 10.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.686 -0.857 . . . . 1.26 108.686 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 56.6 m -86.61 141.27 29.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.06 0.457 . . . . 0.29 110.642 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 3.0 tt0 -64.12 -45.25 89.41 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.094 -0.706 . . . . 1.53 109.094 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -151.55 167.79 26.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.66 -1.155 . . . . 1.26 108.724 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.545 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 1.8 t -142.97 158.55 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.472 -0.566 . . . . 1.07 109.472 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -121.21 156.16 33.04 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.976 -0.379 . . . . 1.87 109.976 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 67.69 -150.08 0.16 Allowed 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 123.577 0.548 . . . . 1.94 109.677 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.419 ' OD1' ' HG ' ' A' ' 79' ' ' LEU . 11.4 p-10 -76.75 0.99 18.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.281 0.563 . . . . 2.12 109.715 174.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 49' ' ' CYS . . . 120.94 24.21 2.56 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.5 -0.773 . . . . 0.51 112.752 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 49' ' ' CYS . 93.7 mt -79.66 -25.55 41.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.82 0.31 . . . . 1.1 111.757 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.0 t -125.8 107.52 17.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.066 -0.346 . . . . 0.33 110.066 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.571 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -102.13 144.65 16.34 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.391 -0.909 . . . . 0.26 112.911 -174.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 mp -100.41 118.21 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.442 -0.379 . . . . 0.3 110.064 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.607 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 93.8 m-20 59.02 43.96 16.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.739 -0.664 . . . . 0.34 111.151 174.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.571 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 69.5 m -78.26 97.16 5.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.842 -0.617 . . . . 0.81 110.958 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 23.8 m -88.4 130.05 47.13 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.725 -0.67 . . . . 0.44 110.207 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.5 Cg_exo -61.07 113.82 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.994 2.463 . . . . 0.39 112.108 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.632 ' HB ' ' OG ' ' A' ' 10' ' ' SER . 7.9 pt -82.47 138.96 44.43 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.91 -0.587 . . . . 0.57 110.835 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 17.1 Cg_exo -70.68 144.08 48.16 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.086 2.524 . . . . 1.05 111.537 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 35.4 mt -92.05 32.75 1.11 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.222 -0.899 . . . . 1.45 109.486 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 C--O 1.248 1.001 0 CA-C-N 115.771 -0.65 . . . . 2.31 111.03 -173.806 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.0 -0.44 . . . . 5.75 112.0 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.0 t -153.26 128.37 9.71 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.323 -0.251 . . . . 4.66 110.323 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.72 27.18 27.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.864 -0.684 . . . . 1.6 112.374 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CD2' ' HB ' ' A' ' 60' ' ' ILE . 58.2 m95 -77.6 161.81 27.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.082 0.468 . . . . 0.81 111.59 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -66.75 109.65 2.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.361 -0.836 . . . . 2.73 110.411 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.3 m -93.95 27.98 2.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.461 -0.79 . . . . 1.75 110.441 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -45.49 -46.81 14.02 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.368 -0.833 . . . . 3.24 112.491 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.4 p -63.08 -23.92 67.67 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.202 -0.454 . . . . 2.05 112.165 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.26 5.12 89.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.097 -0.573 . . . . 0.88 111.702 -176.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.5 m -70.43 -13.89 62.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.565 -0.318 . . . . 1.72 111.635 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -131.91 141.12 49.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.015 0.436 . . . . 1.19 110.507 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -94.6 -30.29 14.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.413 -0.812 . . . . 1.66 112.479 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 p -89.52 -30.03 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.983 0.421 . . . . 0.52 111.947 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.58 3.07 71.98 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.575 -0.821 . . . . 0.43 111.556 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -95.74 87.99 4.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.347 0.594 . . . . 1.64 110.133 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.0 mp -97.35 137.95 35.56 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.351 -0.84 . . . . 0.55 109.758 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.87 145.18 35.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.032 0.444 . . . . 0.29 110.593 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 28.1 m -82.02 102.84 11.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.387 -0.968 . . . . 0.74 108.387 173.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 59.1 m -122.45 156.6 33.73 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.131 0.491 . . . . 0.5 111.544 -169.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -102.85 118.01 35.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.442 -0.799 . . . . 1.65 109.312 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.9 p -80.96 -5.19 57.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.972 0.415 . . . . 0.52 111.368 -174.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -97.43 -19.85 18.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.675 0.75 . . . . 2.2 109.568 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -104.28 137.89 41.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.683 -1.144 . . . . 2.6 110.614 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.501 ' HD3' HG22 ' A' ' 47' ' ' ILE . 33.6 mmtp -127.36 155.07 44.18 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.786 -1.097 . . . . 2.17 110.393 -172.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.499 HG22 ' OE1' ' A' ' 48' ' ' GLN . 6.3 t -111.35 145.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.32 -0.622 . . . . 0.59 109.32 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -84.38 -40.74 17.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.274 -0.421 . . . . 2.83 111.38 -172.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -95.51 126.24 40.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.493 -0.321 . . . . 4.07 110.309 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.5 p -141.82 113.92 8.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.191 -0.459 . . . . 2.46 110.724 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.9 m -140.23 -48.52 0.45 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.197 0.522 . . . . 2.0 110.318 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.98 171.19 32.58 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.385 -0.825 . . . . 1.39 111.899 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -100.85 -51.13 3.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.715 -0.476 . . . . 3.06 109.715 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -84.11 -44.69 13.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.778 -0.646 . . . . 2.44 109.974 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.5 p -75.44 -24.91 57.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.985 -0.552 . . . . 2.36 109.638 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.43 -34.05 73.53 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.52 -0.764 . . . . 2.54 112.972 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.2 tp -74.45 -24.33 59.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.49 0.662 . . . . 3.49 109.904 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.0 tp -91.52 168.91 11.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.474 -0.784 . . . . 4.79 109.81 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -62.12 -14.89 41.41 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.836 0.35 . . . . 6.59 111.6 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -65.5 -20.71 66.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 5.42 111.567 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.45 9.67 73.89 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.814 -0.707 . . . . 3.27 112.333 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.04 -16.95 23.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.034 0.445 . . . . 4.15 110.648 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.35 137.07 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.944 -0.571 . . . . 2.58 111.134 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 42' ' ' LEU . 4.1 mm? -83.98 0.73 46.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.952 -0.758 . . . . 3.5 108.952 173.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.26 -28.7 70.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.641 -1.163 . . . . 2.29 110.32 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.461 ' HB3' HG23 ' A' ' 82' ' ' ILE . 33.9 mt-30 -48.34 135.2 14.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.013 -0.54 . . . . 1.4 110.033 175.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.2 t -96.51 105.13 16.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 116.084 -0.507 . . . . 1.37 109.859 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -102.86 99.67 9.61 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.521 -0.763 . . . . 0.3 110.852 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.501 HG22 ' HD3' ' A' ' 24' ' ' LYS . 19.2 pt -101.89 151.51 5.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.7 -0.682 . . . . 0.23 109.822 174.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.499 ' OE1' HG22 ' A' ' 25' ' ' VAL . 14.7 tp60 -76.82 126.04 30.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.584 -0.734 . . . . 2.38 109.973 -175.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 67.2 m -115.62 156.13 26.4 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.78 -1.1 . . . . 1.15 111.289 -173.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.1 t -160.23 114.08 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.525 -0.762 . . . . 0.6 109.782 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -120.38 131.91 55.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.997 -0.547 . . . . 2.08 111.063 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 64' ' ' CYS . 21.7 mt -63.45 142.74 97.91 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.407 -0.815 . . . . 0.95 110.946 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -37.1 129.41 0.56 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 124.246 3.297 . . . . 0.95 113.352 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -59.55 127.09 30.32 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.054 -0.976 . . . . 1.67 112.712 -171.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.7 mt -110.5 107.88 17.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.636 -0.876 . . . . 1.58 108.636 170.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.3 mt -65.95 134.62 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.23 0.538 . . . . 2.11 111.124 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.16 -12.77 63.65 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.297 -0.865 . . . . 1.03 112.042 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.21 152.06 6.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.748 0.785 . . . . 0.77 111.92 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.52 137.78 33.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.093 -1.412 . . . . 0.68 110.579 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.569 ' HB ' ' CD2' ' A' ' 4' ' ' TRP . 11.1 tt -55.89 -39.67 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.547 -0.751 . . . . 0.69 112.244 -175.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.433 ' N ' HG23 ' A' ' 60' ' ' ILE . 2.3 pm0 -72.96 -12.68 61.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.682 -0.69 . . . . 2.2 110.903 -173.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -110.06 -17.46 13.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.433 0.635 . . . . 1.98 109.501 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -75.14 -40.95 59.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.736 -0.665 . . . . 2.09 110.09 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.543 ' HA ' HD12 ' A' ' 52' ' ' ILE . 13.9 p -108.96 175.55 5.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.012 -0.54 . . . . 0.6 110.006 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -123.82 25.72 7.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.769 0.319 . . . . 2.32 111.245 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 41.3 m-80 -113.25 -169.61 1.52 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.011 -0.366 . . . . 1.06 110.011 177.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 m -79.56 127.05 79.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.004 0.43 . . . . 0.34 110.83 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.51 127.38 5.73 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.875 2.383 . . . . 0.45 110.806 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.3 p -129.76 148.4 51.64 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.745 -0.382 . . . . 0.31 111.113 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 39.7 t -97.29 110.7 23.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.267 -0.642 . . . . 1.26 109.267 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 50.4 m -97.94 141.16 31.26 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.966 -0.561 . . . . 0.29 110.035 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 1.9 tt0 -74.07 -24.48 59.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.435 0.636 . . . . 1.53 109.358 176.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -163.31 164.38 24.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.109 -0.951 . . . . 1.26 108.688 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.533 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.4 t -138.72 138.72 41.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.566 -0.531 . . . . 1.07 109.566 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 25.3 tt0 -108.72 162.0 14.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.943 -0.571 . . . . 1.87 109.888 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.8 t70 65.27 -152.08 0.26 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.616 -0.512 . . . . 1.94 109.616 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.54 -5.74 31.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.609 0.719 . . . . 2.12 110.042 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.533 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 122.38 23.9 2.29 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.585 -0.734 . . . . 0.51 112.254 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.03 -19.8 28.12 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.95 0.405 . . . . 1.1 110.892 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 42.3 t -124.06 101.14 8.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.1 -0.5 . . . . 0.33 110.145 -174.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.629 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -90.77 138.55 14.44 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.073 -1.06 . . . . 0.26 111.95 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.461 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.9 mp -98.72 117.31 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 109.816 -0.439 . . . . 0.3 109.816 178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 92.2 m-20 62.55 52.89 2.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.348 -0.842 . . . . 0.34 110.579 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.629 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 59.7 m -89.96 105.82 18.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.457 -0.792 . . . . 0.81 111.121 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 56.0 m -93.74 129.36 38.41 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.879 -0.601 . . . . 0.44 110.338 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.3 Cg_exo -60.41 119.57 6.83 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.887 2.391 . . . . 0.39 111.509 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 pt -98.19 145.45 29.83 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.893 -0.594 . . . . 0.57 111.932 -172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -73.77 151.77 46.48 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.303 2.669 . . . . 1.05 111.513 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 70.8 mt -90.25 19.21 5.25 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.802 -0.636 . . . . 1.45 110.115 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 90' ' ' ILE . 19.2 pt . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.553 -0.749 . . . . 2.31 110.954 -173.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 111.536 -0.625 . . . . 5.75 111.536 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.4 p -157.47 150.59 23.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.976 -0.379 . . . . 4.66 109.976 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.77 65.09 3.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.074 -0.584 . . . . 1.6 112.098 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -129.13 152.12 49.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.971 0.415 . . . . 0.81 110.889 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -72.69 108.03 5.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.649 -0.705 . . . . 2.73 110.751 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 m -111.52 15.16 21.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.673 -0.694 . . . . 1.75 109.597 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.81 -33.93 76.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.244 -0.889 . . . . 3.24 111.598 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.9 p -65.87 -24.38 66.85 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.929 -0.578 . . . . 2.05 111.4 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.79 16.24 31.65 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.804 -0.713 . . . . 0.88 111.974 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.7 p -65.88 -32.01 73.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.897 0.38 . . . . 1.72 111.96 -177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.5 t -126.01 141.63 51.88 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.869 -0.332 . . . . 1.19 110.91 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.403 ' OD1' HG23 ' A' ' 13' ' ' THR . 7.2 p30 -93.27 -28.62 16.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.917 -0.583 . . . . 1.66 111.914 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 72' ' ' GLU . 1.8 p -98.18 -20.4 17.31 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.495 . . . . 0.52 112.335 -174.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.63 22.7 55.48 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.659 -0.782 . . . . 0.43 112.559 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 51.9 mttp -115.83 92.02 3.78 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.035 -0.357 . . . . 1.64 110.035 176.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.7 mp -98.36 130.5 45.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.907 0.384 . . . . 0.55 110.767 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -149.9 148.89 29.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.16 -0.473 . . . . 0.29 110.412 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 97.0 m -86.3 100.19 12.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.289 0.566 . . . . 0.74 110.283 175.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 61.5 m -114.3 158.06 21.94 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.665 -0.698 . . . . 0.5 109.834 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 2.5 t70 -99.46 129.2 45.62 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.861 -0.792 . . . . 1.65 108.861 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.9 p -84.74 -1.52 56.37 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.713 -0.395 . . . . 0.52 111.116 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -106.14 -14.29 15.19 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.164 -0.68 . . . . 2.2 109.164 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 29.0 mtpp -97.52 101.92 13.56 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.181 -0.918 . . . . 2.6 109.776 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -96.21 158.63 15.35 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.362 -0.381 . . . . 2.17 110.012 176.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.527 HG22 ' OE1' ' A' ' 48' ' ' GLN . 11.1 t -114.43 147.46 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.322 -0.622 . . . . 0.59 109.322 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -76.67 -27.44 55.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.171 -0.468 . . . . 2.83 111.191 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' H ' HG12 ' A' ' 25' ' ' VAL . 31.5 mmmt -93.21 129.49 39.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.58 -0.526 . . . . 4.07 109.58 177.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.3 m -132.84 32.1 3.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.207 0.527 . . . . 2.46 110.516 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.3 m -75.23 -54.85 6.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.41 -0.814 . . . . 2.0 110.331 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.22 111.8 0.71 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.923 -0.656 . . . . 1.39 112.485 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' A' ' 75' ' ' GLU . 39.6 mt-10 -70.35 -47.69 59.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.411 0.148 . . . . 3.06 110.966 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 74' ' ' VAL . 20.4 mm-40 -70.97 -32.15 68.92 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.715 -0.476 . . . . 2.44 109.715 176.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m -52.76 -36.78 58.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.521 -0.763 . . . . 2.36 111.14 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.42 -25.38 74.81 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.88 -0.676 . . . . 2.54 112.331 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -82.42 -30.0 30.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 3.49 109.742 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 36' ' ' LEU . 4.3 mm? -92.55 -176.97 4.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.361 -0.836 . . . . 4.79 110.086 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -82.49 -11.25 58.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.863 0.363 . . . . 6.59 110.471 176.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -26.62 68.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.323 -0.398 . . . . 5.42 111.813 -176.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.39 -7.44 39.56 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 121.271 -0.49 . . . . 3.27 112.818 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -67.68 -31.27 71.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.12 0.486 . . . . 4.15 110.412 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.8 m -109.95 143.26 20.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.821 -0.627 . . . . 2.58 111.953 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 mt -101.27 8.29 42.54 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.651 -0.704 . . . . 3.5 109.428 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -80.97 -8.14 59.7 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.169 -0.923 . . . . 2.29 110.589 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.614 ' HB3' HG23 ' A' ' 82' ' ' ILE . 32.1 mt-30 -47.05 138.76 6.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.598 -0.728 . . . . 1.4 110.609 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.08 105.55 16.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.159 -0.473 . . . . 1.37 110.075 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -98.45 110.42 23.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.519 -0.764 . . . . 0.3 111.29 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 84' ' ' CYS . 19.8 pt -113.31 148.74 16.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.969 -0.56 . . . . 0.23 110.307 174.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.527 ' OE1' HG22 ' A' ' 25' ' ' VAL . 10.4 tp60 -75.05 132.4 41.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.33 -0.85 . . . . 2.38 109.253 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.0 t -126.55 163.82 22.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.679 -0.691 . . . . 1.15 110.463 -171.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 t -161.2 127.96 4.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.12 0.486 . . . . 0.6 110.111 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -121.13 129.81 53.45 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.067 0.461 . . . . 2.08 111.463 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.1 mt -71.66 137.71 83.09 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.217 -0.902 . . . . 0.95 109.717 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.3 109.29 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.037 3.158 . . . . 0.95 112.371 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.98 140.26 52.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.443 -0.798 . . . . 1.67 112.867 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 85.2 mt -93.2 147.55 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.888 -1.051 . . . . 1.58 108.544 167.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.4 mp -71.73 138.19 22.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.088 0.47 . . . . 2.11 110.276 -177.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.59 5.85 83.63 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.427 -0.806 . . . . 1.03 112.715 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.453 HG21 ' OE2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -93.36 154.29 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.569 0.7 . . . . 0.77 111.343 -177.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.32 134.85 33.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.613 -1.176 . . . . 0.68 111.01 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 61' ' ' GLU . 6.6 tp -50.68 -41.45 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.36 -0.836 . . . . 0.69 111.715 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.428 ' N ' HG23 ' A' ' 60' ' ' ILE . 3.0 pt-20 -74.84 -27.68 60.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.752 -0.658 . . . . 2.2 111.716 -174.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -96.39 -22.33 17.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.349 -0.387 . . . . 1.98 110.698 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.453 ' OE2' HG21 ' A' ' 58' ' ' ILE . 9.0 tp10 -68.22 -36.71 79.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.576 0.703 . . . . 2.09 110.091 177.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 2.9 p -118.82 177.22 4.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.489 -0.778 . . . . 0.6 110.345 -172.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -125.53 40.92 3.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.742 0.782 . . . . 2.32 109.824 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 43.4 m-80 -126.65 -165.58 1.47 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.055 -0.975 . . . . 1.06 108.94 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 12.5 m -87.21 125.79 64.84 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 120.438 -0.505 . . . . 0.34 110.836 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.09 121.88 4.58 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.679 2.253 . . . . 0.45 110.472 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.5 p -129.79 151.57 50.22 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.138 -0.625 . . . . 0.31 111.809 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 12.2 t -99.35 101.58 12.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.297 -0.865 . . . . 1.26 109.105 171.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.642 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 59.8 m -84.99 133.2 34.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.627 0.727 . . . . 0.29 110.076 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 83' ' ' ASN . 65.0 mt-10 -63.46 -40.29 96.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.779 -1.1 . . . . 1.53 109.71 175.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -153.61 166.0 34.15 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.31 -0.859 . . . . 1.26 109.002 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.509 HG13 ' HD3' ' A' ' 15' ' ' LYS . 15.8 m -133.98 160.27 41.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.159 0.504 . . . . 1.07 110.697 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.563 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 33.5 tt0 -129.55 155.03 46.44 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.8 -1.185 . . . . 1.87 107.8 173.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER 67.59 -156.01 0.21 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.565 -0.531 . . . . 1.94 109.565 -172.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.439 ' H ' ' HB3' ' A' ' 76' ' ' ASP . 31.2 t70 -73.11 -3.14 24.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.55 0.69 . . . . 2.12 110.224 173.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 121.27 22.94 2.76 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.793 -0.64 . . . . 0.51 111.615 -175.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.4 mt -86.05 -15.78 40.23 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.261 0.553 . . . . 1.1 109.955 175.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 75' ' ' GLU . 73.5 t -123.32 112.86 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.37 -0.832 . . . . 0.33 108.922 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -106.82 137.06 13.72 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.011 -1.09 . . . . 0.26 112.238 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -99.55 120.71 49.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 122.437 0.295 . . . . 0.3 110.454 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 95.6 m-20 59.16 44.07 16.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.537 -0.756 . . . . 0.34 110.997 173.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.553 ' HB2' HD11 ' A' ' 47' ' ' ILE . 45.1 m -77.85 105.11 8.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.387 -0.824 . . . . 0.81 110.864 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 85.7 m -89.35 125.42 61.8 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.986 -0.552 . . . . 0.44 110.13 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 35.2 Cg_exo -62.67 121.97 10.12 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.751 2.301 . . . . 0.39 111.694 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.8 pt -92.44 144.83 29.46 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 116.199 -0.455 . . . . 0.57 110.318 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.3 155.0 72.38 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.008 2.472 . . . . 1.05 112.073 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.94 19.88 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.022 -0.535 . . . . 1.45 110.836 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.44 HG13 ' OXT' ' A' ' 90' ' ' ILE . 29.6 pt . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.202 -0.904 . . . . 2.31 110.604 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 111.751 -0.54 . . . . 5.75 111.751 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 p 45.85 65.46 1.15 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.474 0.71 . . . . 4.66 112.454 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.23 109.75 2.93 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.213 -0.755 . . . . 1.6 111.213 176.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -83.6 164.49 19.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.3 0.571 . . . . 0.81 111.985 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -82.6 109.43 16.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.107 -0.952 . . . . 2.73 111.092 -177.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 t -105.83 28.76 7.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.729 -0.669 . . . . 1.75 109.324 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -26.09 30.73 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.44 -0.8 . . . . 3.24 112.791 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.6 m -78.19 -14.06 59.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.159 0.504 . . . . 2.05 111.003 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.42 16.53 68.63 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.357 -1.497 . . . . 0.88 109.357 -168.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.475 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 2.1 p -69.81 -30.82 68.43 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.887 -1.157 . . . . 1.72 112.775 -169.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.2 t -126.02 143.31 51.15 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.541 -0.464 . . . . 1.19 111.26 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.519 ' OD1' HG23 ' A' ' 13' ' ' THR . 8.4 p30 -92.04 -29.16 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.005 -0.543 . . . . 1.66 111.425 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.519 HG23 ' OD1' ' A' ' 12' ' ' ASN . 22.4 p -97.48 -31.02 12.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.006 0.432 . . . . 0.52 111.97 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.64 2.74 58.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.826 -0.702 . . . . 0.43 111.582 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 71' ' ' CYS . 41.2 mttp -90.89 88.27 6.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.753 0.311 . . . . 1.64 110.376 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.95 122.04 38.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.42 -0.355 . . . . 0.55 110.091 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.549 ' HB1' ' SG ' ' A' ' 49' ' ' CYS . . . -131.25 146.1 52.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.73 0.3 . . . . 0.29 110.58 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 50' ' ' THR . 35.4 m -85.18 98.38 10.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 0.74 109.89 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 49' ' ' CYS . 65.3 m -116.76 157.91 24.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.433 -0.349 . . . . 0.5 111.462 -168.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.591 ' CB ' ' HD3' ' A' ' 23' ' ' LYS . 50.3 m-20 -102.76 112.86 25.84 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.183 -0.673 . . . . 1.65 109.183 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.8 p -74.81 -15.88 60.72 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.388 0.514 . . . . 0.52 112.388 -172.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -98.59 -0.4 43.21 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.764 0.792 . . . . 2.2 109.422 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HD3' ' CB ' ' A' ' 20' ' ' ASP . 35.4 mtpt -112.74 100.95 9.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.564 -1.198 . . . . 2.6 109.685 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.83 161.81 13.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.735 -0.666 . . . . 2.17 111.554 -174.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -127.79 142.31 44.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.045 -1.094 . . . . 0.59 108.045 173.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -90.94 -23.82 20.35 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.789 0.328 . . . . 2.83 111.201 -173.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 28.8 mmmt -103.48 119.78 39.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.112 0.482 . . . . 4.07 111.284 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.531 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 15.4 p -126.42 120.66 30.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.578 -0.737 . . . . 2.46 109.624 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.5 m -88.39 -54.33 4.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.548 -0.296 . . . . 2.0 110.575 -176.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.22 70.38 1.1 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.586 -0.816 . . . . 1.39 111.173 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 22.9 mt-10 -78.94 -27.68 43.64 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.636 0.236 . . . . 3.06 111.636 -174.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -99.13 -37.76 9.2 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.51 -0.476 . . . . 2.44 110.497 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.428 ' HB2' ' HB ' ' A' ' 38' ' ' THR . 26.8 p -64.9 -31.05 72.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.177 -0.465 . . . . 2.36 109.807 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' HA2' ' CA ' ' A' ' 39' ' ' GLY . . . -68.68 -31.55 73.46 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.636 -0.711 . . . . 2.54 112.27 176.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 97.3 mt -71.67 -34.3 69.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.296 0.569 . . . . 3.49 109.591 175.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.3 mt -76.57 -178.31 4.65 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.288 -0.869 . . . . 4.79 109.937 174.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -71.82 -1.98 16.09 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.954 0.407 . . . . 6.59 111.005 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 6.2 m -80.78 -2.44 47.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.104 -0.498 . . . . 5.42 111.25 -177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' CA ' ' HA2' ' A' ' 34' ' ' GLY . . . -69.15 -14.85 69.09 Favored Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.669 -0.777 . . . . 3.27 112.639 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.55 -31.61 53.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.135 0.42 . . . . 4.15 112.135 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 m -85.47 135.49 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.521 0.677 . . . . 2.58 112.012 -174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 59.9 tp -109.18 -2.06 18.28 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.185 -0.916 . . . . 3.5 109.005 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.54 -8.17 54.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.114 -0.948 . . . . 2.29 110.851 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' HB3' HG23 ' A' ' 82' ' ' ILE . 96.2 mt-30 -44.08 143.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.823 -0.626 . . . . 1.4 111.476 173.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.96 119.53 62.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.643 -0.708 . . . . 1.37 110.024 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -100.45 124.99 46.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.962 -0.563 . . . . 0.3 110.899 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 84' ' ' CYS . 18.2 pt -118.93 152.11 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.127 0.489 . . . . 0.23 110.346 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.05 127.7 33.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.556 -0.905 . . . . 2.38 108.556 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.622 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 4.5 t -133.71 169.1 17.53 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.848 -0.614 . . . . 1.15 110.418 -170.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 11.7 t -160.02 137.04 9.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.072 0.463 . . . . 0.6 110.304 178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.27 132.82 55.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.001 0.429 . . . . 2.08 110.1 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.401 HG23 ' HD2' ' A' ' 53' ' ' PRO . 37.2 mm -80.71 144.97 57.14 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.95 110.468 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' HG23 ' A' ' 52' ' ' ILE . 2.7 Cg_exo -37.26 126.75 0.58 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.039 3.16 . . . . 0.95 113.345 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.88 123.71 17.89 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.258 -0.883 . . . . 1.67 113.121 -171.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.7 mt -108.72 129.41 55.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.272 -0.876 . . . . 1.58 109.289 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 56' ' ' ILE . 3.2 mp -69.55 135.73 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.169 0.509 . . . . 2.11 110.7 -176.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.1 11.02 81.71 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.308 -0.86 . . . . 1.03 113.178 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.496 HD13 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -106.07 154.05 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.618 0.723 . . . . 0.77 112.326 -176.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.43 145.87 24.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.402 -1.272 . . . . 0.68 111.215 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 61' ' ' GLU . 7.2 tp -53.22 -43.39 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 122.866 0.466 . . . . 0.69 111.229 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' N ' HG23 ' A' ' 60' ' ' ILE . 8.5 pt-20 -74.33 -22.05 59.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.118 -0.492 . . . . 2.2 111.238 -175.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -90.48 -34.55 15.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.334 0.588 . . . . 1.98 109.753 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -67.9 -35.21 78.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.066 -0.97 . . . . 2.09 110.592 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.0 p -121.82 172.13 8.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.802 -0.635 . . . . 0.6 110.337 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -120.7 21.42 11.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 2.32 111.416 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.534 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 38.6 m-80 -104.12 -168.14 1.45 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.474 -0.565 . . . . 1.06 109.474 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -85.95 120.89 72.97 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-O 121.495 0.664 . . . . 0.34 111.465 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.83 122.52 9.9 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.353 2.702 . . . . 0.45 111.219 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.8 p -132.43 154.86 49.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.699 -0.228 . . . . 0.31 110.633 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 11.8 t -99.72 117.07 33.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.462 -0.57 . . . . 1.26 109.462 171.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 46.6 m -102.46 139.51 37.96 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.119 0.485 . . . . 0.29 109.748 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 6.6 tt0 -78.03 -20.88 51.6 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 121.512 0.673 . . . . 1.53 109.724 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.401 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . 22.8 t0 -159.34 158.96 33.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.325 -0.991 . . . . 1.26 108.325 171.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.496 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 0.6 OUTLIER -148.65 129.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 117.852 0.297 . . . . 1.07 110.465 178.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -91.51 165.91 13.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.731 0.301 . . . . 1.87 110.591 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.82 -150.16 0.31 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.587 -0.733 . . . . 1.94 110.24 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.94 5.08 14.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.96 0.409 . . . . 2.12 110.141 172.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' A' ' 49' ' ' CYS . . . 118.57 24.04 3.25 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.665 -0.779 . . . . 0.51 112.691 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.06 -21.29 29.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.05 0.425 . . . . 1.1 111.534 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.08 102.79 8.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.891 -0.411 . . . . 0.33 109.891 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 46' ' ' ALA . . . -102.34 139.76 14.56 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.455 -0.879 . . . . 0.26 112.966 -176.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.426 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.7 mp -96.0 120.95 46.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 122.737 0.415 . . . . 0.3 109.905 178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 95.5 m-20 60.76 48.62 6.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.525 -0.761 . . . . 0.34 110.975 173.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.622 ' HB2' HD11 ' A' ' 47' ' ' ILE . 57.4 m -83.1 111.42 18.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.619 -0.718 . . . . 0.81 110.564 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 24.7 m -105.29 128.11 27.27 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.704 -0.68 . . . . 0.44 109.918 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 85' ' ' THR . 31.9 Cg_exo -59.95 125.33 17.39 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.976 2.451 . . . . 0.39 112.099 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.475 ' CG2' ' HB2' ' A' ' 10' ' ' SER . 16.2 pt -96.49 162.45 23.4 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 115.55 -0.75 . . . . 0.57 111.107 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.17 149.41 51.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.237 2.624 . . . . 1.05 112.176 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.05 33.53 1.34 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.652 -0.704 . . . . 1.45 110.137 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.266 -0.874 . . . . 2.31 111.443 -172.346 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.016 -0.434 . . . . 5.75 112.016 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 t 61.05 37.13 18.14 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.384 0.611 . . . . 4.66 110.533 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.15 -121.84 0.63 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.705 -0.679 . . . . 1.6 111.624 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.466 ' CZ2' HD22 ' A' ' 54' ' ' LEU . 49.1 m95 -141.74 166.95 23.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.899 0.38 . . . . 0.81 111.219 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.556 ' OE2' ' HD2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -65.77 108.25 2.05 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.629 -0.878 . . . . 2.73 108.629 175.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 m -106.75 28.21 8.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.968 -0.56 . . . . 1.75 112.344 -167.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.556 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -50.35 -25.24 3.62 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.834 0.679 . . . . 3.24 112.834 -177.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 t -71.76 -28.66 63.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 2.05 111.733 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.81 1.44 54.62 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.173 -0.537 . . . . 0.88 113.226 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -77.33 -15.89 59.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.773 0.286 . . . . 1.72 111.773 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.59 139.96 38.19 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.577 -0.449 . . . . 1.19 110.206 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.65 HD22 ' N ' ' A' ' 13' ' ' THR . 0.4 OUTLIER -94.54 -21.73 18.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.748 0.648 . . . . 1.66 112.748 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.65 ' N ' HD22 ' A' ' 12' ' ' ASN . 2.0 p -104.41 -30.89 9.79 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.229 0.455 . . . . 0.52 112.229 -174.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.47 -3.27 59.43 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.612 -0.804 . . . . 0.43 111.999 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.599 ' NZ ' ' HA ' ' A' ' 73' ' ' ASP . 90.4 mttt -87.91 88.07 7.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.095 0.474 . . . . 1.64 109.967 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -93.53 103.07 15.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.865 -0.607 . . . . 0.55 110.189 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.41 154.06 28.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.105 0.478 . . . . 0.29 110.752 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.575 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 65.6 m -88.94 103.62 16.2 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.611 -0.722 . . . . 0.74 109.179 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -125.44 150.72 47.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.057 0.456 . . . . 0.5 112.037 -170.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.87 104.24 16.32 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.619 -0.719 . . . . 1.65 110.321 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.473 HG21 ' HG3' ' A' ' 86' ' ' PRO . 74.4 p -72.48 -5.79 39.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.078 0.466 . . . . 0.52 111.327 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -96.91 -22.68 16.73 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.846 0.831 . . . . 2.2 109.013 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 48' ' ' GLN . 27.5 tptt -106.88 110.98 23.29 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.245 -1.343 . . . . 2.6 109.895 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -100.93 161.88 13.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.428 -0.806 . . . . 2.17 111.861 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 t -126.2 148.0 30.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.236 -0.893 . . . . 0.59 108.807 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -97.93 22.14 9.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.821 0.343 . . . . 2.83 111.419 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -134.45 119.93 19.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.222 -0.444 . . . . 4.07 110.119 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 73.5 p -140.85 86.09 2.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.909 0.385 . . . . 2.46 110.528 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.1 m -108.28 -47.66 3.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.24 0.543 . . . . 2.0 110.203 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.69 164.02 34.16 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.251 -0.886 . . . . 1.39 112.739 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 21.9 mm-40 -101.78 -45.19 5.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.065 0.46 . . . . 3.06 109.915 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.28 -40.92 11.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.829 -0.623 . . . . 2.44 109.78 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 37' ' ' HIS . 68.8 m -83.71 3.02 34.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.036 -0.529 . . . . 2.36 109.968 172.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.5 -38.56 87.89 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.718 -0.674 . . . . 2.54 113.536 -176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.55 -62.95 1.26 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.891 0.377 . . . . 3.49 110.255 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.8 tp -113.59 94.63 4.94 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.194 -0.457 . . . . 4.79 110.316 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.571 ' HB3' ' O ' ' A' ' 33' ' ' SER . 8.2 p80 -114.76 -46.43 2.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.513 -0.312 . . . . 6.59 111.423 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.4 m -66.01 -33.25 75.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.988 0.423 . . . . 5.42 111.241 -174.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.28 -11.67 75.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 3.27 112.165 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -101.87 -51.73 3.35 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.644 -0.502 . . . . 4.15 109.644 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.22 138.6 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.495 -0.775 . . . . 2.58 111.922 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.4 tp -106.08 -7.03 18.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.01 0.91 . . . . 3.5 109.031 172.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.94 1.73 51.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.902 -1.044 . . . . 2.29 111.375 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.548 ' HB3' HG23 ' A' ' 82' ' ' ILE . 27.6 mt-30 -48.29 133.56 15.61 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.236 0.541 . . . . 1.4 111.182 -178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.776 HG12 ' HA ' ' A' ' 83' ' ' ASN . 14.7 p -105.66 127.92 60.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.413 -0.812 . . . . 1.37 110.163 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 81' ' ' GLY . . . -107.82 121.86 45.59 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.36 -0.836 . . . . 0.3 110.379 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.569 HD11 ' HB2' ' A' ' 84' ' ' CYS . 19.1 pt -130.7 160.8 41.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.891 -0.595 . . . . 0.23 109.697 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 1.5 mm-40 -77.34 135.76 38.4 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.504 0.668 . . . . 2.38 110.642 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.6 m -131.11 153.57 49.21 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.453 -1.248 . . . . 1.15 110.146 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 8.4 t -156.56 128.34 7.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.083 0.468 . . . . 0.6 110.038 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 tm0? -120.87 110.62 16.53 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.989 0.424 . . . . 2.08 110.515 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mt -65.73 128.94 94.19 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.619 -0.719 . . . . 0.95 109.889 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -34.0 99.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 125.128 3.885 . . . . 0.95 113.531 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.466 HD22 ' CZ2' ' A' ' 4' ' ' TRP . 3.3 pp -70.29 136.89 50.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.851 -1.068 . . . . 1.67 112.393 -172.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.4 mt -94.95 120.6 35.43 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.494 -0.928 . . . . 1.58 108.494 168.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.06 133.09 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.361 0.601 . . . . 2.11 111.081 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.43 -24.96 22.99 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.085 -0.962 . . . . 1.03 111.478 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 63' ' ' GLU . 0.3 OUTLIER -87.06 155.03 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.466 0.65 . . . . 0.77 111.107 -179.434 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.85 143.94 26.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.666 -1.152 . . . . 0.68 111.624 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 tp -54.71 -35.25 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.018 -0.992 . . . . 0.69 110.974 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -76.79 -16.8 59.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.069 -0.969 . . . . 2.2 111.701 -173.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.33 -24.5 11.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.09 0.471 . . . . 1.98 110.704 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 8.8 tp10 -74.93 -38.04 61.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.848 -0.615 . . . . 2.09 111.1 -175.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.4 p -113.61 173.14 6.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.251 -0.277 . . . . 0.6 110.251 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -118.84 46.19 1.91 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.221 0.534 . . . . 2.32 110.699 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 42.4 m-80 -135.39 -174.16 3.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.822 -0.626 . . . . 1.06 109.331 175.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.6 m -80.35 125.29 81.46 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-O 121.403 0.62 . . . . 0.34 111.786 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -63.05 115.52 3.01 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.339 2.693 . . . . 0.45 110.998 171.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.3 p -127.26 143.32 51.26 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.322 -0.551 . . . . 0.31 111.265 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 36.0 t -93.27 106.19 18.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 1.26 109.68 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 57.1 m -92.73 134.0 35.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.156 -0.474 . . . . 0.29 109.959 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -64.9 -36.08 83.21 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.206 -0.665 . . . . 1.53 109.206 175.154 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.599 ' HA ' ' NZ ' ' A' ' 15' ' ' LYS . 40.3 t0 -152.25 165.55 34.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.368 -0.975 . . . . 1.26 108.368 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.502 ' CG1' ' HA2' ' A' ' 78' ' ' GLY . 2.2 t -136.48 133.55 49.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.633 -0.506 . . . . 1.07 109.633 175.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 31' ' ' GLU . 16.1 tt0 -102.94 164.69 11.47 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.139 -0.482 . . . . 1.87 109.701 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 78' ' ' GLY . 1.8 m-20 63.67 -156.52 0.32 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.272 0.357 . . . . 1.94 110.156 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.45 23.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.895 0.379 . . . . 2.12 110.882 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' HA2' ' CG1' ' A' ' 74' ' ' VAL . . . 95.7 22.62 20.66 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.949 -0.643 . . . . 0.51 111.777 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.401 ' HB3' HE22 ' A' ' 48' ' ' GLN . 81.7 mt -90.21 -18.68 25.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 1.1 111.247 -177.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.9 t -131.69 109.98 16.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.772 -0.455 . . . . 0.33 109.772 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' HA3' ' SG ' ' A' ' 84' ' ' CYS . . . -97.04 144.83 17.58 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.28 -0.962 . . . . 0.26 112.382 -177.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' A' ' 44' ' ' GLN . 1.8 mp -100.77 120.83 50.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.866 -0.42 . . . . 0.3 109.866 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.776 ' HA ' HG12 ' A' ' 45' ' ' VAL . 89.4 m-20 58.46 53.76 6.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.026 -0.534 . . . . 0.34 110.807 175.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.596 ' SG ' ' HA3' ' A' ' 81' ' ' GLY . 66.8 m -89.36 95.44 10.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.728 -0.669 . . . . 0.81 110.94 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 8.0 m -88.18 127.25 57.97 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.718 -0.674 . . . . 0.44 110.732 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.473 ' HG3' HG21 ' A' ' 21' ' ' THR . 39.7 Cg_exo -62.57 118.01 4.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.896 2.397 . . . . 0.39 111.63 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 6.6 pt -97.98 148.45 34.49 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.925 -0.579 . . . . 0.57 111.558 -174.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 20.4 Cg_exo -69.86 161.12 47.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.355 2.703 . . . . 1.05 111.872 175.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.0 mt -93.55 22.61 5.24 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.744 -0.662 . . . . 1.45 110.693 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.9 pt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.472 -0.775 . . . . 2.31 110.973 -174.063 . . . . . . . . 0 0 . 1 stop_ save_